
(IN-PACKAGE :SP)
(DEFPARAMETER SPARSER::*NS-RD-PHASE3-15301-15600*
  '(".142delA" ".5030_5033delCTAA" "A-24" "A-Bora" "A-P50" "A-loop"
    "A-phosphorylatable" "A-tailed" "A1" "A1-G-C-G" "A1298C" "A133S" "A146T"
    "A18D" "A19P" "A1c" "A2" "A2-G-C-G" "A20" "A2780DX5" "A3F" "A3G-HA" "A4"
    "A502-Y503dup" "A533D" "A549-p53-shRNA" "A55T" "A72T" "A91R" "AA1–304"
    "AA305–710" "AAVS1" "ABC294640" "ABCCC" "ABD-N" "ABH" "ABI7900HT"
    "ABL1-positive" "ABSciex" "ABT-700" "ABT-737-resistant" "ABT-R"
    "ACGACCTCAACGCACAGTACG" "AD-like" "ADAMT6S" "ADAMTS" "ADH#3" "ADH-adjacent"
    "ADHD" "ADHs" "ADLH" "ADLH1-MGMT" "AE" "AFF4" "AGC" "AGCTGCGTTTCACCAGGG"
    "AGCTs" "AHNMD" "AI-100" "AI@75" "AIC" "AID-3xFLAG" "AID-HA"
    "AIM2-inflammasome" "AIM2-like" "AJCC" "AKRs" "AKT-Myr" "AKT1‐specific"
    "AKT2_WT" "AKT2in" "ALKBHs" "ALRs" "AM" "AMPK-CA" "AMPK-mTOR-autophagy"
    "AMPK-upstream" "ANLN" "AP-1-Luc" "AP-endonuclese" "AP-site" "AP20"
    "AP24534" "APC-CDH1-mediated" "APC9-11" "APK-1" "AR-FL" "AR-V" "AR-V-null"
    "AR-V7-CHIP" "AR-V7-Mdm2" "AR-V7-TurboFP635" "AR-Vs" "AR-Vs-expressing"
    "AR-Vs." "AR-null" "ARDAs" "ARE-Luciferase" "ARE-like" "ARE-luciferase"
    "ARF-dependent" "ARF–Mdm2–p53pathway" "ARF–p53-independent" "ARIC" "ARQ"
    "ARQ-197" "ARQ197" "ARV7" "ASC-PYD" "ASCO" "ASLXL1" "AT-001" "AT-MSCs"
    "AT-hMSCs" "ATB-263" "ATFs" "ATG19" "ATG22" "ATM-S1981" "ATM-ser1981"
    "ATP-competitive" "ATR-dependent" "ATR-mediated" "ATR-pS435" "ATSP"
    "ATSP-7041" "ATTG" "AUCUGUAAGAGAAAGUAAAUGA" "AV-951" "AVM" "AXXS"
    "AZ+CCND1" "AZ+ODC" "AZ+ODC+CCND1" "AZ-CCND1" "AZD" "AZD-2281" "AZU1"
    "Abbas" "Abcam" "Ac-H3" "Ac-H3K9" "Ac-H4" "Ac-H4K16" "Ac-RHK-K" "Ac-pRb"
    "Ac-peptide" "Act-GAL4" "Ad" "Ad-ACA" "Ad-p63α" "Ad-p63γ" "Ad-p73α"
    "Ad-p73β" "AdBach" "AdBach1" "AdBach1-HUVECs" "AdGFP" "AdGFP-HMVECs"
    "AdGFP-HUVECs" "Adenosyl" "Aegypt" "Affymetrix" "Africa" "African"
    "African-American" "African-Americans" "Afro-Americans" "Afshari" "Ag"
    "Agapova" "Age-dependent" "Ahn" "AiX" "Akt-Myr" "Akt-dependent"
    "Akt-mediated" "Akt8" "Akti‐2" "Alba" "Alli" "AlphaScreen" "Altas"
    "Altieri" "Altieri's" "Alu-PCR" "Alzheimer" "Alzheimer's" "Alzheimer’s"
    "America" "Amish" "Amplex" "Analogy" "Anderson" "Andrew" "Andrulis"
    "Aneurysms" "Aneurysms-osteoarthritis" "AngII" "AngIIstimuli" "AngII "
    "Angeles" "Antibody-drug" "Antonarakis" "Arg1175" "Arg1809Cys‐positive"
    "Arg1809‐missense" "Arg1809‐positive" "Arg72Pro" "Arnold" "Arnold‐Chiari"
    "Artandi" "Asclepiadaceae" "Ashkenazi" "Asian" "Asians" "Asp641–Arg646"
    "Asperger" "Asslaber" "Atadja" "Atg8–PE" "Atlanta" "Ato488" "Atto"
    "Atto488–Grb2" "Atto550–Grb2" "AuNP" "AuNPs" "Aust" "Australia" "Austria"
    "AutoDock" "Avg" "AxxxG" "Aβ" "A–S2C" "A–activating" "B-29" "B-MCAK"
    "B-PLK1" "B-PLK1-MCAK" "B-elicited" "B-leukemic" "B-lineage" "B-lymphoma"
    "B-mediated" "B-orchestrated" "B-precursor" "B-vitamin" "B1" "B1-8" "B2"
    "B3" "B42-HDACs-GBD" "B42AD" "B8" "BA2347-2" "BALB" "BALF" "BAPTA-AM"
    "BAR-Venus" "BARC" "BATTLE" "BBF2H7" "BC" "BC-1382" "BC014369" "BC017935"
    "BC10" "BC111" "BC117" "BC121" "BC132" "BC134" "BC140" "BC142" "BC143"
    "BC152" "BC155" "BC161" "BC164" "BC171" "BC175" "BC19" "BC190" "BC20"
    "BC204" "BC205" "BC21" "BC228" "BC24" "BC28" "BC30" "BC32" "BC37" "BC39"
    "BC52" "BC58" "BC6" "BC7" "BC73" "BC76" "BC81" "BC85" "BC87" "BC88" "BC90"
    "BC99" "BCA" "BCR-ABL1" "BCRs" "BCSC" "BCSCs" "BCVA" "BCoR" "BD" "BETTAIEB"
    "BF693624" "BG-12" "BH3-Only" "BH3-only" "BH3mini" "BI2356" "BIAcore" "BJ"
    "BLBCs" "BLOC-1" "BMS" "BMS-777607" "BO" "BO-1055" "BO-1055or" "BOSTER"
    "BOX-S2" "BP-203PRE-III" "BPBD" "BPTES" "BRAF-chemotherapy" "BRAF-dn"
    "BRAF-inhibitor–induced" "BRAF-wt" "BRCA1+CHK2" "BRCA1+γH2AX"
    "BRCA1-IFI16+EdU" "BRCA1-IFI16+EdU+DAPI" "BRCA1-Si-RNA-transfected"
    "BRD4-CDK9-F" "BRD4-P-TEFb" "BRD4-like" "BRD4∆PID" "BRDT"
    "BS-BLM-CDA-siBLM" "BS-BLM-CDA-siCDA" "BSCS" "BUNCH" "BUZ" "BV02"
    "BX646932" "Bach1-V5" "Bach1siRNA" "Bach1siRNA-HUVECs" "Back-tracking"
    "BafA1" "Bago" "Balachandran" "Balb" "Baldelli" "Balducci" "Balkan"
    "Bannykh" "Barger" "Barok" "Barok's" "Barr" "Batagov" "Bavaria" "BaxBH3"
    "BaxI66AΔC21" "BaxS184L" "BaxΔC" "BaxΔC21" "BaxΔC26" "BaxΔC28" "Bayatti"
    "Bc-CspB" "Bc1-2" "Bcl" "Bcl-2-family" "Bcl-xl" "BeSD" "BeadChip" "Becker"
    "Becton" "Begg" "Begg’s" "Beghé" "Bel-7402" "Belarus" "Belgium" "Bella"
    "Bellizzi" "Bendavia" "Bertola" "Bethesda" "Betz" "Beuege" "Beutler"
    "BeyoECLPlus" "Beyotime" "Bi" "Bi-miR-34a" "Bi-miR-34a-binding"
    "Bi-miR-34a-transfected" "Bi-miR-control" "Bi-miRNA-control" "Bic-C"
    "BidBH3" "Bignami" "BimBH3mini" "Bio" "Bio-Plex" "Bio-Rad" "Bio-Synthesis"
    "Bio-informatic" "BioWest" "Bioanalyzer" "Biocarta" "Biogen" "Biol"
    "Biologicals" "Bioplex" "Biosystems" "Biotinylated-S1P"
    "Biotinylated-S1P-bound" "Bischoff" "Blasiak" "Blau" "Blazo" "Bletri"
    "Bloomington" "Bolli" "Boltzmann" "Bolukbasi" "Bonferroni" "Bora"
    "Borealin" "Bortoluzzi" "Boyden" "Boyden-chamber" "Boyles" "BrMC" "Braak"
    "Brannen" "Brazil" "Breakpoint" "Breitenstein" "Brems" "Brennecke"
    "Breslow-Day" "Bright-field" "Brinkman" "Browser" "Bruni" "Bs" "Bs-CSP"
    "Bs-CspB" "BsmI" "Bufo" "Bulgaria" "Burkitt" "Byfield" "B–Cdk1" "B–P100"
    "C-C" "C-Cdh1" "C-allele" "C-bio" "C-end" "C-erbB-2" "C-glucose" "C-lobe"
    "C-lobes" "C-pocket" "C-r" "C-related" "C-rich" "C-strand" "C-terminally"
    "C-type" "C-variant" "C1" "C1-15" "C10orf128" "C10orf55" "C10orf90" "C2"
    "C2-DLC1" "C2-T319" "C2-T319A" "C2-T319Y" "C2-T321A" "C2-T323A" "C229A"
    "C232A" "C2orf44-ALK" "C3" "C3-O-CH3-S1P" "C3-exoenzyme" "C3T" "C4" "C57"
    "C57BL6" "C667" "C696" "C7-14" "C751" "C781" "C8orf87" "CA12-promoter"
    "CAAT" "CAB016217" "CACATG" "CACGTG" "CAD-dependent" "CAGATG" "CAH" "CAL62"
    "CANNTG" "CAP" "CASQ2" "CBB" "CBEPA" "CBF-AML" "CBF-β" "CBF-β-associated"
    "CBFA2T3" "CBLB502" "CCAAT" "CCCTGATTTGGAGGTGCAGAACC" "CCD-18co" "CCND"
    "CCND2m" "CCNE" "CCR4–NOT" "CCR4–NOT-mediated" "CCTα" "CD-fed" "CD14+ve"
    "CD1CD2" "CD2-1" "CD2-2" "CD28-activated" "CD28-stimulated" "CD28T" "CD301"
    "CD3γ" "CD3γε" "CD4-mediated" "CD4T" "CD4WT" "CDA-defective"
    "CDA-proficient" "CDC2A" "CDDO-Im" "CDK12-F" "CDK13" "CDK2-fluspirilene"
    "CDK4,6" "CDK7tide" "CDK9-F" "CDK9-regulatory" "CDKL5" "CDS-MRE" "CEBPα"
    "CEM-C7-14" "CENTIPEDE" "CEP152-dependent" "CEP17" "CEP7" "CETSAs" "CEU"
    "CFSs" "CFU-EryP" "CFU-Mac" "CGC" "CGGGTCCCCGGCCCAGCCCC" "CGI" "CGIs"
    "CH5183284" "CHDs" "CHIP" "CHIP-qPCR" "CHIR" "CIBMTR" "CINI" "CINI-III"
    "CL" "CL+CL" "CLP" "CM-AVM" "CMML" "CNL" "CNOT" "CNV1152.1" "COG" "COIV"
    "COLO" "COLO-320–hMSC" "CONFIRM-1" "CONSORT" "COSM1462578" "COSMIC428080"
    "COX17" "COXIV" "CP690550" "CPEB4" "CRCT" "CREB3-H" "CREBtide" "CREB‑H"
    "CREB‑HΔTMC" "CRISPR" "CRISPR-Cas9" "CRISPR-Cas9-transfected" "CRISPRCas"
    "CRISPRCas9-transfected" "CRKI" "CRKII" "CRKIII" "CRM1p" "CReP" "CReP’s"
    "CSC-like" "CSCCs" "CSSCs" "CTC1" "CTT" "CVFLVPKSKKPDVKKN" "CXCL12-induced"
    "CXCL17" "CXCR3-B" "CXXC" "CaCl" "CaMKIIγ" "Cal" "Camilli" "Camptotheca"
    "Cap-independent" "Carbamoyl-phosphate" "Carbon-13" "Caribbean" "Carlo"
    "Carmi" "Carney" "Carney-Stratakis" "Carolina" "Caron" "Case-control"
    "Case–control" "Caspase3" "Casy" "Catharanthus" "Caucasians" "Cauchy"
    "Cav-1s" "Cd-induced" "Cd-mediated" "Cd-treated" "Cdc42" "Cdk2-dependent"
    "Cdk2-mediated" "Cd–induced" "Cell-cycle-associated" "CellTiter" "Cen"
    "Cen-8" "Cenp" "Cenp-T" "Ch" "Ch10" "Ch17" "ChIP" "ChIP-Array" "ChIP-PED"
    "ChIP-Seq" "ChIP-data" "ChIP-peaks" "ChIP-qPCR" "ChIP-signal"
    "ChIP-signals" "ChIP–qPCR" "ChR" "Cha" "Chan" "Chang" "Chatterjee"
    "Chaturvedi" "Cheng-Yi" "Cheung" "Chevillet" "Chi-Square" "Chi-square"
    "Chiari" "Chiba" "Chicago" "Chintala" "Chiu" "Chks" "Chks-Cdc25C"
    "Chonglei" "Choo" "Chou" "Cip1" "Cipriano" "CldU" "CldU-IdU" "Cleopatra"
    "Clin" "Clurman" "Cnossen" "Co" "CoMRe" "CoQ" "Coarse-grained" "Codd"
    "Cohen" "Cohen’s" "Colin" "College" "Collins" "Colα1" "Comm"
    "Competing-Networks" "Compusyn" "Con1b" "Congo" "ConsiRNA"
    "ConsiRNA-HUVECs" "Cooke" "Coomassie" "Copetti" "Craig" "Croatia" "Crohn"
    "Crohn’s" "Cross-Complementation" "Cross-talking" "Cruz" "CspB" "Ct" "Cu"
    "Cu-dependency" "CuSO" "CuZn" "CuZn-superoxide" "Cuervo" "Cxs" "Cyline"
    "Cys151–Cys151" "Cys340–Cys385" "Cys–S" "CytoMeter" "CytoSNP"
    "CytoSNP-850k" "Czech" "Cɛ" "C‐terminal" "C–1E" "C–5E" "C–C"
    "D-erythro-3-O-methyl" "D-type" "D-β-hydroxybutyrate" "D1Z9C" "D2" "D21A"
    "D3" "D4" "D816V" "DAAs" "DAC+DASA" "DAGIA" "DAMP" "DAMPs" "DARPin"
    "DARPins" "DAUP" "DAVID" "DCIS-like" "DCISs" "DCP2-DDX6-dependent" "DDFS"
    "DDGFDSDSSLSDSD" "DESeq" "DExD" "DF" "DFG-Phe-out" "DFG-in" "DFG-out" "DHA"
    "DHEA-S" "DHS" "DHSs" "DIV14" "DKs" "DKs-8" "DKs-8-recipient" "DLD1" "DMR"
    "DMRA2" "DNA-FISH" "DNA-ICL" "DNA-SCARS" "DNA-binding"
    "DNA-oligonucleotide-based" "DNA-protein" "DNA–protein" "DNP-PKcs"
    "DNase-seq" "DNase2TF" "DNaseI" "DOI" "DOT1L+HRAS" "DOX-inducible"
    "DOX-supplemented" "DP-2976" "DP-4851" "DPKcs" "DR-GFP" "DSBs" "DSGIS"
    "DSGISE" "DSGX" "DUS3L" "DYRK1A-a" "Dam-Myb" "DamID" "Damaj" "Danish"
    "Danlos" "Danxia" "Dasra" "Datesets" "Dcp2-3XFLAG" "Deardorff" "Debio"
    "Deilich" "Del19" "Denmark" "Dermatophagoides" "Descheemaeker" "Deup1"
    "Dev" "Dex" "Dhh1-mediated" "Diaminedichloroplatinum" "Dichlorophenoxy"
    "Dichroa" "Dickenson" "Dictyostelium" "Didiano" "Dietz" "DiffBind" "Dil"
    "Dil-OxLDL" "Dillies" "DiscoveRx" "Disk-60" "Djavaheri-Mergny" "Dks-8"
    "Doehn" "Dojindo" "Donehower" "Dong" "Dose-response" "Dot-blot" "Dox"
    "Dox-treatment" "Doxo" "DpSGX" "Drobnjak" "Drosophilla" "DrugBank"
    "Dulbecco" "Dulbecco's" "Dulić" "Dummer" "Dunn" "Dunn-Bonferroni" "Duolink"
    "Durando" "Dutch" "Dyrk" "Dysbindin-1A-NLS-EGFP" "E-64d" "E-box" "E-boxes"
    "E-expressing" "E-medium" "E-twenty-six" "E1-AA685" "E137" "E137A" "E145A"
    "E158A" "E158S" "E19A" "E20A" "E21" "E230K" "E2F1-containing" "E3-ligase"
    "E3-ubiquitin-ligase" "E3A" "E4" "E4BP4" "E5" "E74-like" "EBC" "EBPREs"
    "EBioMedicine" "EC-RF24" "EC109" "EC2" "EC50" "ECG1" "ECG2" "ECG3" "ECIS"
    "ECOG-PS" "ECa" "EDys" "EED2" "EFGR" "EGA" "EGF-like" "EGF-response"
    "EGF-treatment" "EGFP-AR-FL" "EGFP-Centrin–expressing" "EGFP-HDAC6-BUZ"
    "EGFP-NLS-dysbindin-1A" "EGFP–WT–MCOLN1" "EGFR-ER-complex" "EGFR-PI3K"
    "EGFR-low" "EGFR-response" "EGFR1" "EGFR2" "EGFRa" "EGFRb" "EGLN" "EGR"
    "EGY48" "EKAREV" "ELISAs" "ELMO" "EMILIA" "EMKA" "EMT-TF"
    "EMT-TF-associated" "EMT-TFs" "EMT-like" "EPIYA" "EPIYA-A" "EPIYA-B"
    "EPIYA-C" "EPIYA-CCC" "EPIYA-D" "EPSQLLR" "EPZ004777" "ER+" "ER-15"
    "ER-ChIP" "ER-co-activator" "ER-coactivator" "ER-cofactor" "ER-negative"
    "ER-resident" "ER-α36" "ERE-Luciferase" "ERE-luciferase" "EREs" "ERO1"
    "ERRβ" "ERα-co-factor" "ERα36" "ERα66" "ER–Golgi" "ESCRTs" "ESI-MS" "ESMO"
    "ETGE" "ETI" "ETS-factors" "EVs" "Earle" "Early-phase" "East-Asian"
    "East-Asians" "EasyBlot" "EasySep" "EcSOD" "Ecad-Fc–coated" "Ecads" "EcoR"
    "EcoRV" "Editor-in" "Edu-HSV-1" "Egger" "Egger’s" "Ehlers" "Ehlers-Danlos"
    "Ehop" "Ehop-016" "Eighty-three" "Eighty-two" "Ekstrom" "Ekvall"
    "Elisabeth" "Elizabeth" "Ellidag" "Ellson" "Emerald-mEps8"
    "Emerald-mEps8-SATA" "Emerald-mEps8Δbund" "Emerald-mEps8Δcap"
    "End-of-treatment" "Endopat2000" "Enfants" "England" "Enhancer"
    "Enhancer-of-zeste" "Entolimod" "Entrez" "Env" "Env-gp120-mediated" "Enzo"
    "Eosin" "EpRE" "EpRE-like" "EphA2-knockdown" "EphB" "Ephs" "EpiCAM"
    "Epithelial-mesenchymal" "Eps8Δcap" "Epstein" "Epstein-Barr" "ErbB"
    "ErbB2-positive" "Erk" "Erk-mediated" "Ero" "Ero1" "Ero1Lα" "Ero1Lβ"
    "Ero1´s" "Ero1α" "EryP" "Est1p" "Euplotes" "Eurasia" "Europe" "European"
    "Europeans" "Evans" "ExAC" "Exon7" "Exosomes" "Expedeon" "F-FLT"
    "F-FLT-PET" "F-fluorothymidine" "F-tractin" "F1" "F1C2" "F2" "F=4.597"
    "F=4.878" "F=6.414" "FACS-based" "FADH" "FAM92A1" "FANCD2-L" "FANTOM"
    "FANTOM5" "FARs" "FASL" "FASP" "FATS-262" "FATS-262D" "FATS-p53" "FBG"
    "FBJ" "FBX4-αB" "FBXO24" "FBXO3" "FD2" "FERM" "FERM-kinase" "FF100" "FF25"
    "FF50" "FFQ" "FGFR1–ponatinib" "FGFR2b" "FIGO" "FLAG-Polι" "FLAG-tag" "FLI"
    "FLISPP" "FLT3-ITD" "FLT3-ITD-Specific" "FLT3-ITD-dependent"
    "FLT3-ITD-driven" "FLT3-ITD-specific" "FNA" "FOLFOX" "FOLFOXIRI" "FOSL"
    "FOSL-1" "FPI" "FPRP-level" "FRA" "FRA10F" "FTSECs" "FUBP1" "FUS1A"
    "Fallot" "Fangshan" "Farnham" "Fc-induced" "Fe" "Fe(II)-dependent" "FeCl"
    "Features" "Feed-back" "Female" "Feng" "Fenton" "Fernandez"
    "Fernandez-Valverde" "FibrilTool" "Fichter" "Ficoll" "Ficoll-Hypaque"
    "Fifty-five" "Fifty-four" "Fifty‐two" "Fig. S1A-C" "Fig. S2A" "Fig. S2B"
    "Fig. S2C" "Fig. S2D" "Fig. S2E" "Fig. S2F" "Fig. S2a" "Fig. S2b"
    "Fig. S3A" "Fig. S3B" "Fig. S3C" "Fig. S3D" "Fig. S3E" "Fig. S3F"
    "Fig. S4A" "Fig. S4B" "Fig. S4C" "Fig. S4D" "Fig. S5A" "Fig. S5B"
    "Fig. S5C" "Figrue" "FinHer" "Finland" "Finley" "Finnish" "Fiona"
    "First-generation" "First-line" "Fischer" "Fitzpatrick" "Five-day" "Flag"
    "Flag-RNF126-A" "Flag-RNF126-C" "Flag-RNF126-WT" "Flag-RNF126-Δb"
    "Flow-induced" "Flow-mediated" "Fluo-3-AM" "Fluo4-AM" "Flynt" "Fn"
    "Folfirinox" "Follow-up" "Fork-head" "Forssman" "Forster" "Forty-five"
    "Forty-nine" "Forty-one" "Forty-seven" "Forty-three" "Forty-two" "Four-way"
    "Fourier" "Framingham" "Francisco" "Fraumeni" "Free-cell" "Freije" "French"
    "French-Canadian" "Friedman" "Fromm" "Fuhrman" "Full-thickness" "Full_BCR"
    "Full_BCR∆34" "Funderburk" "Fura-2" "FusionRed-F-tractin"
    "FusionRed-MII-RLC" "Fv" "Förster" "G-nucleotides" "G-quadruplex"
    "G-quadruplexes" "G-quadruplex–telomere" "G-quartets" "G-rich" "G-to-A"
    "G0" "G0-G1" "G0-to-G1" "G1" "G1-G2" "G1-G3" "G1-S" "G1-to-S" "G12C" "G13D"
    "G2" "G2-M" "G21" "G2–M" "G3-HAVD" "G4N" "G4T" "G5M" "G5N" "G6" "GA"
    "GACCATGGAGGTTCTTGGCA" "GADD45α" "GATOR1" "GATOR2" "GBM-LS43" "GC-MS"
    "GC-content" "GC-susceptible" "GCB" "GCGAACACGAGCTGCCGGA" "GCN2-eIF2α-p21"
    "GCS" "GDC0712" "GEF-deficient" "GEMM" "GFP-ER" "GFP-His-tagged" "GFP-RNAi"
    "GFP-RNAi-1" "GFP-RNAi-YAP" "GFP-UVRAG-expressing" "GFP-spectin"
    "GFP-vector" "GFPSeh1" "GG" "GGAG" "GGGGAGATGTGGACAGCG" "GGU" "GGxxG" "GG "
    "GG " "GI50" "GIT-containing" "GL" "GLTs" "GMP-AMP" "GMPCPP" "GMPCPP-MTs"
    "GNT's" "GREs" "GSE11291" "GSE19383" "GSE2034" "GSE21032" "GSE24504"
    "GSE25066" "GSE26267" "GSE34387" "GSE3494" "GSE36133" "GSE46642" "GSE4786"
    "GSE4922" "GSE53569" "GSE54072" "GSK-3β-mediated" "GSK-B" "GST-DSG"
    "GST-ELMO1Δ662" "GST-ELMO1Δ662-Y720F" "GST-EphA2" "GST-Pull" "GST-p70S6K"
    "GST-pull" "GST-pulldown" "GST-tag" "GTGCTGGACTGCTGGAAAGT" "GVxxL" "Gadek"
    "Gain-of-function" "Gal4N" "Gal4N-driven" "Gal4N-fused" "Gal4N-mediated"
    "GalNAc" "GalNAcα-Ser" "Galeterone" "Galvagni" "Gam3.8" "Gandarillas"
    "Ganley" "García" "García-Cao" "García-Martínez" "Gardner" "Garraway"
    "GdmCl" "Gehan–Breslow–Wilcoxon" "Genecopoeia" "Genentech" "Genome-wide"
    "Genomes" "Gerbaulet" "Germ-line" "German" "Germany" "Geyer" "Gibco"
    "Giemsa" "Giemsa-Wright" "Giralt" "Gleason" "Gloro" "Glover" "Goth"
    "GraphPad" "Grb2–SOS" "Greece" "Greek" "Greer" "Grimson" "Groucho" "Gu"
    "Guangzhou" "Gudkov" "GxxxA" "GxxxG" "Gy" "Gérard" "Gα" "Gαs" "H&E"
    "H-bond" "H-bonds" "H-bounds" "H-box" "H-sensitive" "H1" "H10-2-G3" "H1975"
    "H2" "H2-T-H3" "H2009" "H216" "H216A" "H2DCFH-DA" "H3" "H3Ac" "H3K18"
    "H3K18Ac" "H3K18ac" "H3K27" "H3K56" "H3K79" "H3K9Ac" "H3K9ac" "H3S10ph"
    "H3S28ph" "H3ac" "H4" "H4-K20" "H6-GST-MBD" "H611" "H611A" "H665" "H694"
    "H8" "HA-CA-Mek1" "HA-E2F1" "HA-tag" "HA-wt-HDAC6" "HAE6" "HAECs" "HAF1"
    "HAPE6C7" "HASMC" "HASMC-MC" "HASMCs" "HAUSP-Mdm2-p53-mediated" "HAVD"
    "HB2151" "HCC-LM3" "HCC-like" "HCFs" "HCPT" "HCT-CI" "HDAC1-3" "HDAC3i"
    "HDAC4cN" "HDAC4cT" "HDAC5c" "HDAC5cM" "HDAC5cN" "HDAC6-ΔBUZ" "HDAC6-∆BUZ"
    "HDAC6i" "HDEs" "HDFs" "HDKV" "HDX-MS" "HEM-7200" "HER-293"
    "HER2-dimerization" "HER2-overexpressing" "HER2-positive" "HER2a" "HER2b"
    "HERVs" "HERs" "HFD-fed" "HFD1%" "HFFs" "HFKs" "HG10" "HG11" "HG13" "HG22"
    "HG23" "HG24" "HG25" "HG5" "HG8" "HG9" "HGC" "HGC-803" "HGF–MET-disrupting"
    "HGSOC" "HGSOCs" "HH-MB" "HHV-6" "HIECs" "HIF" "HIF-dependency"
    "HIF-proline" "HIF-α" "HIFα" "HIVNef" "HK" "HKN" "HL-7702" "HLA-DR4"
    "HLMCs" "HMC-1cells" "HMCLs" "HMF" "HMFs" "HMOX" "HMVEC" "HMVEC-d" "HMVECs"
    "HNKs" "HOMA-IR" "HOMA-β" "HOXA5-3UTR" "HOXB-7" "HOXB7-1"
    "HOXB7-promoter-luciferase" "HOXC" "HOXD" "HPV-58" "HR-HPV"
    "HR-HPV-infected" "HR-HPV-positive" "HR-HPV-related" "HR-HPVs" "HRPC"
    "HRasV12" "HRasV12 " "HRs" "HSCPs" "HSE-probe" "HSK" "HSPB" "HSQC"
    "HSV-1-ICP0" "HT29-D4" "HT7" "HTM" "HTSMCs" "HU" "HU-treatedPTEN" "HUSMC"
    "HUSMCs" "HUT-78HIV" "Haber" "Haber–Weiss" "Haferlach" "Hager" "Haigis"
    "Hakvoort" "Hamilton" "Hanein" "HapMap" "HapMap-CEU" "HapMap-CHB"
    "HapMap-JPT" "HapMap3" "Harb" "Harbin" "Hardy-Weinberg" "Hardy–Weinberg"
    "Hatakeyama" "Hausmann" "Hawkins" "Hayflick" "Hazan" "Hda1p" "Hebert"
    "Hec1S44ph" "Hec1Ser44ph" "Hematoxylin-Eosin" "Her2" "Her2-dependent"
    "Her2-negative" "Her2-overexpressing" "Her2-positive" "Herishanu" "HiSeq"
    "Hif-1a" "High-affinity" "High-fat" "High-power" "High-risk" "Hind-limb"
    "HindIII" "Hippo-YAP" "Hirano" "Hirschey" "His-976-Tyr" "His-E2F1"
    "His-HIPK2" "His-RAD18" "His-p65" "His-rich" "Histone" "Histopathology"
    "Hn" "Hn-TNBC" "Hn-TNBCs" "Hobert" "Hodgkin" "Hodgkin's" "Hodgkin-lymphoma"
    "Hodgkin’s" "Hoechst" "Hofbauer" "Hoff" "Holthauzen" "Homology" "Horssen"
    "Hosokawa" "Houang" "Hsp90-fAR" "Hsu" "Huang" "Hui" "Human" "HumanCytoSNP"
    "HumanCytoSNP-12" "Humayun" "Humphrey" "Huntington" "Huntington's"
    "Huntington’s" "Huson" "HxN" "HyClone" "Hydroxycamptothecin-resistant"
    "Hypoxanthine" "Hz" "Hünten" "H–D" "I-A" "I-Ab" "I-II" "I-III" "I-IV"
    "I-specific" "I127" "I127A" "I133" "I133A" "I155R" "I82" "I82A" "I83"
    "I83A" "IB" "IBTKα" "IC-50" "IC50" "IC50s" "ICD-O-3-HISTOLOGY" "ICP-MS"
    "IDCs" "IDT" "IEGs" "IFI" "IFI16+ASC" "IFI16+BRCA1" "IFI16+CHK2"
    "IFI16+γH2AX" "IFI16-DNA" "IFI16-STING-TBK" "IFI16-STING-TBK1-IRF3"
    "IFI16-Si-RNA" "IFI16-genome" "IFI16-inflammasome" "IFI16-inflammasomes"
    "IFI16-viral" "IFN-λ" "IFN-λs" "IGF-axis" "IGF1-receptor" "IGTB4" "II-1"
    "II-BO8" "II-III" "II-IV" "III-1" "III-2" "IIIA" "IIIB" "IIa" "IIγ"
    "II–III" "IKFZ1" "IL-6Rα" "ILD-like" "ILF3-p54" "IM-Q" "IMiD" "IMiDs"
    "INK4a-dependent" "IP-ed" "IP–MS" "IRDye" "IRESes" "IREα" "IRLP" "IRS1-4"
    "IRS1-phosphatidylinositol-3-OH" "ISG" "ISGs" "ISRE-luciferase" "ITAFs"
    "ITC" "ITD+AML" "ITD1" "ITD2" "ITD3" "ITD4" "ITD502–503" "ITD9" "IU"
    "IV–Luc" "Idec" "Ifnar" "Ig-like" "Igκ" "Iijima" "Iijima’s" "Illumina"
    "ImageJ" "Immunostep" "In-frame" "In-silico" "Inc" "Inflammatory-related"
    "Inoue" "Inter-relationships" "Inter-species" "Invitrogen" "Iowa" "Iran"
    "Irwin" "Ischemia-reperfusion" "Ishii" "Ishise" "Itakura" "IκB-alpha"
    "IκB-β" "IκB-γ" "I–III" "J2-3T3" "J558" "JCI" "JEV" "JFH1" "JFH1-2a" "JFP"
    "JGCT" "JGCTs" "JHH" "JHP" "JP" "JPT" "JQ-1" "JQ1" "JTAg" "JUNB" "JUND"
    "Jackman" "Jackman's" "Jackson" "Jacque" "James" "Japanese" "Jcam"
    "Jefferies" "Jewish" "Jews" "Ji" "Jiang" "Jiangsu" "Jilin" "Jilăveanu"
    "Jin" "Jin's" "Johnson" "Juan" "Jun-dimerization" "Jung" "K-function"
    "K21R-NLS-EGFP" "K318Q" "K318R" "K48-ubiquitin-specific" "K5Q" "K5R"
    "K759A" "KAKTLRK" "KASH" "KB" "KB-1458E12" "KB-V1" "KDAC" "KDACs" "KEGG"
    "KG" "KGC-HDACs" "KINOMEscan" "KIT-TETS2-ASXL1" "KLF-9" "KMN" "KN-AML"
    "KPPIPAK" "KRKKRK" "KSFM" "KSP" "KSYE150" "KT-MT" "KU" "KYESE410" "KYSE155"
    "KYSKE30" "Kabbaj" "Kalet" "Kallmann" "Kanagaraj" "Kang" "Kaplan"
    "Kaplan-Meier" "Kaplan-Meier-survival" "Kaplan–Meier" "Kaposi" "Kaposi's"
    "Kaposi’s" "Kar2p" "Karnofsky" "Karnoub" "Karolczak" "Karolczak-Bayatti"
    "Kasap" "Katayama" "Katoh" "Kawai" "Kayes" "Kazakh" "Kd" "Keap"
    "Keap1-Nrf2-ARE" "Kelch" "Kendrick" "Keskin" "Keuls" "Khakoo" "Khoo"
    "Khosrotehrani" "Ki-67" "Kihara" "Kim" "Kip" "Kirstein" "Kirsten" "Kischer"
    "Kit" "Kit-8" "Kit-expressing" "Kit-specific" "Kitadai" "Kitadai’s" "Klein"
    "Klemke" "Klionsky" "Knappskog" "Knock-down" "Knævelsrud" "Koelreuteria"
    "Kolmogorov" "Kolmogorov-Smirnov" "Komarova" "Kong" "Konopka" "Koppers"
    "Koppers-Lalic" "Korea" "Korean" "Kornfeld" "Kramer" "Krebs" "Krek"
    "Krogan" "Kruse" "Krüppel" "Krüppel-like" "Kt-MT" "Kt-fibre" "Kt-fibres"
    "Kulju" "Kumar" "Kusabira" "Kuwabara" "Kwon" "Kyoto" "L-Lactic" "L-VOCCs"
    "L-lactate" "L-leucyl-L-leucine" "L-type" "L1" "L1-L5" "L2" "L3" "L693D"
    "L757A" "L858R" "LASAGNA" "LC3-I" "LC3A-II" "LC3B-I" "LC3B-II"
    "LC3B-II-SQSTM1" "LC3I" "LC3II" "LCL" "LEF-dependent" "LEFTY" "LIN-7"
    "LISA-2" "LKPH4" "LL" "LLOMe" "LM-PAT" "LMVs" "LNCaP95" "LOC646376"
    "LOC646736" "LOC64736" "LOVD" "LPE" "LPHQPPP" "LPSs" "LR" "LTD"
    "LTQ-Orbitrap" "LTR" "LUCA" "LUX-Lung" "LXRXX" "LXRα" "LY29400" "LY49002"
    "Labussière" "Laemmli" "Lalic" "Lan" "Langdon" "Lappalainen" "Laser-based"
    "Late-passage" "Latvia" "Lck-Cre–dependent" "Lck-association" "Legius"
    "Lehman" "Leica" "Leiden" "Leigh" "Leigh's" "Lemmon" "Lentiviral-mediated"
    "Lerman" "Lessard" "Levens" "Li" "Li-Fraumeni" "Liao" "LibDock" "LifeAct"
    "LifeAct-Ruby" "LifeVantage" "Linyi" "Lipid-protein" "Listernick"
    "Lithuania" "Liu" "Ln-5" "LnRHI" "Loeys" "Loeys-Dietz" "Log-rank" "Log2"
    "Logan" "Logue" "Lombard" "Louisiana" "Low-Dose" "Low-grade" "Low-level"
    "Lowy" "Lu" "Luc-100-PT" "Luc-TAZ-a" "Luc-TAZ-aM" "Luc-TAZ-b" "Luc-TAZ-bM"
    "Lucas" "Luciferase-reporter" "Lv-miR-153" "Lxrα" "LxxLL" "Lyngby"
    "LysoTracker-DND-99" "M-arrest" "M-phases" "M0" "M2-polarization" "M6"
    "MA-20" "MA0144.1" "MAB1835" "MAD-MB-231" "MADR" "MALDI-TOF" "MALDI-TOF-MS"
    "MAP1LC3B-I" "MAP1LC3B-II" "MAPK-MNK-eIF4E" "MAPK-cascade" "MAPK-pathway"
    "MAPK1was" "MAX_BCR" "MCBC" "MCBS1" "MCC-E" "MCF-7-EGFR+HER2"
    "MCF-7-TMR-shHOXB7" "MCF7-miR-196a-inhibitor" "MCF7-pDRGFP" "MCF7-vector"
    "MCF7TR" "MCF7–hMSC" "MCOLN" "MCPIPs" "MDA-MB-231-LM2-4175"
    "MDA-MB-231-shNOP14–4" "MDA-MB-231-shRNA-Ctl" "MDA-MB-231Cbl-b"
    "MDA-MB231BR-HER2" "MDDCs" "MDR" "MDSCs" "MEDIPS" "MEE" "MEK-chemotherapy"
    "MEK-inhibitors" "MEM" "MEME" "MEN" "MET-disruptive" "MET-gene"
    "MET-induced" "MET-like" "METLIN" "MFS" "MGL-Fc" "MGL-binders" "MGL-mFc"
    "MIBC" "MIBCs" "MIIA" "MILLIPLEX" "MIRA-1" "MIV-Luc" "MIV-Luc-shIL13Rα2#2"
    "MIV-Luc-shIL13Rα2-injected" "MIV-Luc-shSCR" "MIV-shIL13Rα2#2" "MIV-shSCR"
    "MJDs" "MK167" "ML-SA1" "MLCP" "MM" "MM-004" "MM-039" "MM-146" "MM-151"
    "MM-200" "MM-239" "MM-263" "MM-271" "MM-280" "MM-281" "MM-282" "MM-286"
    "MM-295" "MM-327" "MM-334" "MM-340" "MM-429" "MM-442" "MM-PBSA" "MM2BH"
    "MMLV" "MMP-induced" "MNAM" "MNAM-fed" "MOWIOL" "MPKs" "MPNST6IEPVI" "MREs"
    "MRN" "MS" "MS10" "MSC–tumor" "MSI-H" "MSI-L" "MSI-status" "MSKCC"
    "MSM-Tam" "MST-312" "MTKn3" "MUT+DEL" "MVAC" "MYC-B7-3" "MYC-F" "MYRF"
    "Mac3" "Macedonia" "Madacam1" "Madcam1knockdown" "Madhya" "Maejima"
    "Maertens" "Malades" "Mamczarz" "Manders" "Manley" "Mantel-Cox" "Marega"
    "Marinescu" "Markov" "Martinez" "Martinez-Nunez" "Martínez" "Maryland"
    "Marzec" "MassARRAY" "Masson" "Material" "Matlab" "Mautner" "Mazan"
    "Mazan-Mamczarz" "Mazieres" "Mbp" "McCaughan" "McDermott" "McGaughran"
    "McGuire" "McKay" "Mcl1-deficient" "Mdm2" "MeDIP" "Medcalf" "Mediterranean"
    "Meier" "Mello" "Mendel" "Menendez" "Meng" "Mensink" "Menton" "Mergny"
    "Messiaen" "Met143-Cys207" "Met249-Cys341" "Met94-Cys142" "Met992del"
    "MetaCore" "Methods" "MethylMiner" "MethylMiner-qPCR" "Methylome" "Metz"
    "Mi2" "MiR-137" "MiR-153" "MiR-182" "MiR-198" "MiR-205" "MiR-23" "MiR-375"
    "Miao" "Miapapca-2" "Michaelis" "Michaelis–Menton" "MicroRNA-137"
    "MicroRNA-9-3p" "Microplate" "Mikheev" "Milleron" "Millipore" "Mina"
    "Mini-hSIRT1" "Minkelen" "Minna" "Mios" "Miraversen" "Mirk" "Mito-TEMPO"
    "Mito-tracker" "MitoCarta" "MitoSNO" "Mitochondrial-derived" "Mitotracker"
    "Mittelbrunn" "Mn" "Molina" "Monocyte-derived" "Monte" "Montecalvo"
    "Mookherjee" "Mootha" "Moraceae" "Morrison" "MotifLab" "Mouse" "Moye"
    "Msn2" "Mulay" "Mulero" "MutationTaster" "Mutazyme" "MyBP-C" "Myb-Dam"
    "Myc-like" "Myc-proficient" "N-SH3" "N-acetyl" "N-alkyl" "N-alkylpurine"
    "N-labelled" "N-linked" "N-mustard" "N-mustard-benzene" "N-mustards"
    "N-protected" "N0M0" "N1-methylnicotinamide" "N188" "N2-N4" "N2C" "N4" "N7"
    "N9" "NAIP2" "NAIP6" "NAWM" "NBBC" "NBBCs" "NBBSc" "NCGC" "NCI" "NCRCT"
    "NE2" "NEJ002" "NEXT-1" "NF-κB-Luc" "NF-κB1" "NF-κΒ" "NF1-PAs"
    "NF1‐associated" "NF1‐positive" "NF1‐related" "NFE2L-2" "NFT" "NFTs" "NFY"
    "NFκB-p65-related" "NFκB1" "NFκBI" "NFҡB" "NG108" "NH" "NHFs" "NHKs" "NHOE"
    "NK-252" "NK-kB" "NK1-R" "NKX31" "NL4-3" "NLC" "NLC2" "NMIBC" "NMII"
    "NM_001174066" "NM_032551" "NOD-like" "NOX1-5" "NOX1KO" "NOX4KO" "NOXs"
    "NPRL1" "NRF-2-regulated" "NRF-2α" "NRF-2β1" "NRM" "NS-CL" "NSC207895"
    "NSCC" "NSLC" "NSMB" "NSsh" "NURD" "Nahta" "Najafi" "Najafi-Shoushtari"
    "Najas" "Nakasa" "Nakashima" "Nanogold" "Nantais" "Naosuke" "Napuri"
    "Nasta" "Natsume" "Navab" "Nck-IP" "NcoI" "Necker" "Necker-Enfants" "Neh"
    "Neh1–Neh7" "Neh3" "Neh4" "Neh5" "Neh6" "NetPhos" "NetStart" "Netherlands"
    "Neu" "NeuroD2-SmoA1" "Newman" "Newman-Keuls" "Next-Generation"
    "Next-generation" "Nguyen" "Nicolin" "Nikon" "NimbleGen" "Ninety-six"
    "Nodal" "Noonan" "Notch-dependent" "Notch-targeting" "Nrf-2" "Nrf2"
    "Nrf2-erythroid-derived" "Nrf2-immunoreactive" "Nrf2-null" "Nrf2-small"
    "Nrob2" "NuRD" "Nuc-S184A" "Nuc-S542A" "Numa" "Nunez" "Nup107–160"
    "Nyström" "O-alkyl" "O-alkyl-related" "O-alkylated" "O-alkylating"
    "O-glycosylation" "O-linked" "O2" "O2a" "O3a" "O4" "OA-like" "OAG" "OB2"
    "OB3" "OCILY-8" "OCL-LY-19" "OCUM-2MD3" "OECs" "OER" "OFC" "OFCs" "OLI"
    "OMIM" "OPCs" "OPGs" "OPTHiS" "OR=0.30" "OR=0.33" "OR=0.35" "OR=0.45"
    "ORiP" "ORs" "OXPHOS-to-glycolysis" "Occludens-1" "Oestrogen" "Oevelen"
    "Off-target" "Ohsumi" "Okada" "OligoA" "OligoU" "Oligomycin" "Olivier"
    "Olympus" "Omomyc" "Omron" "Oncology" "Oncomine" "One-hundred"
    "Ongwijitwat" "Opti" "Opti-MEM" "Orbitrap" "Orecchini" "Oregon" "Orwin"
    "Orwin’s" "Orzalli" "Other" "OvCa" "OvCas" "Ox-1-induced-dephosphorylation"
    "Oxindole-1" "Oxytricha" "P1" "P1-treated" "P13K" "P144A" "P2" "P2X" "P2Y"
    "P50" "P52" "P7" "P=0.001" "P=0.002" "P=0.0032" "P=0.007" "P=0.008"
    "P=0.009" "P=0.022" "P=0.027" "P=0.031" "P=0.032" "P=0.033" "P=0.046"
    "PA103" "PAAD" "PAGE" "PAIR4" "PAIR6" "PAM50" "PANC" "PAPOVA" "PAPR"
    "PARPα" "PBS1-4" "PBS3" "PBS4" "PBSC" "PCDHB11" "PCGT" "PCGTs" "PCI-34051"
    "PCI-48012" "PCI4" "PCL-026" "PCL-038" "PCM1-JAK2-positive" "PD1T" "PDGF"
    "PEG-IFN" "PET-CT" "PF-4554878" "PF4554878" "PFI-1" "PGCα" "PHM" "PHPS1"
    "PH‐like" "PI-double" "PI3K-dependent" "PI3KCA" "PI3KCIII" "PI4KIIIβ"
    "PI5P" "PIGF" "PIK3CA_E542K" "PIK3CA_E545K" "PIP-less" "PIP2–PCNA"
    "PIP3-PCNA" "PIP3–PCNA" "PISA" "PJ" "PKB‐beta" "PKCɛ" "PKCβI" "PKCβII"
    "PKCη" "PKCθ" "PKCλ" "PKM1" "PKPFPR" "PKPFPR-motif" "PKPRPP" "PKR-like"
    "PKWS" "PLos" "PMA" "PMI-N8A" "PNAS" "PNGaseF" "POPE" "POS" "POT" "PP3C"
    "PPMS" "PPWM" "PR1+PR2mut" "PR1-BH" "PR1mut" "PR2mut" "PRB" "PRC4"
    "PRKC-RAF1-MAP2K1-dependent" "PRKC-RAF1-MAP2K1-mediated" "PRKCζ" "PRKCλ"
    "PROVEAN" "PRYSPRY" "PS-exposure" "PSA50" "PSC27" "PTEN-C2" "PTEN-null"
    "PTEN–DLC1" "PTEN–PI3K" "PTEN–T319Y" "PTMCs" "PTN11" "PTP-ε" "PWK" "Paf1c"
    "Paglia" "Pagliarini" "Pak" "Pakistan" "Paks" "Pam3CSK4" "Pam3Cys" "Paolo"
    "Papini" "Parasramka" "Parkes" "Parkes-Weber" "Parkinson" "Parkinson's"
    "Parle" "Parle-McDermott" "Partitioning-defective" "Pas" "Pascarella"
    "Pasmant" "Pathscan" "Pauline" "Paulucci" "Paulucci-Holthauzen" "Pb-Cre4"
    "Pdk" "Pdks" "Pearson" "Pearson’s" "Pekka" "Pellegrini" "Pencik" "Penh"
    "PeptideProphet" "Perk-dependent" "PerkinElmer" "Petel" "PgR-any"
    "PgR-positive" "Philadelphia" "Pho8Δ60" "Phospho-Tyrosine"
    "PhosphoSitePlus" "Phosphoserine" "PhyloP" "Phyre2" "Pinna" "Pita" "Plex"
    "Plk1-interaction" "Plümpe" "Poisson" "Poisson-Boltzmann" "Poland"
    "Poly-ADP" "PolyPhen" "PolyPhen-2" "PolyPhen2" "Polδ" "Polη's" "PolηΔC"
    "Polη–PCNA" "Pomatia" "Ponasterone" "Ponceau" "Pontén" "Port-wine"
    "Post-immune" "Post-progression" "Pottery" "Pradesh" "Pragmin" "Prasad"
    "Primescript" "Pro-T" "Pro-T-LBL" "Procentrioles" "Profiler" "PrognoScan"
    "Promega" "Proof-of-concept" "Propodium" "ProteinProphet" "Protoc" "Pro "
    "Prx5" "Puertollano" "Pull-down" "Purkinje" "PxxP" "PxxPxK" "Pyr3"
    "P = 0.007" "P = 0.009" "P = 0.022" "QFISH" "QT" "QUANTO" "Qiagen" "Qiu"
    "QuikChange" "R+3" "R-CHOP" "R-CHOP-like" "R-domain" "R-values" "R0" "R1"
    "R154S" "R2" "R3" "R4" "R446E" "R5" "R5-tropic" "R7" "R8" "RAD6"
    "RAD6–RAD18" "RAREs" "RASF" "RASFF1A" "RASFs" "RAV" "RCAN1-1" "RCAN1-1L"
    "RCAN1-1S" "RCAN1-4" "RCTH" "RERF" "RERF-LC" "RFLP" "RGD" "RGFP966" "RHI"
    "RICTOR-null" "RIME" "RING-between" "RIPM" "RLC-AA" "RLC-DD–GFP" "RLPpS"
    "RLU" "RMSD" "RMSD1" "RMSDm" "RMSFs" "RNA" "RNA-Pol-II" "RNA-like" "RNAPII"
    "RNAhybrid" "RNAi" "RNAi-YAP-1" "RNAi-rescue" "RNA–protein" "RNF"
    "RNF126-C" "RNF126-Δf" "RNS-mediated" "RO-5963" "ROCK-mediated" "ROI"
    "ROIs" "ROS-PKCα-ERK-NFҡB" "ROS-defense" "RP-B-01" "RP-B-02" "RPS6KB"
    "RPTP" "RPTP-κ" "RRKCGRDPAEEHALLVN" "RRKCGRDPAEEHSLLVN" "RRKCGRDPSEEHALLVN"
    "RRKCGRDPSEEHSLLVN" "RRRCWWGYYY" "RSK–EphA2" "RSV-F" "RSXpC" "RTK-pathways"
    "RUNX" "RXXPXXP" "Rac1" "Rac1-GTP" "Rac1-specific" "Rachakonda" "Rad3"
    "Rad3-related" "Radioactive" "Raedt" "Ragulator-Rag" "Raiborg" "Raichu"
    "RalA-GTP" "RalA-depleted" "RalAQ72L" "Ran-GTP" "Ran-dependent" "RanQ69L"
    "Rasanen" "Rayner" "Rb" "RbAps" "Re-ChIP" "Re-epithelialization" "Reata"
    "Receiver-operating" "Recillas" "Recillas-Targa" "RefSeq" "Regalado"
    "Regsubsets" "RelA-binding" "RelA-dependent" "Relaxin-1" "Relaxin-2"
    "Renaux" "Renaux-Petel" "Renilla" "ResponseDX" "Revencu" "Reyes" "RhoA-GTP"
    "RhoA-n19" "RhoA-v14" "RhoG" "RhoG-ELMO1-Dock180" "RhoGTPases" "Rhod-2"
    "Rhode" "Richards" "Riley" "Ring" "Rio" "Ripley" "Ripley’s" "Ristevski"
    "Rna22" "Roadmap" "Roche" "Rojnueangnit" "Romania" "Romano" "Romi" "Rong"
    "Rosmarin" "Rossmann" "Rossmann-fold" "Roxolitinib" "Russell" "Russia"
    "RxRxx" "RxxPxxP" "S-Adenosyl" "S-adenosyl" "S-adenosyl-L-methionine"
    "S-cystiene" "S-glutathionylation" "S-labelled" "S-methionine"
    "S-transferases" "S1" "S1+S2" "S13" "S13A" "S17A" "S18A" "S19A" "S19D"
    "S19P" "S1C" "S1D" "S1D–F" "S235" "S240" "S2481ph" "S2A" "S2C" "S2D" "S2E"
    "S2a" "S2b" "S2d" "S3" "S303" "S307" "S307A" "S307D" "S311D" "S380" "S3C"
    "S3E" "S3I" "S459" "S459A" "S4A" "S4A–C" "S4B" "S4C" "S4D" "S4E" "S4F"
    "S536E-NFκB-p65" "S542A" "S550" "S572,576" "S572A" "S572E" "S576A" "S576E"
    "S5A" "S5A–E" "S5D–F" "S5F" "S5H" "S5c" "S5d" "S6" "S624A" "S624E" "S6A"
    "S6C" "S6K1-S6" "S6K1-activity" "S6K1-response" "S7" "S73–S81" "S767"
    "S797" "S7a" "S7b" "S7c" "S8" "S807" "S87" "S87–S90" "S8a" "S8b" "S9" "S90"
    "S9D" "SA-β-galactosidase-positive" "SAC-dissatisfaction" "SAE-2"
    "SAH-p53-8" "SAPHIR" "SASF" "SASFs" "SAXS" "SB16763" "SCEs" "SCF-dependent"
    "SCKL6" "SCOPE1" "SCOS3" "SCi" "SDAC" "SDACs" "SDF-1α" "SDS–polyacrylamide"
    "SDTTDS" "SEACAT" "SEER" "SELECT-1" "SEQUEST" "SGC791" "SH-5" "SH3-BH"
    "SH3-PR1-BH" "SH3-PR1-BH-PR2" "SH3-domain" "SH3-ligand" "SILAC" "SIRT"
    "SIRT1-3" "SIRT1-7" "SIRT3-LDHA-mediated" "SIRT3-SOD2-dependent"
    "SIRT3-SOD2-mediated" "SIRT3-homo-340" "SIRTs" "SISP2" "SJ-172550" "SK-01"
    "SKB" "SKB-R3" "SKLR" "SKLTR" "SKTR" "SM-AHNMD" "SM-AML" "SM-CEL" "SM-CMML"
    "SM-MDS" "SM-MPN" "SM-NHL" "SMART" "SMCF1" "SMCα-actin" "SMIs" "SNAP-tag"
    "SNORD102" "SNP" "SNPinfo" "SNPs" "SNP–SNP" "SNV" "SNV's" "SNVs" "SNYNE2"
    "SP6000125" "SPFH" "SPMS" "SPPS" "SPSS" "SQSMT1" "SR" "SR11302" "SRD3c"
    "STACs" "STAT3-stromal" "STAT5b-IGF-1Rβ" "STIL" "STMN1-E" "STNM1" "STNM3"
    "STRING" "SU-2" "SU-DHL-16" "SUCRA" "SUM159-shIL13Rα2" "SUMO2-3" "SUNE-1"
    "SV5" "SVIGQGP" "SWH" "SYBR" "SYPRO" "Sabbagh" "Sachadyn" "Sadok" "Saenz"
    "Samsung" "Sancak" "Sanger" "Santoro" "Sarbassov" "Sato" "Sato-Kuwabara"
    "Satterstrom" "ScFv-phage" "Scandinavia" "Scandinavians" "Scansite"
    "Scarpulla" "Schepper" "Schiff" "Schiller" "Schizosaccharomyces"
    "Schnitzler" "Schreiber" "Schulze" "Schwaab" "Schwertman" "Scottish" "Scr"
    "Sdh" "Sean" "Sec24" "Seckel" "Sec‐14" "Sedic" "Semi-quantitative" "Sen"
    "Senchenko" "Seong" "Seoul" "Seq" "Sequence-motif" "Sequence-specific"
    "Sequenom" "Ser-1046" "Ser-897" "Ser-897-phosphorylated" "Ser-Pro" "Ser158"
    "Ser2-P" "Ser210" "Ser217" "Ser38–0.342*Ser63+0.459" "Ser40-Nrf2" "Ser715"
    "Ser715-MCAK" "Ser715-containing" "Ser807" "Serbia" "Serine-2"
    "Serine-to-alanine" "Serrano" "Sestrin1" "Seventy-two" "Sex-specific"
    "Shan" "Shao" "Shapiro" "Shapiro-Wilks" "Sharma" "Sharma’s"
    "Sheet-loop-helix" "Shen" "Sherr" "Shiga" "Shimazu" "Shimozono" "Shirley"
    "Shokat" "Shoushtari" "Shp" "Si-IFI16" "Sigismud" "Sigma–Aldrich"
    "SignalChem" "Simonsen" "Singh" "Sirius" "Sirtuin" "Sirtuins" "Sisoula"
    "Sjögren" "Sjögren's" "Skp1" "Skp1-Cul1-F" "Sliwinski" "Sloan" "Slovak"
    "Slovakia" "Slovenia" "Slug-null" "Sm" "Smad-pathway" "Smad2" "Smad3"
    "Smads" "Smirnov" "SmoA2" "Snyder" "Someya" "SorcererTM"
    "SorcererTM-SEQUEST" "Sorefenib" "Soto" "Soto-Reyes" "Spain" "Spanish"
    "Spearman" "Spearman's" "Spearman’s" "SpectraMax" "Src-I1" "Src-family"
    "SrcY527F" "Stancz" "Stanislawska-Sachadyn" "Stanley" "Staplin" "Staplin-2"
    "Stathmin-1" "Stein" "Steinestel" "Stempro34" "Stephanie" "Stepwise"
    "Steven" "Stickeler" "Stomach-specific" "Stratakis" "Streeper"
    "Streptavidin-PE" "Structure-based" "Sturge" "Sturge-Weber" "Stylonychia"
    "Sulfhydryl" "Sup-B15" "Sup-T1" "Superfect" "Supermix" "Superscript"
    "SurePrint" "Suzuki" "Swartz" "Sweden" "Swiss-Prot" "Swyer" "Syntelin"
    "System-wide" "Szeto" "Szeto-Schiller" "Szwiec" "S–G2–M" "T-LBL" "T-LBLs"
    "T-T-A-A-T" "T-allele" "T-helper" "T-induced" "T-lymphoblastic"
    "T-regulatory" "T-rich" "T-switch" "T-variant" "T1" "T1+T2" "T13–T16"
    "T163A" "T163E" "T1–T12" "T2" "T2-T4" "T202" "T210ph" "T218A" "T218D"
    "T2609" "T288ph" "T2DM" "T2b" "T2–T4" "T3" "T3+T4" "T3-T4" "T311A" "T315D"
    "T319" "T32A" "T32D" "T382" "T383" "T389ph" "T3–T4" "T4" "T628A" "T628E"
    "T7" "T790M" "T92A" "T92E" "TAED1" "TALE-TET1" "TALE-TET1CD" "TALEN"
    "TALENs" "TAS" "TATA" "TAp63γ" "TAp73" "TAp73-transfected" "TAp73-α"
    "TAp73α" "TAp73β" "TCCAGCTACTTGCACTTGTTCCT" "TCM" "TCTGGAACCAGACAGCACCT"
    "TDLU" "TDLUs" "TDM4450g" "TDNP" "TDP1–TAMRA" "TEA" "TEADs" "TEFb" "TEFb's"
    "TEFb-dependent" "TEFb-interacting" "TEFb-interaction" "TEL-JAK2-cDNA"
    "TERT-myc-expressing" "TERT-myc-transfected" "TGACCGCAGAGTCTTTTCCT"
    "TGF-βsignaling" "TGF1" "TGFβ-α" "TGGGTTGGTCATGCTCACTA" "TGRBR2" "TIQ"
    "TIQ-A" "TK-activity" "TKI-naïve" "TLE" "TLR1-10" "TMAnnRTGAYnnnGCRwwww3"
    "TMM" "TMR-miR-196a" "TMR-shMYC" "TMR1" "TMR2" "TNBCs" "TNF-ɑ"
    "TNF-α-induced" "TNF-α-treatment" "TNF1.6" "TNFR" "TNH" "TNM6" "TNS3-C2"
    "TNS3-C2-T323A" "TNS3–ABD" "TNS3–ABD–Y321T" "TO" "TOPflash" "TP53INP"
    "TPAR" "TPR-Met" "TPRC3" "TPX2–Aurora" "TPXX" "TRANSFAC" "TRCN" "TRCN-768"
    "TRCN-769" "TROSY" "TROSY-HSQC" "TSAd-tyrosines" "TSAd-∆Exon7-mCherry"
    "TSCC" "TSR-011" "TTA" "TTAG" "TTCCGG" "TTDR" "TTGGGG" "TTLR" "TUJ1" "TXY"
    "Ta" "TaKaRa" "Taiwan" "Takagi" "Takahashi" "Takemaru" "Talalay" "Taq"
    "Taqman" "Targa" "TargetScan" "Tat-SEC" "Tat-like" "Tau46" "TauC3"
    "Ten-eleven-translocation" "Tet-on" "Tetrahymena" "Tewari" "Th17"
    "Thadani-Mulero" "Therapy-1" "Therapy-Nucleic" "Thermo" "Thermo-Pierce"
    "Thirty-nanomolar" "Thirty-seven" "Thirty-three" "Thornton" "Thr-kinase"
    "Thr-rich" "Thr202" "Thr308-AKT" "Thr321in" "Thrombocythemia" "Ti-oxide"
    "Tianjin" "Time-course" "Time-lapse" "Time-zero" "Tis" "Tis–T2"
    "Titansphere" "Tm" "Tn" "Tokai" "Toll" "Toll-like" "Tomiyama" "Tomoyuki"
    "Tongji" "Tonsgard" "Tooze" "Topham" "Toyama" "Trans-well"
    "Transient-Receptor-Potential" "Transwell" "Trastuzumab-emtansine"
    "Trevigen" "Trialists" "Tribolium" "Trichrome" "Triple-negative"
    "Tris-glycine" "Trithorax" "Try204" "Tseng" "Tub-GAL4" "Tuj-1" "Tukey"
    "Tukey's" "Tumorothèque" "TurboFP" "TurboFP635-tagged" "Turner-Brannen"
    "Twenty-eight" "Twenty-four" "Twenty-nine" "Twenty-seven" "Twenty-two"
    "Two-way" "TxxxS" "Tyner" "Typer" "Tyr-588" "Tyr-99" "Tyr204" "Tyr458"
    "Tyrode" "T→A" "U-shape" "U133" "U1HIV" "U20S" "U251" "U373" "U87s" "UAB"
    "UAB‐R008‐I1" "UAB‐R0143‐I1" "UAB‐R5863‐I1" "UAB‐R6673‐I1" "UAB‐R9216‐I2"
    "UAB‐RSeNF23" "UACC257" "UAS-GFP" "UAS-SNF1A" "UAS-TRPML" "UAS-Tor"
    "UB-dsRed" "UBAs" "UBP" "UBZ" "UBZ-function" "UCHs" "UCSC" "UCSD" "UFB"
    "UFBs" "UG" "UG‐575" "UI" "UISO" "UKALL2003" "UMD" "UNC" "UPlanApo" "USA"
    "USP52" "UTP-induced" "UTR-mutated-Luc" "UTRs" "UUU" "UV-RSV" "UV24"
    "UVRAG-mTOR-mediated" "UVRAG-only" "UbiCRest" "Ukraine" "UniProt"
    "UniProtKB" "Univ" "Univariate" "Upadhyaya" "Urology" "Utah" "Uyghur"
    "V-shape" "V-shaped" "V2" "V3" "V5-SK2" "V5-tagged" "V567es" "V689D"
    "V7-specific" "VAD1" "VAF" "VAFs" "VCAM-1-promoter" "VCAM-1expression"
    "VDDADFMK" "VEGF-null" "VERFR1" "VGCCs" "VGlut-1" "VH" "VH1-a1" "VI" "VJ"
    "VNPPT55" "VNPT55" "VNR" "VOCCs" "VPS34-IN1" "VPS34-IN1-induced" "VRE"
    "VSTM4" "VTE" "VUSs" "VaD" "Valverde" "Van-der-Waals" "Vassilopoulos"
    "Vaziri" "Velos" "Venezuela" "Venn" "Ventura" "Venturin" "Venus"
    "Vergarajauregui" "Vi-CELL" "Vif" "Vif-A3G" "Vif-BC-Cul5" "Vif-CBF-β"
    "Vif-HDAC6" "Vif-non-targeted" "Villarroya" "Villarroya-Bletri" "Vina"
    "Virbasius" "Vita" "Vona" "VpreB" "Vranceanu" "Vybrant" "W+W" "W5" "W55A"
    "WBCs" "WCL" "WEHI" "WEHI-539" "WGS" "WHCO1" "WHI" "WHI-CT" "WIBR#3"
    "WK298" "WST-1" "WT-ELMO1" "WT-Mcl-1" "WT-Raichu" "WT-mCherry" "WT5" "WT6"
    "WT7" "WWP-2" "WYC0209" "Wacholder" "Waldenstrom" "Waldenstrom's" "Wallis"
    "Warburg" "Warner" "Wasson" "Watson" "Watson-Crick" "Watson–Crick" "Webb"
    "Weigel" "Weinberg" "Weindruch" "Weiss" "Well-differentiated" "Wen-fu"
    "Wesierska" "Wesierska-Gadek" "Western" "Western-blot" "Whitney"
    "Whole-exome" "Whyte" "WikiPathway" "Wilcoxon" "Wilks" "Wilma" "Wilson"
    "Wiscott-Aldrich" "Wnt-5α" "Wnt5ɑ" "Wong" "Wong-Riley" "Woude" "Woyach"
    "Wu" "Wuhan" "X-inactivation" "X-irradiation" "X-ray" "X-rays" "X4-tropic"
    "XAV" "XAV-939" "XBP-1s" "XF" "XIX" "XP-V" "XPA-DNA" "XPA-photodamage"
    "XRCC1-proficient" "XTT" "XX" "Xaa" "Xavier" "XeNA" "Xia" "Xinjiang" "Xu"
    "Xue" "Y-box" "Y-family" "Y1173" "Y1173F" "Y204" "Y537" "Y537F" "Y720F"
    "Y724F" "YAPsh" "YM55" "YOK400" "YPD" "YPF" "YVMA" "YXM110" "Yamamoto"
    "Yang" "Yarar" "Yat" "Yat-Sen" "Yates" "Yes-associated" "Yi" "Yoshiara"
    "Youden" "Yu" "Z-DEVD-FMK" "Z-VDDADFMK" "Z-axis" "Z-test" "ZDOCK" "Zeitels"
    "Zhan" "Zhang" "Zhao" "Zhou" "Zhu" "Zhuang" "Zhuo" "Zn" "Zn-superoxide"
    "ZnF" "ZnF-UBP" "ZnSOD" "Zon" "a-KG" "aPKCs" "aa1209-1362" "above-defined"
    "above-listed" "absorbance" "absorbate" "accumulation-defective"
    "acetamide" "acetoacetate" "acetyl-Coenzyme" "acetyl-H3" "acetyl-Lys"
    "acetyl-hnRNP" "acetyl-hnRNPs" "acetyl-lysine" "acetyl-lysine-binding"
    "acetylcholine" "acetylome" "acid-containing" "acid-dependent" "acid-like"
    "acid-sensitive" "acinar-ductal" "acinar-like" "acinar-to-ductal"
    "actinomyosin" "activation‐induced" "activator-like" "activators"
    "active-site" "activity-contingent" "activity-the" "acyl" "adaphostin"
    "add-on" "adduct" "adducts" "adenoid" "adenoma-adenocarcinoma"
    "adenoma-carcinoma" "adenyl" "adenylate" "adenylyl" "adhesion-based"
    "adhesiveness" "adipose-derived" "adult-onset" "advSM" "advanced-stage"
    "advancements" "aediculatus" "aeruginosa" "affibodies" "agar"
    "age-associated" "age-dependence" "age-dependent" "age-driven" "agents"
    "aggregate-associate" "aggresome-autophagic" "aggresome-autophagy"
    "agianst" "agonism" "air–liquid" "alarmin" "albuminoid" "aldo-keto"
    "algorithm" "algorithms" "algoritm" "alkyl" "alkylguanine" "alkylpurine"
    "all-around" "all-atom" "all-or-none" "allantoid" "alles"
    "alllylaminogeldanamycin" "alpha-albumin" "alpha-helical"
    "alpha-naphtoflavone" "alphavbeta3" "alternative-lengthening" "alveoli"
    "amines" "amino-acid" "amino-acids" "amino-terminal" "aminoacid"
    "aminoacyl" "aminobenzamide" "amoeboid" "amphisomes" "amplicon" "amplicons"
    "amylacea" "analogue-induced" "and-6" "andCep63" "andPTEN" "andSNF1A"
    "androsta" "androsta-5" "andthe" "anemicus" "aneuploid" "aneuploidies"
    "aneuploidy" "aneurysm" "aneurysms-osteoarthritis" "angiography" "angiomas"
    "angle-closure" "anisoptropy" "anisotropy" "annulus" "anorexia" "anosmia"
    "anoxia" "antagomiRs" "antagomir" "anterior-derived" "anterior-like"
    "anterior-posterior" "anterograde" "anthrocycline" "antibody-drug"
    "antibody-trastuzumab" "anticalins" "antigen-DR4" "antiparallel"
    "antisense-oligonucleotide-mediated" "antitumour" "antivirus"
    "antracyclines" "aorta-gonad-mesonephros" "apical-basal"
    "apical-basolateral" "apical-lateral" "apico" "apico-basal" "apocrine"
    "apoptotic-like" "appropriateness" "apraxia" "aptamers"
    "apurinic–apyrimidinic" "arisen" "armamentarium" "aroylthiourea"
    "arrest-specific" "arrytmhia" "arteriole" "arteriosus" "arylhydrocarbon"
    "as-says" "assay-by-design" "assay-immunoprecipitation" "asthma-like"
    "at-risk" "athanogene" "athway" "ation" "atypia" "austrabailignan-1"
    "austrobailigan" "austrobailigan-1-induced" "austrobailignan-1"
    "austrobalignan" "austrobalignan-1-induced" "autofocus"
    "autophagic-related" "autophagy-footprint" "autophagy-footprints"
    "autophagy-incompetent" "autophasome" "autophasome-lysosome"
    "autoradiography" "autosomal-recessive" "autrobailignan-1" "avariety"
    "axial" "axilla" "axon" "a–c" "a–d" "a–f" "a–g" "bKO" "baPWV" "baPWVs"
    "backcross" "backcrosses" "bafilomycin" "band-pass" "bar-eyed" "basal-A"
    "basal-B" "basal-like" "basalis" "base-excision" "base-pairs"
    "basic-helix-loop-helix-leucine" "bead–cell" "begun" "benzoporphyrin"
    "beta-barrel" "bi-allelic" "bi-directional" "bi-functional"
    "bi-orientation" "bifid" "bifida" "bilayer" "bilayers" "biliverdin"
    "binder-1" "binding-defective" "binding-partner" "binucleate"
    "bio-function" "bio-informatic" "bio-informaticly" "bio-layer" "bio-marker"
    "bio-markers" "bioimager" "bioinformatics-based" "biomass" "biomembrane"
    "biomolecules" "biospecimen" "biosuperiors" "biotin" "biotin-TEG"
    "bis-chloroethyl" "bisphosphate" "bivariate" "blocker" "blockers"
    "blood-brain" "blood-forming" "bodies-and" "bonafide" "bone-marrow"
    "bothPTEN" "bottleneck-like" "bottom-left" "botulinum" "box-containing"
    "bp" "brachyury" "brain-trophic" "brainstem" "break-apart" "breakapart"
    "bright-field" "brighter" "brightest" "broader" "broadly-expressed"
    "bubble-like" "build-up" "bulkiness" "bund" "bundlers" "burden-related"
    "burst-forming" "butoxypurine" "bwa" "by-products" "byCep63"
    "c-Cbl-mediated" "c-GPX4" "c-Myb-Dam" "c-Myb-footprints" "c-Src-dependent"
    "c-Src-mediated" "c-depleted" "c-depletion" "c-targeted" "cAMP-RE-binding"
    "cBio" "cDNA" "cGAMP" "cIMT" "cIV" "cPKCs" "cadmium-induced"
    "cadmium-treated" "café" "café‐au‐lait" "calcusyn"
    "calorically-unrestricted" "calorie-restriction" "calorimetry"
    "camptothecan" "cancer-mesothelial" "canditate" "caner" "cap-adjacent"
    "cap-dependent" "cap-independent" "cap-structure" "capillary-like" "capita"
    "cappers" "capsid" "carbaNAD" "carbamidomethyl" "carbamoly-phosphate"
    "carbohydrate-glycan" "carbohydrate-recognition" "carbon-13" "carbonyl"
    "carboxi" "carboxi-terminal" "carboxyfluorescein" "carboxyl"
    "carboxyl-terminal" "carboxylcytosine" "carcinogenesis–e" "cardia"
    "cardiac-fibrosis-related" "cardiac-related" "cardiac-specific"
    "cardiomyopathies" "cargos" "carinatum" "carnitine" "carotid" "carriers"
    "cartoon-like" "cartwheel-dependent" "case-control" "case-only"
    "case–control" "casitas" "castaneum" "catabolites" "catalyse" "catalysers"
    "catenations" "caveolion-1" "caveosome" "ceRNA" "ceRNAs" "cell-autonomous"
    "cell-cycle-dependent" "cell-like" "cell-permeable" "cell-to-ECM"
    "cell-to-cell" "cell-type-specific" "cells" "cellswere" "cellulin"
    "cellulo" "centriole" "centromere" "cerebella" "cerebellum" "cerevisae"
    "cerevisiae" "charcoal-stripped" "checkpoint-independent"
    "chemically-induced" "chemo" "chemo-radiotherapy" "chemo-sensitivity"
    "chemo-sensitizer" "chemo-therapies" "chemo-therapy" "chemoattractant"
    "chemokine-like" "chemoradiotherapy" "chemoresistance" "chemoresistant"
    "chemosensitiviy" "chemotherapy+pemetrexed" "chemotherapy+taxane"
    "chemotypes" "chi-square" "chimerism" "chlorodeoxyuridine" "chloroethyl"
    "cholesterol-induced" "cholesteroyl" "choline" "chosen" "chr17" "chromatid"
    "chromatids" "chromosome-proximal" "chronically-inhaled" "ciliate"
    "circuitry" "cis-Diaminedichloroplatinum" "cis-elements" "cis-interactions"
    "cis-interface" "cis-oligomerization" "classes" "classic-DHL" "classifier"
    "clear-cell" "clear-cut" "clear-off" "clears-off" "clevage"
    "clinic-biologic" "clinic-biological" "clinic-pathologic"
    "clinical-pathologic" "clinically-annotated" "clinicians" "clinico"
    "clinico-pathological" "clinicopathologic-risk" "cloroethyl" "close-range"
    "closely-associated" "closely-related" "coarse-grained" "codingRNA"
    "codominant" "codon1333" "coefficient-Rr" "coenzymes" "cofilin-S3D"
    "coiled-coil" "cold-stable" "coli" "colitis-associated" "collagen-like"
    "collagen1A1" "collagens" "colony-forming" "colony-initiating" "colorectum"
    "colostrums" "combination-chemotherapy" "combination-treated" "comedo"
    "comigrate" "comigrates" "commonalities" "commonly-used" "comorbid"
    "comorbidities" "compartment-specific" "compartmentalise"
    "competing-networks" "competition-binding" "competitive-binding"
    "complex-1" "complications" "compound-dependent" "compound-induced"
    "compound-specific" "compression-induced" "concentration-dependently"
    "concentration-survival" "concentration-time" "concomittant" "confounder"
    "confounders" "congenita" "continuum" "contractility-induced"
    "contraindications" "control-Si-RNA" "copy-number" "cornmeal-yeasted"
    "corticosteroid" "corticosteroids" "cost-effective" "counter-receptor"
    "counterregulate" "covalently-linked" "covariance" "covariate" "covariates"
    "coworkers" "cox-regression" "cox–regression" "co‐cultured" "crizontinib"
    "crizotynib" "cross-activation" "cross-interacts" "cross-phosphorylation"
    "cross-react" "cross-reacting" "cross-reactivity" "cross-regulation"
    "cross-resistance" "cross-sample" "cross-sectional" "crosslinkers"
    "crossover" "crystal-derived" "ctDNA" "cullin-RING" "cuminata" "curvatures"
    "cut-off" "cut-offs" "cuvette" "cyan" "cyclohexamide"
    "cycloheximide-treatments" "cyclophillin" "cyclopyrimidine" "cyle"
    "cyropyrin" "cystectomy" "cysteine-thiol" "cysteine–glutamate" "cysteinyl"
    "cysteinyl-phosphate" "cystiene" "cystine-knot" "cytidine-to-thymidine"
    "cyto" "cyto-skeletal" "cytochromes" "cytocrhome" "cytokine-independency"
    "cytology" "cytomembrane" "cytopenias" "cytostatics-disrupting" "dGrb2"
    "dL" "dT4-ring" "dU" "dabrafenib-trametinib" "damage-34"
    "damage-associated" "damage-based" "damage-dependent" "damage-induced"
    "damage-inducing" "damage-mediated" "damage-responsive" "danger-associated"
    "data" "dataset" "datasets" "days-post" "dbSNP" "dbSNP137" "dbSNP139"
    "dbap" "dblA" "ddGTP" "de-differentiated" "de-escalate" "de-identified"
    "de-novo" "de-proteinization" "de-regulated" "de-regulation" "de-repress"
    "deacetylase-dead" "deacetylase-dependent" "deacetylase-independent"
    "deacetylase-ubiquitin-specific" "deacylases" "dead-mutant"
    "deadenylation-dependent" "death-signaling" "deconvolute" "decouple"
    "decouples" "decubitus" "deeper" "defactinib" "deferens" "deficiencey"
    "degeneration-like" "degron" "degrons" "dehydrogenase-A" "del417–418"
    "del419" "del5395" "del559–560" "deleter" "deletions" "delta-delta"
    "denaturant" "deoxynucleotides" "deoxynucleotidyl" "deoxyuridine"
    "dependnet" "dephos" "dephos-phorylation" "depolymerizers"
    "deprivation-induced" "der" "derepresses" "dermatomes" "desaturase-1"
    "desoxyribo" "deubiquitylate" "diacyl" "dichlorodihydrofluorescein"
    "dichlorofluorescein" "dichroism" "dien-28-oate" "diene" "diet-fed"
    "diet-induced" "differently-whereas" "difficile" "difficult-to-treat"
    "dihydrorhod-2" "dihydrorhodamine" "dileneate" "dimer-to-monomer"
    "dimeric–monomeric" "dimerise" "dimerization-defective" "dimethylsulfoxide"
    "dinucleotides" "dioxygenases" "diphosphate" "diploid" "diploidy"
    "diploteneCep63" "dipole" "dipole–dipole" "discrepant" "disease-preventive"
    "dismutase-induced" "dismutes" "displayes" "distal-specific"
    "distribution-increased" "dithiocarbamate" "dithiolethione"
    "dithiolethiones" "dithiotheitol" "docetaxel+placebo"
    "docetaxel-capecitabine" "doi" "domain-domain" "domains"
    "dominant-activating" "dominant-negative" "dominant-negatively"
    "dominant‐negative" "donor-based" "donor-derived" "donor-leukocyte"
    "donor-recipient" "dormancy" "dosage-dependent" "dose-and"
    "dose-dependently" "dose-escalation" "dose-intense" "dose-response"
    "dose–response" "dot-like" "double-blind" "double-exponential"
    "double-knockdown" "double-knockout-mice" "double-label" "double-membrane"
    "double-minute" "double-mutant" "double-phosphodeficient"
    "double-precision" "double-strand" "doublings" "down-modulates"
    "down-modulation" "down-stream" "downregualte" "downshift" "dowstream"
    "drawbacks" "drawn" "droplet" "droplets" "dsDNA" "dsDNAs"
    "dual-phosphatase" "dual-specific" "ductus" "dwarfism" "dyn"
    "dysbindin-1A-EGFP" "dysbindin-1A-NLS" "dysbindin-1A-NLS-EGFP"
    "dysbinin-1A" "dyscrasias" "dyslipidemia" "dysmorphia" "dysmorphism"
    "dysplasia" "dyspraxia" "d–f" "e-Drug" "e-box" "eIF3-subunits" "eIF3bT668P"
    "eIF3c-depleted" "eIF3cP309T" "eIF4E-4EBP1" "eIFs" "eLife" "early-onset"
    "early-passage" "early-stage" "ecdysone" "echocardiography" "ectoderm"
    "ectodomain" "ectopically-expressed" "ed" "edema" "eight-week-old"
    "eightfold" "element-binding" "elomere" "elongation-competent"
    "elongin-C–elongin-B–cullin-2–E3-ubiquitin-ligase" "empty-vector"
    "emtasime" "enantiomer" "end-of-study" "end-of-treatment" "end-stage"
    "endocardium" "endocrinology" "endocrinotherapy" "endoderm" "endokinins"
    "endometrioid" "endometrium" "endometroid" "endonuclese"
    "endoplasmic-reticulum-associated" "endothelial-cell" "endothelial-derived"
    "endothelial-like" "endpoint" "endpoints" "end–directed" "enhancer"
    "enhancer-binding" "enthalpies" "enthalpy" "enthalpy–entropy" "entropies"
    "entropy" "environment-associated" "enzyme-substrate" "enzymes"
    "eosinophil" "eosinophilia" "eosinophils" "epPCR" "ependinomas" "ephrinA"
    "ephrinB1-induced" "epidemoid" "epidermoid" "epigallocathequin"
    "epigallocathequin-3-gallate" "epigenome" "epithelia" "epithelial-cell"
    "epithelial-derived" "epithelial-like" "epithelial-mesenchymal"
    "epithelial-mesenchyme" "epithelial-specific" "epithelial-to-mesenchymal"
    "epithelial–mesenchymal" "epithelioid" "epithelium" "epitopes" "erine"
    "errorless" "erythematosus" "erythro" "erythrocytes" "erythroid-like"
    "erythroleukaemia" "erythromyeloid" "esophagectomy" "estimations"
    "estrogen-only" "et" "ethnic-matched" "ethnic-specific"
    "ethnicity-specific" "ethnicity-wise" "ethynly-deoxyuridine" "et "
    "eukarya" "eumelanin" "evel" "eventhough" "ever-growing"
    "evolutionarily-conserved" "ex" "ex-vivo" "ex19del" "exRNA" "excavatum"
    "exclusion-inclusion" "exoenzyme" "exome" "exon-3" "exon7" "exons"
    "exosomal-delivered" "exosome" "expressers" "expression-levels"
    "expressionis" "expressors" "expressrf" "extra-OH" "extra-VZ" "extra-long"
    "extra-medullary" "extra-mitochondrial" "extra-nuclear" "extra-nucleus"
    "extra-renal" "extra-terminal" "extracellular-signal-regulated"
    "extramembrane" "eﬀects" "fAR" "fAR-Mdm2" "face-to-face" "factor-2"
    "factor-kB" "factor-ҡB" "factors" "facture" "fail-safe" "fallen" "family-1"
    "far-reaching" "far-ultraviolet" "fast-flow" "fast-growing"
    "fastest-migrating" "favism" "fda" "febrifuga" "febrifugine" "feed-back"
    "feedforward" "feedforward-signaling" "ferrodoxin-like"
    "fibrillation-induced" "fibro" "fibro-fatty" "fibroblast-like" "fibrofatty"
    "fibronecin" "fibronectin-1" "fibrosus" "filopodia-like" "fine-grained"
    "fine-needle" "fine-tune" "fine-tuned" "fine-tuning" "finger-like"
    "first-degree" "first-generation" "first-in-class" "first-in-human"
    "first-line" "first-order" "first-time" "five-to" "five-year"
    "flagellin-dependent" "flammei" "flow-induced" "flow-mediated" "flowchart"
    "fluorescein–TAMRA" "fluorescently-labelled" "fluorobenzyl" "fluorophore"
    "fluorophores" "fluoroprotein" "fluorothymidine" "flurouracil" "foam-cell"
    "foldases" "folic" "follicle" "follicles" "follow-up" "follow-ups"
    "forebrain" "forelimb" "fork-associated" "fork-head" "fork-recruitment"
    "formulawhere" "formylcytosine" "four-gene" "four-step" "four-way"
    "four-week" "fragile-site" "frame-shift" "frameshift" "frameshifts"
    "free-energy" "friction-based" "fromCep63" "front-edge" "front–back"
    "front–rear" "front–rear-polarized" "frozen" "fu" "full-proof" "full-size"
    "full-term" "full-thickness" "full-time" "fully-grown" "fumarate"
    "fumarates" "func" "functionalis" "furan-2-yl" "furan-2-yl-carbonyl"
    "furthest" "gDNA" "gDNAs" "gain-of-function" "gain‐of‐function" "galectin"
    "gallate" "gallbladder" "gamitrinib" "gamma-knife" "gap-junctional"
    "gap-repair" "gapdh" "gargarizans" "gastric-specific" "gastro"
    "gastro-intestinal" "gatekeeper" "gatekeepers" "gc" "gc-globulin"
    "gel-like" "gender-specific" "gene-dosage" "gene-environment" "gene-gene"
    "gene-level" "gene-soybean" "genes" "genetically-modified"
    "gene–environment" "gene–gene" "genic" "genome-wide" "genome-widely"
    "genotype" "genotype-phenotype" "genotypes" "genotype–phenotype"
    "geometries" "geranylgeranylacetone" "germ-line" "germline" "glia"
    "glioblastom" "globet" "globulin" "glomerulonephritis" "glucolipid"
    "glucose+palmitate" "glucose-to-lactate" "glucose-to-pyruvate"
    "glucuronosyl" "glutamylcysteine" "glutathione-S-transferases" "gluymine"
    "glycan" "glycans" "glycolysis-OXPHOS" "glycosyl-phosphatidyl-inisotol"
    "goes" "gonad" "gonads" "gone" "gonioscopy" "goosecoid" "grade+0.448"
    "grade-modified" "granulosa" "gravity-driven" "greater" "greatest"
    "group-wise" "grwoth" "guanylyl" "h-treatment" "h1–h4" "h2+1" "hCD45"
    "hERO1-La" "hERO1-Lb" "hESC" "hESCs" "hEST1B" "hKIS" "hMSC–FaDu"
    "hMSC–tumor" "hPSC" "hPSCs" "hR-3" "hSIRT1cd" "hTERT-MKRN1-E3" "hTERT2"
    "hTR-telomere" "hVEGF" "hairpin-RNA" "half-life" "half-lives"
    "half-maximal" "half-submersed" "haplo" "haplo-insufficiency"
    "haploinsufficiency-induced" "haplotype" "haplotypes" "has-miR-137"
    "head-to-head" "health-span" "healthspan" "heart-forming"
    "heat-inactivated" "heat-induced" "heat-shock" "heat-shock-protein"
    "heat-treated" "heathy" "heatmap" "heatmaps" "heavier" "helices" "helix"
    "hemacytometer" "hemato" "hemato-endothelial" "hemi"
    "hemogenic-endothelial" "hemokinins" "henryi" "hepatectomy" "hepatotoxin"
    "herry" "hetero" "hetero-oligomer" "heterocomplex" "heterocomplexes"
    "heteroduplex" "heteroduplexes" "heterotetramer" "heterotetramers"
    "heterozygote" "hexamers" "hexanucleotide" "hg19" "hiPSC-CM" "hidden"
    "high-affinity" "high-cholesterol" "high-density" "high-dose"
    "high-expression" "high-flow" "high-grade" "high-incidence" "high-level"
    "high-miR-182" "high-power" "high-purity" "high-quality" "high-resolution"
    "high-risk" "high-volume" "higher-density" "higher-grade" "highest-scoring"
    "highgrade" "highly-conserved" "hind-limb" "hindlimb" "hindlimbs"
    "histological-pathological" "histology" "histoscores" "histotypes" "hnRNPI"
    "hnRNPs" "hnRNPΙ" "hoc" "holo" "holo-cII" "homeodomain" "hominoid"
    "hominoids" "homo-multimerize" "homo-oligonucleotides" "homogenates"
    "homolog" "homolog-1" "homologs" "homozygote" "homozygotes"
    "hormonal-sensitive" "hormonally-responsive" "hormone-naïve" "host-microbe"
    "host-virus" "hot-spot" "hot-spots" "hotspot" "hotspots" "hr"
    "hsa-miR-193b-3p" "hsa-miR-34b" "hsa-miR-449a" "hydatidiform"
    "hydroethidine" "hydrogen-bond" "hydrogen-deuterium" "hydrogen-exchange"
    "hydrogen–bond" "hydrogen–deuterium-exchange" "hydrolase-like" "hydroxy"
    "hydroxyanisol" "hydroxycamptothecine" "hydroxyl" "hydroxymethylcytosine"
    "hydroxyphenyl" "hyper" "hyper-activity" "hyper-mutation"
    "hyper-proliferative" "hyper-sensitization" "hyperdiploidy" "hypermutant"
    "hypermutations" "hyperplasia-adenoma-carcinoma" "hyperresponsiveness"
    "hypodiploid" "hypoglycemia" "hyposmia" "hypotestosteronemia"
    "hypotriploid" "hypoxic-induced" "hypoximiRs" "hyrax" "i-CDK9-induced"
    "i-CDK9-mediated" "i-CDK9-treated" "i-CDK9-untreated" "iBET" "iBET-151"
    "iPOND" "iPSC-CM" "iTRAQ" "iTRAQ-8plex" "ibosome" "identifier" "idock" "ie"
    "ii" "iii" "iliac" "imidazole" "immediately-applicable" "immotile"
    "immune-magnetic" "immune-related" "immune-response" "immune-staining"
    "immuno" "immunochemistry" "immunoconjugate" "immunocytes"
    "immunocytochemistry" "immunofluorescense" "immunoglobulin"
    "immunohistochemistry" "immunophenotype" "immunoprecipitations"
    "immunoprecipitation–quantitative" "immunoreagents" "immunostainings"
    "immunotherapy" "immunprecipitate" "in-depth" "in-detailed" "in-frame"
    "in-house" "in-line" "in-out" "in-silico" "in-situ" "in-turn" "in-vitro"
    "in-vivo" "in9patientsin" "inCep63" "inKRAS" "inPten" "incompleteness"
    "indel" "indels" "independently-derived" "indivisuals" "indozoles"
    "induced-acetylation" "induced-pluripotent" "inductin" "infection-induced"
    "infectiousness" "infectiveness" "inflammation-associated"
    "inflammation-induced" "inflammation-like" "inflammatory-related"
    "infleunces" "inframe" "inhibitorSNS" "inhibitorSNS-032" "inositide"
    "inover" "insATTG" "insertions" "inside-out" "insulin-dependent"
    "insulin-independent" "insulin-induced" "insulin-like" "insulin-responsive"
    "int" "intactness" "integrators" "intensity-modulated" "inter-SH2"
    "inter-individual" "inter-kinetochore" "inter-origin" "inter-repeat"
    "inter-study" "inter-vertebral" "interaction-defective" "interactome"
    "interferometry" "interleukin-1B" "interleukine-1β" "intermediate-risk"
    "intermembrane" "interobserver" "interstrand" "interwoven" "intima-media"
    "intoα-helices" "intra" "intra-RNA" "intra-abdominal" "intra-cardiac"
    "intra-chromosomal" "intra-epithelial" "intra-peritoneal" "intra-repeat"
    "intra-tumoral" "intracardiac" "intracarotid" "intracrine" "intragland"
    "intralocus" "intramembrane" "intron-1" "intron-exon" "inv-16"
    "invadosomes" "invariance" "invariant" "invasion-inhibiting"
    "invasion-related" "investigator-assessed" "in‐frame" "ionic" "ionmycin"
    "ischemia-reperfusion" "ischemia–reperfusion" "isoenzyme" "isoenzymes"
    "isoflurane" "isoform‐specific" "isomer" "isomers" "isomiRs" "isoquinolin"
    "isoquinolin-5-one" "isotopologues" "isotype" "isozyme" "isozymes" "istar"
    "itochondria" "iv" "iview" "junction-like" "juxta" "juxta-tumoral"
    "juxtacrine" "kBp" "kV" "kappa-B" "kappa-light-chain-enhancer" "karyotype"
    "karyotypes" "kcal" "kcal " "kelch-like" "keratinoctyes" "keratinocyes"
    "keto" "kg" "kilobases" "kinase-3" "kinase-dead-Akt" "kinases-A"
    "kinetochore-recognition" "knock-down" "knock-in" "knocked-down" "knockin"
    "knocout" "kymograph" "l-OHP-induced" "l-type" "lactose" "lacunes" "laevis"
    "lambda" "lamella" "lamellipodia-like" "lamina" "laminin-5" "large-scale"
    "larger-sized" "late-corticogenesis" "late-endosomes" "late-evolving"
    "late-life" "late-onset" "late-passage" "late-replicated" "late-stage"
    "leader-bleb" "leader-bleb-based" "left-anterior" "leftmost" "lemnae"
    "lenti-BRCA1" "lenti-vector" "lentiviral-mediated" "lesion-associated"
    "lesions" "less-well-conserved" "let-7a" "let-7a-2" "leukcytes"
    "leukoencephalopathy" "liang" "libitum" "life-long" "lifespan"
    "ligand-receptor" "ligand–receptor" "ligase-substrate" "lignin" "like-a"
    "limma" "line-by-line" "lineage-dependency" "lineage-negative"
    "lineage-specific" "linewidth" "linker-less" "lipid-laden" "lipofectamine"
    "lipofuscin" "lipolysacharride" "lipopolysaccharide" "lipoproteins"
    "liposome" "lipotropy" "littermate" "littermates" "live-cell" "lo"
    "lobules" "locked-nucleic" "locus-specific" "log-linear" "log2"
    "logarithmically-growing" "long-chain" "long-extending" "long-lived"
    "long-living" "long-noncoding" "long-pass" "long-range" "long-surviving"
    "long-time" "longer-term" "loss-of" "loss-of-function" "loss‐of‐function"
    "loureirin" "low-adhesion" "low-affinity" "low-carbohydrate" "low-cost"
    "low-density" "low-dose" "low-expression" "low-expressors" "low-frequency"
    "low-grade" "low-intracellular" "low-level" "low-magnitude" "low-miR-182"
    "low-nanomolar" "low-penetrance" "low-risk" "low-specificity"
    "low-to-absent" "low-to-high" "lower-MW" "lower-abundance" "lower-density"
    "lower-grade" "lpr" "lsy6" "lucitanib" "luminescence-based" "lupron"
    "lutea" "lymph-node" "lymph-nodes" "lymphatic-invasive" "lymphoblastoid"
    "lymphoma-2" "lymphoma-2-like" "lymphotoxins" "lysis" "lytic-cycle"
    "m-GPX4" "m-old" "mAb414" "mCRPC" "mCherry-GFP-LC3-transfected" "mEGFP"
    "mEos" "mEps8" "mGrb2" "mHaeIII" "mRFP-GFP-LC3B" "mRFP-H2B" "mROS" "mTERC"
    "mTERT" "mTOR-S6K1-S6" "mTOR-S6K1-signaling" "mTOR-ULK" "mTOR-activity"
    "mTOR-eIF3-S6K1" "mTOR-mediated" "mTORC1-mediated" "mU"
    "machinery–associated" "macrophage-like" "macules" "make-up" "make‐up"
    "mal-orientation" "malattachments" "maleCep63" "malformation-arteriovenous"
    "malformation-induced" "mammoplasty" "mammospheres" "mannose-6" "manyCep63"
    "mapper" "mastectomy" "matrix-destructive" "matrixgel" "maytansanoid"
    "mdivi-1" "mean±s" "mean ± S" "mechanisms" "mechano" "melanin"
    "melanogaster" "melatonin" "mellitus" "membrane-impermeable"
    "membrane-permeable" "membrane-substratum" "memory-type" "meningomyelocele"
    "merkel" "mesenchymal-epithelial" "mesenchymal-like"
    "mesenchymal-to-amoeboid" "mesenchymal-to-epithelial"
    "mesenchymal-to-leader" "mesenchyme" "mesendoderm" "mesentery" "meshwork"
    "mesoderm" "mesoporphyrin" "mesothelium" "meta-CF" "meta-levels"
    "meta-substitution" "metalloproteinases-9" "metaphase-anaphase"
    "metaspromotes" "metastases" "metastasise" "metastasises" "metastatectomy"
    "metfromin" "methanesulfonate" "methyl-1-hydroxy-2-naphthoate"
    "methyl-cytosine" "methyladenine" "methylation-dependant" "methylcytosine"
    "methylnicotinamide" "methylpiperazinyl" "methylsulfinylbutane" "miFinder"
    "miR+TNF-α" "miR-100" "miR-100-5p" "miR-101" "miR-101-binding" "miR-102"
    "miR-105" "miR-10a" "miR-10b-HDAC4" "miR-122" "miR-1246" "miR-128a"
    "miR-1290" "miR-130" "miR-130a" "miR-132" "miR-133" "miR-133b" "miR-135b"
    "miR-137" "miR-137-transfected" "miR-137–enriched" "miR-137–treated"
    "miR-140" "miR-140-induced" "miR-141" "miR-143" "miR-144" "miR-145"
    "miR-146" "miR-146b-3p" "miR-153" "miR-155" "miR-15a" "miR-181" "miR-181b"
    "miR-182" "miR-183" "miR-183-EGR1-PTEN" "miR-192" "miR-193b-uPA" "miR-197"
    "miR-197-induced" "miR-198" "miR-200" "miR-200b" "miR-200s" "miR-200 s"
    "miR-205" "miR-206" "miR-208" "miR-20a" "miR-210" "miR-214-3p" "miR-222"
    "miR-223" "miR-224" "miR-23" "miR-23b" "miR-24" "miR-25" "miR-26" "miR-26a"
    "miR-26a-2" "miR-26b" "miR-27a" "miR-27b" "miR-28" "miR-30a" "miR-30e"
    "miR-31" "miR-3138" "miR-320" "miR-320a" "miR-320a-d" "miR-320b" "miR-320d"
    "miR-324-5p-inhibited" "miR-324-5p-overexpressing" "miR-324-5p-repressed"
    "miR-33" "miR-330-5p" "miR-34" "miR-34-deficient" "miR-34-mediated"
    "miR-342" "miR-34a-KO" "miR-34b-5p" "miR-34c" "miR-34c-5p" "miR-375"
    "miR-375-UBE3A" "miR-375-induced" "miR-381" "miR-423" "miR-423-5p"
    "miR-429" "miR-433" "miR-449" "miR-449a" "miR-451" "miR-497" "miR-519a"
    "miR-539" "miR-5702" "miR-603" "miR-612" "miR-612-inhibited"
    "miR-612-overexpressing" "miR-612-specific" "miR-630" "miR-708" "miR-802"
    "miR-9" "miR-9-3" "miR-9-3p" "miR-99b" "miR-scramble" "miR15-a" "miR34a"
    "miR34b" "miR34c" "miRDB" "miRNA" "miRNA-100" "miRNA-103" "miRNA-137"
    "miRNA-196a" "miRNA-23b" "miRNA-3686" "miRNA-593" "miRNA-612" "miRNA-CHIP"
    "miRNA141-driven" "miRNA222" "miRNA34" "miRWalk" "miRanda" "miRecords"
    "miScript" "micro-environment" "microRNA" "microRNA-10b" "microRNA-153"
    "microRNA-196a" "microRNA-26b" "microRNA-324-5p" "microRNA3686"
    "microbleeds" "microdomains" "microenvironment‐mediated" "microfuge"
    "micrographs" "microinfarcts" "microsatellite" "microscale" "microsurgery"
    "mid-gestation" "mid-log" "mid-neurogenesis" "mid-streak" "midpoints"
    "midzone" "milk-derived" "milk-induced" "milk-inducing" "millisecond"
    "mimosine" "mini-BH3" "mini-GIST" "mini-hSIRT1-STAC" "mini-hSIRT1s"
    "minichromosome" "minimally-oxidized" "miniproteins" "minus-strand" "mir"
    "mir-205-5p" "mir-21" "mir-26b" "mir3686" "mir3696" "mis-classification"
    "mis-segregation" "misattachments" "mispairs" "missense" "missenses"
    "mito-tracker" "mitochodria" "mitochondrial-dependent"
    "mitochondrial-derived" "mitochondrial-glycolytic" "mitochondrial-related"
    "mitochondrial-targeted" "mitochondrial-triggered" "mitogen-activated"
    "mitomiRs" "mitoribosome" "mitoribosomes" "mitoses" "mixed-lineage" "ml "
    "mobility-shift" "mock-plasmid" "mock-transduced" "moderate-intensity"
    "moderately-differentiated" "modulins" "moi" "molecularly-targeted"
    "molecule-1" "mono-adducts" "mono-alkylating" "mono-carbonyl"
    "mono-functional" "mono-polar" "mono-resistant" "mono-therapy"
    "mono-treatments" "monobodies" "monoclonals" "monocyte-derived"
    "monocyte-to-macrophage" "monodansylcadav" "monodansylcadav-erine"
    "monohydrate" "monolayer" "monomethylates" "monosome" "monosomy"
    "monotherapy" "monotreatments" "mood-enhancing" "mortem" "motifs" "motile"
    "motoneuronse" "motorneurons" "mucolipin" "mucosa" "multi-cancer"
    "multi-combination" "multi-drug" "multi-factorial" "multi-functional"
    "multi-gene" "multi-institutional" "multi-level" "multi-lineage"
    "multi-modal" "multi-modulator" "multi-omics" "multi-organ" "multi-parity"
    "multi-polar" "multi-protein" "multi-stage" "multi-step" "multi-subunit"
    "multi-therapeutic" "multi-tumour" "multicenter" "multiligand"
    "multilineage" "multiorgan" "multiplate" "multiple-drug"
    "multiple-sequence" "multipoint" "multiprotein" "multisite" "multisystem"
    "multivariate" "muscle-invasive" "muscolaris" "musculus" "mutBRAF"
    "mutKRAS" "mutant-NLS-EGFP" "mutants" "mutations" "mutation‐positive"
    "myc-tag" "myeloid-gene" "myocardium" "myofibroblasts" "myristate" "myxoid"
    "myxovirus" "n=3" "n=9" "nCounter" "nM-as" "nPKCs" "nSH2-iSH2-cSH2"
    "nab-paclitaxel" "nanobodies" "nanoclusters" "nanodiamond" "nanoseconds"
    "nanosilver" "naphthalen-1-ol" "naphtho" "naphthochalcone" "napthoflavone"
    "nasopharynx" "natural-occurring" "naïve" "ncer" "ncomms8354" "ncomms8450"
    "ncomms8505" "ncomms8643" "ncomms8645" "ncomms8678" "ncomms8679"
    "ncomms8721" "ncomms8736" "ncomms8821" "ncomms8877" "near-complete"
    "near-to" "near-ubiquitous" "nearest" "necrostatin" "necrotic-like"
    "negative-image" "negative-sense" "negative-staining" "negatively-charged"
    "neoadjuvant" "neocortex" "neoformans" "neoplasias" "nephron" "nephropathy"
    "nephrotoxins" "neural-crest" "neuraxis" "neuritic-like" "neuroendocrine"
    "neuroepithelium" "neurokinin" "neurophysiology" "neuropil" "neurosphere"
    "neurospheres" "neutralise" "neutrally-charged" "neutropenia"
    "neutrophilia" "never-smokers" "newer" "newly-developed" "newly-diagnosed"
    "newly-identified" "next-generation" "niche-independent" "niche-like"
    "nidus" "ninhydrin" "nitro" "nitro-fatty" "nitropropionate" "nitrosoureas"
    "nmt" "nnnCG" "no-coding" "non-phospho-Src" "nonCM" "noncardia"
    "noncarriers" "nonendometrioid" "nonhistone" "nonhuman"
    "nonlymphatic-invasive" "nonmuscle" "nonobese" "nonog" "nonprotein"
    "nonrandom" "nonself" "nonself-reactive" "nonsense-mediated"
    "nonsignificant" "nonsmall" "nonstimulus" "nontarget" "nonthyroid"
    "nonusers" "non‐truncating" "noranhydro" "normal-hyperplastic-Ad-ACA"
    "not-yet-reached" "nrb" "nt" "nuclear-localization-defective" "nucleases"
    "nucleates" "nucleators" "nucleic-acid" "nucleo" "nucleofilaments"
    "nucleotide-excision" "numerically-improved" "nutrient-poor"
    "nutrient-replete" "octamers" "octylglucoside" "ofCep63" "ofHECTD2"
    "ofSiCCND2" "ofcould" "off-center" "off-rate" "off-switch" "off-target"
    "off-targets" "offs" "ofinto" "ofmiR" "ofmiR-198" "ofto" "oligo" "oligoG"
    "oligoadenylate" "oligodeoxynucleotides" "oligopyrimidine" "oligos"
    "omentum" "omics" "on-beads" "on-off" "on-rate" "on-target" "on-treatment"
    "once-daily" "onco-promoter" "onco-promoters" "onco-protein"
    "onco-suppressive" "oncologists" "oncomiR" "oncoprotein-18" "oncosphere"
    "one-base" "one-dimensional" "one-electron" "one-sample" "one-step"
    "one-tailed" "one-third" "one-way" "one-year" "oneset" "one–as" "ontogeny"
    "oocytes" "oophorectomy" "open-angle" "open-source" "open-up"
    "operator-independent" "or-L" "orHECTD2" "organelle" "organelles"
    "organells" "organotropism" "organs" "orientation-specific" "origin-poor"
    "origine" "oro-pharyngeal" "ortho" "ortho-CF" "orthologue" "orthologues"
    "orthoxenopatients" "or–recurrent" "osTIR1" "osTIR1-9xMyc"
    "osteoblast-like" "osteoblasts" "osteopenia" "out-of-focus" "outside-in"
    "out‐of" "out‐of‐frame" "ovarian-specific" "over-activation" "over-actived"
    "over-aggregating" "over-deposition" "over-interpretation" "over-riding"
    "over-stated" "overtaken" "overview" "oxidases" "oxidatives" "oxo"
    "oxoglutarate" "oxy-radicals" "oxygen-dependant" "oxygen-deprivation"
    "oxygenase-1" "oxygens" "p100δ" "p21Waf1" "p22–21p23" "p249-DCP2" "p27Cip"
    "p27S10" "p27wt" "p38MAPK" "p50α" "p53-DNA" "p53-R175H-expressing"
    "p53-R273H-expressing" "p53-R273H-mediated" "p53-dependency"
    "p53-dependnet" "p53-family" "p53-null" "p53-proficient" "p53Knowledgebase"
    "p53NLS" "p53si-3" "p55α" "p60Cep63" "p73-dependant" "p73alpha" "p73beta"
    "p85α-PTEN" "p85αΔSH3" "p95HER2" "p=0.001" "p=0.013" "p=0.03" "p=0.039"
    "p=6.1" "pBABE-puro-TdTomato" "pC3T" "pCDNA3" "pCMV" "pCMV-CCND1"
    "pCMV-RFP-2A-puro" "pCR3.1" "pCR3.1-∆Np73-α" "pDRGFP" "pDsRed2-NI" "pECFP"
    "pEF-BOS-β-galactosidase" "pEGFPC2-MCOLN1" "pEGFR" "pEZX" "pEZX-MT05"
    "pFRS2" "pGFP" "pGIPZ" "pGL2basic" "pH" "pH2A" "pHER" "pH " "pIRES"
    "pIRES2-EGFP" "pIRESneo2" "pIRF3" "pK656E" "pM" "pMAPK" "pMEK" "pMIR"
    "pMIR-REPORT" "pMIR-REPORT-CCND2" "pMIR-REPORTRβ-gal" "pMagic7.1-Puro"
    "pMagic7.1-RNA" "pN" "pNL4.3" "pPCL" "pPCLs" "pPak1" "pPak2" "pPak4"
    "pRB-pathways" "pRS324UBG" "pRS324UBG-HDAC4c" "pRS325LexA-SRD3c"
    "pRSK-positive" "pRTR" "pRTR-SNAIL-VSV" "pRTR-p53-VSV" "pRhoA" "pS"
    "pS-EphA2" "pS-EphA2-negative" "pS19" "pS2056" "pS435" "pS73" "pS81" "pS87"
    "pSIH-H1" "pSMAD1" "pSMAD2" "pSOCS3" "pSTAT3-GS" "pSTAT3-postive" "pSTAT5"
    "pSTAT5-postive" "pSUPER" "pSer-897" "pSer2" "pSer715-MCAK" "pShc" "pStats"
    "pT-EGFR" "pT2" "pT2609" "pT2–pT4" "pT3" "pTNM" "pTNM6" "pThr210-PLK1"
    "pTyr-blot" "pVEGFR2" "pVgRXR" "pWPI" "pY-EphA2" "pY720" "pY724" "pY759"
    "pack-year" "pack-years" "packings" "pair-correlation" "pair-wise"
    "pairwise" "pan-HDACi" "pan-HDACis" "pan-cancer" "pan-endothelial"
    "pan-inhibitor" "pan-inhibitors" "pan-mesoderm" "pan-neural"
    "pancreaticobiliary-type" "pancreatitis" "panniculitis" "pan‐AKT"
    "paracrine" "paralogues" "parenchyma" "parity-associated" "parthanatos"
    "partial-thickness" "particles" "partten" "pateients" "patho"
    "pathogen-associated" "pathogenic-clinical" "pathogeniceffect"
    "pathophysiology" "pathway1" "pathway2" "pathways" "patientsin"
    "pattern-recognition" "pb" "pcDNA-Smad3" "pcDNA3" "pcFAK" "pcFlot-2"
    "pectus" "peltatum" "penetrance" "penetrant" "penta" "penta-coordinate"
    "pepsinogen" "peptidyl" "peptidyl-transferase" "per-allele" "per-cell"
    "per-sample" "perhaps" "peri-nuclear" "peri-operative" "peri-tumoral"
    "perimenopause" "peritoneum" "person-years" "perturbagens" "phagophore"
    "pharate" "pharmacophore" "phase-contrast" "phase-specific" "phastCons"
    "phastCons46wayPlacental" "phenethyl" "phenol-chloroform" "phenoxyanilino"
    "phenyl" "phenylmethylsulfonylfluoride" "pheomelanin" "pho-CDK2" "pho-Rb"
    "phophorylatedCdk1" "phophosite" "phoshoglycerate" "phosophopeptides"
    "phosphatidylinositol-di" "phosphocholine" "phosphodegron" "phosphodegrons"
    "phosphoinositide-3,4" "phosphoinositides" "phosphoisomers"
    "phospholipid–hydroperoxide" "phosphopeptide" "phosphory-lation"
    "phosphorylation-mimetic" "phosphorylationSer"
    "phosphorylationSer9-GSK-3βand" "phosphosites" "phosphostatus"
    "phosphotidylinositol" "phosphotidylinositol-4,5-bisphosphate"
    "phosphotyrosine-BSA" "phosphotyrosines" "phosphotyrosyl" "photo-converted"
    "photolesion-containing" "photomicrographs" "photoproduct" "photoproducts"
    "phsophorylates" "picoseconds" "pifithrin-α" "pilomyxoid" "pioneer-type"
    "piperacillin" "pitfalls" "pixels" "placebo+docetaxel" "placebo-controlled"
    "plaque-like" "plaque-rich" "plasmon" "platinum-doublet" "platinum-taxane"
    "pleomorphism" "plethysmography" "pleuromesotheliomas" "plexiform" "plugin"
    "plus-end" "pmirGLO-UBE3A-MUT" "pmirGLO-UBE3A-WTvector" "podophyllum"
    "point-spread" "poly-HEMA-treated" "poly-L-Lysine" "poly-glycine" "polyA"
    "polyG" "polyU" "polymorphism" "polymorphisms" "polymorphonuclears"
    "polypeptide-like" "polyphenol" "polyploid" "polypoloid" "polypyrimidine"
    "polysine" "polysomies" "polyvinylidenedifluoride" "pombe" "poor-risk"
    "poorer" "poorly-differentiated" "porphyrin" "port-wine" "porta"
    "positive-cells" "positive-regulatory" "positron" "post-EdU" "post-HCT"
    "post-KSHV" "post-burn" "post-cisplatin" "post-diagnosis" "post-endocytic"
    "post-gastrulation" "post-germinal" "post-heat" "post-hoc" "post-immune"
    "post-implantation" "post-induction" "post-infarction" "post-infection"
    "post-injection" "post-injury" "post-menopausal" "post-mitotic"
    "post-mortem" "post-operative" "post-polycythemia" "post-progression"
    "post-reaction" "post-relapse" "post-release" "post-surgical"
    "post-therapeutic" "post-transcriptional" "post-transcriptionally"
    "post-transfection" "post-translation" "post-translational"
    "post-translationally" "post-transplant" "post-treatment" "post-zygotic"
    "postbaseline" "postdose" "posterior-derived" "posterior-like" "postmortem"
    "potasium" "pp" "precipitation-based" "precomplexes" "precursor-ion"
    "precursor-like" "premalignancies" "premiR" "premiR-205" "pressure-driven"
    "pretangle" "pretangles" "preterm" "primaquine" "primer-terminus" "priori"
    "pro-IL-1β" "pro-MMP-9" "pro-aggresome" "pro-and" "pro-angiogenesis"
    "pro-atherogenic" "pro-collagen" "pro-death" "pro-fibrogenic"
    "pro-fibrotic" "pro-inflammatory" "pro-invasive" "pro-metastatic"
    "pro-monocytic" "pro-neoplastic" "pro-oncogene" "pro-peptide"
    "pro-survival" "pro-tumor" "pro-tumorigenic" "pro-tumourgenic" "proband"
    "probands" "procarbazin" "procaspase1" "procentriole" "procollagen"
    "prodeath" "proforms" "progenitor-specific" "progeny" "progestin"
    "prognose" "prognoses" "progressiong" "proliferative-hypoproliferative"
    "proliferative-quiescent" "proliferator-activated" "proline-rich"
    "prometaphase-like" "prometaphase-to-metaphase" "prominant"
    "promoter-mutation-containing" "promoter-proximal" "promoter-proximally"
    "promoter–Luc" "proof-of-concept" "propeptide" "proportional-hazards"
    "prostatectomy" "proteasome-degradative" "protein-10" "protein-1c"
    "protein-DNA" "protein-RNA" "protein-aggregate" "protein-interaction"
    "protein-laden" "protein-ligand" "protein-lipid" "protein-membrane"
    "protein-nucleic" "protein-transcript" "protein-tyrosine-phosphatases"
    "proteins" "protein–interaction" "protein–ligand" "protein–solvent"
    "proteome" "proteosome" "protien" "protomer" "protomers" "proven"
    "proving-their" "proximity-ligation" "pseudo-puberty" "pseudo-receptor"
    "pseudo-substrate" "pseudogene" "pteronyssinus" "ptfLC3" "pull-down"
    "pull-downs" "pulled-down" "pulling-down" "pulposus" "pulsatile"
    "pulse-chase" "punctae" "pupal" "pure-SM" "pyridin" "pyridin-2-ylmethyl"
    "pyridine" "pyruvate-to-lactate" "p = 0.001" "p = 0.002" "p = 0.03"
    "p≤0.01" "qChIP" "quadruplex" "quadruplexes" "quality-of-life" "qα" "rIFNs"
    "rIL1A" "rLGALS9" "rLGALS9–594" "rRNA" "rU4" "rU4r" "race-specific"
    "rad3-related" "radiation-induced" "radio-resistance-induced"
    "radiochemotherapy" "radioiodine" "radioresistance" "radioresistant"
    "radiosurgery" "random-effect" "random-effects" "range11–184" "rank-sum"
    "rapalogues" "rapamcyin" "rareCep63" "rarer" "ratio-dependent"
    "re-addition" "re-analyzed" "re-categorized" "re-challenged"
    "re-classified" "re-did" "re-directing" "re-distribution" "re-emphasized"
    "re-entry" "re-epithelialization" "re-escalate" "re-established"
    "re-establishing" "re-establishment" "re-evaluation" "re-examined"
    "re-express" "re-expressed" "re-expressing" "re-expression" "re-feeding"
    "re-genotyping" "re-grow" "re-imaged" "re-implanted" "re-import"
    "re-internalisation" "re-internalization" "re-introduction" "re-localized"
    "re-modeling" "re-opened" "re-oxidized" "re-plated" "re-plating"
    "re-probed" "re-probing" "re-sensitize" "re-sensitized" "re-sensitizes"
    "re-sensitizing" "re-stimulate" "re-stimulation" "reacquire"
    "reaction-restriction" "readout" "readouts" "realtime" "reassociate"
    "recepteur" "receptor-4" "receptor-corepressor" "receptor-gamma"
    "receptor-tyrosine-kinases" "red-green" "redundantly-targeted" "reenter"
    "refractile" "reggie" "region-leucine" "regressand" "regressors" "regrowth"
    "regulator-like" "regulators" "reinitiate" "reinitiates" "reinsert"
    "relapse-tumor" "relaxin-2" "remodellers" "repair–proficient"
    "repeat-containing" "repetitively-stretched" "replete-conditions"
    "replication-associated" "replication-dependent" "replication-derived"
    "replication-originated" "replicon" "repopulate" "reportd" "represseses"
    "repressors" "repurpose" "resistance-A" "resp" "responder" "responders"
    "reticulin-poor" "reticulum" "retinol" "retro" "reumatoid" "reverse-IP"
    "reverse-transcription" "revertants" "rhEREG" "rhIFN" "rhIFN-α" "ribo"
    "ribo-oligonucleotides" "ribose" "ribose-5-phosphate" "rightmost"
    "ring-like" "rip-offs" "risk-stratification" "rosea" "rosette-forming"
    "roseus" "rotamers" "rotein" "round-shaped" "rs10069690" "rs1042522"
    "rs1045485" "rs1048612" "rs107251" "rs10787899" "rs10983755" "rs11245007"
    "rs1143623" "rs1143627" "rs1143643" "rs11536878" "rs117039649" "rs12229892"
    "rs1234219" "rs12495941" "rs12572106" "rs12769316G" "rs12947788"
    "rs12999226" "rs1333040" "rs1544410" "rs17107001" "rs17228212" "rs17878362"
    "rs17884306" "rs1800858" "rs1801157" "rs1801276" "rs1801278" "rs1806649"
    "rs182052" "rs182455" "rs1849878" "rs1903858" "rs2070959" "rs2176040"
    "rs2228014" "rs2233406C" "rs2279744" "rs2289263" "rs2293050" "rs2295418"
    "rs2297630" "rs2299939" "rs2299941" "rs2383206" "rs2383207" "rs2494731"
    "rs2494743" "rs2498787" "rs2498794" "rs2673148" "rs2713538" "rs2713547"
    "rs2736100" "rs2736122" "rs2823093" "rs28362491" "rs28362491del"
    "rs28362491ins" "rs285366" "rs2853668" "rs2853669" "rs2886161" "rs28940581"
    "rs2943634" "rs2943641" "rs2943650" "rs3136820" "rs35352882" "rs35652124"
    "rs35874463" "rs360057" "rs3735590" "rs3789210" "rs3824830" "rs3825075"
    "rs3846662" "rs3846663" "rs3865188" "rs4246742" "rs4711690" "rs4975605"
    "rs4983387" "rs555895" "rs570278423" "rs6458238" "rs6565105" "rs662"
    "rs6721961" "rs6912200" "rs6939861" "rs6941539" "rs696" "rs696A" "rs696AA"
    "rs696G" "rs696GG" "rs7081569" "rs744166" "rs7557529" "rs7578326"
    "rs7784168" "rs9471643" "s" "s00401-015-1452-x" "s12864-015-1673-3"
    "s12885-015-1445-0" "s12885-015-1473-9" "s12885-015-1516-2"
    "s12885-015-1520-6" "s12885-015-1561-x" "s12885-015-1570-9"
    "s12916-015-0416-2" "s12929-015-0141-3" "s12943-015-0379-0"
    "s12943-015-0408-z" "s12943-015-0410-5" "s12958-015-0063-7"
    "s12964-015-0113-y" "s12967-015-0611-0" "s12977-015-0181-5"
    "s12977-015-0188-y" "s13024-015-0023-x" "s13046-015-0182-1"
    "s13058-015-0607-y" "s13287-015-0123-0" "s40246-015-0036-0"
    "s40291-015-0153-4" "sCTx" "sMTide" "sMTide-02" "sPCL" "sPCLs" "sTNF"
    "sTNF-R1" "salpingooophorectomy" "salt-bridge" "sarcospheres" "scFv-phage"
    "scape" "scintigraphy" "score≥1.5" "screenings" "second-degree"
    "second-generation" "second-hit" "second-labeled" "second-line"
    "second-most" "secretome" "self-DNA" "self-DNAs" "self-association"
    "self-defense" "self-digestion" "self-dsDNA" "self-dsDNAs" "self-limited"
    "self-organize" "self-regulating" "self-renew" "self-renewal"
    "self-ubiquitination" "selumetinib+docetaxel" "semi" "semi-quantitative"
    "semi-tryptic" "senesce" "senescence-associated-β-galactosidase"
    "senescence-competent" "senescence-like" "senescent-like" "sensitizer"
    "sensitizers" "sepantronium" "sequence-dependent" "sequence-independent"
    "sequence-specific" "serine-to-alanine" "serine-to-glycine" "serines"
    "serum-deprivation" "set-up" "severalCep63" "sex-body" "sex-cord"
    "sex-specific" "sgRNA" "sgRNAs" "shBRCA1" "shBRD4" "shCDA" "shCON" "shCx26"
    "shGPER" "shIKKβ" "shIL13Rα2#2" "shLuc" "shMET" "shMdmx" "shNC" "shNQO1"
    "shNQO1#1" "shNT" "shNrf2" "shPTEN" "shRNA271" "shSCR" "shSIRT1" "shStat3"
    "shTRAP1" "sheet-loop-helix" "shock-induced" "short-hairpin" "short-term"
    "shp21" "shpRb" "si01" "si02" "si02ResGFP-Mio" "siControl" "siCtrl"
    "siCyclin" "siGCN2" "siNT" "siPABPC1" "siPHD3" "siPak4" "siR-MAPK1" "siRNA"
    "siRNA-rescue" "siRNA2" "siRNA3" "siRNF31" "siSTAT5b" "siTERT"
    "side-by-side" "side-chain" "side-chains" "sigmoid" "sigmoideum"
    "signalling-competent" "signiﬁcant" "silencing-1-like" "silico"
    "similarly-designed" "single-allele" "single-allelic" "single-cell"
    "single-center" "single-channel" "single-gene" "single-mutant"
    "single-nucleoside" "single-nucleotide" "single-site" "single-strand"
    "single-substitution" "singleKRAS" "sip27" "sipuleucel" "sipuleucel-T"
    "sirtuin" "sirtuin-3" "sister-chromatid" "sister-chromatids"
    "sister-kinetochore" "situ" "six-stranded" "size+0.946" "size-exclusion"
    "size-fractionated" "skeleton-like" "skin-derived" "skinfold"
    "slippage-induced" "slit-lamp" "slow-exchange" "slow-migrating"
    "slow-release" "slower-migrating" "slowest-migrating" "smFLIM" "small-cell"
    "small-molecule" "small-scale" "smokers" "social-defeat" "socio"
    "socio-economic" "socio-economical" "soft-agar" "soft-tissue" "solute"
    "solutions" "solvent-accessible" "son-of-sevenless" "soybean-rich" "spacer"
    "spacio" "spacio-temportal" "spatio" "spatio-temporal" "specific-PCR"
    "specific-antagonists" "speck-like" "spectin" "spectrometer"
    "spectrophotometer" "speedup" "spermatagonia" "sphenoid" "sphere-derived"
    "sphingosine" "spike-like" "spina" "spindle-associated" "spindle-like"
    "splice-site" "split-thickness" "squamous-cell" "srIL-1R" "srep11497"
    "srep11588" "srep11614" "srep11620" "srep11765" "srep11999" "srep12116"
    "srep12204" "srep12230" "srep12520" "srep12580" "srep12642" "srep12793"
    "ss" "ssDNA" "stabile" "stabilty" "stage–I" "stainings" "stand-alone"
    "stathmin-1" "static-adapted" "status-dependent" "status-specific"
    "steady-state" "stellate" "stem
cell-like"
    "stem-cell-like" "stem-like" "stem-loop" "stemness" "stents" "step-wise"
    "stereoisomers" "steroid-independent" "stimuli" "stopgain"
    "stratification-based" "stress-induced" "stress-inducing" "stress-mediated"
    "stress-responsive" "stress-sensitive" "stress-type" "stressors"
    "stress–e.g." "stretch-induced" "striations" "stromal-like"
    "structural-functional" "structural-related" "structurally-driven"
    "structurally-grouped" "structurally-related" "structure-activity"
    "structure-based" "structure-specific" "strucutres" "studies" "sub-G1"
    "sub-cellular" "sub-clonal" "sub-clone" "sub-clones" "sub-complexes"
    "sub-cytotoxic" "sub-divided" "sub-endothelial" "sub-group" "sub-groups"
    "sub-lethal" "sub-line" "sub-lines" "sub-maximal" "sub-membrane"
    "sub-micromolar" "sub-nanomolar" "sub-nanomolar-binding" "sub-networks"
    "sub-optimal" "sub-population" "sub-populations" "sub-type" "subcategories"
    "subclass" "subcomplex" "subcomplexes" "subdomain" "subfamilies" "subfield"
    "sublineages" "sublines" "subpopulations" "subset" "subsets" "subtype"
    "subunit-β" "subvariant" "subvariants" "succinate" "succinimidyl"
    "succinyl" "sugar-phosphate" "sulfenyl–amide" "sulfonamide" "sulphiredoxin"
    "sunken" "super-enhancer" "super-family" "super-imposed" "super-resolution"
    "super-resolutive" "superfamilies" "supernatant" "supernatants"
    "supershift" "suppressant" "suppresser" "surivivin" "synapse" "synapses"
    "synaptopathies" "synaptophysin-labeled" "sync" "synchronisation–release"
    "synergism" "synkinesia" "synovectomy" "synthases" "synthatse" "synthe"
    "synthesis-linked" "synthetase1" "synthetases" "system-wide" "t-statistics"
    "tachycardia" "tagSNPs" "take-rate" "tamponade" "target-gene"
    "target-genes" "targeted-deep-sequencing" "tau-1" "tau441" "taxoids"
    "tcTERT" "telomerase-dependent" "telomerase-expressing"
    "telomerase-mediated" "telomerase-negative" "telomere-dysfunction"
    "telomere-end" "telopeptide" "temozolamide" "temperature-sensitive"
    "template-directed" "ten-length" "ten-year" "tensins" "testing-not"
    "testosterone-replacement" "tetra-amelia" "tetrachloride"
    "tetracycline-inducible-H1" "tetradecanoylphorbol" "tetralogy" "tetraploid"
    "tetrazolium" "thanCep63" "thatCep63" "thatCnot3" "thatmiR" "thatmiR-137"
    "the164" "theBRAF" "theCep63" "theSNF1A" "theca" "theonine"
    "therapy-induced" "therapy-resistance" "therapy-treated" "thermophila"
    "thetrpml" "thiazolyl" "thin-section" "thiol-disulfide" "thiol-reactive"
    "third-generation" "third-most" "thirty-eight" "thirty-five"
    "three-dimensional" "three-helical" "three-helix" "three-log" "three-piece"
    "three-pronged" "three-residues" "three-way" "threefold-change"
    "threonine-kinases" "threonyl" "thrombi" "thrombus" "thymocytes"
    "thymoglobulin" "tightly-governed" "time-course" "time-courses"
    "time-dependently" "time-effect" "time-lapse" "time-of-flight"
    "time-period" "time-points" "time-scale" "time-series" "timepoints"
    "timespan" "tion" "tipless" "tissue-specifically" "titer" "titre" "to10"
    "tocopheroxyl" "tolerogenic-like" "toll-like" "tonometry" "top12"
    "topoisomerase-1" "topology" "total-4EBP1" "tractin" "trade-off"
    "trade-offs" "trajectories" "trans-4-aminocyclohexyl"
    "trans-generationally" "trans-interaction" "trans-interactions"
    "trans-interface" "trans-membrane" "trans-well" "transcription-6"
    "transcription-PCR" "transcription-quantitative"
    "transcriptional-independent" "transcriptionally-regulated" "transcriptome"
    "transcriptomes" "transdermal-T" "transducer" "transfectant"
    "transfectedPten" "transfections" "transformants" "transgenes"
    "transition-state" "translatome" "transrepress" "transwells"
    "trastuzumab-DM1" "trastuzumab-docetaxel-capecitabine" "tratuzumab"
    "treatedPTEN" "treatment-naïve" "treatments" "treatnemt" "trifluoromethoxy"
    "triglyceridemia" "trimethoxyphenyl" "triphenylphophonium" "triphosphate"
    "triple-hit" "triple-negative" "tripyridyltriazine" "trisomy"
    "trisphosphate" "trisphosphates" "trpml" "tubastatin" "tublin" "tubule"
    "tubules" "tumor-adjacent" "tumor-node-metastasis" "tumor-suppressive"
    "tumor-vascular" "tumori" "tumori-genic" "tumors" "tumorsphere"
    "tumorspheres" "tumour-associated" "tumour-autonomous" "tumour-initiating"
    "tumour-node-metastasis" "tumour-promoting" "tumour-specific"
    "tumour-suppressing" "tumour-suppressive" "tumour-suppressor"
    "tumoursphere" "tumourspheres" "twenty-eight" "twenty-one" "twenty-six"
    "twice-daily" "two-color" "two-factor" "two-hit" "two-hybrid" "two-sample"
    "two-sided" "two-step" "two-tailed" "two-thirds" "two-way" "twofold-change"
    "tymidine" "type-1" "type-2" "type-I" "type-II" "type-IV"
    "tyrosine-phosphorylated" "tyrosine-protein" "tyrosyl" "tyrosylphosphate"
    "tyrosylphosphopeptide" "uORF" "uORF1" "uORF2" "uORFs" "ubiquinol"
    "ubiqutin" "ubstrate" "ultiple" "ultra-centrifugation" "ultra-deep"
    "ultra-low" "ultrafine" "ultrahigh" "ultrahigh-performance"
    "ultrasonography" "ultrastructure" "un" "uncoupler" "under-enriched"
    "under-estimated" "under-expression" "under-replication"
    "under-replication-induced" "underexpressedin" "undergoes" "undergone"
    "underpinnings" "undertaken" "unfavorable-risk" "unmet" "unpubl"
    "unresponsiveness" "up-and" "up-modulated" "up-modulation" "up-regulator"
    "up-stream" "upfield" "upper-left" "upper-right" "urea" "ureidomustin"
    "urinary-type" "urothelium" "urus" "utero" "uveal" "v-ABL1" "v-Akt"
    "v-erb-b2" "v567es" "v61Q" "vEDS" "vacuolar-type" "vacuole" "vacuoles"
    "vad1" "valine-to-lysine" "value=0.013" "values" "var" "variable-sized"
    "vas" "vascular-protective" "vehicle-treated" "velocimetry" "vemrafenib"
    "vemurafenib-cobimetinib" "vena" "venules" "vera" "vessel-forming"
    "vessel-wall" "vide" "vinca" "vincristin" "vindesine" "viral-induced"
    "visualizer" "vitro" "vivarium" "vivo" "voltage-operated" "vs.11.7"
    "vsEGCG" "vsPertu" "vulgaris" "wWT" "water-in-oil" "water-soluble"
    "web-based" "web-service" "website" "websites" "well-balanced" "well-being"
    "well-characterised" "well-conserved" "well-controlled" "well-defined"
    "well-designed" "well-developed" "well-differentiated" "well-documented"
    "well-expressed" "well-founded" "well-maintained" "well-oriented"
    "well-recognized" "well-regarded" "well-structured" "well-studied"
    "well-volumes" "well‐characterized" "wester" "westernblot" "whereR"
    "whetherHECTD2" "whole-body" "whole-gene" "whole-genome" "wide-field"
    "wide-ranging" "wide-type" "widefield" "wild-type-like"
    "wild-type-recipient" "wildtype" "winged-helix" "withBRAF" "withPten"
    "withand" "withdrawn" "withp53" "withthe" "wk" "wo" "work-ups" "workers"
    "world-wide" "wound-closure" "written" "wtBRAF" "wtKRAS" "xMCAK"
    "xanthoastrocytomas" "xc" "xenograft-tumor" "xenograph" "xl" "years-hence"
    "yeast-cornmeal" "yeast-two" "yes-associated" "yet-to-be" "ylmethyl"
    "z-score" "zinc-catalyzed" "zinc-containing" "zinc-dependent" "zipper-type"
    "zymography" "×
10"
    "×
100 "
    "×10" "×100" "×7.76" "×Rag1" "×p53" "× 10" "×κB" "× 10" "× 100" "× 10 "
    "á-vis" "ɛ-N" "˜450.000" "Δ10" "Δ239-274" "Δ60" "Δ662" "Δ662-Y720"
    "Δ662-Y724F" "ΔAI" "ΔAI@75" "ΔC" "ΔC21" "ΔC26" "ΔCC" "ΔDHT" "ΔG" "ΔGBD"
    "ΔLnRHI" "ΔN" "ΔNP63" "ΔNp63" "ΔPHD" "ΔRHI" "ΔS" "ΔSH3" "ΔT" "ΔTMC" "ΔTT"
    "Δb" "Δbind" "Δbund" "Δcap" "Δe" "ΔuORF1" "ΔuORF1,2,3" "ΔuORF2" "ΔΔG" "ΔΔT"
    "ΔΨm" "α-helices" "α-helix" "α-induced" "α-isoforms" "α-lactalbumin"
    "α-lactose" "α-melanocyte" "α-subunit" "α-tocopheroxyl" "α1-α2" "α11"
    "α11-α12" "α12" "α3β1" "α4β1" "α6β4" "α8" "αC" "αC-helix" "αC-out" "αC-β4"
    "αEF" "αF" "αH" "αv" "αv+H2+control" "αv-H2+sR1" "αv-H2+sR2" "αv-integrin"
    "αv-integrins" "α‐helix" "α–η" "β-augmentation" "β-defensin"
    "β-galactoside-binding" "β-hairpin" "β-isoforms" "β-napthoflavone"
    "β-oxidation" "β-selection" "β-sheet" "β-strand" "β-transducing" "β-turn"
    "β1" "β3-β4" "β4" "β5-α9" "β6-α10" "β9-α15" "βcatenin-14-3-3σ" "γ-2"
    "γ-ATP" "γ-GCS" "γ-glutamate" "γ-glutamyl-cysteine" "γ-glutamylcysteine"
    "γ-radiation" "γ2A" "γH2A" "κ-B" "κB" "λ5" "μCi" "μL" "μg" "μg " "μl" "μl "
    "μmol" "μs" "ҡB" "‘CC’" "‘GG’" "‘gatekeepers'" "‘sensitizers'" "”-like"
    "∆239-274" "∆3,4" "∆34" "∆Exon7" "∆G" "∆N" "∆Np73" "∆Np73-induced"
    "∆Np73-α" "∆Np73-α-induced" "∆Np73-α-overexpressing" "∆Np73-β" "∆Np73α"
    "∆Np73α-Sp1" "∆PID" "∆Ψm" "ﬀects"))

(DEFPARAMETER SPARSER::*BIO-ENTITY-HEADS-PHASE3-15301-15600*
  '("CNOT3-" "CNOT" "Pol II elongation factor Paf1c" "Paf1c" "PAIR6" "PAIR4"
    "-Mbp" "Mbp" "VJ" "B1-8" "intralocus" "×Rag1" "EU" "GLTs" "×p53" "Gapdh"
    "the most distal V H J558" "J558" "the more distal V H Gam3.8" "Gam3.8"
    "cre/+" "bKO" "deleter" "nonself-reactive BCRs" "BCRs" "nonself" "VpreB"
    "Inoue" "2B" "CD4 T" "∼2.5-fold" "3 +" "10.1038/srep12793" "Schwertman"
    "Barr" "Epstein" "dependnet" "AXXS" "P/AXXS" "MCPIPs" "MJDs" "UCHs"
    "histopathology" "TG/GG" "aromatic amines" "amines" "~78%" "p=0.032" "Rio"
    "Urology" "UCB" "9/12" "AREDS" "prominant" "cargos" "organells"
    "oxidatives" "a further 16 h" "tymidine" "xc-" "xc" "BafA1"
    "approximately 7 h" "POS" "Lipofuscin" "endoplasmatic reticulum"
    "-dichlorodihydrofluorescein" "dichlorodihydrofluorescein" "DHA"
    "lipofuscin" "± SD" "10X" "2 Study" "6 h" "YANG" "Juan" "ZHANG" "Xia" "LIU"
    "fu" "K562/A02" "cell-like" "±SD" "pCDNA3" "Yoshiara" "≤0.05" "pEGFR"
    "DDFS" "CONSORT" "FinHer" "= 0.19" "= 81" "/D" "expression/HR"
    "C229A/C232A" "Flag- RNF126-Δb" "Δb" "aa130-140" "11aa" "Δe"
    "Flag-RNF126-WT or RNF126-Δf" "Δf" "RNF126-" "RNF" "absorbate" "HA-E2F1"
    "anti-Flag" "IRIF" "pDRGFP" "19p13" "mediator/comediator" "breast/ovarian"
    "19 p13.3" "mdivi-1" "Schiller" "Szeto" "Bendavia" "ubiquinol"
    "triphenylphophonium" "polyphenol" "MPKs" "TXY" "tyrosyl" "threonyl"
    "oxygens" "4-hydroxy-2-nonenal" "MitoSNO" "IREα" "Ero1Lα" "Ero" "anoxia"
    "CuZn" "Ero1α" "Enhancer" "foldases" "Ero1" "is 1:1" "arrytmhia"
    "hypoximiRs" "mitomiRs" "Andrew" "Mello" "Craig" "Keap"
    "dithiocarbamate (PDTC)" "dithiocarbamate" "ITAFs" "nitro" "EpRE"
    "Sulfhydryl" "ETGE" "ecSOD" "heterotetramer" "EcSOD" "Mn" "Cu/ZnSOD" "Cu-"
    "ofto" "sulphiredoxin" "cholesteroyl" "favism" "erythematosus" "FAD"
    "S-glutathionylation" "2GSH/GSSG" "tocopheroxyl" "withand" "-cysteinyl"
    "cysteinyl" "Cu/Zn" "non-functional" "´s" "de-novo" "promoter/enhancer"
    "Neh6" "re-establishing" "Breitenstein" "Ellidag" "Pearson’s"
    "a possible covariance" "covariance" "expressionis" "OSI" "TAS" "=0.02"
    "=0.047" "≥50" "=0.045" "=0.010" "p =0.002" "concurrent MLL /PTD" "/PTD"
    "=0.0005" "Haferlach" "000/μl" "FLT3/" "karyotype (CK)" "=0.021" "=0.004"
    "=0.0041" "lutea" "Relaxin-2" "nonhuman" "pseudogene" "relaxin-2" "hs"
    "MG-63/RLN2" "Gelatinolytic Zymography" "Zymography" "siRNA2" "siRNA3"
    "HRPC" "48 hs" "2 hs" "4 hs" "72 hs" "24 hs" "6 hs" "Thr202/Tyr204"
    "neuroepithelium" "meningomyelocele" "cyclin-dependent kinase inhibitor 1A"
    "Chiu" "forelimb" "Ifnar" "continuum" "co-localised" "GADD45α"
    "motoneuronse" "littermate" "brainstem" "1/500" "/100" "12 h"
    "De-regulation" "= 1.6" "S4C" "= 1.8" "= 1.3" "non-cell-autonomous"
    "oophorectomy" "Rs17878362" "Spanish" "Toyama"
    "the homozygous variant CC genotype" "their respective haplotypes"
    "A1-G-C-G" "the homozygous GG genotype" "hundred ninety-one"
    "antracyclines" "-C-C-G" "Rs17884306" "rs17884306" "rs12947788"
    "rs17878362" "colorectum" "only one polymorphism" "Rs1042522" "rs1042522"
    "-G-C-G" "±5" "non-genetic" "= 0.04" "v-erb-b2" "= 0.30"
    "the ductal epithelium" "counterregulate"
    "the pancreatic ductal epithelium" "immunostainings" "phospho-Smad3/2"
    "westernblot" "±8.3%" "dense monolayer" "co-stimulation"
    "already much greater" "gallbladder" "factor-2"
    "human pancreatic intraepithelial neoplasias" "± 5" "0h" "Smad2/3"
    "Chicago" "SpectraMax" "Microplate" "RIPM" "Dojindo" "BOSTER"
    "Immunoglobulin" "BeyoECLPlus" "polyvinylidenedifluoride"
    "phenylmethylsulfonylfluoride" "Supermix" "SYBR" "Shiga" "TaKaRa"
    "Primescript" "Gibco" "MEM" "Opti" "Francisco" "Ribo" "Beyotime" "Logan"
    "HyClone" "keratinocyes" "underexpressedin" "Chonglei" "miRDB"
    "CytoMeter (FCM)" "CytoMeter" "miR-133b" "ofmiR" "ofSiCCND2" "non-cancer"
    "CoQ" "succinyl" "Sdh" "infantile leukoencephalopathy"
    "leukoencephalopathy" "Succinate" "glucose+palmitate" "live/dead"
    "-succinate" "FADH" "3NP" "cIV" "nitropropionate" "hiPSC-CM"
    "-D-ribofuranosyl-imidazole-4-carboxamide (AICAR)" "non-lethal" "Pdks"
    "hypoxia/reoxygenation" "Pdk" "trifluoromethoxy" "uncoupler" "Leigh's"
    "Leigh" "RRC" "6 h" "~1.7" "~20%" "~15%" "~10-fold" "~30%"
    "ischemia/reperfusion" "DN/c-fos" "shGPER" "patho"
    "a diagnostic classifier" "NMIBC" "Nantais (RON)" "Nantais" "origine"
    "recepteur" "neuroendocrine" "phospholipase C1" "Grb2-associated binder-1"
    "7q21-31" "= 0.032" "≥2" "Petel" "Renaux" "285G/309G" "285C/309G"
    "Knappskog" "285GG/309" "Polymorphism" "rs117039649" "rs2279744"
    "285CC/309GG " "285GC/309GG" "GG " "285GG/309GG" "P  = 0.002" "= 0.010"
    "= 0.017" "= 0.008" "doi:10.1007" "= 0.004" "= 0.005" "P  = 0.022"
    "= 0.021" "= 0.019" "G/G" "= 0.016"
    "miR-375-induced lowered radioresistance" "E3A" "Material/Methods" "/NADH"
    "AngIIstimuli" "AngII " "avariety"
    "the seven mammalian sirtuins, which are a conserved family of proteins possessing NAD + -dependent deacetylase activity"
    "eNOS" "wester" "AngII" "RAAS" "hKIS" "Gardner" "evel" "p27wt"
    "subsequent cell cycle re-entry" "re-entry" "sip27" "siPHD3" "stabile"
    "EGLN" "4 h" "S3C" "S2C" "Genotype" "non-proteolytic"
    "significantly stronger" "262D/N" "only 4 SNPs"
    "a common fragile site (CFS) FRA10F" "FRA10F" "C10orf90" "rs11245007"
    "Guangzhou" "Tianjin" "FATS" "=3" "= 0.042" "≤ 100 " "±5 " "≥ 3"
    "10.1038/srep12642" "α4β1" "peritoneum" "omentum" "Dong" "metastasises"
    "quantitative real-time PCR" "Olivier" "β4" "p53 R248"
    "the peritoneal mesothelium" "mesothelium" "1 μg/ml" "Tap73"
    "prognostic/predictive" "Potential compensatory indels" "2.2×10" ".142delA"
    "candidate compensatory indel" "the compensatory indel"
    "the corresponding compensatory indel" "nonCM" "compensatory indel"
    "Pauline" "nearby compensatory indels" "compensatory indels" "A1298C"
    "causal genes/mutations" "Frameshift" "their compensatory indels" "indel"
    "Markov" "spacio" "immunoconjugate" "intracardiac" "intracarotid"
    "signals showed HER2 co-precipitated" "organotropism" "parenchyma" "αv-H2+"
    "αv" "αv+H2+" "αv+H2-" "αv-H2+sR1" "αv-H2+sR2" "αv-H2-" "TRCN-769" "TRCN"
    "MM2BH" "αv-integrins" "MDA-MB231BR" "αv-integrin" "1μg/ml" "non-trivial"
    "biochemical/structural" "WWP-2" "over-expression/transfection"
    "likelihood/uniqueness" "SAXS" "BUNCH" "only one p85α protomer" "p50α"
    "p55α" "nidus" "non-competitively" "p85α:p110α" "LMVs" "E19A/E20A" "3I5R"
    "D21A/W55A" "RXXPXXP" "PR1+PR2mut" "PR2mut" "PR1mut" "SH3:PR1" "p85αΔSH3"
    "an almost complete p85α" "our isothermal titration calorimetry (ITC)"
    "PKPRPP" "XX" "PISA" "SH3-PR1-BH-PR2" "monomeric p85α" "homodimerized p85α"
    "p85 α" "10/100" "± 0.03" "phosphorylation/dephosphorylation" "DAMPs"
    "anti-fibrotic" "NOXs" "Colα1" "IHC and quantitative real-time PCR"
    "Sirius" "NOX4KO" "NOX1KO" "their respective wild-type (WT) littermates"
    "stellate" "a nonphagocytic NOX homolog" "NOX1/4" "PCNA +" "2H" "-knocout"
    "knocout" "osteoblasts" "Ishii"
    "the microbial component lipopolysaccharide (LPS)"
    "lipopolysaccharide (LPS)" "EIF2α" "Plex" "fibronectin-1" "macrophage-like"
    "SCi" "AKRs" "keto" "diacyl" "NFҡB" "ҡB" "interleukine-1β" "cells/mL"
    "OFCs" "coenzymes" "folate/homocysteine" "the palatal mesenchyme"
    "medial edge epithelia (MEE)" "epithelia (MEE)" "MEE" "VWS" "Woude" "der"
    "Sachadyn" "the homozygous D/D genotype" "Johnson" "McDermott" "Parle"
    "the DHFR 19-bp homozygous D/D genotype" "P=0.031" "OR=0.35" "W/W+W/D"
    "P=0.032" "=0.30" "P=0.046" "=0.45" "W/W" "P=0.027" "=0.33" "bifida"
    "spina" "intron-1" "a water soluble B-vitamin" "Folic" "folic"
    "approximately 1/1,000" "1/1,000"
    "Nonsyndromic or isolated (without other associated abnormalities) CL/P"
    "CL/P" "OFC" "D/D" "CL+CL/P" "the DHFR 19-bp homozygous deletion genotype"
    "codominant" "CL" "Ins/Del" "5q11.2" "=0.031" "=0.35" "=0.032" "=0.027"
    "stents" "postmortem" "Regalado" "widespread arterial aneurysms"
    "computational algorithms"
    "familial and nonfamilial thoracic aortic aneurysms" "III-1" "II-1"
    "the proband's" "a bilateral common iliac artery aneurysm" "iliac"
    "angiography" "15q22" "vEDS" "Danlos" "Ehlers" "LDS" "Dietz" "Loeys" "MFS"
    "multisystem" "bifid" "AOS" "aneurysms" "Aneurysms" "PolyPhen2"
    "TGF- β signaling" "phsophorylates" "Zon" "DPKcs" "EasyBlot" "Cyline"
    "oneset" "reportd" "the inactive phophorylatedCdk1" "DNA-PKcs/T2609"
    "complex/ cyclosome" "Jilăveanu" "Meng" "Balachandran" "Alli"
    "histological subtype" "roseus" "Catharanthus" "rosea" "Vinca" "VNR"
    "-noranhydro" "noranhydro" "crizotynib" "RCTH" "radiochemotherapy"
    "Most prevalent histological subtype" "taxoids" "vinca" "Stathmin-1" "= 6"
    "= 0.011" "= 4" "CVFLVPKSKKPDVKKN" "brighter" "brightest" "Moi" "~66 kDa"
    "nephrotoxins" "D1Z9C" "Abcam" "66 kDa" "Entolimod" "Ji" "McGuire" "RNAPII"
    "factors/signaling pathways" "responder" "Stickeler" "pCR" "~4.5-fold"
    "minichromosome" "SESN1/2" "the major damage-associated alarmin" "alarmin"
    "CBLB502" "~4.5-" "~5-fold" "=0.10" "two common intronic SNPs" "CytoSNP"
    "bps" "MRD" "UKALL 2003" "heteroduplex" "non-truncating" "Exon 7" "exon 7"
    "10.1038/srep12580" "miR-130a" "myxoid" "FASL" "phenethyl" "RAREs" "CBEPA"
    "de-differentiated" "12q13-q22" "anti-miR-26a-2" "protein A5" "miR-26a-2"
    "DDLPS" "IC 50  " "12 h" "clevage" "ABT-737/199" "T92E/T163E" "TPAR" "SPPS"
    "S/TPXX" "E-expressing" "siCyclin" "ABT-737/ABT-263" "ABT-737-resistant"
    "0 h" "Glycogen synthase kinase-3β" "10.1038/srep12520" "IDCs" "Whyte"
    "isozyme" "progressiong" "metaspromotes" "nPKCs" "cPKCs" "aPKCs" "PKCλ/ι"
    "isozymes" "indicated at least three major subtypes" "Occludens-1" "apico"
    "1 μg/mL" "co-repressor" "PKCη" "PRB" "non-endometrioid"
    "small endometrial biopsy" "normal secretory endometrium"
    "secretory ( P = 0.028) endometrium" "Atrophic and secretory endometrium"
    "secretory ( P = 0.004) endometrium" "atrophic and secretory endometrium"
    "hydatidiform" "atrophic endometrium" "secretory endometrium" "D-type"
    "= 0.041" "= 0.047" "= 0.046" "glioblastom"
    "T-cell lymphoblastic leukemia/lymphomas" "PolyPhen-2" "B-precursor" "γ2A"
    "Anti-Mouse" "μ G" "BIAcore" "multiplate" "C57Bl/6" "leukcytes"
    "larger thrombi" "non-bevacizumab" "= 6/group" "IVC" "venous thrombi"
    "thrombus" "bevacizumab-associated VTE" "thrombi" "FeCl" "vena" "VTE"
    "≥ 10 " "C57BL/6 J" "= 6" "± 1.5 "
    "additional clinically-annotated tumor genomic datasets"
    "available datasets" "existing clinically-annotated datasets"
    "incompleteness" "Additional clinically-annotated mutational datasets"
    "Fraumeni" "relatively platinum and taxane chemoresistant"
    "positivity/negativity" "8500/3" "the only significant covariate"
    "Wilcoxon" "185/316" "OvCas" "OvCa" "non-significantly" "= 0.022" "PAM50"
    "= 0.048" "= 0.033" "0 − 1" "= 0.354" "3 × 10" "Hatakeyama" "Klemke" "erbB"
    "CP690550" "Profiler" "refractile" "HPDE/SgK223" "Humphrey"
    "SgK223/Pragmin" "the combined chemotherapeutic modality Folfirinox"
    "Folfirinox" "transwells" "Pragmin" "cell migration/invasion" "rhEREG"
    "Comedo" "comedo" "z" "= 0.011" "low/negative" "endocrinotherapy"
    "Wnt/APC/β-catenin" "#4" "= 11" "thiazolyl" "PCR" "realtime"
    "anthrocycline" "eukaryotic translation initiation factor 3a" "≥ 2"
    "suppresser" "22/107" "a Hodgkin’s" "present at most ITD-specific DHSs"
    "up additional FLT3-ITD-dependent DHSs" "a strong co-association"
    "our recently developed Wellington algorithm" "FAM92A1" "VSTM4/ c10orf128"
    "ITD3" "the distal ITD-specific DHSs"
    "380 ITD-specific promoter-associated DHSs"
    "the above-defined ITD-specific DHSs" "VSTM4" "anti-correlation" "C/EBP"
    "FOX/E-box" "midpoints" "distal ITD1/PBSC DHSs" "ITD1/PBSC" "RUNX"
    "FLT3-ITD-Specific DHSs" "activating FLT3-ITD-specific DHSs" "ITD9" "+5"
    "the 1,216 distal ITD-specific DHSs" "the164" "WT5"
    "the FLT3-ITD-specific DHSs" "the two more mature CD14+ cell datasets"
    "3 previously published DHS datasets" "19,551 distal ITD1/PBSC DHSs"
    "Roadmap" "Epigenome" "a small subset proximal DHSs"
    "the promoter-associated DHSs" "ITD2" "3,728 distal DHSs" "ITD1"
    "FLT3-ITD-specific DHS" "ITD+ AML" "browser" "AZU1" "distal DHSs"
    "the distal DHSs" "ITD+ AMLs" "ITD+AML" "FOX" "ITD4" "CD14+ve" "CD14+"
    "log2" "FLT3-ITD+" "ITD+" "DHS" "FLT3-ITD-specific DHSs" "DHSs" "∼25%"
    "precursor-like" "Cauchy" "omics" "∼2,000" "non-conventional" "COIV"
    "mitoribosomes" "∆Ψm" "non-T cells" "biomass" "mitoribosome"
    "biochemical co-precipitation" "Jcam" "mean ± S" "Anti-phosphotyrosine"
    "pathways/targets" "Indian CSSCs" "14/20" "5/84" "Sweden"
    "the Indian CSCCs" "~1%" "~5%" "massARRAY" "~10%" "non-detection" "71/102"
    "59/102" "42/103" "64/101" "31/100" "100/101" "≥4" "56/101" "50/101"
    "13/65" "3/21" "85/101" "90/101" "CSSCs" "26/65" "4/21" "23/72" "12/19"
    "38/101" "2/60" "and 3/60" "55/60" "≥50 " "FIGO" "5-triphosphate-"
    "comprehensive national cervical cytology" "national cervical cytology"
    "60/101" "14/50" "5/45" "0/91" "19/95" "Pradesh" "Madhya" "CSCCs" "CSCC"
    "= 0.046" "P = 0.022" "= 0.014" "P = 0.009" "= 0.027" "= 0.047" "≤30" "≤2 "
    "P = 0.007" "= 3" "aggressive BLBCs" "longer DMFS" "CXCL17" "BLBCs"
    "significantly longer DMFS" "-ii" "MIV-Luc-shIL13Rα2#2"
    "focal nuclear pleomorphism" "pleomorphism" "S5a" "S4b" "S4a" "DMFS"
    "re-implanted" "MIV" "transcriptomes" "an aggressive subtype" "BLBC"
    "non-obese" "+10 % FBS" "MGMT repairable O-alkyl adducts"
    "genotoxic adducts" "a bulky adduct" "adduct"
    "melphalan predominantly causes N-alkylpurine mono-adducts" "mono-adducts"
    "N-alkylpurine" "ABH2-" "ABH" "mispairs" "necrotic-like" "xenograph"
    "WYC0209" "methanesulfonate (MMS)" "methanesulfonate" "BO-1055 or" "UV24"
    "DSBR" "N-mustards" "alkylpurine" "ALKBHs"
    "mitomycin C (MMC) usually cause interstrand" "interstrand" "nitrosoureas"
    "chloroethyl" "bis" "N-mustard" "novel water-soluble N-mustard BO-1055"
    "BO-1055" "ureidomustin" "BO" "Rad3" "S/G 2" "monomethylates" "DNaseI"
    "phastCons" "DNase2TF" "CENTIPEDE" "Hager" "+/-100"
    "the haematopoietic progenitor CD34+"
    "the haematopoietic progenitors CD34+" "Carlo" "Monte" "H3K9ac" "Farnham"
    "Ponasterone" "pVgRXR" "ecdysone" "KB-1458E12" "DUS3L" "C10orf55" "CD20+"
    "CPEB4" "MotifLab" "available DNase I footprint datasets"
    "erythroleukaemia" "six different haematopoietic cell-types using DGF"
    "DGF" "Snyder" "DamID" "co-regulatory" ": RNA" "co-regulate"
    "10.1038/srep12204" "Shao" "correct malattachments" "KMN" "B-mediated"
    "Shokat" "-addback" "errorless" "malattachments" "Syntelin" "xMCAK"
    "addedback" "addback" "mitotic progression and chromosome stabilty"
    "stabilty" "alles" "the temporal partten" "partten" "Micrographs" "MTs"
    "GMPCPP" "IIγ" "bi" "nonog" "miR-140-induced chemoresistance"
    "resistance/sensitivity" "ER-α36" "14-3-3ζ" "sublines" "EGA" "studies/data"
    "pEZX" "anti-miR-10b" "~7-8-folds" "IC-50" "miR-221/222" "miR-15a/16"
    "miR-126/miR-10a" "miR-519a" "dileneate" "MCF7TR" "microRNA-10b" "EMT/CSC"
    "re-sensitized" "anti-DNA" "histone/DNA" "Histone/DNA" "miR-200 s"
    "10.1038/srep11614" "Romano" "Datesets" "pSUPER" "5-8F-shFlot-2-2"
    "5-8F-shFlot-2-1" "mesentery" "porta" "nucleo" "SPFH"
    "heterogeneous microdomains" "6-10B" "5-8F" "neutrophilia" "Nasta" "Saenz"
    "Alba" "chemoattractant (KC)" "eosinophils" "asthma-like" "Tukey's"
    "GraphPad" "-TTA" "CTT" "gapdh" "IDT" "succinimidyl" "EasySep" "Leica"
    "Histopathology" "SSSCC" "Stanley" "Ponceau" "Enzo" "MILLIPLEX" "Millipore"
    "Bioplex" "T-regulatory" "BALF" "whole-body barometric plethysmography"
    "EMKA" "plethysmography" "Penh" "Greer" "pteronyssinus" "Dermatophagoides"
    "isoflurane" "vivarium" "LSUHSC" "Louisiana" "Jackson" "AZD" "eosinophilia"
    "pack-years" "pY720" "pY724" "active SrcY527F" "ELMO1Δ662" "SrcY527F"
    "Δ662" "Technical Univ" "Univ" "ELMO" "Navab" "multilineage" "Vi"
    "COLO-320" "COLO" "srIL-1R" "SKB" "SurePrint" "EpiCAM" "as 1:64"
    "niche-like" "hMSC" "Khakoo" "Cooke" "Huang" "Karnoub" "co-culturing" "DiL"
    "Vybrant" "hMSCs" "~70 %" "= 0.014" "= 1.3 " "co-cultures" "~80 %"
    "head/neck" "ABI 7900HT" "GCGAACACGAGCTGCCGGA" "GGGGAGATGTGGACAGCG"
    "CCCTGATTTGGAGGTGCAGAACC" "ABI7900HT" "Biosystems" "Beutler" "Paglia"
    "Aust" "Beuege" "Goth" "-tripyridyltriazine" "tripyridyltriazine" "Fe"
    "/22.5" "Ficoll" "FPI" "A1c" "Wuhan" "Tongji" "Endocrinology"
    "erythrocytes" "Suzuki" "heterozygotes" "homozygotes" "ARE-like" "Marzec"
    "Yamamoto" "HOMA-β" "HOMA" "rs6721961" "Neh3" "Neh5" "Neh4" "Neh"
    "newly-diagnosed T2DM" "T2DM" "= 20" "p = 0.002" "= 0.014" "= 0.020"
    "= 0.042" "Kelch-like" "= 0.011" "Zn" "dismutes" "hydroethidine" "MOWIOL"
    "polysine" "WBCs" "cells/ml" "3×10" "catalysers" "neutralise"
    "dihydrorhodamine" "polymorphonuclears" "expressers" "OECs" "FTSECs"
    "FTSEC" "HGSOCs" "HGSOC" "inover" "inhibitorSNS" "Cyclin E1" "4 h"
    "4E-BP1-HIF-1αpathway" "CCD-18co" "Moraceae" "Asclepiadaceae" "IRES" "eIFs"
    "guanylyl" "YXM110" "Non-cancerous" "= 0.027" "invadosomes" "exoenzyme"
    "botulinum" "100X" "70~80%" "a well-defined GJIC enhancer" "shCx26" "Cxs"
    "GJIC" "96 h" "μ l" "4 h" "10.1038/ncomms8877" "Klein" "HKN" "HxN"
    "global entropy" "enhanced protein conformational entropy"
    "favourable enthalpy" "αEF" "displayes" "the proximal A-loop" "millisecond"
    "linewidth" "upfield" "αH" "αC-β4" "αC" "P-loop" "HSQC" "TROSY" "1 H-"
    "=7.9 " "=2.4" "=1.8" "denaturant" "far-ultraviolet circular dichroism
(CD)"
    "GdmCl" "∼70-fold" "ΔS" "a significant favourable entropy" "=1.3 " "An
endothermic enthalpy"
    "exothermic binding enthalpies" "kcal " "entropies" "enthalpies" "Hoff"
    "entropy" "enthalpy" "methylpiperazinyl" "Shan" "PDA" "×
100 "
    "/ 2" "Δ C" "μl " "Non-phosphorylated" "2 H" "∼10-fold" "1 and
2 "
    "=11" "Δ G" "non-phosphorylated" "a 20-year" "Codd" "Scottish" "Danish"
    "Bischoff" "Fitzpatrick" "Amish" "Browser" "Utah" "rs4975605" "WGHS"
    "rs2853668" "rs2736122" "polymorphism (SNP)" "GWA" "Americans"
    "nearly 49,000 SNPs" "ARIC" "oligonucleotide/oligosaccharide" "1-year"
    "p = 0.03" "≥ 1" "= 0.02" "Bayatti" "Karolczak"
    "which holds sister chromatids" "Deardorff" "Kramer" "phoshoglycerate"
    "Kendrick" "5μM/24h" "= 0.02" "STS26T cells" "DNA/apoptosis" "MPNST6IEPVI"
    "5μM/48h" "96h" "PCI4" "XIX" "tubastatin" "anti-MPNST" "RGFP966" "p=0.001"
    "the marsupial gonad" "gonads" "gonad" "ontogeny" "PhyloP" "NM_032551"
    "agianst" "_032551" "23-year-old" "NM_001174066" "lip/palate" "synkinesia"
    "Finland" "hyposmia" "_001174066" "lip/palate (CLP)" "CLP" "anosmia"
    "Kallmann" "18-year-old" "CBMN" "C1/C2" "damage/cell death"
    "apoptotic/necrotic cell death" "nanodiamond" "AuNPs/mL" "particles/mL"
    "cuvette" "formulawhere" "approximately 1.1 × 10 11 particles/ μ L" "cyto-"
    "AuNP" "nanosilver" "BBB" "nanogold" "Nanogold" "NF- κ B1" "× 10 " "μ L"
    "10.1038/ncomms8821" "an aggressive subset" "chemoresistant" "H3ac"
    "EPZ004777" "derepresses" "DOT1L+HRAS" "diabetic/severe" "tumourspheres"
    "tumoursphere" "mesenchymal-like"
    "the ER-negative invasive ductal carcinoma subtype"
    "aggressive breast cancer subtypes" "oestrogen" "Zhang"
    "DOT1L-associated H3K79" "H3K79" "telomeric silencing-1-like" "1:3,000"
    "2 h" "=0.042" "=0.046" "stem
cell-like"
    "S-adenosyl" "10.1038/ncomms8736" "co-deleted" "missense-" "ICGC"
    "underwent radical prostatectomy" "JAK1/2" "Co-deletion"
    "an important gatekeeper" "ARF–Mdm2–p53pathway" "-shStat3" "shStat3"
    "pc−/−" "Pb" "Pencik" "72 h" "48 h" "1 h" "Ki-67 +" "fl/fl"
    "non-aggressive" "SNAIL/" "ERß" "utero" "functionalis" "basalis"
    "Pellegrini" "the endometrial biopsies" "the glandular epithelium"
    "either eutopic or ectopic endometrium" "either eutopic endometrium"
    "glandular epithelium" "the eutopic endometrium" "eutopic gland epithelium"
    "the eutopic gland epithelium" "eutopic endometrium" "= 0.046" "p = 0.002"
    "p = 0.001" "= 0.012" "= 9" "± 5" "= 0.016" "mg/kg/d" "anti-hyperglycemic"
    "Xavier" "treatnemt" "grwoth" "EC109" "metfromin" "curative esophagectomy"
    "esophagectomy" "anti-angiogenesis" "G0/G1" "Gal/VNPT55" "Weigel"
    "anti-prostate" "mitotracker" "non-ligand" "co-treating" "Cal" "gal/VNPT55"
    "ERSR" "μmol/L" "fAR/AR-V7" "Interestingly AR v567es" "Tokai" "vide" "-17-"
    "diene" "androsta" "hydroxy" "progestins" "ARDAs" "sipuleucel" "Mdm2/CHIP"
    "VNPT55" "H & E" "72 h" "ubiquitin/proteasome" "14 h" "GI 50" "1 H"
    "the typical MLIV pathophysiology" "adenylyl" "Vergarajauregui"
    "S572,576/AA" "S 572 E/S 576 E" "mucolipin" "S 572 A/S 576 A" "S572E/S576E"
    "decreased autophagic flux/turnover" "whereupon several phosophopeptides"
    "phosophopeptides" "Phosphopeptide" "heterozygous MCOLN"
    "viability/eclosion" "MCOLN" "theSNF1A 1" "Oregon" "thetrpml" "following:w"
    "TRPML" "UAS" "trpml" "Bloomington" "IRDye" "Supernatants" "microfuge"
    "Laemmli" "S572A/S576A" "μCi" "Laser-based autofocus" "autofocus"
    "Ratiometric Fura-2" "modified Tyrode's" "Dickenson" "Becton" "Nikon"
    "bioimager" "UPlanApo" "Olympus" "Tyrode" "Fura-2" "QuikChange"
    "ProteinProphet" "carbamidomethyl" "PeptideProphet" "SEQUEST" "SorcererTM"
    "kV" "spectrometer" "Velos" "GL" "Titansphere" "Expedeon" "FASP" "Tris/HCl"
    "Biologicals" "Atlanta" "Maryland" "Bethesda" "EcoR" "Iowa" "Carolina"
    "UNC" "RRKCGRDPSEEHALLVN" "RRKCGRDPAEEHSLLVN" "RRKCGRDPAEEHALLVN"
    "RRKCGRDPSEEHSLLVN" "Huntington's" "Amphisomes" "amphisomes"
    "non-responsive" "oligomeric nanoclusters" "nanoclusters" "velocimetry"
    "LifeAct" "intermembrane" "monolayers" "Ecads" "Ripley’s" "NP/µ"
    "junction-like" "L175D-mutated Ecad ectodomain" "ectodomain" "EC2"
    "biomembrane" "cellulo" "= 50" "2 h" "∼90%" "anti–human" "12 h" "± 0.5"
    "siControl" "siTERT" "48 h" "1 h" "delay/bypass" "Hayflick" "knockin"
    "Kumar" "Garraway" "Artandi" "Steven" "reenter" "immortal hESCs"
    "congenita" "none-rescued parental TERT Δ/" "Δ/" "reinsert" "sgRNA" "+67"
    "telomerase-negative hESCs" "non-random" "sgRNAs" "TTCCGG-" "TTCCGG"
    "karyotypes" "Chiba" "Fibroblast-like" "non-dividing" "fibroblast-like"
    "A/C" "Non-coding" "mellitus" "48 h" "1 μg/ml" "1 h" "2 h" "Iijima’s"
    "Iijima" "Pascarella" "Stephanie" "anti-HCV" "non-response" "Responders"
    "JFH1-2a" "ug" "pCR3.1/SOCS1" "IU/mL" "Con1b" "JFH1" "myxovirus" "IFN-λs"
    "DAAs" "SVR" "ISRE" "replicon" "IFN-λ" "with/without" "Non-Responders"
    "6-month" "non-essential" "/signal" "cells/organs" "Gi" "acetylcholine"
    "non-autonomous" "tachycardia" "4h" "S303/S307" "S303/S307D" "C3T" "pC3T"
    "pRhoA" "Active RhoA" "HSPB" "geranylgeranylacetone"
    "involved cervicofacial dermatomes" "dermatomes" "penta" "SWS"
    "indivisuals" "Nakashima" "Lyngby" "NetStart" "#5 harbored variant c" "#5"
    "#7" "The facial PWS" "Sturge" "the previously identified GNAQ c" "PKWS"
    "Parkes" "AVF" "AVM" "Shirley" "OMIM" "The previously reported GNAQ c"
    "PWS" "non-mutant" "HH- MB" "mmol/L" "237mg/dL" "180mg/dL" "HH-MB"
    "cerebella" "Ptch1  +" "insulin-like-growth factor-2" "NeuroD"
    "acetoacetate" "insulin-like" "1  +" "comorbid" "confounders" "≤2" "≤180"
    "NRM" "000/μL" "bivariate" "3-year" "thymoglobulin" "CIBMTR" "WBC"
    "first-time" "allogeneic HCT" "underwent first-time allogeneic HCT" "-ITD"
    "ITD" "Allogeneic HCT" "HCT" "P =0.001" "CD34+" "pathologic subtype"
    "IDH1/2" "FUBP1" "region/17q" "monosomy" "The mesenchymal subtype"
    "the mesenchymal subtype" "0/5" "1/5" "0/4" "/Ch17" "5/86"
    "gains/polysomies" "Ch 17" "JHH" "/2"
    "Of interest IDH1 /2 mutations co-occurred" "astrocytic histology"
    "Permanent H&E" "HISTOLOGY" "Memorial Sloan" "Sloan" "website"
    "the sporadic diffuse glioma subtypes" "the mesenchymal subclass"
    "subclass" "The mesenchymal molecular subtype" "highgrade"
    "co-inactivation" "17q11.2" "adenyl" "4/5" "Ch17" "/17q"
    "the mesenchymal molecular subtype" "∼80%" "6/16" "0-3" "= 3" "17q"
    "co-existed" "polypoloid" "48h" "DNR" "the pro-apoptotic cleaved PAPR"
    "PAPR" "mono-therapy" "Jin's" "Jin" "CalcuSyn" "14h" "12h" "1h"
    "which prompts us" "72h" "BMS-777607" "BMS" "Tetraploid" "Oxindole-1"
    "1 μg/mL" "10h" "G 1 /S" "IARC" "concurrent STAT 3 polymorphism" "family-1"
    "globet" "-511" "Pam3Cys" "co-participation" "ABCCC" "0.76-1.45" "carboxi"
    "rs744166" "EPIYA" "lymphoma-2" "= 0.003" "= 0.19" "p  = 0.002" "≤50 "
    "toll-like" "μL" "= 3" "95 % CI " "RDF" "KAKTLRK" "CGMD" "A-loop"
    "underpinnings" "integrators" "FERM" "Eastern Europe c" "the proband’s"
    "BC117" "BC24" "OB3" "Denmark" "37/41" "BC/ OC" "41/68" "BC58" "BC76"
    "BC85" "BC81" "BC32" "NLC" "BC205" "BC134" "_5403delCCCTTGG" "BC28" "BC132"
    "Ukraine" "the studied Bulgarian patients c" "Venezuela"
    "clear pathogeniceffect:c" "BC190" "BC171" "BC155" "BC143" "BC142" "BC121"
    "BC111" "BC152" "BC204" "BC39" "Northern Russia" "Scandinavia"
    "the most prevalent Slavic mutation c" "Macedonia" "Croatia" "Serbia"
    "Romania" "Balkan" "Lithuania" "Latvia" "Belarus" "Belgium" "Netherlands"
    "Spain" "Germany" "Greece" "Slovenia" "Russia" "11/13" "+ 28C "
    "the intronic variants c" "–c" "_4148delAGA" "Leiden" "LOVD" "548-58delT"
    "442-34C " "36_441 " "_441 " "64delGTA" "_c" "BC30" "UMD" "VUS" "BC10"
    "PROVEAN" "POLYPHEN" "wo" "BC20" "56delGTA" "38delCTT" "Europeans" "VUSs"
    "unclassified variants included missense" "inframe" "BC87" "_8533delAA"
    "BC19" "BC52" "BC90" "BC88" "_9099insA" "_7914delCCTTT" "_5719delCT" "BC37"
    "BC/OC" "only benign polymorphisms" "-Ribose" "Ribose"
    "salpingooophorectomy" "Jews (AJ)" "Pakistan" "Dutch" "Jews"
    "Triple Negative Breast Cancers (TNBC) subtype" "BBC" "in 1-3 " "OC"
    "Bulgaria" "_5854delAGTT" "9098-9099insA" "Eastern European" "_5264insC"
    "at/or" "non-Jewish" "_69 delAG" "+ 28" "μl" "= 11" "= 50" "BRCA1 / 2"
    "95 % CI " ".5030_5033delCTAA" "TIQ" "isoquinolin" "TAp73α" "anti-tumoural"
    "Irwin" "HRasV12" "HRasV12 " "+11" "+22" "co-ordinately" "pCR3.1" "TATA"
    "pGL2basic" "Promega" "Thermo" "BCA" "Protoc" "Harb" "EBC" "pH "
    "-TGGGTTGGTCATGCTCACTA" "TGGGTTGGTCATGCTCACTA" "-TGACCGCAGAGTCTTTTCCT"
    "TGACCGCAGAGTCTTTTCCT" "-TCCAGCTACTTGCACTTGTTCCT" "TCCAGCTACTTGCACTTGTTCCT"
    "-AGCTGCGTTTCACCAGGG" "AGCTGCGTTTCACCAGGG" "-ACGACCTCAACGCACAGTACG"
    "ACGACCTCAACGCACAGTACG" "-GACCATGGAGGTTCTTGGCA" "GACCATGGAGGTTCTTGGCA"
    "-TCTGGAACCAGACAGCACCT" "TCTGGAACCAGACAGCACCT" "-GTGCTGGACTGCTGGAAAGT"
    "GTGCTGGACTGCTGGAAAGT" "MMLV" "Superscript" "hexamers" "Immunostep"
    "Superfect" "pECFP" "Cyan" "Dulbecco's" "ºC" "BioWest" "Dulbecco" "∆Np73-β"
    "PXXP" "∆N" "scape" "∆Np73-α" "∆Np73" "co-ordinate" "+26" "18 bp" "EFGR"
    "RGD" "cancer 2B4" "1E8" "P2Y" "and 2B" "nonthyroid" "underwent FNA" "FNA"
    "ultrasonography" "Ct" "PTMCs" "PTMC" "P  = 0.033" "P  = 0.001" "= 0.022"
    "= 0.041" "= 0.011" "P  = 0.008" "P  = 0.007" "ING1/2" "RbAps" "retinol"
    "Oevelen" "protien" "casitas" "regulation/response"
    "several cellular insults/stimuli" "KDB" "ANLN" "Semi" "transrepress"
    "paralogues" "potasium" "remodellers" "H3K27" "S1D" "non-genotoxic"
    "SDS/PAGE" "by:whereR" "dipole" "fluorophore"
    "the covalently-linked adducts" "adducts" "endonuclese" "weak AP-" "dRP"
    "AP-" "Schiff" "apurinic/apyrimidinic" "±1.3" "~10-" "2–3 " "biospecimen"
    "Amplex" "bafilomycin" "2.9±0.9-fold" "±5 " "dyn/cm 2" "Hz" "ULK" "p53si-3"
    "perturbagens" "NFY" "Z-DEVD-FMK" ": DNA" "ΔNp63" "ΔN" "premiR" "algoritm"
    "RNAhybrid" "SDAC" "mammospheres" "SDACs" "SEER" "2-3" "re-sensitize"
    "non-transcriptional" "sMTide" "WK" "Khoo" "Ventura" "regrowth" "Altas"
    "Sherr" "shMdmx" "Immunohistochemistry (IHC)" "apocrine" "~70%" "~6–"
    "Basal-like" "centromeric UFBs" "unreplicated DNA-associated UFBs"
    "aminobenzamide" "Trevigen" "Cen" "pM" "Glover" "supernumerary UFB"
    "all supernumerary UFBs" "shCDA" "CDA+" "-siCtrl" "siCtrl" "BLM+/CDA+"
    "CDA-" "supernumerary UFBs" "UFB" "dU" "SCEs" "CFS-associated UFBs"
    "catenations" "UFBs" "CFSs" "deoxynucleotides" "ultrafine" "CDA" "1:10,000"
    "5 BS" "prometaphase/metaphase" "BPTES" "miRNA34" "Miraversen" "p=0.002"
    "miR-196a" "MYC-B7-3" "seq" "homeodomain" "re-sensitizes" "co-repressors"
    "10.1038/srep11999" "Mina" "a possible co-regulation" "JUND" "FANTOM"
    "LASAGNA" "EGR" "a typical IEG" "commonalities" "IEGs" "FANTOM5" "FOSL"
    "IEG" "CIDER" "Invariant" "+100" "2/5" "co-regulated" "3 hr" "pMAPK"
    "pVEGFR2" "5-day" "∆3,4" "shNC" "Full_BCR∆34" "Full_BCR" "∆34" "1200_BCR"
    "1443 bp" "_BCR" "_MARS" "_NPM1" "_R2" "_R1" "PBS3" "PBS4" "Breakpoint"
    "1443bp" "heterocomplex" "Lucas" "Marega" "Philadelphia" "± 0.03"
    "p  = 0.03" "1 p  " "± 0" "10.1038/srep12230" "Wu" "MTS" "tumorspheres"
    "A3F" "tumorsphere" "anti-virus" "HERVs" "TaqMan" "Co-Immunoprecipitation"
    "× 100" "well‐characterized" "‐characterized" "∼1/1,000" "Arnold‐Chiari"
    "86/7,000" "≤PC3" "Features/complications" "‐spectrum" "Arg1809‐missense"
    "Pectus" "‐missense" "‐Chiari" "as 1/1280" "Boyles" "Plümpe" "#139150"
    "‐RASGAP" "Revencu" "‐occurrence" "dominant‐negative" "Schepper" "Maertens"
    "‐negative" "‐function" "Nicolin" "‐related" "McCaughan" "Evans"
    "Plexiform" "‐14" "PH‐like" "‐terminal" "‐penetrance" "‐R6673" "‐R5863"
    "‐R008" "clinically re‐evaluated" "‐evaluated" "proband/family" "Bertola"
    "make‐up" "‐up" "68/7,000" "mutation‐positive" "‐R7916" "out‐of" "UG‐575"
    "proband" "UG" "‐old" "‐575" "HRMCA" "Probands" "5 CALMs" "10/91" "Bella"
    "Arg1809‐positive" "Ekvall" "Nyström" "Blazo" "Cnossen" "Listernick"
    "Khosrotehrani" "McGaughran" "Tonsgard" "Huson" "Met992del" "‐associated"
    "stereotactic radiosurgery" "‐R9216" "a multifocal cortical dysplasia"
    "Chiari" "Arnold" "MADR" "‐year" "angiomas" "anemicus" "Becker" "flammei"
    "FSIQ" "dyspraxia" "apraxia" "Asperger" "ADHD" "excavatum" "carinatum"
    "pectus" "‐R4835" "‐R4174‐I1" "‐R0143‐I1" "‐I2" "‐R744" "≥19" "‐I1" "≥9"
    "‐four" "‐two" "_Lys296del" "‐RSeNF23" "21/98" "‐modeling" "α‐helix"
    "‐helix" "‐methylation" "dinucleotides" "CGC" "Richards"
    "21 sporadic probands" "‐frame" "‐of" "‐based" "CADD" "‐causing" "PolyPhen"
    "MutationTaster" "missenses" "ExAC" "Exome" "delay/" "symptomatic OPGs"
    "Rojnueangnit" "Santoro" "Pinna" "OPGs" "Noonan" "Vranceanu" "Friedman"
    "preferentially non‐founder probands" "‐truncating" "Minkelen" "Sabbagh"
    "clinically non‐distinguishable" "‐distinguishable" "Messiaen" "Brems"
    "Legius" "Carmi" "Raedt" "Nguyen" "‐slanting" "facial dysmorphism"
    "Pasmant" "Mautner" "Mensink" "Descheemaeker" "Venturin" "Upadhyaya"
    "Kayes" "dysmorphism" "‐regulating" "tibial dysplasia" "sphenoid"
    "skinfold" "café" "‐lait" "‐au" "UAB" "probands" "a segmental NF1‐patient"
    "‐patient" "‐like" "macules (CALM)" "plexiform" "macules" "= 21" "0/15"
    "16/39" "10/39" "‐positive" "and 2E" "1000Genomes" "≥5" "cuminata"
    "Camptotheca" "a cationic liposome" "Lipofectamine" "matrixgel" "pIRES2"
    "shRNA 271" "SW1116/HCPT" "chemosensitiviy" "Hydroxycamptothecine" "pIRES"
    "SW1116/ RKIP" "SW1116/RKIP" "shRNA271" "lipofectamine" "HCPT"
    "hydroxycamptothecine" "normal colonic mucosa" "UISO" "merkel" "MLNT"
    "CRCT" "NCRCT" "= 0.005" "mg/L" "G0/G1 phase" "mg/mL " "liposomes"
    "non-p53" "34a-KO" "at least 5 miR-34a MREs" "copy/cell" "TALENs" "miR34a"
    "Co-transfection" "Renilla" "Rna22" "MRE" "2 previously reported MREs"
    "NuRD" "p53Knowledgebase" "Bi" "apoptosis/cell death"
    "metabolism/translation" "metabolism/replication/repair" "Nucleases"
    "miR-34b/c" "11q23" "1 μg/ml" "co-transfecting" "Activator-Like"
    "vindesine" "a shorter TTDR" "TTLR" "a shorter median TTDR" "TTDR" "IIIA"
    "Kirstein" "non-squamous" "a 10-year" "=  0.042" "=  0.031" "23% of"
    "60 Gy" "P =  0.022" "=  0.028" "downregualte" "miR-324-5p-repressed"
    "miR-324-5p-inhibited" "-UTR- luciferase"
    "the publicly available algorithm TargetScan" "immotile" "5P" "+10% FBS"
    "PIX::GIT-containing" "mechanisms/pathways" "ΔSH3" "co-precipitation"
    "primaquine" "recycling/re-internalisation" "turnover/trafficking"
    "re-internalization" "efficient re-internalization" "ΔGBD" "PKPFPR" "Seong"
    "internalization/endocytosis" "spatio" "Entrez" "P-values"
    "Co-immunoprecipitations" "non-ubiquitinated"
    "an important AR co-regulator" "several publicly available datasets"
    "MSKCC" "ABSciex" "lupron" "T-cell acute lymphoblastic leukemia/lymphoma"
    "generally bad prognoses" "prognoses" "difficile" "epidemoid" "MDSCs"
    "Polymorphisms" "TSCC" "mean ± S" "anti-human" "Swartz" "perimenopause"
    "=0.000" "=0.165" "pmol/L" "Kabbaj" "Parkinson's" "Parkinson" "HDRS"
    "Hamilton" "=0.020" "p =0.001" "=0.039" "±0" "cell cycle/SAC"
    "the SUMO-activating enzyme SAE-2" "SAE-2" "aneuploidies" "missegregate"
    "co-depleted" "HiSeq" "Illumina" "napthoflavone" "XeNA" "WEHI-539" "WEHI"
    "mitotic blockers" "Cenp" "Omomyc" "activation/repression"
    "complex/cyclosome" "Topham" "blockers" "S3I" "to 10 " "S3E" "3 hr"
    "withthe" "VH1-a1" "VH" "approximately 20 μg/ml" "CD51/61" "molecule-1"
    "HASMC" "anti-Kit" "the bronchial epithelium" "bronchial epithelium" "Fv"
    "HASMCs" "HLMC" "HLMCs" "p  = 0.001" "= 0.017"
    "the healthy and remodeled myocardium" "non-ischemic" "osteoblast-like"
    "VCAM-1 expression" "VCAM-1expression" "HTSMCs" "EGFR/PI3K/Akt/NF-κB"
    "EGFR/PI3K/Akt" "c-Src-mediated" "adhesiveness" "VCAM" "c-Src/EFGR" "HCFs"
    "± 0.4 " "± 0.5 " "~ 90 %" "multicenter" "Rebiopsy" "underwent rebiopsy"
    "Jackman's" "Jackman" "slow/minimal" "continued EGFR TKI monotherapy"
    "radiosurgery" "WBRT" "4/19" "4/55" "non-smokers" "Sen" "Yat" "IMPRESS"
    "minimal/slow" "16 (28.6%) underwent rebiopsy" "rebiopsy" "1/16" "Sigismud"
    "Tukey" "Barok's" "Barok" "Propodium" "micrographs" "caveosome" "EMILIA"
    "maytansanoid" "emtasime" "extramembrane" "+ 1" "pp" "GalNAc" "withBRAF"
    "pomatia" "theBRAF" "Pomatia" "Helix" "C-type" "tumor-associated glycans"
    "glycans" "Tn" "activation/reactivation"
    "the hepatocellular carcinoma (HCC) transcriptome" "AZ" "Lanes 1 and 2"
    "NEXT-1" "2p22-p21" "Houang" "WDCP" "C2orf44" "cetuximab/FOLFIRI"
    "tamponade" "Korean" "gluymine" "2p21–22" "immunohistochemistry (IHC)"
    "breakapart" "3+" "CGP" "IHC using ALK monoclonal antibody 5A4" "5A4"
    "Korea" "Seoul" "Samsung" "peptidyl" "S240/244" "Facs" "spectin"
    "further 16 h" "eIF3b/c" "re-stimulation" "re-plating" "hypotriploid" "eIF"
    "Casy" "S235/236" "re-expressing" "mg/l" "non-treated" "non-transfected"
    "PKM1/PKM2" "the remarkable anti-glioblastoma" "hnRNPΙ" "anti-glycolysis"
    "HnRNPs" "FF100" "XF" "hnRNPI" "PKM1" "diphosphate (ADP)" "isoenzyme (PK)"
    "diphosphate" "isoenzyme" "PKM2/PKM1" "Co-immunoprecipitation" "PEST"
    "Dysbindin-1A" "complex-1" "dysbindin-1A" "Polη/ι" "Polη/κ" "RIRs" "S9D"
    "PolηΔC" "pIRESneo2" "leftmost" "RAD6-" "-oligo" "RAD6" "RIR"
    "motifs/domains" "Polη's" "Durando" "ubz" "called UBZ" "UBZ" "Y-family"
    "Polι" "Polκ" "Polη" "S4B" "Written" "miR-183-EGR1-PTEN" "miR34c" "sync"
    "caner" "miR-34c" "let-7a-2" "= 0.007" "= 0.019" "= 0.028" "NMII" "∼10%"
    "Raichu" "synapses" "control cells exhibited MIIB" "MIIA" "MIIB" "S3D"
    "S19D" "only 2 h" "S19P" "MLCP" "nonmuscle" "synapse" "RhoGTPases" "+ 4"
    "Anti–mouse" "re-distribution" "HIVNef−" "HIVNef" "HIVWT"
    "subcellular localization/redistribution" "non-caveolar" "Cav-1s"
    "myristate" "U1HIV" "HUT-78HIV" "Liao" "y" "co-cultured" "HAECs"
    "Non-adherent" "triglyceridemia" "C57BL6" "Lxrα"
    "an active endogenous metabolite MNAM" "HFD1%" "HFD-fed" "-fed" "bulkiness"
    "cyclohexamide" "nmt" "libitum" "C57BL6/J" "HMDP" "adenosyl" "Adenosyl"
    "co-substrate" "MNAM" "methylnicotinamide" "mg/kg/day" "anti-Mouse"
    "mean ± s" "± 0" "photoproduct" "Holthauzen" "Paulucci"
    "UV-blocking melanin" "-photoproducts" "photoproducts" "cyclopyrimidine"
    "PHMs" "ORiP" "CREBtide" "PHM" "phosphostatus" "adenylate" "ORA"
    "agonism/antagonism" "pheomelanin" "eumelanin" "melanin" "ATR-pS435"
    "photodamage" "EC 50" "10.1038/ncomms8721" "Lowy" "EGF/PDGF" "reassociate"
    "T-switch" "PTEN–T319Y" "–T319" "T319/321A" "P-switch" "SDTTDS"
    "TNS3-C2-T323A" "Thr321 in" "HA-CA-Mek1/2" "Dictyostelium" "-bisphosphate"
    "bisphosphate" "catalyses" "ABD" "tensins" "GTP-bound RhoA" "active RhoA"
    "anti-Phosphoserine" "anti-Phospho-Tyrosine" "Co-expression" "HUSMC"
    "HUSMCs" "a collagen-like internal R-domain" "collagen-like"
    "non-parametric" "Copetti" "Mergny" "shIKKβ" "h" "erine" "monodansylcadav"
    "~18-" "Shen" "ADAMTS" "fibrosus (AF)" "pulposus (NP)" "fibrosus" "annulus"
    "pulposus" "P38 MAPK" "g/ml" "V689D/L693D" "L757A/K759A" "non-confined"
    "T202/Y204" "Lappalainen" "Pekka" "Fiona" "allantoid" "mEos"
    "membranous organelles" "EKAREV" "immunofluorescense" "S624A/T628A"
    "Eps8Δcap" "Emerald-mEps8-SATA" "pS/T"
    "nearly fivefold higher actin bundle anisotropy" "Emerald-mEps8Δcap" "Δcap"
    "Emerald-mEps8Δbund" "bund" "Δbund" "tipless" "FibrilTool" "plugin"
    "anisoptropy" "U20S" "kymograph" "m/min" "non-adherent" "Z-axis"
    "F-tractin" "tractin" "mEps8" "a dense meshwork" "lamella"
    "E pidermal growth factor receptor p athway" "ubstrate" "athway" "bundlers"
    "crosslinkers" "depolymerizers" "cappers" "nucleators" "Logue" "amoeboid"
    "skeleton-like" "non-adhesive" "± 0.5 µ" "± 3 µ" "non-phosphorylatable"
    "TSAd-∆Exon7-mCherry" "IFC" "∆Exon7" "Exon7" "co-localize" "∆239-274"
    "Δ239-274" "the minimal consensus sequence PxxP" "PxxP" "LPHQPPP" "SVIGQGP"
    "KPPIPAK" "EPSQLLR" "Scansite" "phophosite" "JTAg" "phosphotyrosines"
    "SMALI algorithm" "TCR/CD3 complex" "algorithm (SMALI)" "SMALI"
    "P- values " "mg/ml " "1-3 " "24 h" "non-stimulated" "non-catalytic"
    "Non-catalytic" "endocrinology" "VGCCs" "Webb"
    "non-invasive digital peripheral arterial tonometry (PAT)" "+4" "ΔLnRHI"
    "+96 " "ΔDHT" "ΔAI" "ΔTT" "ΔRHI" "+4 " "LnRHI" "VOCCs" "L-type"
    "coronary EDys" "Framingham" "pulsatile"
    "reactive hyperemia peripheral arterial tonometry (PAT)" "tonometry"
    "immunocytes" "EDys" "ΔAI@75" "AI@75" "Endopat2000" "4-day" "RHI"
    "severe hypotestosteronemia" "hypotestosteronemia" "pg/mL" "nmol/L"
    "± 0.3 " "ofcould" "Fourier" "Stronger" "invariance" "ofinto" "widefield"
    "an anisotropic Ripley" "physical crosslinks" "crosslinks"
    "quantitatively address biological co-orientation"
    "no statistically significant co-orientation" "tublin" "SR" "TIRF"
    "the selected circular ROI" "ROIs" "ROI" "Wilks" "Shapiro" "Smirnov"
    "Kolmogorov" "the normalized anisotropic Ripley’s"
    "the normalized anisotropic Ripley" "Ripley" "Co-orientation" "Matlab"
    "the simultaneous co-localization" "nearest" "pixels" "Manders" "motile"
    "co-orientation" "= 0.24" "Spearman's" "spearman" "= 352" "LNM" "P = 0.033"
    "P = 0.03" "non-cancerous" "Hirano" "both the Alzheimer’s"
    "the Alzheimer’s" "pure VaD" "microbleeds" "mature NFTs" "Pretangles"
    "pretangles" "fibrillar NFTs" "active caspase-3 co-localizes" "6E10"
    "anti-Aβ" "Tau46" "Strong co-localization"
    "all identified PHF-1 labeled NFTs" "strong co-localization"
    "Co-localization" "deoxynucleotidyl" "HT7" "Braak" "neuropil" "subfield"
    "lacunes" "diagnosing pure VaD" "only trailing Alzheimer’s" "NFT"
    "pretangle" "TauC3" "plaque-rich regions and corpora amylacea (CA)"
    "amylacea (CA)" "amylacea" "NFTs" "VaD" "Aβ" "ASCO/CAP"
    "over-expression/amplification" "p = 0.03" "ER+/PgR-" "EBCTCG" "Trialists"
    "ER+/PgR+" "Oncology/College" "PgR-" "overexpression/amplification" "PgR+"
    "= 0.77" "= 0.03" "≥10" "CEP17" "Huntington’s" "pharmacophore" "α11-"
    "β9-α15" "α12" "α11" "Gal4N-fused" "acetamide" "β6-α10" "β5-α9" "β3-β4"
    "inhibitor-bound HDAC4c" "the structure-based MSA" "-IIa" "MSA"
    "spectrophotometer" "KGC" "Kusabira" "pRS324UBG" "transformants" "-5c"
    "HDAC5cN" "HDAC5cM" "HDAC5c" "co-transformation" "B42AD" "GBD" "G4T" "G4N"
    "YOK400" "HDAC4cT" "HDAC4cN" "intactness" "OPTHiS" "the unique topology"
    "BCoR" "non-enzymatic" "Hda1p" "octamers" "HDAC4c" "SRID" "SRD3c" "IIa"
    "non-redundant" "HDAC6 is" "Wacholder" "miR-449a"
    "Both unfavorable genotypes" "miR-34b" "rs696A"
    "rs28362491del/ins unfavorable genotype" "rs696GG/AG" "rs28362491del/ins"
    "adverse genotypes" "the combined adverse genotypes" "1.20–1.66"
    "1.09–1.55" "the adverse genotype" "rs696" "the rs696AA adverse genotype"
    "rs28362491ins" "rs696AA" "AIC" "ins/del" "rs28362491" "rs696 G"
    "rs2233406C" "rs12769316G" "NFκBI" "nasopharynx" "rs696G" "rs28362491del"
    "both adverse genotypes" "hsa-miR-449a" "the del/del homozygous genotype"
    "del/del" "insATTG" "NFκB1" "ATTG" "P = 0.007" "P = 0.009" "μ g/mL"
    "95% CI" "Chan" "Thadani-Mulero" "Steinestel" "Mulero" "Antonarakis"
    "mCRPC" "α/β" "the constitutively active AR-V7 or AR v567es" "-TurboFP635"
    "TurboFP635" "TurboFP" "CaCl" "P/S" "Fn/c" "LNCaP95" "v567es" "es" "LBD"
    "re-plated" "METLIN" "Orbitrap" "XL" "isotopologues" "ultrahigh" "G1/G0"
    "febrifuga" "Dichroa" "febrifugine" "non-transformed" "10.1038/srep12116"
    "Molina" "ΔΔT" "lysis" "carboxyfluorescein" "ATSP-7041"
    "a ten-fold smaller IC 50" "Staplin-2" "ΔT" "ATSP" "Staplin" "CETSAs"
    "deconvolute" "biomolecules" "= 0.24 " "IC 50 s" "× 10 "
    "10.1038/ncomms8643" "Moye" "Est1p" "porphyrin" "TTAG" "ddGTP" "TTA"
    "Ciliate" "non-telomeric" "the former
G-quadruplexes"
    "The dimeric parallel G-quadruplex" "mean±s" "Menton" "Michaelis" "∼30%"
    "the
P1-treated linear 7GGT"
    "C-strand" "Watson" "°C " "dimeric G-quadruplex"
    "a unimolecular G-quadruplex" "ESI-MS" "absorbance" "22GGG" "Sr 2+" "TDS"
    "dichroism" "a tetrameric
G-quadruplex"
    "7GGT" "Tetramolecular G-quadruplexes" "TTGGGG" "aediculatus" "Euplotes"
    "thermophila" "Tetrahymena" "Oxytricha" "lemnae" "Stylonychia" "ciliate"
    "TTAGGG" "NMM" "mesoporphyrin" "G-quadruplex" "quadruplex"
    "conformationally homogenous human telomeric G-quadruplexes"
    "G-quadruplexes" "quadruplexes" "Anti-Rabbit" "non-radioactive" "×
10"
    "±0.5 " "modulins" "the gastric epithelium" "TC/TT" "only PGC rs4711690"
    "noncardia" "6p21.1" "rs12229892-" "rs4711690-" "rs6912200-" "Breslow-Day"
    "CG/GG" "GA/AA" "GC/CC" "GA" "rs6912200" "rs4711690" "tagSNPs" "pepsinogen"
    "hidden" "rs1143623" "rs12229892" "ng/μL" "stem/leukemia" "co-targeting"
    "DASA" "LICs" "LIC" "advanced/aggressive" "Gerbaulet" "Chatterjee" "Ehop"
    "Roxolitinib" "bonafide" "association/docking" "Waldenstrom's" "WM" "RFLP"
    "ECNM" "advSM" "KIT-TETS2-ASXL1" "co-occurence" "wilson" "Damaj" "Schwaab"
    "Vita" "co-occurred" "newer" "almost all subtypes" "del419"
    "The last subvariant" "lymphoproliferative AHNMD" "CMML"
    "a special subtype" "a special subvariant" "subvariant" "non-mast cell"
    "subvariants" "AHNMD" "non-KIT" "begun" "PTD" "TKD" "JMD" "4q12" "Greater"
    "Essential Thrombocythemia (ET)" "Thrombocythemia" "CNL" "growth/survival"
    "non-targeted" "Sorefenib" "TME" "non-tumors" "= 0.012" "p38 MAPKs"
    "10.1038/ncomms8679" "vemrafenib" "Kawai" "RhoG" "FRA1-" "FRA" "Doehn"
    "IRLP" "the immunohistochemical co-localization" "RLPpS"
    "Immunohistochemical co-localization" "UACC257" "RSK1/2" "FCS-" "FCS"
    "-tetradecanoylphorbol" "tetradecanoylphorbol" "o" "AGC" "PhosphoSitePlus"
    "Miao" "PKCɛ" "Cɛ" "Zhou" "Ser-897-phosphorylated EphA2 co-localizes"
    "co-localizes" "10.1038/ncomms8678" "RhoA" "non-mitotic" "Hec1Ser44ph"
    "prometaphase-like" "superfamilies" "interactome" "Laevis" "midzone"
    "Papini" "μg " "Phyre2" "ICI" "punctae" "migration/invasion" "WN"
    "PI3KCIII" "AE-" "1-3" "the co-chaperone Bcl2-associated athanogene"
    "co-chaperone" "athanogene" "the predominant subtype" "μ g" "anti-hormone"
    "Core/latch" "BaxBH3" "BidBH3:BaxI66AΔC21" "BimBH3mini:BaxΔC28" "BaxΔC28"
    "BimBH3mini:BaxΔC26" "BH3mini" "BimBH3mini" "4BD2" "rotamers" "BaxS184L"
    "liposome" "A91R" "h2+1" "BimBH3:BaxΔC26" "I82A/I83A" "P144A/E145A" "alkyl"
    "I82/I83" "BaxΔC" "BaxΔC26" "BidBH3:BaxΔC21" "core/latch" "BimBH3:BaxΔC"
    "dimerise" "BaxΔC21" "octylglucoside" "ΔC" "ΔC21" "BidBH3" "BimBH3" "ΔC26"
    "3 P" "IC50s" "reacquire"
    "publicly available miRNA-target prediction websites" "websites" "Kit-8"
    "HIECs" "P- value" "24 h" "P =0.007" "the available immunoreagents"
    "immunoreagents" "SCKL6" "cytology"
    "Atr deficiency causes more severe facial dysmorphia" "dysmorphia"
    "centriolar ultrastructure" "ultrastructure" "cellswere"
    "only one or two single centrioles" "hyrax" "KASH" "crossover" "InCep63"
    "seminiferous tubules" "deferens" "vas" "thatCep63" "polyploid"
    "spermatagonia" "theCep63" "mitoses" "SVZ" "andCep63" "VZ" "inCep63"
    "ofCep63" "Deup1" "forebrain" "heterozygous littermates" "dwarfism"
    "Seckel" "nucleofilaments" "andPten" "bothPten" "transfectedPten"
    "treatedPTEN" "rotein" "iPOND" "andPTEN" "bothPTEN" "centromeres"
    "decouples" "inPTEN" "shPTEN" "HU-" "PTEN +/+" "withPten" "inPten" "CldU"
    "chlorodeoxyuridine" "HU" "non-centromeric" "chromatid" "chromatids"
    "PTEN +" "1+S" "cardia" "RASSF1A polymorphic variant A133S" "A133S" "GI"
    "Oestrogen" "ctDNA" "3p21" "diploidy" "non-GCB" "polysomies" "MCBC" "/BC"
    "MC + BC +" "R-CHOP-like" "COO" "Jiangsu" "= 0.177" "≥ 5" "= 0.016"
    "= 0.005" "= 0.028" "P = 0.001" "P = 0.002" "anti-migratory"
    "25-hydroxy-vitamin D3" "Boyden" "HCT116 p53+/+" "SW480/pRTR" "qChIP"
    "Hünten" "spacer" "RRRCWWGYYY" "25-hydroxy-vitamin D 3" "mg/ml" "or/and"
    "miR-15a" "CYTB" "XTT" "BrPA" "kinase-3" "polypyrimidine" "non-resistant"
    "24 h" "μg" "PI3K/Akt/mTOR" "FBXO3" "Swyer" "systemic corticosteroids"
    "nonstimulus" "BC-1382" "LibDock" "rs7081569"
    "These in vivo studies further support HECTD2 A19P" "orHECTD2" "PA103"
    "nuclear/cytosol" "cyan" "YPF"
    "a naturally occurring HECTD2 A19P polymorphism"
    "a naturally occurring nonsynonymous G/C polymorphism"
    "a naturally occurring polymorphism" "S13/S17A" "S17A" "S13A" "hypermutant"
    "NetPhos" "1/2" "subfamilies" "pancreatitis" "aeruginosa" "A19P"
    "pulmonary edema" "multiorgan" "edema" "to10 µ" "1000 Genomes" "~2.5"
    "indozoles" "nanobodies" "ABT-700" "PIGF" "F-fluorothymidine" "positron"
    "fluorothymidine" "nontarget" "postdose" "BALP" "propeptide" "procollagen"
    "sCTx" "telopeptide" "concentration-time" "•h/mL" "400-mg" "300-mg"
    "200-mg" "identifier" "QT" "and 3+" "2 study" "≥25" "to 10" "≥1" "pMEK1/2"
    "available Cu" "geometries" "Pt" "CETSA" "bound Cu" "pMEK" "± 0.4-fold"
    "10T1/2" "Tm" "SYPRO" "ITDRF" "dithiotheitol (DTT)" "largely Cu +2"
    "dithiotheitol" "CuSO" "exchangeable Cu" "+2" "Cu" "co-occupy" "± 3"
    "± 0.3" "± 2.7" "loureirin" "three publicly available algorithms" "24h"
    "transparent vacuoles" "cytomembrane" "sunken" "miR-23b" "miRNA-23b"
    "TGF-β signaling" "int" "EREs" "DiffBind" "RIME" "progestin" "PR+" "ERα+"
    "mg/mL" "= 0.019" "Co-treatment" "anti-tumourigenic"
    "an anterior-like cardiogenic mesoderm" "hPSC" "a cardiogenic subset"
    "clear myofibrillar striations" "striations" "XAV-939 (XAV)" "XAV"
    "endocardium" "granulocyte/monocyte (GM)" "erythromyeloid"
    "primitive erythroid-like" "EryP" "non-sprouting" "invasion/sprouting"
    "EGM" "/CD34 +" "hemato" "anterior-derived cardiogenic mesoderm"
    "cardiogenic mesoderm" "direct cardiogenic mesoderm" "axial" "/B"
    "brachyury" "goosecoid (GSC)" "goosecoid" "Venus" "fluoroprotein" "hESC"
    "hESCs" "A/BMP4" "hPSCs" "sublineages" "distinct mesodermal subpopulations"
    "Cardiogenic mesoderm" "anterior-like" "posterior-like"
    "distinct anterior-like" "monocyte/macrophage" "Katayama" "synthe"
    "the 5-FU-resistant gastric cancer cell line SGC7901/5-FU"
    "the fluorouracil (5-FU)-resistant human gastric cancer cell line SGC7901/5-FU"
    "the MDR gastric cancer cell line SGC7901/VCR" "SGC7901/VCR" "fallen"
    "the fluorouracil (5-FU)-resistant gastric cell line SGC7901/5-FU"
    "SGC7901/5-FU" "synthatse" "dephos" "OA" "A2780/DDP" "Akt8" "O3a" "ChR"
    "Akt/forkhead box O3a" "8-bromo-7-methoxychrysin" "BrMC" "anti-glioma"
    "Natsume" "cyto" "p85α" "western blot analysis and gelatin zymography" "β1"
    "U251" "G0-to-G1" "LPSs" "wk" "chimerism" "timespan" "HSCPs" "MFI"
    "2,3/CDK4,6" "anti-BrdU" "/G1 phase" "CD34 +" "Procentrioles" "laevis"
    "the mature mother centriole" "mimosine" "supernumerary de novo centrioles"
    "STIL" "IAA" "AID-3xFLAG" "an auxin-inducible degron (AID)" "osTIR1"
    "microsurgery" "aneuploid" "procentriole" "Centrioles" "penetrant"
    "centrioles" "Centriole" "centriole" "a 3xFLAG" "S/G2"
    "publicly available datasets" "UbiCRest" "APC/C" "deubiquitylate"
    "catalyse" "re-establishment" "HIFα" "co-transfections" "non-stressed"
    "confounder" "SMART" "siRNF31" "P -value" "P -values" "mol/L" "DrugBank"
    "NCGC" "fda" "dbap" "holo" "UniProt" "istar" "considerable speedup"
    "speedup" "Vina" "AutoDock" "our convenient visualizer iview" "visualizer"
    "LBVS" "NAE" "piperacillin" "Dichlorophenoxy" "SBVS" "goes" "2-Amino-6-"
    "butoxypurine" "-oxo" "oxo" "BALB/C" "pho" "discrepant" "kcal/mol" "iview"
    "RMSD1" "RMSDm" "co-crystallized" "anti-psychotic" "repurpose"
    "Fluspirilene" "fluspirilene" "idock" "kcal/" "H-bounds" "YB-1 :RNA"
    "picoseconds" "Boltzmann" "Poisson" "rU4r" "rU4" "UUU" "GGU"
    "the bacterial CSP:oligo(dT) complexes 2ES2 and 2HAX" "and 2HAX"
    "CSP:oligo" "re-emphasized" ":sRNA" ":ssRNA" "ssDNA" "polyA" "polyU"
    "polyG" "YB-1:DNA" "YB-1:RNA" ":DNA" "-OH" "a very strong H-bonds" "OligoU"
    "OligoA" ": OligoG" "the Cohen’s" ":oligoG" ":RNA" "oligoG" "P-value"
    "Bs-CSP:oligo" "A/P" "T-rich" "follows: Oligo" "Oligo" ": Oligo" "Cohen’s"
    "RMSFs" "RMSF" "strong H-bonds" "form strong H-bonds" "NH" "The Cohen’s"
    "Cohen" "ΔG" ":oligo" "nanoseconds" ":oligoC" ":oligoT" "∆G" "dG"
    "Van-der-Waals" "non-aromatic" "Bs" "CspB" "RMSD" "G-rich" "ribo"
    "desoxyribo-" "desoxyribo" ":oligonucleotide" "ss" "Y-box"
    "a multifunctional DNA/RNA binding protein" "NA" "H-bonds" "1 ps"
    "synthases" "lymphotoxins" "non-mutually" "subcategories" "aminoacyl"
    "a smaller subset" "x" "catabolites" "ninhydrin" "monosome"
    "lipolysacharride" "Pam3CSK4" "translatome" "μg /ml" "Non-targeting"
    "non-targets" "±1.5" "ATM/Chks" "camptothecan" "austrobalignan"
    "aroylthiourea" "topoisomerase-1" "austrobailigan" "autrobailignan-1"
    "VDDADFMK" "waf1/Cip1" "Chks" "austrabailignan-1" "ser1981" "DSBs"
    "hypodiploid" "lignin" "Austrobailignan-1" "austrobailignan-1" "Taiwan"
    "Dummer" "henryi" "Koelreuteria" "microdomains"
    "conformational flexibility intoα-helices" "intoα-helices" "AxxxG" "GxxxA"
    "bilayers" "G/Ch" "PD1T" "CD28T" "TIRFM" "mEGFP" "Δbind" "58α" "CD4WT" "5c"
    "CD4T" "Förster" "SRBI" "to 2mM" "C-terminally" "invariant" "Forster"
    "GVxxL" "GxxxG" "GGxxG" "-glycero-3-phosphoethanolamine"
    "-glycero-3-phosphocholine" "1-palmitoyl-2-oleoyl-" "Anti-mouse"
    "co-treated" "oligopyrimidine" "rIL1A" "juxtacrine" "non-SASP" "ELISAs"
    "PSC27" "12/34" "senesce" "rapalogues" "~80%" "Jacque" "B–P100/P52"
    "Lessard" "A/P50" "squamous histology" "pTNM6" "isotype" "PCNA+" "juxta"
    "bronchial and alveolar epithelium" "semi" "NF-κB1"
    "the predominant NSCLC subtype" "-κB" "= 6" "C57BL /6" "κB" "JFP" "TNH"
    "JHP" "PWK" "SWH" "‐mediated" "Pan‐AKT" "‐induced" "pan‐AKT" "‐inhibition"
    "‐201" "‐STAT3" "‐culture"
    "Chronic lymphocytic leukaemia cells co‐cultured" "Asslaber" "‐AKT"
    "co‐cultured" "GSK3A/B" "‐down" "‐2" "AiX" "‐specific" "‐cultured"
    "Sarbassov" "‐cultures" "‐beta" "Zhuang" "Hofbauer" "Woyach"
    "mostly G 0 ‐arrested" "‐arrested" "Herishanu" "Takemaru" "RSXpC/TXP"
    "CBY1/14-3-3σ" "re-import" "BV02" "/Axin/glycogen synthase kinase-3β"
    "BCR-ABL1 +" "BCR-ABL1+" "BCR-ABL1" "1 +" "1+" "American" "pSTAT3+"
    "pSTAT5+" "TDLU" "TDLUs" "DCISs" "histologically benign breast epithelia"
    "alveoli" "Transducers" "IDC" "ADHs" "pSTAT3" "pSTAT5" "Jilin" "Transducer"
    "clinicians" "Yi" "NSLC" "MST-312" "Rachakonda" "C-variant" "Naosuke"
    "Labussière" "genotype (CC)" "only TERT rs2736100" "co-activate"
    "the polymorphic rs2853669 SNP" "rs4246742" "rs10069690" "SNV's" "SNV"
    "rs7784168" "POT" "McKay" "rs2736100" "T-allele" "pb" "rs2853669"
    "C-allele" "rs2736100 and rs10069690 SNP's" "5/11" "= 0.007" "p = 0.001"
    "panniculitis" "95CI" "immunotherapy" "advancements" "SUCRA" "1.66-2.44"
    "P = 0.008" "GEMM" "mutated NBBC" "BSCS" "NBBC" "BCSC"
    "-CGGGTCCCCGGCCCAGCCCC" "CGGGTCCCCGGCCCAGCCCC" "TALEN" "nucleases"
    "oncosphere" "Non-NBBCs" "Giemsa" "non-NBBCs" "non-BCSCs" "NBBSc"
    "urothelium" "NBBCs" "BCSCs" "NOD/SCID" "activator-like" "anti-anabolic"
    "ErBb" "pHER" "T→A" "HER2b" "EGFRb" "EGFRa" "ACS" "S/T" "LXRXX" "ribose"
    "~50%" "re-probed" "Non-Radioactive" "Anti-rabbit" "non-tumorigenic"
    "motorneurons" "inositide" "PI4KIIIβ" "Rong" "Phosphoinositides"
    "P-binding" "Chang" "Kanagaraj" "Hanein" "Yarar" "phosphoinositides"
    "Schulze" "the classical ALR tubules" "Betz" "Sancak" "Zhao" "Maejima"
    "LLOMe" "Knævelsrud" "Jung" "Hosokawa" "Ganley" "tion" "func"
    "co-localising" "Russell" "Byfield" "∼70%" "dblA" "Coomassie"
    "Autoradiography" "Choo" "Zhuo" "amino acid-free Earle's" "Earle"
    "Klionsky" "the VPS34-IN1-induced tubules" "Martínez" "KU" "Jefferies"
    "again found significant co-localisation" "Ellson" "Bago" "Funderburk"
    "Tooze" "Simonsen" "Itakura" "Kihara" "Lemmon" "Camilli" "Paolo" "Raiborg"
    "Ohsumi" "Yu" "a digestive organelle" "Puertollano" "et " "S5A" "S4A"
    "Cruz" "Pontén" "Prasad" "Humayun" "Abbas" "Bortoluzzi" "Hausmann"
    "Medcalf" "Cipriano" "Cheung" "Cuervo" "Freije" "Gandarillas" "Gadek"
    "Wesierska" "Chaturvedi" "14-3-3σ" "Serrano" "EcoRV" "Kang" "H3Ac"
    "5-aza-CdR" "Targa" "Recillas" "Reyes" "Soto" "Takagi" "Mamczarz" "Mazan"
    "HNKs" "Afshari" "Stein" "Dulić" "both young and senescent NHKs"
    "MMC-treated NHKs" "young and senescent NHKs" "60s" "epithelia (NHOE)"
    "NHOE" "actively proliferating NHFs" "Sisoula" "Kim"
    "actively proliferating NHKs" "NHFs" "Vaziri" "Kulju" "Atadja" "Komarova"
    "Gudkov" "Feng" "Wilson" "Mikheev" "García" "Tyner" "Kruse" "Donehower"
    "Beghé" "Balducci" "rapidly proliferating NHKs" "NHKs" "× 10" "Ser807/811"
    "Malades" "Enfants" "Necker" "Tumorothèque" "DF" "RAV" "lipotropy"
    "filopodia-like" "co-occurring" "trisphosphates" "Amplicon" "NCI"
    "heteroduplexes" "gDNA" "gDNAs" "exon-3" "amplicons" "Hotspot" "JGCT" "Gαs"
    "AGCTs" "histology" "theca" "granulosa" "non-wild-type" "JGCTs" "10/16"
    "Roche" "Genentech" "HK" "SM" "JP" "H-sensitive"
    "a small yet significant subset" "MET-disrupting monotherapy" "LKPH4"
    "the free tumor-associated hVEGF" "hVEGF" "Ɣ" "2–3" "XBP-1s" "LPE"
    "PNGaseF" "anterograde" "-1α" "SMIs" "Intracrine" "GDC0712" "shMET" "RERF"
    "pleuromesotheliomas" "epidermoid" "ISH" "situ" "ASCO" "monotherapy"
    "~ 50%" "~ 40%" "S2D" "S2B" "~ 2.5" "anti-Rabbit" "neurophysiology" "Najas"
    "EBioMedicine" "trisomy" "Langdon" "SNPinfo" "HumanCytoSNP"
    "subsequent hypoglycemia" "hypoglycemia" "nonsmall" "≤20" "noncarriers"
    "only one SNP" "Only one SNP" "Brinkman" "around AKT1 SNPs"
    "-trisphosphate" "rs2498794" "= 4" "= 9" "ng/ μ L" "CXXC" "aminoacid"
    "strong CGI" "CGI" "CGIs" "5caC" "5fC" "carboxylcytosine" "formylcytosine"
    "dioxygenases" "oxoglutarate" "5hmC" "ation" "methylcytosine"
    "hydroxymethylcytosine" "5mC" "I155R/E158A" "aptamers" "AuNPs"
    "R154S/I155R/E158S" "carboxyl" "an amphipathic α -helix" "-helix"
    "isothermal titration calorimetry (ITC)" "calorimetry (ITC)" "ITC"
    "I155R/E158S" "ionic" "T/S" "RxRxx" "calorimetry" "‘sensitizers'"
    "sensitizers" "prodeath" "repopulate" "sarcospheres" "genic" "tumori"
    "flurouracil" "non-SP" "~2.1%" "corticosteroid" "MA-20" "collagen 1A1"
    "MAB1835" "+18bp" "18bp" "spindle-like" "Bavaria" "Elisabeth" "England"
    "Elizabeth" "facture" "vulgaris" "immunoglobulins" "colostrums" "Eurasia"
    "EC50" "the ancient Aegypt" "Cleopatra" "Aegypt" "urus" "5-bromo-2"
    "10.1038/ncomms8645" "H-bond" "ortho-" "phenyl" "ortho" "KRKKRK" "packings"
    "C-pocket" "strucutres" "multipoint" "CarbaNAD" "ɛ" "+1" "carbaNAD"
    "mini-hSIRT1/" "H2-T-H3" "chemotypes" "mini-hSIRT1s" "GGGS" "GS" "∼15%"
    "hSIRT1cd" "HDX-MS" "substrate/ligand" "Rossmann" "-acyl-ADP-ribose"
    "musculus" "Drosophilla" "-sirtuin" "deacylases" "STACs" "±3" "20 min"
    "co-selection" "carbonyl" "Intra-" "Intra" "droplet"
    "a K D almost 700-fold greater"
    "successfully isolated sub-nanomolar-binding anti-HER2 DARPins"
    "a further 5°C" "revertants" "almost 30°C" "A55T" "offs"
    "stability/function" "the parent and evolved DARPins" "readout"
    "fluorophores" "HDKV" "H10-2-G3" "interferometry" "N2C"
    "solutions/trajectories" "epPCR" "gave ELISA signals greater"
    "soluble DARPins" "mutational hotspots" "hotspots" "Mutazyme" "Taq" "HAVD"
    "mHaeIII" "BeSD" "-DARPin" "-alkylguanine" "alkylguanine"
    "which uses water-in-oil droplets" "compartmentalise" "helices"
    "antiparallel" "eukarya" "anticalins" "miniproteins" "monobodies"
    "affibodies" "curvatures" "biosuperiors" "DARPins" "DARPin"
    "non-overlapping" "TMM" "Dillies" "Chevillet" "Tewari" "Clin" "Parasramka"
    "Zeitels" "Mendel" "Kornfeld" "JCI" "Rayner" "Shoushtari" "Najafi" "PNAS"
    "Flynt" "lsy6" "NSMB" "Hobert" "Didiano" "Li" "Krek" "Grimson" "Biol"
    "PLos" "Brennecke" "Montecalvo" "JEV" "Ekstrom" "Mittelbrunn" "exRNA"
    "DESeq" "ESCRTs" "hnRNP A2B1" "Comm" "Bletri" "Villarroya" "Thornton"
    "Valverde" "Fernandez" "Katoh" "Lalic" "Koppers" "Batagov" "Bolukbasi"
    "Perhaps" "miR-320 as" "R-values" "Morrison" "Sean" "Exosomes" "exosomes"
    "exosome" "non-templated" "non-template-directed" "EV" "Dks" "antagomir"
    "antagomirs" "perfect MREs" "MREs" "GGAG" "MEME" "isomers" "isomiRs" "-5p"
    "5p" "turnover/decay" "miR-320a" "miR-320d" "miR-320b" "miR - 320b" "-e"
    "oncomiR" "miR-100-5p" "DKO-1" "DKs" "non-mappable" "smaller lipoproteins"
    "lipoproteins" "EVs" "Cha" "≥ 1" "|log" "non-genomic" "ERα66" "Fuhrman"
    "nephron" "tubules" "ERα36" "= 0.020" "= 0.017" "= 0.005" "P  = 0.002"
    "P  = 0.022" "Smads" "LY49002" "bilayer" "Trichrome" "Masson" "H&E"
    "zymography" "Hoechst" "hemacytometer" "ECIS" "Rasanen" "TDNP"
    "-4,5-dihydro-1H-pyrazol-3-yl" "sulfonamide" "hydroxyphenyl" "naphtho"
    "Naphthochalcone" "re-modeling" "re-epithelialization" "TDPN"
    "trimethoxyphenyl" "naphthochalcone" "anti-aging" "PI3K/AKT/mTOR" "DMR"
    "miR15-a" "16-1" "Drobnjak" "pCMV" "S4D" "dimethylsulfoxide" "pT2" "pT3"
    "MethylMiner" "unpubl" "hsa-miR-193b-3p" "prostatectomy" "= 9"
    "capillary-like" "TCM" "Hif-1a" "Lan" "× 10" "expressrf" "pMagic7.1-Puro"
    "P=0.0032" "P=0.033" "P= 0.008" "=0.022" "=0.0032" "=0.033" "P=0.008"
    "=0.007" "the PCa glandular epithelium" "TAED1" "TEA" "P=0.002" "Gleason"
    "CRPC" "G1/S" "8/11" "~90%" "P=0.001" "=0.008" "onco" "miR-9-3p" "miScript"
    "miFinder" "/YAP" "Therapy-1" "chemotherapy+pemetrexed"
    "chemotherapy+taxane" "=0.189" "placebo+docetaxel" "selumetinib+docetaxel"
    "BATTLE" "+docetaxel" "=0.009" "non-small-cell" "stability/interaction"
    "centromere" "melanogaster" "Ran-GTP" "orientation/positioning" "S2481ph"
    "si01" "si02" "ΔPHD" "furthest" "Ran-dependent" "T210ph" "T288ph" "BI2356"
    "misattachments" "NEBD" "binucleate" "mAb414" "Mios" "SILAC" "subcomplexes"
    "A/Bora" "Numa" "subcomplex" "activation/deactivation" "SEACAT/GATOR2"
    "anti–mouse" "anti–rabbit" "5 B" "HCC-like" "Duolink" "PI3K/AKT" "Pathscan"
    "any obvious co-localization" "COXIV" "Madcam1 knockdown"
    "Madcam1knockdown" "sTNF" "LTD (CST)" "LTD" "HL-7702" "Doxo" "Caspase3/7"
    "co-incubated" "re-examined" "RT/CRT" "hR" "Fichter" "Liang" "IMRT" "60Gy"
    "COG" "standard definitive chemoradiotherapy" "Western Africa"
    "Eastern and Southern Africa" "Africa" "chemoradiotherapy" "five-year"
    "CD133+" "Alzheimer's" "Zhu" "eosin" "immuno" "radioresistant"
    "Representative photomicrographs" "photomicrographs" "Tuj-1"
    "a slightly higher OER" "oligos" "27a" "miRecords" "glutamylcysteine" "GCS"
    "OER" "Gy" "Neurosphere" "neurospheres" "non-GSCs" "arylhydrocarbon"
    "quinone oxidoreductase-1" "Nuclear factor-erythroid 2-related factor-2"
    "neurosphere" "nuclear factor-erythroid 2-related factor-2" "anti-mouse"
    "Log 2" "miR-27a" "hindlimbs" "TOPFlash" "TOPflash" "promoter/reporter"
    "Transcriptome" "ConsiRNA-" "Bach1siRNA-" "Wnt/β-Catenin" "AdBach1-"
    "AdBach" "Bach1siRNA" "ConsiRNA" "ischemic hindlimb" "arteriole" "AdBach1"
    "AdGFP" "ie" "C57BL/6J" "HMVECs" "oxygenase-1" "the ischemic hindlimb"
    "hindlimb" "Wnt/β-catenin" "Arg72Pro" "72Pro" "PAPOVA" "Egger’s" "Arg/Pro "
    "Pro/Pro" "Arg/Pro" "95 % CI" "Co-segregation" "Blau" "cyropyrin"
    "Schnitzler" "penetrance" "_004895.4:c" "tubule" "Congo"
    "glomerulonephritis" "secondary amyloid nephropathy" "CD3+" "Crohn’s"
    "Crohn" "PRYSPRY" "1955G" "_000243.2:c" "Mediterranean" "Missense" "vera"
    "non-pathogenic" "FMF" "MEFV" "non-malignant" "estrogen/ERα" "HNSCC"
    "co-regulator" "LxxLL" "cytoplasm/nuclear" "MMP1/9" "ARQ-197" "ARQ"
    "cytoplasm/nucleus" "Kalet" "co-regulators" "ERE" "co-activators" "IC  50"
    "0.5-1 " "μg/ml " "chemo-" "Scr" "non-tumor" "acetylation/deacetylation"
    "×10" "anti-rabbit" "non-immune" "B-lymphoma" "non-pathogen" "ETI" "capsid"
    "co-precipitated" "Orzalli" "cGAMP" "response/affinity" "dsDNAs"
    "non-sequence" "orthologue" "pfu/cell" "IFI" "IFI16-STING-TBK"
    "lanes 1 and 2" "1 and 2" "VI" "PFU/cell" "KOS" "pg/ml" "precomplexes"
    "5-ethynyl-2" "lenti" "184B5" "LCL" "lymphoblastoid" "rightmost" "Si" "UI"
    "epitopes/proteins" "oligo" "ed" "0.25 h" "copies/cell" "-deoxyuridine"
    "deoxyuridine" "HMVEC-d" "non-nuclear" "HFF" "d" "HMVEC" "Kaposi's"
    "type-1" "proforms" "multiprotein" "PYD" "NOD-like" "pIRF3"
    "nuclear episomal viral DNA genomes" "nuclear viral genomes" "HSV-1"
    "episomal dsDNA genomes" "dsDNA" "ALRs" "≥3" "× 10" "20 min" "~4.8" "~ 4.8"
    "Swiss" "US" "0–2" "observational cohort studies/studies" "studies/studies"
    "Scandinavians" "FOLFOXIRI" "Microsatellite" "wtKRAS/BRAF" "mutKRAS"
    "sigmoideum" "wtBRAF" "MutBRAF" "wtKRAS" "95%CI" "95% CI" "dysplasia"
    "oncology" "non-resectable" "co-morbidity" "mutBRAF" "= 0.021" "= 0.01"
    "non-metastatic" "re-evaluation" "represseses" "H3K18" "H3K18Ac" "SIRTs"
    "acyl" "Warburg" "histoscores" "Sirtuin" "PAUF" "ibosome" "elomere"
    "itochondria" "orthologues" "pancreatic intraepithelial neoplasias"
    "neoplasias" "clinico" "= 21" "18/23" "GI50" "11q" "17p" "CCF"
    "relapsed neuroblastoma genomes" "genomes" "scintigraphy" "μg/mL" "Hg19"
    "Twenty-one" "coli" "Ser 807/811" "cyclin D/E" "Karnofsky" "gargarizans"
    "bufo" "Bufo" "U/ml" "eliminating mitochondrial-derived O 2  •−"
    "mitochondrial-derived O 2  •− -dependent-autophagy" "-dependent-autophagy"
    "eﬀects" "mitochondrial-derived O 2  •−" "ﬀects" "Cd-mediated" "Cd-treated"
    "mitochodria" "Mitochondrial-derived O 2  •−" "mRFP" "Melatonin" "mROS"
    "Cd–induced" "1H-1,2" "•−" "pyridine" "melatonin" "Cd-induced" "Cd"
    "20 min" "S2A" "Tseng" "Mookherjee" "Chintala" "RNFL" "1G/1G" "Austria"
    "Agapova" "the following polymorphic variants MMP1 -1607 1G/2G" "T/C"
    "resp" "RLU" "C/C" "T/T" "A/A" "A/G" "1G/1G homozygous genotype"
    "-1607 1G/2G heterozygous genotype" "the homozygous genotype -1607 2G/2G"
    "2G/2G" "1G/2G" "JXT" "plaque-like" "the trabecular meshwork (TM)" "IOP"
    "HRT" "gonioscopy" "BCVA" "HTM" "POAG" "C/T" "U/mL" "A shematic overview"
    "NK-252" "ylmethyl" "pyridin" "dithiolethione" "Shimozono" "Okada" "Oh"
    "-methylsulfinylbutane" "methylsulfinylbutane" "dien-28-oate"
    "12-di-oxooleana-1,9" "Reata" "Idec" "Biogen" "LifeVantage"
    "12-dioxooleana-1,9" "imidazole" "dithiolethiones" "hydroxyanisol"
    "Nrf2/ARE" "choline" "backcrosses" "backcross" "carnitine" "Yates"
    "hepatectomy" "-dioxin-" "tetrachloride" "hepatotoxin" "Kwon" "organelles"
    "adaptation/survival" "oxidative/electrophilic" "chemoresistance"
    "response element-like" "Kelch" "G/A" "nnnCG" "S-transferases"
    "glucuronosyl" "mechanisms/factors" "isoenzymes" "2E1" "dyslipidemia"
    "cytochromes" "HFD" "the endoplasmatic reticulum (ER)" "reticulum" "VLDL"
    "droplets" "NAFLD" "C57BL/6" "ubiquitin/proteasomes" "G/C" "≤0.01"
    "the inactive isomer" "Talalay" "Chou" "calcusyn" "PFI-1" "TO/H1" "shCON"
    "Hodgkin’s" "shSCR" "Dox" "tetracycline-inducible-H1" "Waldenstrom"
    "supernatant" "supernatants" "their respective rIFNs" "IMiD" "rIFNs" "cyle"
    "BRDT" "BRD" "Kaposi’s" "Kaposi" "non-Hodgkin" "JQ-1" "enhancers"
    "anti-PEL" "/G 1 phase" "IMiDs" "anti-myeloma" "armamentarium" "uveal"
    "uptake/efflux" "surivivin" "cBio" "muscle-invasive UCC" "~40%"
    "sensitizer" "benzoporphyrin" "cisplatin-treated T24 YAPsh" "1x/week"
    "peltatum" "podophyllum" "pWPI" "pGIPZ" "NSsh" "YAPsh" "TEADs" "muscolaris"
    "sigmoid" "Liu" "amplicon" "un" "co-activator" "MVAC" "cystectomy" "MIBC"
    "MIBCs" "a transcriptional co-activator" "unmet" "UCC" "2 +" "= 0.039"
    "= 0.013" "= 0.031" "non-small" "TCA cycle/OXPHOS" "heavier" "axilla"
    "resensitizes" "oligomycin" "IP/Western" "ENO" "Oligomycin" "ECAR"
    "lactate/glucose" "defactinib" "PF4554878" "homogenates" "pGFP" "pcFAK"
    "CRISPRCas" "Genecopoeia" "KO" "subdomain" "herry" "DMEM" "KSFM" "PANC"
    "OXPHOS" "ng/μl" "WST-1" "10.1038/srep11765" "Jiang" "PI3K/Akt" "Ephs"
    "abdominal aortic aneurysm" "aneurysm" "tau441" "PI3K/GSK-3β" "PI3K/"
    "Tyr458/199" "DG" "Fc" "ephrinB1/Fc" "axon" "synaptopathies" "EphB"
    "ephrinA" "AD-like" "PHF" "VM" "glycogen synthase kinase-3β" "Alzheimer’s"
    "PHPS 1" "synthetase1" "antivirus" "rhIFN" "titre" "PHPS1" "anti-RSV" "hrs"
    "moi" "ISG" "eosinophil" "classical ISGs" "ISGs" "pStats" "transducers"
    "IFN-α/β" "preterm" "synthetases" "-oligoadenylate" "oligoadenylate" "RSV"
    "phosphotyrosyl" "non-protein" "MAPK1 was" "ceRNAs" "HOXD" "HOXC" "EOC"
    "miR-330-5p" "miR-214-3p" "U-shape" "Sadok" "SR11302" "Figrue"
    "-dichlorofluorescein" "dichlorofluorescein" "10 % FBS" "p38 MAPK"
    "doi:10.1186" "Napuri" "co-workers" "Nunez" "Martinez" "Bignami"
    "Orecchini" "Venn" "Pita" "MiRanda" "gp120-treated MDDCs" "miR-135b"
    "Biocarta" "miRWalk" "TRANSFAC" "miR-181b" "MDDCs" "nt" "10 % FBS"
    "co-exist" "miR-20a" "heterocomplexes" "MEN" "EGFR+" "endokinins"
    "hemokinins" "neurokinin" "non-neuronal" "monohydrate"
    "-6,7-dimethoxyquinazoline" "-phenoxyanilino" "phenoxyanilino"
    "c-Src-dependent" "written" "QUANTO" "ORs" "ULR" "Typer" "Sequenom"
    "MassARRAY" "Inflammatory-related SNPs" "FBG" "Omron" "liang" "SWHS" "FFQ"
    "Tomiyama" "≥ 1700" "Colin" "baPWVs" "socio" "Fangshan" "only 16 SNPs"
    "inflammatory-related SNPs" "BsmI" "diabetic nephropathy" "nephropathy"
    "JPT" "CEU" "Caribbean" "g/week" "≤100" "cm/s" "cIMT" "FMD"
    "sirtuins ( SIRT )" "SIRT" "glucolipid" "9p21"
    "numerous disease-associated SNPs" "PWV" "GT/TT" "rs107251" "rs12495941"
    "16 inflammatory-related SNPs" "baPWV" "= 0.004" "= 0.003" "= 0.017"
    "= 0.009" "46/54" "60/8" "75/12" "coworkers" "Konopka" "Slovakia" "ECG3"
    "ECG1" "10p23.31" "nonendometrioid" "CAH" "endometrium" "frameshifts"
    "endometrioid" "A total of 45 endometrial biopsies" "Slovak" "ECa" "10q"
    "FACS" "concomittant" "S-labelled" "pulldown" "0.5–1 " "delta-delta"
    "shSIRT1" "μ g/ml" "interwoven" "the diabetic myocardium"
    "cardiac myofibroblasts" "collagens" "cardiomyopathies" "supershift" "∼40%"
    "immunoglobulin" "TPA" "anti-miR+TNF-α" "FBJ" "ATFs" "myocardium" "∼50%"
    "miR-146a" "NPRL2 / G21" "non-responders" "NPRL1/G21" "Minna" "Lerman"
    "histotypes" "Senchenko" "Spearman’s" "Bioanalyzer" "I/II" "Spearman"
    "Keuls" "Newman" "AJCC" "LCC" "NSCC" "bio" "hemi" "non-codingRNA" "AP20"
    "FARs" "3p21.3" "3p" "vs" "NPRL2/G21" "LUCA" "= 0.01" "= 0.002" "= 0.03"
    "= 0.001" "G13D/WT" "10% FBS" "EGFR1" "arisen" "HAF1" "HAE6"
    "two isogenic HAF1" "G13D/wt" "A146T" "KDAC" "nonhistone" "KDACs"
    "anti-tumoral" "hnRNPs" "inKRAS" "the global acetylome" "acetylome"
    "A146T cells" "singleKRAS" "LEFTY" "extraembryonic mesoderm" "mesendoderm"
    "rs17228212" "rs35874463" "Harbin" "Linyi" "mesoderm" "endoderm" "ectoderm"
    "Nodal/TGF-βsignaling pathway" "rs2295418" "fetal echocardiography"
    "echocardiography" "CHDs" "arteriosus" "ductus" "Fallot" "tetralogy" "SPSS"
    "rs2289263" "Nodal/TGF" "=0.013" "Weindruch" "Anderson" "Takahashi" "Rhode"
    "Fromm" "Gérard" "Galvagni" "CEBPα" "Ristevski" "Ahn" "Yang" "Lehman"
    "ERRβ" "Schreiber" "co-activated" "Bruni" "Haigis" "Satterstrom" "γ-2"
    "NRF-2α" "Collins" "Virbasius" "Marinescu" "MAPPER" "Bellizzi"
    "Vassilopoulos" "Finley" "Riley" "Wong" "Ongwijitwat" "Baldelli" "Mootha"
    "Rosmarin" "Scarpulla" "Pagliarini" "MitoCarta" "kbp" "Warner" "co-induced"
    "Hakvoort" "Streeper" "Barger" "neocortex" "Giralt" "Kong" "Someya" "Qiu"
    "urea" "Shimazu" "Hirschey" "sirtuin-3" "Hebert" "Lombard" "= 0.002"
    "= 0.01" "= 0.003" "10.1038/srep11588" "Blasiak" "Wasson" "twenty-one"
    "homozygote" "non-significant" "Orwin’s" "Orwin" "the Egger’s" "Begg’s"
    "Egger" "Begg" "homozygous common genotype" "heterozygous genotypes (GC)"
    "co-dominant" "Sliwinski" "15q15.1" "African" "European" "America" "‘GG’"
    "‘CC’" "GG" "CC" "GG " "undertaken" "= 0.013" "= 0.004" "= 0.008" "Xu"
    "MetaCore" "immunochemistry" "± 3" "Dunn" "Wallis" "Whitney" "OLI"
    "interobserver" "vincristin" "cloroethyl" "procarbazin" "temozolamide"
    "ependinomas" "iTRAQ" "PI3K/AKT/" "= 4" "multisite" "87/90" "3Ss" "DSGISE"
    "Luc" "LY29400" "CHIR" "SB16763" "pS73" "1–3" "S87/90" "autoradiography"
    "CBB" "anti-epitope" "anti-pS81" "SV5" "anti-pS73" "pS87" "3S+DGS" "3Sd"
    "3S+DSG" "and 3Sd" "CREB-HΔTMC" "DSGX" "comigrates" "CREB‑HΔTMC"
    "comigrate" "ΔTMC" "DAGIA" "DSGIS" "Phosphodegrons" "Xaa" "BBF2H7"
    "severe osteopenia" "osteopenia" "OASIS" "CREB‑H" "intramembrane"
    "organelle" "phosphodegron" "S87/S90" "‑H" "0.5–1" "S2b" "pcDNA"
    "thymocytes" "USA" "10.1038/srep11620" "Ishise" "fibronecin"
    "heterotetramers" "hetero" "mechano" "TPRC3" "decubitus" "Pyr3" "OAG"
    "FPCL" "immunocytochemistry" "Kischer" "GGGACTTTCC"
    "cutaneous scar formation/contracture" "formation/contracture" "synergism"
    "_E542K" "_E545K" "PJ" "Eosin" "cells/mm 2" "TUNEL+" "3d/w" "mg/kg"
    "vsPertu" "vsEGCG" "kg" "mono-treatments" "the developed resistant HER2+"
    "co-exposure" "mono-treatments/combination" "co- treatment" "0value"
    "0values" "co-treatments" "μg/ml" "-cellulin" "cellulin" "Nahta" "SKLTR"
    "SKLR" "SKTR"
    "the classical FASN inhibitor epigallocathequin-3-gallate (EGCG)"
    "epigallocathequin-3-gallate (EGCG)" "gallate" "epigallocathequin"
    "anorexia" "antitumour" "dowstream" "PI3KCA" "tratuzumab" "co-treatment"
    "orthoxenopatients" "LTR" "LR" "HER2+" "± 0.4" "anti-proliferative" "± 1.5"
    "5-dimethylthiazol-2-yl" "p44/42" "HDAC3 is" "antagonise" "myofibroblasts"
    "the hyper-proliferative cervical epithelium" "cervical premalignancies"
    "premalignancies" "publically available gene array datasets" "Z-test"
    "Fischer" "uninfected normal cervical epithelium" "2b" "FGFR2b" "IGF1/2"
    "Romi" "publicly available microarray datasets" "J2-3T3" "co-culture"
    "E-medium" "HFK" "non-invasive" "HFFs" "IGFI/II" "E6/7" "HFKs"
    "the cervical epithelium" "an invasive epithelium"
    "a hyper-proliferative epithelium" "de-regulation" "gone" "CINI"
    "sensitises" "secretome" "oligodeoxynucleotides" "transfectants"
    "transfectant" "antagomiRs" "miRNA222" "CAL62" "221/222" "radioresistance"
    "nonprotein" "trisphosphate" "multiligand" "miR221/222" "DAMP" "Toll-like"
    "postbaseline" "nonrandom" "WHI" "kg/m 2" "0.97–1.01" "atypia" "BPBD"
    "nonusers" "nonsignificant" "10.1038/ncomms8505" "‘gatekeepers'"
    "gatekeepers" "a modest activity shBRCA1" "shBRCA1" "keratinoctyes" "SASF"
    "=4" "=9" "mut/ +" "non-carriers"
    "Semiquantitative immunohistochemistry (IHC)" "mammoplasty" "mastectomy"
    "H3K9" "HDFs" "H4K16" "shpRb" "p15/INK4b" "=0.003" "Avg" "=0.01" "HDEs"
    "HMFs" "HMF" "=0.03" "SASFs" "Ag" "lobules" "QFISH" "tetraploid" "diploid"
    "doublings" "=6" "mut/+" "circuitry" "screenings" "ncer" "Sedic" "/ S"
    "=0.324" "=0.002" "basal-like" "10.1038/srep11497" "Gu" "non-selectively"
    "2study" "BETTAIEB" "Milleron" "Hsu" "ΔΨm" "2+" "MitoTracker" "p53NLS"
    "Mitotracker" "cytocrhome" "°C" "± 0.5 " "infectiousness"
    "neutralisation/degradation" "H216A/H611A" "decouple" "autophasome"
    "co-distributing" "LucR-E-" "pNL4.3" "methyladenine" "co-P" "non-degraded"
    "∆BUZ" "co-localisation" "co-distributed" "nucleates" "ΔBUZ" "UBP" "ZnF"
    "DAUP" "mono-ubiquitin ligase" "actinomyosin-" "actinomyosin"
    "the viral genome" "anti-HIV-1" "unexpected translation termination codons"
    "hypermutations" "polypeptide-like" "infectiveness" "HDAC6/A3G"
    "a cellular co-distribution" "BUZ" "A3G" "non-tagged" "pcDNA 3.1"
    "non-specific" "10.1038/ncomms8450" "Singh" "non-atherosclerotic" "fibro"
    "p38MAPK" "Mac3" "lo" "SMCα-actin" "fibrofatty" "6-week-old" "Dil"
    "migration/adhesion" "monolayer" "deficiencey" "CD-fed" "CD" "pPak1"
    "24-week-old" "chemoattractant" "Paks" "Pak" "eightfold" "stem-like"
    "epigenome" "stemness" "PCGT" "transgenes" "progeny" "GSE53569" "NimbleGen"
    "RefSeq" "lambda" "MeDIP" "MEDIPS" "GSE54072" "lifespan" "PCGTs"
    "healthspan" "stem cell-like" "10.1038/ncomms8354" "doi" "crosslink"
    "dGrb2" "mGrb2" "phosphopeptide" "∼0.7 " "pShc" "tyrosylphosphopeptide"
    "Atto550–" "Atto488–" "Atto" "Atto550" "Atto488" "smFLIM" "protomers"
    "anisotropy" "microscale" "N188/214D" "protomer" "son-of-sevenless (SOS)"
    "tyrosylphosphate" "SOS" "non-receptor" "co-precipitating" "3/112" "8/92"
    "10/106" "Mazieres" "vitro" "6/11" "The predominant histological subtype"
    "4/11" "10/11" "pTNM" "pN" "pT" "duplication/insertion" "YVMA" "Caucasians"
    "Asians" "crizontinib" "potential responders" "responders" "Asian"
    "non-smoking" "canditate" "type 2A" "Australia" "epithelioid" "Codon"
    "stopgain" "dbSNP" "three heterozygous non-silent germline polymorphisms"
    "helix" "Krüppel" "frozen" "MYRF" "non-silent"
    "only germline polymorphisms" "hyper-" "BeadChip" "Methylome"
    "only 90 SNVs" "insertions/deletions" "indels" "22q" "SNP" "hg19" "bwa"
    "mapper" "ESMO" "14q" "Stratakis" "Carney" "succinate" "Krebs"
    "metastasise" "Germline" "gastro" "1p" "pombe" "Schizosaccharomyces"
    "reinitiate" "even stronger" "shp21" "shNT" "non-targeting" "uORF1" "uORF2"
    "NcoI" "HindIII" "S-cystiene" "cystiene" "E1A transformed wildtype" "siNT"
    "reinitiates" "uORF" "IRESes" "kilobases" "non-derepressible" "/S" "uORFs"
    "ISR" "anti-tumorigenic" "thatmiR" "patientsin" "xl" "Bcl" "AKT2_WT"
    "Taqman" "re-introduction" "HGC" "Targetscan" "non-homologous" "RCAN1-1L"
    "GREs" "T-lymphoblastic" "inductin" "±0.3" "EBPRE" "PP3C" "Huntington"
    "early onset Alzheimer’s" "Alzheimer" "PKIIQT" "FLISPP" "RCAN1-1S"
    "21q22.12" "MAC" "C1-15" "EBPREs" "GRE" "RCAN1-1" "E4BP4" "Dex"
    "developing algorithms" "co-regulation" "GSE2034" "GSE25066" "GSE4922"
    "co-modulated" "I/X ( NFIX )" "MK167" "co-occurrence" "overtaken" "v"
    "Qiagen" "non-informative" "regressand" "regressors" "flowchart" "overview"
    "ceRNA" "topology" "Krogan" "cell line/tissue" "CoMRe" "ultiple"
    "co-modulation" "Multi" "Deilich" "Kuwabara" "Sato" "Danxia" "Kitadai’s"
    "Kitadai" "venules" "kBp" "northeastern Iran" "Iran" "Xinjiang" "Kazakh"
    "Uyghur" "= 0.031" "Wnt/" "broader" "the junctional epithelium"
    "hyperresponsiveness" "/SMAD+" "proteosome" "proliferation/quiescence"
    "aneuploidy" "deletion/haploinsufficiency"
    "the pre-invasive adenomatous epithelium" "deeper"
    "multifocal alternating quiescent/proliferative adenomatous epithelium"
    "quiescent/proliferative" "9/16" "12/16" "ADLH" "Ki-67-" "PTEN+"
    "downregulation/absence" "on/off" "intragland" "Ki-67+"
    "normal-hyperplastic-Ad-ACA" "FFPE" "stepwise" "ISC" "CSC-like"
    "PTEN genomic deletion/haploinsufficiency" "re-expressed"
    "adenomatous epithelium" "Stepwise" "chromosome 17p" "18q"
    "decapping/degradation" "DExD/H-box" "autophagic vacuoles" "cytopenias"
    "lipopolysaccharide" "rapamcyin" "intron" "heterozygote"
    "visible transcripts co-localized" "YPD" "proteome" "ATG22" "VAD1" "vad1"
    "homolog" "the fungal pathogen Cryptococcus neoformans" "Pho8Δ60" "DExD"
    "H-box" "Δ60" "transcriptome" "cerevisae" "neoformans" "3XFLAG"
    "appropriateness" "transwell" "French" "Dataset" "the superficial mucosa"
    "mucosa" "re-expression" "non-luminal" "Seq" "pathophysiology"
    "a larger dataset" "a secondary CRC dataset" "a secondary tumor dataset"
    "BD" "heatmaps" "algorithm" "Wilma/Regsubsets" "Regsubsets" "Wilma"
    "covariate" "other publically available datasets"
    "a secondary patient dataset" "≥ 3" "5-aza-2" "epithelium" "CACATG"
    "CAGATG" "hexanucleotide" "CACGTG" "Caco-2/15" "DLD1" "CANNTG" "bp"
    "E-boxes" "ILD-like" "HRs" "carboplatin/paclitaxel" "corticosteroids" "ILD"
    "AEs" "AE" "rash/acne" "0.40–3.21" "0.29–1.12" "0.40–1.43" "hoc" "Oncology"
    "0.20–1.25" "Del19/L858R" "naïve" "Europe" "blocker" "ErbB" "neutropenia"
    "Secondary endpoints" "endpoints" "endpoint" "Del19" "cisplatin/pemetrexed"
    "Japanese" "PFS" "the sub-cellular localization/context" "Clurman"
    "wildtype" "phosphosites" "phosphodegrons" "proteostatic stressors"
    "stressors" "downshift" "degrons" "degron" "DDGFDSDSSLSDSD" "DpSGX"
    "CReP’s" "HA" "UBAs" "CReP" "Andrulis" "paracrine" "undergone" "Bolli"
    "WGS" "adaphostin" "Zhan" "priori" "MM-295" "PCA" "WikiPathway"
    "co-existing" "timepoints" "hyperdiploidy"
    "the identified mutations affected hot-spot codons" "retro" "whose VAF"
    "VAF" "VAFs" "233x" "SNVs" "HMCLs" "sPCLs" "pPCLs" "intra-" "intra" "sPCL"
    "pPCL" "dyscrasias" "exome" "= 0.008" "1/11" "Parthanatos" "Gloro"
    "epithelia" "KYSE155" "CCND" "CCNE" "STRING" "co-association" "DAVID"
    "heatmap" "U133" "Affymetrix" "LC3II" "LC3I" "adenoid" "non-apoptotic"
    "Sepantronium" "Diaminedichloroplatinum" "Concurrent chemo/radiotherapy"
    "solute" "Kasap" "non-Hodgkin's" "hyper" "parthanatos" "suppressant"
    "sepantronium" "anti-apoptotic" "Sjögren's" "Sjögren" "Mulay" "TAA"
    "heathy" "2SD" "lpr" "Anti-MDM2" "titer" "hominoid" "Aldrich" "LOC646376"
    "VAT/SAT" "rs2943634" "hominoids" "SINE" "nonobese" "BC014369" "UCSC"
    "rs2713538" "rs7578326" "BMI" "the 16 possible haplotypes" "Weinberg"
    "SAPHIR" "Genotypes" "rs2943641" "GWAS" "LOC646736" "carotid" "intima"
    "16 possible haplotypes" "= 0.001" "us" "mesenchyme" "andthe"
    "mature mir3686" "AUCUGUAAGAGAAAGUAAAUGA" "microRNA3686" "cerevisiae"
    "mir3686" "arthroscopic synovectomy" "synovectomy" "Nakasa" "Tomoyuki"
    "Brannen" "Wnt-5α" "enhancer" "Hui" "miR-26a" "reumatoid" "comorbidities"
    "phosphorylationSer" "Wnt5ɑ" "miR-26b/GSK-3β" "mir" "RASF" "Stancz" "e"
    "factor-kB" "UTRs" "hormonal infleunces" "infleunces" "miR-26B" "MiR-26b"
    "tetrazolium" "ɑ" "miR-26b" "microRNA-26b" "RAFLS" "RASFs" "non-canonical"
    "non-coding" "mortem" "OPCs" "Horssen" "Fumarates" "fumarates" "CNS"
    "microinfarcts" "biopsy" "Metz" "biopsies" "Fumarate" "MS10" "biliverdin"
    "HMOX" "u" "TUNEL" "co-localization" "co-stained" "j"
    "immunohistochemical double and triple stainings" "stainings" "glia" "PPMS"
    "SPMS" "PPWM" "NAWM" "NWM" "littermates" "anti-oxidative" "Fenton" "Weiss"
    "Haber" "oxidases" "fumarate" "anti-inflammatory" "anti-microtubule"
    "readouts" "prognose" "*Ser25+0.685" "Youden"
    "a traditional prognostic classifier" "*Ser63" "a prognostic classifier"
    "univariate" "IHC" "the classifier's" "phosphoisomers" "subtypes"
    "the traditional TNM classifier" "subtype" "classifier" "= 0.002"
    "signiﬁcant" "favorable DFS" "non-bone" "MDA-MB-231Cbl-b" "pcDNA3.1"
    "non-silencing" "Transwell" "MCF-7/ADR" "Multivariate" "Univariate"
    "multivariate" "BCSS" "DFS" "-b" "expressors" "nCounter" "CellTiter"
    "=0.001" "Tis" "Immunohistochemistry" "-KG" "KG" "sirtuins" "Sirtuins"
    "sirtuin" "antigen" "Forssman" "galectins" "undergoes" "∼2.5" "wWT"
    "phagophore" "LysoTracker-DND-99" "necrostatin" "Hodgkin" "Burkitt-" "vivo"
    "ex" "si" "pH" "Vacuole" "∼95%" "vacuoles" "lactose" "exogenous rLGALS9"
    "galectin" "rLGALS9" "Kirsten" "5B" "eventhough" "Balb/c" "and 3:40000"
    "pateients" "multi" "&E" "ImageJ" "non-target" "siSTAT5b" "Compusyn"
    "milder" "Caron" "IGF-1Rβ" "5b" "transducer" "Altieri's" "Altieri" "iv"
    "radioiodine" "unresponsiveness" "colony/foci"
    "the HSP90/TRAP1 dual inhibitor gamitrinib" "inhibition/silencing"
    "co-transfectants" "co-ip" "l-OHP-" "shTRAP1" "expression/ubiquitination"
    "IRI" "wt" "iii" "ii" "cyclophillin" "monoclonals" "gamitrinib"
    "silencing/inhibition" "synthesis/ubiquitination" "recruitment/"
    "anti-cancer" "estimations" "pSer2:total" "UV" "7SK/HEXIM1"
    "drawbacks/pitfalls" "Ser2-P" "Dev" "feedforward" "#3" "subpopulations"
    "57:506-20" "Vona" "Keskin" "Manley" "James" "dramatic anti-tumor" "shMYC"
    "Levens" "E-box" "Geyer" "non-CDK" "Caspase 3/7" "JUNB" "BDPR" "Ac"
    "BRD4∆PID" "IC 50" "∆PID" "CDK7tide" "Bio" "Invitrogen" "shBRD4"
    "enantiomer" "i-CDK9-treated" "hr" "IC50" "SignalChem" "CDK13" "KINOMEscan"
    "DiscoveRx" "Inc" "PerkinElmer" "AlphaScreen" "co-crystal" "-chloro-N6-"
    "fluorobenzyl" "i-CDK9-induced" "other cellular enzymes/pathways" "perhaps"
    "Burkitt" "JQ1" "iBET" "withdrawn" "DOI" "Xue" "Lu" "eLife" "TEFb's" "TEFb"
    "anti-tumor" "Hawkins" "lucitanib" "AP" "Bannykh" "pilomyxoid" "Meier"
    "Kaplan" "youngest" "Sanger" "Nonneoplastic cerebellum" "Purkinje"
    "11-year-old" "codons" "pleomorphic xanthoastrocytomas"
    "xanthoastrocytomas" "cerebellum" "neuraxis" "Brazil" "PAs" "hotspot"
    "immunohistochemistry" "Pas" "5-year" "drawn" "chemo" "contraindications"
    "ResponseDx" "Pearson" "5.3x10" "9.0x10" "ORR" "UCSD" "pre"
    "microsatellite" "metastatectomy" "FOLFIRI" "FOLFOX" "ECOG" "covariates"
    "TCGA" "the commercially available ResponseDX" "Angeles" "ResponseDX"
    "greatest" "oncologists" "subsets" "rarer" "neoadjuvant" "-c" "c"
    "a premature stop codon" "codon" "_510delGA" "_661delACAAA"
    "immunophenotype" "missense" "_69delAG" "frameshift" "Greek" "Finnish"
    "Czech" "German" "Jewish" "Ashkenazi" "_5033delCTAA" "_3704delGTAAA"
    "Szwiec" "Poland" "Sharma’s" "Sharma" "≤50" "younger" "proven" "6/129" "Hn"
    "MRN" "TNBCs" "TNBC" "BRCA1/2" "non-triple-negative" "germline" "haplo"
    "mTERC" "mTERT" "isomer" "phosphotidylinositol" "soft agar" "agar"
    "C3-O-CH3-S1P" "RING" "ubiqutin" "co-localized" "colocalizes" "Trithorax"
    "var" "ELISA" "Kd" "POPE" "plasmon" "biotin" "-3-O-CH3-S1P" "non-labeled"
    "erythro" "stereoisomers" "hTERT2" "tcTERT" "castaneum" "Tribolium"
    "ABC294640" "sphingosine" "meshwork" "lamina" "OH" "hydroxyl" "#2"
    "intronic SNPs" "exons" "hypothesise" "ovarian primordial follicles"
    "mice more primordial follicles" "haplotypes" "Haplotype" "Rs2299939"
    "rs1903858" "rs1234219" "mammalian primordial follicles" "Follicle"
    "Only two genotypes" "genotypes" "rs17107001" "rs35352882" "Bonferroni"
    "rs2299939" "HWE" "introns" "Only two SNPs" "rs2299941" "rs12572106" "DSB"
    "the global primordial follicles" "oocytes"
    "The remaining primordial follicles" "mature follicles" "antral follicles"
    "partial primordial follicles" "dormancy" "primordial follicles"
    "karyotype" "ovarian follicles" "follicle" "follicles" "haplotype"
    "MALDI-TOF-MS" "genotype" "HapMap" "chosen" "SNPs" "polymorphisms"
    "member 5A" "intracrine" "Rb" "KEGG" "stricter" "et" "Menendez" "~68%"
    "Genome" "Kyoto" "Genomes" "limma" "co-overexpressed" "poorer"
    "EGFR/Arg1175" "RPTP-κ" "RPTP" "stability/expression" "WB" "CHX"
    "PTPH1/S459A" "EGFR/Y1173F" "PTPH1/S459" "GFP-ER/Y537F" "greater" "WCL"
    "ER/Y537" "alllylaminogeldanamycin" "shLuc" "PTPH1/DA" "EGFR/Y1173" "ER+"
    "co-transfection" "co-transfected" "TAp73β" "miR-200s" "Prognoscan"
    "CRKIII" "CRKII" "CRKI" "TAp73"
    "publicly available cancer microarray datasets" "PrognoScan" "dataset"
    "datasets" "TAp63γ" "pMIR" "TargetScan" "miRanda" "algorithms" "mismatches"
    "200b" "200a" "genome" "12p13.31" "1p36.33" "subset" "Oncomine" "-UTR"
    "UTR" "200c" "silico" "miR-200b" "b" "105L/R" "490M/K" "ZDOCK" "V-shaped"
    "V-shape" "4BKE" "pairwise" "homologs" "Co-IP" "-triphosphate"
    "triphosphate" "globulin" "gc" "glycan" "co-IP" "albuminoid" "gatekeeper"
    "anti-oncogenic" "#1" "shNQO1" "kelch-like"
    "nuclear factor (erythroid-derived 2)-like" "stronger" "BJ" "p21-" "p"
    "2BS" "vacuole" "HDF" "kappa-light-chain-enhancer" "polymorphism"
    "NAD(P)H:quinone oxidoreductase"))

(DEFPARAMETER SPARSER::*BIO-CHEMICAL-HEADS-PHASE3-15301-15600*
  '(("Such CNOT3-associated RBPs" . SPARSER::PROTEIN)
    ("RBPs and CNOT3" . SPARSER::COLLECTION)
    ("a posttranscriptional regulator" . SPARSER::REGULATOR)
    ("the miRNA machinery–associated proteins GW182/TNRC6"
     . SPARSER::COLLECTION)
    ("GW182/TNRC6" . SPARSER::COLLECTION) ("pro–" . SPARSER::AMINO-ACID)
    ("premature translation termination codons" . SPARSER::PROTEIN)
    ("aberrant mRNAs" . SPARSER::PROTEIN) ("c" . SPARSER::PROTEIN)
    ("Pax5 and YY1" . SPARSER::COLLECTION)
    ("the largest V H gene family" . SPARSER::PROTEIN-FAMILY)
    ("distal V H genes" . SPARSER::GENE)
    ("the distal V H J558 family" . SPARSER::PROTEIN-FAMILY)
    ("EU" . SPARSER::PROTEIN) ("uridine (EU)" . SPARSER::DRUG)
    ("the distal V H J558 gene" . SPARSER::GENE)
    ("the proximal V H 7183 gene" . SPARSER::GENE) ("DQ" . SPARSER::MOLECULE)
    ("these distal genes" . SPARSER::GENE) ("Ezh2" . SPARSER::PROTEIN)
    ("p53 protein and its target mRNAs" . SPARSER::COLLECTION)
    ("Puma , Bax , and p21" . SPARSER::COLLECTION)
    ("Puma and Bax" . SPARSER::COLLECTION)
    ("pro–B and pre–B cells" . SPARSER::COLLECTION) ("LM" . SPARSER::MOLECULE)
    ("mature p53 mRNA" . SPARSER::PROTEIN)
    ("p53 mature mRNA" . SPARSER::PROTEIN)
    ("Cd79a (∼2-fold decrease) and Irf4 (∼2.5-fold increase)"
     . SPARSER::COLLECTION)
    ("Irf4" . SPARSER::PROTEIN) ("Cd79a" . SPARSER::PROTEIN)
    ("Irf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the proximal V H 7183 family" . SPARSER::PROTEIN-FAMILY)
    ("the IgH distal V H gene" . SPARSER::GENE) ("IgH" . SPARSER::PROTEIN)
    ("Gam" . SPARSER::PROTEIN-FAMILY) ("Cnot3" . SPARSER::PROTEIN)
    ("cre" . SPARSER::PROTEIN)
    ("CNOT3 and other subunits of the CCR4–NOT complex" . SPARSER::FRAGMENT)
    ("CNOT3 and other subunits" . SPARSER::COLLECTION)
    ("pro-B and pre–B cells" . SPARSER::COLLECTION)
    ("sequence-specific RNA-binding proteins" . SPARSER::PROTEIN)
    ("CNOT6 or CNOT6L and CNOT7 or CNOT8" . SPARSER::COLLECTION)
    ("CNOT6L and CNOT7 or CNOT8" . SPARSER::COLLECTION)
    ("CNOT7 or CNOT8" . SPARSER::COLLECTION)
    ("protein, CNOT2, and CNOT3" . SPARSER::COLLECTION)
    ("a general posttranscriptional regulator" . SPARSER::REGULATOR)
    ("IgM" . SPARSER::PROTEIN)
    ("the Ig heavy chain ( Igh ) and Ig light chain ( Igl ) genes ( xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("Igl" . SPARSER::PROTEIN) ("Igh" . SPARSER::PROTEIN)
    ("RP23" . SPARSER::PROTEIN) ("CNOT10" . SPARSER::PROTEIN)
    ("CNOT9" . SPARSER::PROTEIN) ("anti-IgM" . SPARSER::PROTEIN)
    ("CD127" . SPARSER::PROTEIN) ("NOT3" . SPARSER::PROTEIN)
    ("TNRC6" . SPARSER::PROTEIN) ("GW182" . SPARSER::PROTEIN)
    ("Paf1" . SPARSER::PROTEIN) ("1-8" . SPARSER::PROTEIN)
    ("Pax5" . SPARSER::PROTEIN) ("Tgfbr1" . SPARSER::PROTEIN)
    ("Mef2a" . SPARSER::PROTEIN) ("Pim1" . SPARSER::PROTEIN)
    ("IL-7Rα" . SPARSER::PROTEIN) ("IL-7" . SPARSER::PROTEIN)
    ("pro-B" . SPARSER::DRUG) ("CNOT2" . SPARSER::PROTEIN)
    ("CNOT1" . SPARSER::PROTEIN) ("CNOT8" . SPARSER::PROTEIN)
    ("CNOT7" . SPARSER::PROTEIN) ("CNOT6L" . SPARSER::PROTEIN)
    ("CNOT6" . SPARSER::PROTEIN) ("pre–BCR" . SPARSER::BIO-COMPLEX)
    ("pro–B" . SPARSER::DRUG) ("CCR4" . SPARSER::PROTEIN)
    ("CNOT3" . SPARSER::PROTEIN)
    ("p53, Mdm2 and nucleolin" . SPARSER::COLLECTION)
    ("The HAUSP-p53-Mdm2 complex and p53-nucleolin interplay"
     . SPARSER::COLLECTION)
    ("p53-nucleolin" . SPARSER::COLLECTION)
    ("the p53-associated proteins" . SPARSER::PROTEIN)
    ("Mdm2 and nucleolin" . SPARSER::COLLECTION)
    ("Mdm2 and HAUSP" . SPARSER::COLLECTION)
    ("a UV-sensitive syndrome protein UVSSA" . SPARSER::PROTEIN)
    ("TC-NER" . SPARSER::COLLECTION) ("UVSSA" . SPARSER::PROTEIN)
    ("rDNA" . SPARSER::PROTEIN)
    ("PKM2, PP2A, and nucleolin" . SPARSER::COLLECTION)
    ("HAUSP-Mdm2" . SPARSER::COLLECTION) ("HAUSP-p53" . SPARSER::COLLECTION)
    ("Mdm2/p53" . SPARSER::COLLECTION) ("HAUSP and Mdm2" . SPARSER::COLLECTION)
    ("nucleolin and p53" . SPARSER::COLLECTION)
    ("HAUSP, HAUSP and nucleolin" . SPARSER::COLLECTION)
    ("nucleolin, HAUSP, and nucleolin and HAUSP" . SPARSER::COLLECTION)
    ("nucleolin and/or HAUSP siRNA ( xref )" . SPARSER::COLLECTION)
    ("nucleolin and HAUSP" . SPARSER::COLLECTION)
    ("HAUSP or nucleolin" . SPARSER::COLLECTION)
    ("an essential deubiquitinating enzyme" . SPARSER::ENZYME)
    ("Polyubiquitin" . SPARSER::PROTEIN)
    ("p53-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HAUSP and p53" . SPARSER::COLLECTION)
    ("Mdm2, nucleolin, and HAUSP" . SPARSER::COLLECTION)
    ("glutathione S-transferase (GST)" . SPARSER::PROTEIN)
    ("GST-p53" . SPARSER::COLLECTION) ("HAUSP-Mdm2-p53" . SPARSER::COLLECTION)
    ("nucleolin (Nuc-S184A/S542A) and HAUSP" . SPARSER::COLLECTION)
    ("Nuc" . SPARSER::PROTEIN) ("HAUSP and HAUSP" . SPARSER::COLLECTION)
    ("p53-Mdm2" . SPARSER::COLLECTION)
    ("Mdm2 as well as p53" . SPARSER::COLLECTION)
    ("isopeptidase" . SPARSER::PROTEIN)
    ("monoubiquitin or polyubiquitin" . SPARSER::COLLECTION)
    ("Cys, His, and Asp" . SPARSER::COLLECTION)
    ("covalently bound ubiquitins" . SPARSER::PROTEIN)
    ("USP, UCH, OTU and MJD" . SPARSER::COLLECTION)
    ("proteases, and JAMM" . SPARSER::COLLECTION)
    ("JAMM" . SPARSER::PROTEIN-FAMILY) ("MJD" . SPARSER::PROTEIN)
    ("UCH" . SPARSER::PROTEIN)
    ("ovarian tumor proteases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("at least six families" . SPARSER::PROTEIN-FAMILY)
    ("Machado-Josephin" . SPARSER::COLLECTION)
    ("JAMMs" . SPARSER::PROTEIN-FAMILY) ("Josephin" . SPARSER::PROTEIN-FAMILY)
    ("OTUs" . SPARSER::PROTEIN-FAMILY) ("ubiquitins" . SPARSER::PROTEIN)
    ("monoubiquitin" . SPARSER::PROTEIN) ("UPP" . SPARSER::PROTEIN)
    ("HAUSP-nucleolin" . SPARSER::COLLECTION)
    ("Mdm2 and p53" . SPARSER::COLLECTION)
    ("HAUSP and nucleolin" . SPARSER::COLLECTION)
    ("HAUSP-p53-Mdm2" . SPARSER::COLLECTION)
    ("both p53 and its E3 ubiquitin ligase" . SPARSER::COLLECTION)
    ("K63" . SPARSER::PROTEIN) ("annexin-1" . SPARSER::PROTEIN)
    ("ANXA1" . SPARSER::PROTEIN) ("UbE2E1" . SPARSER::PROTEIN)
    ("EBNA1" . SPARSER::PROTEIN) ("nuclear antigen-1" . SPARSER::PROTEIN)
    ("RNA polymerase I" . SPARSER::PROTEIN) ("AA1" . SPARSER::PROTEIN)
    ("TSPYL5" . SPARSER::PROTEIN) ("MOV34" . SPARSER::PROTEIN)
    ("a possible candidate gene" . SPARSER::GENE)
    ("APE1 , XRCC1 , and POLB" . SPARSER::COLLECTION)
    ("complemented" . SPARSER::PROTEIN)
    ("an attractive candidate gene" . SPARSER::GENE)
    ("at least one G allele" . SPARSER::ALLELE)
    ("ultraviolet (UV) light" . SPARSER::PROTEIN)
    ("TG or GG" . SPARSER::COLLECTION) ("rays" . SPARSER::PROTEIN)
    ("Sak" . SPARSER::PROTEIN)
    ("a redox transcriptional co-activator" . SPARSER::PROTEIN)
    ("DSM or recurrence" . SPARSER::COLLECTION) ("DSM" . SPARSER::MOLECULE)
    ("APE1 (52%) and XRCC1 (52%)" . SPARSER::COLLECTION)
    ("APE1 (64%) and POLB (60%)" . SPARSER::COLLECTION)
    ("HG" . SPARSER::MOLECULE) ("APE1, XRCC1 and POLB" . SPARSER::COLLECTION)
    ("its dRP-lyase activity and the main gap-filling enzyme ( xref )"
     . SPARSER::COLLECTION)
    ("the major polymerase" . SPARSER::PROTEIN)
    ("dRP-lyase activity" . SPARSER::PROTEIN-PAIR)
    ("nucleobase" . SPARSER::NUCLEOBASE) ("Tobacco" . SPARSER::DRUG)
    ("pTa/pT1" . SPARSER::COLLECTION) ("pTa" . SPARSER::PROTEIN)
    ("APE1 , XRCC1 and POLB" . SPARSER::COLLECTION) ("POLB" . SPARSER::PROTEIN)
    ("error-prone DNA polymerase" . SPARSER::PROTEIN)
    ("lyase activity" . SPARSER::PROTEIN) ("pT1" . SPARSER::PROTEIN)
    ("APE1" . SPARSER::PROTEIN) ("antioxidants and n-3" . SPARSER::COLLECTION)
    ("mRNA and SQSTM1" . SPARSER::COLLECTION)
    ("proteins and organells" . SPARSER::COLLECTION)
    ("proteins and SQSTM1" . SPARSER::COLLECTION)
    ("proteins or oxidatives" . SPARSER::COLLECTION)
    ("oxidative stress response genes and proteins" . SPARSER::COLLECTION)
    ("genes and proteins" . SPARSER::COLLECTION)
    ("puromycin or cycloheximide" . SPARSER::COLLECTION)
    ("the translational inhibitor cycloheximide (CHX)" . SPARSER::PROTEIN)
    ("premature and misfolded proteins" . SPARSER::PROTEIN)
    ("different cytoprotective genes" . SPARSER::GENE)
    ("NFE2L2 and SQSTM1" . SPARSER::COLLECTION)
    ("HMOX1 and SQSTM1" . SPARSER::COLLECTION)
    ("ROS ( xref ) and NFE2L2 ( xref )" . SPARSER::COLLECTION)
    ("ROS and NFE2L2" . SPARSER::COLLECTION) ("atg5" . SPARSER::PROTEIN)
    ("ATG12–ATG5" . SPARSER::COLLECTION)
    ("NFE2L2, SQSTM1, and ATG5" . SPARSER::COLLECTION)
    ("exogenous antioxidants" . SPARSER::DRUG)
    ("SQSTM1 and HMOX1" . SPARSER::COLLECTION)
    ("the typical NFE2L2" . SPARSER::PROTEIN)
    ("the exogeneous antioxidants N-acetyl-cysteine (NAC)" . SPARSER::DRUG)
    ("N-acetyl-cysteine (NAC)" . SPARSER::DRUG)
    ("oxidative stress response genes" . SPARSER::GENE)
    ("SQSTM1 and MAP1LC3B" . SPARSER::COLLECTION)
    ("MAP1LC3A and GABARAPL1" . SPARSER::COLLECTION)
    ("detergents" . SPARSER::MOLECULE)
    ("SQSTM1 and MAP1LC3B-II" . SPARSER::COLLECTION)
    ("that controls the transcription of a number" . SPARSER::PROTEIN)
    ("rod" . SPARSER::PROTEIN)
    ("kelch-like ECH-associated protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the oxidative stress response regulator NFE2L2/NRF2"
     . SPARSER::COLLECTION)
    ("docosahexaenoic acid (DHA)" . SPARSER::MOLECULE)
    ("NFE2L2/NRF2" . SPARSER::COLLECTION) ("PUFA" . SPARSER::MOLECULE)
    ("PUFAs" . SPARSER::MOLECULE) ("RPE" . SPARSER::PROTEIN)
    ("AMD" . SPARSER::PROTEIN) ("NP40S" . SPARSER::MOLECULE)
    ("COX4I1" . SPARSER::PROTEIN) ("D11" . SPARSER::PROTEIN)
    ("Docosahexaenoic acid" . SPARSER::MOLECULE) ("nfe2l2" . SPARSER::PROTEIN)
    ("amino acid transporter" . SPARSER::PROTEIN)
    ("solute carrier family" . SPARSER::PROTEIN) ("SLC7A11" . SPARSER::PROTEIN)
    ("SRXN1" . SPARSER::PROTEIN) ("HMOX1" . SPARSER::PROTEIN)
    ("N-acetyl-cysteine" . SPARSER::DRUG) ("GABARAPL1" . SPARSER::PROTEIN)
    ("MAP1LC3A" . SPARSER::PROTEIN) ("MAP1LC3B" . SPARSER::PROTEIN)
    ("oleic acid" . SPARSER::MOLECULE) ("n-6" . SPARSER::PROTEIN)
    ("transcription factor EB" . SPARSER::PROTEIN)
    ("sulfiredoxin 1" . SPARSER::PROTEIN) ("member 11" . SPARSER::PROTEIN)
    ("xc- system)" . SPARSER::PROTEIN)
    ("solute carrier family 7 (anionic amino acid transporter light chain"
     . SPARSER::PROTEIN)
    ("polyunsaturated fatty acid" . SPARSER::MOLECULE)
    ("Oleic acid" . SPARSER::MOLECULE)
    ("element binding protein" . SPARSER::PROTEIN)
    ("nuclear factor, erythroid derived 2, like 2" . SPARSER::PROTEIN)
    ("docosahexaenoic acid" . SPARSER::MOLECULE) ("n-3" . SPARSER::PROTEIN)
    ("WANG, and Jun" . SPARSER::COLLECTION) ("WANG" . SPARSER::PROTEIN)
    ("SAPK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Gli1 ( xref ) and Ptch1 ( xref )" . SPARSER::COLLECTION)
    ("Ptch1" . SPARSER::PROTEIN) ("GFP or Flag" . SPARSER::COLLECTION)
    ("GFP or JNK" . SPARSER::COLLECTION) ("APF" . SPARSER::PROTEIN)
    ("p-c-Jun" . SPARSER::COLLECTION)
    ("c-Jun, JunB, and JunD" . SPARSER::COLLECTION) ("JunD" . SPARSER::PROTEIN)
    ("JunB" . SPARSER::PROTEIN) ("JNK1 and JNK2" . SPARSER::COLLECTION)
    ("JNK1, JNK2, and JNK3" . SPARSER::COLLECTION)
    ("traditional cytotoxic drugs" . SPARSER::DRUG)
    ("Gli1 and ptch1" . SPARSER::COLLECTION)
    ("Gli-luciferase" . SPARSER::COLLECTION) ("ptch1" . SPARSER::PROTEIN)
    ("ptch" . SPARSER::PROTEIN) ("Oct4, Sox2, and Nanog" . SPARSER::COLLECTION)
    ("relevant mRNAs and proteins" . SPARSER::COLLECTION)
    ("JNK3" . SPARSER::PROTEIN) ("ATP-binding cassette" . SPARSER::PROTEIN)
    ("Oct4" . SPARSER::PROTEIN) ("JNK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL6 and pSTAT3" . SPARSER::COLLECTION)
    ("RPPA and mRNA" . SPARSER::COLLECTION)
    ("RPPA and gene" . SPARSER::COLLECTION)
    ("IL6-pSTAT3-PTEN" . SPARSER::COLLECTION)
    ("POSTN, SRPX2, ADAM12, DACT1, and ADAMT6S" . SPARSER::COLLECTION)
    ("POSTN" . SPARSER::PROTEIN)
    ("pro-inflammatory cytokines and chemokines" . SPARSER::COLLECTION)
    ("pSTAT3 and trastuzumab" . SPARSER::COLLECTION)
    ("PTEN, elevated IL6, and stromal reactivation" . SPARSER::COLLECTION)
    ("pSTAT3" . SPARSER::PROTEIN) ("pSTAT3-GS" . SPARSER::COLLECTION)
    ("GS" . SPARSER::PROTEIN) ("IL6R" . SPARSER::PROTEIN)
    ("DACT1" . SPARSER::PROTEIN) ("SRPX2" . SPARSER::PROTEIN)
    ("e -5" . SPARSER::PROTEIN)
    ("Signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("one of the most important tumor suppressor genes in breast and ovarian cancers"
     . SPARSER::COLLECTION)
    ("E2F1, TOPBP1 and MCPH1" . SPARSER::COLLECTION)
    ("a relevant therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("IR and PARP" . SPARSER::COLLECTION) ("HR/BRCA1" . SPARSER::COLLECTION)
    ("BRCA1/HR" . SPARSER::COLLECTION) ("IR and PARP1" . SPARSER::COLLECTION)
    ("E2F1-" . SPARSER::PROTEIN) ("RNF126-RNF126" . SPARSER::COLLECTION)
    ("RNF126 or BRCA1" . SPARSER::COLLECTION)
    ("mRNA and proteins" . SPARSER::COLLECTION) ("Δf" . SPARSER::PROTEIN)
    ("RNF126-Δf" . SPARSER::COLLECTION)
    ("lack residues aa130-140" . SPARSER::PROTEIN)
    ("RNF126-" . SPARSER::PROTEIN) ("GST-E2F1" . SPARSER::COLLECTION)
    ("RNF126 (middle panel) or GST" . SPARSER::COLLECTION)
    ("RNF126 and His-E2F1" . SPARSER::COLLECTION)
    ("GST-RNF126" . SPARSER::COLLECTION) ("-RNF126" . SPARSER::COLLECTION)
    ("RNF126 and E2F1" . SPARSER::COLLECTION)
    ("BS/U6-E2F1" . SPARSER::COLLECTION) ("MCF7-E2F1sh" . SPARSER::COLLECTION)
    ("BRCA1/RAD51" . SPARSER::COLLECTION) ("Flag-RNF126" . SPARSER::COLLECTION)
    ("BRCA1 and RAD51" . SPARSER::COLLECTION) ("IRIF" . SPARSER::PROTEIN)
    ("foci (IRIF)" . SPARSER::PROTEIN)
    ("E2F1 and RNF126" . SPARSER::COLLECTION)
    ("RNF126 and HR" . SPARSER::COLLECTION)
    ("HR and BRCA1" . SPARSER::COLLECTION)
    ("RNF126-E2F1" . SPARSER::COLLECTION)
    ("EGFR ( xref ) and AID" . SPARSER::COLLECTION)
    ("multicomponent protein" . SPARSER::PROTEIN)
    ("BRCA1, RAD51 and RAD52" . SPARSER::COLLECTION)
    ("an oncogene or a tumor suppressor" . SPARSER::COLLECTION)
    ("transcriptional co-activators and co-repressors" . SPARSER::COLLECTION)
    ("co-activators and co-repressors" . SPARSER::COLLECTION)
    ("CtIP" . SPARSER::PROTEIN) ("H-15" . SPARSER::PROTEIN)
    ("RPA2" . SPARSER::PROTEIN) ("RPA1" . SPARSER::PROTEIN)
    ("P-1" . SPARSER::PROTEIN) ("TOPBP1" . SPARSER::PROTEIN)
    ("caspase 7" . SPARSER::PROTEIN) ("I-SceI" . SPARSER::PROTEIN)
    ("Zinc finger" . SPARSER::PROTEIN) ("RAD52" . SPARSER::PROTEIN)
    ("tissue type" . SPARSER::PROTEIN) ("RNF126" . SPARSER::PROTEIN)
    ("Drp1 and fission 1" . SPARSER::COLLECTION) ("MitoQ" . SPARSER::DRUG)
    ("TPP" . SPARSER::PROTEIN)
    ("essential signalling molecules" . SPARSER::MOLECULE)
    ("mitochondrial ROS" . SPARSER::PROTEIN)
    ("-isocitrate" . SPARSER::COLLECTION) ("aconitase" . SPARSER::PROTEIN)
    ("nitrotyrosine" . SPARSER::MOLECULE)
    ("two transitional states" . SPARSER::BIO-STATE)
    ("reductants" . SPARSER::MOLECULE)
    ("nitric oxide or its derivatives xref and glutathione xref"
     . SPARSER::COLLECTION)
    ("iNOS and AP1" . SPARSER::COLLECTION)
    ("intracellular kinases" . SPARSER::KINASE)
    ("Raf and MEK" . SPARSER::COLLECTION)
    ("growth factor and cytokine" . SPARSER::COLLECTION)
    ("ligand-" . SPARSER::LIGAND) ("AII" . SPARSER::PROTEIN)
    ("MAP kinase kinase (MKK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a dual specificity kinase" . SPARSER::KINASE)
    ("ERK, c-Jun and p38" . SPARSER::COLLECTION) ("MAPKKK" . SPARSER::PROTEIN)
    ("MKK" . SPARSER::PROTEIN-FAMILY) ("Kinases" . SPARSER::PROTEIN)
    ("the sulfenic acid form" . SPARSER::FORM)
    ("intramolecular disulfide (S–S) or sulfenyl–amide" . SPARSER::COLLECTION)
    ("sulfenyl" . SPARSER::MOLECULE) ("pKa" . SPARSER::PROTEIN)
    ("whose SH" . SPARSER::PROTEIN-FAMILY)
    ("kinases and ion channels" . SPARSER::COLLECTION)
    ("cardiac IR" . SPARSER::PROTEIN)
    ("Reactive aldehydes" . SPARSER::MOLECULE)
    ("intestinal IR" . SPARSER::PROTEIN)
    ("oxygen and glucose" . SPARSER::COLLECTION)
    ("cardiac mitochondria" . SPARSER::PROTEIN)
    ("proteins and DNA" . SPARSER::COLLECTION) ("Ischemia" . SPARSER::PROTEIN)
    ("ASK1–thioredoxin" . SPARSER::COLLECTION)
    ("This trimeric complex" . SPARSER::BIO-COMPLEX)
    ("the tumor necrosis factor receptor-associated factor 2"
     . SPARSER::PROTEIN)
    ("IRE" . SPARSER::PROTEIN) ("tunicamycin" . SPARSER::MOLECULE)
    ("ROS- and ER" . SPARSER::COLLECTION) ("ROS-" . SPARSER::PROTEIN)
    ("Ero-1" . SPARSER::PROTEIN) ("PERK or ATF-4" . SPARSER::COLLECTION)
    ("severe hypoxia or anoxia" . SPARSER::COLLECTION)
    ("hypoxia or anoxia" . SPARSER::COLLECTION) ("GRPs" . SPARSER::PROTEIN)
    ("FAD" . SPARSER::MOLECULE) ("PDI and Ero1" . SPARSER::COLLECTION)
    ("dinucleotide (FAD)" . SPARSER::MOLECULE) ("flavin" . SPARSER::MOLECULE)
    ("the unfolded proteins instead of PERK, ATF6, and IRE1"
     . SPARSER::COLLECTION)
    ("PERK, ATF6, and IRE1" . SPARSER::COLLECTION)
    ("double-stranded RNA-activated protein kinase (PKR)" . SPARSER::PROTEIN)
    ("chaperones and foldases" . SPARSER::COLLECTION)
    ("disulfide isomerase (PDI)" . SPARSER::PROTEIN)
    ("GSSG and GSH" . SPARSER::COLLECTION)
    ("incorrect disulfide" . SPARSER::MOLECULE)
    ("families and redox" . SPARSER::COLLECTION)
    ("the respective proteins" . SPARSER::PROTEIN)
    ("the archetypal hypoxia-regulated transcription factor Hif-1α"
     . SPARSER::PROTEIN)
    ("an adaptive response whereby some miRNAs" . SPARSER::PROTEIN)
    ("miR-146a and miR-23a" . SPARSER::COLLECTION)
    ("DNA-methyl" . SPARSER::DNA) ("exogenous molecules" . SPARSER::MOLECULE)
    ("resveratrol and sulforaphane" . SPARSER::COLLECTION)
    ("endonucleases" . SPARSER::PROTEIN) ("Nrf2 and GSH" . SPARSER::COLLECTION)
    ("which targets GSH biosynthetic enzymes" . SPARSER::ENZYME)
    ("Keap1 and Bach1" . SPARSER::COLLECTION)
    ("the last years miRNAs" . SPARSER::PROTEIN)
    ("a mature miRNA" . SPARSER::PROTEIN)
    ("non-coding genes or even exons xref" . SPARSER::COLLECTION)
    ("essential post-transcriptional regulators" . SPARSER::PROTEIN-FAMILY)
    ("the oxidative state" . SPARSER::BIO-STATE)
    ("antioxidants like butylated hydroxyanisole (BHA) and pyrrolidine dithiocarbamate (PDTC)"
     . SPARSER::COLLECTION)
    ("c-JUN and c-FOS" . SPARSER::COLLECTION)
    ("JNK, p38 MAPK and ERK" . SPARSER::COLLECTION)
    ("pyrrolidine" . SPARSER::DRUG) ("BHA" . SPARSER::MOLECULE)
    ("usually form heterodimers" . SPARSER::HETERODIMER)
    ("-TGACGTCA-3" . SPARSER::COLLECTION)
    ("-TGAG/CTCA-3" . SPARSER::COLLECTION) ("ATF/CREB" . SPARSER::COLLECTION)
    ("CRE" . SPARSER::PROTEIN) ("TRE" . SPARSER::PROTEIN)
    ("JDP" . SPARSER::PROTEIN)
    ("hydroquinone and tert -butyl" . SPARSER::COLLECTION)
    ("TNFα and NF-κB" . SPARSER::COLLECTION)
    ("IκB, and NF-κB" . SPARSER::COLLECTION)
    ("AKT, or NF-κB" . SPARSER::COLLECTION) ("NIK" . SPARSER::PROTEIN)
    ("pyrimidine, and N" . SPARSER::COLLECTION)
    ("-GGGRNNYYCC-3" . SPARSER::COLLECTION)
    ("typical ankyrin" . SPARSER::PROTEIN) ("IκB-" . SPARSER::PROTEIN)
    ("ankyrin" . SPARSER::PROTEIN) ("Ref-1-homology" . SPARSER::COLLECTION)
    ("NF-κB/REL" . SPARSER::COLLECTION)
    ("proteins (p65/RELA, RELB, and c-REL) and the NF-κB"
     . SPARSER::COLLECTION)
    ("RELB, and c-REL" . SPARSER::COLLECTION)
    ("p50, and p52" . SPARSER::COLLECTION)
    ("p105 and p100" . SPARSER::COLLECTION) ("p65/RELA" . SPARSER::COLLECTION)
    ("/REL" . SPARSER::COLLECTION) ("RELB" . SPARSER::PROTEIN)
    ("REL" . SPARSER::PROTEIN) ("Keap1 and Nrf2" . SPARSER::COLLECTION)
    ("protein kinase RNA (PKR)-like ER kinase (PERK) or PKC-δ"
     . SPARSER::COLLECTION)
    ("Nrf2/Keap1" . SPARSER::COLLECTION)
    ("NF-κB, AhR, p53, and homeodomain" . SPARSER::COLLECTION)
    ("AKT, ERK, p38 MAPK and PKC" . SPARSER::COLLECTION)
    ("FYN" . SPARSER::PROTEIN)
    ("autophagy substrate p62 and p53-regulated p21" . SPARSER::COLLECTION)
    ("transporter, and multidrug resistance-associated protein"
     . SPARSER::COLLECTION)
    ("hydrogen peroxide and 4-hydroxynonenal xref" . SPARSER::COLLECTION)
    ("genistein, quercetin, curcumin and sulforaphane" . SPARSER::COLLECTION)
    ("oltipraz, auranofin and acetaminophen" . SPARSER::COLLECTION)
    ("paraquat" . SPARSER::MOLECULE) ("acetaminophen" . SPARSER::DRUG)
    ("auranofin" . SPARSER::DRUG) ("quercetin" . SPARSER::MOLECULE)
    ("phytochemicals" . SPARSER::DRUG) ("Substances" . SPARSER::SUBSTANCE)
    ("-TGACnnnGC-3" . SPARSER::COLLECTION)
    ("electrophiles and oxidants" . SPARSER::COLLECTION)
    ("DLG" . SPARSER::PROTEIN)
    ("a basic region-leucine zipper-type transcription factor"
     . SPARSER::PROTEIN)
    ("NF-E2, Nrf1, Nrf3, Bach1 and Bach2" . SPARSER::COLLECTION)
    ("Nrf1" . SPARSER::PROTEIN) ("-Keap1" . SPARSER::COLLECTION)
    ("SP1 and CREB-1" . SPARSER::COLLECTION)
    ("mitochondrial MnSOD" . SPARSER::PROTEIN)
    ("variant, EcSOD or SOD3" . SPARSER::COLLECTION)
    ("H 2 O 2 , and catalase" . SPARSER::COLLECTION)
    ("oxygen and water" . SPARSER::COLLECTION)
    ("Trx/TrxR" . SPARSER::COLLECTION) ("Trx1 and TrxR1" . SPARSER::COLLECTION)
    ("Trx2 and TrxR2" . SPARSER::COLLECTION) ("TrxR2" . SPARSER::PROTEIN)
    ("Trx2" . SPARSER::PROTEIN) ("Trx1" . SPARSER::PROTEIN)
    ("oxidoreductases" . SPARSER::PROTEIN) ("Trx" . SPARSER::PROTEIN)
    ("thioredoxins" . SPARSER::PROTEIN) ("Prx" . SPARSER::PROTEIN)
    ("organic hydroperoxides" . SPARSER::MOLECULE)
    ("hydroperoxides" . SPARSER::MOLECULE) ("PRXs" . SPARSER::PROTEIN)
    ("catalytic cysteine" . SPARSER::AMINO-ACID)
    ("Peroxiredoxins" . SPARSER::PROTEIN) ("PRX" . SPARSER::PROTEIN)
    ("environmental toxins" . SPARSER::MOLECULE)
    ("a cofactor and substrate for multiple glutaredoxins (Grx)"
     . SPARSER::COLLECTION)
    ("NADPH and GR" . SPARSER::COLLECTION) ("glutaredoxins" . SPARSER::PROTEIN)
    ("GPX and TrxR" . SPARSER::COLLECTION) ("Selenium" . SPARSER::MOLECULE)
    ("enzymes and thioredoxin reductases" . SPARSER::COLLECTION)
    ("selenium" . SPARSER::MOLECULE) ("TrxR" . SPARSER::PROTEIN)
    ("esters and thymine" . SPARSER::COLLECTION)
    ("n-GPX4" . SPARSER::COLLECTION) ("c-GPX4" . SPARSER::PROTEIN-PAIR)
    ("hydroperoxide" . SPARSER::MOLECULE)
    ("an epithelial-specific form" . SPARSER::FORM)
    ("the ubiquitous enzyme" . SPARSER::ENZYME) ("GPXs" . SPARSER::PROTEIN)
    ("Afro-Americans" . SPARSER::PROTEIN-PAIR) ("Afro" . SPARSER::PROTEIN)
    ("antioxidant or pro-oxidant" . SPARSER::COLLECTION)
    ("thiol and GSH" . SPARSER::COLLECTION) ("-Cys" . SPARSER::COLLECTION)
    ("disulfides" . SPARSER::MOLECULE) ("form (GSSG)" . SPARSER::FORM)
    ("a heterodimeric enzyme" . SPARSER::ENZYME) ("GCLm" . SPARSER::PROTEIN)
    ("GCLc" . SPARSER::PROTEIN) ("oxy" . SPARSER::MOLECULE)
    ("reductant" . SPARSER::MOLECULE) ("Glutathione" . SPARSER::DRUG)
    ("DNA, lipid and protein" . SPARSER::COLLECTION)
    ("Nrf2-Keap1" . SPARSER::COLLECTION)
    ("crucial cellular nucleophiles" . SPARSER::MOLECULE)
    ("peroxiredoxins" . SPARSER::PROTEIN) ("nucleophiles" . SPARSER::MOLECULE)
    ("fission 1" . SPARSER::PROTEIN) ("P110" . SPARSER::PROTEIN)
    ("dynamin-related protein 1" . SPARSER::PROTEIN)
    ("creatine kinase" . SPARSER::PROTEIN) ("MAP3K" . SPARSER::PROTEIN)
    ("ASK-1" . SPARSER::PROTEIN) ("ERK5" . SPARSER::PROTEIN)
    ("MAPK kinase kinase" . SPARSER::PROTEIN)
    ("MAP kinase kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("S–S" . SPARSER::PROTEIN) ("thiolate anion" . SPARSER::MOLECULE)
    ("UCP3" . SPARSER::PROTEIN)
    ("mitochondrial uncoupling protein 3" . SPARSER::PROTEIN)
    ("aldehyde dehydrogenase" . SPARSER::PROTEIN) ("ND3" . SPARSER::PROTEIN)
    ("S-nitrosothiols" . SPARSER::MOLECULE) ("JAB1" . SPARSER::PROTEIN)
    ("COP9 signalosome subunit 5" . SPARSER::PROTEIN)
    ("JAB-1" . SPARSER::PROTEIN) ("ATF-4" . SPARSER::PROTEIN)
    ("P4HTM" . SPARSER::PROTEIN) ("hydroxyl radicals" . SPARSER::MOLECULE)
    ("peroxiredoxin 4" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 2" . SPARSER::PROTEIN)
    ("yeast)" . SPARSER::PROTEIN) ("Kar2" . SPARSER::DRUG)
    ("IRE1" . SPARSER::PROTEIN)
    ("double-stranded RNA-activated protein kinase" . SPARSER::PROTEIN)
    ("Hif-1α" . SPARSER::PROTEIN) ("miR-23a" . SPARSER::MOLECULE)
    ("butylated hydroxyanisole" . SPARSER::MOLECULE)
    ("ferritin heavy chain" . SPARSER::PROTEIN) ("LC8" . SPARSER::PROTEIN)
    ("dynein light chain" . SPARSER::PROTEIN) ("kinase-1" . SPARSER::PROTEIN)
    ("IκBs" . SPARSER::PROTEIN) ("BCL-3" . SPARSER::PROTEIN)
    ("Ref-1" . SPARSER::PROTEIN) ("c-REL" . SPARSER::PROTEIN)
    ("PKC-δ" . SPARSER::PROTEIN) ("Cullin 1" . SPARSER::PROTEIN)
    ("La Autoantigen" . SPARSER::PROTEIN) ("factor 4" . SPARSER::PROTEIN)
    ("multidrug resistance-associated protein" . SPARSER::PROTEIN)
    ("Bach2" . SPARSER::PROTEIN) ("Nrf3" . SPARSER::PROTEIN)
    ("NF-E2" . SPARSER::PROTEIN) ("erythroid 2" . SPARSER::PROTEIN)
    ("CREB-1" . SPARSER::PROTEIN) ("SOD3" . SPARSER::PROTEIN)
    ("regulated kinase-1" . SPARSER::PROTEIN) ("TrxR1" . SPARSER::PROTEIN)
    ("Prx2" . SPARSER::PROTEIN) ("Prx3" . SPARSER::PROTEIN)
    ("Prx4" . SPARSER::PROTEIN) ("Prx1" . SPARSER::PROTEIN)
    ("selenoprotein P" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("thioredoxin reductases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("glutathione peroxidases" . SPARSER::PROTEIN-FAMILY)
    ("GPX4" . SPARSER::PROTEIN) ("GPX3" . SPARSER::PROTEIN)
    ("GPX1" . SPARSER::PROTEIN)
    ("Glutathione peroxidases" . SPARSER::PROTEIN-FAMILY)
    ("glutathione S-transferase" . SPARSER::PROTEIN)
    ("GSH synthetase" . SPARSER::PROTEIN) ("γ-glutamyl" . SPARSER::MOLECULE)
    ("ATP-dependent" . SPARSER::PROTEIN) ("α-tocopherol" . SPARSER::MOLECULE)
    ("glycine)" . SPARSER::PROTEIN) ("HDL and SIRT1" . SPARSER::COLLECTION)
    ("HDL and LDL" . SPARSER::COLLECTION) ("TOS and OSI" . SPARSER::COLLECTION)
    ("chronic HF" . SPARSER::PROTEIN) ("ischemic type" . TYPE)
    ("HF, and SIRT1" . SPARSER::COLLECTION)
    ("peripheral monocytes" . SPARSER::PROTEIN)
    ("severe HF" . SPARSER::PROTEIN)
    ("compensated and decompensated HF" . SPARSER::PROTEIN)
    ("Antioxidant" . SPARSER::PROTEIN) ("Trolox" . SPARSER::MOLECULE)
    ("Triglyceride" . SPARSER::MOLECULE) ("compensated HF" . SPARSER::PROTEIN)
    ("histone/protein" . SPARSER::COLLECTION)
    ("oxidant/antioxidant" . SPARSER::COLLECTION) ("TOS" . SPARSER::PROTEIN)
    ("peripheral leukocytes" . SPARSER::PROTEIN)
    ("Low density lipoprotein" . SPARSER::PROTEIN)
    ("yeast homolog" . SPARSER::PROTEIN)
    ("high density lipoprotein" . SPARSER::PROTEIN)
    ("Sirtuin-1" . SPARSER::PROTEIN)
    ("ITD, CEBPA , IDH2, RUNX1 , WT1 and DNMT3A" . SPARSER::COLLECTION)
    ("cohort and AML" . SPARSER::COLLECTION) ("-ITD" . SPARSER::COLLECTION)
    ("TP53 and FLT3 or RAS" . SPARSER::COLLECTION)
    ("FLT3 or RAS" . SPARSER::COLLECTION) ("PML-RARA" . SPARSER::COLLECTION)
    ("the original t(15;17) and trisomy" . SPARSER::COLLECTION)
    ("the original t" . SPARSER::PROTEIN)
    ("t(15;17) and trisomy" . SPARSER::COLLECTION)
    ("having acute promyelocytic leukemia" . SPARSER::PROTEIN)
    ("TP53, DNMT3A , WT1 and RUNX1" . SPARSER::COLLECTION)
    ("CEBPA , IDH2, TP53, DNMT3A , RUNX1 and WT1" . SPARSER::COLLECTION)
    ("TP53 , RUNX1 , WT1 and DNMT3A" . SPARSER::COLLECTION)
    ("NRAS , PTPN11 , CEBPA , RUNX1 , ASXL1 and TET2" . SPARSER::COLLECTION)
    ("TP53-" . SPARSER::PROTEIN)
    ("ITD, CEBPA , RUNX1 , WT1 , DNMT3A and IDH2" . SPARSER::COLLECTION)
    ("FLT3-" . SPARSER::PROTEIN) ("ITD and DNMT3A" . SPARSER::COLLECTION)
    ("FAB" . SPARSER::PROTEIN) ("CR2" . SPARSER::PROTEIN)
    ("CD13" . SPARSER::PROTEIN) ("AKT/NF- κ B/bcl-2" . SPARSER::COLLECTION)
    ("kinase or AKT" . SPARSER::COLLECTION)
    ("RLN2/AKT/NF- κ B" . SPARSER::COLLECTION)
    ("TNF- α and myr-AKT" . SPARSER::COLLECTION)
    ("LY294002, BAY 11-7082, and I κ B α" . SPARSER::COLLECTION)
    ("VEGF and MMP-9" . SPARSER::COLLECTION)
    ("dependent-VEGF and MMP-9" . SPARSER::COLLECTION)
    ("MMP-9 and VEGF" . SPARSER::COLLECTION)
    ("RLN2/p-Akt/NF- κ B" . SPARSER::COLLECTION)
    ("RLN2 and p-AKT protein" . SPARSER::COLLECTION)
    ("molecules and pathways" . SPARSER::COLLECTION)
    ("at least ten major regulatory proteins" . SPARSER::PROTEIN)
    ("the human LGR8 both the relaxin and the peptide INSL3"
     . SPARSER::COLLECTION)
    ("the human LGR8 both the relaxin" . SPARSER::PROTEIN)
    ("RLF" . SPARSER::PROTEIN) ("phosphodiesterases" . SPARSER::PROTEIN)
    ("relaxin, LGR7 and LGR8" . SPARSER::COLLECTION)
    ("relaxin gene 1 (RLN1) and RLN2" . SPARSER::COLLECTION)
    ("the antiapoptotic RLN2" . SPARSER::PROTEIN) ("myr" . SPARSER::MOLECULE)
    ("MMP-9, VEGF, and bcl-2" . SPARSER::COLLECTION)
    ("the RLN2 siRNA1" . SPARSER::PROTEIN)
    ("siRNA2, and RLN2" . SPARSER::COLLECTION)
    ("RLN2 and RXFP1" . SPARSER::COLLECTION) ("kinase (MEK)" . SPARSER::KINASE)
    ("PI 3-kinase/AKT" . SPARSER::COLLECTION) ("genistein" . SPARSER::PROTEIN)
    ("NF- κ B/Bcl-2" . SPARSER::COLLECTION)
    ("drug and AKT or ERK1/2" . SPARSER::COLLECTION)
    ("AKT or ERK1/2" . SPARSER::COLLECTION)
    ("AKT and extracellular signal-regulated kinase" . SPARSER::COLLECTION)
    ("vascular endothelial growth factor (VEGF) and intercellular adhesion molecule 1 (ICAM-1)"
     . SPARSER::COLLECTION)
    ("Relaxin" . SPARSER::PROTEIN) ("RLN2 and p-ERK1/2" . SPARSER::COLLECTION)
    ("AKT/NF- κ B" . SPARSER::COLLECTION) ("relaxin" . SPARSER::PROTEIN)
    ("Extracellular signal-regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Matrix metalloproteinase-9" . SPARSER::PROTEIN)
    ("relaxin-like factor" . SPARSER::PROTEIN) ("INSL3" . SPARSER::PROTEIN)
    ("RLN1" . SPARSER::PROTEIN) ("Retinoblastoma protein" . SPARSER::PROTEIN)
    ("anti- β" . SPARSER::PROTEIN) ("bcl-2" . SPARSER::PROTEIN)
    ("Hema-3" . SPARSER::PROTEIN) ("TNF- α" . SPARSER::PROTEIN)
    ("BAY 11-7082" . SPARSER::DRUG)
    ("intercellular adhesion molecule 1" . SPARSER::PROTEIN)
    ("RXFP2" . SPARSER::PROTEIN) ("LGR8" . SPARSER::PROTEIN)
    ("RXFP1" . SPARSER::PROTEIN)
    ("relaxin family peptide receptor 1" . SPARSER::PROTEIN)
    ("LGR7" . SPARSER::PROTEIN) ("RLN2" . SPARSER::PROTEIN)
    ("Pao" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Brca1 and IGF" . SPARSER::COLLECTION)
    ("P100 and P130" . SPARSER::COLLECTION) ("M2 and M1" . SPARSER::COLLECTION)
    ("Nox2" . SPARSER::PROTEIN) ("tnf" . SPARSER::PROTEIN)
    ("IGF - 1 and IGF - 2" . SPARSER::COLLECTION)
    ("progranulin , Igf1 and osteopontin" . SPARSER::COLLECTION)
    ("progranulin" . SPARSER::PROTEIN)
    ("CD86 , Tnfα , Bcl2a1 a and Cxcl10" . SPARSER::COLLECTION)
    ("Gadd45gip1" . SPARSER::PROTEIN) ("Cxcl10" . SPARSER::PROTEIN)
    ("genes ( Clec7a , Igf1 , Mmp12 , Spp1 and Lgals3 ) and a down-regulation of Retnla and F13a1"
     . SPARSER::COLLECTION)
    ("Clec7a , Igf1 , Mmp12 , Spp1 and Lgals3" . SPARSER::COLLECTION)
    ("Retnla and F13a1" . SPARSER::COLLECTION) ("F13a1" . SPARSER::PROTEIN)
    ("Mmp12" . SPARSER::PROTEIN) ("Igf1" . SPARSER::PROTEIN)
    ("Clec7a" . SPARSER::PROTEIN) ("Retnla" . SPARSER::PROTEIN)
    ("a M2 neuroprotective state" . SPARSER::BIO-STATE)
    ("Brca1 and Iba1" . SPARSER::COLLECTION)
    ("Brca1 and CD11b" . SPARSER::COLLECTION)
    ("Cdkn1a , Myc , Pcna , Stat1 , Gadd45a and Sp3" . SPARSER::COLLECTION)
    ("Brca1 , Cdkn1a , Myc , Pcna and Stat1" . SPARSER::COLLECTION)
    ("Gadd45a and Sp3" . SPARSER::COLLECTION) ("Cdkn1a" . SPARSER::PROTEIN)
    ("Pcna" . SPARSER::PROTEIN) ("microglial Brca1" . SPARSER::PROTEIN)
    ("c - Myc (1.8-FC) and Brca1 (1.76-FC)" . SPARSER::COLLECTION)
    ("p21 (2.18-FC), PCNA (1.85-FC), STAT1 (1.9-FC), c - Myc (1.8-FC) and Brca1 (1.76-FC)"
     . SPARSER::COLLECTION)
    ("Antigen" . SPARSER::PROTEIN)
    ("the commonly dysregulated genes (in motoneurones and microglia) and uniquely dysregulated genes"
     . SPARSER::COLLECTION)
    ("somata" . SPARSER::DRUG) ("microglia/macrophages" . SPARSER::COLLECTION)
    ("pro- and anti-inflammatory" . SPARSER::COLLECTION)
    ("Microglia" . SPARSER::PROTEIN)
    ("TARDBP (also known as TDP-43) and C9ORF72" . SPARSER::COLLECTION)
    ("SOD1 (Cu/Zn superoxide dismutase 1), FUS (fused in sarcoma), TARDBP (also known as TDP-43) and C9ORF72"
     . SPARSER::COLLECTION)
    ("TARDBP" . SPARSER::PROTEIN) ("FUS" . SPARSER::PROTEIN)
    ("a valid therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("human spinal microglia" . SPARSER::PROTEIN) ("ALS" . SPARSER::PROTEIN)
    ("calcium-binding protein" . SPARSER::PROTEIN)
    ("TATA box binding protein" . SPARSER::PROTEIN) ("RPS9" . SPARSER::PROTEIN)
    ("mitochondrial ribosomal protein S9" . SPARSER::PROTEIN)
    ("MAS 5" . SPARSER::PROTEIN) ("APC 1" . SPARSER::PROTEIN)
    ("1 - L" . SPARSER::PROTEIN) ("P130" . SPARSER::PROTEIN)
    ("IL - 10" . SPARSER::PROTEIN) ("IL - 1β" . SPARSER::PROTEIN)
    ("IGFBP4" . SPARSER::PROTEIN) ("IGF - 2" . SPARSER::PROTEIN)
    ("IGF - 1" . SPARSER::PROTEIN) ("Gadd45" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("growth arrest and DNA-damage-inducible" . SPARSER::PROTEIN)
    ("Bcl2a1 a" . SPARSER::PROTEIN) ("Tnfα" . SPARSER::DRUG)
    ("CD86" . SPARSER::PROTEIN) ("Lgals3" . SPARSER::PROTEIN)
    ("Spp1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Gadd45a" . SPARSER::PROTEIN)
    ("ATF - 1" . SPARSER::PROTEIN) ("c - Myc" . SPARSER::PROTEIN)
    ("CXCL13" . SPARSER::PROTEIN) ("alpha-synuclein" . SPARSER::PROTEIN)
    ("P120" . SPARSER::PROTEIN) ("1-L" . SPARSER::PROTEIN)
    ("Iba1" . SPARSER::PROTEIN) ("C9ORF72" . SPARSER::PROTEIN)
    ("TDP-43" . SPARSER::PROTEIN) ("superoxide dismutase 1" . SPARSER::PROTEIN)
    ("Brca1" . SPARSER::PROTEIN) ("hSOD1" . SPARSER::PROTEIN)
    ("P90" . SPARSER::PROTEIN) ("relevant genes" . SPARSER::GENE)
    ("various chemotherapeutic drugs" . SPARSER::DRUG)
    ("a predictive biomarker" . SPARSER::MOLECULE)
    ("1 -C-C-G" . SPARSER::COLLECTION)
    ("homozygous variant genotype A 2 A 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("A 2 A 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("aromatases" . SPARSER::PROTEIN) ("Ins" . SPARSER::PROTEIN)
    ("Anthracycline" . SPARSER::MOLECULE)
    ("hormonal receptors" . SPARSER::PROTEIN) ("1 A 2" . SPARSER::PROTEIN)
    ("1 -C" . SPARSER::PROTEIN) ("PIN3" . SPARSER::PROTEIN)
    ("C-G" . SPARSER::PROTEIN) ("essential part" . SPARSER::COMPONENT)
    ("mesenchymal proteins" . SPARSER::PROTEIN)
    ("vimentin and L1CAM" . SPARSER::COLLECTION)
    ("a residual EMT" . SPARSER::PROTEIN)
    ("some classical EMT" . SPARSER::PROTEIN)
    ("Slug and vimentin" . SPARSER::COLLECTION)
    ("TGF-β1 and JNK" . SPARSER::COLLECTION)
    ("macrophages and certain T-cell subsets" . SPARSER::COLLECTION)
    ("kRas" . SPARSER::PROTEIN)
    ("mediators, TGF-β1 and Nrf2" . SPARSER::COLLECTION)
    ("Nrf2 and E-cadherin" . SPARSER::COLLECTION)
    ("Smad or MAPK" . SPARSER::COLLECTION)
    ("Smad and JNK" . SPARSER::COLLECTION)
    ("tBHQ and SFN" . SPARSER::COLLECTION)
    ("TGF-β1 and tBHQ or SFN" . SPARSER::COLLECTION)
    ("tBHQ (50 μM) or SFN (10 μM)" . SPARSER::COLLECTION)
    ("vimentin and Slug" . SPARSER::COLLECTION)
    ("tBHQ, SFN and TGF-β1" . SPARSER::COLLECTION)
    ("quite uniform fringe" . SPARSER::PROTEIN-FAMILY)
    ("fringe" . SPARSER::PROTEIN-FAMILY)
    ("tBHQ or TGF-β1" . SPARSER::COLLECTION)
    ("tBHQ and TGF-β1" . SPARSER::COLLECTION)
    ("inducers and TGF-β1" . SPARSER::COLLECTION)
    ("tBHQ, SFN or TGF-β1" . SPARSER::COLLECTION)
    ("tBHQ and TGF-β1 or SFN" . SPARSER::COLLECTION)
    ("TGF-β1 or SFN" . SPARSER::COLLECTION)
    ("NQO1 and GCLC" . SPARSER::COLLECTION)
    ("inducer and TGF-β1" . SPARSER::COLLECTION) ("GCLC" . SPARSER::PROTEIN)
    ("tBHQ or sulforaphane" . SPARSER::COLLECTION)
    ("Smad" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGF-β1 and Nrf2" . SPARSER::COLLECTION)
    ("both Nrf2 [ xref , xref , xref ] and TGF-β1 [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("Nrf2 [ xref , xref , xref ] and TGF-β1 [ xref , xref , xref ]"
     . SPARSER::COLLECTION)
    ("vimentin, Slug, L1CAM and E-cadherin" . SPARSER::COLLECTION)
    ("Nrf2 and TGF-β1" . SPARSER::COLLECTION)
    ("sensitive to apoptosis" . SPARSER::PROTEIN) ("L1-9" . SPARSER::PROTEIN)
    ("Tween20" . SPARSER::MOLECULE) ("DPC4" . SPARSER::PROTEIN)
    ("Smad4" . SPARSER::PROTEIN)
    ("Transforming growth factor beta1" . SPARSER::PROTEIN)
    ("AnnexinV" . SPARSER::PROTEIN)
    ("oligonucleotides or CCND2" . SPARSER::COLLECTION)
    ("Kumamoto-ken" . SPARSER::COLLECTION) ("ken" . SPARSER::PROTEIN)
    ("Fractions" . SPARSER::COMPONENT) ("Peroxidase (HRP)" . SPARSER::PROTEIN)
    ("mouse anti-CCND2" . SPARSER::ANTIBODY)
    ("mouse anti-GAPDH" . SPARSER::ANTIBODY) ("Goat" . SPARSER::PROTEIN)
    ("Peroxidase" . SPARSER::PROTEIN) ("sulfate (SDS)" . SPARSER::MOLECULE)
    ("-polyacrylamide" . SPARSER::DRUG) ("sulfate" . SPARSER::MOLECULE)
    ("dodecyl" . SPARSER::MOLECULE)
    ("-TGCGATCATCGACGGTGG-3" . SPARSER::COLLECTION)
    ("-CGCAAGCATGCTCAGACCTT-3" . SPARSER::COLLECTION)
    ("-AACAGCCTCAAGATCATCAGC-3" . SPARSER::COLLECTION)
    ("-GGATGATGTTCTGGAAGAGCC-3" . SPARSER::COLLECTION)
    ("TRizol" . SPARSER::DRUG) ("SiRNA and miRNA" . SPARSER::COLLECTION)
    ("Reagent" . SPARSER::MOLECULE)
    ("-UGCUCCUCAAUAGCCUGCAGCAGUA-3" . SPARSER::COLLECTION)
    ("representing mature miRNAs" . SPARSER::PROTEIN)
    ("streptomycin" . SPARSER::DRUG)
    ("DIAPH1, PLAU and LAMC2" . SPARSER::COLLECTION)
    ("HGF/c-MET" . SPARSER::COLLECTION)
    ("These mature miRNAs" . SPARSER::PROTEIN) ("mature forms" . SPARSER::FORM)
    ("SiRNA" . SPARSER::PROTEIN) ("Pic" . SPARSER::BIO-COMPLEX)
    ("miRNA and CCND2" . SPARSER::COLLECTION)
    ("ElF" . SPARSER::HUMAN-PROTEIN-FAMILY) ("LAMC2" . SPARSER::PROTEIN)
    ("Site 2" . SPARSER::PROTEIN) ("Site 1" . SPARSER::PROTEIN)
    ("miR-302b" . SPARSER::MOLECULE) ("miR-133a" . SPARSER::PROTEIN)
    ("cyclin D2" . SPARSER::PROTEIN) ("FUT8" . SPARSER::PROTEIN)
    ("Fucosyltransferase 8" . SPARSER::PROTEIN) ("CCND2" . SPARSER::PROTEIN)
    ("holoenzyme" . SPARSER::PROTEIN) ("the excessive ROS" . SPARSER::PROTEIN)
    ("electrons" . SPARSER::MOLECULE) ("AMPK-Ppar α" . SPARSER::COLLECTION)
    ("both glucose and fatty acids" . SPARSER::COLLECTION)
    ("AICAR-" . SPARSER::PROTEIN) ("Sirt3-sh" . SPARSER::COLLECTION)
    ("NDUFA9 and complex I" . SPARSER::COLLECTION)
    ("the membrane-impermeable propidium iodide" . SPARSER::PROTEIN)
    ("glucose or fatty acid" . SPARSER::COLLECTION)
    ("etomoxir, AICAR, 3NP or 3NP" . SPARSER::COLLECTION)
    ("Sdhaf1-sh" . SPARSER::COLLECTION)
    ("nutrient and oxygen" . SPARSER::COLLECTION)
    ("the respiratory complexes" . SPARSER::BIO-COMPLEX)
    ("Cpt1 or Tfam" . SPARSER::COLLECTION) ("-sh" . SPARSER::COLLECTION)
    ("Tfam" . SPARSER::PROTEIN) ("Pgc-1 α and Cpt1" . SPARSER::COLLECTION)
    ("Cpt1" . SPARSER::PROTEIN) ("dichloroacetate (DCA)" . SPARSER::MOLECULE)
    ("DCA" . SPARSER::PROTEIN) ("dichloroacetate" . SPARSER::MOLECULE)
    ("glucose and fatty acid" . SPARSER::COLLECTION)
    ("etomoxir" . SPARSER::DRUG) ("Pdk1 and Hif-1 α" . SPARSER::COLLECTION)
    ("Pdk1, Pdk4 or Hif-1 α" . SPARSER::COLLECTION)
    ("Pdk1 (9-fold) and Pdk4 (2.5-fold)" . SPARSER::COLLECTION)
    ("during normoxia and after hypoxia/reoxygenation" . SPARSER::COLLECTION)
    ("Pdk1" . SPARSER::PROTEIN)
    ("during normoxia or after hypoxia (1.5- to 2.4-fold over basal OCR)"
     . SPARSER::COLLECTION)
    ("glucose or amino acid" . SPARSER::COLLECTION)
    ("hydrazone (FCCP)" . SPARSER::MOLECULE) ("hydrazone" . SPARSER::MOLECULE)
    ("palmitate-BSA" . SPARSER::COLLECTION) ("palmitate" . SPARSER::PROTEIN)
    ("subunit A (SDHA)" . SPARSER::PROTEIN) ("Sdha" . SPARSER::PROTEIN)
    ("runs" . SPARSER::PROTEIN-FAMILY)
    ("pyruvate dehydrogenase and AMP-dependent kinase" . SPARSER::COLLECTION)
    ("ND2" . SPARSER::PROTEIN) ("Sdhaf1" . SPARSER::PROTEIN)
    ("assembly factor 1" . SPARSER::PROTEIN)
    ("transcription factor A, mitochondrial" . SPARSER::PROTEIN)
    ("Pgc-1 α" . SPARSER::PROTEIN) ("Ppar α" . SPARSER::PROTEIN)
    ("Pdk4" . SPARSER::PROTEIN) ("Hif-1 α" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor 1-alpha" . SPARSER::PROTEIN)
    ("enzymes, MAPK, PI3-K and p53" . SPARSER::COLLECTION)
    ("ER α and SIRT1" . SPARSER::COLLECTION) ("Inactive" . SPARSER::INACTIVE)
    ("both Cyclin D1 and the proliferative index Ki-67" . SPARSER::COLLECTION)
    ("EGFR/ERK1/2" . SPARSER::COLLECTION)
    ("Cyclin D1, Ki-67 and SIRT1" . SPARSER::COLLECTION)
    ("food and water" . SPARSER::COLLECTION)
    ("no longer evident silencing GPER" . SPARSER::PROTEIN)
    ("etoposide (ETO)" . SPARSER::PROTEIN)
    ("GPER/EGFR/ERK" . SPARSER::COLLECTION)
    ("EGFR and ERK" . SPARSER::COLLECTION)
    ("the EGFR inhibitor AG1478 (AG) or the MEK inhibitor PD98059 (PD)"
     . SPARSER::COLLECTION)
    ("PD98059 (PD)" . SPARSER::MOLECULE) ("AG1478 (AG)" . SPARSER::DRUG)
    ("PKA and PI3-K" . SPARSER::COLLECTION)
    ("CAFs, E2 and G-1" . SPARSER::COLLECTION)
    ("E2 and G-1" . SPARSER::COLLECTION)
    ("GPER and SIRT1" . SPARSER::COLLECTION)
    ("p53, p73 and HIC1" . SPARSER::COLLECTION)
    ("MAPK and PI3-K" . SPARSER::COLLECTION) ("antiestrogens" . SPARSER::DRUG)
    ("GPER or SIRT1" . SPARSER::COLLECTION) ("Sirtinol" . SPARSER::DRUG)
    ("17 β -estradiol (E2) and the selective ligand" . SPARSER::COLLECTION)
    ("EGFR/ERK/c-fos/AP-1" . SPARSER::COLLECTION) ("GPER" . SPARSER::PROTEIN)
    ("suppressor or tumor" . SPARSER::COLLECTION)
    ("RNAse-A" . SPARSER::PROTEIN) ("18 h" . SPARSER::PROTEIN)
    ("Tyrphostin AG1478" . SPARSER::DRUG) ("PPAR -γ" . SPARSER::PROTEIN)
    ("sir2" . SPARSER::PROTEIN) ("HIC1" . SPARSER::PROTEIN)
    ("GPR30" . SPARSER::PROTEIN) ("AXL and PDGFRL" . SPARSER::COLLECTION)
    ("PDGFRA and PDGFRB" . SPARSER::COLLECTION)
    ("PDGFRA and BCa" . SPARSER::COLLECTION)
    ("RON , AXL and PDGFR" . SPARSER::COLLECTION)
    ("called cabozantinib" . SPARSER::DRUG)
    ("MET , VERFR1 , AXL , TIE2 , KIT , FLT3 , and RET" . SPARSER::COLLECTION)
    ("a dual inhibitor" . SPARSER::INHIBITOR) ("/VEGFR2" . SPARSER::COLLECTION)
    ("PDGFRA , PDGFRB , and PDGFRL" . SPARSER::COLLECTION)
    ("PDGFRL" . SPARSER::PROTEIN)
    ("AXL and PDGFR , and BCa" . SPARSER::COLLECTION)
    ("PDGFR , and BCa" . SPARSER::COLLECTION)
    ("intact c-MET" . SPARSER::PROTEIN)
    ("c-MET network genes ( c-MET - AXL - PDGFR ) and disease outcome"
     . SPARSER::COLLECTION)
    ("called neuroendocrine (NE) BCa" . SPARSER::PROTEIN)
    ("PI3-K/Akt/mTOR" . SPARSER::COLLECTION)
    ("Ras/Erk-MAPK" . SPARSER::COLLECTION)
    ("c-MET , AXL , and PDGFR" . SPARSER::COLLECTION)
    ("c-MET and other RTKs" . SPARSER::COLLECTION)
    ("AXL and PDGFR" . SPARSER::COLLECTION) ("XL184" . SPARSER::DRUG)
    ("TIE2" . SPARSER::PROTEIN) ("mitomycin-C" . SPARSER::DRUG)
    ("PLC1" . SPARSER::PROTEIN) ("GAB1" . SPARSER::PROTEIN)
    ("c-MET" . SPARSER::PROTEIN) ("the histological type" . TYPE)
    ("all histological types" . TYPE)
    ("tumor suppressor proteins p53 and retinoblastoma tumor suppressor protein (pRB)"
     . SPARSER::COLLECTION)
    ("variant and 285CC/309GG " . SPARSER::COLLECTION)
    ("MDM2  " . SPARSER::PROTEIN)
    ("The expression apoptosis regulator BAX and the apoptotic marker active caspase 3"
     . SPARSER::COLLECTION)
    ("E6 and UBE3A" . SPARSER::COLLECTION)
    ("E6AP and CIP2A" . SPARSER::COLLECTION)
    ("miR-375 directly targets SHOX2" . SPARSER::PROTEIN)
    ("Bax and active" . SPARSER::COLLECTION) ("si-UBE3A" . SPARSER::COLLECTION)
    ("MiR-375 directly targets UBE3A" . SPARSER::PROTEIN)
    ("a pivotal viral oncogene" . SPARSER::ONCOGENE)
    ("CIP2A" . SPARSER::PROTEIN) ("IA2" . SPARSER::PROTEIN)
    ("UBE3A" . SPARSER::PROTEIN) ("SIRT3-siRNA" . SPARSER::COLLECTION)
    ("peroxynitrite" . SPARSER::MOLECULE) ("siRNA " . SPARSER::PROTEIN)
    ("HUVECS" . SPARSER::PROTEIN)
    ("succinate dehydrogenase (SDH) and NADH dehydrogenase"
     . SPARSER::COLLECTION)
    ("activation manganese superoxide dismutase (MnSOD) and catalase (CAT)"
     . SPARSER::COLLECTION)
    ("dehydrogenase (SDH)" . SPARSER::PROTEIN)
    ("long chain fatty acyl-CoA dehydrogenase (LCAD)" . SPARSER::PROTEIN)
    ("proteins and lipids" . SPARSER::COLLECTION)
    ("nicotinamide adenine dinucleotide phosphate oxidase (NOX)"
     . SPARSER::PROTEIN)
    ("neurotransmitters" . SPARSER::MOLECULE)
    ("siRNA or SIRT3" . SPARSER::COLLECTION) ("eNOS" . SPARSER::PROTEIN)
    ("renin-angiotensin-aldosterone" . SPARSER::COLLECTION)
    ("angiotensin" . SPARSER::PROTEIN) ("renin" . SPARSER::PROTEIN)
    ("manganese superoxide dismutase" . SPARSER::PROTEIN)
    ("ETC." . SPARSER::PROTEIN) ("functional pVHL" . SPARSER::PROTEIN)
    ("PHD1 and −3" . SPARSER::COLLECTION)
    ("Akt and ERK2" . SPARSER::COLLECTION)
    ("FAK [ xref ] and Akt [ xref ]" . SPARSER::COLLECTION)
    ("IKKβ [ xref ], FAK [ xref ] and Akt [ xref ]" . SPARSER::COLLECTION)
    ("SCF-Skp2" . SPARSER::COLLECTION) ("cdk2-p27" . SPARSER::COLLECTION)
    ("At least three cyclin-dependent inhibitors" . SPARSER::INHIBITOR)
    ("p27, p21 and p16" . SPARSER::COLLECTION)
    ("even exploit hypoxia" . SPARSER::PROTEIN)
    ("commonly face hypoxia" . SPARSER::PROTEIN)
    ("the exogenous p27" . SPARSER::PROTEIN)
    ("hypoxia and p27" . SPARSER::COLLECTION)
    ("normoxia or hypoxia" . SPARSER::COLLECTION)
    ("DMOG and CoCl 2" . SPARSER::COLLECTION)
    ("functional HIF-1α" . SPARSER::PROTEIN)
    ("EPAS1/HIF-2α" . SPARSER::COLLECTION)
    ("sip" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PHD3/p27" . SPARSER::COLLECTION)
    ("HeLa cells neither p21 nor p16 CKIs" . SPARSER::COLLECTION)
    ("either siRNA or an independent adenoviral shRNA" . SPARSER::COLLECTION)
    ("an independent adenoviral shRNA" . SPARSER::PROTEIN)
    ("independent adenoviral shRNA and plasmid-delivered shRNAs"
     . SPARSER::COLLECTION)
    ("independent adenoviral shRNA" . SPARSER::PROTEIN)
    ("p16 or p21" . SPARSER::COLLECTION)
    ("PHDs, PHD1 and −3" . SPARSER::COLLECTION)
    ("hypoxia and PHD3" . SPARSER::COLLECTION)
    ("PHD1, PHD2 and PHD3" . SPARSER::COLLECTION)
    ("oxygen or pVHL" . SPARSER::COLLECTION) ("pVHL" . SPARSER::PROTEIN)
    ("transcription factor (HIF)" . SPARSER::PROTEIN)
    ("KPC" . SPARSER::PROTEIN) ("Skp2" . SPARSER::PROTEIN)
    ("Skp" . SPARSER::PROTEIN)
    ("p16(INK4a) and p27(CDKN1B)" . SPARSER::COLLECTION)
    ("hypoxia or VHL" . SPARSER::COLLECTION)
    ("Total and phosphospecific antibodies" . SPARSER::ANTIBODY)
    ("p27/CDKN1B" . SPARSER::COLLECTION)
    ("siRNA and shRNA" . SPARSER::COLLECTION)
    ("PHD3/EGLN3" . SPARSER::COLLECTION) ("S6D" . SPARSER::PROTEIN)
    ("cdk2" . SPARSER::PROTEIN) ("glut1" . SPARSER::PROTEIN)
    ("HIF-2α" . SPARSER::PROTEIN) ("Cep192" . SPARSER::PROTEIN)
    ("EGLN2" . SPARSER::PROTEIN) ("PHD2" . SPARSER::PROTEIN)
    ("PHD1" . SPARSER::PROTEIN)
    ("von Hippel-Lindau protein" . SPARSER::PROTEIN)
    ("prolyl hydroxylase" . SPARSER::PROTEIN)
    ("p27S" . SPARSER::HUMAN-PROTEIN-FAMILY) ("EGLN3" . SPARSER::PROTEIN)
    ("BRCA1 , BRCA2 and TP53" . SPARSER::COLLECTION)
    ("Tp53 or FATS" . SPARSER::COLLECTION)
    ("FATS and p53" . SPARSER::COLLECTION) ("ER or PR" . SPARSER::COLLECTION)
    ("estrogen receptor (ER) or progesterone receptor (PR) (Additional file xref )"
     . SPARSER::COLLECTION)
    ("whose coding protein" . SPARSER::PROTEIN)
    ("the largest exon" . SPARSER::PROTEIN) ("FATS" . SPARSER::PROTEIN)
    ("FATS-p53" . SPARSER::COLLECTION) ("p53-p21" . SPARSER::COLLECTION)
    ("of pregnancy" . SPARSER::PROTEIN) ("2-4 " . SPARSER::PROTEIN)
    ("p-1" . SPARSER::PROTEIN)
    ("p53 R248 or β4-integrin" . SPARSER::COLLECTION)
    ("Src and/or vinculin" . SPARSER::COLLECTION)
    ("Src and vinculin" . SPARSER::COLLECTION) ("vinculin" . SPARSER::PROTEIN)
    ("p63/p73" . SPARSER::COLLECTION) ("Tap63 and Tap73" . SPARSER::COLLECTION)
    ("The anti-ITGB4" . SPARSER::ANTIBODY) ("MIP" . SPARSER::PROTEIN)
    ("p53 and HIPK2" . SPARSER::COLLECTION)
    ("PKP2, CD9, S1PR1, PSEN1, L1CAM, ITGB4, COL14A1, and CLDN3"
     . SPARSER::COLLECTION)
    ("CXCL1, IL1B, IL6, IL8, SISP2, and VEGFA" . SPARSER::COLLECTION)
    ("CCNA, CCNB2, CDK1, CDC25C, PCNA, MYC, IGF1R, EGR1, ATF3, FAS, BCL2L, NFkB2, and ABCB1"
     . SPARSER::COLLECTION)
    ("CCNA" . SPARSER::PROTEIN) ("a conformational mutant" . SPARSER::MUTANT)
    ("DNA-contact" . SPARSER::DNA)
    ("tryptophan or glutamine" . SPARSER::COLLECTION)
    ("p53 and ~40%" . SPARSER::COLLECTION) ("p53 R248Q" . SPARSER::PROTEIN)
    ("wortmannin and LY294002" . SPARSER::COLLECTION)
    ("both FAK and PI3K/Akt ( xref )" . SPARSER::COLLECTION)
    ("FAK and PI3K/Akt ( xref )" . SPARSER::COLLECTION)
    ("FAK and Akt" . SPARSER::COLLECTION)
    ("PKP2, CD9, S1PR1, PSEN1, L1CAM, ITGB4, COL14A1, CLDN3, LGALS7, and NFASC"
     . SPARSER::COLLECTION)
    ("NFASC" . SPARSER::PROTEIN) ("genes and pathways" . SPARSER::COLLECTION)
    ("p53 R248" . SPARSER::PROTEIN)
    ("cancer-associated p53 mutants" . SPARSER::MUTANT)
    ("antibody and the inhibitor LY294002" . SPARSER::COLLECTION)
    ("fibronectin receptor" . SPARSER::PROTEIN) ("ABCB1" . SPARSER::PROTEIN)
    ("BCL2L" . SPARSER::PROTEIN) ("CDC25C" . SPARSER::PROTEIN)
    ("CCNB2" . SPARSER::PROTEIN) ("beta 4" . SPARSER::PROTEIN)
    ("LGALS7" . SPARSER::PROTEIN) ("CLDN3" . SPARSER::PROTEIN)
    ("COL14A1" . SPARSER::PROTEIN) ("L1CAM" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PSEN1" . SPARSER::PROTEIN) ("S1PR1" . SPARSER::PROTEIN)
    ("CD9" . SPARSER::PROTEIN) ("PKP2" . SPARSER::PROTEIN)
    ("HMMs" . SPARSER::DRUG) ("homozygous (b) state" . SPARSER::BIO-STATE)
    ("homozygous state" . SPARSER::BIO-STATE)
    ("the same allele or different alleles" . SPARSER::COLLECTION)
    ("β -myosin heavy chain (MHC) and myosin-binding protein C (MyBP-C) genes"
     . SPARSER::COLLECTION)
    ("heavy chain (MHC)" . SPARSER::PROTEIN) ("-myosin" . SPARSER::COLLECTION)
    ("multiple neutral variants" . SPARSER::VARIANT) ("HMM" . SPARSER::DRUG)
    ("homologous proteins" . SPARSER::PROTEIN)
    ("multiple variants or the associations" . SPARSER::COLLECTION)
    ("-MHC" . SPARSER::COLLECTION) ("MyBP" . SPARSER::PROTEIN-FAMILY)
    ("TP53 and PTEN" . SPARSER::COLLECTION)
    ("compensatory indel variants" . SPARSER::VARIANT)
    ("TP53 and phosphatase and tensin homolog" . SPARSER::COLLECTION)
    ("myosin-binding protein C" . SPARSER::PROTEIN)
    ("s  2" . SPARSER::MOLECULE) ("ABCB5" . SPARSER::PROTEIN)
    ("Transcript 3" . SPARSER::PROTEIN) ("Transcript 2" . SPARSER::PROTEIN)
    ("Class 1" . SPARSER::PROTEIN-FAMILY) ("class 1" . SPARSER::PROTEIN-FAMILY)
    ("ORAI1" . SPARSER::PROTEIN) ("integrin-HER2" . SPARSER::COLLECTION)
    ("integrin and HER2" . SPARSER::COLLECTION)
    ("trastuzumab or Trastuzumab-emtansine" . SPARSER::COLLECTION)
    ("the dual low HER2 and low αv-integrin" . SPARSER::COLLECTION)
    ("the dual low HER2" . SPARSER::PROTEIN)
    ("HER2 and integrins" . SPARSER::COLLECTION)
    ("HER2 and integrin" . SPARSER::COLLECTION)
    ("integrin and growth factor" . SPARSER::COLLECTION)
    ("active and inactive" . SPARSER::COLLECTION)
    ("proteins and LIN-7" . SPARSER::COLLECTION)
    ("E-cadherin and αv-integrin" . SPARSER::COLLECTION)
    ("erbin and/or LIN-7" . SPARSER::COLLECTION)
    ("actin-associated PDZ-domain proteins" . SPARSER::PROTEIN)
    ("erbin" . SPARSER::PROTEIN) ("integrins and HER2" . SPARSER::COLLECTION)
    ("a negative diagnostic biomarker" . SPARSER::MOLECULE)
    ("lapatinib and trastuzumab" . SPARSER::COLLECTION)
    ("receptor tyrosine kinase and integrin" . SPARSER::COLLECTION)
    ("live cell flow cytometry" . SPARSER::PROTEIN)
    ("intense globular HER2" . SPARSER::PROTEIN)
    ("HER2 and αv-integrin" . SPARSER::COLLECTION)
    ("Live cell flow cytometry" . SPARSER::PROTEIN)
    ("MDA-MB231BR" . SPARSER::PROTEIN)
    ("MDA-MB231BR-HER2" . SPARSER::PROTEIN-PAIR)
    ("integrins and various growth factor receptors" . SPARSER::COLLECTION)
    ("intetumumab and cilengitide" . SPARSER::COLLECTION)
    ("intetumumab or αvβ3-" . SPARSER::COLLECTION)
    ("αvβ5-integrins" . SPARSER::COLLECTION) ("αvβ3-" . SPARSER::PROTEIN)
    ("cilengitide" . SPARSER::DRUG) ("intetumumab" . SPARSER::DRUG)
    ("-integrin" . SPARSER::COLLECTION)
    ("essential mediators" . SPARSER::PROTEIN) ("αvβ6" . SPARSER::PROTEIN)
    ("surface protein" . SPARSER::PROTEIN) ("β4-integrin" . SPARSER::PROTEIN)
    ("lysosome-associated membrane protein 2" . SPARSER::PROTEIN)
    ("brain)" . SPARSER::PROTEIN) ("F-Actin" . SPARSER::BIO-COMPLEX)
    ("orphan receptor" . SPARSER::PROTEIN) ("αvβ3" . SPARSER::PROTEIN)
    ("αvβ 3" . SPARSER::PROTEIN)
    ("the SH3-BH fragment and the nSH2 -iSH2-cSH2 fragment"
     . SPARSER::COLLECTION)
    ("-iSH2-cSH2" . SPARSER::COLLECTION)
    ("dimeric and monomeric p85 α" . SPARSER::PROTEIN)
    ("full-length and fragments" . SPARSER::COLLECTION)
    ("the shorter N-terminal fragment" . SPARSER::FRAGMENT)
    ("p85α and PTEN or WWP2" . SPARSER::COLLECTION)
    ("PTEN or WWP2" . SPARSER::COLLECTION)
    ("p85α and p85β" . SPARSER::COLLECTION)
    ("Rapamycin and MK2206" . SPARSER::COLLECTION)
    ("mTOR and AKT" . SPARSER::COLLECTION)
    ("both S6K and Rictor siRNA" . SPARSER::COLLECTION)
    ("S6K or Rictor siRNA" . SPARSER::COLLECTION)
    ("p85α or WWP2" . SPARSER::COLLECTION)
    ("S6K or mTORC2" . SPARSER::COLLECTION)
    ("PTEN/p85 α/WWP2" . SPARSER::COLLECTION) ("p85 α" . SPARSER::PROTEIN)
    ("PTEN and WWP-2" . SPARSER::COLLECTION)
    ("the relevant complex" . SPARSER::BIO-COMPLEX)
    ("p85 homodimers and/or WWP2" . SPARSER::COLLECTION)
    ("Homodimer" . SPARSER::HOMODIMER) ("Monomer" . SPARSER::MONOMER)
    ("p110, p85α, and PTEN" . SPARSER::COLLECTION)
    ("PTEN (the first 13 residues) and p85α (the PR2 region, and the loop between residues 123 and 130)"
     . SPARSER::COLLECTION)
    ("the dimer's" . SPARSER::DIMER)
    ("only one p85α molecule" . SPARSER::MOLECULE)
    ("PTEN:p85α" . SPARSER::BIO-COMPLEX)
    ("p110α, p55α, and p50α" . SPARSER::COLLECTION)
    ("monomeric p85α-bound p110α" . SPARSER::PROTEIN)
    ("p85α and PTEN" . SPARSER::COLLECTION)
    ("less stable yet more active" . SPARSER::ACTIVE)
    ("Homodimeric p85α" . SPARSER::PROTEIN)
    ("monomer and homodimer" . SPARSER::COLLECTION)
    ("substrate (IRS)" . SPARSER::SUBSTRATE)
    ("p85:p110" . SPARSER::BIO-COMPLEX) ("IRS" . SPARSER::PROTEIN)
    ("a I127A/I133A/E137A triple p85α mutant" . SPARSER::MUTANT)
    ("the homodimerized p85α:PTEN complex" . SPARSER::BIO-COMPLEX)
    ("p85α:PTEN" . SPARSER::BIO-COMPLEX)
    ("the bulky hydrophobic isoleucine" . SPARSER::AMINO-ACID)
    ("isoleucine" . SPARSER::AMINO-ACID)
    ("PTEN and PI3K" . SPARSER::COLLECTION)
    ("homodimeric p85α" . SPARSER::PROTEIN)
    ("monomeric p85α" . SPARSER::PROTEIN)
    ("PTEN and p85α" . SPARSER::COLLECTION)
    ("WWP2 only binds PTEN" . SPARSER::PROTEIN)
    ("WWP2 and PTEN" . SPARSER::COLLECTION) ("p85α" . SPARSER::PROTEIN)
    ("p85α-PTEN" . SPARSER::PROTEIN-PAIR)
    ("WWP2 or p85α" . SPARSER::COLLECTION)
    ("S6K, mTORC2, and AKT" . SPARSER::COLLECTION)
    ("PTEN:WWP2" . SPARSER::BIO-COMPLEX)
    ("PTEN and WWP2" . SPARSER::COLLECTION)
    ("c-cbl and cbl-b" . SPARSER::COLLECTION)
    ("anti-p85α antibodies ( xref ) or directly using anti-PTEN antibodies ( xref )"
     . SPARSER::COLLECTION)
    ("soluble PIP 3 substrate" . SPARSER::SUBSTRATE)
    ("mTOR or AKT" . SPARSER::COLLECTION)
    ("the S6K and Rictor siRNAs" . SPARSER::COLLECTION)
    ("PTEN and WT p85α or the PR1+PR2mut" . SPARSER::COLLECTION)
    ("mTORC2, and feedforward" . SPARSER::COLLECTION)
    ("the homodimer-disrupting mutants (R18A, E19A/E20A, D21A/W55A, and R66A in SH3; PR1mut, PR1mut’ in PR1; M176A in BH) and PTEN binding-disrupting mutants (PR2mut and PR2mut')"
     . SPARSER::COLLECTION)
    ("LacZ" . SPARSER::PROTEIN)
    ("the crystal-derived BH:BH dimer" . SPARSER::DIMER)
    ("The crystallographic dimer" . SPARSER::DIMER)
    ("homodimerized p85α binds PTEN, PR1mut, and PR1mut" . SPARSER::COLLECTION)
    ("PTEN, PR1mut, and PR1mut" . SPARSER::COLLECTION)
    ("either the key prolines or basic residues in the PR1"
     . SPARSER::COLLECTION)
    ("SL" . SPARSER::PROTEIN) ("VA" . SPARSER::MOLECULE)
    ("PL" . SPARSER::PROTEIN) ("PHT" . SPARSER::MOLECULE)
    ("fragment and full-length" . SPARSER::COLLECTION)
    ("p110α-bound p85α monomer and p110α-free p85α homodimer"
     . SPARSER::COLLECTION)
    ("novel biomarkers or therapeutic opportunities" . SPARSER::COLLECTION)
    ("quiescent p110" . SPARSER::PROTEIN)
    ("nSH2-iSH2-cSH2" . SPARSER::COLLECTION)
    ("Rho-GAP/BCR-homology" . SPARSER::COLLECTION)
    ("p110-bound heterodimers and p110-free homodimers" . SPARSER::COLLECTION)
    ("‘homodimer’" . SPARSER::HOMODIMER)
    ("This ‘heterodimeric’ enzyme" . SPARSER::ENZYME)
    ("P-2" . SPARSER::PROTEIN) ("P 87" . SPARSER::PROTEIN)
    ("p110β" . SPARSER::PROTEIN) ("p55" . SPARSER::PROTEIN)
    ("INPP4B" . SPARSER::PROTEIN) ("IL3" . SPARSER::PROTEIN)
    ("interleukin-3" . SPARSER::PROTEIN) ("cbl-b" . SPARSER::PROTEIN)
    ("c-cbl" . SPARSER::PROTEIN) ("PIP 3" . SPARSER::PIP3)
    ("PDB 1" . SPARSER::PROTEIN) ("p85β" . SPARSER::PROTEIN)
    ("K88" . SPARSER::PROTEIN) ("E19" . SPARSER::PROTEIN)
    ("PIK3R1" . SPARSER::PROTEIN) ("iSH2" . SPARSER::PROTEIN)
    ("cSH2" . SPARSER::PROTEIN) ("nSH2" . SPARSER::PROTEIN)
    ("Rho-GAP" . SPARSER::PROTEIN) ("PR1" . SPARSER::PROTEIN)
    ("class 1A" . SPARSER::PROTEIN) ("WWP2" . SPARSER::PROTEIN)
    ("ROS and the Hh responsive genes" . SPARSER::COLLECTION)
    ("Gli1, Gli2 and Gli3" . SPARSER::COLLECTION) ("Gli2" . SPARSER::PROTEIN)
    ("Gli" . SPARSER::PROTEIN) ("Patched" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a master developmental regulator" . SPARSER::REGULATOR)
    ("PAMPs and DAMPs" . SPARSER::COLLECTION) ("DAMPs" . SPARSER::DAMP)
    ("the three MAPKs [ xref ] and AKT [ xref ]" . SPARSER::COLLECTION)
    ("ligands (LPS)" . SPARSER::LIGAND)
    ("pro-inflammatory cytokines and ROS" . SPARSER::COLLECTION)
    ("cytokines and ROS" . SPARSER::COLLECTION)
    ("various chemokines and adhesion molecules" . SPARSER::COLLECTION)
    ("LPS/TLR4" . SPARSER::COLLECTION)
    ("chemokine genes and proliferative genes" . SPARSER::COLLECTION)
    ("NOX1, NOX4, and GKT137831" . SPARSER::COLLECTION)
    ("fibrotic genes" . SPARSER::GENE) ("NOX1/NOX4" . SPARSER::COLLECTION)
    ("pro-fibrogenic agonists" . SPARSER::AGONIST)
    ("The classic NOX2" . SPARSER::PROTEIN)
    ("NOX1, NOX2 and NOX4" . SPARSER::COLLECTION) ("Duox" . SPARSER::PROTEIN)
    ("particular NOX4" . SPARSER::PROTEIN)
    ("These fibrogenic genes" . SPARSER::GENE)
    ("fibrogenic genes" . SPARSER::GENE)
    ("α-SMA, TIMP1 and TGFBR2" . SPARSER::COLLECTION)
    ("fibrogenic mediators" . SPARSER::PROTEIN)
    ("Cyclin D1, Bcl-2, PCNA and PDGFRB" . SPARSER::COLLECTION)
    ("PDGFRB" . SPARSER::PROTEIN) ("desmin and PCNA" . SPARSER::COLLECTION)
    ("Gli1, Ptch1, Bcl-2 and Cyclin D1" . SPARSER::COLLECTION)
    ("Gli1 and its downstream genes Ptch1, Bcl-2 and Cyclin D1"
     . SPARSER::COLLECTION)
    ("its downstream genes Ptch1, Bcl-2 and Cyclin D1" . SPARSER::COLLECTION)
    ("Ptch1, Bcl-2 and Cyclin D1" . SPARSER::COLLECTION)
    ("PCNA, Bcl-2 and Cyclin D1" . SPARSER::COLLECTION)
    ("Bambi" . SPARSER::PROTEIN) ("Ccl3" . SPARSER::PROTEIN)
    ("Ccl2" . SPARSER::PROTEIN) ("Cxcl1" . SPARSER::PROTEIN)
    ("Ccl" . SPARSER::DRUG)
    ("derived growth factor (PDGF)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("inflammatory and fibrotic cytokines" . SPARSER::PROTEIN)
    ("TNF-α, MCP-1, IL-1β and MIP-1" . SPARSER::COLLECTION)
    ("Desmin" . SPARSER::PROTEIN)
    ("small molecule NOX1/4 dual inhibitors" . SPARSER::INHIBITOR)
    ("NOX1 or NOX2" . SPARSER::COLLECTION) ("BDL" . SPARSER::PROTEIN)
    ("the classic NOX" . SPARSER::PROTEIN)
    ("The multicomponent nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) enzyme"
     . SPARSER::ENZYME)
    ("chemokines and extracellular matrix proteins [ xref ]"
     . SPARSER::COLLECTION)
    ("inflammatory cytokines, chemokines and extracellular matrix proteins [ xref ]"
     . SPARSER::COLLECTION)
    ("quiescent HSCs" . SPARSER::PROTEIN) ("desmin" . SPARSER::PROTEIN)
    ("The NOX1/4 dual inhibitor GKT137831" . SPARSER::DRUG)
    ("Shh" . SPARSER::PROTEIN) ("NOX1 or NOX4" . SPARSER::COLLECTION)
    ("NOX1 and NOX4" . SPARSER::COLLECTION)
    ("pro-fibrotic genes" . SPARSER::GENE)
    ("a dual NOX1/4 inhibitor" . SPARSER::INHIBITOR)
    ("Gli3" . SPARSER::PROTEIN)
    ("chronic granulomatous disease" . SPARSER::PROTEIN)
    ("Gli1" . SPARSER::PROTEIN) ("Cxcl2" . SPARSER::PROTEIN)
    ("MIP-1" . SPARSER::PROTEIN) ("thiobarbituric acid" . SPARSER::MOLECULE)
    ("Thiobarbituric Acid" . SPARSER::MOLECULE) ("Nox4" . SPARSER::PROTEIN)
    ("CM-H" . SPARSER::MOLECULE) ("Ang II" . SPARSER::PROTEIN)
    ("Angiotensin II" . SPARSER::PROTEIN) ("vitamin A" . SPARSER::MOLECULE)
    ("sonic hedgehog" . SPARSER::PROTEIN) ("NOX4" . SPARSER::PROTEIN)
    ("GKT137831" . SPARSER::DRUG)
    ("nicotinamide adenine dinucleotide phosphate oxidase" . SPARSER::PROTEIN)
    ("-PKCα" . SPARSER::COLLECTION) ("ROS-ER" . SPARSER::COLLECTION)
    ("elevated cellular ROS" . SPARSER::PROTEIN)
    ("IL-1β and TNFα" . SPARSER::COLLECTION)
    ("cytokines, PMA, and vitamin D 3" . SPARSER::COLLECTION)
    ("Isoliquiritigenin" . SPARSER::DRUG)
    ("nrf2 -null macrophages" . SPARSER::PROTEIN)
    ("peritoneal foam cell macrophages" . SPARSER::PROTEIN)
    ("ROS and ER" . SPARSER::COLLECTION)
    ("classically activated pro-inflammatory macrophages" . SPARSER::PROTEIN)
    ("immunosuppressive cytokine IL-10 and multiple growth factors"
     . SPARSER::COLLECTION)
    ("IL-1, and TNFα" . SPARSER::COLLECTION)
    ("PKCα-ERK-NFκB" . SPARSER::COLLECTION)
    ("PMA-treated NRF2" . SPARSER::PROTEIN)
    ("the basal p50" . SPARSER::PROTEIN) ("p-EIF2α" . SPARSER::PROTEIN-PAIR)
    ("p-PERK" . SPARSER::COLLECTION) ("NRF2-" . SPARSER::PROTEIN)
    ("increased cellular ROS" . SPARSER::PROTEIN)
    ("NQO1 and GCLM" . SPARSER::COLLECTION) ("GCLM" . SPARSER::PROTEIN)
    ("DCFDA" . SPARSER::DRUG)
    ("carboxy-H 2 DCFDA-incubated NRF2" . SPARSER::PROTEIN)
    ("cytokines, IL-1β, IL-6, and TNFα" . SPARSER::COLLECTION)
    ("IL-1β, IL-6, TNFα, and chemokine" . SPARSER::COLLECTION)
    ("PMA-inducible pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("macrophage-associated genes" . SPARSER::GENE)
    ("intercellular adhesion molecule-1 (MCP-1) and fibronectin-1 (FN-1)"
     . SPARSER::COLLECTION)
    ("CD44 and CD14" . SPARSER::COLLECTION)
    ("NQO1 and AKR1c1" . SPARSER::COLLECTION) ("AKR1c1" . SPARSER::PROTEIN)
    ("PKC and MAPKs" . SPARSER::COLLECTION)
    ("KEAP1 or NRF2" . SPARSER::COLLECTION) ("ligase (GCL)" . SPARSER::LIGASE)
    ("aldo" . SPARSER::PROTEIN) ("NFκB and MAPKs" . SPARSER::COLLECTION)
    ("IRE1α, and activating transcription factor 6" . SPARSER::COLLECTION)
    ("PKCα and PKCε" . SPARSER::COLLECTION)
    ("nuclear factor-κB (NFκB) and activator protein-1 (AP-1)"
     . SPARSER::COLLECTION)
    ("a strong activator" . SPARSER::ACTIVATOR)
    ("glycerol (DAG)" . SPARSER::PROTEIN)
    ("an exogenous chemical" . SPARSER::MOLECULE)
    ("nitric oxide (NO)" . SPARSER::MOLECULE)
    ("molecules (ECM)" . SPARSER::MOLECULE) ("Monocytes" . SPARSER::PROTEIN)
    ("pro-inflammatory macrophages" . SPARSER::PROTEIN)
    ("IL-1β and IL-6" . SPARSER::COLLECTION)
    ("cellular ROS" . SPARSER::PROTEIN)
    ("p50 and extracellular signal-regulated kinase" . SPARSER::COLLECTION)
    ("IL-6, and tumor necrosis factor-α" . SPARSER::COLLECTION)
    ("interleukine" . SPARSER::PROTEIN) ("Runx2" . SPARSER::PROTEIN)
    ("Runt-related transcription factor 2" . SPARSER::PROTEIN)
    ("nrf2" . SPARSER::PROTEIN) ("IL-4 receptor" . SPARSER::PROTEIN)
    ("FN-1" . SPARSER::PROTEIN)
    ("intercellular adhesion molecule-1" . SPARSER::PROTEIN)
    ("hypoxanthine-guanine phosphoribosyltransferase" . SPARSER::PROTEIN)
    ("H 2 DCFDA" . SPARSER::DRUG)
    ("2',7'-dichlorodihydrofluorescein diacetate" . SPARSER::DRUG)
    ("Fluo-4" . SPARSER::DRUG) ("BAY11-7082" . SPARSER::DRUG)
    ("EIF2" . SPARSER::PROTEIN) ("CUL3" . SPARSER::PROTEIN)
    ("Cullin 3" . SPARSER::PROTEIN) ("protein kinase R" . SPARSER::PROTEIN)
    ("CREB binding protein" . SPARSER::PROTEIN)
    ("monocyte chemotactic protein 1" . SPARSER::PROTEIN)
    ("phorbol-12-myristate-13-acetate" . SPARSER::DRUG)
    ("NF-E2-related factor 2" . SPARSER::PROTEIN)
    ("purine and pyrimidine" . SPARSER::COLLECTION)
    ("glycosaminoglycan" . SPARSER::MOLECULE)
    ("Bmp2 and Bmp4" . SPARSER::COLLECTION) ("Bmp2" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor 1 (FGFR1) and FGF8, and bone morphogenetic protein 4 (BMP4)"
     . SPARSER::COLLECTION)
    ("TGFA, msh homeobox 1 (MSX1), fibroblast growth factor receptor 1 (FGFR1) and FGF8, and bone morphogenetic protein 4 (BMP4)"
     . SPARSER::COLLECTION)
    ("FGF8, and bone morphogenetic protein 4" . SPARSER::COLLECTION)
    ("transforming growth factor-alpha (TGFA)" . SPARSER::PROTEIN)
    ("b (TGFB)" . SPARSER::PROTEIN)
    ("bone morphogenetic proteins" . SPARSER::PROTEIN)
    ("TGFB" . SPARSER::PROTEIN) ("Bmp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGFA" . SPARSER::PROTEIN) ("WNT3 and WNT9B" . SPARSER::COLLECTION)
    ("WNTs" . SPARSER::PROTEIN)
    ("WNT3A, WNT5A, WNT8A, and WNT11" . SPARSER::COLLECTION)
    ("tetra" . SPARSER::MOLECULE)
    ("p63 and interferon regulatory factor 6" . SPARSER::COLLECTION)
    ("WNT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("some congenital malformations" . SPARSER::PROTEIN)
    ("dihydrofolate (DHF)" . SPARSER::PROTEIN) ("THF" . SPARSER::MOLECULE)
    ("tetrahydrofolate" . SPARSER::MOLECULE)
    ("dihydrofolate" . SPARSER::PROTEIN) ("dietary folate" . SPARSER::MOLECULE)
    ("congenital malformations" . SPARSER::PROTEIN)
    ("anticonvulsants" . SPARSER::DRUG) ("Syndromic forms" . SPARSER::FORM)
    ("common congenital malformations" . SPARSER::PROTEIN)
    ("folate" . SPARSER::MOLECULE)
    ("Nonsyndromic cleft lip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Msx1" . SPARSER::PROTEIN) ("Bmp4" . SPARSER::PROTEIN)
    ("bone morphogenetic protein 4" . SPARSER::PROTEIN)
    ("MSX1" . SPARSER::PROTEIN) ("msh homeobox 1" . SPARSER::PROTEIN)
    ("fibroblast growth factors" . SPARSER::PROTEIN-FAMILY)
    ("transforming growth factor-alpha" . SPARSER::PROTEIN)
    ("clf1" . SPARSER::PROTEIN) ("WNT9B" . SPARSER::PROTEIN)
    ("WNT11" . SPARSER::PROTEIN) ("WNT3" . SPARSER::PROTEIN)
    ("interferon regulatory factor 6" . SPARSER::PROTEIN)
    ("chromosomal region 1" . SPARSER::PROTEIN) ("IRF6" . SPARSER::PROTEIN)
    ("Interferon regulatory factor 6" . SPARSER::PROTEIN)
    ("1 µL" . SPARSER::PROTEIN) ("dihydrofolate reductase" . SPARSER::PROTEIN)
    ("Dihydrofolate reductase" . SPARSER::PROTEIN)
    ("TGFBR1 and TGRBR2" . SPARSER::COLLECTION)
    ("TGFBR1 or TGFBR2" . SPARSER::COLLECTION)
    ("evolutionary highly conserved amino acid" . SPARSER::AMINO-ACID)
    ("the causative gene" . SPARSER::GENE) ("TAAD" . SPARSER::DRUG)
    ("Genome, and dbSNP139" . SPARSER::COLLECTION) ("CTA" . SPARSER::PROTEIN)
    ("20 pathogenic SMAD3 sequence variants" . SPARSER::VARIANT)
    ("Marfan syndrome (MFS)" . SPARSER::PROTEIN) ("TGFBR2" . SPARSER::PROTEIN)
    ("TGFBR1" . SPARSER::PROTEIN) ("I-2" . SPARSER::PROTEIN)
    ("I-1" . SPARSER::PROTEIN) ("MH1" . SPARSER::PROTEIN)
    ("Marfan syndrome" . SPARSER::PROTEIN)
    ("our works here shed light" . SPARSER::PROTEIN)
    ("Cyclin B1 and many other cell cycle regulators (such as PLK1 and Aurora A, B)"
     . SPARSER::COLLECTION)
    ("Cyclin A/Cdk2" . SPARSER::COLLECTION) ("Cks" . SPARSER::PROTEIN)
    ("Cdc20 and APC" . SPARSER::COLLECTION)
    ("Both specific siRNA and chemical kinase inhibitor" . SPARSER::COLLECTION)
    ("-Cdh1" . SPARSER::COLLECTION) ("APC/C" . SPARSER::PROTEIN)
    ("the exogenous Cdh1" . SPARSER::PROTEIN)
    ("the exogenous Myc-tagged Cdh1" . SPARSER::PROTEIN)
    ("DNA-PKcs and Cyclin B1" . SPARSER::COLLECTION)
    ("APC/C-Cdh1" . SPARSER::COLLECTION)
    ("DNA-PKcs (DPKcs) and APC2" . SPARSER::COLLECTION)
    ("HRP" . SPARSER::PROTEIN) ("heavy chain (HC)" . SPARSER::PROTEIN)
    ("APC2 and IgG" . SPARSER::COLLECTION)
    ("APC/C core factor APC2 (Figure xref A) as well as Cdh1 (Figure xref C, D)"
     . SPARSER::COLLECTION)
    ("anti-APC2, Cdh1, Cyclin B1 and DNA-PKcs" . SPARSER::COLLECTION)
    ("Cdh1 and Cyclin B1" . SPARSER::COLLECTION)
    ("siRNA, and cycloheximide (CHX)" . SPARSER::COLLECTION)
    ("siRNA, and cycloheximide" . SPARSER::COLLECTION)
    ("cdh1" . SPARSER::PROTEIN) ("cdh" . SPARSER::PROTEIN)
    ("Cdc20 and Cdh1" . SPARSER::COLLECTION)
    ("the siRNA targeting-DNA-PKcs and negative control siRNA"
     . SPARSER::COLLECTION)
    ("NC-siRNA" . SPARSER::COLLECTION)
    ("these well-described mitotic regulation proteins" . SPARSER::PROTEIN)
    ("DPKcs-siRNA" . SPARSER::COLLECTION)
    ("siRNA and DNA-PKcs" . SPARSER::COLLECTION)
    ("Cdk1/Cyclin B1" . SPARSER::COLLECTION)
    ("Cdk1/Cdc2" . SPARSER::COLLECTION)
    ("Cdk1/cyclin B1" . SPARSER::COLLECTION)
    ("ATM and DNA-PKcs" . SPARSER::COLLECTION)
    ("Ku70/Ku80" . SPARSER::COLLECTION) ("exogenous Cdh1" . SPARSER::PROTEIN)
    ("APC/C core component APC2 and its co-activator Cdh1"
     . SPARSER::COLLECTION)
    ("β-TrCP" . SPARSER::PROTEIN) ("APC3" . SPARSER::PROTEIN)
    ("DNA-PKCS" . SPARSER::PROTEIN) ("ANAPC2" . SPARSER::PROTEIN)
    ("AF3" . SPARSER::PROTEIN) ("Cdc27" . SPARSER::PROTEIN)
    ("p55 CDC" . SPARSER::PROTEIN) ("Nu7026" . SPARSER::DRUG)
    ("CDC26" . SPARSER::PROTEIN) ("APC9" . SPARSER::PROTEIN-FAMILY)
    ("APC1" . SPARSER::PROTEIN) ("Cdc2" . SPARSER::PROTEIN)
    ("APC2" . SPARSER::PROTEIN) ("E 3" . SPARSER::MOLECULE)
    ("Cyclin B1" . SPARSER::PROTEIN)
    ("DNA-dependent protein kinase" . SPARSER::PROTEIN)
    ("carboplatin, paclitaxel, and sorafenib" . SPARSER::COLLECTION)
    ("b-actin" . SPARSER::COLLECTION)
    ("gemcitabine or vinorelbine" . SPARSER::COLLECTION)
    ("gene and disease" . SPARSER::COLLECTION)
    ("the different polymorphic variants" . SPARSER::VARIANT)
    ("only poor PS" . SPARSER::PROTEIN)
    ("other polymorphic variants" . SPARSER::VARIANT)
    ("alkaloids and taxanes" . SPARSER::COLLECTION)
    ("vinblastine and vincristine" . SPARSER::COLLECTION)
    ("a semisynthetic derivative" . SPARSER::DERIVATIVE)
    ("Vinorelbine" . SPARSER::DRUG)
    ("gemcitabine, vinorelbine, docetaxel, and pemetrexed"
     . SPARSER::COLLECTION)
    ("CTH" . SPARSER::PROTEIN) ("alkaloids" . SPARSER::MOLECULE)
    ("oncoprotein 18" . SPARSER::PROTEIN)
    ("Nrf2 western blot" . SPARSER::PROTEIN)
    ("immunodepleting Nrf2" . SPARSER::PROTEIN)
    ("SFN and Nrf2" . SPARSER::COLLECTION)
    ("Nrf2 protein or an alternatively spliced form" . SPARSER::COLLECTION)
    ("a competent antibody" . SPARSER::PROTEIN)
    ("commercially available, and specific antibody" . SPARSER::PROTEIN)
    ("MG132, tBHQ, or SFN" . SPARSER::COLLECTION)
    ("a relatively new commercial monoclonal Nrf2 antibody"
     . SPARSER::ANTIBODY)
    ("the monoclonal EP1808Y antibody" . SPARSER::ANTIBODY)
    ("Nrf2 or another protein" . SPARSER::COLLECTION)
    ("C-20 and the other two antibodies" . SPARSER::COLLECTION)
    ("a western blot" . SPARSER::PROTEIN)
    ("SFN or MG132" . SPARSER::COLLECTION)
    ("an Nrf2 isoform or the result of nonspecific binding"
     . SPARSER::COLLECTION)
    ("immunogen" . SPARSER::MOLECULE) ("HA-Nrf2" . SPARSER::COLLECTION)
    ("a highly avid Nrf2 antibody" . SPARSER::ANTIBODY)
    ("tBHQ or SFN" . SPARSER::COLLECTION)
    ("the fourth commercially available antibody" . SPARSER::PROTEIN)
    ("the four commercially available antibodies" . SPARSER::ANTIBODY)
    ("sulforaphane (SFN)" . SPARSER::DRUG) ("tBHQ" . SPARSER::DRUG)
    ("hydroquinone" . SPARSER::MOLECULE) ("SFN" . SPARSER::PROTEIN)
    ("approximately 100 kDa" . SPARSER::PROTEIN) ("Lau" . SPARSER::MOLECULE)
    ("toxins" . SPARSER::MOLECULE) ("isoform 1" . SPARSER::PROTEIN)
    ("isoform 3" . SPARSER::PROTEIN) ("β–tubulin" . SPARSER::PROTEIN)
    ("tert-butyl" . SPARSER::MOLECULE) ("immune-related genes" . SPARSER::GENE)
    ("p38, NFkB, PI3K and STAT3" . SPARSER::COLLECTION)
    ("p53/TLR5" . SPARSER::COLLECTION) ("p53/TLR" . SPARSER::COLLECTION)
    ("subunits, PIK3R3 and PIK3CD" . SPARSER::COLLECTION)
    ("pre-initiation complex and RNAPII-dependent transcription (see [ xref ] for review)"
     . SPARSER::COLLECTION)
    ("histone methyltransferases (PRMT1 and CARM1) and histone acetyltransferases (p300/CBP, pCAF, GCN5 and TIP60)"
     . SPARSER::COLLECTION)
    ("PRMT1 and CARM1" . SPARSER::COLLECTION)
    ("pCAF, GCN5 and TIP60" . SPARSER::COLLECTION) ("pCAF" . SPARSER::PROTEIN)
    ("p53/NFκB/STAT3" . SPARSER::COLLECTION)
    ("p53 and TNFα" . SPARSER::COLLECTION)
    ("p53 and estrogen receptor" . SPARSER::COLLECTION)
    ("p53 or estrogen receptor" . SPARSER::COLLECTION)
    ("each Synergistic Target gene" . SPARSER::GENE)
    ("40 Synergistic Target genes" . SPARSER::GENE)
    ("Synergistic genes" . SPARSER::GENE)
    ("a secondary wave" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PAMP" . SPARSER::PROTEIN) ("PI3 kinase and p38" . SPARSER::COLLECTION)
    ("CCL22, S100A8, S100A9 and SAA2" . SPARSER::COLLECTION)
    ("IL6, IL8 and PLAU" . SPARSER::COLLECTION)
    ("p53 and flagellin" . SPARSER::COLLECTION)
    ("p38 and PI3K" . SPARSER::COLLECTION)
    ("CCL22, S100A8, S100A9, SAA2 and IL6" . SPARSER::COLLECTION)
    ("IL8 and PLAU" . SPARSER::COLLECTION)
    ("the regulatory subunit p55 gamma PIK3R3 and catalytic p110 delta subunit PIK3CD (Figure xref )"
     . SPARSER::COLLECTION)
    ("PI3 kinase, the regulatory subunit p55 gamma PIK3R3 and catalytic p110 delta subunit PIK3CD (Figure xref )"
     . SPARSER::COLLECTION)
    ("Synergistic Target genes" . SPARSER::GENE)
    ("PI3 kinase and STAT3" . SPARSER::COLLECTION)
    ("the Synergistic Targets genes" . SPARSER::GENE)
    ("IL8, PLAU and PLAUR" . SPARSER::COLLECTION)
    ("IL6, CCL22, CXCL10, SAA2, S100A8 and S100A9" . SPARSER::COLLECTION)
    ("208 Synergistic Target genes" . SPARSER::GENE)
    ("JNK and p38 MAP kinases" . SPARSER::COLLECTION)
    ("several Synergistic Target genes" . SPARSER::GENE)
    ("IL6, CCL20, PIK3R3 or CSF1" . SPARSER::COLLECTION)
    ("BBC3, PLAU and ATF3" . SPARSER::COLLECTION)
    ("NFκB and p53" . SPARSER::COLLECTION)
    ("p65 and p50" . SPARSER::COLLECTION)
    ("DMSO or Nutlin-3" . SPARSER::COLLECTION)
    ("Nutlin-3 and Bay-117082" . SPARSER::COLLECTION)
    ("synergistic genes" . SPARSER::GENE)
    ("functional TLR5" . SPARSER::PROTEIN)
    ("ATF3, BBC3, SAA2, S100A9 and UBD" . SPARSER::COLLECTION)
    ("ATF3, SAA2, PLAU, PLAUR, S100A8, S100A9, WNT4 and UBD"
     . SPARSER::COLLECTION)
    ("Nutlin-3 or DMSO" . SPARSER::COLLECTION)
    ("BBC3, IL6, IL8, and CCL22" . SPARSER::COLLECTION)
    ("antimicrobial proteins" . SPARSER::PROTEIN)
    ("chemokines and cytokines" . SPARSER::COLLECTION)
    ("PLAUR" . SPARSER::PROTEIN)
    ("Nutlin-3 and flagellin" . SPARSER::COLLECTION)
    ("Nutlin-3 or flagellin" . SPARSER::COLLECTION)
    ("Flagellin" . SPARSER::PROTEIN) ("Targets" . SPARSER::TARGET-PROTEIN)
    ("p53/p21/E2F" . SPARSER::COLLECTION)
    ("minichromosome maintenance (MCM) genes and DNA polymerases (Table xref )"
     . SPARSER::COLLECTION)
    ("MCM" . SPARSER::PROTEIN) ("Maspin" . SPARSER::PROTEIN)
    ("p53 and its well-established target p21" . SPARSER::COLLECTION)
    ("epithelial-mesenchymal transition-associated genes" . SPARSER::GENE)
    ("TLR7 and TLR9" . SPARSER::COLLECTION) ("adjuvants" . SPARSER::DRUG)
    ("Ligands" . SPARSER::LIGAND) ("PAMPs" . SPARSER::PROTEIN)
    ("NFκB and MAP kinase" . SPARSER::COLLECTION)
    ("MAP kinase, PI3K and STAT3" . SPARSER::COLLECTION)
    ("p53 and TLR5" . SPARSER::COLLECTION)
    ("p53 and TLR" . SPARSER::COLLECTION) ("TIP60" . SPARSER::PROTEIN)
    ("GCN5" . SPARSER::PROTEIN) ("CARM1" . SPARSER::PROTEIN)
    ("PRMT1" . SPARSER::PROTEIN) ("IL21" . SPARSER::PROTEIN)
    ("IL10" . SPARSER::PROTEIN) ("S3I-201" . SPARSER::MOLECULE)
    ("Jak-STAT" . SPARSER::PROTEIN) ("p110 delta" . SPARSER::PROTEIN)
    ("p55 gamma" . SPARSER::PROTEIN) ("CXCL10" . SPARSER::PROTEIN)
    ("p38 MAP kinases" . SPARSER::PROTEIN) ("CSF1" . SPARSER::PROTEIN)
    ("PIK3R3" . SPARSER::PROTEIN) ("Bay-117082" . SPARSER::DRUG)
    ("S100A9" . SPARSER::PROTEIN) ("S100A8" . SPARSER::PROTEIN)
    ("SAA2" . SPARSER::PROTEIN) ("BCL2A1" . SPARSER::PROTEIN)
    ("WNT4" . SPARSER::PROTEIN) ("S100A7" . SPARSER::PROTEIN)
    ("GBP2" . SPARSER::PROTEIN) ("GBP1" . SPARSER::PROTEIN)
    ("CXCL11" . SPARSER::PROTEIN) ("CCL22" . SPARSER::PROTEIN)
    ("CCL20" . SPARSER::PROTEIN) ("Sestrin1" . SPARSER::PROTEIN)
    ("SESN1" . SPARSER::PROTEIN) ("SERPINB5" . SPARSER::DRUG)
    ("GADD45" . SPARSER::PROTEIN) ("cyclin G2" . SPARSER::PROTEIN)
    ("CCNG2" . SPARSER::PROTEIN) ("P72" . SPARSER::PROTEIN)
    ("TLR1" . SPARSER::PROTEIN) ("TLR5" . SPARSER::PROTEIN)
    ("PI3K or AKT" . SPARSER::COLLECTION) ("glucocorticoid" . SPARSER::PROTEIN)
    ("NOTCH1 -mutant and/or FBXW7 -mutant" . SPARSER::COLLECTION)
    ("NOTCH1  Single  FBXW7  WT and NOTCH1" . SPARSER::COLLECTION)
    ("PTEN and/or RAS genotype" . SPARSER::COLLECTION)
    ("PTEN/RAS" . SPARSER::COLLECTION) ("ABN and PTEN" . SPARSER::COLLECTION)
    ("NOTCH1 or NOTCH1 and FBXW7" . SPARSER::COLLECTION)
    ("PTEN and RAS" . SPARSER::COLLECTION)
    ("NOTCH1 and FBXW7" . SPARSER::COLLECTION)
    ("PTEN or RAS" . SPARSER::COLLECTION)
    ("Neither PTEN nor RAS genotype" . SPARSER::COLLECTION)
    ("ABN" . SPARSER::PROTEIN) ("NOTCH1/FBXW7" . SPARSER::COLLECTION)
    ("Type 1" . SPARSER::PROTEIN) ("N-RAS" . SPARSER::PROTEIN)
    ("FBXW7" . SPARSER::PROTEIN) ("NOTCH1" . SPARSER::PROTEIN)
    ("pro-apoptotic target genes" . SPARSER::GENE)
    ("HOXB7 and NFKBIA" . SPARSER::COLLECTION)
    ("HOXA5 and RELA" . SPARSER::COLLECTION)
    ("CASP8 and CASP9" . SPARSER::COLLECTION)
    ("c-myc or miR-130a" . SPARSER::COLLECTION)
    ("LPS (MRC)" . SPARSER::PROTEIN) ("MRC" . SPARSER::PROTEIN)
    ("RAN-exportin-1" . SPARSER::COLLECTION) ("RAN" . SPARSER::PROTEIN)
    ("ConA" . SPARSER::DRUG)
    ("25 mg/ml caffeic acid phenethyl ester (CAPE)" . SPARSER::MOLECULE)
    ("ester (CAPE)" . SPARSER::MOLECULE) ("CAPE" . SPARSER::PROTEIN)
    ("RARB" . SPARSER::PROTEIN) ("ATRA" . SPARSER::DRUG)
    ("HOXA5 and TP53" . SPARSER::COLLECTION)
    ("PARP protein as well as various caspases ( xref )" . SPARSER::COLLECTION)
    ("PPARG" . SPARSER::PROTEIN) ("CEBPB" . SPARSER::PROTEIN)
    ("intra-abdominal adipocytes" . SPARSER::PROTEIN)
    ("the target genes, RCC1 and BTB domain-containing protein 1 (RCBTB1)"
     . SPARSER::GENE)
    ("RCC1 and BTB domain-containing protein 1 (RCBTB1)" . SPARSER::COLLECTION)
    ("MDM2-p53" . SPARSER::COLLECTION) ("Nutlins" . SPARSER::DRUG)
    ("an E3 ubiquitin-protein ligase and an important inhibitor"
     . SPARSER::COLLECTION)
    ("Tissue Type" . SPARSER::PROTEIN) ("CASP8" . SPARSER::PROTEIN)
    ("exportin-1" . SPARSER::PROTEIN) ("TNFR2" . SPARSER::PROTEIN)
    ("S15" . SPARSER::PROTEIN) ("as 2 " . SPARSER::PROTEIN)
    ("Nec-1" . SPARSER::PROTEIN) ("ZVAD-FMK" . SPARSER::DRUG)
    ("RCBTB1" . SPARSER::PROTEIN) ("RG7112" . SPARSER::DRUG)
    ("tumor-suppressor protein" . SPARSER::PROTEIN)
    ("HOXA5" . SPARSER::PROTEIN) ("Mcl-1/Bim" . SPARSER::COLLECTION)
    ("ABT-199 or ABT-737" . SPARSER::COLLECTION)
    ("Cdk1, Cdk2, Cdk5, and Cdk9" . SPARSER::COLLECTION)
    ("multi-CDK" . SPARSER::COLLECTION)
    ("subsequently many pan-CDK inhibitors" . SPARSER::INHIBITOR)
    ("Bcl-2 or Bcl-xL" . SPARSER::COLLECTION)
    ("MEK [ xref ] or PI3K [ xref , xref ]" . SPARSER::COLLECTION)
    ("Ser64 increased Mcl-1's" . SPARSER::PROTEIN)
    ("Cdk1, Cdk2, JNK, ERK, and GSK-3β" . SPARSER::COLLECTION)
    ("OCL" . SPARSER::MOLECULE)
    ("Mcl-1 and other Bcl-2 family proteins" . SPARSER::COLLECTION)
    ("Mcl-1 and Bim" . SPARSER::COLLECTION)
    ("cyclin E and cyclin" . SPARSER::COLLECTION)
    ("cyclin E/CDK2" . SPARSER::COLLECTION)
    ("Mcl-1:Bim" . SPARSER::BIO-COMPLEX)
    ("Mcl-1 phosphomimetic mutants" . SPARSER::MUTANT)
    ("TPPP" . SPARSER::PROTEIN) ("Substrate" . SPARSER::SUBSTRATE)
    ("Mcl-1 and Cyclin E" . SPARSER::COLLECTION)
    ("cyclin E and Bim" . SPARSER::COLLECTION)
    ("Myc-Mcl-1" . SPARSER::COLLECTION) ("HA-cyclin E" . SPARSER::COLLECTION)
    ("cyclin B1, and pro-survival" . SPARSER::COLLECTION)
    ("Cdk2 and cyclin" . SPARSER::COLLECTION)
    ("ABT-737 or ABT-199" . SPARSER::COLLECTION)
    ("cyclin E and Mcl-1" . SPARSER::COLLECTION) ("venetoclax" . SPARSER::DRUG)
    ("Cdk1/Cdk2" . SPARSER::COLLECTION) ("ERK/JNK" . SPARSER::COLLECTION)
    ("ERK-1/JNK/p38" . SPARSER::COLLECTION)
    ("proline, glutamic acid, serine and threonine" . SPARSER::COLLECTION)
    ("Bcl-2-homology" . SPARSER::COLLECTION)
    ("E2F, Rb, nucleophosmin, and NPAT" . SPARSER::COLLECTION)
    ("NPAT" . SPARSER::PROTEIN)
    ("Cyclin E/cyclin-dependent kinase" . SPARSER::COLLECTION)
    ("Mcl-1, Bcl-2, and Bcl-xL" . SPARSER::COLLECTION)
    ("family and Cdk" . SPARSER::COLLECTION)
    ("ABT-737 and ABT-199" . SPARSER::COLLECTION)
    ("dinaciclib" . SPARSER::DRUG)
    ("ABT-199 and ABT-737" . SPARSER::COLLECTION)
    ("cyclin E/Cdk2" . SPARSER::COLLECTION)
    ("Cyclin E/Cdk2" . SPARSER::COLLECTION) ("Cdk5" . SPARSER::PROTEIN)
    ("F-box and WD repeat domain containing 7" . SPARSER::PROTEIN)
    ("SCH727965" . SPARSER::DRUG) ("poly-ubiquitin" . SPARSER::PROTEIN)
    ("Myc-tagged" . SPARSER::PROTEIN) ("ERK-1" . SPARSER::PROTEIN)
    ("Mcl-1 protein" . SPARSER::PROTEIN) ("ABT-737-" . SPARSER::DRUG)
    ("ABT-199" . SPARSER::DRUG) ("E-cadherin and Zonula" . SPARSER::COLLECTION)
    ("Paul" . SPARSER::PROTEIN) ("PKCζ-NFκB-p65" . SPARSER::COLLECTION)
    ("several EMT-associated transcription regulators" . SPARSER::REGULATOR)
    ("Snail, Twist 1, ZEB1 and ZEB2" . SPARSER::COLLECTION)
    ("aggressive forms" . SPARSER::FORM)
    ("junctional proteins E-cadherin and ZO-1" . SPARSER::COLLECTION)
    ("cellular junctional proteins" . SPARSER::PROTEIN)
    ("PKCζ-NFκB" . SPARSER::COLLECTION)
    ("E-Cadherin and ZO1" . SPARSER::COLLECTION)
    ("E-Cadherin and ZO-1" . SPARSER::COLLECTION) ("Yin" . SPARSER::PROTEIN)
    ("ZO-1 and E-cadherin" . SPARSER::COLLECTION)
    ("ZO-2, ZO-3, and Afadin" . SPARSER::COLLECTION)
    ("Afadin" . SPARSER::PROTEIN)
    ("two junctional proteins" . SPARSER::PROTEIN)
    ("PKCζ, phospho-PKCζ, PAR3, and PAR6" . SPARSER::COLLECTION)
    ("PAR3 and PAR6" . SPARSER::COLLECTION)
    ("PKCζ and phospho-PKCζ" . SPARSER::COLLECTION)
    ("PKCζ–NFκB-p65" . SPARSER::COLLECTION)
    ("diacylglycerol and Ca 2+" . SPARSER::COLLECTION)
    ("diacylglycerol and phospholipids" . SPARSER::COLLECTION)
    ("conventional PKC (cPKCs; PKCα, PKCβI, PKCβII, and PKCγ) and novel PKC (nPKCs; PKCδ, PKCε, PKCη, and PKCθ) subfamilies"
     . SPARSER::COLLECTION)
    ("PKCα, PKCβI, PKCβII, and PKCγ" . SPARSER::COLLECTION)
    ("PKCδ, PKCε, PKCη, and PKCθ" . SPARSER::COLLECTION)
    ("Atypical PKCs, PKCζ and PKCλ/ι" . SPARSER::COLLECTION)
    ("PKCs, PKCζ and PKCλ/ι" . SPARSER::COLLECTION)
    ("PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("junctional proteins" . SPARSER::PROTEIN)
    ("PAR3, PAR6, and aPKC" . SPARSER::COLLECTION)
    ("PKCζ and PKCλ/ι" . SPARSER::COLLECTION) ("aPKC" . SPARSER::PROTEIN)
    ("these cellular junctional complexes" . SPARSER::BIO-COMPLEX)
    ("ER/PR" . SPARSER::COLLECTION)
    ("targetable surface receptors" . SPARSER::RECEPTOR)
    ("ERBB2/HER2" . SPARSER::COLLECTION)
    ("E-cadherin and ZO-1" . SPARSER::COLLECTION)
    ("NFκB-p65" . SPARSER::COLLECTION) ("PKCζ–" . SPARSER::PROTEIN)
    ("E-cadherin and tight junction" . SPARSER::COLLECTION)
    ("Zonula" . SPARSER::PROTEIN)
    ("normal cellular junctional complexes" . SPARSER::BIO-COMPLEX)
    ("Atypical Protein Kinase C zeta (PKCζ) forms Partitioning-defective (PAR) polarity complex"
     . SPARSER::BIO-COMPLEX)
    ("zeta" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Twist 1" . SPARSER::PROTEIN)
    ("E-Cadherin" . SPARSER::PROTEIN) ("no 2" . SPARSER::MOLECULE)
    ("ZO-3" . SPARSER::PROTEIN) ("ZO-2" . SPARSER::PROTEIN)
    ("ZO1" . SPARSER::PROTEIN) ("PKCε" . SPARSER::PROTEIN)
    ("PKCγ" . SPARSER::PROTEIN) ("PKCβ" . SPARSER::PROTEIN)
    ("PKCα" . SPARSER::PROTEIN) ("PAR6" . SPARSER::PROTEIN)
    ("PAR3" . SPARSER::PROTEIN) ("ZO-1" . SPARSER::PROTEIN)
    ("tight junction" . SPARSER::PROTEIN) ("PKCζ" . SPARSER::PROTEIN)
    ("Atypical Protein Kinase" . SPARSER::PROTEIN)
    ("PRA and PRB" . SPARSER::COLLECTION) ("PRA" . SPARSER::PROTEIN)
    ("ER α and PR" . SPARSER::COLLECTION) ("ER α and ER" . SPARSER::COLLECTION)
    ("hyperactive Rac3" . SPARSER::PROTEIN)
    ("Pak1 and Pak2" . SPARSER::COLLECTION)
    ("cell cycle-related gene cyclin D1 and steroid receptors, ER α and PR"
     . SPARSER::COLLECTION)
    ("receptors, ER α and PR" . SPARSER::COLLECTION)
    ("Pak1 and Pak4 mRNA ( xref ) and protein ( xref )" . SPARSER::COLLECTION)
    ("cyclin D1, ERα and PR" . SPARSER::COLLECTION)
    ("Significantly higher cytoplasmic and nuclear p-Pak2"
     . SPARSER::COLLECTION)
    ("p-PAK4" . SPARSER::COLLECTION)
    ("p16, VEGF and MT1-MMP" . SPARSER::COLLECTION)
    ("Pak4/c-Src/EGFR/cyclin D1/CDC25A" . SPARSER::COLLECTION)
    ("c-Src/MEK-1/MMP2" . SPARSER::COLLECTION)
    ("p38/VEGF" . SPARSER::COLLECTION) ("-Pak2" . SPARSER::COLLECTION)
    ("Pak1 and Pak4" . SPARSER::COLLECTION) ("Paks1-3" . SPARSER::COLLECTION)
    ("two major clinicopathological types" . TYPE)
    ("Pak1 and PR" . SPARSER::COLLECTION)
    ("significantly higher Pak1" . SPARSER::PROTEIN)
    ("p-Pak4" . SPARSER::COLLECTION) ("p-Pak2" . SPARSER::COLLECTION)
    ("Rac3" . SPARSER::PROTEIN) ("PAK4" . SPARSER::PROTEIN)
    ("MEK-1" . SPARSER::PROTEIN) ("Paks1" . SPARSER::PROTEIN)
    ("Type II" . SPARSER::HUMAN-PROTEIN-FAMILY) ("-aza" . SPARSER::DRUG)
    ("decitabine" . SPARSER::DRUG) ("JAK1 and JAK3" . SPARSER::COLLECTION)
    ("lymphoid and myeloid" . SPARSER::COLLECTION)
    ("JAK2-STAT" . SPARSER::COLLECTION) ("MPO" . SPARSER::PROTEIN)
    ("ProT" . SPARSER::PROTEIN) ("JAK2 and LMO2" . SPARSER::COLLECTION)
    ("intact JAK2" . SPARSER::PROTEIN)
    ("SOCS3 , SOCS1 and SHP-1" . SPARSER::COLLECTION)
    ("SHP1 and SOCS1" . SPARSER::COLLECTION) ("Epo" . SPARSER::PROTEIN)
    ("exogenous cytokines" . SPARSER::PROTEIN) ("mutant-" . SPARSER::MUTANT)
    ("JAK2-STAT5" . SPARSER::COLLECTION) ("JAK2-protein" . SPARSER::COLLECTION)
    ("STAT5-luciferase" . SPARSER::COLLECTION) ("JAK2-" . SPARSER::PROTEIN)
    ("childhood B-precursor acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("Ets" . SPARSER::HUMAN-PROTEIN-FAMILY) ("JH" . SPARSER::PROTEIN)
    ("JAK1 and JAK2" . SPARSER::COLLECTION)
    ("SHP1 , SOCS1 and SOCS3" . SPARSER::COLLECTION)
    ("LBLs" . SPARSER::PROTEIN) ("EpoR" . SPARSER::PROTEIN)
    ("LBL" . SPARSER::PROTEIN) ("LIM domain Only 2" . SPARSER::PROTEIN)
    ("PCM1" . SPARSER::PROTEIN) ("STAT5A" . SPARSER::PROTEIN)
    ("β2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SHP1" . SPARSER::PROTEIN)
    ("JAK3" . SPARSER::PROTEIN)
    ("orally available pharmacological inhibitor" . SPARSER::INHIBITOR)
    ("bevacizumab or vehicle control" . SPARSER::COLLECTION)
    ("Pai1" . SPARSER::PROTEIN) ("IVC" . SPARSER::PROTEIN)
    ("a prothrombotic state" . SPARSER::BIO-STATE)
    ("tissue-type plasminogen activator (tPA) and urinary-type plasminogen activator (uPA)"
     . SPARSER::COLLECTION)
    ("tPA" . SPARSER::PROTEIN)
    ("a recombinant humanized monoclonal neutralizing antibody"
     . SPARSER::ANTIBODY)
    ("cava" . SPARSER::PROTEIN)
    ("tissue-type plasminogen activator" . SPARSER::PROTEIN)
    ("Plasminogen activator inhibitor-1" . SPARSER::PROTEIN)
    ("PAI-039" . SPARSER::DRUG) ("Plasminogen activator" . SPARSER::PROTEIN)
    ("platinum and taxane" . SPARSER::COLLECTION)
    ("progesterone, estrogen or HER2" . SPARSER::COLLECTION)
    ("invasive ductal (ICD-0-3 code 8500/3) histologic type" . TYPE)
    ("− 1" . SPARSER::PROTEIN) ("group, and TP53" . SPARSER::COLLECTION)
    ("group, or TP53" . SPARSER::COLLECTION) ("SLH" . SPARSER::PROTEIN-FAMILY)
    ("CNAs" . SPARSER::PROTEIN) ("the most common histologic type" . TYPE)
    ("HGS" . SPARSER::PROTEIN) ("5 − 2" . SPARSER::PROTEIN)
    ("4 − 1" . SPARSER::PROTEIN) ("1 − 2" . SPARSER::PROTEIN)
    ("2 − 4" . SPARSER::PROTEIN) ("− 2" . SPARSER::PROTEIN)
    ("1 − 1" . SPARSER::PROTEIN)
    ("regulators or scaffolds" . SPARSER::COLLECTION)
    ("JAK/Stat3" . SPARSER::COLLECTION) ("Erk and Stat3" . SPARSER::COLLECTION)
    ("Src and its regulators" . SPARSER::COLLECTION)
    ("paxillin and p130Cas" . SPARSER::COLLECTION)
    ("erbB2, and SgK269" . SPARSER::COLLECTION) ("erbB2" . SPARSER::PROTEIN)
    ("gp130 and Stat3" . SPARSER::COLLECTION)
    ("Stat3 and JAK1" . SPARSER::COLLECTION)
    ("gp130 and JAK" . SPARSER::COLLECTION) ("STATTIC" . SPARSER::DRUG)
    ("G-CSF and IL-1α" . SPARSER::COLLECTION)
    ("JAK/Stat" . SPARSER::COLLECTION) ("JAK1 and Stat3" . SPARSER::COLLECTION)
    ("appropriate phosphospecific antibodies" . SPARSER::ANTIBODY)
    ("JAK2 and TYK2" . SPARSER::COLLECTION)
    ("Stat3 and Grb2" . SPARSER::COLLECTION) ("saracatinib" . SPARSER::DRUG)
    ("Src family kinases, the EGFR, and the JAKs" . SPARSER::COLLECTION)
    ("Erk and Akt" . SPARSER::COLLECTION)
    ("p130Cas (on Y249) and paxillin (on Y31)" . SPARSER::COLLECTION)
    ("p130Cas and paxillin" . SPARSER::COLLECTION)
    ("The latter included TGFB1 and MMP2" . SPARSER::COLLECTION)
    ("TGFB1 and MMP2" . SPARSER::COLLECTION)
    ("the ectopically-expressed SgK223" . SPARSER::PROTEIN)
    ("Grb2 and Shc1" . SPARSER::COLLECTION) ("Shc1" . SPARSER::PROTEIN)
    ("Csk" . SPARSER::PROTEIN) ("SgK223 and SgK269" . SPARSER::COLLECTION)
    ("-ATP" . SPARSER::ATP) ("closely-related proteins" . SPARSER::PROTEIN)
    ("the transcriptional regulator and downstream target"
     . SPARSER::COLLECTION)
    ("the EGFR [ xref ] and the related receptor ERBB3 [ xref ]"
     . SPARSER::COLLECTION)
    ("ADM" . SPARSER::PROTEIN) ("KRas" . SPARSER::PROTEIN)
    ("JAK1/Stat3" . SPARSER::COLLECTION) ("Erk or Akt" . SPARSER::COLLECTION)
    ("kinases and Stat3" . SPARSER::COLLECTION)
    ("SgK223 and Stat3" . SPARSER::COLLECTION)
    ("PDAC and PDAC" . SPARSER::COLLECTION)
    ("SgK269/PEAK1" . SPARSER::COLLECTION)
    ("targets and biomarkers" . SPARSER::COLLECTION)
    ("Growth Factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AZD0530" . SPARSER::DRUG) ("TC-PTP" . SPARSER::PROTEIN)
    ("G-CSF" . SPARSER::PROTEIN) ("AG490" . SPARSER::DRUG)
    ("TGFB1" . SPARSER::PROTEIN) ("kinase-like" . SPARSER::PROTEIN-FAMILY)
    ("PEAK1" . SPARSER::PROTEIN) ("SgK269" . SPARSER::PROTEIN)
    ("SgK223" . SPARSER::PROTEIN) ("EGFR and MMP-1" . SPARSER::COLLECTION)
    ("here link MMP-1" . SPARSER::PROTEIN)
    ("EREG and AREG" . SPARSER::COLLECTION)
    ("EREG-MMP-1" . SPARSER::COLLECTION)
    ("the chemotherapeutic agent doxorubicin" . SPARSER::PROTEIN)
    ("a reasonable candidate gene" . SPARSER::GENE)
    ("phospho-histone" . SPARSER::PROTEIN)
    ("shRNA or EREG" . SPARSER::COLLECTION)
    ("either non-targeting shRNA or an EREG shRNA" . SPARSER::COLLECTION)
    ("an HRAS-transformed derivative" . SPARSER::DERIVATIVE)
    ("soluble EREG" . SPARSER::PROTEIN)
    ("AREG and HB-EGF" . SPARSER::COLLECTION)
    ("EGF and TGFα" . SPARSER::COLLECTION)
    ("EREG , AREG , EGF , HB-EGF and TGFα" . SPARSER::COLLECTION)
    ("AREG and EREG" . SPARSER::COLLECTION)
    ("heparin-bound EGF (HB-EGF) and transforming growth factor alpha (TGFα)"
     . SPARSER::COLLECTION)
    ("EGF, epiregulin (EREG), amphiregulin (AREG), heparin-bound EGF (HB-EGF) and transforming growth factor alpha (TGFα)"
     . SPARSER::COLLECTION)
    ("EREG and MMP-1" . SPARSER::COLLECTION)
    ("exogenous EREG" . SPARSER::PROTEIN)
    ("epiregulin (EREG)" . SPARSER::PROTEIN) ("FOXN1" . SPARSER::PROTEIN)
    ("FRS2α" . SPARSER::PROTEIN) ("FGF-13" . SPARSER::PROTEIN)
    ("FGF-2" . SPARSER::PROTEIN)
    ("interstitial collagenase" . SPARSER::PROTEIN) ("TGFα" . SPARSER::PROTEIN)
    ("transforming growth factor alpha" . SPARSER::PROTEIN)
    ("an applicable prognostic biomarker" . SPARSER::MOLECULE)
    ("NOP14 and NRIP1" . SPARSER::COLLECTION)
    ("APC and β-catenin" . SPARSER::COLLECTION)
    ("an applicable early warning biomarker" . SPARSER::MOLECULE)
    ("both ER ( P = 0.026) and progesterone receptor (PR; P = 0.01)"
     . SPARSER::COLLECTION)
    ("NRIP1, β-catenin and GSK-3β" . SPARSER::COLLECTION)
    ("APC and NOP14" . SPARSER::COLLECTION)
    ("NRIP1 and NOP14" . SPARSER::COLLECTION) ("Ctl" . SPARSER::PROTEIN)
    ("exogenous human NOP14 gene" . SPARSER::GENE)
    ("the polycomb repressive complex" . SPARSER::BIO-COMPLEX)
    ("a stress-responsive gene" . SPARSER::GENE) ("PAXIP1" . SPARSER::PROTEIN)
    ("NOP14" . SPARSER::PROTEIN)
    ("an inhibitor of CDKs and plays important role in regulating cell cycle and growth arrest"
     . SPARSER::COLLECTION)
    ("GGR" . SPARSER::PROTEIN)
    ("the major chemotherapeutic drugs" . SPARSER::DRUG)
    ("Platinum" . SPARSER::MOLECULE) ("p27 Kip1 and XPC" . SPARSER::COLLECTION)
    ("a regulator and potential DDP-based chemotherapy response marker"
     . SPARSER::COLLECTION)
    ("DDP and anthrocycline" . SPARSER::COLLECTION)
    ("ribonucleotide reductase M2 and some DNA repair molecules [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("Western Blot" . SPARSER::PROTEIN)
    ("XPC and p27 Kip1" . SPARSER::COLLECTION)
    ("xeroderma pigmentosum complementation group C (XPC) and p27 Kip1"
     . SPARSER::COLLECTION)
    ("group C (XPC)" . SPARSER::PROTEIN) ("XPC" . SPARSER::PROTEIN)
    ("ribosomal subunit" . SPARSER::FRAGMENT)
    ("cyclin dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p27 kip1" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 3" . SPARSER::PROTEIN)
    ("NAs" . SPARSER::PROTEIN) ("si-" . SPARSER::PROTEIN)
    ("PIK3CA and pAKT" . SPARSER::COLLECTION)
    ("miR203 and PIK3CA" . SPARSER::COLLECTION)
    ("gastric cancer genesis" . SPARSER::PROTEIN)
    ("-AKT" . SPARSER::COLLECTION) ("miR203-" . SPARSER::PROTEIN)
    ("MiR203" . SPARSER::PROTEIN) ("miR203" . SPARSER::PROTEIN)
    ("genes, and genes" . SPARSER::COLLECTION)
    ("JUN and IRF5" . SPARSER::COLLECTION)
    ("MYC or BCLXL" . SPARSER::COLLECTION) ("cis-" . SPARSER::PROTEIN)
    ("AP-1/ATF" . SPARSER::COLLECTION) ("STAT and MAPK" . SPARSER::COLLECTION)
    ("tie" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FOX, E-box, C/EBP, RUNX1, and AP-1" . SPARSER::COLLECTION)
    ("ETS and AP-1" . SPARSER::COLLECTION)
    ("the 134 or 77 FLT3-ITD-specific upregulated or downregulated genes"
     . SPARSER::GENE)
    ("chromatin remodeling and the activation of specific genes"
     . SPARSER::COLLECTION)
    ("siRNA or MAPK" . SPARSER::COLLECTION)
    ("FOS and RUNX1" . SPARSER::COLLECTION)
    ("several previously defined ITD-specific genes" . SPARSER::GENE)
    ("MEK, JNK, and p38 MAPK" . SPARSER::COLLECTION)
    ("ERK1/2 and RSK2" . SPARSER::COLLECTION) ("ITD+" . SPARSER::PROTEIN)
    ("FLT-ITD+" . SPARSER::PROTEIN-PAIR)
    ("NRAS or SOCS1" . SPARSER::COLLECTION)
    ("FOXC1 , DSC2 , AK2 , and ID1" . SPARSER::COLLECTION)
    ("SCARA3 , CTSG , MDGA1 , MED16 , GZMB , VSTM4/ c10orf128 , and CCNA1"
     . SPARSER::COLLECTION)
    ("FOX" . SPARSER::PROTEIN) ("RUNX1 and FOXC1" . SPARSER::COLLECTION)
    ("RUNX1, AP-1, FOX/E-box, and C/EBP" . SPARSER::COLLECTION)
    ("ETS, RUNX, C/EBP, and AP-1" . SPARSER::COLLECTION)
    ("HOXB, AK2 , VSTM4/c10orf128 , and ID1" . SPARSER::COLLECTION)
    ("IRFs" . SPARSER::PROTEIN) ("NF-κB and ATF" . SPARSER::COLLECTION)
    ("ATF" . SPARSER::PROTEIN) ("TAL1/SCL" . SPARSER::COLLECTION)
    ("HOMER" . SPARSER::PROTEIN-FAMILY)
    ("RUNX1 and AP-1" . SPARSER::COLLECTION)
    ("RUNX1 and MAPK" . SPARSER::COLLECTION)
    ("WT1 and/or WT6" . SPARSER::COLLECTION)
    ("activating FLT3-ITD-specific genes" . SPARSER::GENE)
    ("the +5 kb element indeed binds STAT5" . SPARSER::PROTEIN)
    ("a previously defined ITD target gene" . SPARSER::GENE)
    ("FOXC1 , DSC2 , and AK2" . SPARSER::COLLECTION)
    ("CTSG/GZMB" . SPARSER::COLLECTION) ("GZMB" . SPARSER::PROTEIN)
    ("ITD-Specific Genes and an Activation Signature" . SPARSER::COLLECTION)
    ("the distal DNase-seq" . SPARSER::COLLECTION)
    ("LPPR3 , AZU1 , PRTN3 , ELANE , and CFD" . SPARSER::COLLECTION)
    ("CFD" . SPARSER::PROTEIN) ("GATA2 and CEBPA" . SPARSER::COLLECTION)
    ("CEBPA" . SPARSER::PROTEIN) ("seq" . SPARSER::PROTEIN)
    ("RUNX1 , IGFBP2 , PRDM16 , PTP4A3 , and CCNA1" . SPARSER::COLLECTION)
    ("134 upregulated genes and 77 downregulated genes" . SPARSER::COLLECTION)
    ("much larger cohorts" . SPARSER::MOLECULE)
    ("the only FOX gene" . SPARSER::GENE)
    ("EVI1 and PRDM16" . SPARSER::COLLECTION)
    ("IL2RA , IL3RA , TNFSF9 , TNFRSF4 , and TNFRSF18" . SPARSER::COLLECTION)
    ("CCL1 and CCL5" . SPARSER::COLLECTION)
    ("ELANE , PRTN3 , and AZU1" . SPARSER::COLLECTION)
    ("ELANE" . SPARSER::PROTEIN) ("CTSG" . SPARSER::PROTEIN)
    ("MEL1" . SPARSER::PROTEIN) ("ITD1, ITD2, and ITD3" . SPARSER::COLLECTION)
    ("frequently partner FLT3-ITD" . SPARSER::COLLECTION)
    ("DNMT3A and TET2" . SPARSER::COLLECTION)
    ("RUNX1, GATA2, and C/EBPα" . SPARSER::COLLECTION)
    ("NRAS , PTN11 , SOCS1 , and JAK2" . SPARSER::COLLECTION)
    ("PTN" . SPARSER::PROTEIN) ("ITD3, ITD5, and ITD7" . SPARSER::COLLECTION)
    ("global DNase" . SPARSER::PROTEIN) ("DNase-seq" . SPARSER::COLLECTION)
    ("a mononuclear fraction" . SPARSER::COMPONENT)
    ("CD34 or CD117" . SPARSER::COLLECTION) ("ITDs" . SPARSER::PROTEIN)
    ("FLT3 and KIT" . SPARSER::COLLECTION) ("KN" . SPARSER::PROTEIN)
    ("RUNX1/ETO" . SPARSER::COLLECTION) ("ETO" . SPARSER::PROTEIN)
    ("the leukemic state" . SPARSER::BIO-STATE)
    ("AP-1 and RUNX1" . SPARSER::COLLECTION) ("ITD" . SPARSER::PROTEIN)
    ("FLT3-ITD" . SPARSER::COLLECTION) ("IRF5" . SPARSER::PROTEIN)
    ("ID1  " . SPARSER::PROTEIN) ("NF1X" . SPARSER::PROTEIN)
    ("Factor 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MDGA1" . SPARSER::PROTEIN)
    ("c10orf128" . SPARSER::PROTEIN) ("LYL1" . SPARSER::PROTEIN)
    ("top 1" . SPARSER::PROTEIN) ("ID1" . SPARSER::PROTEIN)
    ("WDR86" . SPARSER::PROTEIN) ("A–S2" . SPARSER::PROTEIN)
    ("MED16" . SPARSER::PROTEIN) ("EVI1" . SPARSER::PROTEIN)
    ("SCARA3" . SPARSER::PROTEIN) ("DSC2" . SPARSER::PROTEIN)
    ("AK2" . SPARSER::PROTEIN) ("LPPR3" . SPARSER::PROTEIN)
    ("PRTN3" . SPARSER::PROTEIN) ("MMP15" . SPARSER::PROTEIN)
    ("ADAMTS14" . SPARSER::PROTEIN) ("CCL1" . SPARSER::PROTEIN)
    ("PBX3" . SPARSER::PROTEIN) ("HOXB6" . SPARSER::PROTEIN)
    ("HOXB2" . SPARSER::PROTEIN) ("PRL3" . SPARSER::PROTEIN)
    ("PTP4A3" . SPARSER::PROTEIN) ("TNFRSF18" . SPARSER::PROTEIN)
    ("TNFRSF4" . SPARSER::PROTEIN) ("TNFSF9" . SPARSER::PROTEIN)
    ("IL3RA" . SPARSER::PROTEIN) ("IL2RA" . SPARSER::PROTEIN)
    ("PRDM16" . SPARSER::PROTEIN) ("C–1" . SPARSER::PROTEIN)
    ("WT2" . SPARSER::PROTEIN) ("C/EBPα" . SPARSER::PROTEIN)
    ("GATA2" . SPARSER::PROTEIN)
    ("Tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("all previously reported PTKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Lck-associated leukemia" . SPARSER::PROTEIN)
    ("a unique protein" . SPARSER::PROTEIN)
    ("mitochondrial heat shock protein 70" . SPARSER::PROTEIN)
    ("the authentic Lck-interacting proteins" . SPARSER::PROTEIN)
    ("distinct PTK and the downstream effector proteins" . SPARSER::COLLECTION)
    ("distinct PTK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("several previously reported PTK-targeted mitochondrial proteins"
     . SPARSER::PROTEIN)
    ("COII, pyruvate dehydrogenase kinase 1, and NADH dehydrogenase"
     . SPARSER::COLLECTION)
    ("flavoprotein" . SPARSER::PROTEIN-FAMILY)
    ("Jurkat and CRIF1" . SPARSER::COLLECTION)
    ("phosphorylating various substrates" . SPARSER::SUBSTRATE)
    ("human leukemic T-cell" . SPARSER::PROTEIN)
    ("mitochondrial PTKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CRIF1-Tid1" . SPARSER::COLLECTION)
    ("lack mitochondrial Lck" . SPARSER::PROTEIN)
    ("Complex I and Complex" . SPARSER::COLLECTION)
    ("ND1 and COI" . SPARSER::COLLECTION) ("COI" . SPARSER::PROTEIN)
    ("CRIF1 and Lck" . SPARSER::COLLECTION) ("Lck-CRIF1" . SPARSER::COLLECTION)
    ("Lck and CRIF1" . SPARSER::COLLECTION)
    ("the associated CRIF1" . SPARSER::PROTEIN)
    ("Lck-associated proteins" . SPARSER::PROTEIN)
    ("mitochondrial ErbB2" . SPARSER::PROTEIN)
    ("Jurkat and Jcam" . SPARSER::COLLECTION)
    ("Lck and mito-tracker co-localize" . SPARSER::COLLECTION)
    ("mito" . SPARSER::DRUG) ("GAPDH and lamin B1" . SPARSER::COLLECTION)
    ("human large granular lymphocytic leukemia" . SPARSER::PROTEIN)
    ("Mitochondrial Lck" . SPARSER::PROTEIN)
    ("mitochondrial CRIF1" . SPARSER::PROTEIN)
    ("the key PTK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a plasma membrane-associated protein" . SPARSER::PROTEIN)
    ("PTK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Fyn, Lyn and Fgr" . SPARSER::COLLECTION) ("Fgr" . SPARSER::PROTEIN)
    ("mitochondrial c-Src" . SPARSER::PROTEIN)
    ("Mitochondrial c-Src" . SPARSER::PROTEIN)
    ("FGFR1 and ErbB2" . SPARSER::COLLECTION) ("II (COII)" . SPARSER::PROTEIN)
    ("COII" . SPARSER::PROTEIN) ("PTKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitochondrial genomes" . SPARSER::PROTEIN)
    ("CR6-interacting factor 1 (CRIF1) and tumorous imaginal disc"
     . SPARSER::COLLECTION)
    ("tumorous imaginal disc" . SPARSER::BIO-COMPLEX)
    ("the mitochondrial genome" . SPARSER::PROTEIN)
    ("the mitochondrial circular DNA" . SPARSER::DNA)
    ("ETC" . SPARSER::PROTEIN) ("CRIF1 and Tid1" . SPARSER::COLLECTION)
    ("mitochondrial Lck" . SPARSER::PROTEIN)
    ("mitochondrial superoxide" . SPARSER::MOLECULE)
    ("the human leukemic T-cell line Jurkat" . SPARSER::PROTEIN)
    ("a key T-cell kinase" . SPARSER::PROTEIN)
    ("NADH dehydrogenase" . SPARSER::PROTEIN)
    ("pyruvate dehydrogenase kinase 1" . SPARSER::PROTEIN)
    ("ANT1" . SPARSER::PROTEIN)
    ("Adenine nucleotide translocator 1" . SPARSER::PROTEIN)
    ("Complex I" . SPARSER::PROTEIN) ("K4" . SPARSER::PROTEIN)
    ("glyceraldehyde 3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("cytochrome c oxidase subunit IV" . SPARSER::PROTEIN)
    ("subunit I" . SPARSER::PROTEIN)
    ("NADH dehydrogenase subunit 1" . SPARSER::PROTEIN)
    ("ND1" . SPARSER::PROTEIN) ("VDAC1" . SPARSER::PROTEIN)
    ("Tid1" . SPARSER::PROTEIN) ("CRIF1" . SPARSER::PROTEIN)
    ("CR6-interacting factor 1" . SPARSER::PROTEIN)
    ("EGFR or ERK" . SPARSER::COLLECTION)
    ("AKT, mTOR or ERK" . SPARSER::COLLECTION)
    ("EGFR or mTOR" . SPARSER::COLLECTION)
    ("precision/individualized/personalized medicine" . SPARSER::DRUG)
    ("EGFR, p53 and pRB" . SPARSER::COLLECTION)
    ("ErbB-2, or enzymes" . SPARSER::COLLECTION)
    ("phospho-AKT and phospho-mTOR" . SPARSER::COLLECTION)
    ("EGFR/AKT/mTOR" . SPARSER::COLLECTION) ("IHC PIK3CA" . SPARSER::PROTEIN)
    ("PIK3CA and KRAS" . SPARSER::COLLECTION) ("MDC" . SPARSER::PROTEIN)
    ("PI3K-PTEN-AKT" . SPARSER::COLLECTION)
    ("anti-MAPK/ERK" . SPARSER::COLLECTION)
    ("MEK1/2 and thence ERK1/2" . SPARSER::COLLECTION)
    ("PIK3CA or pAKT" . SPARSER::COLLECTION) ("p-MAPK" . SPARSER::COLLECTION)
    ("p " . SPARSER::PROTEIN) ("PNA-Clamp" . SPARSER::COLLECTION)
    ("Clamp" . SPARSER::PROTEIN-FAMILY)
    ("dual PI3K/mTOR inhibitors" . SPARSER::INHIBITOR)
    ("p110α, AKT, or mTOR" . SPARSER::COLLECTION)
    ("PI3K/mTOR" . SPARSER::COLLECTION) ("PI3K-AKT" . SPARSER::COLLECTION)
    ("receptor tyrosine kinase or RAS" . SPARSER::COLLECTION)
    ("EGFR or KRAS" . SPARSER::COLLECTION)
    ("KRAS or BRAF" . SPARSER::COLLECTION)
    ("jun and fos" . SPARSER::COLLECTION)
    ("cyclins, cytokines and growth factors" . SPARSER::COLLECTION)
    ("fos" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("jun" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR and GAP" . SPARSER::COLLECTION)
    ("EGFR or GAP" . SPARSER::COLLECTION)
    ("B-RAF and MEK 1/2" . SPARSER::COLLECTION) ("GTP-" . SPARSER::NUCLEOTIDE)
    ("anti-EGFR monoclonal antibodies" . SPARSER::ANTIBODY)
    ("KRAS, BRAF, MEK and ERK1/2" . SPARSER::COLLECTION)
    ("mitogen-activated protein kinase/extracellular signal-regulated kinase"
     . SPARSER::COLLECTION)
    ("receptor tyrosine kinase (RTK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MDCs" . SPARSER::PROTEIN) ("LDCs" . SPARSER::PROTEIN)
    ("EGFR and phospho-AKT" . SPARSER::COLLECTION)
    ("phospho-mTOR and phospho-44/42 MAPK (ERK1/2)" . SPARSER::COLLECTION)
    ("EGFR, PIK3CA, PTEN, phospho-AKT, phospho-mTOR and phospho-44/42 MAPK (ERK1/2)"
     . SPARSER::COLLECTION)
    ("PNA-clamp" . SPARSER::COLLECTION) ("PNA" . SPARSER::PROTEIN)
    ("actionable pharmacological targets" . SPARSER::TARGET-PROTEIN)
    ("ErbB-2" . SPARSER::PROTEIN) ("P-ERK1/2" . SPARSER::PROTEIN)
    ("AS 3" . SPARSER::PROTEIN) ("AS 2" . SPARSER::PROTEIN)
    ("a 15 " . SPARSER::PROTEIN) ("tween 20" . SPARSER::MOLECULE)
    ("β-globin" . SPARSER::PROTEIN)
    ("PI3-Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY) ("S6 K" . SPARSER::PROTEIN)
    ("PDK1" . SPARSER::PROTEIN) ("protein phosphatase" . SPARSER::PROTEIN)
    ("phosphatidylinositol-4, 5-bisphosphate 3-kinase"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERK 1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MEK 1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("B-RAF" . SPARSER::PROTEIN)
    ("Anti-EGFR" . SPARSER::PROTEIN)
    ("accessible molecular targets" . SPARSER::TARGET-PROTEIN)
    ("SERPINB3 , and SERPINB4" . SPARSER::COLLECTION)
    ("the most aggressive subtypes" . SPARSER::PROTEIN)
    ("STAT6 and TP63" . SPARSER::COLLECTION)
    ("IL-13-STAT6-TP63" . SPARSER::COLLECTION)
    ("TP63 , CFI , GPX2 , SERPINB13 , MLLT3 , and CXCL17"
     . SPARSER::COLLECTION)
    ("CFI" . SPARSER::PROTEIN) ("critically important genes" . SPARSER::GENE)
    ("IL13Rα2 or its ligand IL-13" . SPARSER::COLLECTION)
    ("MIV" . SPARSER::PROTEIN)
    ("either scrambled shRNA (MIV-Luc-shSCR) or shRNA" . SPARSER::COLLECTION)
    ("MIV-Luc" . SPARSER::COLLECTION) ("S5b" . SPARSER::PROTEIN)
    ("the predominant STAT protein" . SPARSER::PROTEIN)
    ("/PR" . SPARSER::COLLECTION) ("progesterone receptor-" . SPARSER::PROTEIN)
    ("estrogen receptor-" . SPARSER::PROTEIN)
    ("pleiotropically acting cytokines" . SPARSER::PROTEIN)
    ("Interleukins" . SPARSER::PROTEIN)
    ("TP63 and STAT6" . SPARSER::COLLECTION)
    ("STAT6-TP63" . SPARSER::COLLECTION) ("SERPINB4" . SPARSER::PROTEIN)
    ("SERPINB3" . SPARSER::PROTEIN) ("MLLT3" . SPARSER::PROTEIN)
    ("SERPINB13" . SPARSER::PROTEIN) ("GPX2" . SPARSER::PROTEIN)
    ("pCL1" . SPARSER::PROTEIN) ("keratin 8" . SPARSER::PROTEIN)
    ("keratin 17" . SPARSER::PROTEIN) ("keratin 5" . SPARSER::PROTEIN)
    ("cl2" . SPARSER::PROTEIN) ("IL13Rα2" . SPARSER::PROTEIN)
    ("JAK-STAT" . SPARSER::PROTEIN) ("IL4Rα" . SPARSER::PROTEIN)
    ("IL13Rα1" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 6" . SPARSER::PROTEIN)
    ("IL13Ralpha2" . SPARSER::PROTEIN) ("interleukin-13" . SPARSER::PROTEIN)
    ("ATR and FA" . SPARSER::COLLECTION) ("ATR and ATM" . SPARSER::COLLECTION)
    ("fix" . SPARSER::PROTEIN) ("FA, NER, HR, or MGMT" . SPARSER::COLLECTION)
    ("HR and FA" . SPARSER::COLLECTION) ("mustards" . SPARSER::DRUG)
    ("ATR/Chk1" . SPARSER::COLLECTION)
    ("ATM, Chk2, or Rad51" . SPARSER::COLLECTION)
    ("MMC or BO-1055" . SPARSER::COLLECTION)
    ("water-soluble acid salts" . SPARSER::DRUG) ("salts" . SPARSER::DRUG)
    ("KU55933 or NU6027" . SPARSER::COLLECTION)
    ("the ATM inhibitor KU55933 [ xref ] or the ATR inhibitor NU6027 [ xref ]"
     . SPARSER::COLLECTION)
    ("Chk2 and Chk1" . SPARSER::COLLECTION)
    ("Chk1 and Chk2" . SPARSER::COLLECTION)
    ("DDRs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("-BG" . SPARSER::COLLECTION)
    ("an O-alkyl-related DNA methyltransferase" . SPARSER::PROTEIN)
    ("ABH2 and MPG" . SPARSER::COLLECTION)
    ("MPG, ABH2, and XRCC1" . SPARSER::COLLECTION)
    ("-adenine and N 3" . SPARSER::COLLECTION)
    ("-cytosine" . SPARSER::NUCLEOBASE) ("-adenine" . SPARSER::NUCLEOBASE)
    ("EM9" . SPARSER::PROTEIN) ("-guanine" . SPARSER::COLLECTION)
    ("MMC and BO-1055" . SPARSER::COLLECTION)
    ("group B (XPB)" . SPARSER::PROTEIN) ("AA8" . SPARSER::PROTEIN)
    ("an indispensable core protein" . SPARSER::PROTEIN)
    ("The structure-specific endonuclease xeroderma pigmentosum complementation group G (XPG)"
     . SPARSER::PROTEIN)
    ("complementation group G (XPG)" . SPARSER::PROTEIN)
    ("XPG" . SPARSER::PROTEIN) ("PKcs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DNP" . SPARSER::DRUG) ("Rad51, ATM, or Chk2" . SPARSER::COLLECTION)
    ("ATM (Figure xref ) and Chk2 (Figure xref )" . SPARSER::COLLECTION)
    ("the key DSB-corresponding checkpoint proteins, ATM (Figure xref ) and Chk2 (Figure xref )"
     . SPARSER::COLLECTION)
    ("the repair protein Rad51 recombinase (Figure xref ) and the DNA protein kinase catalytic subunit (DNA-PKcs)"
     . SPARSER::COLLECTION)
    ("a FA-associated E3 ubiquitin ligase" . SPARSER::PROTEIN)
    ("FANCL" . SPARSER::PROTEIN) ("MPG" . SPARSER::PROTEIN)
    ("HR and NER" . SPARSER::COLLECTION)
    ("HR and Fanconi" . SPARSER::COLLECTION)
    ("NER and HR" . SPARSER::COLLECTION) ("alkB" . SPARSER::PROTEIN)
    ("ataxia telangiectasia mutated (ATM) and the ATM- and Rad3-related (ATR) kinases"
     . SPARSER::COLLECTION)
    ("the ATM- and Rad3-related (ATR) kinases" . SPARSER::COLLECTION)
    ("ATM-" . SPARSER::PROTEIN) ("ICL" . SPARSER::PROTEIN)
    ("BCNU" . SPARSER::DRUG) ("bis" . SPARSER::PROTEIN)
    ("carmustine" . SPARSER::DRUG) ("chlorambucil" . SPARSER::DRUG)
    ("cyclophosphamide" . SPARSER::DRUG)
    ("NER, HR, and MGMT" . SPARSER::COLLECTION)
    ("mitomycin C and melphalan" . SPARSER::COLLECTION)
    ("melphalan" . SPARSER::DRUG) ("O 6 -benzylguanine" . SPARSER::DRUG)
    ("NU6027" . SPARSER::DRUG) ("KU55933" . SPARSER::DRUG)
    ("alkylating agent" . SPARSER::MOLECULE) ("N 3" . SPARSER::PROTEIN)
    ("XRCC1" . SPARSER::PROTEIN)
    ("X-ray repair cross-complementing protein 1" . SPARSER::PROTEIN)
    ("group B" . SPARSER::PROTEIN)
    ("complementation group G" . SPARSER::PROTEIN)
    ("NU7441" . SPARSER::MOLECULE) ("DNA-PKcs" . SPARSER::PROTEIN)
    ("ABH2" . SPARSER::PROTEIN) ("AlkB homolog 2" . SPARSER::PROTEIN)
    ("DNA repair protein" . SPARSER::PROTEIN)
    ("N-methylpurine-DNA glycosylase" . SPARSER::PROTEIN)
    ("G 2 /M" . SPARSER::PROTEIN)
    ("O 6 -methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("checkpoint kinase 2" . SPARSER::PROTEIN)
    ("ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("Menin" . SPARSER::PROTEIN) ("p300 and CHD3" . SPARSER::COLLECTION)
    ("SIN3A/SAP30/RBBP5" . SPARSER::COLLECTION)
    ("two other known c-Myb co-factors p300 [ xref ] and CHD3 [ xref ]"
     . SPARSER::COLLECTION)
    ("SIN3A, SAP30 and RBBP5" . SPARSER::COLLECTION)
    ("RBBP5, ETS1 and SIN3A" . SPARSER::COLLECTION)
    ("the previously identified Myb" . SPARSER::PROTEIN)
    ("substantially more c-Myb" . SPARSER::PROTEIN)
    ("glucocorticoid receptor (GR)" . SPARSER::PROTEIN)
    ("clear DNase I" . SPARSER::PROTEIN) ("PyAACG/TG" . SPARSER::COLLECTION)
    ("A-Myb, B-Myb or c-Myb" . SPARSER::COLLECTION)
    ("B-Myb ( MYBL2 ) and c-Myb ( MYB )" . SPARSER::COLLECTION)
    ("six different cell-types using digital DNase I" . SPARSER::PROTEIN)
    ("GRSF1 , RUVBL2 , UBE2N and SMNDC1" . SPARSER::COLLECTION)
    ("an even larger fraction" . SPARSER::COMPONENT)
    ("the mixed-lineage leukaemia (MLL) complex RBBP5 [ xref ] and the two TFs ETS1 [ xref ] and SIN3A [ xref ]"
     . SPARSER::COLLECTION)
    ("the two TFs ETS1 [ xref ] and SIN3A [ xref ]" . SPARSER::COLLECTION)
    ("103 chromatin-associated proteins" . SPARSER::PROTEIN)
    ("repressive H3K27me3" . SPARSER::PROTEIN)
    ("only 31 (0.02%) c-Myb" . SPARSER::PROTEIN)
    ("transcriptional activator and repressor" . SPARSER::COLLECTION)
    ("KCNH2 , LMO2 , MYADM , GRSF1 and RUNX1" . SPARSER::COLLECTION)
    ("KCNH2 , MYADM , GRSF1 , SENP1 , RABEPK , DCAF7 and C10orf55"
     . SPARSER::COLLECTION)
    ("the minimal SV40-promoter" . SPARSER::PROMOTER)
    ("KCNH2 , LMO2 , MYADM , GRSF1 , IKZF1 , SENP1 , DUS3L , RABEPK and DCAF7"
     . SPARSER::COLLECTION)
    ("RABEPK" . SPARSER::PROTEIN) ("c-Myb-2KR" . SPARSER::COLLECTION)
    ("CV-1" . SPARSER::PROTEIN) ("introns" . SPARSER::PROTEIN)
    ("SH3BGRL3 and SLC30A10" . SPARSER::COLLECTION) ("CPEB" . SPARSER::PROTEIN)
    ("LEPR" . SPARSER::PROTEIN) ("GLUL" . SPARSER::PROTEIN)
    ("KCNH2 , LMO2 , MYB , MYADM , STNM3 , EPCAM and GRSF1"
     . SPARSER::COLLECTION)
    ("MYADM" . SPARSER::PROTEIN)
    ("6061 and 12338 evolutionary conserved c-Myb" . SPARSER::PROTEIN)
    ("MEL" . SPARSER::PROTEIN) ("ER-MYB" . SPARSER::COLLECTION)
    ("Myb" . SPARSER::PROTEIN)
    ("a key regulatory transcription factor (TF)" . SPARSER::PROTEIN)
    ("c-Myb and one protein" . SPARSER::COLLECTION) ("2KR" . SPARSER::PROTEIN)
    ("MLL3" . SPARSER::PROTEIN) ("MLL1" . SPARSER::PROTEIN)
    ("CHD3" . SPARSER::PROTEIN) ("ALL-1" . SPARSER::PROTEIN)
    ("MYBL2" . SPARSER::PROTEIN) ("B-Myb" . SPARSER::PROTEIN)
    ("MYBL1" . SPARSER::PROTEIN) ("A-Myb" . SPARSER::PROTEIN)
    ("SMNDC1" . SPARSER::PROTEIN) ("UBE2N" . SPARSER::PROTEIN)
    ("RUVBL2" . SPARSER::PROTEIN) ("c- Myb" . SPARSER::PROTEIN)
    ("RBBP5" . SPARSER::PROTEIN) ("PA2G4" . SPARSER::PROTEIN)
    ("BHLHE40" . SPARSER::PROTEIN) ("CBFA2" . SPARSER::PROTEIN)
    ("ecdysone receptor" . SPARSER::PROTEIN) ("DCAF7" . SPARSER::PROTEIN)
    ("SENP1" . SPARSER::PROTEIN) ("SLC30A10" . SPARSER::PROTEIN)
    ("SH3BGRL3" . SPARSER::PROTEIN) ("MRAP2" . SPARSER::PROTEIN)
    ("GDF15" . SPARSER::PROTEIN) ("GRSF1" . SPARSER::PROTEIN)
    ("LMO2" . SPARSER::PROTEIN) ("KCNH2" . SPARSER::PROTEIN)
    ("CD20" . SPARSER::PROTEIN) ("c-Myb" . SPARSER::PROTEIN)
    ("MCAK and PLK1" . SPARSER::COLLECTION)
    ("outer-centromeres" . SPARSER::PROTEIN)
    ("pSer715 antibody ( xref ) and MCAK S715A" . SPARSER::COLLECTION)
    ("centromeric phospho-Ser715 MCAK" . SPARSER::PROTEIN)
    ("ATPs" . SPARSER::ATP) ("PLK1 and MCAK" . SPARSER::COLLECTION)
    ("mitotic centromeres" . SPARSER::PROTEIN) ("addback" . SPARSER::PROTEIN)
    ("mal" . SPARSER::PROTEIN)
    ("yellow fluorescent proteins" . SPARSER::PROTEIN)
    ("CFP–YFP" . SPARSER::COLLECTION)
    ("other mitotic kinases" . SPARSER::KINASE)
    ("The double-exponential curve fit" . SPARSER::PROTEIN-FAMILY)
    ("GFP-tubulin" . SPARSER::COLLECTION) ("addedback" . SPARSER::PROTEIN)
    ("the central spindle-associated pSer715-MCAK" . SPARSER::PROTEIN)
    ("centromeric pSer715-MCAK" . SPARSER::PROTEIN)
    ("GFP-His-tagged MCAK" . SPARSER::PROTEIN)
    ("rhodamine-tubulins" . SPARSER::COLLECTION) ("GTPs" . SPARSER::NUCLEOTIDE)
    ("tubulins" . SPARSER::PROTEIN) ("rhodamine" . SPARSER::PROTEIN)
    ("GMP-" . SPARSER::GMP) ("MCAK S715A or MCAK S715E" . SPARSER::COLLECTION)
    ("GST-EB1" . SPARSER::COLLECTION) ("EB1" . SPARSER::PROTEIN)
    ("exogenous MCAK" . SPARSER::PROTEIN) ("CaMKII" . SPARSER::PROTEIN)
    ("mitotic centromere-associated kinesin (MCAK)" . SPARSER::PROTEIN)
    ("CENP-B" . SPARSER::PROTEIN) ("Kif2b" . SPARSER::PROTEIN)
    ("CENP-E" . SPARSER::PROTEIN) ("Myt1" . SPARSER::PROTEIN)
    ("Ca 2+ /Calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("Kinesin-13" . SPARSER::PROTEIN)
    ("mitotic centromere-associated kinesin" . SPARSER::PROTEIN)
    ("Sox2 and nonog" . SPARSER::COLLECTION)
    ("Suberoylanilide hydroxamic acid (SAHA)" . SPARSER::DRUG)
    ("miR-126 and miR-10a" . SPARSER::COLLECTION)
    ("miR-375 targets metadherin [ xref ] and miR-200b/c target ZEB1 [ xref ]"
     . SPARSER::COLLECTION)
    ("Bcl-2 [ xref ], miR-451 targets 14-3-3ζ [ xref ], let7s target ER-α36 [ xref ], miR-375 targets metadherin [ xref ] and miR-200b/c target ZEB1 [ xref ]"
     . SPARSER::COLLECTION)
    ("metadherin" . SPARSER::PROTEIN)
    ("tumor suppressors p27Kip1 [ xref , xref ] and TIMP3 [ xref ]"
     . SPARSER::COLLECTION)
    ("mesenchymal marker vimentin" . SPARSER::PROTEIN)
    ("Nicastrin and Notch4" . SPARSER::COLLECTION)
    ("Nicastrin" . SPARSER::PROTEIN) ("HDAC4 and ER" . SPARSER::COLLECTION)
    ("MCR" . SPARSER::PROTEIN) ("miR-10b and HDAC4" . SPARSER::COLLECTION)
    ("ER and/or progesterone receptor (PR)" . SPARSER::COLLECTION)
    ("Suberoylanilide hydroxamic acid" . SPARSER::DRUG)
    ("TIMP3" . SPARSER::PROTEIN) ("p27Kip1" . SPARSER::PROTEIN)
    ("FoxM1" . SPARSER::PROTEIN) ("Notch4" . SPARSER::PROTEIN)
    ("Pin-1" . SPARSER::PROTEIN) ("KLF4" . SPARSER::PROTEIN)
    ("PKD1" . SPARSER::PROTEIN) ("HOXD10" . SPARSER::PROTEIN)
    ("let-7 s" . SPARSER::RNA)
    ("Alkaline Phosphatase" . SPARSER::PROTEIN-FAMILY) ("let7s" . SPARSER::RNA)
    ("miR-221" . SPARSER::PROTEIN) ("NF-κB and PI3K" . SPARSER::COLLECTION)
    ("homo-oligomers" . SPARSER::PROTEIN)
    ("Flot-2/PI3K/Akt3" . SPARSER::COLLECTION)
    ("PI3K/Akt/mTOR" . SPARSER::COLLECTION)
    ("Akt1/Foxo3a/p21/p27" . SPARSER::COLLECTION)
    ("share considerable homology" . SPARSER::PROTEIN)
    ("Akt, Akt1, Akt2 and Akt3" . SPARSER::COLLECTION)
    ("Foxo1 and mTOR" . SPARSER::COLLECTION)
    ("NF-κB/MMPs" . SPARSER::COLLECTION)
    ("Flot-2 and NF-κB" . SPARSER::COLLECTION)
    ("Flot-1 and Flot-1" . SPARSER::COLLECTION)
    ("Flot-2 and Flot-1" . SPARSER::COLLECTION)
    ("flotillins" . SPARSER::PROTEIN-FAMILY)
    ("Foxo1, p21, E-cadherin, and p53" . SPARSER::COLLECTION)
    ("phospho-Akt3, PI3K, phospho-p65 and phospho-Foxo1" . SPARSER::COLLECTION)
    ("VIII, and siRNA-mediated" . SPARSER::COLLECTION)
    ("VIII" . SPARSER::PROTEIN) ("neither Akt1 nor Akt2" . SPARSER::COLLECTION)
    ("CCNA1 and CCNE2" . SPARSER::COLLECTION)
    ("Akt3 and Foxo1" . SPARSER::COLLECTION)
    ("Bcl-xL, Bcl-2, and Bax" . SPARSER::COLLECTION)
    ("MMP2, MMP7 and MMP9" . SPARSER::COLLECTION)
    ("shFlot-2-2" . SPARSER::COLLECTION) ("shFlot-2-1" . SPARSER::COLLECTION)
    ("pcDNA3.1" . SPARSER::PROTEIN) ("6-10B-pcDNA3.1" . SPARSER::COLLECTION)
    ("6-10B" . SPARSER::PROTEIN) ("6-10B-Flot-2" . SPARSER::COLLECTION)
    ("Flot-1 or Flot-2" . SPARSER::COLLECTION) ("oligomer" . SPARSER::MOLECULE)
    ("stomatin/prohibitin" . SPARSER::COLLECTION) ("HflK" . SPARSER::PROTEIN)
    ("PHB" . SPARSER::PROTEIN) ("prohibitin" . SPARSER::PROTEIN)
    ("stomatin" . SPARSER::PROTEIN) ("PI3K/Akt3" . SPARSER::COLLECTION)
    ("Flotillin-2" . SPARSER::PROTEIN) ("pEF1" . SPARSER::PROTEIN)
    ("Glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("CCNE2" . SPARSER::PROTEIN) ("CCNA1" . SPARSER::PROTEIN)
    ("MMP7" . SPARSER::PROTEIN) ("Foxo1" . SPARSER::PROTEIN)
    ("carrageenan" . SPARSER::MOLECULE) ("CD3 and CD28" . SPARSER::COLLECTION)
    ("PARP-1 and IL-17" . SPARSER::COLLECTION)
    ("IFN-γ and IP-10 " . SPARSER::COLLECTION)
    ("IL-12(p70) and IP-10 " . SPARSER::COLLECTION)
    ("NF-κB and STAT-6" . SPARSER::COLLECTION)
    ("NF-κB [ xref ] and STAT-6 [ xref ]" . SPARSER::COLLECTION)
    ("gata -3" . SPARSER::PROTEIN) ("GATA-3 and IL-4" . SPARSER::COLLECTION)
    ("hydroxide" . SPARSER::MOLECULE) ("IgE" . SPARSER::PROTEIN)
    ("/Foxp3" . SPARSER::COLLECTION) ("/CD25" . SPARSER::COLLECTION)
    ("IL-22, keratinocyte chemoattractant (KC) and granulocyte macrophage colony-stimulating factor (GM-CSF)"
     . SPARSER::COLLECTION)
    ("olaparib or PARP-1" . SPARSER::COLLECTION)
    ("PARP and IL-17" . SPARSER::COLLECTION) ("Il13" . SPARSER::PROTEIN)
    ("Il5" . SPARSER::PROTEIN) ("Il4" . SPARSER::PROTEIN)
    ("eotaxin, IL-4, IL-5 and IL-10" . SPARSER::COLLECTION)
    ("IFN-γ or IL-2" . SPARSER::COLLECTION)
    ("IL-12 and IP-10" . SPARSER::COLLECTION)
    ("eotaxin, IL-4, IL-5 and IL-13" . SPARSER::COLLECTION)
    ("eotaxin" . SPARSER::PROTEIN) ("IFN-γ or IL-10" . SPARSER::COLLECTION)
    ("PRISM" . SPARSER::PROTEIN)
    ("T-box transcription factor ( t-bet ) or gapdh (glyceraldehyde-3-phosphate dehydrogenase)"
     . SPARSER::COLLECTION)
    ("mouse il17 (forward: 5′-GGT CAA CCT CAA AGT CTT TAA CTC-3′; reverse: 5′-TTA AAA ATG CAA GTA AGT TTG CTG-3′) or mouse β-actin (forward: 5′-CGGTTCCGATGCCCTGAGGCTCTT-3′; reverse: 5′-CGTCACACTTCATGATGGAATTGA-3′)"
     . SPARSER::COLLECTION)
    ("-CGTCACACTTCATGATGGAATTGA-3" . SPARSER::COLLECTION)
    ("-CGGTTCCGATGCCCTGAGGCTCTT-3" . SPARSER::COLLECTION)
    ("CTG-3" . SPARSER::COLLECTION) ("CTC-3" . SPARSER::COLLECTION)
    ("-GGT" . SPARSER::COLLECTION) ("il17" . SPARSER::PROTEIN)
    ("TTG" . SPARSER::PROTEIN) ("GTA" . SPARSER::PROTEIN)
    ("TTA" . SPARSER::NUCLEOTIDE) ("TAA" . SPARSER::PROTEIN)
    ("anti-CD3 and anti-CD28" . SPARSER::COLLECTION)
    ("ester (CFSE)" . SPARSER::MOLECULE) ("CFSE" . SPARSER::DRUG)
    ("immuno-immobilized anti-CD3" . SPARSER::ANTIBODY)
    ("FITC-labelled secondary antibodies" . SPARSER::ANTIBODY)
    ("Scott" . SPARSER::PROTEIN) ("Alcohol" . SPARSER::DRUG)
    ("sera or cell culture media" . SPARSER::COLLECTION)
    ("methacholine" . SPARSER::DRUG) ("State" . SPARSER::BIO-STATE)
    ("chronically-inhaled HDM" . SPARSER::PROTEIN)
    ("PARP-1 and PARP-2" . SPARSER::COLLECTION) ("HDMs" . SPARSER::PROTEIN)
    ("allergens" . SPARSER::MOLECULE) ("ovalbumin (OVA)" . SPARSER::PROTEIN)
    ("ovalbumin" . SPARSER::PROTEIN) ("/IL-4" . SPARSER::COLLECTION)
    ("gata-3" . SPARSER::PROTEIN) ("gata" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GATA" . SPARSER::PROTEIN) ("HDM" . SPARSER::PROTEIN)
    ("IP-10 " . SPARSER::PROTEIN) ("PARP-1 " . SPARSER::PROTEIN)
    ("IL-22" . SPARSER::PROTEIN) ("GATA-3" . SPARSER::PROTEIN)
    ("IP-10" . SPARSER::PROTEIN) ("interferon gamma" . SPARSER::PROTEIN)
    ("t-bet" . SPARSER::PROTEIN) ("FoxP3" . SPARSER::PROTEIN)
    ("forkhead box P3" . SPARSER::PROTEIN)
    ("6-carboxyfluorescein" . SPARSER::DRUG) ("anti-CD28" . SPARSER::PROTEIN)
    ("T-cell receptor" . SPARSER::PROTEIN) ("IL-17" . SPARSER::PROTEIN)
    ("IL-17 " . SPARSER::PROTEIN) ("protein-3" . SPARSER::PROTEIN)
    ("/Crk/Dock180" . SPARSER::COLLECTION) ("Src-Rac" . SPARSER::COLLECTION)
    ("αvβ5 and β1" . SPARSER::COLLECTION)
    ("CrkII/Dock180" . SPARSER::COLLECTION)
    ("p130 Cas , paxillin, and FAK" . SPARSER::COLLECTION)
    ("Crk and ERM" . SPARSER::COLLECTION) ("ERM" . SPARSER::PROTEIN)
    ("pTyr-Asp-Phe-Val" . SPARSER::COLLECTION)
    ("polyproline" . SPARSER::PROTEIN)
    ("ELMO1 and Dock180" . SPARSER::COLLECTION)
    ("CrkII and Dock180" . SPARSER::COLLECTION) ("CrkII" . SPARSER::PROTEIN)
    ("intrinsic ELMO1" . SPARSER::PROTEIN)
    ("extrinsic Dock180" . SPARSER::PROTEIN)
    ("both Dock180 and wild-type ELMO1" . SPARSER::COLLECTION)
    ("Dock180 and ELMO1" . SPARSER::COLLECTION)
    ("exogenous ELMO1" . SPARSER::PROTEIN)
    ("Dock180 and wild-type ELMO1" . SPARSER::COLLECTION)
    ("single substitutional mutant" . SPARSER::MUTANT)
    ("GST-ELMO1Δ662" . SPARSER::PROTEIN-PAIR)
    ("phenylalanine" . SPARSER::AMINO-ACID) ("Src-" . SPARSER::PROTEIN)
    ("GST-ELMO1" . SPARSER::COLLECTION)
    ("Lck, Lyn, and Hck" . SPARSER::COLLECTION)
    ("Fyn, Lyn, Lck, and Hck" . SPARSER::COLLECTION) ("Lyn" . SPARSER::PROTEIN)
    ("Axl" . SPARSER::PROTEIN) ("ELMO1/Dock180" . SPARSER::COLLECTION)
    ("the ternary complex" . SPARSER::BIO-COMPLEX) ("NGF" . SPARSER::PROTEIN)
    ("ARM" . SPARSER::PROTEIN)
    ("the trimolecular complex" . SPARSER::BIO-COMPLEX)
    ("Crk/Dock180/ELMO1" . SPARSER::COLLECTION)
    ("Fak or components" . SPARSER::COLLECTION)
    ("Fak" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the essential molecules" . SPARSER::MOLECULE) ("Crk" . SPARSER::PROTEIN)
    ("wild-type ELMO1 or its Y724F mutant" . SPARSER::COLLECTION)
    ("Src and Fyn" . SPARSER::COLLECTION) ("Hck" . SPARSER::PROTEIN)
    ("Dock180/ELMO1" . SPARSER::COLLECTION) ("PAK2" . SPARSER::PROTEIN)
    ("αvβ5" . SPARSER::PROTEIN)
    ("hematopoietic cell kinase" . SPARSER::PROTEIN)
    ("p130 Cas" . SPARSER::PROTEIN) ("ELMO1" . SPARSER::PROTEIN)
    ("Dock180" . SPARSER::PROTEIN) ("CDH1 and IL-1β" . SPARSER::COLLECTION)
    ("FAK and MAPK" . SPARSER::COLLECTION) ("COLO-320" . SPARSER::PROTEIN)
    ("CDH1/IL-1β" . SPARSER::COLLECTION)
    ("ki67 and PCNA" . SPARSER::COLLECTION) ("hMSC–MCF7" . SPARSER::COLLECTION)
    ("hMSCs and MCF7" . SPARSER::COLLECTION)
    ("lipophilic tracer" . SPARSER::MOLECULE)
    ("COLO-320–hMSC" . SPARSER::PROTEIN-PAIR)
    ("MCF7-hMSC" . SPARSER::COLLECTION)
    ("soluble recombinant IL-1 receptor" . SPARSER::RECEPTOR)
    ("GX" . SPARSER::PROTEIN) ("FAK or MAPKK" . SPARSER::COLLECTION)
    ("FAK ( P  = 1.3 × 10 −7 ) and MAPKK ( P  = 0.014)" . SPARSER::COLLECTION)
    ("FAK, MAPKK, and actin" . SPARSER::COLLECTION)
    ("the hMSCs and no ALP" . SPARSER::COLLECTION) ("ALP" . SPARSER::PROTEIN)
    ("VEGFA, SOX9, FOS, PLAU, BGN, BMP2, CDH11, SNAI1, and SPARC"
     . SPARSER::COLLECTION)
    ("SPARC" . SPARSER::PROTEIN) ("BGN" . SPARSER::PROTEIN)
    ("218 upregulated genes and 92 downregulated genes" . SPARSER::COLLECTION)
    ("MCF7 and BT-20 co-cultures" . SPARSER::COLLECTION)
    ("hMSCs" . SPARSER::PROTEIN) ("hMSC" . SPARSER::PROTEIN)
    ("MCF7–hMSC" . SPARSER::COLLECTION) ("mcherry" . SPARSER::PROTEIN)
    ("CCL5/CCR5" . SPARSER::COLLECTION) ("CAFs" . SPARSER::PROTEIN)
    ("CDH1 and IL1-Beta" . SPARSER::COLLECTION)
    ("Ki67 and PCNA" . SPARSER::COLLECTION)
    ("FAK and MAPKK" . SPARSER::COLLECTION)
    ("MAPKK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("using soluble recombinant IL-1R" . SPARSER::PROTEIN)
    ("mCherry, and luciferase" . SPARSER::COLLECTION)
    ("DiO" . SPARSER::MOLECULE) ("protein (GFP)" . SPARSER::PROTEIN)
    ("hMSC-GFP" . SPARSER::COLLECTION) ("MSC" . SPARSER::PROTEIN)
    ("regenerative medicine" . SPARSER::DRUG) ("MSCs" . SPARSER::PROTEIN)
    ("CDH11" . SPARSER::PROTEIN) ("BMP2" . SPARSER::PROTEIN)
    ("SOX9" . SPARSER::PROTEIN) ("p200" . SPARSER::PROTEIN)
    ("Proliferating cell nuclear antigen" . SPARSER::PROTEIN)
    ("Alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("CD326" . SPARSER::PROTEIN) ("cytochalasin D" . SPARSER::DRUG)
    ("mitogen-activated protein kinase kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PF-573228" . SPARSER::DRUG) ("F12 " . SPARSER::PROTEIN)
    ("d -glucose" . SPARSER::MOLECULE)
    ("epithelial cadherin" . SPARSER::PROTEIN)
    ("chemokine (C–X–C motif) ligand 7" . SPARSER::PROTEIN)
    ("C–C motif" . SPARSER::PROTEIN) ("IL-1R" . SPARSER::PROTEIN)
    ("IL1-Beta" . SPARSER::PROTEIN) ("ABI" . SPARSER::PROTEIN-FAMILY)
    ("chloroform" . SPARSER::MOLECULE) ("hydroxylamine" . SPARSER::MOLECULE)
    ("FPG (mmol/L) − 3.5" . SPARSER::PROTEIN)
    ("hemoglobin and hemoglobin" . SPARSER::COLLECTION)
    ("GPX" . SPARSER::PROTEIN) ("Hypaque" . SPARSER::DRUG)
    ("glucose (FPG)" . SPARSER::MOLECULE)
    ("NRF2 and its representative target NQO1 mRNAs" . SPARSER::COLLECTION)
    ("its representative target NQO1 mRNAs" . SPARSER::PROTEIN)
    ("hyperglycemia" . SPARSER::PROTEIN)
    ("antioxidants and antioxidant" . SPARSER::COLLECTION)
    ("antioxidant and phase II enzyme genes" . SPARSER::COLLECTION)
    ("HOMA" . SPARSER::PROTEIN) ("hemin" . SPARSER::MOLECULE)
    ("protein and NQO1" . SPARSER::COLLECTION)
    ("heterozygotes" . SPARSER::PROTEIN)
    ("enzymes and antioxidant" . SPARSER::COLLECTION)
    ("prooxidants and antioxidants" . SPARSER::COLLECTION)
    ("prooxidants" . SPARSER::MOLECULE) ("excessive ROS" . SPARSER::PROTEIN)
    ("lipids, and proteins" . SPARSER::COLLECTION)
    ("superoxide anion and hydroxyl radical" . SPARSER::COLLECTION)
    ("NGT" . SPARSER::PROTEIN) ("MDA" . SPARSER::DRUG)
    ("FPG" . SPARSER::PROTEIN-FAMILY)
    ("multiple reactive cysteine" . SPARSER::AMINO-ACID)
    ("NRF2 and Cullin3" . SPARSER::COLLECTION)
    ("CNC homology-associated protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the diabetic disease state" . SPARSER::BIO-STATE)
    ("malondialdehyde" . SPARSER::MOLECULE)
    ("a pivotal transcription factor" . SPARSER::PROTEIN)
    ("− 3" . SPARSER::PROTEIN) ("pro-oxidant" . SPARSER::MOLECULE)
    ("tert -butylhydroquinone" . SPARSER::DRUG)
    ("vitamin C" . SPARSER::MOLECULE) ("hydroxyl radical" . SPARSER::MOLECULE)
    ("Neh2" . SPARSER::PROTEIN) ("Neh1" . SPARSER::PROTEIN)
    ("β-cell" . SPARSER::PROTEIN) ("NF-E2 related factor 2" . SPARSER::PROTEIN)
    ("antioxidants and iron" . SPARSER::COLLECTION)
    ("intracellular redoxactive iron" . SPARSER::MOLECULE)
    ("antioxidants and chelators" . SPARSER::COLLECTION)
    ("Antioxidants and chelators" . SPARSER::COLLECTION)
    ("chelators" . SPARSER::MOLECULE) ("Antioxidants" . SPARSER::DRUG)
    ("proteins, lipids and lipoproteins" . SPARSER::COLLECTION)
    ("Iron" . SPARSER::MOLECULE) ("siRNA or gene" . SPARSER::COLLECTION)
    ("Bivalent ions" . SPARSER::MOLECULE) ("EPR" . SPARSER::PROTEIN)
    ("MAPKs and p47" . SPARSER::COLLECTION)
    ("ERK1/2 and p38" . SPARSER::COLLECTION)
    ("inhibitors or bacteria" . SPARSER::COLLECTION)
    ("a secondary fluorescent antibody" . SPARSER::PROTEIN)
    ("p-p38 or anti" . SPARSER::COLLECTION)
    ("JNK, p38 and ERK1/2" . SPARSER::COLLECTION)
    ("p-p38 and p-ERK1/2" . SPARSER::COLLECTION)
    ("p-JNK" . SPARSER::COLLECTION)
    ("an indirect regulator" . SPARSER::REGULATOR)
    ("protein subunits and a cytosolic complex" . SPARSER::COLLECTION)
    ("Neutrophil" . SPARSER::PROTEIN)
    ("NADPH oxidase and diethyldithiocarbamate" . SPARSER::COLLECTION)
    ("DDC" . SPARSER::PROTEIN) ("diethyldithiocarbamate" . SPARSER::MOLECULE)
    ("DHR" . SPARSER::PROTEIN) ("p-p47" . SPARSER::PROTEIN)
    ("ammonium chloride" . SPARSER::MOLECULE) ("SB202190" . SPARSER::DRUG)
    ("Mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p47" . SPARSER::PROTEIN) ("Hydrogen peroxide" . SPARSER::MOLECULE)
    ("using currently available Cdk2 inhibitor" . SPARSER::INHIBITOR)
    ("Cdk1 and Cdk4" . SPARSER::COLLECTION)
    ("Cdks" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mutated BRAF in melanomas [ xref ] and Bcr-Abl in chronic myeloid leukemia [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("Oncogene" . SPARSER::ONCOGENE)
    ("Cdk1 JNJ-7706621 [ xref ] or Cdk2 SNS-032 [ xref ]"
     . SPARSER::COLLECTION)
    ("CCNE1 and Cdk1 or Cdk2" . SPARSER::COLLECTION)
    ("Cdk1 or Cdk2" . SPARSER::COLLECTION) ("histological types" . TYPE)
    ("various histological types" . TYPE)
    ("all three histological types" . TYPE)
    ("enzyme or receptor" . SPARSER::COLLECTION)
    ("their histological types" . TYPE) ("Cdk4" . SPARSER::PROTEIN)
    ("JNJ-7706621" . SPARSER::DRUG) ("cyclin E1" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 2" . SPARSER::PROTEIN)
    ("an excellent drug target" . SPARSER::TARGET-PROTEIN)
    ("VEGF-A and VEGF-C" . SPARSER::COLLECTION)
    ("soluble VEGF-A" . SPARSER::PROTEIN)
    ("HIF1α and VEGFA" . SPARSER::COLLECTION)
    ("4E-BP1 or eIF4E" . SPARSER::COLLECTION)
    ("4E-BP1 and eIF4E" . SPARSER::COLLECTION)
    ("Ras-Raf" . SPARSER::COLLECTION) ("p-4E-BP1" . SPARSER::COLLECTION)
    ("eIF4E and 4E-BP1" . SPARSER::COLLECTION)
    ("a new phenanthroquinolizidine" . SPARSER::DRUG)
    ("cap-dependent firefly luciferase and cap-independent Renilla luciferase genes (Figure xref )"
     . SPARSER::COLLECTION)
    ("cap-independent Renilla luciferase genes" . SPARSER::GENE)
    ("hypoxia, and YXM110" . SPARSER::COLLECTION)
    ("4E-BP1 and CRC" . SPARSER::COLLECTION) ("CCD" . SPARSER::PROTEIN)
    ("a valuable prognostic biomarker" . SPARSER::MOLECULE)
    ("phenanthroquinolizidine" . SPARSER::DRUG)
    ("nitric oxide synthase ( NOS )" . SPARSER::PROTEIN)
    ("NOS" . SPARSER::PROTEIN) ("EPO" . SPARSER::PROTEIN)
    ("a constitutively expressed HIF-1β subunit and a highly regulated HIF-1α subunit [ xref ]"
     . SPARSER::COLLECTION)
    ("Oxygen" . SPARSER::MOLECULE) ("4E-BP1 and eIF4G" . SPARSER::COLLECTION)
    ("growth factor ( VEGFA )" . SPARSER::GROWTH-FACTOR)
    ("Cellular mRNAs" . SPARSER::PROTEIN)
    ("cap-independent mRNAs" . SPARSER::PROTEIN)
    ("relevant biomarkers" . SPARSER::MOLECULE)
    ("loss of heterozygosity, p53, SMAD4, thymidylate synthase, KRAS, and BRAF"
     . SPARSER::COLLECTION)
    ("several targeted monoclonal antibodies" . SPARSER::ANTIBODY)
    ("traditional chemotherapy drugs" . SPARSER::DRUG)
    ("bevacizumab, cetuximab, panitumumab, and capecitabine"
     . SPARSER::COLLECTION)
    ("KRAS , MLH1 , MSH2 , TP53 , and EGFR" . SPARSER::COLLECTION)
    ("cryptopleurine" . SPARSER::DRUG) ("C-5" . SPARSER::PROTEIN)
    ("TG-3" . SPARSER::PROTEIN) ("VEGF-C" . SPARSER::PROTEIN)
    ("HIF-1β" . SPARSER::PROTEIN)
    ("Hypoxia-inducible factor-1" . SPARSER::PROTEIN)
    ("fibroblast growth factor 2" . SPARSER::PROTEIN)
    ("thymidylate synthase" . SPARSER::PROTEIN)
    ("Rho and Rac" . SPARSER::COLLECTION)
    ("a possible regulator" . SPARSER::REGULATOR)
    ("Rac and Cdc42" . SPARSER::COLLECTION)
    ("neither Sprouty2 nor ERK" . SPARSER::COLLECTION)
    ("Sprouty2 or ERK" . SPARSER::COLLECTION)
    ("FLAG-SHP2" . SPARSER::COLLECTION)
    ("The C-terminal Src kinase [ xref ] and Sprouty proteins [ xref ]"
     . SPARSER::COLLECTION)
    ("Sprouty" . SPARSER::PROTEIN-FAMILY)
    ("actin-associated proteins" . SPARSER::PROTEIN)
    ("components and regulators" . SPARSER::COLLECTION)
    ("macrophages and osteoclasts" . SPARSER::COLLECTION)
    ("Type IV collagen" . SPARSER::PROTEIN) ("Ras-binding" . SPARSER::PROTEIN)
    ("CS6" . SPARSER::PROTEIN) ("AS2" . SPARSER::PROTEIN)
    ("SPRY2" . SPARSER::PROTEIN) ("p190" . SPARSER::PROTEIN)
    ("D-10" . SPARSER::PROTEIN) ("K-23" . SPARSER::PROTEIN)
    ("Sprouty2" . SPARSER::PROTEIN) ("HT-1080" . SPARSER::PROTEIN)
    ("PTP-PEST" . SPARSER::PROTEIN) ("PTP-1B" . SPARSER::PROTEIN)
    ("Cx26 or Akt" . SPARSER::COLLECTION)
    ("LY294002 or wortmannin" . SPARSER::COLLECTION)
    ("temozolomide or cisplatin" . SPARSER::COLLECTION)
    ("Cx43, Cx37, Cx32, and Cx26" . SPARSER::COLLECTION)
    ("EMT and cisplatin" . SPARSER::COLLECTION)
    ("Cx32 and Cx31.1" . SPARSER::COLLECTION)
    ("Cx26 and PI3K/Akt in NSCLC cells" . SPARSER::COLLECTION)
    ("EMT and drug" . SPARSER::COLLECTION)
    ("Cx26 and PI3K" . SPARSER::COLLECTION)
    ("chimeric Cx26" . SPARSER::PROTEIN)
    ("mesenchymal marker vimentin and slug" . SPARSER::COLLECTION)
    ("vimentin and slug" . SPARSER::COLLECTION) ("slug" . SPARSER::PROTEIN)
    ("Cx26, Cx32, Cx31.1, and Cx43" . SPARSER::COLLECTION)
    ("Cx26 and gefitinib" . SPARSER::COLLECTION)
    ("cisplatin and docetaxel" . SPARSER::COLLECTION)
    ("Gap" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Connexins" . SPARSER::PROTEIN)
    ("GJIC-deficient chimeric Cx26" . SPARSER::PROTEIN)
    ("EMT and gefitinib" . SPARSER::COLLECTION)
    ("HCC827 GR and PC9 GR" . SPARSER::COLLECTION)
    ("the predominant Cx isoform" . SPARSER::ISOFORM)
    ("Cx" . SPARSER::PROTEIN-FAMILY) ("MK3" . SPARSER::PROTEIN)
    ("Akt-induced" . SPARSER::PROTEIN) ("TGF- β 1" . SPARSER::PROTEIN)
    ("insulin-like growth factor receptor" . SPARSER::PROTEIN)
    ("Cx37" . SPARSER::PROTEIN) ("Cx31" . SPARSER::PROTEIN)
    ("Cx43" . SPARSER::PROTEIN) ("Cx32" . SPARSER::PROTEIN)
    ("Cx26" . SPARSER::PROTEIN) ("connexin 26" . SPARSER::PROTEIN)
    ("–dovitinib" . SPARSER::DRUG)
    ("PD173074
and dovitinib"
     . SPARSER::COLLECTION)
    ("dovitinib" . SPARSER::DRUG) ("HPN" . SPARSER::PROTEIN)
    ("ponatinib and PDA" . SPARSER::COLLECTION)
    ("Abl and FGFR1" . SPARSER::COLLECTION)
    ("kinase and B-Raf" . SPARSER::COLLECTION)
    ("just one
amino acid"
     . SPARSER::AMINO-ACID)
    ("EF" . SPARSER::PROTEIN) ("PDA and the P-loop" . SPARSER::COLLECTION)
    ("inter-lobe" . SPARSER::PROTEIN)
    ("PDA
and ponatinib"
     . SPARSER::COLLECTION)
    ("Amide" . SPARSER::MOLECULE) ("amides" . SPARSER::MOLECULE)
    ("substantial CSPs" . SPARSER::PROTEIN) ("Local CSPs" . SPARSER::PROTEIN)
    ("PDA and
ponatinib"
     . SPARSER::COLLECTION)
    ("PDA or ponatinib" . SPARSER::COLLECTION)
    ("FGFR1 and Abl" . SPARSER::COLLECTION)
    ("inhibitor and
protein"
     . SPARSER::COLLECTION)
    ("type I and type II" . SPARSER::COLLECTION) ("AV" . SPARSER::MOLECULE)
    ("tivozanib" . SPARSER::DRUG)
    ("enthalpic and entropic
components"
     . SPARSER::COMPONENT)
    ("Ponatinib and PDA" . SPARSER::COLLECTION)
    ("PDA and ponatinib" . SPARSER::COLLECTION) ("PDA" . SPARSER::PROTEIN)
    ("−12.1 kcal mol −1 (PDA) and
−12.4 kcal mol −1 (SU5402)"
     . SPARSER::COLLECTION)
    ("−1 (PDA)" . SPARSER::PROTEIN) ("Abl" . SPARSER::PROTEIN)
    ("representative type I inhibitors" . SPARSER::INHIBITOR)
    ("the respective A-loop conformations" . SPARSER::BIO-CONFORMATION)
    ("only type I inhibitors" . SPARSER::INHIBITOR)
    ("individual kinases" . SPARSER::KINASE)
    ("kinases
and type II"
     . SPARSER::COLLECTION)
    ("tripeptide" . SPARSER::MOLECULE) ("Asp–Phe–Gly" . SPARSER::COLLECTION)
    ("DFG" . SPARSER::PROTEIN) ("K −1" . SPARSER::PROTEIN)
    ("T200" . SPARSER::PROTEIN) ("P20" . SPARSER::PROTEIN)
    ("NH 4 Cl" . SPARSER::MOLECULE)
    ("insulin
receptor"
     . SPARSER::PROTEIN)
    ("t -butyl" . SPARSER::MOLECULE) ("−2  " . SPARSER::PROTEIN)
    ("a
2"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SU5402" . SPARSER::DRUG) ("BIRB-796" . SPARSER::DRUG)
    ("−3  " . SPARSER::PROTEIN) ("PD173074" . SPARSER::DRUG)
    ("PTP1B" . SPARSER::PROTEIN)
    ("type
II"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("STI-571" . SPARSER::DRUG) ("Bcr-Abl" . SPARSER::PROTEIN)
    ("TERC [ xref ] as well as other genes" . SPARSER::COLLECTION)
    ("the Scottish Lothian Birth Cohort" . SPARSER::MOLECULE)
    ("ASW" . SPARSER::PROTEIN) ("a true causative variant" . SPARSER::VARIANT)
    ("fatal CHD" . SPARSER::PROTEIN) ("Terc" . SPARSER::PROTEIN)
    ("the enzyme’s" . SPARSER::ENZYME) ("1.03 – 1.40" . SPARSER::PROTEIN)
    ("incident CHD" . SPARSER::PROTEIN) ("403 incident CHD" . SPARSER::PROTEIN)
    ("allele and genotype" . SPARSER::COLLECTION)
    ("the large biracial population-based ARIC cohort" . SPARSER::MOLECULE)
    ("telomerase RNA component (TERC)" . SPARSER::RNA)
    ("ZNF676" . SPARSER::PROTEIN)
    ("zinc finger protein 676" . SPARSER::PROTEIN) ("OBFC1" . SPARSER::PROTEIN)
    ("cardiac muscle" . SPARSER::PROTEIN)
    ("High density lipoprotein" . SPARSER::PROTEIN)
    ("PRDX6, PGAM1, and HMGB1" . SPARSER::COLLECTION)
    ("discernible gene" . SPARSER::GENE) ("cytarabine" . SPARSER::MOLECULE)
    ("HDAC8-SMC3" . SPARSER::COLLECTION)
    ("pan-HDAC inhibitors and HDAC6 inhibitors" . SPARSER::COLLECTION)
    ("PARK7/DJ-1" . SPARSER::COLLECTION) ("vis-" . SPARSER::DRUG)
    ("vis" . SPARSER::DRUG) ("Annexin V/PI" . SPARSER::COLLECTION)
    ("tubulin, histone 3, and histone 4" . SPARSER::COLLECTION)
    ("HDACi" . SPARSER::MOLECULE)
    ("Waf1/Cip1 and NTRK1/TrkA which was associated with cell line growth inhibition [ xref ]"
     . SPARSER::COLLECTION)
    ("NTRK1/TrkA" . SPARSER::COLLECTION) ("TrkA" . SPARSER::PROTEIN)
    ("hydroxamate" . SPARSER::MOLECULE)
    ("histones or tubulin" . SPARSER::COLLECTION)
    ("protein (CHIP)" . SPARSER::PROTEIN)
    ("human ever shorter telomeres 1B" . SPARSER::PROTEIN)
    ("Recently developed HDAC-specific inhibitors" . SPARSER::INHIBITOR)
    ("tubacin" . SPARSER::DRUG) ("HDACis" . SPARSER::MOLECULE)
    ("Annexin V-PI" . SPARSER::COLLECTION) ("PCI" . SPARSER::PROTEIN)
    ("Hsp20" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SMC family" . SPARSER::PROTEIN)
    ("structural maintenance of chromosomes 3" . SPARSER::PROTEIN)
    ("SMC3" . SPARSER::PROTEIN) ("DJ-1" . SPARSER::PROTEIN)
    ("peroxiredoxin 6" . SPARSER::PROTEIN) ("histone 4" . SPARSER::PROTEIN)
    ("Histone 4" . SPARSER::PROTEIN) ("Histone 3" . SPARSER::PROTEIN)
    ("α-SMA" . SPARSER::PROTEIN) ("alpha-actin" . SPARSER::PROTEIN)
    ("estrogen-related receptor alpha" . SPARSER::PROTEIN)
    ("CK2" . SPARSER::PROTEIN) ("PRDX6" . SPARSER::PROTEIN)
    ("PGAM1" . SPARSER::PROTEIN) ("PARK7" . SPARSER::PROTEIN)
    ("Fgfr1" . SPARSER::PROTEIN) ("new light" . SPARSER::PROTEIN)
    ("hCG" . SPARSER::PROTEIN)
    ("KAL1 , FGFR1 , NELF , FGF8 , CHD7 , WDR11 , SEMA3A , PROKR2, and PROK2"
     . SPARSER::COLLECTION)
    ("complete KS" . SPARSER::PROTEIN) ("FGFRs" . SPARSER::PROTEIN)
    ("GERP" . SPARSER::PROTEIN) ("at least one gene" . SPARSER::GENE)
    ("KAL1 , GNRHR , FGFR1 , KISS1R , TAC3 , TACR3 , FGF8 , PROKR2 , PROK2 , CHD7 , NELF , GNRH1 , and WDR11"
     . SPARSER::COLLECTION)
    ("15 selected IHH/KS casual genes" . SPARSER::GENE)
    ("PGM" . SPARSER::PROTEIN)
    ("synonymous exonic variants" . SPARSER::VARIANT)
    ("intronic variants" . SPARSER::VARIANT) ("IHH/KS" . SPARSER::COLLECTION)
    ("KAL1 , FGFR1 , PROKR2 , PROK2 , NELF , FGF8 , CHD7 , WDR11 , SEMA3A , KISS1R , KISS1 , TAC3 , TACR3 , GNRH1 , and GNRHR"
     . SPARSER::COLLECTION)
    ("normosmic IHH" . SPARSER::PROTEIN) ("GnRH" . SPARSER::PROTEIN)
    ("KS and CLP" . SPARSER::COLLECTION)
    ("KAL1 , FGFR1 , NELF , FGF8 , CHD7 , WDR11 , SEMA3A , KISS1R , KISS1 , PROKR2 , PROK2 , TAC3 , TACR3 , GNRH1 , and GNRHR"
     . SPARSER::COLLECTION)
    ("GNRHR" . SPARSER::PROTEIN) ("lip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IHH" . SPARSER::PROTEIN) ("neuronal migration" . SPARSER::PROTEIN)
    ("GPR54" . SPARSER::PROTEIN) ("Kit 2" . SPARSER::PROTEIN)
    ("GNRH1" . SPARSER::PROTEIN) ("PROK2" . SPARSER::PROTEIN)
    ("PROKR2" . SPARSER::PROTEIN) ("KISS1" . SPARSER::PROTEIN)
    ("KISS1R" . SPARSER::PROTEIN) ("SEMA3A" . SPARSER::PROTEIN)
    ("WDR11" . SPARSER::PROTEIN) ("CHD7" . SPARSER::PROTEIN)
    ("FGF8" . SPARSER::PROTEIN) ("KAL1" . SPARSER::PROTEIN)
    ("NF- κ B and 53BP1" . SPARSER::COLLECTION) ("53BP1-" . SPARSER::PROTEIN)
    ("protein-" . SPARSER::PROTEIN)
    ("tumor suppressor p53 and BRCA1" . SPARSER::COLLECTION)
    ("MLH3 and Rev1 , and genes" . SPARSER::COLLECTION)
    ("Rev1 , and genes" . SPARSER::COLLECTION)
    ("glutaredoxin" . SPARSER::PROTEIN)
    ("oxidative stress related proteins" . SPARSER::PROTEIN)
    ("oxidoreductase" . SPARSER::PROTEIN) ("ubiquinone" . SPARSER::DRUG)
    ("NF- κ B/NF- κ B" . SPARSER::COLLECTION)
    ("p65 (RelA), p50, p52, c-Rel, and RelB and the mammalian NF- κ B protein family"
     . SPARSER::COLLECTION)
    ("a dimeric transcription factor" . SPARSER::PROTEIN)
    ("p50, p52, c-Rel, and RelB" . SPARSER::COLLECTION)
    ("p52/p100" . SPARSER::COLLECTION) ("p50/p105" . SPARSER::COLLECTION)
    ("glutathione (GSH)" . SPARSER::DRUG)
    ("Hsp70, IFN- γ , and caspase 3" . SPARSER::COLLECTION)
    ("NF- κ B, JUN, and FOS" . SPARSER::COLLECTION)
    ("protein and DNA" . SPARSER::COLLECTION)
    ("a 2-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Cytotoxic" . SPARSER::PROTEIN)
    ("AgNPs" . SPARSER::MOLECULE)
    ("nontoxic 20 nm gold nanoparticles" . SPARSER::MOLECULE)
    ("Gold" . SPARSER::MOLECULE) ("glutathione reductase" . SPARSER::PROTEIN)
    ("Rev1" . SPARSER::PROTEIN) ("MLH3" . SPARSER::PROTEIN)
    ("SCN1" . SPARSER::PROTEIN) ("secernin-1" . SPARSER::PROTEIN)
    ("TXNL1" . SPARSER::PROTEIN)
    ("thioredoxin-like protein 1" . SPARSER::PROTEIN)
    ("heterogeneous nuclear ribonucleoprotein" . SPARSER::PROTEIN)
    ("PDIA3" . SPARSER::PROTEIN) ("disulfide isomerase" . SPARSER::PROTEIN)
    ("NDUFS1" . SPARSER::PROTEIN) ("I κ B α" . SPARSER::PROTEIN)
    ("NF- κ B2" . SPARSER::PROTEIN) ("IFN- γ" . SPARSER::PROTEIN)
    ("Cho" . SPARSER::PROTEIN)
    ("AF10, ENL, ELL,
AF4 and AF9"
     . SPARSER::COLLECTION)
    ("ELL" . SPARSER::PROTEIN) ("ENL" . SPARSER::PROTEIN)
    ("the core components of DOT1L and
c-Myc-containing transcription regulatory complex and their roles"
     . SPARSER::COLLECTION)
    ("DOT1L and
c-Myc-containing transcription regulatory complex"
     . SPARSER::COLLECTION)
    ("c-Myc-containing
transcriptional active complex"
     . SPARSER::BIO-COMPLEX)
    ("HDAC
or DNMT"
     . SPARSER::COLLECTION)
    ("directly CBP and p300 acetyltransferases" . SPARSER::PROTEIN)
    ("TRRAP" . SPARSER::PROTEIN) ("H3K4 and H3K79" . SPARSER::COLLECTION)
    ("epigenetic modifiers and EMT-TFs" . SPARSER::COLLECTION)
    ("modifiers and EMT-TFs" . SPARSER::COLLECTION)
    ("DOT1L and c-Myc" . SPARSER::COLLECTION)
    ("c-Myc and CBP/p300
co-activator complex"
     . SPARSER::COLLECTION)
    ("a
transcriptionally active complex"
     . SPARSER::BIO-COMPLEX)
    ("c-Myc and
CBP/p300 co-activator complex"
     . SPARSER::COLLECTION)
    ("SNAIL, ZEB1 and ZEB2" . SPARSER::COLLECTION)
    ("DNMT1 and HDAC1" . SPARSER::COLLECTION)
    ("both
the HDAC1 and DNMT1 transcriptional repressive complex and p300 active complex"
     . SPARSER::COLLECTION)
    ("p300 active complex" . SPARSER::BIO-COMPLEX)
    ("both
the HDAC1 and DNMT1 transcriptional repressive complex"
     . SPARSER::BIO-COMPLEX)
    ("c-Myc, DOT1L and histone" . SPARSER::COLLECTION)
    ("DOT1L-c-Myc" . SPARSER::COLLECTION)
    ("c-Myc and
smad2/3"
     . SPARSER::COLLECTION)
    ("DNMT or HDAC" . SPARSER::COLLECTION) ("CBP/p300" . SPARSER::COLLECTION)
    ("DOT1L and RNA" . SPARSER::COLLECTION)
    ("DOT1L and H3K79" . SPARSER::COLLECTION)
    ("several mesenchymal regulator genes" . SPARSER::GENE)
    ("EMT and CSC-like" . SPARSER::COLLECTION)
    ("Snail and ZEB2" . SPARSER::COLLECTION)
    ("protein
and mRNA"
     . SPARSER::COLLECTION)
    ("Snail, ZEB1
and ZEB2"
     . SPARSER::COLLECTION)
    ("DOT1L-" . SPARSER::PROTEIN)
    ("DOT1L
and HRAS"
     . SPARSER::COLLECTION)
    ("Snail, ZEB1 and ZEB2" . SPARSER::COLLECTION)
    ("DOT1L
or HRAS"
     . SPARSER::COLLECTION)
    ("DOT1L and an
activated form"
     . SPARSER::COLLECTION)
    ("DOT1L or HRAS" . SPARSER::COLLECTION)
    ("DOT1L and HRAS" . SPARSER::COLLECTION)
    ("BMI-1 and LBX1" . SPARSER::COLLECTION) ("/ESA" . SPARSER::COLLECTION)
    ("/CD24" . SPARSER::COLLECTION) ("ESA" . SPARSER::PROTEIN)
    ("inducer, or TGF-β" . SPARSER::COLLECTION)
    ("N-cadherin and Vimentin" . SPARSER::COLLECTION)
    ("Vimentin" . SPARSER::PROTEIN) ("receptor (ER)" . SPARSER::RECEPTOR)
    ("EMT and stem
cell-like"
     . SPARSER::COLLECTION)
    ("a novel transcriptional active complex" . SPARSER::BIO-COMPLEX)
    ("c-Myc
and p300"
     . SPARSER::COLLECTION)
    ("E-cadherin, Snail and ZEB1" . SPARSER::COLLECTION)
    ("methyltransferase, G9a
and SET8"
     . SPARSER::COLLECTION)
    ("c-Myc, Bmi-1
and Wnt"
     . SPARSER::COLLECTION)
    ("DOT1L-c-Myc-p300" . SPARSER::COLLECTION)
    ("SNAIL , ZEB1 and ZEB2" . SPARSER::COLLECTION)
    ("HDAC1 and DNMT1" . SPARSER::COLLECTION)
    ("c-Myc-p300" . SPARSER::COLLECTION)
    ("epithelial–mesenchymal transition (EMT) regulators" . SPARSER::REGULATOR)
    ("c-Myc and p300" . SPARSER::COLLECTION)
    ("basic fibroblast
growth factor"
     . SPARSER::PROTEIN)
    ("Glutathione S-transferase" . SPARSER::PROTEIN)
    ("SB
431542"
     . SPARSER::DRUG)
    ("epidermal growth
factor"
     . SPARSER::PROTEIN)
    ("anti-oestrogen" . SPARSER::DRUG) ("AF9" . SPARSER::PROTEIN)
    ("AF4" . SPARSER::PROTEIN)
    ("transcriptional activator" . SPARSER::PROTEIN-FAMILY)
    ("smad2" . SPARSER::PROTEIN) ("LBX1" . SPARSER::PROTEIN)
    ("BMI-1" . SPARSER::PROTEIN) ("CD24" . SPARSER::PROTEIN)
    ("SB 431542" . SPARSER::DRUG) ("SET8" . SPARSER::PROTEIN)
    ("G9a" . SPARSER::PROTEIN) ("SIP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SNAI2" . SPARSER::PROTEIN) ("SNAI1" . SPARSER::PROTEIN)
    ("Twist1" . SPARSER::PROTEIN) ("Bmi-1" . SPARSER::PROTEIN)
    ("DOT1L" . SPARSER::PROTEIN) ("anti-IL-6-STAT3" . SPARSER::COLLECTION)
    ("PTEN , SMAD4 , CCND1 and SPP1" . SPARSER::COLLECTION)
    ("aggressive lethal PCa" . SPARSER::PROTEIN)
    ("STAT3–ARF" . SPARSER::COLLECTION)
    ("inflammatory cytokines and/or growth factors" . SPARSER::COLLECTION)
    ("Pten and p19  ARF" . SPARSER::COLLECTION) ("Stat3-" . SPARSER::PROTEIN)
    ("senescence-competent PCa" . SPARSER::PROTEIN)
    ("STAT3 and its transcriptional target ARF" . SPARSER::COLLECTION)
    ("primary and metastatic PCa" . SPARSER::PROTEIN)
    ("STAT3 and/or CDKN2A" . SPARSER::COLLECTION)
    ("STAT3 (2.5%) and CDKN2A (2.3%)" . SPARSER::COLLECTION)
    ("matched primary and metastatic PCa" . SPARSER::PROTEIN)
    ("STAT3 and/or p14 ARF" . SPARSER::COLLECTION)
    ("matched primary and metastatic human PCa" . SPARSER::PROTEIN)
    ("p14 ARF and STAT3" . SPARSER::COLLECTION)
    ("STAT3 or p14 ARF" . SPARSER::COLLECTION)
    ("IL-6 or STAT3" . SPARSER::COLLECTION)
    ("a dual-specific JAK1/2 kinase inhibitor" . SPARSER::INHIBITOR)
    ("JAK2/STAT3" . SPARSER::COLLECTION) ("Ruxolitinib" . SPARSER::DRUG)
    ("ruxolitinib" . SPARSER::DRUG)
    ("high-grade invasive PCa" . SPARSER::PROTEIN)
    ("IL-6 and Pten" . SPARSER::COLLECTION)
    ("Socs3 and c-fos" . SPARSER::COLLECTION) ("Socs3" . SPARSER::PROTEIN)
    ("Stat3 and p19 ARF" . SPARSER::COLLECTION) ("–p53" . SPARSER::COLLECTION)
    ("ISG15 and Stat3" . SPARSER::COLLECTION)
    ("p53 and ARF" . SPARSER::COLLECTION)
    ("IFNβ–STAT1–ISG15" . SPARSER::COLLECTION)
    ("–Mdm2–p53" . SPARSER::COLLECTION) ("p53 and Pten" . SPARSER::COLLECTION)
    ("protein (PML)" . SPARSER::PROTEIN) ("Cdkn1" . SPARSER::PROTEIN)
    ("STAT3 and PTEN" . SPARSER::COLLECTION) ("PIN" . SPARSER::PROTEIN)
    ("pY-Stat3" . SPARSER::COLLECTION) ("Pten and Stat3" . SPARSER::COLLECTION)
    ("Stat3 , IL-6Rα and IL-6" . SPARSER::COLLECTION)
    ("PTEN and STAT3" . SPARSER::COLLECTION)
    ("Stat3 and Pten" . SPARSER::COLLECTION)
    ("IL-6/Stat3" . SPARSER::COLLECTION) ("PTEN–STAT3" . SPARSER::COLLECTION)
    ("Pten and p53" . SPARSER::COLLECTION) ("ARF–p53" . SPARSER::COLLECTION)
    ("IL-6 and STAT3" . SPARSER::COLLECTION)
    ("the sensitive yet diagnostically unspecific biomarker prostate-specific antigen (PSA)"
     . SPARSER::PROTEIN)
    ("prostate-specific antigen (PSA)" . SPARSER::PROTEIN)
    ("IL6-STAT3" . SPARSER::COLLECTION) ("STAT3 and ARF" . SPARSER::COLLECTION)
    ("metastatic PCa" . SPARSER::PROTEIN)
    ("STAT3 and p14 ARF" . SPARSER::COLLECTION)
    ("STAT3 and CDKN2A" . SPARSER::COLLECTION)
    ("ARF–Mdm2–p53" . SPARSER::COLLECTION)
    ("Stat3 or IL-6" . SPARSER::COLLECTION)
    ("IL-6/STAT3" . SPARSER::COLLECTION)
    ("Hyperactive STAT3" . SPARSER::PROTEIN) ("A15" . SPARSER::PROTEIN)
    ("L11" . SPARSER::PROTEIN) ("SPP1" . SPARSER::PROTEIN)
    ("IFN gamma" . SPARSER::PROTEIN) ("p19  ARF" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase inhibitor 1" . SPARSER::PROTEIN)
    ("IL-6R" . SPARSER::PROTEIN) ("p14 ARF" . SPARSER::PROTEIN)
    ("p19 ARF" . SPARSER::PROTEIN)
    ("The transcription factor TWIST1 and the oncogene MYC"
     . SPARSER::COLLECTION)
    ("TWIST1 and vice versa" . SPARSER::COLLECTION)
    ("epithelial TWIST1 and MYC" . SPARSER::COLLECTION)
    ("estradiol and higher concentrations" . SPARSER::COLLECTION)
    ("epithelial MYC and TWIST1" . SPARSER::COLLECTION)
    ("ZEB1, and ZEB2" . SPARSER::COLLECTION) ("TGF-" . SPARSER::DRUG)
    ("ß-estradiol" . SPARSER::COLLECTION)
    ("OCT4 and TWIST1" . SPARSER::COLLECTION)
    ("SLUG and CDH1" . SPARSER::COLLECTION)
    ("CDH1 , TWIST1 and MYC" . SPARSER::COLLECTION)
    ("rAFS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("epithelial MYC" . SPARSER::PROTEIN)
    ("TWIST1 and CDH1" . SPARSER::COLLECTION)
    ("positive epithelial MYC" . SPARSER::PROTEIN)
    ("MYC and TWIST1" . SPARSER::COLLECTION)
    ("showed positive stromal MYC" . SPARSER::PROTEIN)
    ("stromal MYC" . SPARSER::PROTEIN)
    ("TWIST1 and SNAIL" . SPARSER::COLLECTION)
    ("CDH1 and TWIST1, CDH1 and SNAIL, CDH1 and SLUG, and TWIST1 and MYC"
     . SPARSER::COLLECTION)
    ("TWIST1, CDH1 and SNAIL, CDH1 and SLUG, and TWIST1 and MYC"
     . SPARSER::COLLECTION)
    ("SNAIL, CDH1 and SLUG, and TWIST1 and MYC" . SPARSER::COLLECTION)
    ("SLUG, and TWIST1 and MYC" . SPARSER::COLLECTION)
    ("MYC, Cyclin D1, and Ki67" . SPARSER::COLLECTION)
    ("the pro-apoptotic factor BAX" . SPARSER::PROTEIN)
    ("mesenchymal cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Epithelial TWIST1" . SPARSER::PROTEIN)
    ("TWIST1 or MYC" . SPARSER::COLLECTION)
    ("TWIST1, SNAIL and SLUG" . SPARSER::COLLECTION)
    ("TWIST1 and MYC" . SPARSER::COLLECTION)
    ("TWIST1/SNAIL/SLUG" . SPARSER::COLLECTION)
    ("TWIST1 and MYC protein" . SPARSER::COLLECTION)
    ("CDH1, TWIST1, SNAIL and SLUG" . SPARSER::COLLECTION)
    ("TWIST1, CDH1 and MYC" . SPARSER::COLLECTION) ("SLUG" . SPARSER::PROTEIN)
    ("Snail1" . SPARSER::PROTEIN) ("Chi 2" . SPARSER::PROTEIN)
    ("basic helix-loop-helix" . SPARSER::PROTEIN) ("TWIST1" . SPARSER::PROTEIN)
    ("P53 and p21 CIP1" . SPARSER::COLLECTION)
    ("hypoxia and ischemia" . SPARSER::COLLECTION)
    ("p21 CIP1 , p27 KIP1 , and p53" . SPARSER::COLLECTION)
    ("AMPK and other regulators" . SPARSER::COLLECTION)
    ("an antidiabetic drug" . SPARSER::DRUG)
    ("p53, p21 CIP1 and p27 KIP1" . SPARSER::COLLECTION)
    ("metformin and ESCC" . SPARSER::COLLECTION)
    ("p53 and p21 CIP1" . SPARSER::COLLECTION) ("CDKI" . SPARSER::DRUG)
    ("cyclinD1, p53, p21 CIP1 and p27 KIP1" . SPARSER::COLLECTION)
    ("phosphorylated AMPK and its primary substrate" . SPARSER::COLLECTION)
    ("ACC" . SPARSER::PROTEIN) ("Acetyl" . SPARSER::MOLECULE)
    ("metformin and AMPK" . SPARSER::COLLECTION)
    ("p27 KIP1 and p21 CIP1" . SPARSER::COLLECTION)
    ("metformin or 1mM" . SPARSER::COLLECTION)
    ("proteins, p21 CIP1 and p27 KIP1" . SPARSER::COLLECTION)
    ("AICAR and metformin" . SPARSER::COLLECTION)
    ("metformin and AICAR" . SPARSER::COLLECTION)
    ("growth factor and miRNA" . SPARSER::COLLECTION)
    ("a tumor suppressor and an up-stream regulator of p21 CIP1"
     . SPARSER::COLLECTION)
    ("CDKIs, p21 CIP1 and p27 KIP1" . SPARSER::COLLECTION)
    ("cyclin/CDK" . SPARSER::COLLECTION)
    ("cyclin D1 and CDKs" . SPARSER::COLLECTION)
    ("cyclin-dependent kinases (CDKs) and CDK inhibitors (CDKIs)"
     . SPARSER::COLLECTION)
    ("CDKIs" . SPARSER::DRUG) ("metabolic poisons" . SPARSER::MOLECULE)
    ("poisons" . SPARSER::MOLECULE) ("Metformin" . SPARSER::DRUG)
    ("the major histological type" . TYPE)
    ("metformin and cell cycle arrest" . SPARSER::COLLECTION)
    ("AMPK, p53, p21 CIP1 , p27 KIP1 and cyclinD1" . SPARSER::COLLECTION)
    ("p21 CIP1 and p27 KIP1" . SPARSER::COLLECTION)
    ("compound C" . SPARSER::MOLECULE) ("etc ." . SPARSER::PROTEIN)
    ("adenosine monophosphate" . SPARSER::MOLECULE)
    ("p21 CIP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ARs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("gal and its analogs" . SPARSER::COLLECTION)
    ("Bax/Bcl-2" . SPARSER::COLLECTION) ("Bcl2 and Bax" . SPARSER::COLLECTION)
    ("caspase-3 and PARP" . SPARSER::COLLECTION)
    ("AR-Hsp90 disruptive inhibitors" . SPARSER::INHIBITOR)
    ("co-activators/chaperones" . SPARSER::COLLECTION)
    ("mutants or variants" . SPARSER::COLLECTION)
    ("pharmacologic inhibitors" . SPARSER::INHIBITOR)
    ("AR-V7 and cyclin D1" . SPARSER::COLLECTION)
    ("cyclin D1 and Bcl2" . SPARSER::COLLECTION)
    ("Galeterone and VNPT55" . SPARSER::COLLECTION)
    ("PR, RARα and RARβ" . SPARSER::COLLECTION)
    ("progesterone receptor (PR)" . SPARSER::PROTEIN)
    ("estrogen receptor beta (ERβ) and retinoic acid receptors (RAR-α and -β)"
     . SPARSER::COLLECTION)
    ("nuclear receptors in LNCaP cells and AR in PWR-1E and WPMY-1 prostate cells"
     . SPARSER::COLLECTION)
    ("cytochrome c (green) and mitotracker (red)" . SPARSER::COLLECTION)
    ("Bax-mitochondria" . SPARSER::COLLECTION)
    ("the pro-apoptotic protein" . SPARSER::PROTEIN)
    ("annexin-v" . SPARSER::COLLECTION) ("AO/EB" . SPARSER::COLLECTION)
    ("AO" . SPARSER::PROTEIN)
    ("Mdm2 and CHIP E3 ligases" . SPARSER::COLLECTION)
    ("Hsp90-AR" . SPARSER::COLLECTION) ("Hsp70-AR-V7" . SPARSER::COLLECTION)
    ("AR-Hsp90" . SPARSER::COLLECTION)
    ("a heteromeric complex" . SPARSER::BIO-COMPLEX)
    ("AR-Mdm2" . SPARSER::COLLECTION)
    ("the well-studied and established E3 ligases" . SPARSER::LIGASE)
    ("LY294002 or U0126" . SPARSER::COLLECTION)
    ("LY294002 and UO126" . SPARSER::COLLECTION)
    ("PI3k-Akt" . SPARSER::COLLECTION) ("Akt/Mdm2" . SPARSER::COLLECTION)
    ("Mdm2 (at Ser166) and AR (at Ser210/213 and Ser790)"
     . SPARSER::COLLECTION)
    ("PI3k" . SPARSER::PROTEIN-FAMILY) ("Akt and Mdm2" . SPARSER::COLLECTION)
    ("gal and MG132" . SPARSER::COLLECTION)
    ("AR and AR-V7" . SPARSER::COLLECTION)
    ("gal- and VNPT55" . SPARSER::COLLECTION) ("gal-" . SPARSER::PROTEIN)
    ("gal or VNPT55" . SPARSER::COLLECTION) ("the analog’s" . SPARSER::ANALOG)
    ("full length AR and splice variant AR-Vs." . SPARSER::COLLECTION)
    ("receptors and AR" . SPARSER::COLLECTION)
    ("gal and its analog" . SPARSER::COLLECTION)
    ("AR/AR-V7" . SPARSER::COLLECTION)
    ("gal and its 3β-carbamate analog" . SPARSER::COLLECTION)
    ("carbamate" . SPARSER::MOLECULE) ("androgen/AR" . SPARSER::COLLECTION)
    ("PSA, TMPRSS2, and Nkx3.1" . SPARSER::COLLECTION)
    ("gal and abiraterone" . SPARSER::COLLECTION)
    ("galeterone or TOK-001" . SPARSER::COLLECTION) ("VN" . SPARSER::PROTEIN)
    ("galeterone" . SPARSER::DRUG) ("benzimidazole" . SPARSER::DRUG)
    ("prednisone, cabazitaxel, abiraterone acetate, sipuleucel-T and enzalutamide"
     . SPARSER::COLLECTION)
    ("Gal and VNPT55" . SPARSER::COLLECTION) ("Bax/Bcl2" . SPARSER::COLLECTION)
    ("posttranslational modified receptors" . SPARSER::RECEPTOR)
    ("gal and VNPT55" . SPARSER::COLLECTION) ("f-AR" . SPARSER::COLLECTION)
    ("Rv" . SPARSER::MOLECULE) ("gal" . SPARSER::PROTEIN)
    ("Galeterone" . SPARSER::DRUG) ("STUB1" . SPARSER::PROTEIN)
    ("Androgen receptor" . SPARSER::PROTEIN) ("RARα" . SPARSER::PROTEIN)
    ("RAR-α" . SPARSER::PROTEIN) ("estrogen receptor beta" . SPARSER::PROTEIN)
    ("receptor proteins" . SPARSER::RECEPTOR-PROTEIN)
    ("calpain inhibitor" . SPARSER::PROTEIN) ("ZVAD-fmk" . SPARSER::DRUG)
    ("calpain 1" . SPARSER::PROTEIN)
    ("Heat shock protein 90" . SPARSER::PROTEIN)
    ("MAPK kinase" . SPARSER::PROTEIN) ("N-C" . SPARSER::PROTEIN)
    ("Hsp70" . SPARSER::PROTEIN) ("TMPRSS2" . SPARSER::PROTEIN)
    ("TOK-001" . SPARSER::DRUG) ("hormone-sensitive" . SPARSER::PROTEIN)
    ("abiraterone acetate" . SPARSER::DRUG) ("CYP17" . SPARSER::PROTEIN)
    ("intralysosomal Ca 2+" . SPARSER::CALCIUM-ION)
    ("PKBα [protein kinase Bα] and MAPKAP-K1b [MAPK (mitogen-activated protein kinase)-activated protein kinase-1b]"
     . SPARSER::COLLECTION)
    ("-activated protein kinase-1b" . SPARSER::COLLECTION)
    ("mitogen-" . SPARSER::MITOGEN) ("rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ROCKII" . SPARSER::PROTEIN)
    ("a robust TOR substrate" . SPARSER::SUBSTRATE)
    ("S3A, S3B and S4A" . SPARSER::COLLECTION) ("Lysosomal" . SPARSER::PROTEIN)
    ("microtubule-associated protein 1A/1B-light chain 3"
     . SPARSER::COLLECTION)
    ("CoCl 2 (an AMPK activator [ xref , xref ]) or DMSO (vehicle)"
     . SPARSER::COLLECTION)
    ("MCOLN1 and AMPK" . SPARSER::COLLECTION)
    ("KD–AMPKα" . SPARSER::COLLECTION)
    ("dominant-negative S6 kinase" . SPARSER::PROTEIN-FAMILY)
    ("MCOLN1 , MCOLN2 and MCOLN3" . SPARSER::COLLECTION)
    ("TRPML1 , TRPML2 and TRPML3" . SPARSER::COLLECTION)
    ("secondary antibody" . SPARSER::PROTEIN)
    ("UAS-AMPK α" . SPARSER::COLLECTION)
    ("transgene or loss-of-function" . SPARSER::COLLECTION)
    ("UAS-SNF4" . SPARSER::COLLECTION) ("UAS" . SPARSER::PROTEIN)
    ("UAS-GFP" . SPARSER::PROTEIN-PAIR) ("UAS-S6k" . SPARSER::COLLECTION)
    ("UAS-AMPKα" . SPARSER::COLLECTION) ("Ubi-GAL4" . SPARSER::COLLECTION)
    ("Secondary antibodies" . SPARSER::ANTIBODY)
    ("LI-COR" . SPARSER::COLLECTION) ("COR" . SPARSER::PROTEIN-FAMILY)
    ("Triton X-100 and protease" . SPARSER::COLLECTION)
    ("antibody and Protein A/G" . SPARSER::COLLECTION)
    ("v/v" . SPARSER::COLLECTION) ("GFP–MCOLN1" . SPARSER::COLLECTION)
    ("mixtures" . SPARSER::MOLECULE) ("AMP and ATP" . SPARSER::COLLECTION)
    ("EDTA" . SPARSER::MOLECULE) ("Hepes" . SPARSER::MOLECULE)
    ("GFP and Fura-2" . SPARSER::COLLECTION)
    ("EGFP and Fura-2" . SPARSER::COLLECTION)
    ("Swiss-Prot" . SPARSER::PROTEIN-PAIR) ("Prot" . SPARSER::PROTEIN)
    ("LTQ" . SPARSER::MOLECULE) ("grade-modified trypsin" . SPARSER::PROTEIN)
    ("TiO" . SPARSER::PROTEIN) ("trypsin" . SPARSER::PROTEIN)
    ("benzonase nuclease (Thermo Fisher Scientific) and protease (Sigma–Aldrich)"
     . SPARSER::COLLECTION)
    ("CoCl 2 or DMSO" . SPARSER::COLLECTION) ("Aldrich" . SPARSER::PROTEIN)
    ("RFP-LC3" . SPARSER::COLLECTION) ("myc-TOR" . SPARSER::COLLECTION)
    ("Sal" . SPARSER::PROTEIN)
    ("anti-α-tubulin (clone B-5-1-2; Sigma–Aldrich) and anti-GFP (A11122 for IP and A6455 for Western; Molecular Probes)"
     . SPARSER::COLLECTION)
    ("anti-LC3 [1:1000 (in milk); MBL International], anti-c-Myc [1:40 dilution for 1 mg/ml lysate for immunoprecipitation (IP); Developmental Studies Hybridoma Bank, University of Iowa], anti-α-tubulin (clone B-5-1-2; Sigma–Aldrich) and anti-GFP (A11122 for IP and A6455 for Western; Molecular Probes)"
     . SPARSER::COLLECTION)
    ("Sigma–Aldrich" . SPARSER::COLLECTION) ("B-5-1-2" . SPARSER::COLLECTION)
    ("MBL" . SPARSER::PROTEIN) ("Chemical" . SPARSER::MOLECULE)
    ("understand MLIV and other lysosomal" . SPARSER::COLLECTION)
    ("TOR–TRPML1" . SPARSER::COLLECTION)
    ("AMPK and MCOLN1" . SPARSER::COLLECTION) ("catabolism" . SPARSER::PROTEIN)
    ("lysosomal hydrolases nor related lysosomal proteins [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("mucopolysaccharides" . SPARSER::MOLECULE)
    ("AMPK and the lysosomal Ca 2+ efflux channel TRPML1 [transient receptor potential mucolipin 1 (MCOLN1; UniProtKB–Q9GZU1)]"
     . SPARSER::COLLECTION)
    ("UniProtKB–Q9GZU1" . SPARSER::COLLECTION)
    ("TSC1–TSC2" . SPARSER::COLLECTION)
    ("degradatory enzymes" . SPARSER::ENZYME)
    ("cellular macromolecules" . SPARSER::MOLECULE) ("LSDs" . SPARSER::DRUG)
    ("MLIV" . SPARSER::PROTEIN) ("type " . TYPE) ("LSD" . SPARSER::DRUG)
    ("activated protein kinase" . SPARSER::PROTEIN)
    ("MAPKAP-K1b" . SPARSER::PROTEIN) ("PKBα" . SPARSER::PROTEIN)
    ("stress-activated protein kinase 1" . SPARSER::PROTEIN)
    ("MSK1" . SPARSER::PROTEIN) ("S5B" . SPARSER::PROTEIN)
    ("microtubule-associated protein 1A" . SPARSER::PROTEIN)
    ("TRPML1 " . SPARSER::PROTEIN) ("TRPML3" . SPARSER::PROTEIN)
    ("TRPML2" . SPARSER::PROTEIN) ("MCOLN3" . SPARSER::PROTEIN)
    ("MCOLN2" . SPARSER::PROTEIN) ("MCOLN  2" . SPARSER::PROTEIN)
    ("SNF4" . SPARSER::PROTEIN) ("S6k" . SPARSER::PROTEIN)
    ("1A 1" . SPARSER::PROTEIN) ("MCOLN  1" . SPARSER::PROTEIN)
    ("GAL4" . SPARSER::PROTEIN) ("SA1" . SPARSER::PROTEIN)
    ("per 2 " . SPARSER::PROTEIN) ("MHY1485" . SPARSER::DRUG)
    ("32P" . SPARSER::|32P|) ("Q9GZU1" . SPARSER::PROTEIN)
    ("AMPK α" . SPARSER::PROTEIN-FAMILY) ("SNF1" . SPARSER::PROTEIN-FAMILY)
    ("MCOLN1" . SPARSER::PROTEIN) ("mucolipin 1" . SPARSER::PROTEIN)
    ("TRPML1" . SPARSER::PROTEIN) ("Cadherin–catenin" . SPARSER::COLLECTION)
    ("Cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ecad and actin" . SPARSER::COLLECTION)
    ("cellular Ecad" . SPARSER::PROTEIN)
    ("tailless cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("This flexible long arm" . SPARSER::PROTEIN)
    ("the flexible GFP-bearing arm" . SPARSER::PROTEIN)
    ("wt Ecad and cis-Ecad cell monolayers" . SPARSER::COLLECTION)
    ("PIV" . SPARSER::PROTEIN)
    ("the Brownian motion component" . SPARSER::COMPONENT)
    ("Dt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Both wt and cis-Ecad cell monolayers" . SPARSER::COLLECTION)
    ("Ecad–actin" . SPARSER::COLLECTION)
    ("cadherin–actin" . SPARSER::COLLECTION)
    ("Ecad and cis" . SPARSER::COLLECTION)
    ("cadherin–catenin" . SPARSER::COLLECTION)
    ("cadherin and catenin molecules and formation of AJs"
     . SPARSER::COLLECTION)
    ("cadherin and catenin" . SPARSER::COLLECTION)
    ("stabilizing junctional Ecad" . SPARSER::PROTEIN)
    ("dual wavelength FRAP" . SPARSER::PROTEIN)
    ("α-catenin-mCherry" . SPARSER::COLLECTION)
    ("wt and cis-Ecad expressing cells ( xref )" . SPARSER::COLLECTION)
    ("junctional molecules" . SPARSER::MOLECULE)
    ("junctional cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("wt Ecad and cis-Ecad molecules" . SPARSER::COLLECTION)
    ("a 15-" . SPARSER::PROTEIN) ("the oligomeric forms" . SPARSER::FORM)
    ("very few NPs" . SPARSER::PROTEIN)
    ("two adjacent cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NPs" . SPARSER::PROTEIN) ("nanoparticles (NP)" . SPARSER::MOLECULE)
    ("anti-GFP-NP" . SPARSER::COLLECTION)
    ("cis-oligomers" . SPARSER::COLLECTION)
    ("tailless Ecad" . SPARSER::PROTEIN) ("cis and wt" . SPARSER::COLLECTION)
    ("Ecad-Fc" . SPARSER::COLLECTION)
    ("wt and cis-mutant" . SPARSER::COLLECTION)
    ("cis-Ecad-GFP" . SPARSER::COLLECTION) ("Ecad-GFP" . SPARSER::COLLECTION)
    ("full-length wt and cis-Ecad (V81D, L175D double mutant) in Ecad-deficient A431D cells"
     . SPARSER::COLLECTION)
    ("oligomeric Ecad" . SPARSER::PROTEIN)
    ("catenins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cis-Ecad" . SPARSER::COLLECTION)
    ("trans- and cis-interactions" . SPARSER::COLLECTION)
    ("a neighboring cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ecad" . SPARSER::PROTEIN)
    ("desmosomal cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("connexins" . SPARSER::PROTEIN)
    ("short living intercellular protein–protein" . SPARSER::COLLECTION)
    ("an oligomeric state" . SPARSER::BIO-STATE)
    ("junctional E-cadherin" . SPARSER::PROTEIN)
    ("oligomeric cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NI2" . SPARSER::PROTEIN)
    ("αE-catenin" . SPARSER::PROTEIN) ("Cell membrane" . SPARSER::PROTEIN)
    ("anti–β" . SPARSER::PROTEIN) ("D-L" . SPARSER::PROTEIN)
    ("α-catenin" . SPARSER::PROTEIN) ("E-cadherins" . SPARSER::PROTEIN)
    ("nucleolar PinX1" . SPARSER::PROTEIN) ("si-TERT" . SPARSER::COLLECTION)
    ("TERT and PinX1" . SPARSER::COLLECTION)
    ("the nucleolar forms" . SPARSER::FORM) ("myc-PinX1" . SPARSER::COLLECTION)
    ("GFP-PinX1" . SPARSER::COLLECTION) ("HA-" . SPARSER::PROTEIN)
    ("GFP-fused" . SPARSER::COLLECTION) ("HA-PinX1" . SPARSER::COLLECTION)
    ("the nucleolar form" . SPARSER::FORM)
    ("subunits, TERT and TR" . SPARSER::COLLECTION)
    ("RAP1, TIN2, TPP1, and POT1" . SPARSER::COLLECTION)
    ("TRF1 and TRF2" . SPARSER::COLLECTION)
    ("proteins, and POT1" . SPARSER::COLLECTION)
    ("shelterin" . SPARSER::PROTEIN) ("TR and TERT" . SPARSER::COLLECTION)
    ("other accessory proteins" . SPARSER::PROTEIN)
    ("both PinX1 1–328 and PinX1" . SPARSER::COLLECTION)
    ("nucleolar forms" . SPARSER::FORM) ("TERT-myc" . SPARSER::COLLECTION)
    ("a nucleolar fragment" . SPARSER::FRAGMENT)
    ("PinX1 and TERT" . SPARSER::COLLECTION) ("3 − 1" . SPARSER::PROTEIN)
    ("TPP1" . SPARSER::PROTEIN) ("TIN2" . SPARSER::PROTEIN)
    ("RAP1" . SPARSER::PROTEIN)
    ("telomeric DNA-binding protein" . SPARSER::PROTEIN)
    ("PinX1" . SPARSER::PROTEIN)
    ("an otherwise mostly intact genome" . SPARSER::PROTEIN)
    ("the aberrant telomerase activity" . SPARSER::PROTEIN)
    ("a mitotic inhibitor" . SPARSER::INHIBITOR)
    ("mRNA and telomerase activity" . SPARSER::COLLECTION)
    ("both NPCs and neurons" . SPARSER::COLLECTION)
    ("neuronal marker genes" . SPARSER::GENE) ("NEUN" . SPARSER::PROTEIN)
    ("robust telomerase activity" . SPARSER::PROTEIN)
    ("EB" . SPARSER::PROTEIN-FAMILY) ("EBs" . SPARSER::PROTEIN)
    ("wild type human pluripotent stem cells TR"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TERT and TR" . SPARSER::COLLECTION) ("Southern blot" . SPARSER::PROTEIN)
    ("attempted conventional donor-based genome" . SPARSER::PROTEIN)
    ("proteins and other molecules" . SPARSER::COLLECTION)
    ("OCT4" . SPARSER::PROTEIN) ("COL1A1" . SPARSER::PROTEIN)
    ("telomerase RNA component" . SPARSER::RNA)
    ("Nrf2 and its target genes" . SPARSER::COLLECTION)
    ("proteins, and Bcl-xL" . SPARSER::COLLECTION)
    ("Nrf2-shRNA" . SPARSER::COLLECTION)
    ("Nrf2 and its downstream genes" . SPARSER::COLLECTION)
    ("enzymes, and transporters" . SPARSER::COLLECTION)
    ("pEGFP-Nrf2" . SPARSER::COLLECTION) ("shRNA-Nrf2" . SPARSER::COLLECTION)
    ("parenchymal hepatocytes" . SPARSER::PROTEIN)
    ("antioxidant and detoxification enzymes [ xref ]" . SPARSER::COLLECTION)
    ("a reliable prognostic biomarker" . SPARSER::MOLECULE)
    ("aflatoxin" . SPARSER::MOLECULE)
    ("Bcl-xL and MMP-9" . SPARSER::COLLECTION)
    ("Nrf2 or NFE2L2" . SPARSER::COLLECTION)
    ("ISRE-activity and ISG" . SPARSER::COLLECTION)
    ("ISRE-activity" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("a typical negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("type I (IFN-α) and type III (IFN-λ)" . SPARSER::COLLECTION)
    ("PEG-IFN-α" . SPARSER::COLLECTION) ("ribavirin" . SPARSER::DRUG)
    ("NRs" . SPARSER::PROTEIN)
    ("100 IU/mL IFN-α and 50 ng/mL IFN-λ" . SPARSER::COLLECTION)
    ("IFN-α (from 19.7±1.22 to 13.6±0.47-fold) and IFN-λ (from 5.57±1.02 to 1.64±0.19-fold)"
     . SPARSER::COLLECTION)
    ("IFN-α (from 29.7±3.65 to 12.8±1.43-fold) and IFN-λ (from 11.6±1.77 to 5.47±1.21-fold)"
     . SPARSER::COLLECTION)
    ("type I or type III" . SPARSER::COLLECTION)
    ("IFN-α or IFN-λ" . SPARSER::COLLECTION)
    ("100 IU/mL IFN-α or 50 ng/mL IFN-λ" . SPARSER::COLLECTION)
    ("SOCS1 and ISGs" . SPARSER::COLLECTION)
    ("ISG15 and MxA" . SPARSER::COLLECTION)
    ("exogenous IFN-α and IFN-λ" . SPARSER::COLLECTION)
    ("KIR" . SPARSER::PROTEIN)
    ("the classical inhibitors" . SPARSER::INHIBITOR)
    ("gene 15 (ISG15) and myxovirus resistance-A (MxA)" . SPARSER::COLLECTION)
    ("MxA" . SPARSER::PROTEIN)
    ("Janus kinase 1 (JAK1) and tyrosine kinase 2 (TYK2)"
     . SPARSER::COLLECTION)
    ("ISRE" . SPARSER::DNA-RESPONSE-ELEMENT) ("RBV" . SPARSER::DRUG)
    ("PEG" . SPARSER::PROTEIN)
    ("direct acting antiviral antivirals" . SPARSER::DRUG)
    ("antivirals" . SPARSER::DRUG) ("IFN-α and IFN-λ" . SPARSER::COLLECTION)
    ("type I and type III" . SPARSER::COLLECTION)
    ("Jak/STAT" . SPARSER::COLLECTION) ("IFNAR2" . SPARSER::PROTEIN)
    ("IL28B" . SPARSER::PROTEIN) ("USP18" . SPARSER::PROTEIN)
    ("interferon-induced" . SPARSER::PROTEIN)
    ("IFN-lambda1" . SPARSER::PROTEIN) ("Tyk2" . SPARSER::PROTEIN)
    ("ISGF3" . SPARSER::PROTEIN) ("TYK2" . SPARSER::PROTEIN)
    ("tyrosine kinase 2" . SPARSER::PROTEIN) ("JAK1" . SPARSER::PROTEIN)
    ("Janus kinase 1" . SPARSER::PROTEIN) ("IFNα" . SPARSER::PROTEIN)
    ("Suppressor of cytokine signaling 1" . SPARSER::PROTEIN)
    ("serotonin and other systemic factors such as endothelin-1, angiotensin II, noradrenaline, and acetylcholine"
     . SPARSER::COLLECTION)
    ("endothelin-1, angiotensin II, noradrenaline, and acetylcholine"
     . SPARSER::COLLECTION)
    ("RhoGEF" . SPARSER::PROTEIN) ("noradrenaline" . SPARSER::PROTEIN)
    ("serotonin" . SPARSER::MOLECULE) ("pre-" . SPARSER::PROTEIN)
    ("GGA" . SPARSER::MOLECULE) ("SUMO1, or SUMO2-3" . SPARSER::COLLECTION)
    ("S303/S307A" . SPARSER::PROTEIN)
    ("HSPA1A, HSPCA, HSPB1, DNAJB1, and HSPD1" . SPARSER::COLLECTION)
    ("calpeptin" . SPARSER::MOLECULE) ("SRE-luciferase" . SPARSER::COLLECTION)
    ("RhoA" . SPARSER::PROTEIN)
    ("P190RhoGAP (that reduces RhoA activity) or the dominant negative RhoA-n19 ( xref )"
     . SPARSER::COLLECTION)
    ("RhoA-v14" . SPARSER::PROTEIN-PAIR)
    ("response element (SRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("SRE" . SPARSER::PROTEIN) ("HSPA1A-luc" . SPARSER::COLLECTION)
    ("GAPs and GDIs" . SPARSER::COLLECTION) ("GDIs" . SPARSER::PROTEIN)
    ("hspb1" . SPARSER::PROTEIN) ("monomeric HSF1" . SPARSER::PROTEIN)
    ("trimer" . SPARSER::TRIMER) ("TRiC" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HSPCA" . SPARSER::PROTEIN) ("HSF1-HSE" . SPARSER::COLLECTION)
    ("HL-1" . SPARSER::PROTEIN) ("proteins (HSP)" . SPARSER::PROTEIN)
    ("HSE" . SPARSER::PROTEIN) ("p190RhoGAP" . SPARSER::PROTEIN)
    ("AKAP-Lbc" . SPARSER::PROTEIN) ("angiotensin II" . SPARSER::PROTEIN)
    ("TX100" . SPARSER::DRUG) ("PD150606" . SPARSER::DRUG)
    ("P190RhoGAP" . SPARSER::PROTEIN) ("DNAJB1" . SPARSER::PROTEIN)
    ("HSPD1" . SPARSER::PROTEIN) ("HSPA5" . SPARSER::PROTEIN)
    ("TOTO-3" . SPARSER::MOLECULE) ("β-Galactosidase" . SPARSER::PROTEIN)
    ("SUMO2" . SPARSER::PROTEIN) ("SUMO1" . SPARSER::PROTEIN)
    ("member A" . SPARSER::PROTEIN)
    ("Ras homolog gene family" . SPARSER::PROTEIN)
    ("Heat shock transcription factor 1" . SPARSER::PROTEIN)
    ("HSF1" . SPARSER::PROTEIN)
    ("heat shock transcription factor 1" . SPARSER::PROTEIN)
    ("SMARCA4 , EPHA3 , MYB , PDGFR-β , and PIK3CA" . SPARSER::COLLECTION)
    ("MYB" . SPARSER::PROTEIN) ("a polar glutamine" . SPARSER::AMINO-ACID)
    ("the subcutaneous fat" . SPARSER::PROTEIN)
    ("a previously identified p" . SPARSER::PROTEIN)
    ("the embryonic vasculature" . SPARSER::PROTEIN)
    ("healthy control DNA" . SPARSER::DNA)
    ("GNAQ and RASA1" . SPARSER::COLLECTION)
    ("additional causative genetic variants" . SPARSER::VARIANT)
    ("fast-flow arteriovenous malformations (AVM)" . SPARSER::PROTEIN)
    ("membrane receptor and downstream effectors" . SPARSER::COLLECTION)
    ("Gq" . SPARSER::DRUG) ("GNAQ" . SPARSER::PROTEIN)
    ("wine" . SPARSER::MOLECULE) ("EPHA3" . SPARSER::PROTEIN)
    ("SMARCA4" . SPARSER::PROTEIN) ("Protein Kinase B" . SPARSER::PROTEIN)
    ("Mitogen-Activated Protein Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Extracellular Signal-Regulated Kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("guanosine triphosphate" . SPARSER::MOLECULE)
    ("Ras p21 protein activator" . SPARSER::PROTEIN)
    ("protein and fat" . SPARSER::COLLECTION) ("metformin" . SPARSER::DRUG)
    ("Ketone" . SPARSER::MOLECULE) ("AmpK and pyruvate" . SPARSER::COLLECTION)
    ("NeuroD2" . SPARSER::PROTEIN) ("AmpK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SMO" . SPARSER::PROTEIN) ("NeuroD" . SPARSER::PROTEIN)
    ("ketones" . SPARSER::MOLECULE)
    ("lactate and glutamine" . SPARSER::COLLECTION)
    ("non-essential amino acids such as serine [ xref ]" . SPARSER::AMINO-ACID)
    ("Ptch" . SPARSER::PROTEIN) ("Smo" . SPARSER::PROTEIN)
    ("GDC-0449" . SPARSER::DRUG)
    ("Hedgehog Antagonist GDC-0449" . SPARSER::DRUG)
    ("BR 3" . SPARSER::PROTEIN) ("19A" . SPARSER::PROTEIN)
    ("Foxo3a" . SPARSER::PROTEIN) ("TR 3" . SPARSER::PROTEIN)
    ("x 25" . SPARSER::PROTEIN) ("IGF-2" . SPARSER::PROTEIN)
    ("insulin-like-growth factor" . SPARSER::PROTEIN)
    ("the high CIBMTR cytogenetic risk group" . SPARSER::MOLECULE)
    ("alemtuzumab" . SPARSER::DRUG) ("FMS" . SPARSER::PROTEIN)
    ("2−4" . SPARSER::PROTEIN)
    ("Granulocyte colony-stimulating factor" . SPARSER::PROTEIN)
    ("mycophenolate mofetil" . SPARSER::DRUG)
    ("calcineurin inhibitor" . SPARSER::PROTEIN)
    ("FMS-like tyrosine kinase 3" . SPARSER::PROTEIN)
    ("HR 1" . SPARSER::PROTEIN-FAMILY) ("HR 2" . SPARSER::PROTEIN)
    ("HR 3" . SPARSER::PROTEIN)
    ("group, and CIC and FUBP1" . SPARSER::COLLECTION)
    ("CIC and FUBP1" . SPARSER::COLLECTION) ("histologic type" . TYPE)
    ("The predominant histologic type" . TYPE)
    ("C/EBPβ and STAT3" . SPARSER::COLLECTION)
    ("Podoplanin" . SPARSER::PROTEIN)
    ("specifically demonstrating distinct glial fibrillary acidic Protein (GFAP)"
     . SPARSER::PROTEIN)
    ("reticulin" . SPARSER::MOLECULE) ("CIC" . SPARSER::PROTEIN)
    ("NF1 and IDH1/2" . SPARSER::COLLECTION)
    ("IDH1 or IDH2" . SPARSER::COLLECTION)
    ("YKL40, CD44, and STAT3" . SPARSER::COLLECTION)
    ("separated proneural, mesenchymal and proliferative classes" . CLASS)
    ("Nf1 and Tp53" . SPARSER::COLLECTION) ("Tp53" . SPARSER::PROTEIN)
    ("Nf1" . SPARSER::PROTEIN) ("types and grades" . SPARSER::COLLECTION)
    ("the predominant tumor type" . TYPE)
    ("the mesenchymal marker podoplanin" . SPARSER::PROTEIN)
    ("strong p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("podoplanin" . SPARSER::PROTEIN) ("C/EBPβ" . SPARSER::PROTEIN)
    ("glial fibrillary acidic Protein" . SPARSER::PROTEIN)
    ("YKL40" . SPARSER::PROTEIN)
    ("inhibitor and polyploid" . SPARSER::COLLECTION)
    ("CD34 surface antigen [ xref ] and Bcl-xL ( xref and xref )"
     . SPARSER::COLLECTION)
    ("ABT-263 or Bcl-xL" . SPARSER::COLLECTION) ("Vinblastine" . SPARSER::DRUG)
    ("VEGF receptor tyrosine kinase Flk-1 and CDK4/cyclin D1 enzyme inhibitor"
     . SPARSER::COLLECTION)
    ("inhibitors and drugs" . SPARSER::COLLECTION)
    ("DMSO, Ox-1, or ZM" . SPARSER::COLLECTION) ("ATB" . SPARSER::PROTEIN)
    ("Daunorubicin" . SPARSER::DRUG)
    ("both Bcl-2 (Figure xref ) and Bcl-xL (Figure xref )"
     . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-xL, and Bcl-w" . SPARSER::COLLECTION)
    ("Bcl-2 and Bcl-xL" . SPARSER::COLLECTION)
    ("1 μM ABT-263 (CI = 0.231; Q = 1.24) or 20 μM Ox-1 and 2 μM ABT-263 (CI = 0.260; Q = 1.25)"
     . SPARSER::COLLECTION)
    ("orally bioavailable ABT-263" . SPARSER::DRUG)
    ("Bcl-xL, Bcl-2, and Bcl-w" . SPARSER::COLLECTION)
    ("RO-3306 (RO)" . SPARSER::DRUG) ("Ros" . SPARSER::PROTEIN)
    ("Roscovitine" . SPARSER::DRUG)
    ("cyclin B1 and cleavage PARP" . SPARSER::COLLECTION)
    ("Bcl-xL and p-Bcl-xL (Ser62)" . SPARSER::COLLECTION)
    ("p-Bcl-xL" . SPARSER::COLLECTION) ("Bcl-xL/Bcl-2" . SPARSER::COLLECTION)
    ("MTI" . SPARSER::PROTEIN)
    ("pro-apoptotic protein cleavage PARP" . SPARSER::PROTEIN)
    ("MAD2 and BubR1" . SPARSER::COLLECTION)
    ("proteins, MAD2 and BubR1" . SPARSER::COLLECTION)
    ("CDK4/cyclin D1" . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-xL, and Mcl-1" . SPARSER::COLLECTION)
    ("MOMP" . SPARSER::PROTEIN) ("ABT-263, or siRNAs" . SPARSER::COLLECTION)
    ("/cyclin B1" . SPARSER::COLLECTION) ("Oxindole" . SPARSER::DRUG)
    ("inhibitors or drugs" . SPARSER::COLLECTION)
    ("cyclinB1" . SPARSER::PROTEIN) ("Bcl-w" . SPARSER::PROTEIN)
    ("RO-3306" . SPARSER::DRUG) ("BubR1" . SPARSER::PROTEIN)
    ("MAD2" . SPARSER::PROTEIN) ("Cdc20" . SPARSER::PROTEIN)
    ("NB4" . SPARSER::PROTEIN) ("Flk-1" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 1" . SPARSER::PROTEIN)
    ("Ras-ERK" . SPARSER::COLLECTION) ("AG or GG" . SPARSER::COLLECTION)
    ("a gastric-specific tumour suppressor" . SPARSER::SUPPRESSOR)
    ("IBD" . SPARSER::PROTEIN) ("cyclin D1 and MYCC" . SPARSER::COLLECTION)
    ("MYCC" . SPARSER::PROTEIN) ("AA and AG" . SPARSER::COLLECTION)
    ("LPS or Pam3Cys" . SPARSER::COLLECTION) ("AG or AA" . SPARSER::COLLECTION)
    ("AG " . SPARSER::PROTEIN) ("AA " . SPARSER::MOLECULE)
    ("the rs744166 polymorphic G allele" . SPARSER::ALLELE)
    ("AG ( p  = 0.002; OR = 3.27; 95 % CI = 1.42 – 7.67) or GG ( p  = 0.01; OR = 4.2; 95 % CI = 1.32 – 14.20) genotypes"
     . SPARSER::COLLECTION)
    ("ABCC and ABCCC" . SPARSER::COLLECTION)
    ("ABCC" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AA, AG and GG" . SPARSER::COLLECTION)
    ("the polymorphic allele" . SPARSER::ALLELE)
    ("/ERK1/2-JAK/STAT3" . SPARSER::COLLECTION)
    ("SHP-2/mitogen-activated protein kinases" . SPARSER::COLLECTION)
    ("Glu-Pro-Ile-Tyr-Ala" . SPARSER::COLLECTION)
    ("the cytotoxin-associated antigen" . SPARSER::PROTEIN)
    ("SHP-2/ERK1/2" . SPARSER::COLLECTION) ("JAK/STAT3" . SPARSER::COLLECTION)
    ("IL-6 and IL-11 and JAK" . SPARSER::COLLECTION)
    ("IL-11 and JAK" . SPARSER::COLLECTION) ("-2/ERK" . SPARSER::COLLECTION)
    ("/STAT3-SHP" . SPARSER::COLLECTION) ("SHP" . SPARSER::PROTEIN)
    ("janus" . SPARSER::PROTEIN-FAMILY) ("TNFA" . SPARSER::PROTEIN)
    ("STAT 3 rs744166 G allele and infection" . SPARSER::COLLECTION)
    ("AG and AA" . SPARSER::COLLECTION) ("p-STAT3" . SPARSER::COLLECTION)
    ("LPS (lipopolysaccharide) or Pam3Cys" . SPARSER::COLLECTION)
    ("The rs744166 polymorphic G allele" . SPARSER::ALLELE)
    ("SHP-2/ERK-JAK/STAT3" . SPARSER::COLLECTION) ("TFF 1" . SPARSER::PROTEIN)
    ("TFF 3" . SPARSER::PROTEIN) ("family3" . SPARSER::PROTEIN)
    ("3-phosphate dehydrogenase" . SPARSER::PROTEIN) ("C-1" . SPARSER::PROTEIN)
    ("C-15 " . SPARSER::PROTEIN) ("C-2 " . SPARSER::PROTEIN)
    ("TLR-4" . SPARSER::PROTEIN) ("p120" . SPARSER::PROTEIN)
    ("IL-11" . SPARSER::PROTEIN) ("IL1RN" . SPARSER::PROTEIN)
    ("SHP-2" . SPARSER::PROTEIN) ("STAT 3" . SPARSER::PROTEIN)
    ("a possible secondary PIP 2" . SPARSER::PIP2)
    ("ATP and PIP 2" . SPARSER::COLLECTION)
    ("neutrally-charged phospholipids" . SPARSER::PHOSPHOLIPID)
    ("the autoinhibitory conformation" . SPARSER::BIO-CONFORMATION)
    ("kinase and FERM" . SPARSER::COLLECTION) ("-FAK" . SPARSER::COLLECTION)
    ("lysine or arginine" . SPARSER::COLLECTION)
    ("PIP 2 and N" . SPARSER::COLLECTION) ("at least 2/3" . SPARSER::PROTEIN)
    ("DOPC" . SPARSER::DRUG) ("divalent cations" . SPARSER::MOLECULE)
    ("FAK and PIP 2" . SPARSER::COLLECTION)
    ("phosphatidylinositol 4,5-bisphosphate (PIP 2 ) directly binds FAK"
     . SPARSER::PROTEIN)
    ("Moesin" . SPARSER::PROTEIN) ("Radixin" . SPARSER::PROTEIN)
    ("Group I" . SPARSER::PROTEIN) ("PDB 2" . SPARSER::PROTEIN)
    ("band 4.1" . SPARSER::PROTEIN) ("PIP 2" . SPARSER::PIP2)
    ("phosphatidylinositol 4,5-bisphosphate" . SPARSER::PIP2)
    ("Figure S2 and Additional file xref" . SPARSER::COLLECTION)
    ("BRCA1 , and c" . SPARSER::COLLECTION)
    ("only five missense variants" . SPARSER::VARIANT)
    ("the Hungarian BC/ OC families" . SPARSER::PROTEIN-FAMILY)
    ("a premature stop codon" . SPARSER::PROTEIN)
    ("BRCA2/AD2" . SPARSER::COLLECTION) ("exon-intron" . SPARSER::COLLECTION)
    ("intron" . SPARSER::PROTEIN) ("6 intronic variants" . SPARSER::VARIANT)
    ("BRCA1 and the variants" . SPARSER::COLLECTION)
    ("synonymous and intronic variants" . SPARSER::VARIANT)
    ("BRCA1 (four frameshift, one nonsense, one missense) and 7 frameshift"
     . SPARSER::COLLECTION)
    ("intron-exon" . SPARSER::PROTEIN-PAIR) ("Polymerase" . SPARSER::PROTEIN)
    ("disease-associated BRCA1 and BRCA2 alleles" . SPARSER::ALLELE)
    ("estrogen, progesterone, and HER2" . SPARSER::COLLECTION)
    ("BRCA1 or BRCA2" . SPARSER::COLLECTION)
    ("BRCA1 [MIM#113705] and BRCA2 [MIM#600185]" . SPARSER::COLLECTION)
    ("insA" . SPARSER::PROTEIN) ("insC" . SPARSER::PROTEIN)
    ("DSS1" . SPARSER::PROTEIN) ("AD2" . SPARSER::PROTEIN)
    ("PDZK1 or IGF-1R" . SPARSER::COLLECTION)
    ("cyclin D1 and IGF-1R" . SPARSER::COLLECTION)
    ("PDZK1, cyclin D1 and IGF-1R" . SPARSER::COLLECTION)
    ("IL-4 or allergen" . SPARSER::COLLECTION) ("allergen" . SPARSER::MOLECULE)
    ("iNOS, TNF-α, IL-1β, IL-5, and IL-13" . SPARSER::COLLECTION)
    ("PDZK1 and cyclin D1" . SPARSER::COLLECTION)
    ("PARP-1 and cyclin D1" . SPARSER::COLLECTION) ("iNOS" . SPARSER::PROTEIN)
    ("Neu, EGFR and Cdc37" . SPARSER::COLLECTION) ("Cdc37" . SPARSER::PROTEIN)
    ("Neu, and EGFR" . SPARSER::COLLECTION) ("Neu" . SPARSER::PROTEIN)
    ("MEK/ERK1/2" . SPARSER::COLLECTION) ("leading drug" . SPARSER::DRUG)
    ("ER, PDZK1, and IGF-1R" . SPARSER::COLLECTION)
    ("ER/IGF-1R/PDZK1" . SPARSER::COLLECTION)
    ("PDZK1 and IGF-1R" . SPARSER::COLLECTION)
    ("BRCA" . SPARSER::PROTEIN-FAMILY)
    ("pathophysiological cues" . SPARSER::PROTEIN-FAMILY)
    ("ER-α" . SPARSER::PROTEIN) ("STAT-6" . SPARSER::PROTEIN)
    ("IL-5" . SPARSER::PROTEIN) ("KLF8" . SPARSER::PROTEIN)
    ("AG1024" . SPARSER::DRUG) ("17β-Estradiol" . SPARSER::PROTEIN)
    ("DNA repair enzyme" . SPARSER::PROTEIN) ("AZD2281" . SPARSER::DRUG)
    ("PDZK1" . SPARSER::PROTEIN) ("TA and ∆N" . SPARSER::COLLECTION)
    ("Pulldown" . SPARSER::PROTEIN) ("TA or ∆N" . SPARSER::COLLECTION)
    ("an heterologous basic promoter" . SPARSER::PROMOTER)
    ("BIK, NOXA or PUMA" . SPARSER::COLLECTION)
    ("PUMA, NOXA, EGR1 and BIK" . SPARSER::COLLECTION)
    ("BIK, PUMA and NOXA" . SPARSER::COLLECTION)
    ("BIK and PUMA" . SPARSER::COLLECTION)
    ("p21 and NOXA" . SPARSER::COLLECTION) ("m1 or m2" . SPARSER::COLLECTION)
    ("m1 and m2" . SPARSER::COLLECTION)
    ("Sp1 or ∆Np73-α" . SPARSER::COLLECTION)
    ("a critic CC dinucleotide" . SPARSER::MOLECULE)
    ("Sp1 and ∆Np73" . SPARSER::COLLECTION)
    ("p53 and Sp1" . SPARSER::COLLECTION)
    ("site showed no consensus response element"
     . SPARSER::DNA-RESPONSE-ELEMENT)
    ("BIK, NOXA and PUMA" . SPARSER::COLLECTION)
    ("group A or group D2" . SPARSER::COLLECTION)
    ("cisplatin or mitomycin C" . SPARSER::COLLECTION)
    ("p73 and the pro-apoptotic gene BIK" . SPARSER::COLLECTION)
    ("the pro-apoptotic gene BIK" . SPARSER::PROTEIN)
    ("FANCC" . SPARSER::PROTEIN)
    ("Luciferase and β-galactosidase" . SPARSER::COLLECTION)
    ("pEF" . SPARSER::MOLECULE) ("PVDF" . SPARSER::DRUG)
    ("Na" . SPARSER::PROTEIN) ("aprotinin" . SPARSER::DRUG)
    ("Tris" . SPARSER::MOLECULE) ("rec" . SPARSER::PROTEIN)
    ("ethidium" . SPARSER::MOLECULE)
    ("p21 (5′-GAGGCACTCAGA-GGAGGCGCCAT and 5′-CACACGCTCCCAGGCG-AAGTC) and β2- microglobulin (B2M)"
     . SPARSER::COLLECTION)
    ("p53 up-regulated modulator of apoptosis (PUMA)" . SPARSER::PROTEIN)
    ("phorbol-12-myristate-13-acetate-induced protein 1 (NOXA)"
     . SPARSER::PROTEIN)
    ("reverse transcriptase–polymerase" . SPARSER::COLLECTION)
    ("TRIZOL" . SPARSER::DRUG)
    ("an anti-Annexin V-FITC antibody (Immunostep) and propidium iodide"
     . SPARSER::COLLECTION)
    ("several pro-apoptotic genes" . SPARSER::GENE)
    ("p53 or TAp73 and ∆Np73" . SPARSER::COLLECTION)
    ("Fanconi" . SPARSER::PROTEIN-FAMILY)
    ("p53 and TAp73" . SPARSER::COLLECTION)
    ("at least seven variants" . SPARSER::VARIANT)
    ("p53 and p63" . SPARSER::COLLECTION)
    ("a functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HRas" . SPARSER::PROTEIN)
    ("Bcl-2-interacting killer (BIK)" . SPARSER::PROTEIN)
    ("BIK" . SPARSER::PROTEIN)
    ("p53 and the transactivation (TA) isoforms" . SPARSER::COLLECTION)
    ("pro-apoptotic genes" . SPARSER::GENE) ("RasV12" . SPARSER::DRUG)
    ("Sp1 " . SPARSER::PROTEIN) ("group D" . SPARSER::PROTEIN)
    ("group A" . SPARSER::PROTEIN) ("group C" . SPARSER::PROTEIN)
    ("pGL2" . SPARSER::PROTEIN) ("β2- microglobulin" . SPARSER::PROTEIN)
    ("early growth response 1" . SPARSER::PROTEIN)
    ("phorbol-12-myristate-13-acetate-induced protein 1" . SPARSER::PROTEIN)
    ("p53 up-regulated modulator of apoptosis" . SPARSER::PROTEIN)
    ("a 20 " . SPARSER::PROTEIN) ("FA-A" . SPARSER::PROTEIN)
    ("caspase-2S" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TP73" . SPARSER::PROTEIN)
    ("Bcl-2-interacting killer" . SPARSER::PROTEIN)
    ("extracellular ATP or UTP stimulation" . SPARSER::COLLECTION)
    ("EGFR/ErbB3" . SPARSER::COLLECTION)
    ("kinase, and cofilin" . SPARSER::COLLECTION)
    ("IP3 and significant intracellular Ca 2+ mobilization"
     . SPARSER::COLLECTION)
    ("DAG" . SPARSER::DAG) ("PLCb" . SPARSER::PROTEIN-FAMILY)
    ("ATP or UTP stimulation" . SPARSER::COLLECTION)
    ("100 nM AG1478 (EGFR inhibitor) or 10 μM U0126 (MEK1/2 inhibitor)"
     . SPARSER::COLLECTION)
    ("ATP and UTP" . SPARSER::COLLECTION) ("AG1478-" . SPARSER::DRUG)
    ("AG1478 (EGFR inhibitor, 100 nM) and U0126 (MEK1/2 inhibitor, 10 μM)"
     . SPARSER::COLLECTION)
    ("EGFR-ERK1/2" . SPARSER::COLLECTION)
    ("only P2Y2 receptor" . SPARSER::RECEPTOR)
    ("Extracellular adenosine" . SPARSER::PROTEIN)
    ("receptors and extracellular signaling molecules [ xref ]"
     . SPARSER::COLLECTION)
    ("P2Y2-EGFR-ERK1/2" . SPARSER::COLLECTION)
    ("receptor and EGFR" . SPARSER::COLLECTION)
    ("EGFR and ERK1/2" . SPARSER::COLLECTION)
    ("some epithelial-mesenchymal transition/invasion-related genes"
     . SPARSER::GENE)
    ("IL-8, E-cadherin, Snail and Claudin-1" . SPARSER::COLLECTION)
    ("UTP" . SPARSER::MOLECULE) ("Monoclonal antibody" . SPARSER::DRUG)
    ("αVβ 3" . SPARSER::PROTEIN) ("G-protein coupled" . SPARSER::PROTEIN)
    ("PLCb2" . SPARSER::PROTEIN) ("IP3" . SPARSER::IP3)
    ("inositol 1,4,5-trisphosphate" . SPARSER::MOLECULE)
    ("phospholipase C" . SPARSER::PROTEIN)
    ("G protein-coupled receptor" . SPARSER::PROTEIN)
    ("P2Y1" . SPARSER::PROTEIN) ("P2X1" . SPARSER::PROTEIN)
    ("ligand-gated ion channel" . SPARSER::PROTEIN)
    ("Claudin-1" . SPARSER::PROTEIN) ("P2Y2" . SPARSER::PROTEIN)
    ("Thyroid" . SPARSER::PROTEIN) ("PTC and PTMC" . SPARSER::COLLECTION)
    ("iodine" . SPARSER::MOLECULE) ("PTCs" . SPARSER::PROTEIN)
    ("PTC" . SPARSER::PROTEIN) ("OR 1" . SPARSER::PROTEIN)
    ("6-Carboxyfluorescein" . SPARSER::DRUG)
    ("histones and DNA" . SPARSER::COLLECTION)
    ("H3K9 and H3K27" . SPARSER::COLLECTION)
    ("HDAC1/HDAC2" . SPARSER::COLLECTION)
    ("Sin3B–RBP2–HP1" . SPARSER::COLLECTION)
    ("microtubule-associated protein 4 ( MAP4 ) and stathmin ( STMN1 ) genes [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("MHC Class II Transactivator (CIITA) and major histocompatibility complex (MHC II)"
     . SPARSER::COLLECTION)
    ("MHC " . SPARSER::PROTEIN) ("CIITA" . SPARSER::PROTEIN)
    ("cyclin B2, CDC25c and cyclin" . SPARSER::COLLECTION)
    ("ataxia telangiectasia and Rad3-related protein (ATR)" . SPARSER::PROTEIN)
    ("CLU" . SPARSER::PROTEIN) ("clusterin" . SPARSER::PROTEIN)
    ("p53–Sin3B–HDAC1" . SPARSER::COLLECTION)
    ("Sin3B–HDAC1" . SPARSER::COLLECTION) ("–Sin3B" . SPARSER::COLLECTION)
    ("MAD1, CRYZ and ANLN" . SPARSER::COLLECTION)
    ("bleomycin and the endogenous promoter occupancy" . SPARSER::COLLECTION)
    ("Sin3B–HDAC" . SPARSER::COLLECTION) ("Iodide" . SPARSER::PROTEIN)
    ("p53, Sin3B and HDAC1" . SPARSER::COLLECTION)
    ("CDC25c" . SPARSER::PROTEIN) ("anillin" . SPARSER::PROTEIN)
    ("crystallin" . SPARSER::PROTEIN) ("CRYZ" . SPARSER::PROTEIN)
    ("p53–Sin3B" . SPARSER::COLLECTION)
    ("using p53 and phospho Ser 15 -p53 antibody" . SPARSER::COLLECTION)
    ("types " . TYPE) ("poison" . SPARSER::MOLECULE)
    ("p53 and Sin3B" . SPARSER::COLLECTION)
    ("Sin3B and p53" . SPARSER::COLLECTION)
    ("Sin3B and stress-related protein" . SPARSER::COLLECTION)
    ("a radiomimetic drug" . SPARSER::DRUG)
    ("Sin3A/Sin3B" . SPARSER::COLLECTION)
    ("Sin3A and Sin3B" . SPARSER::COLLECTION)
    ("associated HDACs" . SPARSER::PROTEIN)
    ("HDAC1 and HDAC2 " . SPARSER::COLLECTION)
    ("SID" . SPARSER::PROTEIN-FAMILY)
    ("activator and repressor" . SPARSER::COLLECTION)
    ("Sin3–HDAC" . SPARSER::COLLECTION)
    ("Sin3B and tumour suppressor protein" . SPARSER::COLLECTION)
    ("The multiprotein SWI-independent 3 (Sin3)–HDAC (histone deacetylase) corepressor complex"
     . SPARSER::BIO-COMPLEX)
    ("–HDAC" . SPARSER::COLLECTION) ("SWI" . SPARSER::PROTEIN)
    ("ING 2" . SPARSER::PROTEIN) ("N -acetylglucosamine" . SPARSER::MOLECULE)
    ("retinoblastoma-associated proteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ING1" . SPARSER::PROTEIN) ("SAP18" . SPARSER::PROTEIN)
    ("Suv39H1" . SPARSER::PROTEIN) ("SAP30" . SPARSER::PROTEIN)
    ("RBP2" . SPARSER::PROTEIN) ("MAP4" . SPARSER::PROTEIN)
    ("microtubule-associated protein 4" . SPARSER::PROTEIN)
    ("MHC Class II Transactivator" . SPARSER::PROTEIN)
    ("silencing mediator of retinoic acid and thyroid hormone receptor"
     . SPARSER::PROTEIN)
    ("MeCP2" . SPARSER::PROTEIN) ("CpG binding protein" . SPARSER::PROTEIN)
    ("CDC2" . SPARSER::PROTEIN) ("cyclin B2" . SPARSER::PROTEIN)
    ("NF-Y" . SPARSER::PROTEIN) ("RFC4" . SPARSER::PROTEIN)
    ("HMG-coA" . SPARSER::DRUG)
    ("ataxia telangiectasia and Rad3-related protein" . SPARSER::PROTEIN)
    ("cell division cycle 25C" . SPARSER::PROTEIN) ("zeta)" . SPARSER::PROTEIN)
    ("HSPA8" . SPARSER::PROTEIN)
    ("MAD1 (mitotic arrest deficient" . SPARSER::PROTEIN)
    ("ring finger protein 220" . SPARSER::PROTEIN)
    ("RNF220" . SPARSER::PROTEIN) ("stress-related protein" . SPARSER::PROTEIN)
    ("Sin3 " . SPARSER::PROTEIN) ("Sin3A" . SPARSER::PROTEIN)
    ("HDAC2 " . SPARSER::PROTEIN) ("Sin3" . SPARSER::PROTEIN)
    ("Sin3B" . SPARSER::PROTEIN) ("the latter protein" . SPARSER::PROTEIN)
    ("TDP1 and fluorescein" . SPARSER::COLLECTION)
    ("PARP1–FAM" . SPARSER::COLLECTION)
    ("acceptor (TAMRA)" . SPARSER::MOLECULE)
    ("Fluorescein and TAMRA" . SPARSER::COLLECTION)
    ("TAMRA" . SPARSER::MOLECULE) ("Fluorescein" . SPARSER::MOLECULE)
    ("the biological macromolecules" . SPARSER::MOLECULE)
    ("chromophore" . SPARSER::MOLECULE) ("fluorescein" . SPARSER::MOLECULE)
    ("TDP1 and PARP1" . SPARSER::COLLECTION)
    ("fluorescently-labelled DNA" . SPARSER::DNA)
    ("nucleoside" . SPARSER::MOLECULE) ("-DNA" . SPARSER::DNA)
    ("-lyase" . SPARSER::COLLECTION) ("-deoxyribose" . SPARSER::MOLECULE)
    ("lyase" . SPARSER::PROTEIN) ("deoxyribose" . SPARSER::MOLECULE)
    ("the negatively-charged polymer" . SPARSER::MOLECULE)
    ("radiomimetic drugs" . SPARSER::DRUG)
    ("Protein–protein" . SPARSER::COLLECTION)
    ("the former protein" . SPARSER::PROTEIN)
    ("fluorescently-labelled proteins" . SPARSER::PROTEIN)
    ("TDP1–PARP1" . SPARSER::COLLECTION)
    ("PARP1 and TDP1" . SPARSER::COLLECTION) ("BP1" . SPARSER::PROTEIN)
    ("carboxy group" . SPARSER::MOLECULE)
    ("N-hydroxysuccinimide" . SPARSER::DRUG)
    ("N -hydroxysuccinimide" . SPARSER::DRUG) ("TDP1 " . SPARSER::PROTEIN)
    ("Top1" . SPARSER::PROTEIN)
    ("tyrosyl–DNA phosphodiesterase 1" . SPARSER::PROTEIN)
    ("Tdp1" . SPARSER::PROTEIN) ("TDP1" . SPARSER::PROTEIN)
    ("tyrosyl-DNA phosphodiesterase 1" . SPARSER::PROTEIN)
    ("conversely all alleles" . SPARSER::ALLELE) ("-mutant" . SPARSER::MUTANT)
    ("AZD9291" . SPARSER::DRUG) ("redox-" . SPARSER::PROTEIN)
    ("Sirt1/FoxO" . SPARSER::COLLECTION) ("autophagic genes" . SPARSER::GENE)
    ("Sirt1-FoxO" . SPARSER::COLLECTION)
    ("LC3, Atg5, Atg8, Atg12, Bnip3, and beclin-1" . SPARSER::COLLECTION)
    ("beclin-1 or LC3B" . SPARSER::COLLECTION)
    ("autophagic genes beclin-1, Atg5, and LC3A" . SPARSER::COLLECTION)
    ("beclin-1, Atg5, LC3A, and glutathione peroxidase-1"
     . SPARSER::COLLECTION)
    ("the wild-type FoxO1 and the constitutively active FoxO1-AAA mutant"
     . SPARSER::COLLECTION)
    ("resveratrol and H 2 O 2" . SPARSER::COLLECTION)
    ("Sirt1 and FoxO1" . SPARSER::COLLECTION)
    ("FoxO" . SPARSER::PROTEIN-FAMILY) ("LC3 western blot" . SPARSER::PROTEIN)
    ("-acetyl" . SPARSER::MOLECULE) ("Sirt1 and LC3-II" . SPARSER::COLLECTION)
    ("the NADPH oxidase inhibitors diphenyleneiodonium (DPI, 10  μ M) and diapocynin (100  μ M, purchased from Sigma; xref )"
     . SPARSER::COLLECTION)
    ("Sigma" . SPARSER::PROTEIN-FAMILY) ("diapocynin" . SPARSER::DRUG)
    ("diphenyleneiodonium" . SPARSER::DRUG)
    ("beclin-1, Atg5, and LC3A" . SPARSER::COLLECTION)
    ("Atg5, Atg7, Atg12, beclin-1, Bnip3, and LC3A" . SPARSER::COLLECTION)
    ("resveratrol" . SPARSER::PROTEIN) ("mTOR or ULK1" . SPARSER::COLLECTION)
    ("ULK" . SPARSER::PROTEIN) ("mTOR-ULK" . SPARSER::COLLECTION)
    ("LC3A, beclin-1, and Atg5" . SPARSER::COLLECTION)
    ("pathological types" . TYPE) ("LC3 and beclin-1" . SPARSER::COLLECTION)
    ("LC3A, beclin-1, Atg5, Atg7, and Atg12" . SPARSER::COLLECTION)
    ("Atg5 and Atg7" . SPARSER::COLLECTION) ("Atg7" . SPARSER::PROTEIN)
    ("Atg5" . SPARSER::PROTEIN)
    ("the deacetylase-dead mutant" . SPARSER::MUTANT)
    ("caspase3" . SPARSER::PROTEIN) ("FoxO1A" . SPARSER::PROTEIN)
    ("FoxO3a" . SPARSER::PROTEIN) ("EUK-134" . SPARSER::DRUG)
    ("L-arginine" . SPARSER::MOLECULE)
    ("Hydrogen Peroxide" . SPARSER::MOLECULE) ("Bnip3" . SPARSER::PROTEIN)
    ("Atg12" . SPARSER::PROTEIN) ("beclin-1" . SPARSER::PROTEIN)
    ("protein and transcription factor" . SPARSER::COLLECTION)
    ("Cyclin G2 and Sharp1" . SPARSER::COLLECTION) ("Sharp" . SPARSER::PROTEIN)
    ("p53 (an indicator of the presence of gain-of-function mutant p53) and strong phospho-AKT"
     . SPARSER::COLLECTION)
    ("strong phospho-AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosho-AKT" . SPARSER::COLLECTION) ("AKT and BMF" . SPARSER::COLLECTION)
    ("PI3K and AKT" . SPARSER::COLLECTION)
    ("wortmannin and LY-294002" . SPARSER::COLLECTION)
    ("vorinostat and trichostatin" . SPARSER::COLLECTION)
    ("sirolimus" . SPARSER::DRUG) ("Map" . SPARSER::PROTEIN)
    ("LZTFL1, POU2F3 and SOSTDC1" . SPARSER::COLLECTION)
    ("TMBIM1, ICAM1 and LIFR" . SPARSER::COLLECTION)
    ("LIFR" . SPARSER::PROTEIN)
    ("the p53-R175H conformational mutant" . SPARSER::MUTANT)
    ("HEMA" . SPARSER::PROTEIN) ("a lentiviral p53 shRNA" . SPARSER::PROTEIN)
    ("p53si-3" . SPARSER::COLLECTION)
    ("expressing wild-type p53 or various mutants (R280T, R175H, R179R, L194F and M246I)"
     . SPARSER::COLLECTION)
    ("cellular anoikis" . SPARSER::PROTEIN) ("BMF/BCL-X" . SPARSER::COLLECTION)
    ("BCL2 or BCL-X" . SPARSER::COLLECTION)
    ("BAD, BAX, BID, BIM, PUMA and BOK" . SPARSER::COLLECTION)
    ("p-BAD" . SPARSER::COLLECTION) ("BOK" . SPARSER::PROTEIN)
    ("the pro-apoptotic BCL2 family proteins" . SPARSER::PROTEIN)
    ("caspase 9, caspase 3 and pan-caspase" . SPARSER::COLLECTION)
    ("caspase 9 and caspase 3" . SPARSER::COLLECTION)
    ("two independent p53-specific lentiviral shRNAs" . SPARSER::RNA)
    ("AAD" . SPARSER::MOLECULE)
    ("R175H conformational mutant" . SPARSER::MUTANT)
    ("the p53-R175 conformational mutant" . SPARSER::MUTANT)
    ("TAp63 and TAp73" . SPARSER::COLLECTION)
    ("MYC, BAG1, MDR1, NFκB2, EGR1, GEF-H1, ID4 and MAD1"
     . SPARSER::COLLECTION)
    ("ATF3, CD-95, ID2, hTERT and MST1" . SPARSER::COLLECTION)
    ("p63, p73, NFY and BRD1" . SPARSER::COLLECTION)
    ("conformational mutants" . SPARSER::MUTANT)
    ("p53-R175H conformational mutant" . SPARSER::MUTANT)
    ("BMF" . SPARSER::PROTEIN) ("Z-IETD-FMK" . SPARSER::DRUG)
    ("Cyclin G2" . SPARSER::PROTEIN)
    ("Rab-coupling protein" . SPARSER::PROTEIN)
    ("TGF- β" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TMBIM1" . SPARSER::PROTEIN)
    ("SOSTDC1" . SPARSER::PROTEIN) ("POU2F3" . SPARSER::PROTEIN)
    ("LZTFL1" . SPARSER::PROTEIN) ("caspase 8" . SPARSER::PROTEIN)
    ("caspase 9" . SPARSER::PROTEIN) ("BRD1" . SPARSER::PROTEIN)
    ("MST1" . SPARSER::PROTEIN) ("ID2" . SPARSER::PROTEIN)
    ("CD-95" . SPARSER::PROTEIN) ("ATF3" . SPARSER::PROTEIN)
    ("MAD1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ID4" . SPARSER::PROTEIN)
    ("GEF-H1" . SPARSER::PROTEIN) ("BAG1" . SPARSER::PROTEIN)
    ("directly targets ERBB receptors" . SPARSER::RECEPTOR)
    ("the angiogenic gene VEGFA" . SPARSER::PROTEIN)
    ("xref  pro-metastatic factors Zeb1" . SPARSER::PROTEIN)
    ("Zeb-2" . SPARSER::COLLECTION) ("p63-3" . SPARSER::COLLECTION)
    ("-ERBB" . SPARSER::COLLECTION) ("ERBB2-3" . SPARSER::COLLECTION)
    ("EGFR and ErbB2" . SPARSER::COLLECTION) ("pSIH" . SPARSER::PROTEIN)
    ("ErbB2 and EGFR" . SPARSER::COLLECTION)
    ("ERBB2 and EGFR" . SPARSER::COLLECTION)
    ("ErbB2, p63 and EGFR" . SPARSER::COLLECTION)
    ("Virtually all human genes" . SPARSER::GENE) ("MiRNA" . SPARSER::PROTEIN)
    ("adjuvant Trastuzumab (humanized antibody anti-Her2-Herceptin) or Lapatinib (small tyrosine kinases inhibitor molecule)"
     . SPARSER::COLLECTION)
    ("Zeb1 and ErbB3" . SPARSER::COLLECTION) ("Zeb1" . SPARSER::PROTEIN)
    ("Zeb" . SPARSER::PROTEIN) ("anti-ErbB2" . SPARSER::DRUG)
    ("Tap63" . SPARSER::PROTEIN) ("U44" . SPARSER::PROTEIN)
    ("ΔNp63α" . SPARSER::PROTEIN) ("SHIP2" . SPARSER::PROTEIN)
    ("ZEB-1" . SPARSER::PROTEIN) ("TP63" . SPARSER::PROTEIN)
    ("5p" . SPARSER::PROTEIN) ("molecules and peptides" . SPARSER::COLLECTION)
    ("stapled peptides (SAH-p53-8, sMTide-02/O2a and ATSP-7041) and other modified peptides (pDI, PMI and PMI-N8A)"
     . SPARSER::COLLECTION)
    ("pDI, PMI and PMI-N8A" . SPARSER::COLLECTION)
    ("p53–Mdmx" . SPARSER::COLLECTION) ("PMI" . SPARSER::PROTEIN)
    ("pDI" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RO" . SPARSER::PROTEIN)
    ("Ray" . SPARSER::PROTEIN) ("fatty tissue lack Mdmx" . SPARSER::PROTEIN)
    ("p21 and Mdm2" . SPARSER::COLLECTION)
    ("contralateral mammary fat" . SPARSER::PROTEIN)
    ("the conditional Mdmx KD" . SPARSER::PROTEIN)
    ("pifithrin-" . SPARSER::DRUG) ("Mdmx and Mdm2" . SPARSER::COLLECTION)
    ("Mdm2, Mdmx and p53" . SPARSER::COLLECTION)
    ("Mdm2 and/or Mdmx" . SPARSER::COLLECTION)
    ("Mdm2 (38%) and Mdmx (65%)" . SPARSER::COLLECTION)
    ("Mdm" . SPARSER::PROTEIN) ("Mdm2 and Mdmx" . SPARSER::COLLECTION)
    ("BrCas" . SPARSER::PROTEIN-FAMILY) ("Mdm2 or Mdmx" . SPARSER::COLLECTION)
    ("Mdmx" . SPARSER::PROTEIN) ("SE 1" . SPARSER::PROTEIN)
    ("β -Gal" . SPARSER::PROTEIN) ("SP6" . SPARSER::PROTEIN)
    ("ki67" . SPARSER::PROTEIN) ("HSP 60" . SPARSER::PROTEIN)
    ("HSP-90" . SPARSER::PROTEIN) ("SNP309" . SPARSER::PROTEIN)
    ("β -gal" . SPARSER::PROTEIN) ("β -galactosidase" . SPARSER::PROTEIN)
    ("mdm2" . SPARSER::PROTEIN) ("masking" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitotic DNA synthesis foci" . SPARSER::PROTEIN)
    ("PICH and BLM" . SPARSER::COLLECTION)
    ("the cellular dNTP" . SPARSER::MOLECULE)
    ("dCTP and NAD +" . SPARSER::COLLECTION)
    ("dTTP or dUTP" . SPARSER::COLLECTION)
    ("cellular dUTP" . SPARSER::MOLECULE)
    ("CDA and PARP-1" . SPARSER::COLLECTION)
    ("foci, and UFBs" . SPARSER::COLLECTION)
    ("CDA or PARP-1" . SPARSER::COLLECTION) ("Olaparib" . SPARSER::DRUG)
    ("olaparib" . SPARSER::DRUG) ("polymerase-1" . SPARSER::COLLECTION)
    ("γH2AX and Chk2" . SPARSER::COLLECTION)
    ("polymerase-helicase" . SPARSER::COLLECTION)
    ("no detectable CDA protein and significantly less CDA mRNA"
     . SPARSER::COLLECTION)
    ("significantly less CDA mRNA" . SPARSER::PROTEIN)
    ("an adenoviral short hairpin RNA" . SPARSER::RNA) ("THU" . SPARSER::DRUG)
    ("tetrahydrouridine" . SPARSER::DRUG) ("BLM/CDA" . SPARSER::COLLECTION)
    ("BS-BLM-CDA" . SPARSER::COLLECTION) ("BS-CDA" . SPARSER::COLLECTION)
    ("BS-Ctrl" . SPARSER::COLLECTION) ("DAPI and PICH" . SPARSER::COLLECTION)
    ("BLM and CDA" . SPARSER::COLLECTION) ("BS-BLM" . SPARSER::COLLECTION)
    ("GFP-BLM" . SPARSER::COLLECTION) ("BLM-" . SPARSER::PROTEIN)
    ("defective CDA" . SPARSER::PROTEIN) ("SCE" . SPARSER::PROTEIN)
    ("cytidine and deoxycytidine" . SPARSER::COLLECTION)
    ("uridine and deoxyuridine" . SPARSER::COLLECTION)
    ("cytidine deaminase (CDA)" . SPARSER::PROTEIN)
    ("catenanes" . SPARSER::DRUG)
    ("either FANCD2 or its partner FANCI" . SPARSER::COLLECTION)
    ("FANCD2/FANCI" . SPARSER::COLLECTION) ("FANCI" . SPARSER::PROTEIN)
    ("aphidicolin" . SPARSER::PROTEIN) ("CFS" . SPARSER::PROTEIN)
    ("PICH" . SPARSER::PROTEIN) ("DNA and chromosome" . SPARSER::COLLECTION)
    ("RecQ" . SPARSER::PROTEIN-FAMILY) ("BLM" . SPARSER::PROTEIN)
    ("CDA" . SPARSER::PROTEIN) ("dCTP" . SPARSER::MOLECULE)
    ("deoxyuridine triphosphate" . SPARSER::MOLECULE)
    ("ml − 1" . SPARSER::PROTEIN) ("Fanconi anemia" . SPARSER::PROTEIN)
    ("helicase-like protein" . SPARSER::PROTEIN) ("A-T" . SPARSER::PROTEIN)
    ("MYC or miRNAs" . SPARSER::COLLECTION)
    ("HER2-MYC-HOXB7" . SPARSER::COLLECTION)
    ("Inorganic nanoparticle" . SPARSER::MOLECULE)
    ("oxide and iron" . SPARSER::COLLECTION)
    ("PEI and PLGA" . SPARSER::COLLECTION) ("PLGA" . SPARSER::DRUG)
    ("PEI" . SPARSER::MOLECULE) ("oxide" . SPARSER::MOLECULE)
    ("mature miRNA" . SPARSER::PROTEIN) ("Dinaciclib" . SPARSER::DRUG)
    ("liposomal nanoparticles" . SPARSER::MOLECULE)
    ("just one upstream gene" . SPARSER::GENE)
    ("efficient cytotoxic" . SPARSER::PROTEIN)
    ("tamoxifen or AI-resistant breast cancer" . SPARSER::COLLECTION)
    ("EGFR/HER2 dual tyrosine kinase inhibitor" . SPARSER::INHIBITOR)
    ("Gefitinib" . SPARSER::DRUG)
    ("as yet another target" . SPARSER::TARGET-PROTEIN)
    ("exogenous estrogen" . SPARSER::MOLECULE)
    ("tamoxifen ( xref , xref , xref ) or aromatase inhibitors (AIs) such as anastrozole"
     . SPARSER::COLLECTION)
    ("letrozole ( xref ) or the selective ER downregulator (SERD)"
     . SPARSER::COLLECTION)
    ("Fulvestrant" . SPARSER::DRUG) ("SERD" . SPARSER::DRUG)
    ("letrozole" . SPARSER::DRUG) ("exemestane" . SPARSER::DRUG)
    ("anastrozole" . SPARSER::DRUG) ("AIs" . SPARSER::PROTEIN)
    ("HOXB7, HER2 and MYC" . SPARSER::COLLECTION)
    ("HOXB7 and MYC or HOXB7 and HER2" . SPARSER::COLLECTION)
    ("MYC or HOXB7 and HER2" . SPARSER::COLLECTION)
    ("HOXB7, HER2, and MYC" . SPARSER::COLLECTION)
    ("dominant-negative MYC" . SPARSER::PROTEIN)
    ("TMR-shMYC" . SPARSER::PROTEIN-PAIR) ("global mapping" . SPARSER::PROTEIN)
    ("sh-MYC" . SPARSER::COLLECTION)
    ("HOXB7, HER2, and ER" . SPARSER::COLLECTION)
    ("TMR, and H12" . SPARSER::COLLECTION)
    ("miRNAs and their target genes" . SPARSER::COLLECTION)
    ("miR-196a-HOXB7" . SPARSER::COLLECTION)
    ("nanoparticle" . SPARSER::MOLECULE)
    ("TMR, and miR-196a" . SPARSER::COLLECTION)
    ("TMR ( xref ) and MCF7-miR-196a-inhibitor" . SPARSER::COLLECTION)
    ("MCF7-EGFR-HER2" . SPARSER::COLLECTION)
    ("MCF7-miR-196a" . SPARSER::COLLECTION) ("HOXB7-3" . SPARSER::COLLECTION)
    ("miR-196a" . SPARSER::PROTEIN) ("TMR-miR-196a" . SPARSER::PROTEIN-PAIR)
    ("ER target gene and HER2 expression in TMR cells" . SPARSER::COLLECTION)
    ("prototypic molecules" . SPARSER::MOLECULE)
    ("MCF7-HOXB7" . SPARSER::COLLECTION)
    ("dual EGFR/HER2 inhibitor" . SPARSER::INHIBITOR)
    ("MCF7-TMR" . SPARSER::COLLECTION) ("HER3 and HER4" . SPARSER::COLLECTION)
    ("TMR and H12" . SPARSER::COLLECTION)
    ("MAPK, S6K, and 4EBP1" . SPARSER::COLLECTION)
    ("HOXB7/ER" . SPARSER::COLLECTION) ("HOXB7 and HER2" . SPARSER::COLLECTION)
    ("ER and its cofactors" . SPARSER::COLLECTION)
    ("HER2 and ER" . SPARSER::COLLECTION)
    ("CA12 and MYC" . SPARSER::COLLECTION) ("co-activator" . SPARSER::PROTEIN)
    ("MYC-B7-2" . SPARSER::COLLECTION) ("MYC-B7-1" . SPARSER::COLLECTION)
    ("MYC-luciferase" . SPARSER::COLLECTION)
    ("CA12-HOXB7-1" . SPARSER::COLLECTION)
    ("CA12-HOXB7-2" . SPARSER::COLLECTION) ("ER-HOXB7" . SPARSER::COLLECTION)
    ("CA12 or MYC" . SPARSER::COLLECTION)
    ("ER-coactivators" . SPARSER::COLLECTION)
    ("ER and HOXB7" . SPARSER::COLLECTION) ("co-activators" . SPARSER::PROTEIN)
    ("pioneer factors FOXA1 ( xref ) and PBX1 ( xref )" . SPARSER::COLLECTION)
    ("AIB1, SRC-1, CBP, p300, NCOR, and PAX2" . SPARSER::COLLECTION)
    ("PBX2 and Meis1" . SPARSER::COLLECTION) ("NCOR" . SPARSER::PROTEIN)
    ("promoter or intron" . SPARSER::COLLECTION)
    ("RARA, GREB1, MYC, XBP1, FOS, CCND1, CXCL12, NRIP1 , and CA12"
     . SPARSER::COLLECTION)
    ("HOXB7-ER" . SPARSER::COLLECTION)
    ("estrogen and TAM" . SPARSER::COLLECTION)
    ("estrogen or tamoxifen" . SPARSER::COLLECTION)
    ("MCF-7-HOXB7, T47D-HOXB7, and ERIN-HOXB7 cells ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("MCF-7-HOXB7 ( xref ; xref ), T47D-HOXB7 ( xref ), and ERIN-HOXB7 cells ( xref )"
     . SPARSER::COLLECTION)
    ("HOXB7 and ER" . SPARSER::COLLECTION) ("HOXB" . SPARSER::PROTEIN)
    ("ERIN-HOXB7" . SPARSER::COLLECTION) ("TMR" . SPARSER::PROTEIN)
    ("PED" . SPARSER::PROTEIN) ("ER-co-activator" . SPARSER::PROTEIN-PAIR)
    ("fulvestrant" . SPARSER::DRUG) ("SERMs" . SPARSER::DRUG)
    ("MYC-HOXB7-HER2" . SPARSER::COLLECTION)
    ("ER-target genes and HER2" . SPARSER::COLLECTION)
    ("EGFR-HER2" . SPARSER::COLLECTION) ("HOXB7-ERα" . SPARSER::COLLECTION)
    ("β-GAL" . SPARSER::PROTEIN) ("PAX-2" . SPARSER::PROTEIN)
    ("Meis-1" . SPARSER::PROTEIN) ("PBX-1" . SPARSER::PROTEIN)
    ("di-methyl" . SPARSER::DRUG) ("MRX34" . SPARSER::PROTEIN)
    ("B7-2" . SPARSER::PROTEIN) ("Meis1" . SPARSER::PROTEIN)
    ("PBX2" . SPARSER::PROTEIN) ("PAX2" . SPARSER::PROTEIN)
    ("AIB1" . SPARSER::PROTEIN) ("CA12" . SPARSER::PROTEIN)
    ("XBP1" . SPARSER::PROTEIN) ("GREB1" . SPARSER::PROTEIN)
    ("H12" . SPARSER::PROTEIN) ("B7-1" . SPARSER::PROTEIN)
    ("PBX1" . SPARSER::PROTEIN) ("HOXC11" . SPARSER::PROTEIN)
    ("HOXC10" . SPARSER::PROTEIN) ("HOXB13" . SPARSER::PROTEIN)
    ("HOXB7" . SPARSER::PROTEIN) ("DUSP1 and DUSP2" . SPARSER::COLLECTION)
    ("RAR and estrogen receptor" . SPARSER::COLLECTION)
    ("RAR" . SPARSER::PROTEIN) ("Hua" . SPARSER::PROTEIN)
    ("RARs" . SPARSER::PROTEIN) ("the regulatory map" . SPARSER::PROTEIN)
    ("DUSP5 and DUSP10" . SPARSER::COLLECTION)
    ("p38,
JNK and ERK"
     . SPARSER::COLLECTION)
    ("phosphatases (DUSP)" . SPARSER::PHOSPHATASE)
    ("tyrosine/serine/threonine" . SPARSER::COLLECTION)
    ("h-2 " . SPARSER::PROTEIN) ("FOS/FOSL1" . SPARSER::COLLECTION)
    ("FOS and
FOSL1"
     . SPARSER::COLLECTION)
    ("homodimers and heterodimers" . SPARSER::COLLECTION)
    ("c-JUN, JUNB and JUND" . SPARSER::COLLECTION)
    ("FRA-2/FOSL-2" . SPARSER::COLLECTION)
    ("FOS, FOSL1, JUN and JUNB" . SPARSER::COLLECTION)
    ("HRG-" . SPARSER::PROTEIN) ("FOSB" . SPARSER::PROTEIN)
    ("MARA" . SPARSER::PROTEIN) ("DUSP1 and CTGF" . SPARSER::COLLECTION)
    ("FOS , EGR1 and EGR2" . SPARSER::COLLECTION)
    ("FOS , EGR1 , EGR2 and NR4A1" . SPARSER::COLLECTION)
    ("FOS , EGR1 , EGR2 , EGR4 , DUSP1 and NR4A1" . SPARSER::COLLECTION)
    ("IEG" . SPARSER::GENE)
    ("EGF
or HRG"
     . SPARSER::COLLECTION)
    ("SRF and FOS" . SPARSER::COLLECTION)
    ("EGF
and HRG"
     . SPARSER::COLLECTION)
    ("SRF and ELK1" . SPARSER::COLLECTION)
    ("the largest component" . SPARSER::COMPONENT) ("NFYA" . SPARSER::PROTEIN)
    ("the two regulatory maps" . SPARSER::PROTEIN)
    ("SRF, FOS and JUN" . SPARSER::COLLECTION)
    ("EGFR, ErbB2, ERK, JNK, p38 MAPK
and Akt"
     . SPARSER::COLLECTION)
    ("EGFR, ErbB2 and Akt" . SPARSER::COLLECTION)
    ("HRG and EGF" . SPARSER::COLLECTION)
    ("MAPK and Akt" . SPARSER::COLLECTION) ("EGF or HRG" . SPARSER::COLLECTION)
    ("EGF and
HRG"
     . SPARSER::COLLECTION)
    ("gene (IEG)" . SPARSER::GENE)
    ("FOS, FOSL and
MYC"
     . SPARSER::COLLECTION)
    ("EGF and HRG" . SPARSER::COLLECTION)
    ("heregulin (HRG)" . SPARSER::PROTEIN)
    ("ELK1 and the Serum Response Factor (SRF)" . SPARSER::COLLECTION)
    ("Serum Response Factor (SRF)" . SPARSER::PROTEIN)
    ("Akt and MAPK" . SPARSER::COLLECTION)
    ("ERK,
JNK and p38 MAPK"
     . SPARSER::COLLECTION)
    ("DUSP5 and RARA" . SPARSER::COLLECTION) ("RARA" . SPARSER::PROTEIN)
    ("FOS and FOSL1" . SPARSER::COLLECTION)
    ("DUSP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SRF" . SPARSER::PROTEIN)
    ("epidermal growth factor (EGF) or heregulin (HRG)" . SPARSER::COLLECTION)
    ("HRG" . SPARSER::PROTEIN) ("heregulin" . SPARSER::PROTEIN)
    ("growth
hormone"
     . SPARSER::PROTEIN)
    ("estrogen receptor activity" . SPARSER::PROTEIN)
    ("interferon regulatory factor 1" . SPARSER::PROTEIN)
    ("Retinoic acid" . SPARSER::MOLECULE) ("Retinoic Acid" . SPARSER::MOLECULE)
    ("FOXO3" . SPARSER::PROTEIN) ("DUSP10" . SPARSER::PROTEIN)
    ("-2 " . SPARSER::PROTEIN) ("c-JUN" . SPARSER::PROTEIN)
    ("FOSL-2" . SPARSER::PROTEIN) ("FRA-2" . SPARSER::PROTEIN)
    ("FRA-1" . SPARSER::PROTEIN) ("EGR2" . SPARSER::PROTEIN)
    ("EGR4" . SPARSER::PROTEIN) ("NR4A1" . SPARSER::PROTEIN)
    ("Activator Protein 1" . SPARSER::PROTEIN) ("FOXC1" . SPARSER::PROTEIN)
    ("E2F4" . SPARSER::PROTEIN) ("E2F3" . SPARSER::PROTEIN)
    ("growth
factor"
     . SPARSER::GROWTH-FACTOR)
    ("DUSP5" . SPARSER::PROTEIN) ("FOSL1" . SPARSER::PROTEIN)
    ("Serum Response Factor" . SPARSER::PROTEIN)
    ("VEGF/VEGFR2" . SPARSER::COLLECTION)
    ("MAPK and AKT" . SPARSER::COLLECTION)
    ("pAKT and pMAPK" . SPARSER::COLLECTION)
    ("MK2206 or AZD6244" . SPARSER::COLLECTION)
    ("VEGFR2 and MAPK" . SPARSER::COLLECTION)
    ("the AKT inhibitor or MEK inhibitor ( xref )" . SPARSER::COLLECTION)
    ("AKT or p42/44" . SPARSER::COLLECTION)
    ("MK2206 (AKT inhibitor) or AZD6244 (MEK inhibitor)" . SPARSER::COLLECTION)
    ("The chemotherapeutic drugs" . SPARSER::DRUG)
    ("docetaxel, pemetrexed, gemcitabine, cisplatin or cediranib"
     . SPARSER::COLLECTION)
    ("functional VEGFR2" . SPARSER::PROTEIN)
    ("cisplatin, docetaxel or gemcitabine" . SPARSER::COLLECTION)
    ("AKT (MK2206) or MEK (AZD6244)" . SPARSER::COLLECTION)
    ("cediranib" . SPARSER::DRUG) ("Cediranib" . SPARSER::DRUG)
    ("peptidylprolyl isomerase A" . SPARSER::PROTEIN)
    ("AZD2171" . SPARSER::DRUG) ("Vascular endothelial" . SPARSER::PROTEIN)
    ("which places BCR" . SPARSER::PROTEIN)
    ("both BCR and BCR/ABL1 promoters" . SPARSER::COLLECTION)
    ("GMPs" . SPARSER::GMP) ("CMPs" . SPARSER::CMP)
    ("a lentiviral MYC" . SPARSER::PROTEIN)
    ("both BCR and BCR/ABL1 (MAX_BCR fold induction: 0.83 ± 0.79, p  = 0.78; MAX_BCR/ABL1 fold induction: 1.30 ± 0.32, p  = 0.2)"
     . SPARSER::COLLECTION)
    ("_BCR/ABL1" . SPARSER::COLLECTION)
    ("BCR and BCR/ABL1" . SPARSER::COLLECTION)
    ("MYC, MAX and MYC/MAX in the BCR/ABL1-positive K562 cell line (Fig.  xref - xref )"
     . SPARSER::COLLECTION)
    ("methionyl-tRNA synthetase ( MARS )" . SPARSER::PROTEIN)
    ("MARS" . SPARSER::PROTEIN) ("Nucleophosmin" . SPARSER::PROTEIN)
    ("PBS2 (-1279 to -1269 bp), PBS3 (- 813 bp to -803 bp) and PBS4 (-767 bp to -757 bp)"
     . SPARSER::COLLECTION)
    ("MYC and MAX" . SPARSER::COLLECTION)
    ("BCR/ABL1 tyrosine kinase" . SPARSER::COLLECTION)
    ("HNRPK" . SPARSER::PROTEIN) ("a cooperative oncogene" . SPARSER::ONCOGENE)
    ("bHLH-LZ" . SPARSER::COLLECTION) ("LZ" . SPARSER::PROTEIN)
    ("any acute leukemia" . SPARSER::PROTEIN)
    ("BCR/ABL1" . SPARSER::COLLECTION) ("beta-catenin" . SPARSER::PROTEIN)
    ("v-ABL" . SPARSER::PROTEIN)
    ("methionyl-tRNA synthetase" . SPARSER::PROTEIN)
    ("PBS2" . SPARSER::PROTEIN) ("ABL1 tyrosine kinase" . SPARSER::PROTEIN)
    ("beta catenin" . SPARSER::PROTEIN) ("ABL1" . SPARSER::PROTEIN)
    ("TrkB" . SPARSER::PROTEIN)
    ("the C2 tensin-type and PDZ domains of PTEN and the CD2 domain of A3G"
     . SPARSER::COLLECTION)
    ("kinase (IKK)" . SPARSER::KINASE)
    ("the pro-apoptotic protein Bad" . SPARSER::PROTEIN)
    ("Bcl-2, Bcl-xL and Mcl-1" . SPARSER::COLLECTION)
    ("Bid, Bad, Noxa, Puma, Bim, Bax, Bak, and Bok" . SPARSER::COLLECTION)
    ("Bok" . SPARSER::PROTEIN) ("Puma" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("complex (DISC)" . SPARSER::BIO-COMPLEX)
    ("Apo1/Fas" . SPARSER::COLLECTION) ("DISC" . SPARSER::BIO-COMPLEX)
    ("Caspase-3 and Caspase-7" . SPARSER::COLLECTION)
    ("Ding" . SPARSER::PROTEIN) ("eukaryotic DNA" . SPARSER::DNA)
    ("CD1 and CD2" . SPARSER::COLLECTION)
    ("The possible reason A3G-expressing group" . SPARSER::MOLECULE)
    ("CD1-1" . SPARSER::PROTEIN) ("CD1" . SPARSER::PROTEIN)
    ("A3G and PTEN" . SPARSER::COLLECTION)
    ("phospho-Akt (Thr308) and phospho-Akt (Ser473)" . SPARSER::COLLECTION)
    ("the Bcl-2 family pro-apoptotic protein Bid" . SPARSER::PROTEIN)
    ("Bcl-2, Mcl-1 and phospho-Bcl-2" . SPARSER::COLLECTION)
    ("proteins and Akt" . SPARSER::COLLECTION) ("Annexin" . SPARSER::PROTEIN)
    ("proteins, A3G and APOBEC3F" . SPARSER::COLLECTION)
    ("catalytic polypeptide (APOBEC) family proteins" . SPARSER::PROTEIN)
    ("the canonical Wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a special form" . SPARSER::FORM) ("anoikis" . SPARSER::PROTEIN)
    ("Anoikis" . SPARSER::PROTEIN) ("varieties" . SPARSER::VARIETY)
    ("a polypeptide" . SPARSER::PROTEIN)
    ("phosphatidylinositol-3,4,5- trisphosphate" . SPARSER::PIP3)
    ("Phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Caspase-8" . SPARSER::PROTEIN) ("Apo1" . SPARSER::PROTEIN)
    ("Caspase-7" . SPARSER::PROTEIN) ("APOBEC3F" . SPARSER::PROTEIN)
    ("Apolipoprotein-B" . SPARSER::PROTEIN)
    ("the Arg1809 cohort and the classic NF1 cohorts (12.5% vs. 1.1%)"
     . SPARSER::COLLECTION)
    ("larger cohorts" . SPARSER::MOLECULE) ("Cohorts" . SPARSER::MOLECULE)
    ("this recurrent p" . SPARSER::PROTEIN)
    ("the classic NF1 cohorts" . SPARSER::MOLECULE)
    ("triphosphatase" . SPARSER::PROTEIN) ("RASGAP" . SPARSER::PROTEIN)
    ("Arg, His, and Lys" . SPARSER::COLLECTION) ("PH" . SPARSER::PROTEIN)
    ("a rare polymorphic variant" . SPARSER::VARIANT)
    ("his" . SPARSER::AMINO-ACID) ("Melting" . SPARSER::DRUG)
    ("Families" . SPARSER::PROTEIN-FAMILY) ("classic NF1" . SPARSER::PROTEIN)
    ("classic NF1 cohorts" . SPARSER::MOLECULE) ("Codon" . SPARSER::PROTEIN)
    ("the superior right frontal lobe" . SPARSER::PROTEIN)
    ("the superior frontal lobes" . SPARSER::PROTEIN)
    ("PC " . SPARSER::PROTEIN) ("rib" . SPARSER::DRUG)
    ("A symptomatic OPG" . SPARSER::PROTEIN)
    ("segmental NF1" . SPARSER::PROTEIN) ("PNF" . SPARSER::PROTEIN)
    ("Neutral Variants" . SPARSER::VARIANT) ("Variants" . SPARSER::VARIANT)
    ("the very similar basic amino acid" . SPARSER::AMINO-ACID)
    ("Arginine" . SPARSER::AMINO-ACID) ("classic cohorts" . SPARSER::MOLECULE)
    ("Lisch" . SPARSER::PROTEIN) ("CALM" . SPARSER::PROTEIN)
    ("activating protein" . SPARSER::PROTEIN) ("IRA1" . SPARSER::PROTEIN)
    ("IRA2" . SPARSER::PROTEIN)
    ("GTPase activating protein" . SPARSER::PROTEIN)
    ("Multidrug resistance gene ABCG2 and cell cycle related gene p21"
     . SPARSER::COLLECTION)
    ("Multidrug" . SPARSER::PROTEIN) ("alkaloid" . SPARSER::MOLECULE)
    ("indole" . SPARSER::DRUG) ("p21 and PCNA" . SPARSER::COLLECTION)
    ("pIRES2-EGFP" . SPARSER::PROTEIN-PAIR)
    ("Raf/MAP kinase" . SPARSER::COLLECTION)
    ("Ras/Raf/MEK/ERK" . SPARSER::COLLECTION)
    ("Raf/MEK/ERK" . SPARSER::COLLECTION) ("PEBP" . SPARSER::PROTEIN)
    ("-EGFP/PEBP-1" . SPARSER::COLLECTION)
    ("RKIP and P-ERK" . SPARSER::COLLECTION)
    ("mismatch repair–proficient CRC" . SPARSER::PROTEIN)
    ("TWEAK" . SPARSER::PROTEIN) ("RKIP/KEAP1" . SPARSER::COLLECTION)
    ("extracellular signal-regulated kinase (ERK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("G protein coupled receptor (GPCR)" . SPARSER::PROTEIN)
    ("myelogenous leukemia" . SPARSER::PROTEIN) ("PEBPs" . SPARSER::PROTEIN)
    ("protein (RKIP)" . SPARSER::PROTEIN)
    ("G-protein-coupled receptor" . SPARSER::PROTEIN)
    ("ERK-1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("F-12 " . SPARSER::PROTEIN)
    ("G protein coupled receptor" . SPARSER::PROTEIN)
    ("PEBP-1" . SPARSER::PROTEIN) ("P-ERK" . SPARSER::PROTEIN)
    ("5FU or etoposide" . SPARSER::COLLECTION)
    ("doxorubicin or 5FU" . SPARSER::COLLECTION)
    ("the mature miRNA" . SPARSER::PROTEIN)
    ("mature miR-34b and miR-34c" . SPARSER::COLLECTION)
    ("a gene’s" . SPARSER::GENE)
    ("these reports all these genes" . SPARSER::GENE)
    ("the negative transcriptional modulator MDM4 [ xref – xref ] and the transcription factor YY1 [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("MTA2/HDAC1" . SPARSER::COLLECTION)
    ("HDAC1, YY1 and MDM4" . SPARSER::COLLECTION)
    ("MDM4, MTA2 and YY1" . SPARSER::COLLECTION)
    ("SIRT1 or HDAC1" . SPARSER::COLLECTION)
    ("mRNAs and proteins" . SPARSER::COLLECTION)
    ("annexin V and propidium" . SPARSER::COLLECTION)
    ("annexin-PI" . SPARSER::COLLECTION) ("annexin" . SPARSER::PROTEIN)
    ("Northern blot" . SPARSER::PROTEIN)
    ("deleted miR-34a" . SPARSER::MOLECULE)
    ("residual miR-34a" . SPARSER::MOLECULE)
    ("neither TP53INP1 nor PUMA" . SPARSER::COLLECTION)
    ("PITA" . SPARSER::PROTEIN) ("Rna" . SPARSER::RNA)
    ("UBC and SDHA" . SPARSER::COLLECTION) ("SDHA" . SPARSER::PROTEIN)
    ("UBC" . SPARSER::PROTEIN)
    ("CDKN1A , PUMA and TP53INP1" . SPARSER::COLLECTION)
    ("HDAC1 , MTA2 and YY1" . SPARSER::COLLECTION)
    ("CDKN1A , PUMA and TP53INP" . SPARSER::COLLECTION)
    ("CDS" . SPARSER::PROTEIN) ("SIRT1 and HDAC1" . SPARSER::COLLECTION)
    ("p53 network gene (68-fold, xref ) and the fifth most enriched gene"
     . SPARSER::COLLECTION)
    ("miR-34a, miR-34b or miR-34c" . SPARSER::COLLECTION)
    ("miR-34a and miR-34b/c" . SPARSER::COLLECTION)
    ("miR-34b-5p" . SPARSER::PROTEIN-PAIR)
    ("pG13-luc, CDKN1A and PUMA" . SPARSER::COLLECTION)
    ("CDKN1A (the gene encoding p21/WAF1) and BAX" . SPARSER::COLLECTION)
    ("p21/WAF1" . SPARSER::COLLECTION)
    ("FAS , MDM2 , PUMA and CDKN1A" . SPARSER::COLLECTION)
    ("BAX , MDM2 , PUMA , PIG3 , FAS , CDKN1A , GADD45A and TP53INP1"
     . SPARSER::COLLECTION)
    ("p53 and miR-34a" . SPARSER::COLLECTION) ("Effector" . SPARSER::EFFECTOR)
    ("miR-34b or miR-34c" . SPARSER::COLLECTION)
    ("four other post-translational inhibitors" . SPARSER::INHIBITOR)
    ("a strong p53 transactivation inhibitor" . SPARSER::INHIBITOR)
    ("miR-34b and miR-34c" . SPARSER::COLLECTION) ("P30" . SPARSER::DRUG)
    ("hMLH1" . SPARSER::PROTEIN) ("5FU" . SPARSER::DRUG)
    ("replication/repair" . SPARSER::PROTEIN) ("TP53INP1" . SPARSER::PROTEIN)
    ("PIG3" . SPARSER::PROTEIN) ("YY1" . SPARSER::PROTEIN)
    ("MDM4" . SPARSER::PROTEIN) ("exon " . SPARSER::PROTEIN)
    ("a shorter RFS" . SPARSER::PROTEIN)
    ("sequential or concurrent CRT" . SPARSER::PROTEIN)
    ("concurrent carboplatin and vindesine" . SPARSER::COLLECTION)
    ("concurrent carboplatin" . SPARSER::DRUG)
    ("ifosfamide, carboplatin and etoposide" . SPARSER::COLLECTION)
    ("ifosfamide" . SPARSER::DRUG) ("RR and RFS" . SPARSER::COLLECTION)
    ("a shorter median RFS (Fig. xref , 6.1 vs 10.9 months, P =  0.083) and a statistically significant shorter median SPP (Fig. xref , 2.5 vs 7.3 months, P =  0.028)"
     . SPARSER::COLLECTION)
    ("a statistically significant shorter median SPP" . SPARSER::PROTEIN)
    ("a shorter median RFS" . SPARSER::PROTEIN) ("SPP" . SPARSER::PROTEIN)
    ("nedaplatin" . SPARSER::DRUG)
    ("the sequential CRT group" . SPARSER::MOLECULE)
    ("the concurrent CRT group" . SPARSER::MOLECULE)
    ("vinorelbine" . SPARSER::DRUG) ("sequential CRT" . SPARSER::PROTEIN)
    ("concurrent CRT" . SPARSER::PROTEIN) ("ECOG-PS" . SPARSER::PROTEIN-PAIR)
    ("definitive CRT" . SPARSER::PROTEIN)
    ("MMP1 and MMP3" . SPARSER::COLLECTION)
    ("MMP-1 and MMP-9" . SPARSER::COLLECTION)
    ("MMP-1, MMP-2, MMP-3, MMP-9 and urokinase type" . SPARSER::COLLECTION)
    ("ETS and SP1" . SPARSER::COLLECTION)
    ("ETS1 or SP1-specific siRNA" . SPARSER::COLLECTION)
    ("an ETS1 or SP1-specific siRNA" . SPARSER::COLLECTION)
    ("ETS1 or SP1" . SPARSER::COLLECTION) ("SP1-3" . SPARSER::COLLECTION)
    ("ETS1-3" . SPARSER::COLLECTION)
    ("microRNAs and their targets" . SPARSER::COLLECTION)
    ("MMP2 or MMP9" . SPARSER::COLLECTION)
    ("the subjacent stromal matrix" . SPARSER::PROTEIN-FAMILY)
    ("almost any component" . SPARSER::COMPONENT)
    ("proteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ETS1 and SP1" . SPARSER::COLLECTION) ("MTA2" . SPARSER::PROTEIN)
    ("plasminogen activator" . SPARSER::PROTEIN)
    ("urokinase type" . SPARSER::PROTEIN) ("MMP-3" . SPARSER::PROTEIN)
    ("zinc-finger protein" . SPARSER::PROTEIN) ("SP-1" . SPARSER::PROTEIN)
    ("GAG-3" . SPARSER::PROTEIN) ("cellular EGFR" . SPARSER::PROTEIN)
    ("adequate sensor molecules" . SPARSER::MOLECULE)
    ("Src tyrosine-protein kinase and focal adhesion kinase (FAK)"
     . SPARSER::COLLECTION)
    ("Src and/or FAK" . SPARSER::COLLECTION)
    ("βPIX::Cbl" . SPARSER::BIO-COMPLEX)
    ("near-to perfect EGFR homeostasis c-Cbl" . SPARSER::PROTEIN)
    ("c-Cbl and αPIX" . SPARSER::COLLECTION)
    ("the respective receptors" . SPARSER::PROTEIN) ("avid" . SPARSER::DRUG)
    ("two essential components" . SPARSER::COMPONENT)
    ("GIT-ARF6" . SPARSER::COLLECTION) ("PIX and GIT" . SPARSER::COLLECTION)
    ("components and vesicles" . SPARSER::COLLECTION)
    ("Rab11 and sorting nexin 27" . SPARSER::COLLECTION)
    ("PIX::GIT" . SPARSER::BIO-COMPLEX)
    ("Cdc42 and Rac1" . SPARSER::COLLECTION)
    ("αPIX and EGFR" . SPARSER::COLLECTION)
    ("un-ubiquitylated recyclable EGFRs" . SPARSER::PROTEIN)
    ("15KR-EGFR" . SPARSER::PROTEIN) ("KR" . SPARSER::PROTEIN-FAMILY)
    ("αPIX-" . SPARSER::PROTEIN) ("Cbl and βPIX" . SPARSER::COLLECTION)
    ("Cbl, βPIX and EGFR" . SPARSER::COLLECTION)
    ("βPIX and Cdc42" . SPARSER::COLLECTION)
    ("PIX and Cbl" . SPARSER::COLLECTION) ("GIT-" . SPARSER::PROTEIN)
    ("αPIX/c-Cbl" . SPARSER::COLLECTION)
    ("a novel bidirectional trafficking regulator" . SPARSER::REGULATOR)
    ("the ARF6 and diverse RAB GTPases, effectors and regulators"
     . SPARSER::COLLECTION)
    ("GTPases, effectors and regulators" . SPARSER::COLLECTION)
    ("RAB" . SPARSER::PROTEIN) ("GAPex5" . SPARSER::PROTEIN)
    ("Bromodeoxyuridine" . SPARSER::DRUG)
    ("αPIX and GIT" . SPARSER::COLLECTION)
    ("progressive EGFR" . SPARSER::PROTEIN)
    ("internal EGFR" . SPARSER::PROTEIN)
    ("exclusively study EGFR" . SPARSER::PROTEIN)
    ("leupeptin and pepstatin" . SPARSER::COLLECTION)
    ("c-Cbl and EGFR" . SPARSER::COLLECTION)
    ("V5-tagged αPIX" . SPARSER::PROTEIN) ("chloramphenicol" . SPARSER::DRUG)
    ("endocytic EGFR" . SPARSER::PROTEIN) ("EGFRs" . SPARSER::PROTEIN)
    ("Proteasomal" . SPARSER::PROTEIN)
    ("the binding-deficient variants αPIX W197K or c-Cbl R829A"
     . SPARSER::COLLECTION)
    ("growth factor-" . SPARSER::GROWTH-FACTOR)
    ("HA-αPIX" . SPARSER::COLLECTION)
    ("still co-precipitated c-Cbl" . SPARSER::PROTEIN)
    ("αPIX and βPIX" . SPARSER::COLLECTION)
    ("the multifunctional GIT (G protein-coupled receptor kinase-interacting target) family proteins"
     . SPARSER::PROTEIN)
    ("αPIX and Cbl" . SPARSER::COLLECTION)
    ("a potent bimodal regulator of EGFR trafficking by controlling receptor recycling and degradation"
     . SPARSER::COLLECTION)
    ("Cbl::PIX" . SPARSER::BIO-COMPLEX) ("PIX" . SPARSER::PROTEIN)
    ("essential endocytic proteins" . SPARSER::PROTEIN)
    ("βPIX, Cbl and EGFR" . SPARSER::COLLECTION)
    ("Cbl-b and Cbl-c" . SPARSER::COLLECTION)
    ("αPIX and Cbl-b" . SPARSER::COLLECTION) ("Dbl" . SPARSER::PROTEIN)
    ("Cool-2" . SPARSER::PROTEIN)
    ("the novel recycling regulator αPIX and the degradation factor c-Cbl"
     . SPARSER::COLLECTION)
    ("a strong promoter" . SPARSER::PROMOTER)
    ("c-Cbl or αPIX" . SPARSER::COLLECTION) ("GIT" . SPARSER::PROTEIN)
    ("αPIX and c-Cbl" . SPARSER::COLLECTION)
    ("c-Cbl and c-Cbl" . SPARSER::COLLECTION)
    ("αPIX::c-Cbl" . SPARSER::BIO-COMPLEX)
    ("a potent bimodal regulator" . SPARSER::REGULATOR)
    ("Sulfo-NHS" . SPARSER::DRUG) ("R-1" . SPARSER::PROTEIN)
    ("early endosome antigen 1" . SPARSER::PROTEIN) ("pRK5" . SPARSER::PROTEIN)
    ("pMT2" . SPARSER::PROTEIN) ("sorting nexin 27" . SPARSER::PROTEIN)
    ("Rab11" . SPARSER::PROTEIN) ("GTPase activating" . SPARSER::PROTEIN)
    ("CIN85" . SPARSER::PROTEIN) ("ARF6" . SPARSER::PROTEIN)
    ("AIP1" . SPARSER::PROTEIN) ("Sprouty 2" . SPARSER::PROTEIN)
    ("GIT2" . SPARSER::PROTEIN)
    ("G protein-coupled receptor kinase" . SPARSER::PROTEIN)
    ("Cbl-c" . SPARSER::PROTEIN) ("βPIX" . SPARSER::PROTEIN)
    ("non-syndromic" . SPARSER::PROTEIN) ("ARHGEF6" . SPARSER::PROTEIN)
    ("c-Cbl" . SPARSER::PROTEIN) ("αPIX" . SPARSER::PROTEIN)
    ("Paxillin" . SPARSER::PROTEIN)
    ("PABPC1 and the AR form" . SPARSER::COLLECTION)
    ("GFP or GFP-AR" . SPARSER::COLLECTION)
    ("PABPC1 and full length AR" . SPARSER::COLLECTION)
    ("GFP-AR" . SPARSER::COLLECTION) ("TOF/TOF" . SPARSER::COLLECTION)
    ("TOF" . SPARSER::PROTEIN) ("eukaryotic mRNA" . SPARSER::PROTEIN)
    ("abiraterone and enzalutamide" . SPARSER::COLLECTION)
    ("Abiraterone and enzalutamide" . SPARSER::COLLECTION)
    ("Abiraterone" . SPARSER::DRUG) ("bicalutamide" . SPARSER::DRUG)
    ("LNCaP and C4-2" . SPARSER::COLLECTION)
    ("pulled down proteins" . SPARSER::PROTEIN) ("CRM-1" . SPARSER::PROTEIN)
    ("FKBP5" . SPARSER::PROTEIN) ("Nkx3.1" . SPARSER::PROTEIN)
    ("AT-3" . SPARSER::PROTEIN) ("F-2" . SPARSER::PROTEIN)
    ("AF1" . SPARSER::PROTEIN)
    ("poly (A) binding protein cytoplasmic 1" . SPARSER::PROTEIN)
    ("C4-2" . SPARSER::PROTEIN) ("protein, and mRNA" . SPARSER::COLLECTION)
    ("CXCR4/SDF-1" . SPARSER::COLLECTION) ("MAML" . SPARSER::PROTEIN)
    ("onco-protein" . SPARSER::PROTEIN-PAIR) ("Periostin" . SPARSER::PROTEIN)
    ("another pro-inflammatory cytokine" . SPARSER::PROTEIN)
    ("IL-1α and IL-1β" . SPARSER::COLLECTION)
    ("IL-1α or IL-1β" . SPARSER::COLLECTION) ("Neutrophils" . SPARSER::PROTEIN)
    ("both CXCR4 ( xref ) and IL-1β ( xref )" . SPARSER::COLLECTION)
    ("JNK and p38" . SPARSER::COLLECTION)
    ("ERK, JNK and p38" . SPARSER::COLLECTION)
    ("NF-κB and MAPK" . SPARSER::COLLECTION) ("NICD" . SPARSER::PROTEIN)
    ("IL-1β and CXCR4" . SPARSER::COLLECTION)
    ("a strong antagonist" . SPARSER::MOLECULE)
    ("CCR6 or CCR7" . SPARSER::COLLECTION)
    ("The pro-inflammatory cytokines TNF-α and IL-1β" . SPARSER::COLLECTION)
    ("A wide variety of potential drugs targeting CXCL12/CXCR4 and downstream signaling pathways"
     . SPARSER::COLLECTION)
    ("CXCL12/CXCR4" . SPARSER::COLLECTION)
    ("CXCL12 and CXCR4" . SPARSER::COLLECTION)
    ("small pro-inflammatory chemoattractant cytokines" . SPARSER::PROTEIN)
    ("Chemokines" . SPARSER::PROTEIN)
    ("a pleiotropic pro-inflammatory cytokine" . SPARSER::PROTEIN)
    ("IL-1β and IL-1R1" . SPARSER::COLLECTION)
    ("IL-1Ra or RNA" . SPARSER::COLLECTION) ("SDF1" . SPARSER::PROTEIN)
    ("Dll4" . SPARSER::PROTEIN) ("RBP-J" . SPARSER::PROTEIN)
    ("γ-secretase" . SPARSER::PROTEIN) ("MAML1" . SPARSER::PROTEIN)
    ("IL-1α" . SPARSER::PROTEIN) ("toll-like receptor 5" . SPARSER::PROTEIN)
    ("Hes1" . SPARSER::PROTEIN) ("IL-1R2" . SPARSER::PROTEIN)
    ("IL-1RI" . SPARSER::PROTEIN)
    ("glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("CCR7" . SPARSER::PROTEIN) ("CCR6" . SPARSER::PROTEIN)
    ("IL1R2" . SPARSER::PROTEIN) ("CD184" . SPARSER::PROTEIN)
    ("derived factor-1" . SPARSER::PROTEIN) ("G-protein" . SPARSER::PROTEIN)
    ("non-small-cell" . SPARSER::PROTEIN) ("IL-R1" . SPARSER::PROTEIN)
    ("extracellular signal regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL-1Ra" . SPARSER::PROTEIN) ("derived factor" . SPARSER::PROTEIN)
    ("IL-1R1" . SPARSER::PROTEIN)
    ("MKP-1, BDNF, and gonadal" . SPARSER::COLLECTION)
    ("BDNF and E 2" . SPARSER::COLLECTION)
    ("neither testosterone nor free testosterone" . SPARSER::COLLECTION)
    ("DHEAS" . SPARSER::MOLECULE)
    ("E 2 , T, P, LH, and FSH" . SPARSER::COLLECTION)
    ("=−2.236" . SPARSER::COLLECTION) ("=−2.194" . SPARSER::COLLECTION)
    ("=−3.811" . SPARSER::COLLECTION) ("=−3.712" . SPARSER::COLLECTION)
    ("=−3.133" . SPARSER::COLLECTION) ("=−3.608" . SPARSER::COLLECTION)
    ("=−2.624" . SPARSER::COLLECTION) ("=−3.144" . SPARSER::COLLECTION)
    ("=−2.170" . SPARSER::COLLECTION) ("=−1.550" . SPARSER::COLLECTION)
    ("=−1.689" . SPARSER::COLLECTION) ("=−3.069" . SPARSER::COLLECTION)
    ("=−1.391" . SPARSER::COLLECTION) ("=−2.855" . SPARSER::COLLECTION)
    ("=−3.612" . SPARSER::COLLECTION) ("BDNF and MKP-1" . SPARSER::COLLECTION)
    ("estradiol, testosterone, BDNF, and MKP-1" . SPARSER::COLLECTION)
    ("androgens or estradiol" . SPARSER::COLLECTION)
    ("Testosterone or estradiol" . SPARSER::COLLECTION)
    ("ERK2, JNK, and p38" . SPARSER::COLLECTION)
    ("testosterone and estradiol" . SPARSER::COLLECTION)
    ("BDNF and gonadal" . SPARSER::COLLECTION)
    ("gonadal" . SPARSER::PROTEIN-FAMILY) ("neurotrophin" . SPARSER::PROTEIN)
    ("estrogens and testosterone" . SPARSER::COLLECTION)
    ("antidepressant" . SPARSER::DRUG) ("Estrogens" . SPARSER::MOLECULE)
    ("neurotrophic factor" . SPARSER::PROTEIN)
    ("phosphatase-1" . SPARSER::PROTEIN)
    ("Brain-derived neurotrophic factor" . SPARSER::PROTEIN)
    ("E 2" . SPARSER::MOLECULE) ("MKP-1" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase phosphatase-1" . SPARSER::PROTEIN)
    ("brain-derived neurotrophic factor" . SPARSER::PROTEIN)
    ("an attractive anti-cancer target" . SPARSER::TARGET-PROTEIN)
    ("predicative biomarkers" . SPARSER::MOLECULE)
    ("Bcl2/Bcl-xL" . SPARSER::COLLECTION) ("navitoclax" . SPARSER::DRUG)
    ("Mcl1 and Bcl-xL" . SPARSER::COLLECTION)
    ("docetaxel and capecitabine" . SPARSER::COLLECTION)
    ("taxol and carboplatin" . SPARSER::COLLECTION)
    ("several mitotic regulators" . SPARSER::REGULATOR)
    ("the pro-apoptotic BH3-only proteins" . SPARSER::PROTEIN)
    ("BIM and NOXA" . SPARSER::COLLECTION)
    ("metazoan" . SPARSER::PROTEIN-FAMILY)
    ("yet apoptotic regulators" . SPARSER::REGULATOR)
    ("Bcl-xL and Mcl1" . SPARSER::COLLECTION)
    ("ICAD and Myc" . SPARSER::COLLECTION) ("ICAD" . SPARSER::PROTEIN)
    ("Myc and Egr1" . SPARSER::COLLECTION)
    ("Bim and Noxa" . SPARSER::COLLECTION)
    ("955 downregulated genes and 1,214 upregulated genes ( xref A)"
     . SPARSER::COLLECTION)
    ("Myc, Kcnk1, and Snta1" . SPARSER::COLLECTION) ("Egr1" . SPARSER::PROTEIN)
    ("Znf791 and Snta1" . SPARSER::COLLECTION)
    ("Kcnk1, Znf791, and Snta1" . SPARSER::COLLECTION)
    ("KCNK1 , ZNF791 and SNTA1" . SPARSER::COLLECTION)
    ("Kcnk1, Snta1, and Znf791" . SPARSER::COLLECTION)
    ("Znf791" . SPARSER::PROTEIN)
    ("a conditional MYC allele" . SPARSER::ALLELE)
    ("Myc and cell cycle/SAC" . SPARSER::COLLECTION)
    ("Myc and several housekeeping genes" . SPARSER::COLLECTION)
    ("the SAC and cell cycle genes" . SPARSER::COLLECTION)
    ("mitotic regulators" . SPARSER::REGULATOR) ("colcemid" . SPARSER::DRUG)
    ("tet" . SPARSER::PROTEIN) ("Antimitotic " . SPARSER::MOLECULE)
    ("Bim/Bid/Noxa" . SPARSER::COLLECTION)
    ("Bim, Bid, and Noxa" . SPARSER::COLLECTION)
    ("this residual Mcl1" . SPARSER::PROTEIN) ("Mcl1" . SPARSER::PROTEIN)
    ("Mcl" . SPARSER::PROTEIN)
    ("BH3-Only Pro-apoptotic Proteins" . SPARSER::PROTEIN)
    ("BH3-only pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("Bid, Bim, and Noxa" . SPARSER::COLLECTION)
    ("Survivin and Mad2" . SPARSER::COLLECTION) ("Mad2" . SPARSER::PROTEIN)
    ("Mad" . SPARSER::PROTEIN) ("Interestingly Myc V394D" . SPARSER::PROTEIN)
    ("the DMSO and JQ1" . SPARSER::COLLECTION)
    ("the Brd4 transcriptional elongation factor" . SPARSER::PROTEIN)
    ("cells underwent DiM" . SPARSER::PROTEIN-FAMILY)
    ("four distinct siRNAs" . SPARSER::PROTEIN)
    ("ARF-MDM2-p53" . SPARSER::COLLECTION) ("bHLH-Zip" . SPARSER::COLLECTION)
    ("bHLH" . SPARSER::PROTEIN) ("Regulator" . SPARSER::REGULATOR)
    ("KCNK1 , ZNF791 , SNTA1 , and MYC" . SPARSER::COLLECTION)
    ("Regulators" . SPARSER::REGULATOR)
    ("the apoptotic trigger" . SPARSER::PROTEIN)
    ("DiM" . SPARSER::PROTEIN-FAMILY)
    ("the mitotic state" . SPARSER::BIO-STATE) ("SAC" . SPARSER::PROTEIN)
    ("mitotic kinesins and mitotic kinases" . SPARSER::COLLECTION)
    ("mitotic kinases" . SPARSER::KINASE)
    ("mitotic kinesins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("kinesins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Antimitotic" . SPARSER::MOLECULE)
    ("redundant pro-apoptotic BH3-only proteins" . SPARSER::PROTEIN)
    ("Taxol" . SPARSER::DRUG) ("T-REx" . SPARSER::PROTEIN-FAMILY)
    ("CyclinB1" . SPARSER::PROTEIN) ("Snta1" . SPARSER::PROTEIN)
    ("Kcnk1" . SPARSER::PROTEIN) ("C–5" . SPARSER::PROTEIN)
    ("antimitotic agent" . SPARSER::DRUG) ("Mps1" . SPARSER::PROTEIN)
    ("Cenp-E" . SPARSER::PROTEIN) ("Myc protein" . SPARSER::PROTEIN)
    ("SNTA1" . SPARSER::PROTEIN) ("ZNF791" . SPARSER::PROTEIN)
    ("KCNK1" . SPARSER::PROTEIN) ("caspase-activated DNase" . SPARSER::PROTEIN)
    ("a Kit-specific antibody" . SPARSER::PROTEIN) ("Ig" . SPARSER::MOLECULE)
    ("scFV" . SPARSER::PROTEIN)
    ("a commercial Kit antibody" . SPARSER::ANTIBODY)
    ("approximately 145 kDa" . SPARSER::PROTEIN)
    ("Glycerol" . SPARSER::PROTEIN) ("Six distinct scFvs" . SPARSER::PROTEIN)
    ("soluble antibodies" . SPARSER::ANTIBODY)
    ("Unique scFvs" . SPARSER::PROTEIN) ("Monoclonal scFv" . SPARSER::PROTEIN)
    ("approximately 3.7 × 10 7 different antibodies" . SPARSER::ANTIBODY)
    ("ScFv" . SPARSER::PROTEIN) ("The post-immune sera" . SPARSER::PROTEIN)
    ("histamine" . SPARSER::PROTEIN)
    ("the post-immune sera" . SPARSER::PROTEIN)
    ("TGFβ and TNFα" . SPARSER::COLLECTION)
    ("recognised integrins or their ligands [ xref ]" . SPARSER::COLLECTION)
    ("integrins and C-type" . SPARSER::COLLECTION)
    ("lectins" . SPARSER::HUMAN-PROTEIN-FAMILY) ("scFvs" . SPARSER::PROTEIN)
    ("Mast cell" . SPARSER::PROTEIN) ("scFv" . SPARSER::PROTEIN)
    ("c-kit" . SPARSER::PROTEIN) ("A1 at" . SPARSER::DRUG)
    ("IgG1" . SPARSER::BIO-COMPLEX) ("-3 " . SPARSER::PROTEIN)
    ("C-myc" . SPARSER::PROTEIN) ("a 3 " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pSD3" . SPARSER::PROTEIN) ("K  +" . SPARSER::MOLECULE)
    ("r K" . SPARSER::PROTEIN) ("CD51" . SPARSER::PROTEIN)
    ("CADM1" . SPARSER::PROTEIN)
    ("TNFR1, c-Src, EGFR, PI3K/Akt, and NF-κB" . SPARSER::COLLECTION)
    ("the predominant type" . TYPE)
    ("PP1, AG1478, LY294002, and Bay11-7082" . SPARSER::COLLECTION)
    ("c-Src and Akt" . SPARSER::COLLECTION)
    ("p110 siRNA (a PI3K subunit) or Akt siRNA" . SPARSER::COLLECTION)
    ("PI3K (LY294002) and Akt (SH-5)" . SPARSER::COLLECTION)
    ("their respective inhibitors (PP1 and AG1478) and siRNAs transfection"
     . SPARSER::COLLECTION)
    ("their respective inhibitors" . SPARSER::INHIBITOR)
    ("PP1 and AG1478" . SPARSER::COLLECTION)
    ("c-Src/EGFR" . SPARSER::COLLECTION)
    ("TNF-α and their respective pharmacological inhibitors"
     . SPARSER::COLLECTION)
    ("their respective pharmacological inhibitors" . SPARSER::INHIBITOR)
    ("PP1, AG1478, LY294002, or Bay11-7082" . SPARSER::COLLECTION)
    ("siRNA, AG1478, LY294002, or Akt" . SPARSER::COLLECTION)
    ("mRNA and promoter" . SPARSER::COLLECTION)
    ("siRNA, or AG1478" . SPARSER::COLLECTION)
    ("p110 (a PI3K subunit) or Akt" . SPARSER::COLLECTION)
    ("p110 or Akt" . SPARSER::COLLECTION)
    ("PI3K (LY294002) and Akt (SH-5) inhibitors" . SPARSER::COLLECTION)
    ("protein, mRNA, and promoter" . SPARSER::COLLECTION)
    ("myoglobin" . SPARSER::PROTEIN) ("receptor (TNFR)" . SPARSER::RECEPTOR)
    ("EGFR, PI3K/Akt, and NF-κB" . SPARSER::COLLECTION)
    ("c-Src and NF-κB" . SPARSER::COLLECTION)
    ("c-Src kinase and NF-κB" . SPARSER::COLLECTION)
    ("VCAM-1 and TNF-α" . SPARSER::COLLECTION)
    ("ICAM-1 and VCAM-1" . SPARSER::COLLECTION)
    ("intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1"
     . SPARSER::COLLECTION)
    ("vascular cell adhesion molecule (VCAM)-1" . SPARSER::PROTEIN)
    ("intercellular adhesion molecule (ICAM)-1" . SPARSER::PROTEIN)
    ("ICAM" . SPARSER::PROTEIN-FAMILY) ("a major cytokine" . SPARSER::PROTEIN)
    ("cyclooxygenase" . SPARSER::PROTEIN) ("substances" . SPARSER::SUBSTANCE)
    ("Several pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("receptor (EGFR)" . SPARSER::RECEPTOR) ("TNFR" . SPARSER::PROTEIN)
    ("a proinflammatory cytokine" . SPARSER::PROTEIN)
    ("Bay11-7082" . SPARSER::DRUG) ("c-Src kinase" . SPARSER::PROTEIN)
    ("G protein-coupled" . SPARSER::PROTEIN) ("TNFR1" . SPARSER::PROTEIN)
    ("VCAM-1" . SPARSER::PROTEIN)
    ("vascular cell adhesion molecule-1" . SPARSER::PROTEIN)
    ("Tumor necrosis factor" . SPARSER::PROTEIN)
    ("gefitinib or erlotinib" . SPARSER::COLLECTION)
    ("continued EGFR TKI" . SPARSER::PROTEIN)
    ("PFS1 and PFS2" . SPARSER::COLLECTION) ("EGFR-TKI" . SPARSER::PROTEIN)
    ("PFS2" . SPARSER::PROTEIN) ("PFS1" . SPARSER::PROTEIN)
    ("endocytic protein caveolin-1" . SPARSER::PROTEIN)
    ("HER-3 or IGF1-R" . SPARSER::COLLECTION)
    ("the chemotherapeutic drugs" . SPARSER::DRUG)
    ("trastuzumab, T-DM1 and paclitaxel" . SPARSER::COLLECTION)
    ("GFP-caveolin-1" . SPARSER::COLLECTION)
    ("trastuzumab, T-DM1, and paclitaxel" . SPARSER::COLLECTION)
    ("Trastuzumab and T-DM1" . SPARSER::COLLECTION)
    ("trastuzumab or T-DM1" . SPARSER::COLLECTION)
    ("trastuzumab and T-DM1" . SPARSER::COLLECTION)
    ("the two major endocytic proteins clathrin and caveolin-1"
     . SPARSER::COLLECTION)
    ("clathrin and caveolin-1" . SPARSER::COLLECTION)
    ("the ER (+) and PR (+)" . SPARSER::COLLECTION)
    ("the ER(-) and PR(-)" . SPARSER::COLLECTION)
    ("a membrane endocytic protein" . SPARSER::PROTEIN)
    ("Clathrin" . SPARSER::PROTEIN) ("HER-2-T-DM1" . SPARSER::COLLECTION)
    ("TDM" . SPARSER::PROTEIN) ("trastuzumab and taxane" . SPARSER::COLLECTION)
    ("NCCN" . SPARSER::MOLECULE)
    ("the dual tyrosine kinase inhibitor lapatinib" . SPARSER::DRUG)
    ("capecitabine" . SPARSER::DRUG) ("thioether" . SPARSER::MOLECULE)
    ("specific monoclonal antibodies" . SPARSER::ANTIBODY)
    ("trastuzumab and anthracyclines" . SPARSER::COLLECTION)
    ("the Food and Drug Administration (FDA)" . SPARSER::COLLECTION)
    ("caveolin-1 or caveolin-1" . SPARSER::COLLECTION)
    ("T-DM1 and caveolin-1" . SPARSER::COLLECTION)
    ("Antibody" . SPARSER::PROTEIN) ("Kadcyla" . SPARSER::DRUG)
    ("emtansine" . SPARSER::DRUG) ("IGF1-R" . SPARSER::PROTEIN)
    ("HER-3" . SPARSER::PROTEIN) ("Z-VAD-FMK" . SPARSER::DRUG)
    ("f3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Rab family" . SPARSER::PROTEIN)
    ("anti-mitotic" . SPARSER::MOLECULE) ("T-DM1" . SPARSER::PROTEIN)
    ("glycosyltransferases" . SPARSER::PROTEIN) ("mucins" . SPARSER::PROTEIN)
    ("T-synthase and Cosmc" . SPARSER::COLLECTION) ("Cosmc" . SPARSER::PROTEIN)
    ("immunosuppressive cytokines" . SPARSER::PROTEIN)
    ("a novel prognostic biomarker" . SPARSER::MOLECULE)
    ("BRAF V600E and its downstream target MEK" . SPARSER::COLLECTION)
    ("the selective BRAF V600E inhibitors PLX4032 (Vemurafenib) and PLX4720"
     . SPARSER::COLLECTION)
    ("agglutinin" . SPARSER::PROTEIN) ("-chelator" . SPARSER::MOLECULE)
    ("EGTA" . SPARSER::MOLECULE) ("Fc" . SPARSER::PROTEIN)
    ("especially Tn antigen" . SPARSER::PROTEIN)
    ("MGL-Fc" . SPARSER::COLLECTION) ("BRAF and MSI" . SPARSER::COLLECTION)
    ("KRAS and EGFR" . SPARSER::COLLECTION)
    ("MSS or MSI" . SPARSER::COLLECTION)
    ("MSI or microsatellite" . SPARSER::COLLECTION)
    ("tolerogenic antigen" . SPARSER::PROTEIN)
    ("tumor-associated Tn antigen" . SPARSER::PROTEIN)
    ("cancer-associated aberrant O -glycans" . SPARSER::MOLECULE)
    ("mucin" . SPARSER::PROTEIN) ("Agglutinin" . SPARSER::PROTEIN)
    ("snail" . SPARSER::PROTEIN) ("dys" . SPARSER::PROTEIN)
    ("an important negative prognostic biomarker" . SPARSER::MOLECULE)
    ("immunogenic neo-antigens" . SPARSER::COLLECTION)
    ("neo-antigens" . SPARSER::COLLECTION)
    ("lectin (MGL)" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MGL" . SPARSER::PROTEIN)
    ("T-synthase" . SPARSER::PROTEIN) ("PLX4720" . SPARSER::DRUG)
    ("ERK-CREB" . SPARSER::PROTEIN) ("MUC1" . SPARSER::PROTEIN)
    ("CLEC10A" . SPARSER::PROTEIN) ("O -glycans" . SPARSER::MOLECULE)
    ("GalNAcα" . SPARSER::MOLECULE)
    ("AZ, CCND1 and CDK4" . SPARSER::COLLECTION)
    ("AZ and its interacting proteins" . SPARSER::COLLECTION)
    ("the cellular ODC dimers and CCND1-CDK4 complex" . SPARSER::COLLECTION)
    ("CCND1-CDK4" . SPARSER::COLLECTION)
    ("the AZ-CCND1 complex and the ODC-AZ-CCND1 ternary complex"
     . SPARSER::COLLECTION)
    ("CCND1, ODC and AZI" . SPARSER::COLLECTION)
    ("the minimal AZ peptide" . SPARSER::PEPTIDE)
    ("ternary complexes" . SPARSER::BIO-COMPLEX)
    ("ODC/AZ/CCND1" . SPARSER::COLLECTION)
    ("ODC-AZ-CCND1 ternary complexes" . SPARSER::BIO-COMPLEX)
    ("ODC and CCND1, ODC and CCND1" . SPARSER::COLLECTION)
    ("CCND1, ODC and CCND1" . SPARSER::COLLECTION)
    ("anti-ODC and anti-CCND1" . SPARSER::COLLECTION)
    ("AZ/ODC" . SPARSER::COLLECTION) ("AZ-CCND1/ODC" . SPARSER::COLLECTION)
    ("AZ-ODC/CCND1" . SPARSER::COLLECTION)
    ("a binary complex" . SPARSER::BIO-COMPLEX)
    ("this ternary complex" . SPARSER::BIO-COMPLEX)
    ("ODC (or AZI) and CCND1" . SPARSER::COLLECTION)
    ("AZ, AZI and CCND1" . SPARSER::COLLECTION)
    ("the predominant form" . SPARSER::FORM)
    ("AZ, ODC and CCND1" . SPARSER::COLLECTION)
    ("AZ and its interacting proteins, or ODC, AZI and CCND1"
     . SPARSER::COLLECTION)
    ("proteins, or ODC, AZI and CCND1" . SPARSER::COLLECTION)
    ("ODC and AZI" . SPARSER::COLLECTION)
    ("AZ and ODC, AZI and CCND1" . SPARSER::COLLECTION)
    ("ODC, AZI and CCND1" . SPARSER::COLLECTION) ("ODC-" . SPARSER::PROTEIN)
    ("Mixtures" . SPARSER::MOLECULE)
    ("ODC and much weaker" . SPARSER::COLLECTION)
    ("-AZI" . SPARSER::COLLECTION)
    ("AZ and its interacting proteins, or ODC, CCND1 and AZI"
     . SPARSER::COLLECTION)
    ("proteins, or ODC, CCND1 and AZI" . SPARSER::COLLECTION)
    ("ODC, CCND1 and AZI" . SPARSER::COLLECTION)
    ("ODC-AZ" . SPARSER::COLLECTION)
    ("kinase and Aurora-A" . SPARSER::COLLECTION)
    ("kinase and Smad1" . SPARSER::COLLECTION)
    ("ODC and polyamine" . SPARSER::COLLECTION)
    ("polyamine" . SPARSER::MOLECULE) ("a unique type" . TYPE)
    ("the first enzyme and a rate-limiting enzyme" . SPARSER::COLLECTION)
    ("polyamines" . SPARSER::MOLECULE) ("1b" . SPARSER::PROTEIN)
    ("Mirk" . SPARSER::PROTEIN) ("GSK3β-" . SPARSER::PROTEIN)
    ("antizyme (AZ)" . SPARSER::PROTEIN) ("acetylase" . SPARSER::PROTEIN)
    ("an active complex" . SPARSER::BIO-COMPLEX)
    ("CCND1 and ODC" . SPARSER::COLLECTION) ("-CCND1" . SPARSER::COLLECTION)
    ("-ODC" . SPARSER::COLLECTION)
    ("the ODC-AZ-CCND1 ternary complex" . SPARSER::BIO-COMPLEX)
    ("ODC-AZ-CCND1" . SPARSER::COLLECTION)
    ("the AZ N-terminal peptide (AZ 34–124 ) and AZ C-terminal peptide (AZ 100–228 )"
     . SPARSER::COLLECTION)
    ("AZ-AZI" . SPARSER::COLLECTION) ("AZ-ODC" . SPARSER::COLLECTION)
    ("the binary AZ-CCND1 complex" . SPARSER::BIO-COMPLEX)
    ("AZ and CCND1" . SPARSER::COLLECTION) ("AZ-CCND1" . SPARSER::COLLECTION)
    ("AZ" . SPARSER::PROTEIN) ("ODC and CCND1" . SPARSER::COLLECTION)
    ("antizyme" . SPARSER::PROTEIN)
    ("cyclin D1 (CCND1) and antizyme inhibitor (AZI)" . SPARSER::COLLECTION)
    ("Ornithine decarboxylase (ODC), cyclin D1 (CCND1) and antizyme inhibitor (AZI)"
     . SPARSER::COLLECTION)
    ("AZI" . SPARSER::PROTEIN) ("ODC" . SPARSER::PROTEIN)
    ("kinase interacting protein" . SPARSER::PROTEIN)
    ("Smad1" . SPARSER::PROTEIN) ("Aurora-A" . SPARSER::PROTEIN)
    ("Antizyme inhibitor" . SPARSER::PROTEIN)
    ("ornithine decarboxylase" . SPARSER::PROTEIN)
    ("p38 SAPK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("regulator of cell cycle" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 4" . SPARSER::PROTEIN)
    ("antizyme inhibitor" . SPARSER::PROTEIN)
    ("Ornithine decarboxylase" . SPARSER::PROTEIN) ("TSR" . SPARSER::PROTEIN)
    ("SMEK2-ALK" . SPARSER::COLLECTION) ("-ALK" . SPARSER::COLLECTION)
    ("protein (WDCP)" . SPARSER::PROTEIN) ("C2orf44" . SPARSER::PROTEIN)
    ("WDCP-ALK" . SPARSER::COLLECTION) ("C2orf44-ALK" . SPARSER::PROTEIN-PAIR)
    ("ALK and its downstream signal molecules" . SPARSER::COLLECTION)
    ("leucovorin" . SPARSER::DRUG) ("NEXT" . SPARSER::PROTEIN)
    ("Aspartate" . SPARSER::PROTEIN) ("Carbamoyl" . SPARSER::MOLECULE)
    ("KIF5B , EML4 , KLC1 , SMCF1 and C2orf44" . SPARSER::COLLECTION)
    ("orf" . SPARSER::PROTEIN) ("distal GC" . SPARSER::PROTEIN)
    ("GC and CRC" . SPARSER::COLLECTION) ("Food" . SPARSER::MOLECULE)
    ("crizotinib and entrectinib" . SPARSER::COLLECTION)
    ("entrectinib" . SPARSER::DRUG)
    ("ALK FISH and a novel CAD-ALK (C35; A20) fusion variant"
     . SPARSER::COLLECTION)
    ("p22" . SPARSER::PROTEIN)
    ("Four hundred thirty-two GC and 172 CRC" . SPARSER::COLLECTION)
    ("FISH, nCounter assays, and NGS-based comprehensive genomic profiling (CGP)"
     . SPARSER::COLLECTION)
    ("NTRK3" . SPARSER::PROTEIN) ("NTRK2" . SPARSER::PROTEIN)
    ("NTRK1" . SPARSER::PROTEIN) ("S11" . SPARSER::PROTEIN)
    ("SMEK2" . SPARSER::PROTEIN) ("KLC1" . SPARSER::PROTEIN)
    ("KIF5B" . SPARSER::PROTEIN)
    ("anaplastic lymphoma kinase" . SPARSER::PROTEIN)
    ("Anaplastic lymphoma kinase" . SPARSER::PROTEIN)
    ("mTOR and eIF3" . SPARSER::COLLECTION)
    ("a negative regulator or stabilization of a positive regulator"
     . SPARSER::COLLECTION)
    ("Cycloheximide" . SPARSER::PROTEIN)
    ("hyperactive S6K1" . SPARSER::PROTEIN) ("b or c" . SPARSER::COLLECTION)
    ("stringent external cues" . SPARSER::PROTEIN-FAMILY)
    ("cancer-associated eIF3bT668P and eIF3cP309T mutants" . SPARSER::MUTANT)
    ("GFP-spectrin" . SPARSER::COLLECTION) ("spectrin" . SPARSER::PROTEIN)
    ("eIF3b/c" . SPARSER::PROTEIN)
    ("the respective eIF3b and eIF3c-depleted" . SPARSER::COLLECTION)
    ("eIF3b and eIF3c-depleted" . SPARSER::COLLECTION)
    ("rapamycin and PF-4708671" . SPARSER::COLLECTION)
    ("rapamycin and cycloheximide" . SPARSER::COLLECTION)
    ("rapamycin-" . SPARSER::DRUG) ("a concurrent eIF3" . SPARSER::BIO-COMPLEX)
    ("the translational preinitiation complex (PIC)" . SPARSER::BIO-COMPLEX)
    ("eIF3b, eIF3c and eIF3b/c" . SPARSER::COLLECTION)
    ("p-S6 and p-CAD" . SPARSER::COLLECTION)
    ("mTOR and inhibitor" . SPARSER::COLLECTION)
    ("Cyclin D1 and p27Cip/Kip" . SPARSER::COLLECTION)
    ("eIF3b and/or eIF3c" . SPARSER::COLLECTION)
    ("eIF3b or eIF3c" . SPARSER::COLLECTION)
    ("mTOR-S6K1" . SPARSER::COLLECTION)
    ("eIF3b and eIF3c" . SPARSER::COLLECTION)
    ("eIF3a, eIF3b, eIF3c, eIF3e, eIF3f, and eIF3" . SPARSER::COLLECTION)
    ("eIF3a, eIF3b, and eIF3c" . SPARSER::COLLECTION)
    ("eIF3f" . SPARSER::PROTEIN) ("eIF3e" . SPARSER::PROTEIN)
    ("eIF3c" . SPARSER::PROTEIN) ("eIF3b" . SPARSER::PROTEIN)
    ("eIF3a" . SPARSER::PROTEIN)
    ("the much larger 43S translation PIC" . SPARSER::BIO-COMPLEX)
    ("the eukaryotic initiation factor 3 (eIF3) subunit" . SPARSER::FRAGMENT)
    ("complex (PIC)" . SPARSER::BIO-COMPLEX) ("PIC" . SPARSER::BIO-COMPLEX)
    ("S6K1 or S6K1 and S6K2" . SPARSER::COLLECTION)
    ("S6K1 and S6K2" . SPARSER::COLLECTION)
    ("the ribosomal S6 protein kinase (S6K) and the eukaryotic initiation factor 4E (eIF4E)"
     . SPARSER::COLLECTION)
    ("the ribosomal S6 protein kinase" . SPARSER::KINASE)
    ("two important translational regulators" . SPARSER::REGULATOR)
    ("external cues" . SPARSER::PROTEIN-FAMILY)
    ("IGF/AKT/mTOR" . SPARSER::COLLECTION) ("αTubulin" . SPARSER::PROTEIN)
    ("Foxp3" . SPARSER::PROTEIN) ("p70" . SPARSER::PROTEIN)
    ("p-S6K" . SPARSER::PROTEIN) ("PDCD4" . SPARSER::PROTEIN)
    ("p70 S6K1" . SPARSER::PROTEIN) ("S6K2" . SPARSER::PROTEIN)
    ("cap-binding protein" . SPARSER::PROTEIN) ("PF-4708671" . SPARSER::DRUG)
    ("eIF3" . SPARSER::BIO-COMPLEX) ("NF-κB/RelA-PKM2" . SPARSER::COLLECTION)
    ("RelA and HIF1α" . SPARSER::COLLECTION)
    ("Glut3 [ xref ] and PKM2 [ xref ]" . SPARSER::COLLECTION)
    ("PPARα/RelA/PKM2" . SPARSER::COLLECTION)
    ("PKM2, hnRNPA1 and hnRNPΙ" . SPARSER::COLLECTION)
    ("PPARα, RelA, PKM1/2 and hnRNPs" . SPARSER::COLLECTION)
    ("hnRNPA1 and hnRNPΙ" . SPARSER::COLLECTION)
    ("PPARα and RelA" . SPARSER::COLLECTION) ("RHD" . SPARSER::PROTEIN)
    ("HnRNP" . SPARSER::PROTEIN) ("sh-HIF1α" . SPARSER::COLLECTION)
    ("U87 and U251" . SPARSER::COLLECTION) ("esterases" . SPARSER::PROTEIN)
    ("p65/p50" . SPARSER::COLLECTION) ("RelB, and c-Rel" . SPARSER::COLLECTION)
    ("three heterogeneous nuclear ribonucleoproteins (hnRNPs) proteins"
     . SPARSER::PROTEIN)
    ("hnRNPA1, and hnRNPA2" . SPARSER::COLLECTION) ("PTB" . SPARSER::PROTEIN)
    ("Pyruvate kinase isoenzyme type M2 (PKM1) and Pyruvate kinase isoenzyme type M2 (PKM2)"
     . SPARSER::COLLECTION)
    ("pyruvate and adenosine triphosphate (ATP)" . SPARSER::COLLECTION)
    ("phosphoenolpyruvate and adenosine" . SPARSER::COLLECTION)
    ("pyruvate and adenosine triphosphate" . SPARSER::COLLECTION)
    ("fenofibrate" . SPARSER::DRUG) ("NF-κB/RelA" . SPARSER::COLLECTION)
    ("PKM" . SPARSER::PROTEIN)
    ("a lipid-lowering drug and an agonist of the peroxisome proliferator-activated receptor alpha (PPARα)"
     . SPARSER::COLLECTION)
    ("Fenofibrate" . SPARSER::DRUG) ("Transcription Factor" . SPARSER::PROTEIN)
    ("D-glucose" . SPARSER::MOLECULE) ("pre-mRNA" . SPARSER::RNA)
    ("Glut3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GW9662" . SPARSER::DRUG)
    ("p105" . SPARSER::PROTEIN)
    ("polypyrimidine tract-binding protein" . SPARSER::PROTEIN)
    ("hypoxia inducible factor1" . SPARSER::PROTEIN)
    ("PPARα" . SPARSER::PROTEIN)
    ("peroxisome proliferator-activated receptor alpha" . SPARSER::PROTEIN)
    ("p65 or MMP-9" . SPARSER::COLLECTION)
    ("dysbindin-1A and dysbindin-1A-NLS" . SPARSER::COLLECTION)
    ("Polyubiquitination" . SPARSER::PROTEIN)
    ("its functional NES" . SPARSER::PROTEIN)
    ("dysbindin-1A and p65" . SPARSER::COLLECTION)
    ("PRKACA and MMP-9" . SPARSER::COLLECTION) ("PRKACA" . SPARSER::PROTEIN)
    ("a classical NF-kappa B target" . SPARSER::TARGET-PROTEIN)
    ("EGFP/EGFP-p65" . SPARSER::COLLECTION)
    ("GST-dysbindin-1A" . SPARSER::COLLECTION)
    ("Flag-dysbindin-1A" . SPARSER::COLLECTION)
    ("EGFP-p65" . SPARSER::COLLECTION)
    ("dysbindin-1A and NF-kappa" . SPARSER::COLLECTION)
    ("EGFP-dysbindin-1A" . SPARSER::COLLECTION)
    ("Lysines" . SPARSER::AMINO-ACID) ("BDM" . SPARSER::PROTEIN-FAMILY)
    ("DMSO or MG132" . SPARSER::COLLECTION) ("Dysbindin-1A" . SPARSER::PROTEIN)
    ("dysbindin-1A-NES" . SPARSER::COLLECTION)
    ("dysbindin-1A" . SPARSER::PROTEIN)
    ("dysbindin-1A-EGFP" . SPARSER::COLLECTION) ("LMB" . SPARSER::MOLECULE)
    ("Tripartite motif protein" . SPARSER::PROTEIN)
    ("Synapsin" . SPARSER::PROTEIN)
    ("the synaptic vesicle phosphoprotein synapsin I" . SPARSER::PROTEIN)
    ("necdin" . SPARSER::PROTEIN)
    ("soluble N -ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins"
     . SPARSER::PROTEIN)
    ("SNARE" . SPARSER::PROTEIN) ("WAVE2 and Abi-1" . SPARSER::COLLECTION)
    ("Dysbindin" . SPARSER::PROTEIN) ("MMP-9 and TNF-α" . SPARSER::COLLECTION)
    ("dysbindin" . SPARSER::PROTEIN) ("neurotransmitter" . SPARSER::MOLECULE)
    ("NF-YB" . SPARSER::PROTEIN) ("del 2" . SPARSER::PROTEIN)
    ("exportin 1" . SPARSER::PROTEIN) ("anti-Histone" . SPARSER::PROTEIN)
    ("dys 1" . SPARSER::PROTEIN) ("B subunit" . SPARSER::PROTEIN)
    ("TRIM32" . SPARSER::PROTEIN) ("synapsin I" . SPARSER::PROTEIN)
    ("leptomycin B" . SPARSER::MOLECULE)
    ("N -ethylmaleimide-sensitive factor attachment protein"
     . SPARSER::PROTEIN)
    ("Abi-1" . SPARSER::PROTEIN) ("WAVE2" . SPARSER::PROTEIN)
    ("Dysbindin-1" . SPARSER::PROTEIN) ("dysbindin-1" . SPARSER::PROTEIN)
    ("DTNBP1" . SPARSER::PROTEIN)
    ("Dystrobrevin-binding protein 1" . SPARSER::PROTEIN)
    ("accumulation-defective PIP2 mutant" . SPARSER::MUTANT)
    ("PIPs and UBDs" . SPARSER::COLLECTION) ("UBDs" . SPARSER::PROTEIN)
    ("Pol η" . SPARSER::PROTEIN) ("PIP–PCNA" . SPARSER::COLLECTION)
    ("Polκ and Polι" . SPARSER::COLLECTION) ("PCNA-Polη" . SPARSER::COLLECTION)
    ("PIP1–PCNA" . SPARSER::COLLECTION) ("PIP and UBD" . SPARSER::COLLECTION)
    ("rir1" . SPARSER::PROTEIN) ("polη-REV1" . SPARSER::COLLECTION)
    ("RIRs, RIR1 and RIR2" . SPARSER::COLLECTION) ("RIRs" . SPARSER::PROTEIN)
    ("PIP3 and RIR1 share" . SPARSER::COLLECTION)
    ("PCNA and REV1" . SPARSER::COLLECTION)
    ("PIP and UBZ" . SPARSER::COLLECTION) ("PIPs" . SPARSER::PROTEIN)
    ("The resultant mUb-PCNA" . SPARSER::COLLECTION)
    ("polη" . SPARSER::PROTEIN) ("PIP3 or PIP2" . SPARSER::COLLECTION)
    ("PCNA and foci" . SPARSER::COLLECTION)
    ("PIP1, PIP3, PIP2 and UBZ" . SPARSER::COLLECTION)
    ("pip1 and pip3" . SPARSER::COLLECTION)
    ("Polη and PCNA" . SPARSER::COLLECTION)
    ("anti-Polη and anti-PCNA" . SPARSER::COLLECTION)
    ("Polκ and its pip mutants" . SPARSER::COLLECTION)
    ("Polι (Figure xref ) as well as its pip1 mutant (Figure xref )"
     . SPARSER::COLLECTION)
    ("Polι and Polκ" . SPARSER::COLLECTION)
    ("at least one PIP" . SPARSER::PROTEIN)
    ("The pip1 pip3 pip2 triple mutant" . SPARSER::MUTANT)
    ("pip2 or pip3" . SPARSER::COLLECTION) ("Polι" . SPARSER::PROTEIN)
    ("FLAG-Polι" . SPARSER::PROTEIN-PAIR) ("GFP-Polκ" . SPARSER::COLLECTION)
    ("Polκ or Polι" . SPARSER::COLLECTION)
    ("Polη and Polκ" . SPARSER::COLLECTION)
    ("PCNA, and PIP1 and PIP2" . SPARSER::COLLECTION)
    ("Polκ" . SPARSER::PROTEIN)
    ("pip1 and the double mutants" . SPARSER::COLLECTION)
    ("pip1 and pip2" . SPARSER::COLLECTION)
    ("pip2 and double mutants (Figure xref ; Supplementary Figure S3B)"
     . SPARSER::COLLECTION)
    ("the respective PIP" . SPARSER::PROTEIN)
    ("the internal PIP1 and PIP3" . SPARSER::COLLECTION)
    ("PIP1 and PIP3" . SPARSER::COLLECTION)
    ("polymerases, Polκ and Polι" . SPARSER::COLLECTION)
    ("PIP1-" . SPARSER::PROTEIN) ("PIP1 or PIP3" . SPARSER::COLLECTION)
    ("the pip1 pip3 pip2 triple mutant" . SPARSER::MUTANT)
    ("pip2 and pip3" . SPARSER::COLLECTION)
    ("RPA and RFC" . SPARSER::COLLECTION) ("RPA" . SPARSER::PROTEIN)
    ("PIP3 and PIP2" . SPARSER::COLLECTION) ("Polη" . SPARSER::PROTEIN)
    ("pip and ubz" . SPARSER::COLLECTION) ("Polη–PCNA" . SPARSER::PROTEIN-PAIR)
    ("RAD18 and Polη" . SPARSER::COLLECTION) ("RFC" . SPARSER::PROTEIN)
    ("RAD18 and PCNA" . SPARSER::COLLECTION)
    ("pip1 pip3 pip2 triple mutants" . SPARSER::MUTANT)
    ("pip3" . SPARSER::PIP3) ("pip1 or pip2" . SPARSER::COLLECTION)
    ("damage-induced mUb-PCNA" . SPARSER::COLLECTION)
    ("mUb-PCNA" . SPARSER::COLLECTION) ("mUb" . SPARSER::PROTEIN)
    ("the newly found PIP3" . SPARSER::PIP3)
    ("PIP1, PIP2 and UBZ" . SPARSER::COLLECTION)
    ("PIP1, PIP2 or UBZ" . SPARSER::COLLECTION)
    ("the pip1 pip2 double mutant and a mutant" . SPARSER::COLLECTION)
    ("PIP1, UBZ and PIP2" . SPARSER::COLLECTION)
    ("a pip2 ubz double mutant ( xref , xref ) and a mutant"
     . SPARSER::COLLECTION)
    ("PIP2 and UBZ" . SPARSER::COLLECTION) ("pip2" . SPARSER::PIP2)
    ("pip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("replicative DNA polymerase" . SPARSER::PROTEIN)
    ("UBM" . SPARSER::PROTEIN) ("UBD" . SPARSER::PROTEIN)
    ("RAD5/HLTF" . SPARSER::COLLECTION) ("SHPRH" . SPARSER::PROTEIN)
    ("HLTF" . SPARSER::PROTEIN) ("PIP1 and PIP2" . SPARSER::COLLECTION)
    ("proliferating cell nuclear antigen (PCNA) and the three Y-family human DNA polymerases (Polη, Polι and Polκ)"
     . SPARSER::COLLECTION)
    ("two functionally distinct PIP" . SPARSER::PROTEIN)
    ("protein (PIP)" . SPARSER::PROTEIN) ("polymerases" . SPARSER::PROTEIN)
    ("RIR2" . SPARSER::PROTEIN) ("RIR1" . SPARSER::PROTEIN)
    ("REV1" . SPARSER::PROTEIN) ("mp18" . SPARSER::PROTEIN)
    ("RAD6A" . SPARSER::PROTEIN) ("UBCH5c" . SPARSER::PROTEIN)
    ("pip1" . SPARSER::PROTEIN) ("RAD5" . SPARSER::PROTEIN)
    ("RAD18" . SPARSER::PROTEIN) ("xeroderma pigmentosum" . SPARSER::PROTEIN)
    ("PIP1" . SPARSER::PROTEIN)
    ("EGFR mutation group and wild type group" . SPARSER::COLLECTION)
    ("early growth response-1" . SPARSER::COLLECTION)
    ("tumor suppressor gene, and miRNAs" . SPARSER::COLLECTION)
    ("EGFR/PTEN/AKT" . SPARSER::COLLECTION)
    ("the unique miRNAs" . SPARSER::PROTEIN)
    ("EGR1 and PTEN" . SPARSER::COLLECTION) ("miR-16-1" . SPARSER::COLLECTION)
    ("p53 and c-myc" . SPARSER::COLLECTION) ("Bmf" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase(CDK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("post-transcriptional gene" . SPARSER::GENE)
    ("CDK-6, cyclinE2, and Bcl2" . SPARSER::COLLECTION)
    ("miR-34a, miR-34b, and miR-34c" . SPARSER::COLLECTION)
    ("desperately need more accurate and effective treatment target"
     . SPARSER::TARGET-PROTEIN)
    ("EGFR , gefitinib and erlotinib" . SPARSER::COLLECTION)
    ("some physiologically relevant miRNAs" . SPARSER::PROTEIN)
    ("unique miRNAs" . SPARSER::PROTEIN)
    ("colon cancer, and leukemia" . SPARSER::COLLECTION)
    ("oncogenes or tumor suppressors" . SPARSER::COLLECTION)
    ("diagnostic and prognostic biomarkers" . SPARSER::MOLECULE)
    ("EGFR mutation group and wild type group" . SPARSER::COLLECTION)
    ("three unique miRNAs" . SPARSER::PROTEIN)
    ("early growth response" . SPARSER::PROTEIN)
    ("Bcl-2-modifying factor" . SPARSER::PROTEIN) ("c-5" . SPARSER::PROTEIN)
    ("cyclinE2" . SPARSER::PROTEIN) ("CDK-6" . SPARSER::PROTEIN)
    ("napsin A" . SPARSER::PROTEIN) ("TTF-1" . SPARSER::PROTEIN)
    ("prune" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phospho–cofilin" . SPARSER::PROTEIN) ("RLC-S19" . SPARSER::COLLECTION)
    ("cofilin-S3D–GFP" . SPARSER::COLLECTION) ("S3D" . SPARSER::PROTEIN)
    ("cofilin-S3D" . SPARSER::COLLECTION)
    ("phosphomimetic RLC T18D" . SPARSER::PROTEIN)
    ("myosin RLC ( xref ) and form synapses ( xref and xref )"
     . SPARSER::COLLECTION)
    ("–protein" . SPARSER::COLLECTION) ("synaptophysin" . SPARSER::PROTEIN)
    ("Phalloidin" . SPARSER::MOLECULE) ("MIIB" . SPARSER::PROTEIN)
    ("IIB (MIIB)" . SPARSER::PROTEIN)
    ("a cofilin-S3D phosphomimetic mutant" . SPARSER::MUTANT)
    ("phosphomimetic mutants" . SPARSER::MUTANT)
    ("RLC and cofilin" . SPARSER::COLLECTION) ("Cofilin" . SPARSER::PROTEIN)
    ("ROCK1 or ROCK2" . SPARSER::COLLECTION) ("PSDs" . SPARSER::PROTEIN)
    ("myosin RLC and the actin-severing protein cofilin" . SPARSER::COLLECTION)
    ("the myosin RLC and actin-severing protein cofilin" . SPARSER::COLLECTION)
    ("p3 and p4" . SPARSER::COLLECTION) ("GFP-ROCK2" . SPARSER::COLLECTION)
    ("GFP-ROCK1" . SPARSER::COLLECTION)
    ("ROCK1 and ROCK2, and Y-27632" . SPARSER::COLLECTION)
    ("ROCK2, and Y-27632" . SPARSER::COLLECTION) ("PSD" . SPARSER::PROTEIN)
    ("myosin regulatory light chain (RLC)" . SPARSER::PROTEIN)
    ("RhoA-driven actomyosin filament" . SPARSER::PROTEIN-FAMILY)
    ("ROCK1 and ROCK2" . SPARSER::COLLECTION)
    ("kinase (ROCK)" . SPARSER::KINASE) ("cofilin" . SPARSER::PROTEIN)
    ("Green fluorescent" . SPARSER::PROTEIN) ("AP-5" . SPARSER::PROTEIN)
    ("B-27" . SPARSER::PROTEIN) ("CCM1" . SPARSER::PROTEIN)
    ("MHC-IIB" . SPARSER::PROTEIN) ("Calyculin A" . SPARSER::MOLECULE)
    ("D-4" . SPARSER::PROTEIN) ("Vglut-1" . SPARSER::PROTEIN)
    ("ROCK-1" . SPARSER::PROTEIN) ("LIMK2" . SPARSER::PROTEIN)
    ("LIMK1" . SPARSER::PROTEIN) ("MYPT1" . SPARSER::PROTEIN)
    ("exchange factors" . SPARSER::EXCHANGE-FACTOR)
    ("ATPase activity" . SPARSER::PROTEIN) ("ROCK-2" . SPARSER::PROTEIN)
    ("VGlut-1" . SPARSER::PROTEIN) ("calyculin A" . SPARSER::MOLECULE)
    ("K1" . SPARSER::PROTEIN) ("p4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("S19" . SPARSER::PROTEIN)
    ("myosin light chain" . SPARSER::PROTEIN) ("ROCK2" . SPARSER::PROTEIN)
    ("Cav-1 as well as HDL" . SPARSER::COLLECTION)
    ("This molecule, which is particularly enriched in endothelial cells and the most prominent component"
     . SPARSER::COLLECTION)
    ("Sucrose" . SPARSER::MOLECULE)
    ("ABCA1, ABCG1, SR-BI or Cav-1" . SPARSER::COLLECTION)
    ("Cav-1, ABCG1 and SR-BI" . SPARSER::COLLECTION)
    ("Cav-1, ABCA1, ABCG1 and SR-BI" . SPARSER::COLLECTION)
    ("the lower density caveolar fractions" . SPARSER::COMPONENT)
    ("the caveolar fractions" . SPARSER::COMPONENT)
    ("Flotilin-1" . SPARSER::COLLECTION) ("carbonate" . SPARSER::MOLECULE)
    ("ABCA1, ABCG1, SR-BI and Cav-1" . SPARSER::COLLECTION)
    ("ABCG1 and SR-BI" . SPARSER::COLLECTION)
    ("Cav-1, ABCA1, SR-B1 and ABCG1" . SPARSER::COLLECTION)
    ("Cav-1, ABCA1, ABCG1, and SR-B1" . SPARSER::COLLECTION)
    ("uninfected parental A3.01" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("The inefficient apoA-I" . SPARSER::PROTEIN)
    ("viral proteins" . SPARSER::PROTEIN)
    ("a proatherogenic protein" . SPARSER::PROTEIN)
    ("v-src" . SPARSER::COLLECTION)
    ("human macrophages and arterial SMCs" . SPARSER::COLLECTION)
    ("arterial SMCs" . SPARSER::PROTEIN)
    ("lipid laden macrophages" . SPARSER::PROTEIN)
    ("human arterial SMCs" . SPARSER::PROTEIN)
    ("Flotillin-1" . SPARSER::PROTEIN) ("CO 3" . SPARSER::PROTEIN)
    ("SF2" . SPARSER::PROTEIN) ("NL4" . SPARSER::PROTEIN)
    ("SR-BI" . SPARSER::PROTEIN) ("receptor type" . SPARSER::PROTEIN)
    ("ACH2" . SPARSER::PROTEIN) ("apo-AI" . SPARSER::PROTEIN)
    ("TO-901317" . SPARSER::DRUG) ("ABCA-1" . SPARSER::PROTEIN)
    ("integral membrane protein" . SPARSER::PROTEIN)
    ("Caveolin-1" . SPARSER::PROTEIN)
    ("High-density lipoprotein" . SPARSER::PROTEIN)
    ("Cav-1" . SPARSER::PROTEIN) ("caveolin 1" . SPARSER::PROTEIN)
    ("apoA-I" . SPARSER::PROTEIN)
    ("ATP-binding cassette transporter" . SPARSER::PROTEIN)
    ("Nr1h3 (encoding Lxrα) and Nr1h4 (encoding Fxr)" . SPARSER::COLLECTION)
    ("Nr1h4" . SPARSER::PROTEIN) ("Fxr" . SPARSER::PROTEIN)
    ("Lxr" . SPARSER::PROTEIN)
    ("fatty acid and cholesterol synthesis" . SPARSER::COLLECTION)
    ("other major methyltransferases" . SPARSER::PROTEIN)
    ("a major methyltransferase" . SPARSER::PROTEIN)
    ("NNMT and LDL" . SPARSER::COLLECTION)
    ("Nnmt and MNAM" . SPARSER::COLLECTION)
    ("Tnf and Il6" . SPARSER::COLLECTION) ("Il6" . SPARSER::PROTEIN)
    ("Tnf" . SPARSER::PROTEIN) ("Srebf2 and Nr1h3" . SPARSER::COLLECTION)
    ("Abcg8" . SPARSER::PROTEIN) ("Abca1" . SPARSER::PROTEIN)
    ("Nr1h3" . SPARSER::PROTEIN) ("LXR" . SPARSER::PROTEIN)
    ("lipoprotein" . SPARSER::PROTEIN) ("hepatocytes (HFD)" . SPARSER::PROTEIN)
    ("MNAM-treated hepatocytes" . SPARSER::PROTEIN)
    ("Sirt1 or Nnmt" . SPARSER::COLLECTION)
    ("toxic metabolite" . SPARSER::MOLECULE)
    ("the wt or the Nnmt mutants" . SPARSER::COLLECTION)
    ("Nnmt-wt" . SPARSER::COLLECTION) ("Nampt" . SPARSER::PROTEIN)
    ("intracellular NAD + and NAM content" . SPARSER::COLLECTION)
    ("substrates and products" . SPARSER::COLLECTION)
    ("inhibitor-treated hepatocytes" . SPARSER::PROTEIN)
    ("G6pc and Pck1" . SPARSER::COLLECTION)
    ("sirtinol and EX-527" . SPARSER::COLLECTION) ("sirtinol" . SPARSER::DRUG)
    ("cortisol" . SPARSER::PROTEIN) ("NNMT" . SPARSER::PROTEIN)
    ("hepatic glucose and cholesterol metabolism in vivo"
     . SPARSER::COLLECTION)
    ("Hmgcr and Hmgcs1" . SPARSER::COLLECTION)
    ("receptors and transporters" . SPARSER::COLLECTION)
    ("Abcg5 , Scarb1 , and Abcb11" . SPARSER::COLLECTION)
    ("Abcb11" . SPARSER::PROTEIN) ("Scarb1" . SPARSER::PROTEIN)
    ("Abcg5" . SPARSER::PROTEIN) ("Hmgcs1" . SPARSER::PROTEIN)
    ("Srebf2" . SPARSER::PROTEIN) ("Hmgcr" . SPARSER::PROTEIN)
    ("G6pc and fructose" . SPARSER::COLLECTION)
    ("Pck1 and pyruvate carboxylase" . SPARSER::COLLECTION)
    ("Fbp1" . SPARSER::PROTEIN) ("Pcx" . SPARSER::PROTEIN)
    ("fructose" . SPARSER::PROTEIN) ("Pck1" . SPARSER::PROTEIN)
    ("G6pc" . SPARSER::PROTEIN)
    ("high-density lipoprotein (HDL)" . SPARSER::PROTEIN)
    ("which aims" . SPARSER::PROTEIN)
    ("glucose, lipid and cholesterol" . SPARSER::COLLECTION)
    ("pyridone" . SPARSER::MOLECULE)
    ("the universal methyl donor S-Adenosyl methionine (SAM)"
     . SPARSER::MOLECULE)
    ("methionine (SAM)" . SPARSER::MOLECULE)
    ("homocysteine" . SPARSER::MOLECULE)
    ("nutritional states" . SPARSER::BIO-STATE) ("DIO" . SPARSER::MOLECULE)
    ("Srebp-1" . SPARSER::PROTEIN) ("Srebp" . SPARSER::PROTEIN-FAMILY)
    ("Crtc2" . SPARSER::PROTEIN)
    ("glucose and cholesterol metabolism" . SPARSER::COLLECTION)
    ("Nnmt" . SPARSER::PROTEIN) ("cyclophilin A" . SPARSER::PROTEIN)
    ("Cyclophilin A" . SPARSER::PROTEIN)
    ("cholesterol oxidase" . SPARSER::PROTEIN)
    ("cholesterol esterase" . SPARSER::PROTEIN)
    ("glucose oxidase" . SPARSER::PROTEIN) ("3–2" . SPARSER::PROTEIN)
    ("pyruvate carboxylase" . SPARSER::PROTEIN)
    ("phosphoenolpyruvate carboxykinase 1" . SPARSER::PROTEIN)
    ("glucose-6-phosphatase" . SPARSER::PROTEIN)
    ("aldehyde oxidase" . SPARSER::PROTEIN) ("FoxO1" . SPARSER::PROTEIN)
    ("forkhead box O 1" . SPARSER::PROTEIN) ("Pgc1α" . SPARSER::PROTEIN)
    ("Nicotinamide N-methyltransferase" . SPARSER::PROTEIN)
    ("MC1R/cAMP signaling controls melanocytic NER" . SPARSER::PROTEIN)
    ("MC1R/cAMP" . SPARSER::COLLECTION)
    ("XPA and possibly other DNA repair proteins" . SPARSER::COLLECTION)
    ("possibly other DNA repair proteins" . SPARSER::PROTEIN)
    ("here link MC1R agonists" . SPARSER::AGONIST)
    ("MSH or forskolin" . SPARSER::COLLECTION)
    ("in turn up-regulated ATR’s" . SPARSER::PROTEIN)
    ("agonists and antagonists of MC1R" . SPARSER::COLLECTION)
    ("either ASIP ( xref ) or HBD3 ( xref )" . SPARSER::COLLECTION)
    ("-PP" . SPARSER::COLLECTION) ("PP" . SPARSER::PROTEIN)
    ("CPDs" . SPARSER::PROTEIN)
    ("a single chemically-induced thymine dimer" . SPARSER::DIMER)
    ("α-MSH-MC1R-cAMP" . SPARSER::COLLECTION)
    ("photodamage-associated XPA or ATR-pS435" . SPARSER::COLLECTION)
    ("either XPA ( xref ) or ATR-pS435 ( xref )" . SPARSER::COLLECTION)
    ("XPA or ATR-pS435" . SPARSER::COLLECTION)
    ("XPA and ATR-pS435" . SPARSER::COLLECTION)
    ("photodamage" . SPARSER::PROTEIN)
    ("stem cell factor (kit ligand; SCF) nor hepatocyte growth factor (HGF)"
     . SPARSER::COLLECTION)
    ("α-MSH and ACTH" . SPARSER::COLLECTION)
    ("neither ASIP nor HBD3" . SPARSER::COLLECTION)
    ("protein and β-defensin" . SPARSER::COLLECTION) ("MSH" . SPARSER::PROTEIN)
    ("Agouti" . SPARSER::PROTEIN-FAMILY)
    ("a functional biomarker" . SPARSER::MOLECULE)
    ("PKI" . SPARSER::PROTEIN-FAMILY) ("tyrosinase" . SPARSER::PROTEIN)
    ("Forskolin" . SPARSER::PROTEIN) ("MC1R-RHC" . SPARSER::COLLECTION)
    ("α-MSH or forskolin" . SPARSER::COLLECTION)
    ("forskolin" . SPARSER::PROTEIN) ("MC1R or mutant" . SPARSER::COLLECTION)
    ("PHMs" . SPARSER::PROTEIN) ("ASIP or HBD3" . SPARSER::COLLECTION)
    ("XPA-photodamage" . SPARSER::COLLECTION)
    ("XPA or ATR" . SPARSER::COLLECTION)
    ("agonistic and antagonistic ligands" . SPARSER::LIGAND)
    ("promoted ATR’s" . SPARSER::PROTEIN) ("ATR-XPA" . SPARSER::COLLECTION)
    ("ATR and XPA" . SPARSER::COLLECTION) ("α-MSH-MC1R" . SPARSER::COLLECTION)
    ("other NER and damage response proteins ( xref )" . SPARSER::COLLECTION)
    ("eight essential NER proteins" . SPARSER::PROTEIN)
    ("RHC" . SPARSER::PROTEIN) ("a neutral antagonist" . SPARSER::MOLECULE)
    ("agonistic ligands" . SPARSER::LIGAND)
    ("ACTH or α-melanocyte" . SPARSER::COLLECTION)
    ("a neutral MC1R antagonist" . SPARSER::MOLECULE)
    ("ASIP and HBD3" . SPARSER::COLLECTION)
    ("MC1R antagonists agouti signaling protein (ASIP) or human β-defensin"
     . SPARSER::COLLECTION)
    ("agouti signaling protein (ASIP)" . SPARSER::PROTEIN)
    ("defensin" . SPARSER::PROTEIN) ("ASIP" . SPARSER::PROTEIN)
    ("melanocytic NER" . SPARSER::PROTEIN) ("ACTH" . SPARSER::PROTEIN)
    ("ATR-pS435" . SPARSER::COLLECTION) ("MC1R-cAMP" . SPARSER::COLLECTION)
    ("XPA" . SPARSER::PROTEIN) ("NER" . SPARSER::PROTEIN)
    ("cAMP and PKA" . SPARSER::COLLECTION) ("PKA" . SPARSER::PROTEIN)
    ("m2" . SPARSER::MOLECULE) ("pp38" . SPARSER::PROTEIN)
    ("s -protein" . SPARSER::PROTEIN)
    ("endothelin-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HBD3" . SPARSER::PROTEIN) ("agouti signaling protein" . SPARSER::PROTEIN)
    ("adrenocorticotropic hormone" . SPARSER::PROTEIN)
    ("α-MSH" . SPARSER::PROTEIN) ("MC1R" . SPARSER::PROTEIN)
    ("melanocortin 1 receptor" . SPARSER::PROTEIN) ("EGF-" . SPARSER::PROTEIN)
    ("ROCK" . SPARSER::PROTEIN-FAMILY) ("DLC1–PTEN" . SPARSER::COLLECTION)
    ("Tiam1, Vav2 and Asef" . SPARSER::COLLECTION) ("Asef" . SPARSER::PROTEIN)
    ("a directional cue" . SPARSER::PROTEIN-FAMILY)
    ("cue" . SPARSER::PROTEIN-FAMILY) ("PTEN and CTEN" . SPARSER::COLLECTION)
    ("DLC1, PI3K, PTEN, TNS3 and CTEN" . SPARSER::COLLECTION)
    ("CTEN" . SPARSER::PROTEIN) ("SAM and RhoGAP" . SPARSER::COLLECTION)
    ("PI3K–PTEN" . SPARSER::COLLECTION) ("DLC1–TNS3" . SPARSER::COLLECTION)
    ("DLC1 and/or PTEN ( xref )" . SPARSER::COLLECTION)
    ("the binding-defective mutants PTEN–T319A" . SPARSER::PROTEIN)
    ("PTEN–T319A" . SPARSER::PROTEIN)
    ("the constitutively binding PTEN mutant T319E" . SPARSER::PROTEIN)
    ("PI3K ( xref ) and Rac1-GTP ( xref )" . SPARSER::COLLECTION)
    ("DLC1 ( xref ) and RhoA-GTP ( xref )" . SPARSER::COLLECTION)
    ("TNS3 and PI3K" . SPARSER::COLLECTION)
    ("PTEN and DLC1" . SPARSER::COLLECTION)
    ("TNS3 and DLC1" . SPARSER::COLLECTION) ("paxillin" . SPARSER::PROTEIN)
    ("PI3K and PTEN" . SPARSER::COLLECTION) ("IF" . SPARSER::PROTEIN)
    ("the wt PTEN or the T319Y specificity-switching mutant"
     . SPARSER::COLLECTION)
    ("the wt PTEN nor the PTEN–T319Y mutant" . SPARSER::COLLECTION)
    ("Ala or Glu" . SPARSER::COLLECTION)
    ("pulled down DLC1" . SPARSER::PROTEIN)
    ("FLAG-DLC1 or FLAG-PI3K–p85 from HEK293 cells" . SPARSER::COLLECTION)
    ("FLAG-PI3K–p85" . SPARSER::COLLECTION)
    ("GST–TNS3–ABD" . SPARSER::COLLECTION)
    ("DLC1 and TNS3" . SPARSER::COLLECTION)
    ("PTEN or PTEN-C2" . SPARSER::COLLECTION)
    ("TNS3-ABD" . SPARSER::COLLECTION)
    ("an Ala or a Glu residue" . SPARSER::COLLECTION)
    ("PTEN and TNS3" . SPARSER::COLLECTION)
    ("DLC1 and PI3K" . SPARSER::COLLECTION)
    ("DLC1 or p85" . SPARSER::COLLECTION)
    ("Mek1/2 or Erk1/2" . SPARSER::COLLECTION)
    ("Mek1/2 and Erk1/2" . SPARSER::COLLECTION)
    ("Mek1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mek" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTEN or a truncation mutant ( xref )" . SPARSER::COLLECTION)
    ("FLAG-DLC1" . SPARSER::COLLECTION)
    ("PTEN or TNS3–ABD" . SPARSER::COLLECTION) ("–PTEN" . SPARSER::COLLECTION)
    ("PI3K–p85" . SPARSER::COLLECTION) ("ABD–DLC1" . SPARSER::COLLECTION)
    ("ABD" . SPARSER::PROTEIN) ("TNS3–ABD" . SPARSER::COLLECTION)
    ("PTEN–p85" . SPARSER::COLLECTION)
    ("DLC1, TNS3, PI3K and PTEN" . SPARSER::COLLECTION)
    ("TNS3 or PTEN" . SPARSER::COLLECTION)
    ("DLC1 or PI3K" . SPARSER::COLLECTION)
    ("TNS3, PTEN, DLC1 and PI3K" . SPARSER::COLLECTION)
    ("The latter complexes" . SPARSER::BIO-COMPLEX)
    ("external guidance cues" . SPARSER::PROTEIN-FAMILY)
    ("HEK" . SPARSER::PROTEIN) ("PI3K and PIP3" . SPARSER::COLLECTION)
    ("Cten" . SPARSER::PROTEIN) ("STAR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RhoGAP" . SPARSER::PROTEIN) ("SAM" . SPARSER::MOLECULE)
    ("GAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GAPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rac1 and Cdc42" . SPARSER::COLLECTION)
    ("tensin-3 and phosphatase and tensin" . SPARSER::COLLECTION)
    ("Rac1 and RhoA" . SPARSER::COLLECTION)
    ("TNS3 and PTEN" . SPARSER::COLLECTION) ("PTEN–DLC1" . SPARSER::COLLECTION)
    ("TNS3–PI3K" . SPARSER::COLLECTION) ("PTEN–PI3K" . SPARSER::COLLECTION)
    ("TNS3–DLC1" . SPARSER::COLLECTION)
    ("phosphatase and tensin homologue (PTEN) and phosphoinositide-3-kinase (PI3K)"
     . SPARSER::COLLECTION)
    ("liver cancer 1 (DLC1), tensin-3 (TNS3), phosphatase and tensin homologue (PTEN) and phosphoinositide-3-kinase (PI3K)"
     . SPARSER::COLLECTION)
    ("homologue (PTEN)" . SPARSER::PROTEIN)
    ("GTPases, Rac1 and RhoA" . SPARSER::COLLECTION) ("G-1" . SPARSER::PROTEIN)
    ("P35" . SPARSER::PROTEIN) ("p21 Activated Kinase 1" . SPARSER::PROTEIN)
    ("Inhibitor 1" . SPARSER::PROTEIN) ("PDGF-BB" . SPARSER::PROTEIN)
    ("Phospho-Threonine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("A-14" . SPARSER::PROTEIN) ("C-12" . SPARSER::PROTEIN)
    ("PDGFR-α" . SPARSER::PROTEIN) ("SHIP1" . SPARSER::PROTEIN)
    ("Vav2" . SPARSER::PROTEIN) ("CDCP1" . SPARSER::PROTEIN)
    ("PKCδ" . SPARSER::PROTEIN) ("PDGFR-β" . SPARSER::PROTEIN)
    ("HA-CA" . SPARSER::PROTEIN)
    ("fibroblast growth factor" . SPARSER::PROTEIN-FAMILY)
    ("Tiam1" . SPARSER::PROTEIN) ("p110" . SPARSER::PROTEIN)
    ("Tensin-1" . SPARSER::PROTEIN) ("GTPase-activating" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factors" . SPARSER::GEF)
    ("PI 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TNS3" . SPARSER::PROTEIN)
    ("tensin-3" . SPARSER::PROTEIN) ("DLC1" . SPARSER::PROTEIN)
    ("gal-3 and β-catenin" . SPARSER::COLLECTION)
    ("contractile-associated proteins calponin" . SPARSER::PROTEIN)
    ("a synthetic-associated protein" . SPARSER::PROTEIN)
    ("Neither gal-3 nor the non-targeting siRNA" . SPARSER::COLLECTION)
    ("trans-" . SPARSER::PROTEIN-FAMILY) ("OPN" . SPARSER::PROTEIN)
    ("minimally-oxidized LDL" . SPARSER::PROTEIN)
    ("aldosterone" . SPARSER::PROTEIN)
    ("laminin, fibronectin, and collagen" . SPARSER::COLLECTION)
    ("protein, and calponin and α-actin" . SPARSER::COLLECTION)
    ("calponin and α-actin" . SPARSER::COLLECTION)
    ("calponin" . SPARSER::PROTEIN)
    ("osteopontin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("oxLDL" . SPARSER::MOLECULE) ("gal3" . SPARSER::PROTEIN)
    ("Gal-3" . SPARSER::PROTEIN) ("galactoside-binding" . SPARSER::PROTEIN)
    ("gal-3" . SPARSER::PROTEIN) ("galectin-3" . SPARSER::PROTEIN)
    ("NF-κB, JNK, ERK and P38 MAPK" . SPARSER::COLLECTION)
    ("NF-κB and p38" . SPARSER::COLLECTION)
    ("LC3 and Beclin-1" . SPARSER::COLLECTION)
    ("MMP3 and COX2" . SPARSER::COLLECTION)
    ("MMP3 , MMP9 , ADAMTS4 and COX2" . SPARSER::COLLECTION)
    ("significant inflammatory cytokines" . SPARSER::PROTEIN)
    ("MMP3, MMP9, ADAMTS4, ADAMTS5 and COX2" . SPARSER::COLLECTION)
    ("proteoglycan" . SPARSER::PROTEIN)
    ("TNF-α and IL-1β, NF-κB and JNK" . SPARSER::COLLECTION)
    ("IL-1β, NF-κB and JNK" . SPARSER::COLLECTION)
    ("TNF-α or IL-1β" . SPARSER::COLLECTION)
    ("SM7368 or SP600125" . SPARSER::COLLECTION)
    ("SM7368 and SP600125" . SPARSER::COLLECTION)
    ("SM7368, PD98059, SP600125 and SB203580" . SPARSER::COLLECTION)
    ("NF-κB or MAPK" . SPARSER::COLLECTION)
    ("Beclin-1 and LC3-II" . SPARSER::COLLECTION)
    ("MMP3 and ADAMTS5" . SPARSER::COLLECTION)
    ("ADAMTS4 and COX2" . SPARSER::COLLECTION)
    ("MMP3 and MMP9" . SPARSER::COLLECTION)
    ("rapamycin (1 µ M) or 3-MA (5 mM)" . SPARSER::COLLECTION)
    ("cytokines, TNF-α and IL-1β" . SPARSER::COLLECTION)
    ("MMP13 and ADAMTS5" . SPARSER::COLLECTION)
    ("matrix metalloproteinase (MMP) and a disintegrin and metalloproteinase"
     . SPARSER::COLLECTION)
    ("degradative enzymes" . SPARSER::ENZYME)
    ("IVD, TNF-α and IL-1β" . SPARSER::COLLECTION)
    ("disintegrin and metalloproteinase" . SPARSER::COLLECTION)
    ("thrombospondin" . SPARSER::PROTEIN)
    ("metalloproteinase" . SPARSER::PROTEIN) ("disintegrin" . SPARSER::PROTEIN)
    ("Inflammatory cytokines" . SPARSER::PROTEIN)
    ("proteinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("normal IVDs" . SPARSER::PROTEIN)
    ("collagen and proteoglycans" . SPARSER::COLLECTION)
    ("proteoglycans" . SPARSER::PROTEIN) ("AF" . SPARSER::PROTEIN)
    ("the intervertebral discs" . SPARSER::BIO-COMPLEX)
    ("discs" . SPARSER::BIO-COMPLEX) ("LBP" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinases and p38" . SPARSER::COLLECTION)
    ("NF-κB and JNK" . SPARSER::COLLECTION) ("NP" . SPARSER::PROTEIN)
    ("activator and inhibitor" . SPARSER::COLLECTION)
    ("IVDs" . SPARSER::PROTEIN) ("IVD" . SPARSER::PROTEIN)
    ("Proteoglycan" . SPARSER::PROTEIN) ("ADAMTS4" . SPARSER::PROTEIN)
    ("Acridine orange" . SPARSER::MOLECULE) ("Beclin-1" . SPARSER::PROTEIN)
    ("SM7368" . SPARSER::DRUG) ("ADAMTS5" . SPARSER::PROTEIN)
    ("MMP13" . SPARSER::PROTEIN) ("L757A/K759A/V689D/L693D" . SPARSER::PROTEIN)
    ("Eps8-actin" . SPARSER::COLLECTION) ("Ezrin-Eps8" . SPARSER::COLLECTION)
    ("Ezrin" . SPARSER::PROTEIN) ("ezrin-Eps8" . SPARSER::COLLECTION)
    ("ezrin or actin" . SPARSER::COLLECTION) ("BDNF" . SPARSER::PROTEIN)
    ("Effectors" . SPARSER::EFFECTOR) ("Drugs" . SPARSER::DRUG)
    ("Raf/MEK/Erk/MLCK/RLC/myosin" . SPARSER::COLLECTION)
    ("MLCK" . SPARSER::PROTEIN) ("Ras/Raf/MEK/Erk" . SPARSER::COLLECTION)
    ("soluble components" . SPARSER::COMPONENT)
    ("soluble monomeric Eos" . SPARSER::PROTEIN) ("Eos" . SPARSER::PROTEIN)
    ("soluble proteins" . SPARSER::PROTEIN)
    ("Erk, MEK and B-Raf" . SPARSER::COLLECTION)
    ("either soluble EGFP, or EGFP" . SPARSER::COLLECTION)
    ("EGFP, or EGFP" . SPARSER::COLLECTION) ("YFP/CFP" . SPARSER::COLLECTION)
    ("phospho-Eps8 or active" . SPARSER::COLLECTION)
    ("central actin" . SPARSER::PROTEIN) ("MEK/Erk" . SPARSER::COLLECTION)
    ("Eps8/actin" . SPARSER::COLLECTION)
    ("phospho-serine and phospho-threonine" . SPARSER::COLLECTION)
    ("-MII-RLC" . SPARSER::COLLECTION)
    ("circumferential actin" . SPARSER::PROTEIN)
    ("EGFP-α-actinin" . SPARSER::COLLECTION) ("blebbistatin" . SPARSER::DRUG)
    ("myosin II regulatory light chain" . SPARSER::PROTEIN)
    ("Eps8-KD" . SPARSER::COLLECTION) ("EGFP-MII-RLC" . SPARSER::COLLECTION)
    ("the distal tip" . SPARSER::PROTEIN) ("distal tip" . SPARSER::PROTEIN)
    ("actin and Eps8" . SPARSER::COLLECTION) ("tip" . SPARSER::PROTEIN)
    ("Eps8 and F-actin" . SPARSER::COLLECTION)
    ("Eps8 and actin" . SPARSER::COLLECTION)
    ("red fluorescent dextran" . SPARSER::DEXTRAN)
    ("MII-RLC" . SPARSER::COLLECTION)
    ("EGFP-tagged myosin II regulatory light chain" . SPARSER::PROTEIN)
    ("GFP-MII-RLC" . SPARSER::COLLECTION) ("RLC" . SPARSER::PROTEIN)
    ("MII" . SPARSER::PROTEIN) ("cortical actin" . SPARSER::PROTEIN)
    ("Eps8 or expressing Emerald-tagged mouse Eps8 (Emerald-mEps8)"
     . SPARSER::COLLECTION)
    ("fluorescent phalloidin" . SPARSER::MOLECULE) ("mEps" . SPARSER::PROTEIN)
    ("phalloidin" . SPARSER::MOLECULE) ("Raf/MEK/Erk" . SPARSER::COLLECTION)
    ("AFM" . SPARSER::PROTEIN) ("SOS1 and Abi1" . SPARSER::COLLECTION)
    ("EGF/Ras/Raf/MEK/Erk" . SPARSER::COLLECTION)
    ("ezrin/radixin/moesin" . SPARSER::COLLECTION)
    ("moesin" . SPARSER::PROTEIN) ("radixin" . SPARSER::PROTEIN)
    ("ezrin" . SPARSER::PROTEIN) ("MAT" . SPARSER::PROTEIN)
    ("myosin" . SPARSER::PROTEIN-FAMILY) ("slab" . SPARSER::PROTEIN)
    ("a key MAP kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Protein-G" . SPARSER::PROTEIN) ("Erk1" . SPARSER::PROTEIN)
    ("Kinase Activity" . SPARSER::PROTEIN) ("U20" . SPARSER::PROTEIN)
    ("linker protein" . SPARSER::PROTEIN) ("B-Raf" . SPARSER::PROTEIN)
    ("Abi1" . SPARSER::PROTEIN) ("capping protein" . SPARSER::PROTEIN)
    ("Eps8" . SPARSER::PROTEIN) ("Lck as well as SLP-76" . SPARSER::COLLECTION)
    ("a multimolecular complex" . SPARSER::BIO-COMPLEX)
    ("TSAd, Lck, Itk, Nck and SLP-76" . SPARSER::COLLECTION)
    ("both SLP-76 [ xref ] and TSAd [ xref , xref , xref ]"
     . SPARSER::COLLECTION)
    ("Lck and TSAd" . SPARSER::COLLECTION)
    ("less TSAd and more SLP-76" . SPARSER::COLLECTION)
    ("Nck-Vav1" . SPARSER::COLLECTION) ("Nck-TSAd-Lck" . SPARSER::COLLECTION)
    ("a competitive substrate" . SPARSER::SUBSTRATE)
    ("Nck and a kinase" . SPARSER::COLLECTION)
    ("CD3ε, Nck and a kinase" . SPARSER::COLLECTION)
    ("Lck and Nck" . SPARSER::COLLECTION) ("Nck or Lck" . SPARSER::COLLECTION)
    ("CD3ε-Nck" . SPARSER::COLLECTION) ("TSAd and Lck" . SPARSER::COLLECTION)
    ("exogenous TSAd" . SPARSER::PROTEIN)
    ("the three C-terminal tyrosines of TSAd" . SPARSER::PROTEIN)
    ("Nck-" . SPARSER::PROTEIN) ("Nck1" . SPARSER::PROTEIN)
    ("OPAL" . SPARSER::MOLECULE) ("polymerized F-actin" . SPARSER::BIO-COMPLEX)
    ("mCherry-" . SPARSER::PROTEIN) ("IFC" . SPARSER::PROTEIN)
    ("polymerized actin" . SPARSER::PROTEIN)
    ("Nck and SLP-76" . SPARSER::COLLECTION)
    ("SLP-76 or Vav1" . SPARSER::COLLECTION)
    ("the cytosolic adaptor SLP-76 [ xref ] as well as the guanine nucleotide exchange factor Vav1 [ xref ]"
     . SPARSER::COLLECTION)
    ("PMA and ionomycin" . SPARSER::COLLECTION) ("ionomycin" . SPARSER::DRUG)
    ("Nck and intact or mutated TSAd molecules" . SPARSER::COLLECTION)
    ("cytometry (IFC)" . SPARSER::PROTEIN)
    ("TSAd-mCherry" . SPARSER::COLLECTION) ("Nck-GFP" . SPARSER::COLLECTION)
    ("CD3/CD28" . SPARSER::COLLECTION)
    ("exogenous TSAd and Nck" . SPARSER::COLLECTION)
    ("the PRR and the three C-terminal TSAd tyrosines (Fig. xref )"
     . SPARSER::COLLECTION)
    ("Exon" . SPARSER::PROTEIN)
    ("HA-tagged TSAd molecules and GFP-tagged Nck molecules"
     . SPARSER::COLLECTION)
    ("TSAd-Nck" . SPARSER::COLLECTION)
    ("Nck, Lck or Itk" . SPARSER::COLLECTION)
    ("proteins and TSAd" . SPARSER::COLLECTION)
    ("HA-TSAd" . SPARSER::COLLECTION) ("aa " . SPARSER::MOLECULE)
    ("the three penultimate tyrosines (Y280,290,305 F) of TSAd (Fig. xref , lane 4)"
     . SPARSER::PROTEIN)
    ("Lck and various TSAd" . SPARSER::COLLECTION)
    ("prolines" . SPARSER::AMINO-ACID) ("Lck and Itk" . SPARSER::COLLECTION)
    ("the strong tyrosine phosphatase inhibitor pervanadate (PV)"
     . SPARSER::PROTEIN)
    ("pervanadate (PV)" . SPARSER::PROTEIN)
    ("TSAd or TSAd" . SPARSER::COLLECTION)
    ("TSAd as well as the kinase Lck" . SPARSER::COLLECTION)
    ("GST-Nck" . SPARSER::COLLECTION) ("nitrocellulose" . SPARSER::MOLECULE)
    ("a C-terminal part consisting of a PRR and several tyrosine phosphorylation sites"
     . SPARSER::COLLECTION)
    ("intact and mutated TSAd and Nck" . SPARSER::COLLECTION)
    ("TSAd and Nck" . SPARSER::COLLECTION)
    ("cytoskeletal regulators" . SPARSER::REGULATOR)
    ("Vav1 and SLP-76" . SPARSER::COLLECTION)
    ("Nck and Vav1" . SPARSER::COLLECTION)
    ("TSAd and the adaptor Nck" . SPARSER::COLLECTION)
    ("Itk" . SPARSER::PROTEIN)
    ("the Src family protein tyrosine kinase Lck [ xref , xref ] as well as Src"
     . SPARSER::COLLECTION)
    ("Lck and Zap-70" . SPARSER::COLLECTION) ("LAT" . SPARSER::PROTEIN)
    ("Nck-SLP-76" . SPARSER::COLLECTION) ("Nck-Lck" . SPARSER::COLLECTION)
    ("Nck and Lck" . SPARSER::COLLECTION)
    ("Lck and SLP-76" . SPARSER::COLLECTION)
    ("Nck and TSAd" . SPARSER::COLLECTION) ("Nck-TSAd" . SPARSER::COLLECTION)
    ("pTyr" . SPARSER::PHOSPHORYLATED-AMINO-ACID) ("Nck" . SPARSER::PROTEIN)
    ("Lck and Src" . SPARSER::COLLECTION) ("TSAd" . SPARSER::PROTEIN)
    ("C-14" . SPARSER::PROTEIN) ("CD3ζ" . SPARSER::PROTEIN)
    ("CD3ε" . SPARSER::PROTEIN) ("T-cell kinase" . SPARSER::PROTEIN)
    ("SH2D2A" . SPARSER::PROTEIN) ("Zap-70" . SPARSER::PROTEIN)
    ("Vav1" . SPARSER::PROTEIN) ("SLP-76" . SPARSER::PROTEIN)
    ("dL" . SPARSER::MOLECULE)
    ("the most prominent biomarkers" . SPARSER::MOLECULE)
    ("neuropeptide Y, dehydroepiandrosterone and T" . SPARSER::COLLECTION)
    ("dehydroepiandrosterone" . SPARSER::MOLECULE)
    ("AI and AI@75" . SPARSER::COLLECTION) ("SE" . SPARSER::PROTEIN)
    ("E2 and SHBG" . SPARSER::COLLECTION) ("polyglutamine" . SPARSER::MOLECULE)
    ("testosterone (TT and FT, respectively) and dehydroepiandrosterone sulfate (DHEA-S) concentrations"
     . SPARSER::COLLECTION)
    ("DHEA" . SPARSER::DRUG) ("testosterone " . SPARSER::MOLECULE)
    ("a potent L-type voltage-operated calcium channels (L-VOCCs) antagonist"
     . SPARSER::MOLECULE)
    ("the dominant arm" . SPARSER::PROTEIN) ("vasodilator" . SPARSER::PROTEIN)
    ("CRFs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("endothelial-derived nitric oxide (NO)" . SPARSER::MOLECULE)
    ("anticoagulant" . SPARSER::DRUG) ("DHT" . SPARSER::PROTEIN)
    ("Testosterone" . SPARSER::MOLECULE) ("neuropeptide Y" . SPARSER::PROTEIN)
    ("voltage-gated" . SPARSER::PROTEIN)
    ("ion channels" . SPARSER::PROTEIN-FAMILY)
    ("sex hormone binding globulin" . SPARSER::PROTEIN)
    ("dehydroepiandrosterone sulfate" . SPARSER::MOLECULE)
    ("−2 and p" . SPARSER::COLLECTION) ("mere" . SPARSER::PROTEIN-FAMILY)
    ("cos" . SPARSER::MOLECULE) ("subregions" . SPARSER::PROTEIN)
    ("the actin and keratin filaments" . SPARSER::COLLECTION)
    ("plectin" . SPARSER::PROTEIN)
    ("tubulin and vimentin" . SPARSER::COLLECTION)
    ("cytoskeletal filaments" . SPARSER::PROTEIN-FAMILY)
    ("A representative example" . SPARSER::EXAMPLE)
    ("the previous example" . SPARSER::EXAMPLE)
    ("keratins, vimentin and lamins" . SPARSER::COLLECTION)
    ("lamins" . SPARSER::PROTEIN) ("keratins" . SPARSER::PROTEIN)
    ("associated cross-linking proteins" . SPARSER::PROTEIN)
    ("myosins" . SPARSER::PROTEIN)
    ("vimentin and tubulin" . SPARSER::COLLECTION)
    ("keratin 14" . SPARSER::PROTEIN) ("Serum Albumin" . SPARSER::PROTEIN)
    ("EGFR and other proteins" . SPARSER::COLLECTION)
    ("oligomers" . SPARSER::PROTEIN) ("Flot-2 or EGFR" . SPARSER::COLLECTION)
    ("Flot-2/EGFR" . SPARSER::COLLECTION)
    ("Flotillins and EGFR" . SPARSER::COLLECTION)
    ("Tyr-" . SPARSER::AMINO-ACID) ("leading target" . SPARSER::TARGET-PROTEIN)
    ("Flotillins" . SPARSER::PROTEIN-FAMILY)
    ("Flot-1 and Flot-2" . SPARSER::COLLECTION)
    ("flotillin-2/reggie-1" . SPARSER::COLLECTION)
    ("flotillin-1/reggie-2" . SPARSER::COLLECTION)
    ("flotillin" . SPARSER::PROTEIN)
    ("the two major histological subtypes" . SPARSER::PROTEIN)
    ("Flot-2 and EGFR" . SPARSER::COLLECTION) ("reggie-1" . SPARSER::PROTEIN)
    ("flotillin-2" . SPARSER::PROTEIN) ("Flot-1" . SPARSER::PROTEIN)
    ("reggie-2" . SPARSER::PROTEIN) ("flotillin-1" . SPARSER::PROTEIN)
    ("epidermal growth factor receptors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Flot-2" . SPARSER::PROTEIN) ("Flotillin 2" . SPARSER::PROTEIN)
    ("polymerized proteins" . SPARSER::PROTEIN) ("DAB" . SPARSER::MOLECULE)
    ("PAS and ubiquitin" . SPARSER::COLLECTION)
    ("the subsequent ischemia" . SPARSER::PROTEIN)
    ("neither MC-1 nor AT8" . SPARSER::COLLECTION)
    ("tau and full-length" . SPARSER::COLLECTION)
    ("either MC-1 ( xref ) or AT8 ( xref )" . SPARSER::COLLECTION)
    ("more mature hyperphosphorylated forms" . SPARSER::FORM)
    ("a conformational specific antibody" . SPARSER::ANTIBODY)
    ("MC-1 and AT8" . SPARSER::COLLECTION)
    ("PHF-1 and bright-field" . SPARSER::COLLECTION)
    ("PHF-1 and TauC3" . SPARSER::COLLECTION) ("PAS" . SPARSER::PROTEIN)
    ("nick" . SPARSER::PROTEIN) ("dUTP" . SPARSER::MOLECULE)
    ("Bright" . SPARSER::PROTEIN) ("cerebral ischemia" . SPARSER::PROTEIN)
    ("MC-1, AT8, and PHF-1" . SPARSER::COLLECTION)
    ("dystrophic" . SPARSER::PROTEIN) ("beta-amyloid" . SPARSER::PROTEIN)
    ("PHF-1" . SPARSER::PROTEIN) ("AT8" . SPARSER::PROTEIN)
    ("MC-1" . SPARSER::PROTEIN) ("ER or PgR" . SPARSER::COLLECTION)
    ("significantly worse TTR" . SPARSER::PROTEIN)
    ("Hormone" . SPARSER::MOLECULE) ("ER and PgR" . SPARSER::COLLECTION)
    ("ER- and PgR" . SPARSER::COLLECTION) ("PgR-" . SPARSER::PROTEIN)
    ("TTR" . SPARSER::PROTEIN)
    ("the all zinc-dependent HDAC enzymes" . SPARSER::ENZYME)
    ("activators or inhibitors" . SPARSER::COLLECTION)
    ("our SRID mutant" . SPARSER::MUTANT)
    ("interaction-defective missense mutants" . SPARSER::MUTANT)
    ("the interaction-defective alleles" . SPARSER::ALLELE)
    ("HDAC4c or -5c" . SPARSER::COLLECTION)
    ("LexA-fused" . SPARSER::COLLECTION)
    ("SMRT, NCoR, SRC-1, ASC-2 and TRAP220" . SPARSER::COLLECTION)
    ("HDACs and SRD3c" . SPARSER::COLLECTION)
    ("HDAC4c and -5c" . SPARSER::COLLECTION)
    ("HDAC3 and HDAC4c" . SPARSER::COLLECTION) ("HDAC4c" . SPARSER::PROTEIN)
    ("25 SRID mutants" . SPARSER::MUTANT) ("SRID Allele" . SPARSER::ALLELE)
    ("all zinc-dependent HDAC enzymes" . SPARSER::ENZYME)
    ("20 SRID alleles" . SPARSER::ALLELE) ("-IIb" . SPARSER::DRUG)
    ("the SRID mutants" . SPARSER::MUTANT)
    ("the isolated SRID mutants" . SPARSER::MUTANT)
    ("SMRT and HDAC3" . SPARSER::COLLECTION)
    ("KGC-HDACs" . SPARSER::COLLECTION) ("KGC" . SPARSER::PROTEIN)
    ("protein/protein" . SPARSER::COLLECTION)
    ("20 representative mutants" . SPARSER::MUTANT)
    ("SRID alleles" . SPARSER::ALLELE) ("the SRID alleles" . SPARSER::ALLELE)
    ("GST-fused" . SPARSER::COLLECTION) ("TNT" . SPARSER::PROTEIN)
    ("LexA" . SPARSER::PROTEIN) ("Glu, Pro, Arg or Val" . SPARSER::COLLECTION)
    ("36 SRID alleles" . SPARSER::ALLELE) ("SRID Mutants" . SPARSER::MUTANT)
    ("Mutants" . SPARSER::MUTANT) ("prey" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SRID mutant alleles" . SPARSER::ALLELE)
    ("interaction-defective alleles" . SPARSER::ALLELE)
    ("pRS" . SPARSER::PROTEIN) ("SRID mutants" . SPARSER::MUTANT)
    ("serial truncation mutants" . SPARSER::MUTANT)
    ("SRID Alleles" . SPARSER::ALLELE) ("Alleles" . SPARSER::ALLELE)
    ("HDAC4 (HDAC4c) and HDAC5 (HDAC5c)" . SPARSER::COLLECTION)
    ("molecule and zinc" . SPARSER::COLLECTION)
    ("target repressor proteins and the SMRT/NCoR-HDAC3 complex"
     . SPARSER::COLLECTION)
    ("SMRT/NCoR-HDAC3" . SPARSER::COLLECTION)
    ("MEF2, FOXP3 and RUNX2" . SPARSER::COLLECTION) ("CtBP" . SPARSER::PROTEIN)
    ("Rev-erbs" . SPARSER::COLLECTION) ("erbs" . SPARSER::PROTEIN)
    ("Rev" . SPARSER::PROTEIN-FAMILY) ("NCoR/SMRT" . SPARSER::COLLECTION)
    ("SMRT/NCoR" . SPARSER::COLLECTION)
    ("NCoR (nuclear receptor-corepressor) and SMRT (silencing mediator for retinoid and thyroid receptor)"
     . SPARSER::COLLECTION)
    ("retinoid and thyroid" . SPARSER::COLLECTION)
    ("retinoid" . SPARSER::PROTEIN)
    ("called SIN3A, NURD/Mi2 and CoREST" . SPARSER::COLLECTION)
    ("SIN3A, NURD/Mi2 and CoREST" . SPARSER::COLLECTION)
    ("CoREST" . SPARSER::PROTEIN) ("Class" . CLASS) ("IIb" . SPARSER::DRUG)
    ("SAHA (vorinostat) and FK228 (romidepsin)" . SPARSER::COLLECTION)
    ("vorinostat" . SPARSER::DRUG) ("HAT and HDAC" . SPARSER::COLLECTION)
    ("HAT" . SPARSER::PROTEIN) ("nucleosomal histones" . SPARSER::PROTEIN)
    ("HATs" . SPARSER::PROTEIN)
    ("SRD3c interaction-defective (SRID) mutants" . SPARSER::MUTANT)
    ("SMRT-HDAC3" . SPARSER::COLLECTION) ("TRAP220" . SPARSER::PROTEIN)
    ("ASC-2" . SPARSER::PROTEIN) ("pH 3" . SPARSER::MOLECULE)
    ("LEU2" . SPARSER::PROTEIN) ("ura3" . SPARSER::PROTEIN)
    ("leu2" . SPARSER::PROTEIN) ("cNR2" . SPARSER::PROTEIN)
    ("T-1" . SPARSER::PROTEIN) ("HDAC5" . SPARSER::PROTEIN)
    ("HDAC7" . SPARSER::PROTEIN) ("HDAC8" . SPARSER::PROTEIN)
    ("RUNX2" . SPARSER::PROTEIN) ("FOXP3" . SPARSER::PROTEIN)
    ("MEF2" . SPARSER::PROTEIN) ("RD3" . SPARSER::PROTEIN)
    ("RD1" . SPARSER::PROTEIN) ("SIN3A" . SPARSER::PROTEIN)
    ("HDAC11" . SPARSER::PROTEIN) ("HDAC10" . SPARSER::PROTEIN)
    ("Hda1" . SPARSER::PROTEIN) ("Rpd3" . SPARSER::PROTEIN)
    ("FK228" . SPARSER::DRUG) ("preset" . SPARSER::PROTEIN-FAMILY)
    ("FPRP" . SPARSER::PROTEIN) ("NFκB and IκBα" . SPARSER::COLLECTION)
    ("the NFκB and its inhibitory protein IκBα" . SPARSER::COLLECTION)
    ("NFkB1 and IκBα" . SPARSER::COLLECTION) ("miR-34b" . SPARSER::PROTEIN)
    ("hsa-miR-34b" . SPARSER::COLLECTION) ("CNE-1" . SPARSER::PROTEIN)
    ("rs28362491ins/ins adverse variant" . SPARSER::VARIANT)
    ("AG" . SPARSER::PROTEIN) ("NFκB2 and IκBα" . SPARSER::COLLECTION)
    ("NFκB and IκB" . SPARSER::COLLECTION) ("NFκB/IκB" . SPARSER::COLLECTION)
    ("NFκB/IκBα" . SPARSER::COLLECTION) ("ins/ins" . SPARSER::COLLECTION)
    ("ins" . SPARSER::PROTEIN) ("LMP1" . SPARSER::PROTEIN)
    ("NFkB1" . SPARSER::PROTEIN) ("ATG-3" . SPARSER::PROTEIN)
    ("I κ B" . SPARSER::PROTEIN) ("NFκ" . SPARSER::PROTEIN)
    ("NFκB2" . SPARSER::PROTEIN) ("bipartite" . SPARSER::PROTEIN)
    ("cryptic" . SPARSER::PROTEIN)
    ("GFP or hemagglutinin" . SPARSER::COLLECTION)
    ("hemagglutinin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a larger cohort" . SPARSER::MOLECULE)
    ("enzalutamide or abiraterone" . SPARSER::COLLECTION)
    ("AR-V7 and ARv567es" . SPARSER::COLLECTION)
    ("p53, Rb, and parathyroid hormone-related protein" . SPARSER::COLLECTION)
    ("PTHrP" . SPARSER::PROTEIN) ("cytoprotective proteins" . SPARSER::PROTEIN)
    ("TurboFP635" . SPARSER::PROTEIN) ("importazole" . SPARSER::DRUG)
    ("importin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AR-V7-TurboFP635 or AR" . SPARSER::COLLECTION)
    ("AR-V7-TurboFP635" . SPARSER::PROTEIN-PAIR)
    ("Importin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a novel peptidomimetic inhibitor" . SPARSER::INHIBITOR)
    ("FRAP" . SPARSER::PROTEIN)
    ("docetaxel and paclitaxel" . SPARSER::COLLECTION)
    ("EGFP-AR-V7" . SPARSER::COLLECTION)
    ("docetaxel or paclitaxel" . SPARSER::COLLECTION)
    ("AR-V7/AR" . SPARSER::COLLECTION)
    ("a V7-specific shRNA" . SPARSER::PROTEIN)
    ("paclitaxel and cabazitaxel" . SPARSER::COLLECTION)
    ("AR-V7 or AR" . SPARSER::COLLECTION)
    ("paclitaxel and docetaxel" . SPARSER::COLLECTION)
    ("Taxane" . SPARSER::DRUG)
    ("enzalutamide and abiraterone" . SPARSER::COLLECTION)
    ("AR-V7 (also known as AR3) and AR v567es" . SPARSER::COLLECTION)
    ("androgens and drive prostate cancer growth in a castration-resistant manner"
     . SPARSER::COLLECTION)
    ("antimitotic" . SPARSER::MOLECULE) ("Gan" . SPARSER::PROTEIN)
    ("Taxanes" . SPARSER::DRUG)
    ("Paclitaxel, docetaxel, and cabazitaxel" . SPARSER::COLLECTION)
    ("enzalutamide" . SPARSER::DRUG) ("antiandrogen" . SPARSER::DRUG)
    ("abiraterone" . SPARSER::DRUG) ("androgens" . SPARSER::DRUG)
    ("Androgen" . SPARSER::PROTEIN) ("AR-V7 and AR" . SPARSER::COLLECTION)
    ("Vs" . SPARSER::PROTEIN) ("androgen receptor (AR)" . SPARSER::PROTEIN)
    ("docetaxel and cabazitaxel" . SPARSER::COLLECTION)
    ("cabazitaxel" . SPARSER::DRUG) ("Docetaxel" . SPARSER::DRUG)
    ("P40" . SPARSER::PROTEIN) ("ARR3" . SPARSER::PROTEIN)
    ("ARv567es" . SPARSER::PROTEIN)
    ("parathyroid hormone-related protein" . SPARSER::PROTEIN)
    ("glucocorticoid receptor" . SPARSER::PROTEIN) ("KX-01" . SPARSER::DRUG)
    ("Enhanced green fluorescent protein" . SPARSER::PROTEIN)
    ("CYP17A1" . SPARSER::PROTEIN) ("anti-androgens" . SPARSER::DRUG)
    ("AR-V7" . SPARSER::PROTEIN) ("GLUT1 and HK-II" . SPARSER::COLLECTION)
    ("glucose transporter GLUT1 and the enzyme HK-II" . SPARSER::COLLECTION)
    ("selectively killing CRC" . SPARSER::PROTEIN)
    ("fatty acid synthase (FAS)" . SPARSER::PROTEIN)
    ("Metabolite" . SPARSER::MOLECULE)
    ("phosphatidylglycerol" . SPARSER::MOLECULE)
    ("Coenzyme" . SPARSER::MOLECULE) ("m+2 and m+4" . SPARSER::COLLECTION)
    ("malate" . SPARSER::MOLECULE)
    ("pyruvate dehydrogenase (PDH) and lactate dehydrogenase A (LDHA)"
     . SPARSER::COLLECTION)
    ("pyruvate kinase (PKM2), pyruvate dehydrogenase (PDH) and lactate dehydrogenase A (LDHA)"
     . SPARSER::COLLECTION)
    ("dehydrogenase (PDH)" . SPARSER::PROTEIN)
    ("an isotopic tracer" . SPARSER::MOLECULE) ("tracer" . SPARSER::MOLECULE)
    ("Akt, mTORC1 and p70S6K" . SPARSER::COLLECTION)
    ("glucose-6-phosphate dehydrogenase (G6PD, EC: 1.1.1.49) and 6-phosphogluconate dehydrogenase (PGD, EC: 1.1.1.44)"
     . SPARSER::COLLECTION)
    ("ME" . SPARSER::PROTEIN) ("PGD" . SPARSER::PROTEIN)
    ("annexin V/PI" . SPARSER::COLLECTION) ("MIHA" . SPARSER::PROTEIN)
    ("ROS and NADPH" . SPARSER::COLLECTION)
    ("acute promyelocytic leukemia" . SPARSER::PROTEIN)
    ("alpha-1" . SPARSER::PROTEIN) ("glucose and lipid" . SPARSER::COLLECTION)
    ("a strong reducing agent" . SPARSER::MOLECULE)
    ("oxidative arm" . SPARSER::PROTEIN)
    ("GLUT1 and hexokinase-2" . SPARSER::COLLECTION)
    ("Halofuginone" . SPARSER::DRUG) ("HF" . SPARSER::PROTEIN)
    ("halofuginone" . SPARSER::DRUG) ("Akt/mTORC1" . SPARSER::COLLECTION)
    ("NADP+" . SPARSER::MOLECULE) ("C20" . SPARSER::PROTEIN)
    ("3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("Dnase I" . SPARSER::PROTEIN) ("lipid droplet" . SPARSER::PROTEIN)
    ("m+2" . SPARSER::MOLECULE) ("HK-II" . SPARSER::PROTEIN)
    ("phosphogluconate dehydrogenase" . SPARSER::PROTEIN)
    ("NADP +" . SPARSER::MOLECULE) ("voltage-dependent" . SPARSER::PROTEIN)
    ("N-Acetyl-L-cysteine" . SPARSER::MOLECULE)
    ("promyelocytic leukemia" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-2" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 4E" . SPARSER::PROTEIN)
    ("reducing agent" . SPARSER::MOLECULE) ("GLUT1" . SPARSER::PROTEIN)
    ("Peptides" . SPARSER::PEPTIDE) ("alkene" . SPARSER::MOLECULE)
    ("oximes" . SPARSER::MOLECULE) ("lactams" . SPARSER::MOLECULE)
    ("thioethers" . SPARSER::MOLECULE) ("disulphides" . SPARSER::MOLECULE)
    ("Bcl-2/Bcl-xL" . SPARSER::COLLECTION) ("Mdm2-p53" . SPARSER::COLLECTION)
    ("p53 and Mdm2" . SPARSER::COLLECTION) ("nutlin" . SPARSER::DRUG)
    ("sharp" . SPARSER::PROTEIN) ("Mdm2 and/or Mdm4" . SPARSER::COLLECTION)
    ("Mdm2/Mdm4 antagonistic stapled peptides" . SPARSER::PEPTIDE)
    ("larger peptide molecules" . SPARSER::MOLECULE)
    ("Mdm2/Mdm4/p53" . SPARSER::COLLECTION)
    ("proteins, lipids and biomolecules" . SPARSER::COLLECTION)
    ("the soluble proteins" . SPARSER::PROTEIN)
    ("more generic cytotoxic drugs" . SPARSER::DRUG)
    ("Mdm2/Mdm4" . SPARSER::COLLECTION) ("Mdm2 and Mdm4" . SPARSER::COLLECTION)
    ("Mdm2/Mdm4-p53" . SPARSER::COLLECTION) ("MTH1" . SPARSER::PROTEIN)
    ("AML2" . SPARSER::PROTEIN) ("a 15 " . SPARSER::PROTEIN)
    ("a 2 " . SPARSER::HUMAN-PROTEIN-FAMILY) ("a 37 " . SPARSER::PROTEIN)
    ("t-butyl" . SPARSER::MOLECULE) ("MI-219" . SPARSER::DRUG)
    ("nutlin-3" . SPARSER::DRUG) ("Mdm4" . SPARSER::PROTEIN)
    ("substrate and site" . SPARSER::COLLECTION)
    ("telomerase-mediated telomere elongation" . SPARSER::PROTEIN)
    ("neither hTERT nor dyskerin" . SPARSER::COLLECTION) ("hTR" . SPARSER::RNA)
    ("DNase" . SPARSER::PROTEIN)
    ("three nucleotides (TAG) and four nucleotides (TTAG)"
     . SPARSER::COLLECTION)
    ("nucleotides (TTAG)" . SPARSER::NUCLEOTIDE)
    ("nucleotides (TAG)" . SPARSER::NUCLEOTIDE)
    ("-dTTP and dATP" . SPARSER::COLLECTION)
    ("two nucleotides (TA) and three nucleotides (TTA)" . SPARSER::COLLECTION)
    ("nucleotides (TTA)" . SPARSER::NUCLEOTIDE)
    ("nucleotides (TA)" . SPARSER::NUCLEOTIDE) ("-dGTP" . SPARSER::DGTP)
    ("dATP" . SPARSER::DATP) ("dGTP" . SPARSER::DGTP)
    ("-dTTP" . SPARSER::MOLECULE) ("dTTP" . SPARSER::MOLECULE)
    ("a less-favourable
substrate"
     . SPARSER::SUBSTRATE)
    ("G4R1 or RHAU" . SPARSER::COLLECTION) ("RHAU" . SPARSER::PROTEIN)
    ("hTERT and dyskerin" . SPARSER::COLLECTION)
    ("dyskerin" . SPARSER::PROTEIN) ("glycerol" . SPARSER::PROTEIN)
    ("exonuclease" . SPARSER::PROTEIN)
    ("the 9C complementary oligonucleotide" . SPARSER::MOLECULE)
    ("SrCl" . SPARSER::PROTEIN) ("bimolecular DNA" . SPARSER::DNA)
    ("The predominant ions" . SPARSER::MOLECULE)
    ("predominant ions" . SPARSER::MOLECULE) ("ions" . SPARSER::MOLECULE)
    ("GGG" . SPARSER::MOLECULE) ("KCl" . SPARSER::MOLECULE)
    ("K + or
Na +"
     . SPARSER::COLLECTION)
    ("stabilizers" . SPARSER::MOLECULE)
    ("the
components and multimeric state"
     . SPARSER::COLLECTION)
    ("multimeric state" . SPARSER::BIO-STATE) ("cations" . SPARSER::MOLECULE)
    ("D-1" . SPARSER::PROTEIN) ("bis-Tris" . SPARSER::MOLECULE)
    ("A 20" . SPARSER::PROTEIN)
    ("amino
acids"
     . SPARSER::AMINO-ACID)
    ("ribonucleoprotein complexes" . SPARSER::BIO-COMPLEX)
    ("1-l" . SPARSER::PROTEIN) ("M −1  " . SPARSER::PROTEIN)
    ("Est1" . SPARSER::PROTEIN) ("G4R1" . SPARSER::PROTEIN)
    ("DHX36" . SPARSER::PROTEIN) ("Na +" . SPARSER::MOLECULE)
    ("K +" . SPARSER::MOLECULE)
    ("telomerase reverse
transcriptase"
     . SPARSER::PROTEIN)
    ("virulence factors or modulins" . SPARSER::COLLECTION)
    ("a critical gastric effector" . SPARSER::EFFECTOR)
    ("PTPN11 and PGC" . SPARSER::COLLECTION)
    ("cytokine and Shp2" . SPARSER::COLLECTION)
    ("ERK and MAPK" . SPARSER::COLLECTION) ("fine-mapping" . SPARSER::PROTEIN)
    ("PGC , PTPN11 , and IL1B" . SPARSER::COLLECTION)
    ("PGC, PTPN11, and IL1B" . SPARSER::COLLECTION)
    ("TLR4 and IL-1B" . SPARSER::COLLECTION)
    ("PGC, PTPN11, TLR4, and IL1B" . SPARSER::COLLECTION)
    ("PGC , PTPN11 , TLR4 , and IL1B" . SPARSER::COLLECTION)
    ("the virulence factors LPS (lipopolysaccharide) and CagA (cytotoxin-associated antigen)"
     . SPARSER::COLLECTION)
    ("PTPN11 and TLR4" . SPARSER::COLLECTION) ("cytotoxin" . SPARSER::PROTEIN)
    ("CagA" . SPARSER::PROTEIN)
    ("these bacterial components" . SPARSER::COMPONENT)
    ("virulence factors and toxic components [ xref ]" . SPARSER::COLLECTION)
    ("toxic components" . SPARSER::COMPONENT)
    ("around one gene" . SPARSER::GENE)
    ("PGC and PTPN11" . SPARSER::COLLECTION)
    ("PGC, PTPN11 , and IL1B" . SPARSER::COLLECTION)
    ("PGC, PTPN11, TLR4 , and IL1B" . SPARSER::COLLECTION)
    ("IL-1B" . SPARSER::PROTEIN)
    ("virulence factors" . SPARSER::PROTEIN-FAMILY)
    ("TET2 , ASXL1 and SRSF2" . SPARSER::COLLECTION)
    ("the aggressive form" . SPARSER::FORM)
    ("the aggressive (ASM) form" . SPARSER::FORM)
    ("molecules and modifiers" . SPARSER::COLLECTION)
    ("modifiers" . SPARSER::MOLECULE)
    ("Imatinib and Midostaurin" . SPARSER::COLLECTION)
    ("DP" . SPARSER::PROTEIN) ("a rational drug" . SPARSER::DRUG)
    ("‘active’ or ‘inactive’" . SPARSER::COLLECTION)
    ("‘inactive’" . SPARSER::INACTIVE) ("‘active’" . SPARSER::ACTIVE)
    ("the unique structural conformation KIT receptor" . SPARSER::RECEPTOR)
    ("SHP2, FAK, RAC1, and PAK1" . SPARSER::COLLECTION)
    ("Ponatinib and Midostaurin or Dasatinib" . SPARSER::COLLECTION)
    ("Midostaurin or Dasatinib" . SPARSER::COLLECTION)
    ("Ponatinib" . SPARSER::DRUG) ("DASA" . SPARSER::DRUG)
    ("AKT, STAT5 or STAT3" . SPARSER::COLLECTION)
    ("the KIT D816V receptor and its downstream substrates"
     . SPARSER::COLLECTION)
    ("DAC" . SPARSER::PROTEIN) ("Decitabine" . SPARSER::DRUG)
    ("AZA" . SPARSER::DRUG) ("azacytidine" . SPARSER::DRUG)
    ("BTK, PI3K and JAK" . SPARSER::COLLECTION) ("LICs" . SPARSER::PROTEIN)
    ("FAK, RAC1 and PAK1" . SPARSER::COLLECTION)
    ("Dasatinib and Midostaurin" . SPARSER::COLLECTION)
    ("antineoplastic drugs" . SPARSER::DRUG)
    ("Dasatinib, Midostaurin and Bortezomib" . SPARSER::COLLECTION)
    ("synergizes" . SPARSER::PROTEIN)
    ("BCLXL, BCL2 and MCL1" . SPARSER::COLLECTION) ("BCLXL" . SPARSER::PROTEIN)
    ("Obatoclax" . SPARSER::DRUG)
    ("the pro-apoptotic protein BIM" . SPARSER::PROTEIN)
    ("more aggressive forms" . SPARSER::FORM)
    ("Cladribine and Interferon-α" . SPARSER::COLLECTION)
    ("Cladribine" . SPARSER::PROTEIN) ("ASM and MCL" . SPARSER::COLLECTION)
    ("PKC, VEGFR-2, PDGFR, FLT3 and KIT" . SPARSER::COLLECTION)
    ("PDGFR" . SPARSER::PROTEIN) ("dup" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SHP2/RAC1/PAK1/FAK" . SPARSER::COLLECTION)
    ("RAC1/PAK1/FAK/SHP2" . SPARSER::COLLECTION)
    ("STAT5 and OSM" . SPARSER::COLLECTION) ("OSM" . SPARSER::PROTEIN)
    ("STAT5 and MITF" . SPARSER::COLLECTION) ("MITF" . SPARSER::PROTEIN)
    ("FAK and PAK1" . SPARSER::COLLECTION)
    ("FAK or PAK1" . SPARSER::COLLECTION)
    ("FAK/TIAM1/RAC1/PAK1" . SPARSER::COLLECTION) ("RAC" . SPARSER::PROTEIN)
    ("VAV1/RAC1/PAK" . SPARSER::COLLECTION) ("PAK" . SPARSER::PROTEIN-FAMILY)
    ("PI3Kinase/RHOA" . SPARSER::COLLECTION) ("RHOA" . SPARSER::PROTEIN)
    ("PI3K and GAB2" . SPARSER::COLLECTION) ("AKT/ERK" . SPARSER::COLLECTION)
    ("Pacritinib" . SPARSER::DRUG) ("Lestaurtinib" . SPARSER::DRUG)
    ("JAKs" . SPARSER::PROTEIN) ("PI3Kinase/AKT" . SPARSER::COLLECTION)
    ("PI3K [ xref ] and BTK [ xref ]" . SPARSER::COLLECTION)
    ("FOXO, NF-kB, and CREB" . SPARSER::COLLECTION)
    ("mTORC" . SPARSER::PROTEIN)
    ("Dasatinib and Bosutinib" . SPARSER::COLLECTION)
    ("LYN/BTK" . SPARSER::COLLECTION) ("Bosutinib" . SPARSER::DRUG)
    ("LYN and BTK" . SPARSER::COLLECTION) ("BTK" . SPARSER::PROTEIN)
    ("c-CBL and SHC" . SPARSER::COLLECTION)
    ("AKT and ERK1/2" . SPARSER::COLLECTION) ("SHC" . SPARSER::PROTEIN)
    ("respective genes" . SPARSER::GENE)
    ("KIT, TET2, DNMT3A, ASXL1 and CBL" . SPARSER::COLLECTION)
    ("KIT-SRSF2-ASXL1" . SPARSER::COLLECTION)
    ("KIT-SRSF2-RUNX1" . SPARSER::COLLECTION)
    ("KIT-TET2-SRSF2" . SPARSER::COLLECTION)
    ("DNMT3A and EZH2" . SPARSER::COLLECTION)
    ("EZH2 (5.1%) and ETV6" . SPARSER::COLLECTION)
    ("CBL (3.8%-20.5%), DNMT3A (12%), KRAS, NRAS, JAK2, EZH2 (5.1%) and ETV6"
     . SPARSER::COLLECTION)
    ("TET2 and SRSF2" . SPARSER::COLLECTION)
    ("SF3B1, SRSF2 , and U2AF1" . SPARSER::COLLECTION)
    ("MDS and CMML" . SPARSER::COLLECTION) ("U2AF1" . SPARSER::PROTEIN)
    ("SF3B1" . SPARSER::PROTEIN) ("Spliceosomes" . SPARSER::BIO-COMPLEX)
    ("Spliceosome" . SPARSER::BIO-COMPLEX)
    ("RUNX1 (23%) and CBL (20%)" . SPARSER::COLLECTION)
    ("TET2 (39%), SRSF2 (36%), ASXL1 (20%), RUNX1 (23%) and CBL (20%)"
     . SPARSER::COLLECTION)
    ("KIT and TET2" . SPARSER::COLLECTION) ("severe forms" . SPARSER::FORM)
    ("DNMT3A and/or ASXL1" . SPARSER::COLLECTION)
    ("DNMT3A or TET2" . SPARSER::COLLECTION)
    ("DNMT3A , ASXL1 and CBL" . SPARSER::COLLECTION) ("CBL" . SPARSER::PROTEIN)
    ("Midostaurin" . SPARSER::DRUG) ("Gleevec" . SPARSER::DRUG)
    ("chronic eosinophilic leukemia" . SPARSER::PROTEIN)
    ("chronic myelomonocytic leukemia" . SPARSER::PROTEIN)
    ("PMF" . SPARSER::PROTEIN) ("MCL and perhaps" . SPARSER::COLLECTION)
    ("CD2 and/or CD25" . SPARSER::COLLECTION) ("tryptase" . SPARSER::PROTEIN)
    ("MCS" . SPARSER::PROTEIN) ("MCL" . SPARSER::PROTEIN)
    ("mast cell" . SPARSER::PROTEIN) ("the aggressive forms" . SPARSER::FORM)
    ("ASM" . SPARSER::PROTEIN) ("leukemic variants" . SPARSER::VARIANT)
    ("a more aggressive form" . SPARSER::FORM)
    ("the indolent form" . SPARSER::FORM)
    ("Stem cell factor (SCF) or KIT ligand" . SPARSER::COLLECTION)
    ("Chronic Eosinophilic Leukemia (CEL)" . SPARSER::PROTEIN)
    ("Vera (PV)" . SPARSER::PROTEIN)
    ("Chronic Neutrophilic Leukemia (CNL)" . SPARSER::PROTEIN)
    ("Chronic Myelogeneous Leukemia (CML)" . SPARSER::PROTEIN)
    ("CEL" . SPARSER::PROTEIN) ("PM" . SPARSER::PROTEIN)
    ("Vera" . SPARSER::PROTEIN) ("Leukemia" . SPARSER::PROTEIN)
    ("MPNs" . SPARSER::PROTEIN) ("anti-neoplastic" . SPARSER::DRUG)
    ("Fas cell surface death receptor" . SPARSER::PROTEIN)
    ("MCL1" . SPARSER::PROTEIN) ("FLT3" . SPARSER::PROTEIN)
    ("VEGFR-2" . SPARSER::PROTEIN)
    ("microphthalmia-associated transcription factor" . SPARSER::PROTEIN)
    ("Oncostatin M" . SPARSER::PROTEIN) ("TIAM1" . SPARSER::PROTEIN)
    ("RAC1" . SPARSER::PROTEIN) ("VAV1" . SPARSER::PROTEIN)
    ("ROCK1" . SPARSER::PROTEIN) ("SHP2" . SPARSER::PROTEIN)
    ("SB1518" . SPARSER::DRUG) ("CEP-701" . SPARSER::DRUG)
    ("GAB2" . SPARSER::PROTEIN) ("PI3Kinase" . SPARSER::PROTEIN)
    ("GSK2141795" . SPARSER::DRUG) ("mTORC 1" . SPARSER::PROTEIN)
    ("c-CBL" . SPARSER::PROTEIN) ("ETV6" . SPARSER::PROTEIN)
    ("U2AF" . SPARSER::BIO-COMPLEX) ("SF3" . SPARSER::PROTEIN)
    ("SRSF2" . SPARSER::PROTEIN) ("ASXL1" . SPARSER::PROTEIN)
    ("DNMT3A" . SPARSER::PROTEIN) ("PKC412" . SPARSER::DRUG)
    ("CD25" . SPARSER::PROTEIN) ("CD2" . SPARSER::PROTEIN)
    ("KIT ligand" . SPARSER::PROTEIN) ("Stem cell factor" . SPARSER::PROTEIN)
    ("Type III" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("miR-101 directly targets DUSP1" . SPARSER::PROTEIN)
    ("a multifunctional cytokine" . SPARSER::PROTEIN)
    ("the most potent hepatic pro-fibrogenic cytokine" . SPARSER::PROTEIN)
    ("apoptosis signal-regulating kinase 1, and MEK kinase 3"
     . SPARSER::COLLECTION)
    ("p38 and JNK" . SPARSER::COLLECTION)
    ("Ras, Raf and ERK" . SPARSER::COLLECTION)
    ("a classical M1 polarization state" . SPARSER::BIO-STATE)
    ("IL-6, IL-10 and CD206" . SPARSER::COLLECTION)
    ("CD206 and TGF-β" . SPARSER::COLLECTION)
    ("Developed HCC" . SPARSER::PROTEIN)
    ("a pivotal growth factor" . SPARSER::GROWTH-FACTOR)
    ("TGF-β and M2" . SPARSER::COLLECTION)
    ("the mesenchymal markers vimentin and fibronectin" . SPARSER::COLLECTION)
    ("vimentin and fibronectin" . SPARSER::COLLECTION)
    ("Macrophage" . SPARSER::PROTEIN)
    ("sorafenib, or sorafenib" . SPARSER::COLLECTION)
    ("SB203580, SP600125, or PD98059" . SPARSER::COLLECTION)
    ("SB203580 or JNK" . SPARSER::COLLECTION)
    ("LPS and TGF-β" . SPARSER::COLLECTION)
    ("ERK1/2, p38 or JNK" . SPARSER::COLLECTION)
    ("the miR-101 inhibitor or negative control" . SPARSER::COLLECTION)
    ("macrophage-derived growth factors" . SPARSER::COLLECTION)
    ("vimentin, N-cadherin, and fibronectin" . SPARSER::COLLECTION)
    ("IL-12 or IL-10" . SPARSER::COLLECTION)
    ("CD68 and HLA-DR" . SPARSER::COLLECTION)
    ("polarized monocyte-derived macrophage" . SPARSER::PROTEIN)
    ("the drug's" . SPARSER::DRUG)
    ("LPS or other microbial components" . SPARSER::COLLECTION)
    ("other microbial components" . SPARSER::COMPONENT)
    ("TNF-α and IL-6" . SPARSER::COLLECTION)
    ("a dual-specificity phosphatase and a negative regulator"
     . SPARSER::COLLECTION)
    ("TNF-α, IL-1, IL-6, and endothelial growth factor" . SPARSER::COLLECTION)
    ("JNK/stress-activated protein kinase" . SPARSER::COLLECTION)
    ("macrophage-driven HCC" . SPARSER::PROTEIN) ("Sorafenib" . SPARSER::DRUG)
    ("TGF-β and CD206" . SPARSER::COLLECTION)
    ("ERK1/2, p38 and JNK" . SPARSER::COLLECTION)
    ("Hepatocellular carcinoma (HCC)-associated macrophages"
     . SPARSER::PROTEIN)
    ("colony-stimulating factor" . SPARSER::PROTEIN)
    ("MEK kinase 3" . SPARSER::PROTEIN) ("anti-angiogenic" . SPARSER::DRUG)
    ("Tyrosine kinase" . SPARSER::PROTEIN) ("LY2157299" . SPARSER::DRUG)
    ("derived growth factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("endothelial growth factor" . SPARSER::PROTEIN)
    ("stress-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("interleukin-4" . SPARSER::PROTEIN) ("Th2" . SPARSER::PROTEIN)
    ("dual specificity phosphatase 1" . SPARSER::PROTEIN)
    ("siRNA or small molecule inhibitors" . SPARSER::COLLECTION)
    ("A3 and A4 ligands" . SPARSER::COLLECTION)
    ("ephrin-A1, A3 and A4 ligands" . SPARSER::COLLECTION)
    ("integrins and Rho" . SPARSER::COLLECTION)
    ("Rho" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ephexin4" . SPARSER::PROTEIN)
    ("RSK and EphA2" . SPARSER::COLLECTION)
    ("filamin" . SPARSER::PROTEIN-FAMILY)
    ("prometastatic genes" . SPARSER::GENE)
    ("RSK or Akt" . SPARSER::COLLECTION) ("EphA1" . SPARSER::PROTEIN)
    ("tyrosine kinase-" . SPARSER::PROTEIN) ("RXXpS/pT" . SPARSER::COLLECTION)
    ("pT" . SPARSER::PROTEIN) ("EphA2 and RSK" . SPARSER::COLLECTION)
    ("pRSK and pS-EphA2" . SPARSER::COLLECTION)
    ("U0126 and each targeted tyrosine kinase inhibitor" . SPARSER::COLLECTION)
    ("abrogated pS-EphA2" . SPARSER::COLLECTION)
    ("gefitinib and crizotinib" . SPARSER::COLLECTION)
    ("EML4-ALK" . SPARSER::COLLECTION) ("PC-9" . SPARSER::PROTEIN)
    ("protein and pS-EphA2" . SPARSER::COLLECTION)
    ("kinase-dead EphA2" . SPARSER::PROTEIN-FAMILY)
    ("GST-RSK2" . SPARSER::COLLECTION) ("GST-RSK1" . SPARSER::COLLECTION)
    ("neither RSK1 nor RSK2" . SPARSER::COLLECTION)
    ("EphA2 and RSK1" . SPARSER::COLLECTION)
    ("RSK or its downstream kinases" . SPARSER::COLLECTION)
    ("U0126 and BI-D1870" . SPARSER::COLLECTION)
    ("pT-EGFR" . SPARSER::PROTEIN-PAIR)
    ("MEK inhibitor (U0126) or RSK inhibitor (BI-D1870)" . SPARSER::COLLECTION)
    ("pRSK" . SPARSER::PROTEIN) ("Akt and RSKs" . SPARSER::COLLECTION)
    ("RSKs" . SPARSER::PROTEIN) ("RSK1 and RSK2" . SPARSER::COLLECTION)
    ("shRNA or siRNA" . SPARSER::COLLECTION)
    ("transforming growth factor-β-activated kinase" . SPARSER::KINASE)
    ("MAPK and NF-κB" . SPARSER::COLLECTION)
    ("MK-2206 and LY294002" . SPARSER::COLLECTION)
    ("PI3K inhibitor (LY294002) or an allosteric Akt inhibitor (MK-2206)"
     . SPARSER::COLLECTION)
    ("TNF-α and interleukin-1β" . SPARSER::COLLECTION)
    ("EphA2 (SA)" . SPARSER::PROTEIN)
    ("TNF-α and ephrin-A1" . SPARSER::COLLECTION)
    ("ephrin-A1" . SPARSER::PROTEIN)
    ("phospho-Ser-897 EphA2 (pS-EphA2) antibody and phospho-Tyr-588 EphA2 (pY-EphA2) antibody"
     . SPARSER::PROTEIN)
    ("antibody and phospho-Tyr-588" . SPARSER::COLLECTION)
    ("pY-EphA2" . SPARSER::COLLECTION) ("pS-EphA2" . SPARSER::COLLECTION)
    ("EphA2 and EGFR" . SPARSER::COLLECTION) ("-Phos-tag" . SPARSER::DRUG)
    ("ERK–RSK" . SPARSER::COLLECTION)
    ("an inflammatory cytokine" . SPARSER::PROTEIN)
    ("p90 ribosomal S6 kinase" . SPARSER::PROTEIN-FAMILY)
    ("the largest Eph" . SPARSER::PROTEIN) ("RSK-" . SPARSER::PROTEIN)
    ("RSK" . SPARSER::PROTEIN) ("EphA2" . SPARSER::PROTEIN)
    ("phos-tag" . SPARSER::DRUG) ("C-21" . SPARSER::PROTEIN)
    ("FRA1" . SPARSER::PROTEIN) ("EML4" . SPARSER::PROTEIN)
    ("BI-D1870" . SPARSER::MOLECULE) ("RSK1" . SPARSER::PROTEIN)
    ("MK-2206" . SPARSER::MOLECULE) ("Phos-tag" . SPARSER::DRUG)
    ("Zn 2+" . SPARSER::MOLECULE) ("PI3K–Akt" . SPARSER::PROTEIN)
    ("ephrin-A" . SPARSER::PROTEIN-FAMILY) ("RSK2" . SPARSER::PROTEIN)
    ("S6 kinase" . SPARSER::PROTEIN-FAMILY) ("p90" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor 1" . SPARSER::PROTEIN)
    ("Receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a small GTPase and the CPC" . SPARSER::COLLECTION)
    ("Cdk1–cyclin" . SPARSER::COLLECTION) ("TD-60/RalA" . SPARSER::COLLECTION)
    ("Knl1" . SPARSER::PROTEIN) ("Ndc80/Hec1" . SPARSER::COLLECTION)
    ("at least six other GEFs" . SPARSER::GEF)
    ("Rac, RhoA and Cdc42" . SPARSER::COLLECTION)
    ("RalA and RalB" . SPARSER::COLLECTION) ("RalB" . SPARSER::PROTEIN)
    ("calmodulin" . SPARSER::PROTEIN) ("exocyst" . SPARSER::BIO-COMPLEX)
    ("significantly less active" . SPARSER::ACTIVE)
    ("monastrol" . SPARSER::DRUG) ("Hec1/Ndc80" . SPARSER::COLLECTION)
    ("centromere-associated CPC" . SPARSER::PROTEIN)
    ("TD-60 or RalA-specific siRNAs" . SPARSER::COLLECTION)
    ("Survivin and INCENP" . SPARSER::COLLECTION)
    ("chromokinesin" . SPARSER::PROTEIN)
    ("CPC and TD-60" . SPARSER::COLLECTION) ("GEFs" . SPARSER::PROTEIN)
    ("SBP-TD-60" . SPARSER::COLLECTION) ("protein (SBP)" . SPARSER::PROTEIN)
    ("Arf6 and cortactin" . SPARSER::COLLECTION)
    ("cortactin" . SPARSER::PROTEIN) ("Rac1 and Arf6" . SPARSER::COLLECTION)
    ("TD-60 and Arf6" . SPARSER::COLLECTION)
    ("α5β1-fibronectin" . SPARSER::COLLECTION)
    ("TD-60/RCC2" . SPARSER::COLLECTION)
    ("exchange factor (GEF)" . SPARSER::EXCHANGE-FACTOR)
    ("Survivin and Borealin/Dasra" . SPARSER::COLLECTION)
    ("Borealin" . SPARSER::PROTEIN) ("INCENP" . SPARSER::PROTEIN)
    ("complex (CPC)" . SPARSER::BIO-COMPLEX)
    ("TD-60 and RalA" . SPARSER::COLLECTION)
    ("TD-60 or RalA" . SPARSER::COLLECTION) ("RalA" . SPARSER::PROTEIN)
    ("CPC" . SPARSER::PROTEIN) ("Sigma 1" . SPARSER::PROTEIN)
    ("AIM-1" . SPARSER::PROTEIN) ("Drp1" . SPARSER::PROTEIN)
    ("B/Cdk1" . SPARSER::PROTEIN) ("RalBP1" . SPARSER::PROTEIN)
    ("Ndc80" . SPARSER::PROTEIN) ("Hec1" . SPARSER::PROTEIN)
    ("CENP-C" . SPARSER::PROTEIN) ("S10" . SPARSER::PROTEIN)
    ("KIF4A" . SPARSER::PROTEIN) ("Ran-binding" . SPARSER::PROTEIN-FAMILY)
    ("Rho GTPase" . SPARSER::PROTEIN) ("Rab5A" . SPARSER::PROTEIN)
    ("Ras-related protein" . SPARSER::PROTEIN) ("Rab5a" . SPARSER::PROTEIN)
    ("Rabex5" . SPARSER::PROTEIN) ("phospholipase D" . SPARSER::PROTEIN)
    ("Ras-like GTPase" . SPARSER::PROTEIN) ("Arf6" . SPARSER::PROTEIN)
    ("α5β1" . SPARSER::PROTEIN) ("inner centromere protein" . SPARSER::PROTEIN)
    ("RCC1" . SPARSER::PROTEIN) ("exchange factor" . SPARSER::EXCHANGE-FACTOR)
    ("RCC2" . SPARSER::PROTEIN) ("TD-60" . SPARSER::PROTEIN)
    ("medicine and biomarker" . SPARSER::COLLECTION)
    ("Several mTOR and PI3K inhibitors or mTOR/PI3K dual inhibitors"
     . SPARSER::COLLECTION)
    ("mTOR/PI3K dual inhibitors" . SPARSER::INHIBITOR)
    ("mTOR/PI3K" . SPARSER::COLLECTION) ("mTOR and PI3K" . SPARSER::COLLECTION)
    ("BAG3 and Major Vault Protein" . SPARSER::COLLECTION)
    ("WIPI1 and BAG3" . SPARSER::COLLECTION)
    ("LC3 and SQSMT1" . SPARSER::COLLECTION) ("ICI" . SPARSER::DRUG)
    ("ICI 182780 (ICI)" . SPARSER::DRUG)
    ("mTOR, PI3KCIII and MAPK" . SPARSER::COLLECTION)
    ("BAG3, ATG7 and WIPI1" . SPARSER::COLLECTION)
    ("LC3 and SQSTM1" . SPARSER::COLLECTION)
    ("red fluorescent protein (RFP) and green fluorescent protein (GFP)"
     . SPARSER::COLLECTION)
    ("red fluorescent protein (RFP)" . SPARSER::PROTEIN)
    ("GFP-RFP-LC3" . SPARSER::COLLECTION) ("BafA" . SPARSER::PROTEIN)
    ("DRAM1 and SQSTM1" . SPARSER::COLLECTION)
    ("WIPI1 and ATG7" . SPARSER::COLLECTION) ("PtdIns" . SPARSER::PROTEIN)
    ("Wortmannin (WN)" . SPARSER::MOLECULE)
    ("LC3-II as well as NBR1" . SPARSER::COLLECTION)
    ("multiple genes and key autophagy components" . SPARSER::COLLECTION)
    ("ATGs" . SPARSER::DRUG) ("SK-ER β" . SPARSER::COLLECTION)
    ("SK-ER α" . SPARSER::COLLECTION)
    ("receptor and HER2" . SPARSER::COLLECTION)
    ("ER α and ER β" . SPARSER::COLLECTION)
    ("proteins and protein" . SPARSER::COLLECTION)
    ("WIPI1-3" . SPARSER::COLLECTION) ("ATG8/LC3" . SPARSER::COLLECTION)
    ("ATG12-ATG5" . SPARSER::COLLECTION) ("atg" . SPARSER::DRUG)
    ("classical autophagy inhibitors" . SPARSER::INHIBITOR)
    ("classical mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("ER α or ER β" . SPARSER::COLLECTION) ("RPL19" . SPARSER::PROTEIN)
    ("No 2" . SPARSER::MOLECULE) ("Major Vault Protein" . SPARSER::PROTEIN)
    ("HSP70" . SPARSER::PROTEIN) ("heat-shock protein 70" . SPARSER::PROTEIN)
    ("ICI 182780" . SPARSER::DRUG) ("DRAM1" . SPARSER::PROTEIN)
    ("Mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NBR1" . SPARSER::PROTEIN) ("17 β -estradiol" . SPARSER::PROTEIN)
    ("Bcl-2-associated athanogene 3" . SPARSER::PROTEIN)
    ("WIPI1" . SPARSER::PROTEIN) ("WD repeat domain" . SPARSER::PROTEIN)
    ("ATG18" . SPARSER::PROTEIN) ("ATG12" . SPARSER::PROTEIN)
    ("BAG3" . SPARSER::PROTEIN) ("ER β" . SPARSER::PROTEIN)
    ("ER α" . SPARSER::PROTEIN) ("oligomerisation" . SPARSER::PROTEIN-FAMILY)
    ("the prosurvival protein" . SPARSER::PROTEIN)
    ("prosurvival proteins" . SPARSER::PROTEIN)
    ("Bid or Bim" . SPARSER::COLLECTION) ("Bim-" . SPARSER::PROTEIN)
    ("I82A/I83A" . SPARSER::PROTEIN) ("BimBH3 and Bcl-x" . SPARSER::COLLECTION)
    ("a shorter peptide" . SPARSER::PEPTIDE) ("mers" . SPARSER::PROTEIN)
    ("the Bcl-x L ΔC complex at least five amino acids" . SPARSER::AMINO-ACID)
    ("prosurvival molecules" . SPARSER::MOLECULE)
    ("BimBH3:Bcl-x" . SPARSER::BIO-COMPLEX)
    ("Bax and Bcl-x" . SPARSER::COLLECTION)
    ("endogenous prosurvival proteins" . SPARSER::PROTEIN)
    ("mutant BH3 peptides BimBH3 R153A and BidBH3 A91R" . SPARSER::COLLECTION)
    ("BimBH3 or BidBH3" . SPARSER::COLLECTION)
    ("BimBH3 and BidBH3" . SPARSER::COLLECTION)
    ("P144A/E145A" . SPARSER::PROTEIN) ("BimBH3" . SPARSER::PROTEIN)
    ("BimBH3 P144A/E145A" . SPARSER::PROTEIN) ("Alanine" . SPARSER::AMINO-ACID)
    ("Bim and BidBH3" . SPARSER::COLLECTION)
    ("complementing" . SPARSER::PROTEIN)
    ("proline and glutamic acid" . SPARSER::COLLECTION)
    ("governing Bid's" . SPARSER::PROTEIN)
    ("membrane-associated Bax" . SPARSER::PROTEIN)
    ("Bid and Bax" . SPARSER::COLLECTION) ("Complexes" . SPARSER::BIO-COMPLEX)
    ("Bim, Bid, Bak and Bax" . SPARSER::COLLECTION)
    ("proapoptotic Bax and Bak" . SPARSER::COLLECTION)
    ("Bax or Bak" . SPARSER::COLLECTION)
    ("the essential effectors Bax and Bak" . SPARSER::COLLECTION)
    ("Bim and Bid" . SPARSER::COLLECTION) ("MX2" . SPARSER::PROTEIN)
    ("carboxy-fluorescein" . SPARSER::DRUG) ("C62" . SPARSER::PROTEIN)
    ("R–R" . SPARSER::PROTEIN) ("BD2" . SPARSER::PROTEIN)
    ("Bcl-x" . SPARSER::PROTEIN) ("BH3-only protein" . SPARSER::PROTEIN)
    ("AKT1 and AKT3" . SPARSER::COLLECTION)
    ("cyclin D1, Bcl2, and Bax" . SPARSER::COLLECTION)
    ("N-cadherin and E-cadherin" . SPARSER::COLLECTION)
    ("an evolutionarily-conserved serine/threonine kinase" . SPARSER::KINASE)
    ("miR-29b and miR" . SPARSER::COLLECTION)
    ("ZEB1 and ZEB2" . SPARSER::COLLECTION)
    ("cyclin D1 and N-cadherin" . SPARSER::COLLECTION)
    ("EMT- and proliferation-related proteins" . SPARSER::COLLECTION)
    ("EMT-" . SPARSER::PROTEIN)
    ("N-cadherin and cyclin D1" . SPARSER::COLLECTION)
    ("an miR-612-specific antisense oligonucleotide inhibitor"
     . SPARSER::INHIBITOR)
    ("miR-10b and miR-192/215" . SPARSER::COLLECTION)
    ("miRNAs and mRNAs" . SPARSER::COLLECTION) ("ZEB2" . SPARSER::PROTEIN)
    ("the precise trigger" . SPARSER::PROTEIN)
    ("microtubules and LINC" . SPARSER::COLLECTION)
    ("MCPH1 or ATR" . SPARSER::COLLECTION) ("Meiotic" . SPARSER::DRUG)
    ("the grossly normal DDR" . SPARSER::PROTEIN)
    ("Chk2 or Atm" . SPARSER::COLLECTION) ("Atm" . SPARSER::PROTEIN)
    ("Microcephaly" . SPARSER::PROTEIN)
    ("Mcph1 or Cep63" . SPARSER::COLLECTION)
    ("Atr or Mcph1" . SPARSER::COLLECTION) ("Mcph1" . SPARSER::PROTEIN)
    ("CDK5RAP2 and PCNT" . SPARSER::COLLECTION)
    ("anti-NEDD1 or anti-γ-tubulin" . SPARSER::COLLECTION)
    ("pericentrin (PCNT) and centrin" . SPARSER::COLLECTION)
    ("centrin" . SPARSER::PROTEIN)
    ("correct meiotic homologue" . SPARSER::PROTEIN)
    ("LINC" . SPARSER::PROTEIN) ("Linker" . SPARSER::LINKER)
    ("centrosomal CEP63 and CEP152" . SPARSER::COLLECTION)
    ("CEP63 or CEP152" . SPARSER::COLLECTION) ("longer SCs" . SPARSER::PROTEIN)
    ("SCs" . SPARSER::PROTEIN) ("COs" . SPARSER::MOLECULE)
    ("MLH1" . SPARSER::PROTEIN) ("RAD51 and DMC1" . SPARSER::COLLECTION)
    ("the synaptonemal complex" . SPARSER::BIO-COMPLEX)
    ("SCP3 and SCP1" . SPARSER::COLLECTION)
    ("p53, ATM or CHK2" . SPARSER::COLLECTION)
    ("extensive γH2AX" . SPARSER::PROTEIN)
    ("CHK2 or ATM" . SPARSER::COLLECTION)
    ("CHK2 and ATM" . SPARSER::COLLECTION)
    ("γH2AX or p53" . SPARSER::COLLECTION) ("Atr" . SPARSER::PROTEIN)
    ("dim" . SPARSER::PROTEIN-FAMILY)
    ("antibodies and DAPI" . SPARSER::COLLECTION)
    ("centrosomes and DNA" . SPARSER::COLLECTION)
    ("RGPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CEP63/CEP152" . SPARSER::COLLECTION) ("focal CEP152" . SPARSER::PROTEIN)
    ("CEP152 or CEP63" . SPARSER::COLLECTION)
    ("Plk4 and Cep152" . SPARSER::COLLECTION) ("paralogue" . SPARSER::PROTEIN)
    ("Anapc13" . SPARSER::PROTEIN) ("ATM or CHK2" . SPARSER::COLLECTION)
    ("CEP63 and CEP152" . SPARSER::COLLECTION)
    ("the apical DDR kinases ATM and ATR" . SPARSER::COLLECTION)
    ("The centrosomal protein CEP63" . SPARSER::PROTEIN)
    ("NPCs" . SPARSER::MOLECULE) ("PCNT/MCPH1" . SPARSER::COLLECTION)
    ("PCNT" . SPARSER::PROTEIN) ("MCPH1 and CEP152" . SPARSER::COLLECTION)
    ("microcephaly (MCPH)" . SPARSER::PROTEIN)
    ("microcephaly" . SPARSER::PROTEIN)
    ("a centrosomal protein" . SPARSER::PROTEIN) ("M-1" . SPARSER::PROTEIN)
    ("H2O2" . SPARSER::DRUG) ("TBR2" . SPARSER::PROTEIN)
    ("P60" . SPARSER::PROTEIN) ("WT1" . SPARSER::PROTEIN)
    ("TRF1" . SPARSER::PROTEIN) ("SUN1" . SPARSER::PROTEIN)
    ("CDK5RAP2" . SPARSER::PROTEIN) ("NEDD1" . SPARSER::PROTEIN)
    ("H1t" . SPARSER::PROTEIN) ("DMC1" . SPARSER::PROTEIN)
    ("SCP1" . SPARSER::PROTEIN) ("SCP3" . SPARSER::PROTEIN)
    ("p60" . SPARSER::PROTEIN) ("p5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p10" . SPARSER::PROTEIN) ("Tbr2" . SPARSER::PROTEIN)
    ("SAS4" . SPARSER::PROTEIN) ("p-H3" . SPARSER::PROTEIN)
    ("Cep152" . SPARSER::PROTEIN) ("MCPH1" . SPARSER::PROTEIN)
    ("autosomal recessive" . SPARSER::PROTEIN) ("CEP63" . SPARSER::PROTEIN)
    ("discrete foci" . SPARSER::PROTEIN) ("PTEN-Rad51" . SPARSER::COLLECTION)
    ("PTEN or Rad51" . SPARSER::COLLECTION)
    ("neither Rad51 nor Chk1" . SPARSER::COLLECTION)
    ("Rad51 or Chk1" . SPARSER::COLLECTION)
    ("Rad51 and Chk1" . SPARSER::COLLECTION)
    ("clamp" . SPARSER::PROTEIN-FAMILY)
    ("PTEN and Rad51" . SPARSER::COLLECTION)
    ("Rad51 or PCNA" . SPARSER::COLLECTION)
    ("PCNA and Chk1" . SPARSER::COLLECTION)
    ("chromatin-associated Rad51, PCNA and Chk1" . SPARSER::COLLECTION)
    ("Rad51, PCNA and Chk1" . SPARSER::COLLECTION)
    ("Pten -null MEFs" . SPARSER::PROTEIN) ("IdU" . SPARSER::DRUG)
    ("analogs" . SPARSER::ANALOG) ("IOD" . SPARSER::MOLECULE)
    ("APH and hydroxyurea" . SPARSER::COLLECTION)
    ("hydroxyurea" . SPARSER::DRUG) ("APH or HU" . SPARSER::COLLECTION)
    ("FANC" . SPARSER::PROTEIN-FAMILY) ("APH" . SPARSER::PROTEIN)
    ("Aphidicolin" . SPARSER::PROTEIN) ("DAPI and CENPA" . SPARSER::COLLECTION)
    ("CENPA" . SPARSER::PROTEIN) ("mitotic proteins" . SPARSER::PROTEIN)
    ("the latter facilitating chromatin" . SPARSER::BIO-COMPLEX)
    ("Rad51 or PTEN" . SPARSER::COLLECTION) ("CENP-A" . SPARSER::PROTEIN)
    ("Histone deacetylase" . SPARSER::PROTEIN) ("FANCD2" . SPARSER::PROTEIN)
    ("Rad51" . SPARSER::PROTEIN) ("predominantly wt K-Ras" . SPARSER::PROTEIN)
    ("RASSF1A , APC and ATM" . SPARSER::COLLECTION)
    ("other classic tumour-suppressor genes" . SPARSER::GENE)
    ("the polymorphic variant" . SPARSER::VARIANT) ("GCA" . SPARSER::PROTEIN)
    ("gemcitabine or paclitaxel" . SPARSER::COLLECTION)
    ("much larger patient cohorts" . SPARSER::MOLECULE)
    ("PR-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ER- and progesterone receptor" . SPARSER::COLLECTION)
    ("ER-" . SPARSER::PROTEIN)
    ("clinically relevant biomarkers" . SPARSER::MOLECULE)
    ("an attractive biomarker" . SPARSER::MOLECULE)
    ("Ras/RAF/MEK/ERK" . SPARSER::COLLECTION)
    ("one strong emerging candidate biomarker" . SPARSER::MOLECULE)
    ("surprisingly few such biomarkers" . SPARSER::MOLECULE)
    ("prognostic biomarkers" . SPARSER::MOLECULE)
    ("Adequate biomarkers" . SPARSER::MOLECULE)
    ("MYC CNA (except for PFS), BCL2 CNA and double CNA" . SPARSER::COLLECTION)
    ("discrete MYC" . SPARSER::PROTEIN) ("CISH" . SPARSER::PROTEIN)
    ("MYC (7.5%) or BCL2 (27.1%)" . SPARSER::COLLECTION)
    ("an indispensable component" . SPARSER::COMPONENT)
    ("MYC CNA (MC) and BCL2 CNA (BC)" . SPARSER::COLLECTION)
    ("CNA (BC)" . SPARSER::PROTEIN) ("CNA (MC)" . SPARSER::PROTEIN)
    ("vs" . SPARSER::PROTEIN) ("rituximab" . SPARSER::DRUG)
    ("Eastern Cooperative Oncology Group" . SPARSER::MOLECULE)
    ("CNA and BCL2" . SPARSER::COLLECTION)
    ("MYC (Table xref ) and BCL2 (Table xref )" . SPARSER::COLLECTION)
    ("MYC and BCL6" . SPARSER::COLLECTION)
    ("MYC, BCL2, and BCL6" . SPARSER::COLLECTION)
    ("IGH and IGL" . SPARSER::COLLECTION) ("IGL" . SPARSER::PROTEIN)
    ("IG" . SPARSER::MOLECULE) ("MYC and BCL2 or BCL6" . SPARSER::COLLECTION)
    ("BCL2 or BCL6" . SPARSER::COLLECTION) ("THL" . SPARSER::PROTEIN)
    ("IPI" . SPARSER::PROTEIN)
    ("BCL2 CNA and double CNA" . SPARSER::COLLECTION)
    ("MYC CNA, BCL2 CNA and double CNA" . SPARSER::COLLECTION)
    ("MYC and BCL2" . SPARSER::COLLECTION) ("BCL2/BCL6" . SPARSER::COLLECTION)
    ("MYC or BCL2" . SPARSER::COLLECTION)
    ("MYC , BCL2 , and BCL6" . SPARSER::COLLECTION) ("MUM1" . SPARSER::PROTEIN)
    ("heavy chain" . SPARSER::PROTEIN) ("BCL6" . SPARSER::PROTEIN)
    ("β-catenin/TCF" . SPARSER::COLLECTION)
    ("doxorubicin or cisplatin" . SPARSER::COLLECTION)
    ("PRIMA or MIRA-1" . SPARSER::COLLECTION) ("MIRA" . SPARSER::PROTEIN)
    ("PRIMA" . SPARSER::PROTEIN)
    ("calcium and phosphate" . SPARSER::COLLECTION)
    ("prohormone" . SPARSER::MOLECULE) ("cystatin" . SPARSER::PROTEIN)
    ("E-cadherin/CDH1" . SPARSER::COLLECTION)
    ("SNAIL and VDR" . SPARSER::COLLECTION)
    ("p53 and the VDR" . SPARSER::COLLECTION)
    ("calcitriol or both agents (Figure xref )" . SPARSER::COLLECTION)
    ("their isogenic p53-deficient variants" . SPARSER::VARIANT)
    ("SW480/pRTR-p53-VSV" . SPARSER::COLLECTION)
    ("p21 and CST5" . SPARSER::COLLECTION)
    ("the colorectal cancer cell line SW480" . SPARSER::PROTEIN)
    ("pRTR-p53-VSV" . SPARSER::COLLECTION) ("VSV" . SPARSER::PROTEIN)
    ("p53 and VDR" . SPARSER::COLLECTION)
    ("adenine or thymine" . SPARSER::COLLECTION) ("purine" . SPARSER::DRUG)
    ("Cathepsins" . SPARSER::PROTEIN) ("cathepsins" . SPARSER::PROTEIN)
    ("cystein" . SPARSER::MOLECULE)
    ("BIRC5 , CDKN1A , CDH1 or HIF1α" . SPARSER::COLLECTION)
    ("Calcitriol" . SPARSER::MOLECULE)
    ("CYP27A1 and CYP27B1" . SPARSER::COLLECTION) ("SNAIL" . SPARSER::PROTEIN)
    ("calcitriol" . SPARSER::MOLECULE)
    ("nutlin-3a or etoposide" . SPARSER::COLLECTION)
    ("a conditional p53 allele" . SPARSER::ALLELE)
    ("colorectal cancer (CRC) cells CST5" . SPARSER::PROTEIN)
    ("receptor (VDR)" . SPARSER::RECEPTOR) ("cathepsin" . SPARSER::PROTEIN)
    ("chemo-attractant" . SPARSER::PROTEIN) ("Mitomycin C" . SPARSER::DRUG)
    ("Nutlin-3a" . SPARSER::DRUG) ("cystatin family" . SPARSER::PROTEIN)
    ("cystatin D" . SPARSER::PROTEIN) ("vitamin D 3" . SPARSER::MOLECULE)
    ("CYP27B1" . SPARSER::PROTEIN) ("CYP27A1" . SPARSER::PROTEIN)
    ("Vitamin D3" . SPARSER::MOLECULE) ("nutlin-3a" . SPARSER::DRUG)
    ("vitamin D3" . SPARSER::MOLECULE) ("CST5" . SPARSER::PROTEIN)
    ("Cystatin D" . SPARSER::PROTEIN) ("antiestrogen" . SPARSER::DRUG)
    ("mTOR/HIF-1α" . SPARSER::COLLECTION) ("mTOR/P70S6K" . SPARSER::COLLECTION)
    ("mTOR and/or PI3K" . SPARSER::COLLECTION)
    ("molecules or pathways" . SPARSER::COLLECTION)
    ("Akt or mTOR" . SPARSER::COLLECTION)
    ("tamoxifen or trastuzumab" . SPARSER::COLLECTION)
    ("PI3K, Akt, and mTOR" . SPARSER::COLLECTION) ("ErbB2" . SPARSER::PROTEIN)
    ("enzymes and enzymes" . SPARSER::COLLECTION)
    ("p-TSC2" . SPARSER::COLLECTION) ("p-AMPK" . SPARSER::COLLECTION)
    ("Akt and mTOR" . SPARSER::COLLECTION)
    ("siRNA or 3-BrPA-treated" . SPARSER::COLLECTION)
    ("HK-2 or 3-BrPA" . SPARSER::COLLECTION)
    ("either phosphoinositide 3-kinase (PI3K) or mTOR" . SPARSER::COLLECTION)
    ("VHL, Akt, and mTOR" . SPARSER::COLLECTION)
    ("full mitochondrial genome" . SPARSER::PROTEIN)
    ("glutathione (GSH) and oxidized glutathione (GSSG)" . SPARSER::COLLECTION)
    ("-lactate" . SPARSER::LACTATE) ("-glucose" . SPARSER::COLLECTION)
    ("BrPA" . SPARSER::PROTEIN) ("a 3-BrPA" . SPARSER::PROTEIN-PAIR)
    ("citrate or 3-BrPA" . SPARSER::COLLECTION) ("citrate" . SPARSER::PROTEIN)
    ("mTOR and AMPK" . SPARSER::COLLECTION)
    ("4-OHT and ICI 182,780" . SPARSER::COLLECTION)
    ("4-hydroxytamoxifen (the active metabolite of tamoxifen; 4-OHT) and ICI 182,780"
     . SPARSER::COLLECTION)
    ("mTOR, p70S6K and 4E-BP1" . SPARSER::COLLECTION)
    ("glucose transporters and glycolytic enzymes [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("doxorubicin, cytosine arabinoside, taxol, cisplatin, and vincristine"
     . SPARSER::COLLECTION)
    ("taxol" . SPARSER::DRUG) ("17β-estradiol-" . SPARSER::PROTEIN)
    ("Akt/mTOR/HIF-1α" . SPARSER::COLLECTION)
    ("Akt/mTOR" . SPARSER::COLLECTION) ("MCF7—" . SPARSER::PROTEIN)
    ("cytochrome B" . SPARSER::PROTEIN) ("hexokinase 2" . SPARSER::PROTEIN)
    ("HK-2" . SPARSER::PROTEIN) ("P70S6K" . SPARSER::PROTEIN)
    ("MgSO 4" . SPARSER::DRUG) ("tert -butyl" . SPARSER::MOLECULE)
    ("5-aminoimidazole-4-carboxamide" . SPARSER::MOLECULE)
    ("ICI 182,780" . SPARSER::DRUG) ("4-OHT" . SPARSER::DRUG)
    ("4-hydroxytamoxifen" . SPARSER::DRUG) ("HIF-1" . SPARSER::PROTEIN)
    ("cytosine arabinoside" . SPARSER::DRUG)
    ("lactic acid" . SPARSER::MOLECULE) ("hexokinase-2" . SPARSER::PROTEIN)
    ("protein (SRY)" . SPARSER::PROTEIN) ("SRY" . SPARSER::PROTEIN)
    ("a naturally occurring amino acid variant" . SPARSER::VARIANT)
    ("a much bigger cohort" . SPARSER::MOLECULE)
    ("HECTD2 and PIAS1" . SPARSER::COLLECTION)
    ("only one target" . SPARSER::TARGET-PROTEIN)
    ("TNF-α and TNF" . SPARSER::COLLECTION)
    ("receptor or cytokine" . SPARSER::COLLECTION)
    ("HECTD2-PIAS1" . SPARSER::COLLECTION) ("BAL" . SPARSER::PROTEIN)
    ("LPS-induced proinflammatory cytokines" . SPARSER::PROTEIN)
    ("PIAS1 , PIAS4 , or HECTD2" . SPARSER::COLLECTION)
    ("PIAS3, PIAS4, and HECTD2" . SPARSER::COLLECTION)
    ("HECTD2-HECT" . SPARSER::COLLECTION) ("pdb" . SPARSER::MOLECULE)
    ("PIAS1-cytokine" . SPARSER::COLLECTION)
    ("shRNA or HECTD2" . SPARSER::COLLECTION)
    ("protein, IL-1, or IL-6" . SPARSER::COLLECTION)
    ("LPS and PIAS1" . SPARSER::COLLECTION)
    ("shRNA or PIAS1" . SPARSER::COLLECTION) ("CG or CC" . SPARSER::COLLECTION)
    ("CG" . SPARSER::PROTEIN) ("cohort (REF)" . SPARSER::MOLECULE)
    ("REF" . SPARSER::PROTEIN) ("lentiviral gene" . SPARSER::GENE)
    ("CFP-PIAS1" . SPARSER::COLLECTION)
    ("the first 40 amino acids of HECTD2" . SPARSER::PROTEIN)
    ("CTP" . SPARSER::PROTEIN)
    ("40 amino acids of HECTD2 ( xref )" . SPARSER::PROTEIN)
    ("YFP-HECTD2" . SPARSER::COLLECTION) ("–HECTD2" . SPARSER::COLLECTION)
    ("YFP" . SPARSER::PROTEIN) ("LPS and TNF" . SPARSER::COLLECTION)
    ("polyubiquitinate" . SPARSER::PROTEIN)
    ("PIAS1, S13A and S17A" . SPARSER::COLLECTION)
    ("an authentic regulator" . SPARSER::REGULATOR)
    ("the first 20 amino acids of PIAS1 ( xref )" . SPARSER::PROTEIN)
    ("an authentic E3 ligase" . SPARSER::LIGASE) ("TNF-" . SPARSER::PROTEIN)
    ("LPS-" . SPARSER::PROTEIN) ("ubiquitin and HECTD2" . SPARSER::COLLECTION)
    ("MLE" . SPARSER::PROTEIN) ("LPS, TNF, or IFN-γ" . SPARSER::COLLECTION)
    ("E1 and E2" . SPARSER::COLLECTION)
    ("ligases, KIAA0317 and HACE1" . SPARSER::COLLECTION)
    ("prion" . SPARSER::PROTEIN-FAMILY)
    ("E6AP, Smurf, and NEDD4" . SPARSER::COLLECTION)
    ("Smurf" . SPARSER::PROTEIN) ("HECT" . SPARSER::PROTEIN)
    ("proteasomal or lysosomal" . SPARSER::COLLECTION)
    ("serum proinflammatory cytokines" . SPARSER::PROTEIN)
    ("ALI" . SPARSER::PROTEIN) ("SAP" . SPARSER::PROTEIN)
    ("PIAS3 , and PIASy" . SPARSER::COLLECTION) ("genes—" . SPARSER::GENE)
    ("PIASy" . SPARSER::PROTEIN) ("PIASx" . SPARSER::PROTEIN)
    ("multifunctional proteins" . SPARSER::PROTEIN)
    ("PIAS" . SPARSER::PROTEIN-FAMILY) ("HECTD2/PIAS1" . SPARSER::COLLECTION)
    ("GSK3b" . SPARSER::PROTEIN) ("kinase (JAK)" . SPARSER::KINASE)
    ("a multifunctional and potent anti-inflammatory protein"
     . SPARSER::PROTEIN)
    ("Ubc5" . SPARSER::PROTEIN) ("streptavidin-agarose" . SPARSER::DRUG)
    ("1-C" . SPARSER::PROTEIN)
    ("Yellow fluorescent protein" . SPARSER::PROTEIN)
    ("S17" . SPARSER::PROTEIN) ("GSK3β" . SPARSER::PROTEIN)
    ("HACE1" . SPARSER::PROTEIN) ("KIAA0317" . SPARSER::PROTEIN)
    ("NEDD4" . SPARSER::PROTEIN) ("E6AP" . SPARSER::PROTEIN)
    ("PIAS4" . SPARSER::PROTEIN) ("PIAS2" . SPARSER::PROTEIN)
    ("HECTD2" . SPARSER::PROTEIN) ("PIAS1" . SPARSER::PROTEIN)
    ("MET and indozoles" . SPARSER::COLLECTION)
    ("Monoclonal antibodies" . SPARSER::ANTIBODY)
    ("onartuzumab and rilotumumab" . SPARSER::COLLECTION)
    ("rilotumumab" . SPARSER::DRUG) ("ABT" . SPARSER::MOLECULE)
    ("inhibitors (eg, volitinib) and others" . SPARSER::COLLECTION)
    ("crizotinib and cabozantinib" . SPARSER::COLLECTION)
    ("crizotinib" . SPARSER::DRUG) ("volitinib" . SPARSER::DRUG)
    ("MET and other receptors" . SPARSER::COLLECTION)
    ("EGFR, HER2, integrin, and RON" . SPARSER::COLLECTION)
    ("RON" . SPARSER::PROTEIN)
    ("inhibitor and microtubule" . SPARSER::COLLECTION)
    ("tivantinib" . SPARSER::DRUG)
    ("HER-2 and trastuzumab" . SPARSER::COLLECTION)
    ("prednisone" . SPARSER::DRUG) ("that cabozantinib's" . SPARSER::DRUG)
    ("a dual MET/VEGF-R2 inhibitor" . SPARSER::INHIBITOR)
    ("MET/VEGF-R2" . SPARSER::COLLECTION) ("foretinib" . SPARSER::DRUG)
    ("cabozantinib" . SPARSER::DRUG) ("VEGF/MET" . SPARSER::COLLECTION)
    ("Biomarkers" . SPARSER::MOLECULE) ("SUV" . SPARSER::PROTEIN)
    ("FLT" . SPARSER::PROTEIN) ("PRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("alkaline phosphatase (BALP)" . SPARSER::PROTEIN-FAMILY)
    ("placental growth factor" . SPARSER::GROWTH-FACTOR)
    ("soluble MET" . SPARSER::PROTEIN) ("sFlt-1" . SPARSER::COLLECTION)
    ("PlGF" . SPARSER::PROTEIN) ("ST" . SPARSER::PROTEIN)
    ("aminotransferase (ALT)" . SPARSER::PROTEIN)
    ("treatment-related serious AEs" . SPARSER::PROTEIN)
    ("creatinine" . SPARSER::PROTEIN) ("DLTs" . SPARSER::PROTEIN)
    ("DLT" . SPARSER::PROTEIN)
    ("MET and vascular endothelial" . SPARSER::COLLECTION)
    ("MTD" . SPARSER::PROTEIN) ("AMG" . SPARSER::PROTEIN)
    ("SAR125844" . SPARSER::DRUG) ("MSC2156119J" . SPARSER::DRUG)
    ("INC280" . SPARSER::DRUG) ("c-Kit" . SPARSER::PROTEIN)
    ("cDDP and MEK1/2" . SPARSER::COLLECTION)
    ("ATOX1 [ xref , xref , xref , xref ] and ATP7B [ xref , xref , xref ]"
     . SPARSER::COLLECTION)
    ("prot" . SPARSER::PROTEIN) ("cDDP and Cu bind" . SPARSER::COLLECTION)
    ("MEK1-MEK5" . SPARSER::COLLECTION)
    ("CTRL and H-Ras" . SPARSER::COLLECTION) ("ICP" . SPARSER::PROTEIN)
    ("H-Ras and MEK" . SPARSER::COLLECTION)
    ("a representative Western blot" . SPARSER::PROTEIN)
    ("cDDP and the Cu chelating agent tetrathiomolybdate (TTM)"
     . SPARSER::COLLECTION)
    ("tetrathiomolybdate (TTM)" . SPARSER::DRUG) ("TTM" . SPARSER::PROTEIN)
    ("tetrathiomolybdate" . SPARSER::DRUG)
    ("MAPK and PI3K" . SPARSER::COLLECTION) ("subline" . SPARSER::PROTEIN)
    ("cDDP and Cu" . SPARSER::COLLECTION) ("DTT" . SPARSER::MOLECULE)
    ("cDDP and U0126" . SPARSER::COLLECTION)
    ("cDDP, and ATOX1" . SPARSER::COLLECTION) ("thiols" . SPARSER::MOLECULE)
    ("methionines" . SPARSER::AMINO-ACID)
    ("ATOX1, CCS or COX17" . SPARSER::COLLECTION)
    ("ATP7A and ATP7B" . SPARSER::COLLECTION) ("COX" . SPARSER::PROTEIN)
    ("Cu-binding chaperones and efflux transporters" . SPARSER::COLLECTION)
    ("an essential micronutrient" . SPARSER::MOLECULE)
    ("micronutrient" . SPARSER::MOLECULE)
    ("transporters and chaperones" . SPARSER::COLLECTION)
    ("a polar molecule" . SPARSER::MOLECULE) ("cDDP" . SPARSER::DRUG)
    ("ID 3" . SPARSER::PROTEIN) ("Alpha-tubulin" . SPARSER::PROTEIN)
    ("alpha-tubulin" . SPARSER::PROTEIN) ("pMEK1" . SPARSER::PROTEIN)
    ("ERK1" . SPARSER::PROTEIN) ("MEK5" . SPARSER::PROTEIN)
    ("chelating agent" . SPARSER::MOLECULE) ("ATP7B" . SPARSER::PROTEIN)
    ("ATP7A" . SPARSER::PROTEIN) ("ATOX1" . SPARSER::PROTEIN)
    ("CTR1" . SPARSER::PROTEIN)
    ("TGF-β/bone morphogenetic protein" . SPARSER::COLLECTION)
    ("Notch1/NF-κB" . SPARSER::COLLECTION)
    ("a tumor suppressor gene [ xref ] or oncogene [ xref ]"
     . SPARSER::COLLECTION)
    ("Notch1 and TGF-β" . SPARSER::COLLECTION) ("pcDNA" . SPARSER::PROTEIN)
    ("pcDNA-Smad3" . SPARSER::COLLECTION)
    ("MiR-23 directly targets Smad3" . SPARSER::PROTEIN)
    ("group and the migration capacity" . SPARSER::COLLECTION)
    ("Notch1 and TGF-β signaling" . SPARSER::COLLECTION)
    ("Smad2" . SPARSER::PROTEIN) ("miR-29b" . SPARSER::MOLECULE)
    ("bone morphogenetic protein" . SPARSER::PROTEIN)
    ("miR-29" . SPARSER::PROTEIN) ("Notch1" . SPARSER::PROTEIN)
    ("PR-ERα" . SPARSER::COLLECTION)
    ("estrogens and progestogens" . SPARSER::COLLECTION)
    ("PgR and this subset" . SPARSER::COLLECTION) ("PAM" . SPARSER::PROTEIN)
    ("the METABRIC cohort" . SPARSER::MOLECULE) ("CNA" . SPARSER::PROTEIN)
    ("Example" . SPARSER::EXAMPLE)
    ("estrogen or estrogen" . SPARSER::COLLECTION)
    ("estrogen and estrogen" . SPARSER::COLLECTION)
    ("estrogen and progesterone" . SPARSER::COLLECTION)
    ("dual hormone" . SPARSER::MOLECULE)
    ("complex and DNA" . SPARSER::COLLECTION)
    ("ERα/PR/p300" . SPARSER::COLLECTION) ("PREs" . SPARSER::PROTEIN)
    ("ERα, PR and p300" . SPARSER::COLLECTION)
    ("complete (estrogenic) media" . SPARSER::PROTEIN)
    ("ERα/PR" . SPARSER::COLLECTION)
    ("PR and the ERα complex" . SPARSER::COLLECTION)
    ("ERα-PR" . SPARSER::COLLECTION)
    ("ERα and known ERα-associated co-factors" . SPARSER::COLLECTION)
    ("PR and chaperone/co-chaperone" . SPARSER::COLLECTION)
    ("HSP90 and FKBP4/5" . SPARSER::COLLECTION)
    ("PR and known ERα-associated co-factors" . SPARSER::COLLECTION)
    ("known ERα-associated co-factors" . SPARSER::MOLECULE)
    ("NRIP1, GATA3 and TLE3" . SPARSER::COLLECTION)
    ("PR and ERα" . SPARSER::COLLECTION) ("Ligand" . SPARSER::LIGAND)
    ("a nonfunctional ERα complex" . SPARSER::BIO-COMPLEX)
    ("ERα and PR" . SPARSER::COLLECTION)
    ("PR−" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an active ERα complex" . SPARSER::BIO-COMPLEX)
    ("tamoxifen or aromatase" . SPARSER::COLLECTION)
    ("aromatase" . SPARSER::PROTEIN) ("ERα, PR and HER2" . SPARSER::COLLECTION)
    ("progestogens" . SPARSER::MOLECULE)
    ("medroxyprogesterone" . SPARSER::DRUG) ("progestins" . SPARSER::DRUG)
    ("progestogen" . SPARSER::MOLECULE) ("PgR" . SPARSER::PROTEIN)
    ("Progesterone" . SPARSER::PROTEIN)
    ("an ERα-associated protein" . SPARSER::PROTEIN)
    ("PR – 1" . SPARSER::PROTEIN) ("MIB1" . SPARSER::PROTEIN)
    ("μgs" . SPARSER::PROTEIN) ("L-Arginine" . SPARSER::MOLECULE)
    ("FoxA1" . SPARSER::PROTEIN) ("FKBP4" . SPARSER::PROTEIN)
    ("TLE3" . SPARSER::PROTEIN) ("NRIP1" . SPARSER::PROTEIN)
    ("co-factors" . SPARSER::MOLECULE)
    ("Progesterone receptor" . SPARSER::PROTEIN)
    ("relatively higher activin/nodal" . SPARSER::COLLECTION)
    ("a junctional mechanosensory complex" . SPARSER::BIO-COMPLEX)
    ("VE-cadherin, CD31 and KDR" . SPARSER::COLLECTION)
    ("KDR and CD34" . SPARSER::COLLECTION)
    ("NFATC1 and HAND1" . SPARSER::COLLECTION)
    ("/VE-cadherin" . SPARSER::COLLECTION)
    ("high-purity definitive mesodermal derivatives" . SPARSER::DERIVATIVE)
    ("ion channel and calcium-handling proteins (GJA1, GJA5, KCNN4, CASQ2)"
     . SPARSER::COLLECTION)
    ("the cardiac maturation factor HOPX" . SPARSER::PROTEIN)
    ("MYL2 and MYH7" . SPARSER::COLLECTION) ("HOPX" . SPARSER::PROTEIN)
    ("Some cardiac genes" . SPARSER::GENE)
    ("NKX2.5 and cTnT" . SPARSER::COLLECTION)
    ("SCL and VE-cadherin" . SPARSER::COLLECTION)
    ("tankyrase" . SPARSER::PROTEIN)
    ("GATA4 ( xref E) and MYL7 ()" . SPARSER::COLLECTION)
    ("cardiac-related genes" . SPARSER::GENE)
    ("hemogenic endothelial differentiation" . SPARSER::PROTEIN)
    ("the primarily primitive erythroid type" . TYPE)
    ("/CD235a" . SPARSER::COLLECTION) ("larger erythroid" . SPARSER::PROTEIN)
    ("erythroid and myeloid" . SPARSER::COLLECTION) ("GM" . SPARSER::PROTEIN)
    ("CD235a and/or CD41 ( xref G-I)" . SPARSER::COLLECTION)
    ("hematopoietic cytokines" . SPARSER::PROTEIN)
    ("CD45 (PTPRC)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTPRC" . SPARSER::PROTEIN)
    ("the earliest hematopoietic markers CD43 (SPN) and CD235a (GYPA)"
     . SPARSER::COLLECTION)
    ("CD43 (SPN)" . SPARSER::PROTEIN) ("GYPA" . SPARSER::PROTEIN)
    ("SPN" . SPARSER::PROTEIN) ("methylcellulose" . SPARSER::DRUG)
    ("/CD73" . SPARSER::COLLECTION) ("CD31 and VWF" . SPARSER::COLLECTION)
    ("CD31 and the endothelial marker von Willebrand factor (VWF)"
     . SPARSER::COLLECTION)
    ("von Willebrand factor (VWF)" . SPARSER::PROTEIN)
    ("VWF" . SPARSER::PROTEIN)
    ("bFGF (FGF2) and the GSK3 inhibitor CHIR-99021" . SPARSER::COLLECTION)
    ("VEGF, bFGF (FGF2) and the GSK3 inhibitor CHIR-99021"
     . SPARSER::COLLECTION)
    ("bFGF" . SPARSER::PROTEIN)
    ("SOX17, EFNB2 and CXCR4" . SPARSER::COLLECTION)
    ("anterior-derived mesodermal derivatives" . SPARSER::DERIVATIVE)
    ("the cardiogenic factor GATA4" . SPARSER::PROTEIN)
    ("NFATC1 and GATA4" . SPARSER::COLLECTION)
    ("TMEM88, WNT5A and DKK1" . SPARSER::COLLECTION)
    ("hemato-endothelial development SCL" . SPARSER::PROTEIN)
    ("CD144, or CDH5" . SPARSER::COLLECTION)
    ("CD34, RUNX1 and GATA1" . SPARSER::COLLECTION) ("SCL" . SPARSER::PROTEIN)
    ("CHIR-99021 and FGF" . SPARSER::COLLECTION)
    ("CDX1 and WNT8A" . SPARSER::COLLECTION)
    ("a more repressive state" . SPARSER::BIO-STATE)
    ("TMEM88 and WNT5A" . SPARSER::COLLECTION)
    ("/PDGFRα" . SPARSER::COLLECTION) ("CPCs" . SPARSER::PROTEIN)
    ("cTnT" . SPARSER::PROTEIN)
    ("downstream mesodermal derivatives" . SPARSER::DERIVATIVE)
    ("eomesodermin (EOMES)" . SPARSER::PROTEIN) ("EOMES" . SPARSER::PROTEIN)
    ("eomesodermin" . SPARSER::PROTEIN)
    ("the mesodermal subtypes" . SPARSER::PROTEIN) ("Hox" . SPARSER::PROTEIN)
    ("NODAL" . SPARSER::PROTEIN) ("bicoid" . SPARSER::PROTEIN-FAMILY)
    ("the pan-mesoderm markers KDR ( VEGFR2 ) and MESP1" . SPARSER::COLLECTION)
    ("KDR" . SPARSER::PROTEIN) ("WNT3A and WNT8A" . SPARSER::COLLECTION)
    ("Wnt modulatory proteins" . SPARSER::PROTEIN) ("dsRed" . SPARSER::PROTEIN)
    ("all mesodermal subtypes" . SPARSER::PROTEIN)
    ("BMP4 and Wnt/β-catenin" . SPARSER::COLLECTION)
    ("unique functional derivatives" . SPARSER::DERIVATIVE)
    ("mesodermal derivatives" . SPARSER::DERIVATIVE)
    ("nodal and BMP" . SPARSER::COLLECTION) ("nodal/BMP" . SPARSER::COLLECTION)
    ("morphogen" . SPARSER::PROTEIN) ("activin/BMP" . SPARSER::COLLECTION)
    ("BMPs and Wnt/β-catenin" . SPARSER::COLLECTION)
    ("activin/nodal" . SPARSER::COLLECTION) ("BMPs" . SPARSER::PROTEIN)
    ("activin" . SPARSER::PROTEIN) ("morphogens" . SPARSER::PROTEIN)
    ("Endothelial differentiation" . SPARSER::PROTEIN)
    ("ELF1" . SPARSER::PROTEIN) ("TBX5" . SPARSER::PROTEIN)
    ("KCNN4" . SPARSER::PROTEIN) ("GJA5" . SPARSER::PROTEIN)
    ("GJA1" . SPARSER::PROTEIN) ("MYH7" . SPARSER::PROTEIN)
    ("MYL2" . SPARSER::PROTEIN) ("MEF2C" . SPARSER::PROTEIN)
    ("HAND2" . SPARSER::PROTEIN) ("TNNI1" . SPARSER::PROTEIN)
    ("ATP2A2" . SPARSER::PROTEIN) ("CACNA1C" . SPARSER::PROTEIN)
    ("α-actinin" . SPARSER::PROTEIN) ("NKX2.5" . SPARSER::PROTEIN)
    ("MYL7" . SPARSER::PROTEIN) ("G-J" . SPARSER::PROTEIN)
    ("G-I" . SPARSER::PROTEIN) ("D-F" . SPARSER::PROTEIN)
    ("ITGA2B" . SPARSER::PROTEIN) ("CD41" . SPARSER::PROTEIN)
    ("NT5E" . SPARSER::PROTEIN) ("CD73" . SPARSER::PROTEIN)
    ("von Willebrand factor" . SPARSER::PROTEIN) ("PECAM1" . SPARSER::PROTEIN)
    ("EFNB2" . SPARSER::PROTEIN) ("SOX17" . SPARSER::PROTEIN)
    ("HAND1" . SPARSER::PROTEIN) ("Nfatc1" . SPARSER::PROTEIN)
    ("GATA4" . SPARSER::PROTEIN) ("NFATC1" . SPARSER::PROTEIN)
    ("GATA1" . SPARSER::PROTEIN) ("RUNX1" . SPARSER::PROTEIN)
    ("CDH5" . SPARSER::PROTEIN) ("CD144" . SPARSER::PROTEIN)
    ("TAL1" . SPARSER::PROTEIN)
    ("endothelial differentiation" . SPARSER::PROTEIN)
    ("CHIR-99021" . SPARSER::MOLECULE) ("WNT5A" . SPARSER::PROTEIN)
    ("TMEM88" . SPARSER::PROTEIN) ("PDGFRα" . SPARSER::PROTEIN)
    ("A-D" . SPARSER::PROTEIN) ("TNNT2" . SPARSER::PROTEIN)
    ("MIXL1" . SPARSER::PROTEIN) ("CDX1" . SPARSER::PROTEIN)
    ("MESP1" . SPARSER::PROTEIN) ("DKK1" . SPARSER::PROTEIN)
    ("WNT8A" . SPARSER::PROTEIN) ("WNT3A" . SPARSER::PROTEIN)
    ("A-C" . SPARSER::PROTEIN) ("BMP4" . SPARSER::PROTEIN)
    ("kinases and p38" . SPARSER::COLLECTION)
    ("serine, threonine and tyrosine" . SPARSER::COLLECTION)
    ("MAPK1-3" . SPARSER::COLLECTION)
    ("the chemotherapeutic 5-FU" . SPARSER::PROTEIN)
    ("the most commonly used chemotherapeutic drug" . SPARSER::DRUG)
    ("resistance-associated genes" . SPARSER::GENE)
    ("miR-21 and miR-200b" . SPARSER::COLLECTION)
    ("miR-15b or miR-16" . SPARSER::COLLECTION)
    ("vincristine, doxorubicin, etoposide and cisplatin" . SPARSER::COLLECTION)
    ("vincristine" . SPARSER::DRUG)
    ("miR-15b and miR-16" . SPARSER::COLLECTION) ("VCR" . SPARSER::DRUG)
    ("P-glycoprotein (P-gp) and MDR1 mRNA" . SPARSER::COLLECTION)
    ("essential protein" . SPARSER::PROTEIN)
    ("complex (RISC)" . SPARSER::BIO-COMPLEX)
    ("Mature miRNA" . SPARSER::PROTEIN) ("mature miRNAs" . SPARSER::PROTEIN)
    ("b" . SPARSER::PROTEIN)
    ("Extracellular signal-regulated kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("miR-16" . SPARSER::PROTEIN) ("miR-15b" . SPARSER::MOLECULE)
    ("MDR1" . SPARSER::PROTEIN) ("P-gp" . SPARSER::PROTEIN)
    ("P-glycoprotein" . SPARSER::PROTEIN) ("RNase III" . SPARSER::PROTEIN)
    ("exportin 5" . SPARSER::PROTEIN) ("Pre-miRNA" . SPARSER::RNA)
    ("pre-miRNA" . SPARSER::RNA) ("Drosha ribonuclease III" . SPARSER::PROTEIN)
    ("pri-miRNA" . SPARSER::RNA)
    ("Bim, caspase-3 and PP2A" . SPARSER::COLLECTION)
    ("p-FOXO3a" . SPARSER::COLLECTION)
    ("Bim-caspase-Akt" . SPARSER::COLLECTION)
    ("caspase-3-PP2A-Akt" . SPARSER::COLLECTION)
    ("caspase-3 and PP2A" . SPARSER::COLLECTION)
    ("PP2A-Akt" . SPARSER::COLLECTION) ("z-DEVD-fmk" . SPARSER::COLLECTION)
    ("fmk" . SPARSER::PROTEIN) ("ZVAD-CHO" . SPARSER::COLLECTION)
    ("Bcl-2 and Bcl-XL" . SPARSER::COLLECTION)
    ("Bax, PUMA and NOXA" . SPARSER::COLLECTION)
    ("cisplatin and apoptosis" . SPARSER::COLLECTION)
    ("Akt/FOXO3a/Bim" . SPARSER::COLLECTION)
    ("X protein (Bax) and Bcl-2 homologous antagonist/killer (Bak)"
     . SPARSER::COLLECTION)
    ("pro-apoptotic proteins Bcl-2" . SPARSER::PROTEIN)
    ("an active natural bioflavonoid" . SPARSER::DRUG)
    ("bioflavonoid" . SPARSER::DRUG) ("Chrysin" . SPARSER::DRUG)
    ("Akt/FOXO3a" . SPARSER::COLLECTION) ("DDP" . SPARSER::PROTEIN)
    ("chrysin" . SPARSER::DRUG) ("FOXO3A" . SPARSER::PROTEIN)
    ("Asp-Glu" . SPARSER::MOLECULE) ("Bcl-XL" . SPARSER::PROTEIN)
    ("Bcl-2 homologous antagonist/killer" . SPARSER::PROTEIN)
    ("forkhead box O3" . SPARSER::PROTEIN) ("all intracranial types" . TYPE)
    ("phosphatidylinositol-3-kinase/protein kinase B" . SPARSER::COLLECTION)
    ("-2 and MMP-9" . SPARSER::COLLECTION) ("girdin" . SPARSER::PROTEIN)
    ("Girdin" . SPARSER::PROTEIN) ("p85" . SPARSER::PROTEIN)
    ("P110α" . SPARSER::PROTEIN) ("CDK4 and CDK6" . SPARSER::COLLECTION)
    ("the INK4 family and the entire CIP/KIP family" . SPARSER::COLLECTION)
    ("Cumulative BrdU" . SPARSER::DRUG) ("pRb and Rb" . SPARSER::COLLECTION)
    ("fragmented DNA and underwent apoptosis after transduction ( xref )"
     . SPARSER::COLLECTION)
    ("CCN–CDK" . SPARSER::COLLECTION) ("phenotypic HSPCs" . SPARSER::PROTEIN)
    ("GM-CSF or IL-3" . SPARSER::COLLECTION)
    ("CDK4 or CCND1" . SPARSER::COLLECTION)
    ("CDK4 or CDK6" . SPARSER::COLLECTION) ("CCND1-" . SPARSER::PROTEIN)
    ("CDK4-" . SPARSER::PROTEIN)
    ("donor-derived GFP + CD34 + HSPCs" . SPARSER::PROTEIN)
    ("mature lymphoid" . SPARSER::PROTEIN)
    ("leukocytes and CD34 +" . SPARSER::COLLECTION)
    ("transduced cells carried phosphorylated retinoblastoma protein"
     . SPARSER::PROTEIN)
    ("CCND1 and CDK4" . SPARSER::COLLECTION) ("CB" . SPARSER::PROTEIN)
    ("negative cell cycle regulators of the INK4 and CIP/KIP families and range"
     . SPARSER::COLLECTION)
    ("the INK4 and CIP/KIP families" . SPARSER::COLLECTION)
    ("functional HSCs" . SPARSER::PROTEIN)
    ("CCND1,2,3/CDK4,6 and CCNE1" . SPARSER::COLLECTION)
    ("/CDK2" . SPARSER::COLLECTION)
    ("/cyclin-dependent kinase (CDK)" . SPARSER::COLLECTION)
    ("/cyclin-dependent kinase" . SPARSER::COLLECTION)
    ("CKIs" . SPARSER::PROTEIN) ("CCN" . SPARSER::PROTEIN-FAMILY)
    ("functional HSPCs" . SPARSER::PROTEIN) ("HSPC" . SPARSER::PROTEIN)
    ("HSPCs" . SPARSER::PROTEIN) ("CCNE1–CDK2" . SPARSER::COLLECTION)
    ("CCND1–CDK4" . SPARSER::COLLECTION) ("HSCs" . SPARSER::PROTEIN)
    ("TX-100" . SPARSER::DRUG) ("hIL-3" . SPARSER::PROTEIN)
    ("4 – 1" . SPARSER::PROTEIN) ("NK1.1" . SPARSER::PROTEIN)
    ("Gr-1" . SPARSER::PROTEIN) ("C11" . SPARSER::PROTEIN)
    ("CD235a" . SPARSER::PROTEIN) ("CD45RA" . SPARSER::PROTEIN)
    ("CD38" . SPARSER::PROTEIN) ("CD33" . SPARSER::PROTEIN)
    ("CD15" . SPARSER::DRUG) ("CD10" . SPARSER::PROTEIN)
    ("HI30" . SPARSER::PROTEIN) ("CD16" . SPARSER::PROTEIN)
    ("stem cell factor" . SPARSER::PROTEIN) ("Gag-Pol" . SPARSER::PROTEIN)
    ("p130" . SPARSER::PROTEIN) ("p107" . SPARSER::PROTEIN)
    ("IL-3" . SPARSER::PROTEIN) ("S–G2" . SPARSER::PROTEIN)
    ("INK4" . SPARSER::PROTEIN) ("CCNE1" . SPARSER::PROTEIN)
    ("a distal appendage protein" . SPARSER::PROTEIN)
    ("the proximal centriole marker CNAP1" . SPARSER::PROTEIN)
    ("EGFP-Centrin–expressing Plk4 AID/AID" . SPARSER::COLLECTION)
    ("EGFP-Centrin" . SPARSER::COLLECTION)
    ("Plk4, CPAP, CEP135, CEP152, CEP164, and CEP192" . SPARSER::COLLECTION)
    ("asters" . SPARSER::BIO-COMPLEX) ("Pericentrin" . SPARSER::PROTEIN)
    ("chronically treated Plk4 AID/AID" . SPARSER::COLLECTION)
    ("EM" . SPARSER::PROTEIN)
    ("CPAP, SAS6, STIL, CEP135, CEP152, and CEP192" . SPARSER::COLLECTION)
    ("EGFP-Cep63" . SPARSER::COLLECTION)
    ("EGFP-Histone H2B" . SPARSER::COLLECTION)
    ("TagRFP-tubulin" . SPARSER::COLLECTION)
    ("CPAP, CEP135, CEP152, CEP192, SAS6, CNAP1, CEP164, Centrin, γ-tubulin, and STIL"
     . SPARSER::COLLECTION)
    ("Centrin" . SPARSER::PROTEIN) ("CPAP" . SPARSER::PROTEIN)
    ("the monoclonal FLAG antibody" . SPARSER::ANTIBODY)
    ("IAA" . SPARSER::MOLECULE)
    ("indole - 3 - acetic acid (IAA)" . SPARSER::MOLECULE)
    ("exogenous auxin" . SPARSER::MOLECULE) ("AID-FLAG" . SPARSER::COLLECTION)
    ("AID/AID" . SPARSER::COLLECTION) ("AID-HA" . SPARSER::COLLECTION)
    ("AID" . SPARSER::PROTEIN)
    ("essential centriole components" . SPARSER::COMPONENT)
    ("PCM" . SPARSER::PROTEIN) ("Plk4" . SPARSER::PROTEIN)
    ("Plk" . SPARSER::PROTEIN) ("Delta–" . SPARSER::PROTEIN)
    ("Histone H2A.X" . SPARSER::PROTEIN) ("LATS2" . SPARSER::PROTEIN)
    ("3 d" . SPARSER::PROTEIN-FAMILY) ("3 D" . SPARSER::PROTEIN-FAMILY)
    ("Cep63" . SPARSER::PROTEIN)
    ("Histone H2B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CENP-F" . SPARSER::PROTEIN) ("CEP164" . SPARSER::PROTEIN)
    ("CNAP1" . SPARSER::PROTEIN) ("SAS6" . SPARSER::PROTEIN)
    ("CEP192" . SPARSER::PROTEIN) ("CEP152" . SPARSER::PROTEIN)
    ("CEP135" . SPARSER::PROTEIN)
    ("indole - 3 - acetic acid" . SPARSER::MOLECULE)
    ("RPE-1" . SPARSER::PROTEIN) ("TIR1" . SPARSER::PROTEIN)
    ("an attractive new drug target" . SPARSER::TARGET-PROTEIN)
    ("c-Myc and E2F1" . SPARSER::COLLECTION)
    ("SP1 and SP3" . SPARSER::COLLECTION) ("-Myc" . SPARSER::COLLECTION)
    ("Cezanne and HIF2α" . SPARSER::COLLECTION)
    ("E2F1 and Cezanne" . SPARSER::COLLECTION) ("Cdh1" . SPARSER::PROTEIN)
    ("anaphase-promoting complex/cyclosome" . SPARSER::COLLECTION)
    ("Cdh" . SPARSER::PROTEIN) ("cyclosome" . SPARSER::PROTEIN)
    ("PHD3 and BNIP3" . SPARSER::COLLECTION)
    ("HIF1α or HIF1β" . SPARSER::COLLECTION)
    ("SP1 or NF-κB" . SPARSER::COLLECTION)
    ("NF-κB, E2F1 and SP1" . SPARSER::COLLECTION)
    ("PHD and vHL" . SPARSER::COLLECTION) ("PHD-" . SPARSER::PROTEIN)
    ("DFX or DMOG" . SPARSER::COLLECTION) ("DMOG" . SPARSER::DRUG)
    ("DFX" . SPARSER::PROTEIN) ("Glut1, PHD3 and BNIP3" . SPARSER::COLLECTION)
    ("-luciferase" . SPARSER::COLLECTION)
    ("OTUD7B/Cezanne" . SPARSER::COLLECTION) ("PHD–vHL" . SPARSER::COLLECTION)
    ("HIFs" . SPARSER::PROTEIN)
    ("the ovarian tumour protease (OTU) DUB Cezanne" . SPARSER::PROTEIN)
    ("DUB" . SPARSER::PROTEIN) ("OTU" . SPARSER::PROTEIN-FAMILY)
    ("USP20 and USP8" . SPARSER::COLLECTION) ("USP" . SPARSER::PROTEIN)
    ("USPs" . SPARSER::PROTEIN)
    ("attractive therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("DUBs" . SPARSER::PROTEIN) ("elongin" . SPARSER::PROTEIN)
    ("Prolyl" . SPARSER::PROTEIN) ("ODD" . SPARSER::PROTEIN)
    ("PHDs" . SPARSER::PROTEIN) ("prolyl" . SPARSER::PROTEIN)
    ("HIF1α and HIF2α" . SPARSER::COLLECTION)
    ("three O 2 -labile α subunits (HIF1α, HIF2α or HIF3α; encoded by HIF1A , EPAS1 and HIF3A , respectively) and an O 2 -insensitive β subunit (encoded by ARNT )"
     . SPARSER::COLLECTION)
    ("HIF1α, HIF2α or HIF3α" . SPARSER::COLLECTION)
    ("HIF1A , EPAS1 and HIF3A" . SPARSER::COLLECTION)
    ("-labile" . SPARSER::COLLECTION) ("ARNT" . SPARSER::PROTEIN)
    ("Exogenous E2F1" . SPARSER::PROTEIN)
    ("E2F1, and Cezanne" . SPARSER::COLLECTION)
    ("hypoxia and proteasomal" . SPARSER::COLLECTION)
    ("Cezanne" . SPARSER::PROTEIN) ("deubiquitylase" . SPARSER::DEUBIQUITYLASE)
    ("deubiquitylases" . SPARSER::DEUBIQUITYLASE)
    ("Deubiquitylases" . SPARSER::DEUBIQUITYLASE) ("vHL" . SPARSER::PROTEIN)
    ("NaHCO 3" . SPARSER::DRUG) ("N-ethylmaleimide" . SPARSER::MOLECULE)
    ("2F1" . SPARSER::PROTEIN) ("EPAS-1" . SPARSER::PROTEIN)
    ("protein-G" . SPARSER::PROTEIN) ("PA1" . SPARSER::PROTEIN)
    ("a 2 " . SPARSER::HUMAN-PROTEIN-FAMILY) ("per 3" . SPARSER::PROTEIN)
    ("or 2 µ" . SPARSER::MOLECULE) ("MLN9708" . SPARSER::DRUG)
    ("l -Glutamine" . SPARSER::MOLECULE) ("SP3" . SPARSER::PROTEIN)
    ("activator protein" . SPARSER::PROTEIN)
    ("anaphase-promoting complex" . SPARSER::PROTEIN)
    ("NFKB2" . SPARSER::PROTEIN) ("K11" . SPARSER::PROTEIN)
    ("PHD3" . SPARSER::PROTEIN) ("HIF1" . SPARSER::PROTEIN)
    ("USP19" . SPARSER::PROTEIN) ("USP8" . SPARSER::PROTEIN)
    ("USP20" . SPARSER::PROTEIN) ("HIF1β" . SPARSER::PROTEIN)
    ("co-factor" . SPARSER::MOLECULE) ("cullin-2" . SPARSER::PROTEIN)
    ("HIF3A" . SPARSER::PROTEIN) ("HIF1A" . SPARSER::PROTEIN)
    ("HIF3α" . SPARSER::PROTEIN) ("HIF1α" . SPARSER::PROTEIN)
    ("OTUD7B" . SPARSER::PROTEIN) ("EPAS1" . SPARSER::PROTEIN)
    ("HIF2α" . SPARSER::PROTEIN)
    ("Functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERα and p53" . SPARSER::COLLECTION)
    ("p53 and/or MDM2" . SPARSER::COLLECTION)
    ("factor-κB, ERα and c-Jun" . SPARSER::COLLECTION)
    ("several atypical E3 ligases" . SPARSER::LIGASE)
    ("RNF31, RBCK1 and Parkin" . SPARSER::COLLECTION)
    ("Parkin" . SPARSER::PROTEIN)
    ("p53-polyubiquitination" . SPARSER::COLLECTION)
    ("RNF31, p53 and MDM2" . SPARSER::COLLECTION)
    ("p53 and MDM2" . SPARSER::COLLECTION)
    ("available antibodies" . SPARSER::ANTIBODY)
    ("p53, MDM2 and RNF31" . SPARSER::COLLECTION)
    ("the p53/MDM2 complex and increases p53 polyubiquitination in an MDM2-dependent manner"
     . SPARSER::COLLECTION)
    ("p21 , IGFBP3 and BTG2" . SPARSER::COLLECTION)
    ("IGFBP3 and BTG2" . SPARSER::COLLECTION)
    ("iodide and annexin V" . SPARSER::COLLECTION)
    ("RNF31 or both RNF31 and p53" . SPARSER::COLLECTION)
    ("p53 and RNF31" . SPARSER::COLLECTION) ("MDM2/p53" . SPARSER::COLLECTION)
    ("the chemotherapeutic compound cisplatin" . SPARSER::MOLECULE)
    ("CDKN1A , BTG2 and BAX" . SPARSER::COLLECTION)
    ("HOIP and ZIBRA" . SPARSER::COLLECTION) ("RBR" . SPARSER::PROTEIN-FAMILY)
    ("ZIBRA" . SPARSER::PROTEIN) ("HOIP" . SPARSER::PROTEIN)
    ("receptors and HER2" . SPARSER::COLLECTION)
    ("RNF31 and p53" . SPARSER::COLLECTION)
    ("IGFBP3 and BTG1" . SPARSER::COLLECTION)
    ("p53/MDM2" . SPARSER::COLLECTION)
    ("The atypical E3 ubiquitin ligase RNF31" . SPARSER::PROTEIN)
    ("PARK2" . SPARSER::PROTEIN) ("RBCK1" . SPARSER::PROTEIN)
    ("RNF53" . SPARSER::PROTEIN) ("COP1" . SPARSER::PROTEIN)
    ("EP300" . SPARSER::PROTEIN) ("BTG1" . SPARSER::PROTEIN)
    ("RNF31" . SPARSER::PROTEIN)
    ("fluspirilene and 5-fluorouracil" . SPARSER::COLLECTION)
    ("KEGG DRUG [ xref ] and e-Drug 3D [ xref ]" . SPARSER::COLLECTION)
    ("DRUG" . SPARSER::DRUG) ("art" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("enzyme (NAE)" . SPARSER::ENZYME) ("auxin" . SPARSER::MOLECULE)
    ("cyclin-CDK" . SPARSER::COLLECTION)
    ("CDKs and cyclins" . SPARSER::COLLECTION)
    ("cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MBP" . SPARSER::PROTEIN)
    ("firmly holding fluspirilene" . SPARSER::PROTEIN)
    ("holding fluspirilene" . SPARSER::PROTEIN) ("cation-" . SPARSER::MOLECULE)
    ("Fluspirilene" . SPARSER::PROTEIN) ("fluspirilene" . SPARSER::PROTEIN)
    ("CDK2-fluspirilene" . SPARSER::PROTEIN-PAIR)
    ("CDK2, Rb, pho-CDK2, pho-Rb and cyclin E" . SPARSER::COLLECTION)
    ("cyclin D1 and cyclin B1" . SPARSER::COLLECTION)
    ("pho-CDK2" . SPARSER::PROTEIN-PAIR)
    ("Totally 4,914 FDA-approved drugs" . SPARSER::DRUG)
    ("roscovitine [ xref ] and olomoucine [ xref ]" . SPARSER::COLLECTION)
    ("olomoucine" . SPARSER::DRUG) ("roscovitine" . SPARSER::DRUG)
    ("attractive drug" . SPARSER::DRUG) ("HCCs" . SPARSER::PROTEIN)
    ("a potential CDK2 inhibitor and a candidate anti-cancer drug"
     . SPARSER::COLLECTION)
    ("CDK2, cyclin E and Rb" . SPARSER::COLLECTION) ("PAD4" . SPARSER::PROTEIN)
    ("type 4" . SPARSER::PROTEIN) ("arginine deiminase" . SPARSER::PROTEIN)
    ("NEDD8" . SPARSER::PROTEIN) ("ID 1" . SPARSER::PROTEIN)
    ("P24941" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinase 2" . SPARSER::PROTEIN)
    ("a more favorable conformation" . SPARSER::BIO-CONFORMATION)
    ("YB-1 and RNA" . SPARSER::COLLECTION)
    ("the CSD YB-1 and the bacterial CSPs" . SPARSER::COLLECTION)
    ("aromatic molecules" . SPARSER::MOLECULE)
    ("highly flexible molecules" . SPARSER::MOLECULE) ("PBSA" . SPARSER::DRUG)
    ("respective nucleotide" . SPARSER::NUCLEOTIDE) ("NA" . SPARSER::PROTEIN)
    ("oligosaccharide" . SPARSER::MOLECULE)
    ("bacterial CSP" . SPARSER::PROTEIN) ("ssRNA" . SPARSER::RNA)
    ("Both YB-1 (  xref  ) and CSD YB-1 (  xref  ) bind RNA"
     . SPARSER::COLLECTION)
    ("YB-1 or CSD" . SPARSER::COLLECTION)
    ("-AGGAUGGGUGAGUGAGGUAG-3" . SPARSER::COLLECTION)
    ("-AGGATGGGTGAGTGAGGTAG-3" . SPARSER::COLLECTION)
    ("ribonucleotides" . SPARSER::MOLECULE)
    ("Deoxyribonucleotides" . SPARSER::MOLECULE)
    ("oligoribonucleotides" . SPARSER::MOLECULE)
    ("CSD and oligoG" . SPARSER::COLLECTION)
    ("protein and oligo" . SPARSER::COLLECTION)
    ("DNA and RNA" . SPARSER::COLLECTION) ("Bs" . SPARSER::PROTEIN)
    ("YB-1:NA" . SPARSER::PROTEIN-PAIR) ("GGT" . SPARSER::PROTEIN)
    ("the bacterial proteins" . SPARSER::PROTEIN)
    ("bacterial CSPs and the CSD YB-1 (  xref  )" . SPARSER::COLLECTION)
    ("guanines" . SPARSER::NUCLEOBASE) ("adenines" . SPARSER::NUCLEOBASE)
    ("Bs-CSP" . SPARSER::PROTEIN-PAIR)
    ("slightly more preferable ligand" . SPARSER::LIGAND)
    ("CSD and oligo" . SPARSER::COLLECTION) ("N2 and N3" . SPARSER::COLLECTION)
    ("dC" . SPARSER::MOLECULE) ("dT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("dA" . SPARSER::MOLECULE)
    ("the bacterial CSPs and the CSD YB-1" . SPARSER::COLLECTION)
    ("The CSD YB-1 and the CSPs" . SPARSER::COLLECTION)
    ("bacterial CSPs and the CSD YB-1" . SPARSER::COLLECTION)
    ("N1 and N2" . SPARSER::COLLECTION) ("Van" . SPARSER::PROTEIN)
    ("YB-1 and Bs-CspB" . SPARSER::COLLECTION)
    ("RNP-1/RNP-2" . SPARSER::COLLECTION)
    ("The CSD YB-1 and bacterial CSPs" . SPARSER::COLLECTION)
    ("The CSD YB-1 and the bacterial CSPs" . SPARSER::COLLECTION)
    ("nucleic-acid binding proteins" . SPARSER::PROTEIN)
    ("MDS" . SPARSER::PROTEIN) ("the bacterial CSPs" . SPARSER::PROTEIN)
    ("pyrimidine" . SPARSER::DRUG) ("bacterial CSPs" . SPARSER::PROTEIN)
    ("CSPs" . SPARSER::PROTEIN)
    ("many nucleic acids binding proteins" . SPARSER::PROTEIN)
    ("eukaryotic YB-1 proteins and prokaryotic CSD proteins (CSP,  xref  )"
     . SPARSER::COLLECTION)
    ("prokaryotic CSD proteins" . SPARSER::PROTEIN)
    ("eukaryotic YB-1 proteins" . SPARSER::PROTEIN)
    ("RNP-1 and RNP-2" . SPARSER::COLLECTION)
    ("alanine/proline" . SPARSER::COLLECTION)
    ("poly(A) binding protein (PABP)" . SPARSER::PROTEIN)
    ("YB-1 and eIF4F" . SPARSER::COLLECTION) ("PABP" . SPARSER::PROTEIN)
    ("YB-1/mRNA" . SPARSER::COLLECTION) ("nascent mRNA" . SPARSER::PROTEIN)
    ("The eukaryotic Y-box binding protein 1" . SPARSER::PROTEIN)
    ("the related bacterial Cold Shock Proteins (CSP)" . SPARSER::PROTEIN)
    ("Proteins (CSP)" . SPARSER::PROTEIN) ("CSP" . SPARSER::PROTEIN)
    ("RNA and DNA" . SPARSER::COLLECTION) ("CSD" . SPARSER::PROTEIN)
    ("U3" . SPARSER::PROTEIN) ("U9" . SPARSER::PROTEIN)
    ("U4" . SPARSER::PROTEIN) ("O6" . SPARSER::PROTEIN)
    ("dT4" . SPARSER::MOLECULE) ("oxygen atom" . SPARSER::MOLECULE)
    ("N5" . SPARSER::PROTEIN) ("TIP3" . SPARSER::PROTEIN)
    ("PF4" . SPARSER::PROTEIN) ("site 2" . SPARSER::PROTEIN)
    ("N3" . SPARSER::PROTEIN) ("RNP-2" . SPARSER::PROTEIN)
    ("RNP-1" . SPARSER::PROTEIN) ("poly(A) binding protein" . SPARSER::PROTEIN)
    ("Y-box binding protein 1" . SPARSER::PROTEIN) ("YB1" . SPARSER::PROTEIN)
    ("YB-1" . SPARSER::PROTEIN) ("key IFN-γ" . SPARSER::PROTEIN)
    ("mTORC1 and mRNA" . SPARSER::COLLECTION)
    ("IFN-γ and type I" . SPARSER::COLLECTION)
    ("transformed cells IFN-γ" . SPARSER::PROTEIN)
    ("Akt-mTORC1" . SPARSER::COLLECTION) ("canonical IFN-γ" . SPARSER::PROTEIN)
    ("miRNA and ribosome" . SPARSER::COLLECTION)
    ("miR-146a, miR-9 and miR-132" . SPARSER::COLLECTION)
    ("IL-6 and TNF" . SPARSER::COLLECTION)
    ("Transporters of amino acids and other metabolites" . SPARSER::COLLECTION)
    ("Transporters" . SPARSER::PROTEIN)
    ("inflammatory cytokines and chemokines" . SPARSER::COLLECTION)
    ("IL-6, TNF, LTA, LTB, CXCL2 and CXCL3" . SPARSER::COLLECTION)
    ("LTB" . SPARSER::PROTEIN) ("LTA" . SPARSER::PROTEIN)
    ("leucyl-tRNA-synthetase (LARS)" . SPARSER::COLLECTION)
    ("leucyl-tRNA-synthetase" . SPARSER::COLLECTION)
    ("LARS" . SPARSER::PROTEIN) ("eIF4" . SPARSER::PROTEIN)
    ("tRNA" . SPARSER::PROTEIN) ("IPA" . SPARSER::MOLECULE)
    ("mRNA and RPF" . SPARSER::COLLECTION)
    ("PABPC3 and PABPC4" . SPARSER::COLLECTION)
    ("PABPC3, PABPC4 and EEF2" . SPARSER::COLLECTION)
    ("RPF and RNA" . SPARSER::COLLECTION) ("cpm" . SPARSER::PROTEIN)
    ("RPF" . SPARSER::PROTEIN) ("Ribosome" . SPARSER::BIO-COMPLEX)
    ("4EBP-eIF4E" . SPARSER::COLLECTION)
    ("Myc and M-CSFR" . SPARSER::COLLECTION)
    ("an okadaic acid-sensitive phosphatase" . SPARSER::PHOSPHATASE)
    ("SHIP or PTEN" . SPARSER::COLLECTION) ("SHIP" . SPARSER::PROTEIN)
    ("Akt-GSK3" . SPARSER::COLLECTION) ("PI3K-Akt-TSC" . SPARSER::COLLECTION)
    ("TSC" . SPARSER::PROTEIN) ("exogenous tryptophan" . SPARSER::AMINO-ACID)
    ("intracellular tryptophan" . SPARSER::AMINO-ACID)
    ("indoleamine 2,3-dioxygenase (IDO)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a strong inducer" . SPARSER::PROTEIN) ("IDO" . SPARSER::PROTEIN)
    ("Rheb" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mTOR and LAMP1" . SPARSER::COLLECTION)
    ("LC3A and LC3B" . SPARSER::COLLECTION)
    ("proteins and organelles" . SPARSER::COLLECTION)
    ("Torin1 and PP242" . SPARSER::COLLECTION)
    ("4E-BP and p70S6K" . SPARSER::COLLECTION)
    ("dual specificity phosphatases" . SPARSER::PHOSPHATASE)
    ("DUSPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p38 and ERK" . SPARSER::COLLECTION)
    ("the signaling inhibitor I-κBα and the transcription factor IRF8"
     . SPARSER::COLLECTION)
    ("MNK1 and eIF4E" . SPARSER::COLLECTION) ("p-MNK1" . SPARSER::COLLECTION)
    ("p-eIF4E" . SPARSER::COLLECTION)
    ("mitogen activated protein kinase (MAPK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("distinct mRNAs" . SPARSER::PROTEIN)
    ("PABPC1 and HES1" . SPARSER::COLLECTION) ("ACTB" . SPARSER::PROTEIN)
    ("polysome and monosome" . SPARSER::COLLECTION)
    ("Polysome" . SPARSER::BIO-COMPLEX)
    ("polysome or monosome" . SPARSER::COLLECTION)
    ("monomeric 80S ribosomes" . SPARSER::BIO-COMPLEX)
    ("heavy polysome fractions 9-12 and a minimal suppressive effect on light polysome fractions 6-8"
     . SPARSER::COLLECTION)
    ("the proteasome inhibitor MG132 nor autophagosome-lysosome fusion inhibitor Bafilomycin A1"
     . SPARSER::COLLECTION)
    ("IFN-γ-treated macrophages" . SPARSER::PROTEIN) ("CSK" . SPARSER::PROTEIN)
    ("Pam" . SPARSER::PROTEIN) ("IL-6 and IL-12" . SPARSER::COLLECTION)
    ("monocytes and macrophages" . SPARSER::COLLECTION)
    ("BPs" . SPARSER::PROTEIN)
    ("protein, lipid and nucleotide" . SPARSER::COLLECTION)
    ("amino acid and energy" . SPARSER::COLLECTION)
    ("distinct mTORC1 and mTORC2" . SPARSER::COLLECTION)
    ("kinases and mechanistic target of rapamycin" . SPARSER::COLLECTION)
    ("cytokine, chemokine and transcription factor" . SPARSER::COLLECTION)
    ("I-κBα and IRF7" . SPARSER::COLLECTION)
    ("HES1 and HEY1" . SPARSER::COLLECTION) ("IFN-γ-" . SPARSER::PROTEIN)
    ("TLR2" . SPARSER::PROTEIN) ("Interferon-γ" . SPARSER::PROTEIN)
    ("H4A" . SPARSER::PROTEIN) ("LAMP-1" . SPARSER::PROTEIN)
    ("MNK2" . SPARSER::PROTEIN) ("DUSP16" . SPARSER::PROTEIN)
    ("DUSP8" . SPARSER::PROTEIN) ("DUSP4" . SPARSER::PROTEIN)
    ("DUSP2" . SPARSER::PROTEIN) ("DUSP1" . SPARSER::PROTEIN)
    ("MKNK2" . SPARSER::PROTEIN) ("MKNK1" . SPARSER::PROTEIN)
    ("IDO1" . SPARSER::PROTEIN) ("Leucyl tRNA synthetase" . SPARSER::PROTEIN)
    ("p38α" . SPARSER::PROTEIN) ("p-p38" . SPARSER::PROTEIN)
    ("Mnk1" . SPARSER::PROTEIN) ("IκB-α" . SPARSER::PROTEIN)
    ("LY 294002" . SPARSER::MOLECULE) ("Torin 1" . SPARSER::DRUG)
    ("L-Tryptophan" . SPARSER::MOLECULE) ("anti-microbial" . SPARSER::DRUG)
    ("CXCL3" . SPARSER::PROTEIN) ("CXCL2" . SPARSER::PROTEIN)
    ("EEF2" . SPARSER::PROTEIN) ("PABPC4" . SPARSER::PROTEIN)
    ("PABPC3" . SPARSER::PROTEIN) ("CSF1R" . SPARSER::PROTEIN)
    ("M-CSFR" . SPARSER::PROTEIN)
    ("colony stimulating factor" . SPARSER::PROTEIN)
    ("GSK3" . SPARSER::PROTEIN)
    ("indoleamine 2,3-dioxygenase" . SPARSER::PROTEIN)
    ("GTP-binding protein Rheb" . SPARSER::PROTEIN) ("LC3A" . SPARSER::PROTEIN)
    ("Torin1" . SPARSER::DRUG) ("4E-BP" . SPARSER::PROTEIN)
    ("mRNA cap-binding protein" . SPARSER::PROTEIN)
    ("DUSP 1" . SPARSER::PROTEIN) ("CGP57380" . SPARSER::DRUG)
    ("IRF8" . SPARSER::PROTEIN) ("MNK1" . SPARSER::PROTEIN)
    ("PABPC1" . SPARSER::PROTEIN)
    ("eukaryotic initiation factor 4E" . SPARSER::PROTEIN-FAMILY)
    ("I-κBα" . SPARSER::PROTEIN) ("HEY1" . SPARSER::PROTEIN)
    ("HES1" . SPARSER::PROTEIN)
    ("cisplatin and doxorubicin" . SPARSER::COLLECTION)
    ("ATM/Chks-Cdc25C" . SPARSER::PROTEIN-PAIR) ("honokiol" . SPARSER::DRUG)
    ("functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pro-apoptotic proteins Bcl-2 and Mcl-1" . SPARSER::COLLECTION)
    ("p21 Cip1/Kip1" . SPARSER::COLLECTION)
    ("Bax, Noxa, and PUMA" . SPARSER::COLLECTION)
    ("cyclin-Cdk" . SPARSER::COLLECTION) ("waf and p27" . SPARSER::COLLECTION)
    ("waf" . SPARSER::PROTEIN)
    ("camptothecin and irinotecan" . SPARSER::COLLECTION)
    ("caspase-9 and -3" . SPARSER::COLLECTION)
    ("pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("mitochondrial cytochrome c" . SPARSER::PROTEIN)
    ("Bax and PUMA" . SPARSER::COLLECTION) ("PIDD" . SPARSER::PROTEIN)
    ("mitochondrial-related caspase-2" . SPARSER::PROTEIN)
    ("receptor or endoplasmic reticulum-related-caspase-8"
     . SPARSER::COLLECTION)
    ("irinotecan and topotecan" . SPARSER::COLLECTION)
    ("ATM-Chk1/Chk2-Cdc25C" . SPARSER::COLLECTION)
    ("ATM-Chk1/Chk2" . SPARSER::COLLECTION)
    ("Cdc25C-Cdk1" . SPARSER::COLLECTION)
    ("Cdc25c, and inhibitors" . SPARSER::COLLECTION)
    ("WAF1/CIP1" . SPARSER::COLLECTION) ("Cdc25c" . SPARSER::PROTEIN)
    ("cyclin B1/Cdk1" . SPARSER::COLLECTION)
    ("cyclin-dependent kinase (Cdk) and cyclin" . SPARSER::COLLECTION)
    ("ATM/γH2AX" . SPARSER::COLLECTION) ("Chk1/Chk2" . SPARSER::COLLECTION)
    ("ATM and γH2AX" . SPARSER::COLLECTION) ("alkaline" . SPARSER::PROTEIN)
    ("lignans" . SPARSER::MOLECULE)
    ("camptothecin and its derivatives" . SPARSER::COLLECTION)
    ("topotecan, irinotecan and belotecan" . SPARSER::COLLECTION)
    ("belotecan" . SPARSER::DRUG) ("topotecan" . SPARSER::DRUG)
    ("the topological state" . SPARSER::BIO-STATE)
    ("-shRNA" . SPARSER::COLLECTION)
    ("releasing mitochondrial cytochrome c" . SPARSER::PROTEIN)
    ("pro-apoptotic molecules Bax, Bak, and PUMA" . SPARSER::COLLECTION)
    ("Bax, Bak, and PUMA" . SPARSER::COLLECTION)
    ("Bcl-2, Mcl-1, Bax, Bak, and PUMA" . SPARSER::COLLECTION)
    ("FMK" . SPARSER::PROTEIN)
    ("caspase-2, -9," . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("caspase-2, -9, and -3" . SPARSER::COLLECTION)
    ("death receptor-related caspase-8 and endoplasmic reticulum-associated caspase-12"
     . SPARSER::COLLECTION)
    ("endoplasmic reticulum-associated caspase-12" . SPARSER::PROTEIN)
    ("Waf1/Cip1 and p27 KIP 1" . SPARSER::COLLECTION)
    ("Waf1/Cip1 , p27 Kip 1 and Cdc25C" . SPARSER::COLLECTION)
    ("Cdk1 and Cdk2" . SPARSER::COLLECTION)
    ("Waf1/Cip1 , p27 Kip1 and cyclin B1" . SPARSER::COLLECTION)
    ("cyclin B1 and Cdc25C" . SPARSER::COLLECTION)
    ("Cdc25A, Cdc25B and Cdc25C" . SPARSER::COLLECTION)
    ("ATM, Chk1, and Chk2" . SPARSER::COLLECTION)
    ("ATM-ser1981" . SPARSER::PROTEIN-PAIR) ("thr" . SPARSER::AMINO-ACID)
    ("ser" . SPARSER::AMINO-ACID) ("Topoisomerase" . SPARSER::PROTEIN)
    ("Camptothecin" . SPARSER::DRUG)
    ("various pro-apoptotic genes" . SPARSER::GENE)
    ("Bax, Noxa, PUMA, Fas, and DR5" . SPARSER::COLLECTION)
    ("Lignans" . SPARSER::MOLECULE) ("phytoestrogen" . SPARSER::MOLECULE)
    ("Lignan" . SPARSER::MOLECULE)
    ("the pro-apoptotic protein Bax" . SPARSER::PROTEIN)
    ("Bcl-2 and Mcl-1" . SPARSER::COLLECTION)
    ("ATM, and Chk1" . SPARSER::COLLECTION)
    ("PUMA and Bax" . SPARSER::COLLECTION)
    ("Mcl-1 and Bcl-2" . SPARSER::COLLECTION)
    ("Waf1/Cip1 and p27 Kip1" . SPARSER::COLLECTION)
    ("Austrobailignan-1" . SPARSER::COLLECTION) ("lignan" . SPARSER::MOLECULE)
    ("Kip1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p27 KIP1" . SPARSER::PROTEIN)
    ("CIP1" . SPARSER::PROTEIN) ("G2 /M" . SPARSER::PROTEIN)
    ("caspases-2" . SPARSER::PROTEIN) ("p27 KIP 1" . SPARSER::PROTEIN)
    ("Cdk2" . SPARSER::PROTEIN) ("waf1" . SPARSER::PROTEIN)
    ("Cdc25B" . SPARSER::PROTEIN) ("Cdc25A" . SPARSER::PROTEIN)
    ("dual specificity phosphatase" . SPARSER::PROTEIN)
    ("p27 Kip 1" . SPARSER::PROTEIN) ("DR5" . SPARSER::PROTEIN)
    ("DNA topoisomerase 1" . SPARSER::PROTEIN) ("Cl 2" . SPARSER::PROTEIN)
    ("CH 2" . SPARSER::MOLECULE) ("Z-LEHD-FMK" . SPARSER::DRUG)
    ("caspase -9" . SPARSER::PROTEIN) ("COX IV" . SPARSER::PROTEIN)
    ("cyclin A1" . SPARSER::PROTEIN) ("Cdk1" . SPARSER::PROTEIN)
    ("Cdc25" . SPARSER::PROTEIN) ("topoisomerase-I" . SPARSER::PROTEIN)
    ("caspase-2" . SPARSER::PROTEIN) ("Cdc25C" . SPARSER::PROTEIN)
    ("Waf1/Cip1" . SPARSER::PROTEIN) ("CD40 and CD44" . SPARSER::COLLECTION)
    ("detergent" . SPARSER::MOLECULE)
    ("CD4 and an unidentified protein" . SPARSER::COLLECTION)
    ("weak dimers" . SPARSER::DIMER) ("weak homodimers" . SPARSER::HOMODIMER)
    ("TCR-CD3 and CD4" . SPARSER::COLLECTION)
    ("Streptavidin" . SPARSER::PROTEIN) ("spiked" . SPARSER::PROTEIN)
    ("GFP and mCherry" . SPARSER::COLLECTION)
    ("CD28 (CD28T) and PD1 (PD1T)" . SPARSER::COLLECTION)
    ("the same short flexible linker" . SPARSER::LINKER)
    ("a short flexible linker" . SPARSER::LINKER)
    ("homodimer" . SPARSER::HOMODIMER) ("-MCC" . SPARSER::COLLECTION)
    ("a weak agonist" . SPARSER::AGONIST) ("ligand (APL)" . SPARSER::MOLECULE)
    ("APL" . SPARSER::PROTEIN)
    ("valine (G403V) or leucine (G406L)" . SPARSER::COLLECTION)
    ("MCC" . SPARSER::PROTEIN) ("GpA" . SPARSER::PROTEIN)
    ("glycophorin" . SPARSER::PROTEIN-FAMILY)
    ("glycines" . SPARSER::AMINO-ACID) ("ECD" . SPARSER::PROTEIN)
    ("the Src kinases p56 lck (Lck) or p59 fyn (Fyn)" . SPARSER::COLLECTION)
    ("Fyn" . SPARSER::PROTEIN) ("ITAMs" . SPARSER::PROTEIN)
    ("receptor (TCR)" . SPARSER::RECEPTOR) ("APCs" . SPARSER::PROTEIN)
    ("pMHC" . SPARSER::BIO-COMPLEX) ("Lck" . SPARSER::PROTEIN)
    ("MHC" . SPARSER::PROTEIN) ("CD40" . SPARSER::PROTEIN)
    ("gp41" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CD3 complex" . SPARSER::PROTEIN)
    ("ICAM-1" . SPARSER::PROTEIN) ("iminodiacetic acid" . SPARSER::MOLECULE)
    ("IL-2" . SPARSER::PROTEIN) ("TCRβ" . SPARSER::PROTEIN)
    ("GK1" . SPARSER::PROTEIN) ("β - cell" . SPARSER::PROTEIN)
    ("beta subunit" . SPARSER::PROTEIN) ("alpha subunit" . SPARSER::PROTEIN)
    ("PD1" . SPARSER::PROTEIN) ("CD28" . SPARSER::PROTEIN)
    ("I-E" . SPARSER::PROTEIN) ("pP2" . SPARSER::DRUG)
    ("scavenger receptor class B" . SPARSER::PROTEIN)
    ("co-receptor" . SPARSER::PROTEIN) ("p59 fyn" . SPARSER::PROTEIN)
    ("Src kinase" . SPARSER::PROTEIN) ("p56 lck" . SPARSER::PROTEIN)
    ("major histocompatibility complex" . SPARSER::PROTEIN)
    ("genotoxins" . SPARSER::MOLECULE) ("immunosuppressants" . SPARSER::DRUG)
    ("potent inflammatory cytokines" . SPARSER::PROTEIN)
    ("sterile" . SPARSER::PROTEIN-FAMILY)
    ("rapamycin and mitoxantrone" . SPARSER::COLLECTION)
    ("the chemotherapeutic agent mitoxantrone" . SPARSER::DRUG)
    ("mitoxantrone" . SPARSER::DRUG)
    ("cell-associated rapamycin" . SPARSER::DRUG)
    ("IL1A–NF-κB" . SPARSER::COLLECTION)
    ("amphiregulin (AREG) and CXCL1" . SPARSER::COLLECTION)
    ("AREG" . SPARSER::PROTEIN) ("RELA, IL1A or raptor" . SPARSER::COLLECTION)
    ("MTORC" . SPARSER::PROTEIN) ("rapamycin or raptor" . SPARSER::COLLECTION)
    ("IL1A or raptor" . SPARSER::COLLECTION)
    ("RAS-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RELA" . SPARSER::PROTEIN)
    ("HCA2 or PSC27" . SPARSER::COLLECTION)
    ("IL6 and IL8" . SPARSER::COLLECTION) ("RACE" . SPARSER::PROTEIN)
    ("protein-4/CCL13" . SPARSER::COLLECTION)
    ("IL1B, IL6 and IL8" . SPARSER::COLLECTION)
    ("polyribosomes" . SPARSER::BIO-COMPLEX) ("rIL" . SPARSER::PROTEIN)
    ("rapamycin, IRAK1 and IκBα" . SPARSER::COLLECTION)
    ("IRAK1 and IκBα" . SPARSER::COLLECTION)
    ("IRAK1 (interleukin-1 receptor-associated kinase 1) and IκBα"
     . SPARSER::COLLECTION)
    ("NFKBIA" . SPARSER::PROTEIN) ("IL1A-NF-κB" . SPARSER::COLLECTION)
    ("NF-κB and IL1A" . SPARSER::COLLECTION)
    ("the pro-inflammatory cytokine IL1A" . SPARSER::PROTEIN)
    ("NF-κB–luciferase" . SPARSER::COLLECTION)
    ("potentially sequestering EIF4E" . SPARSER::PROTEIN)
    ("ERK (otherwise known as MAPK1) and S6K" . SPARSER::COLLECTION)
    ("stable secondary mRNA" . SPARSER::PROTEIN)
    ("EIF4B and EIF4E" . SPARSER::COLLECTION)
    ("S6K and 4EBP1" . SPARSER::COLLECTION) ("ATP-competitive" . SPARSER::ATP)
    ("RPTOR" . SPARSER::PROTEIN) ("senescent HCA2" . SPARSER::PROTEIN)
    ("several pro-inflammatory cytokines, chemokines and growth factors"
     . SPARSER::COLLECTION)
    ("cytokines, chemokines and growth factors" . SPARSER::COLLECTION)
    ("MCF-10A and 184A1" . SPARSER::COLLECTION) ("MCF-10A" . SPARSER::PROTEIN)
    ("HCA2" . SPARSER::PROTEIN)
    ("the pro-inflammatory cytokine IL6" . SPARSER::PROTEIN)
    ("cytokines, growth factors and proteases" . SPARSER::COLLECTION)
    ("disrupted chromatin and strong mitogenic signals (for example, those provided by activated oncogenes) xref"
     . SPARSER::COLLECTION)
    ("SASPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("exogenous IL1A" . SPARSER::PROTEIN) ("SASP" . SPARSER::PROTEIN)
    ("per 1" . SPARSER::PROTEIN) ("RPL13A" . SPARSER::PROTEIN)
    ("CXCL1" . SPARSER::PROTEIN) ("TUBA1A" . SPARSER::PROTEIN)
    ("CCL13" . SPARSER::PROTEIN) ("protein-4" . SPARSER::PROTEIN)
    ("MCP-4" . SPARSER::PROTEIN) ("ribosomal protein S6" . SPARSER::PROTEIN)
    ("alpha)" . SPARSER::PROTEIN) ("IκBα" . SPARSER::PROTEIN)
    ("interleukin-1 receptor-associated kinase 1" . SPARSER::PROTEIN)
    ("IL1R1" . SPARSER::PROTEIN) ("EIF4E" . SPARSER::PROTEIN)
    ("EIF4B" . SPARSER::PROTEIN) ("EIF4A1" . SPARSER::PROTEIN)
    ("PP242" . SPARSER::DRUG) ("RPS6" . SPARSER::PROTEIN)
    ("kappa light polypeptide gene" . SPARSER::PROTEIN)
    ("MKK6" . SPARSER::PROTEIN) ("RASV12" . SPARSER::DRUG)
    ("CXCL8" . SPARSER::PROTEIN) ("IL8" . SPARSER::PROTEIN)
    ("MTORC1" . SPARSER::PROTEIN) ("IL1A" . SPARSER::PROTEIN)
    ("IL6" . SPARSER::PROTEIN) ("TORC1 complex" . SPARSER::BIO-COMPLEX)
    ("proinflammatory cytokines and chemokines" . SPARSER::COLLECTION)
    ("secretory genes" . SPARSER::GENE) ("canonical Rel" . SPARSER::PROTEIN)
    ("IKKα and IKKβ" . SPARSER::COLLECTION)
    ("stromal NF-κB" . SPARSER::PROTEIN) ("N2 and pTNM6" . SPARSER::COLLECTION)
    ("the different histologic subtypes" . SPARSER::PROTEIN)
    ("simultaneous hematoxylin" . SPARSER::MOLECULE)
    ("hematoxylin" . SPARSER::MOLECULE) ("PCNA" . SPARSER::PROTEIN)
    ("the different NSCLC histologic subtypes" . SPARSER::PROTEIN)
    ("a semi-quantitative NF-κB subunit" . SPARSER::FRAGMENT)
    ("Gprc5a" . SPARSER::PROTEIN) ("urethane" . SPARSER::MOLECULE)
    ("Trp" . SPARSER::AMINO-ACID) ("etc" . SPARSER::PROTEIN)
    ("endotoxins" . SPARSER::MOLECULE) ("/P50" . SPARSER::COLLECTION)
    ("P100/P52" . SPARSER::COLLECTION) ("P105/P50" . SPARSER::COLLECTION)
    ("two main histologic types" . TYPE) ("IIB" . SPARSER::PROTEIN)
    ("P52/P100" . SPARSER::COLLECTION) ("CRM1" . SPARSER::PROTEIN)
    ("exportin1" . SPARSER::PROTEIN) ("A-P" . SPARSER::PROTEIN)
    ("B–P" . SPARSER::PROTEIN) ("cmH 2" . SPARSER::PROTEIN)
    ("IKKα" . SPARSER::PROTEIN) ("NF-κB2" . SPARSER::PROTEIN)
    ("P105" . SPARSER::PROTEIN) ("c- Rel" . SPARSER::PROTEIN)
    ("proliferating cell nuclear antigen" . SPARSER::PROTEIN)
    ("P100" . SPARSER::PROTEIN) ("P52" . SPARSER::PROTEIN)
    ("P50" . SPARSER::PROTEIN)
    ("the predominant AKT1 isoform" . SPARSER::ISOFORM)
    ("AKT or STAT3" . SPARSER::COLLECTION) ("fludarabine" . SPARSER::DRUG)
    ("Ibrutinib or Idelalisib" . SPARSER::COLLECTION)
    ("mimic in vitro at least part" . SPARSER::COMPONENT)
    ("AKT1 or AKT2" . SPARSER::COLLECTION)
    ("the pan‐AKT inhibitors MK2206 and AiX" . SPARSER::COLLECTION)
    ("Akti" . SPARSER::PROTEIN) ("Dii" . SPARSER::MOLECULE)
    ("mRNA and AKT2" . SPARSER::COLLECTION)
    ("AKT1 , AKT2 and AKT3" . SPARSER::COLLECTION)
    ("protein kinase B (PKB)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3K and PKC" . SPARSER::COLLECTION)
    ("Ibrutinib, and phosphatidylinositol" . SPARSER::COLLECTION)
    ("Idelalisib" . SPARSER::DRUG) ("Ibrutinib" . SPARSER::DRUG)
    ("GSK3A" . SPARSER::PROTEIN) ("MK2206" . SPARSER::DRUG)
    ("AKT3" . SPARSER::PROTEIN) ("Bruton tyrosine kinase" . SPARSER::PROTEIN)
    ("14-3-3σ and JNK" . SPARSER::COLLECTION)
    ("SUMO and JNK" . SPARSER::COLLECTION) ("CBY" . SPARSER::PROTEIN)
    ("scaffolding protein and CBY1" . SPARSER::COLLECTION)
    ("a pivotal regulator" . SPARSER::REGULATOR) ("TXP" . SPARSER::DRUG)
    ("GAS2 and Fap1" . SPARSER::COLLECTION)
    ("the stress-responsive kinase" . SPARSER::KINASE)
    ("BCL-2-associated X protein (BAX)" . SPARSER::PROTEIN)
    ("protein (BAX)" . SPARSER::PROTEIN)
    ("transcription factor and c-ABL" . SPARSER::COLLECTION)
    ("BAD" . SPARSER::PROTEIN)
    ("a stable tripartite complex" . SPARSER::BIO-COMPLEX)
    ("ubiquitous adapter proteins" . SPARSER::PROTEIN)
    ("anti-CBY1 and anti-SUMO" . SPARSER::COLLECTION)
    ("Bortezomib" . SPARSER::DRUG) ("HD" . SPARSER::PROTEIN)
    ("JNK and 14-3-3σ" . SPARSER::COLLECTION)
    ("RAD001 and CBY1" . SPARSER::COLLECTION)
    ("JNK/14-3-3σ" . SPARSER::COLLECTION)
    ("βcatenin/14-3-3σ" . SPARSER::COLLECTION)
    ("kinase (JNK)" . SPARSER::KINASE) ("everolimus" . SPARSER::DRUG)
    ("14-3-3σ" . SPARSER::PROTEIN) ("βcatenin-14-3-3σ" . SPARSER::PROTEIN-PAIR)
    ("CBY1 and βcatenin" . SPARSER::COLLECTION)
    ("CBY1 and β-catenin" . SPARSER::COLLECTION)
    ("anti-CBY1 or anti-β-catenin antibody" . SPARSER::COLLECTION)
    ("anti-β-catenin" . SPARSER::COLLECTION)
    ("a transcriptionally active complex" . SPARSER::BIO-COMPLEX)
    ("TCF/LEF1" . SPARSER::COLLECTION)
    ("β-catenin and/or Fas-associated phosphatase 1 (Fap1, which inactivates GSK-3β through de-phosphorylation)"
     . SPARSER::COLLECTION)
    ("Fas-associated phosphatase 1" . SPARSER::PROTEIN)
    ("the adenomatous polyposis coli (APC)/Axin/glycogen synthase kinase-3β (GSK-3β) destruction complex"
     . SPARSER::BIO-COMPLEX)
    ("Axin" . SPARSER::PROTEIN)
    ("Nilotinib and Dasatinib" . SPARSER::COLLECTION)
    ("Nilotinib" . SPARSER::DRUG) ("imatinib (IM)" . SPARSER::DRUG)
    ("imatinib" . SPARSER::DRUG) ("tyrosine kinase (TK)" . SPARSER::PROTEIN)
    ("p210-kDa" . SPARSER::COLLECTION) ("ABL" . SPARSER::PROTEIN)
    ("client proteins" . SPARSER::PROTEIN) ("TK and AKT" . SPARSER::COLLECTION)
    ("Chibby" . SPARSER::PROTEIN) ("ataxin-1" . SPARSER::PROTEIN)
    ("HIPK1" . SPARSER::PROTEIN)
    ("homeodomain-interacting protein kinase 1" . SPARSER::PROTEIN)
    ("c-ABL" . SPARSER::PROTEIN) ("forkhead box O1" . SPARSER::PROTEIN)
    ("AKT-induced" . SPARSER::PROTEIN) ("βcatenin" . SPARSER::PROTEIN)
    ("scaffolding protein" . SPARSER::PROTEIN) ("C22orf2" . SPARSER::PROTEIN)
    ("c-Abl" . SPARSER::PROTEIN) ("RAD001" . SPARSER::DRUG)
    ("L-Glutamine" . SPARSER::MOLECULE) ("LEF1" . SPARSER::PROTEIN)
    ("factor 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Fap1" . SPARSER::PROTEIN)
    ("phosphatase 1" . SPARSER::PROTEIN) ("GAS2" . SPARSER::PROTEIN)
    ("p210" . SPARSER::PROTEIN) ("CBY1" . SPARSER::PROTEIN)
    ("STAT5 and/or STAT3" . SPARSER::COLLECTION)
    ("pure ADH and tumor-adjacent ADH" . SPARSER::COLLECTION)
    ("either pure ADH or tumor-adjacent ADH" . SPARSER::COLLECTION)
    ("either pure ADH" . SPARSER::PROTEIN) ("pure ADH" . SPARSER::PROTEIN)
    ("STAT5 and STAT3" . SPARSER::COLLECTION)
    ("STATs form homodimers as well as heterodimers" . SPARSER::COLLECTION)
    ("homodimers" . SPARSER::HOMODIMER) ("STATs" . SPARSER::PROTEIN)
    ("Transducers and Activators" . SPARSER::COLLECTION)
    ("factors—STAT1, STAT2, STAT3, STAT4, STAT5a, STAT5b, and STAT6"
     . SPARSER::COLLECTION)
    ("STAT5a" . SPARSER::PROTEIN) ("Activators" . SPARSER::ACTIVATOR)
    ("Transducers" . SPARSER::PROTEIN) ("ADH" . SPARSER::PROTEIN)
    ("STAT3 and STAT5" . SPARSER::COLLECTION) ("De-" . SPARSER::MOLECULE)
    ("STAT4" . SPARSER::PROTEIN) ("IL-6 and IL-6" . SPARSER::COLLECTION)
    ("TNFα or IL-1β" . SPARSER::COLLECTION) ("OB" . SPARSER::PROTEIN)
    ("IDH1/IDH2" . SPARSER::COLLECTION)
    ("telomerase activity and TERT" . SPARSER::COLLECTION)
    ("TA" . SPARSER::PROTEIN) ("promoter, and Xu" . SPARSER::COLLECTION)
    ("TNFα, IL-1β or TERT" . SPARSER::COLLECTION)
    ("variant (TT)" . SPARSER::VARIANT) ("variant (CC)" . SPARSER::VARIANT)
    ("– 1" . SPARSER::PROTEIN)
    ("The AC and CT genotypes" . SPARSER::COLLECTION)
    ("95% CI 1.23 – 3.8" . SPARSER::PROTEIN)
    ("TERT and POT1" . SPARSER::COLLECTION)
    ("TERT and pro-inflammatory" . SPARSER::COLLECTION)
    ("NFκB and co-activate" . SPARSER::COLLECTION)
    ("IL-6 and TNFα" . SPARSER::COLLECTION)
    ("These mutational hot" . SPARSER::PROTEIN)
    ("the isocitrate dehydrogenase 1 ( IDH1) and 2 ( IDH2) genes"
     . SPARSER::GENE)
    ("isocitrate" . SPARSER::PROTEIN)
    ("-Methylguanine-DNA methyltransferase" . SPARSER::COLLECTION)
    ("TERT and IL-6" . SPARSER::COLLECTION) ("SDS 1" . SPARSER::PROTEIN)
    ("Hypoxanthine-guanine phosphoribosyltransferase" . SPARSER::PROTEIN)
    ("β-glucuronidase" . SPARSER::PROTEIN) ("POT1" . SPARSER::PROTEIN)
    ("protection of telomeres 1" . SPARSER::PROTEIN)
    ("Methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("Interleukin-6" . SPARSER::PROTEIN)
    ("Telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("BRAF/MEK" . SPARSER::COLLECTION) ("cobimetinib" . SPARSER::DRUG)
    ("dabrafenib and trametinib" . SPARSER::COLLECTION)
    ("gap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NRAS and MEK2" . SPARSER::COLLECTION)
    ("anti-CTLA4, anti-PD-1, and anti-PD-L1" . SPARSER::COLLECTION)
    ("the BRAF inhibitor dabrafenib and the MEK inhibition trametinib"
     . SPARSER::COLLECTION)
    ("Concurrent targeting BRAF and MEK" . SPARSER::COLLECTION)
    ("trametinib" . SPARSER::DRUG) ("RAS and MEK" . SPARSER::COLLECTION)
    ("dabrafenib, vemurafenib and sorafenib" . SPARSER::COLLECTION)
    ("sorafenib" . SPARSER::DRUG) ("dabrafenib" . SPARSER::DRUG)
    ("BRAF or MEK" . SPARSER::COLLECTION) ("BRAF-MEK" . SPARSER::COLLECTION)
    ("BRAF and MEK" . SPARSER::COLLECTION) ("MEK2" . SPARSER::PROTEIN)
    ("PD-L1" . SPARSER::PROTEIN) ("PD-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CTLA4" . SPARSER::PROTEIN) ("ribonucleoprotein" . SPARSER::PROTEIN)
    ("transcriptional activators or repressors" . SPARSER::COLLECTION)
    ("-CCCCTTCCGGG-3" . SPARSER::COLLECTION)
    ("CTCCGGGCCCTCCCAGCCC-3" . SPARSER::COLLECTION)
    ("thymidine" . SPARSER::MOLECULE) ("TERC" . SPARSER::PROTEIN)
    ("TICs" . SPARSER::PROTEIN) ("Telomerase activity" . SPARSER::PROTEIN)
    ("Ta-T1" . SPARSER::PROTEIN) ("T1–4" . SPARSER::PROTEIN)
    ("G1–3" . SPARSER::PROTEIN)
    ("transcriptional activators" . SPARSER::PROTEIN-FAMILY)
    ("CK20" . SPARSER::PROTEIN) ("CK5" . SPARSER::PROTEIN)
    ("non-muscle" . SPARSER::PROTEIN) ("chr5" . SPARSER::PROTEIN)
    ("agonists" . SPARSER::AGONIST)
    ("pertuzumab and TDM1" . SPARSER::COLLECTION)
    ("a small molecule dual inhibitor" . SPARSER::INHIBITOR)
    ("other previously unrecognized phosphorylation substrates"
     . SPARSER::SUBSTRATE)
    ("NSG" . SPARSER::PROTEIN-FAMILY) ("threonines" . SPARSER::AMINO-ACID)
    ("that AICAR's" . SPARSER::PROTEIN)
    ("AMPK and acetyl-CoA" . SPARSER::COLLECTION)
    ("EGF and AICAR" . SPARSER::COLLECTION)
    ("exogenous ligand" . SPARSER::LIGAND)
    ("HER2 (associated with gene amplification) or EGFR" . SPARSER::COLLECTION)
    ("exogenous growth factors" . SPARSER::GROWTH-FACTOR)
    ("Raptor" . SPARSER::PROTEIN) ("Kinase (AMPK)" . SPARSER::KINASE)
    ("P81" . SPARSER::PROTEIN) ("L15" . SPARSER::PROTEIN)
    ("AMPKα1" . SPARSER::PROTEIN) ("Compound C" . SPARSER::MOLECULE)
    ("AMPKβ" . SPARSER::PROTEIN) ("TDM1" . SPARSER::DRUG)
    ("AMPK β" . SPARSER::PROTEIN) ("myc-tagged" . SPARSER::PROTEIN)
    ("ACC1" . SPARSER::PROTEIN) ("HMG-CoA" . SPARSER::DRUG)
    ("AMPKα" . SPARSER::PROTEIN-FAMILY) ("p53 and c-MYC" . SPARSER::COLLECTION)
    ("Genome" . SPARSER::PROTEIN)
    ("its cancer-associated mutants" . SPARSER::MUTANT)
    ("pentose" . SPARSER::MOLECULE)
    ("glucose and glutamine" . SPARSER::COLLECTION)
    ("exogenous nucleosides" . SPARSER::MOLECULE)
    ("nucleosides" . SPARSER::MOLECULE) ("ribonucleotide" . SPARSER::MOLECULE)
    ("RAS or BRAF" . SPARSER::COLLECTION) ("dNTP" . SPARSER::MOLECULE)
    ("G6PD" . SPARSER::PROTEIN)
    ("glucose-6-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("RRM2" . SPARSER::PROTEIN)
    ("kinases and phosphatases" . SPARSER::COLLECTION)
    ("SPASTIZIN" . SPARSER::PROTEIN) ("Dynamin" . SPARSER::PROTEIN)
    ("VPS34 and its associated complexes" . SPARSER::COLLECTION)
    ("its associated complexes" . SPARSER::BIO-COMPLEX)
    ("VPS34–BECLIN1–UVRAG" . SPARSER::COLLECTION)
    ("ULK1 (Russell et al , xref ) and mTOR (Yuan et al , xref ) kinases"
     . SPARSER::COLLECTION)
    ("VPS34–BECLIN1–ATG14L" . SPARSER::COLLECTION)
    ("mTOR and VPS34" . SPARSER::COLLECTION)
    ("Ku70-DNA-PK" . SPARSER::COLLECTION)
    ("the lysosomotropic reagent L-leucyl-L-leucine methyl ester"
     . SPARSER::MOLECULE)
    ("reagent" . SPARSER::MOLECULE)
    ("receptors and hydrolases" . SPARSER::COLLECTION)
    ("hydrolases" . SPARSER::PROTEIN) ("lysotracker" . SPARSER::DRUG)
    ("mTOR-UVRAG-VPS34" . SPARSER::COLLECTION)
    ("VPS34–UVRAG" . SPARSER::COLLECTION) ("mTOR-UVRAG" . SPARSER::COLLECTION)
    ("EEA1 or CI-MPR" . SPARSER::COLLECTION)
    ("phosphate receptor—CI-MPR" . SPARSER::COLLECTION)
    ("mannose" . SPARSER::MOLECULE) ("cation" . SPARSER::MOLECULE)
    ("VPS34, BECLIN1 and RUBICON" . SPARSER::COLLECTION)
    ("UVRAG, BECLIN1, ATG14L or RUBICON" . SPARSER::COLLECTION)
    ("RUBICON" . SPARSER::PROTEIN)
    ("the VPS34-associated proteins" . SPARSER::PROTEIN)
    ("ATG14L instead of UVRAG" . SPARSER::COLLECTION)
    ("Exogenous UVRAG" . SPARSER::PROTEIN) ("UVRAG–mTOR" . SPARSER::COLLECTION)
    ("4E-BP1 and p70S6K" . SPARSER::COLLECTION)
    ("GFP-UVRAG" . SPARSER::COLLECTION) ("FLAG-UVRAG" . SPARSER::COLLECTION)
    ("further implicating UVRAG" . SPARSER::PROTEIN)
    ("FLAG-BECLIN1" . SPARSER::COLLECTION) ("GST-ATG14L" . SPARSER::COLLECTION)
    ("GST-UVRAG" . SPARSER::COLLECTION) ("RAPTOR" . SPARSER::PROTEIN)
    ("RICTOR" . SPARSER::PROTEIN) ("Phosphatase" . SPARSER::PHOSPHATASE)
    ("UVRAG or ATG14L" . SPARSER::COLLECTION)
    ("VPS34 and BECLIN1" . SPARSER::COLLECTION)
    ("UVRAG–VPS34" . SPARSER::COLLECTION) ("LAMP1-GFP" . SPARSER::COLLECTION)
    ("mCherry-LC3" . SPARSER::COLLECTION) ("GFP-LAMTOR" . SPARSER::COLLECTION)
    ("PIKfyve" . SPARSER::PROTEIN) ("LAMP1-mCherry" . SPARSER::COLLECTION)
    ("secondary anti-GST" . SPARSER::ANTIBODY)
    ("LAMP1 and LAMTOR" . SPARSER::COLLECTION)
    ("regulator (LAMTOR)" . SPARSER::REGULATOR)
    ("LAMTOR" . SPARSER::PROTEIN-FAMILY) ("VPS34 and PI" . SPARSER::COLLECTION)
    ("at least two distinct VPS34" . SPARSER::PROTEIN)
    ("VPS34, VPS15 and BECLIN1" . SPARSER::COLLECTION)
    ("ATG14L/BARKOR" . SPARSER::COLLECTION) ("BARKOR" . SPARSER::PROTEIN)
    ("essential proteins" . SPARSER::PROTEIN) ("UVRAG" . SPARSER::PROTEIN)
    ("unwanted, damaged and toxic biological components" . SPARSER::COMPONENT)
    ("1L" . SPARSER::PROTEIN) ("MnCl 2" . SPARSER::DRUG)
    ("ddH 2" . SPARSER::PROTEIN) ("p40 phox" . SPARSER::PROTEIN)
    ("Bafilomycin A1" . SPARSER::DRUG) ("LAMTOR1" . SPARSER::PROTEIN)
    ("P-S" . SPARSER::PROTEIN) ("PIP5Ks" . SPARSER::PROTEIN)
    ("PI4" . SPARSER::PROTEIN) ("PIP5K1A" . SPARSER::PROTEIN)
    ("PIP5K1B" . SPARSER::PROTEIN) ("FYVE-CENT" . SPARSER::PROTEIN)
    ("SNX9" . SPARSER::PROTEIN) ("Dynamin 2" . SPARSER::PROTEIN)
    ("S6B" . SPARSER::PROTEIN) ("DNA-PK" . SPARSER::PROTEIN)
    ("Ku70" . SPARSER::HUMAN-PROTEIN-FAMILY) ("L-leucine" . SPARSER::MOLECULE)
    ("phospho-threonine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("bafilomycin A1" . SPARSER::DRUG) ("D–F" . SPARSER::PROTEIN)
    ("transferrin receptor" . SPARSER::PROTEIN) ("CI-MPR" . SPARSER::PROTEIN)
    ("phosphate receptor" . SPARSER::PROTEIN) ("ULK1" . SPARSER::PROTEIN)
    ("KU0063794" . SPARSER::DRUG) ("LAMP3" . SPARSER::PROTEIN)
    ("CD63" . SPARSER::PROTEIN) ("LAMP1" . SPARSER::PROTEIN)
    ("p40phox" . SPARSER::PROTEIN) ("ATG14L" . SPARSER::PROTEIN)
    ("BECLIN1" . SPARSER::PROTEIN) ("VPS15" . SPARSER::PROTEIN)
    ("VPS34" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-phosphate" . SPARSER::MOLECULE)
    ("Noda" . SPARSER::PROTEIN-FAMILY)
    ("esophageal keratinocytes" . SPARSER::PROTEIN)
    ("dominant-negative p53 mutants" . SPARSER::MUTANT)
    ("condensation" . SPARSER::PROTEIN-FAMILY)
    ("the repressive histone" . SPARSER::PROTEIN)
    ("the open chromatin conformation and not DNA hypermethylation"
     . SPARSER::COLLECTION)
    ("NHK/H-Ras" . SPARSER::COLLECTION) ("p  " . SPARSER::PROTEIN)
    ("tri" . SPARSER::PROTEIN) ("zebularine" . SPARSER::DRUG)
    ("p21, GADD45A, and 14-3-3σ" . SPARSER::COLLECTION)
    ("p53 and p21" . SPARSER::COLLECTION)
    ("ribosomal protein L26 or HuR" . SPARSER::COLLECTION)
    ("MMC" . SPARSER::PROTEIN) ("mixture" . SPARSER::MOLECULE)
    ("p21 and PUMA" . SPARSER::COLLECTION) ("Cao" . SPARSER::MOLECULE)
    ("pCR2" . SPARSER::PROTEIN) ("mL −1" . SPARSER::PROTEIN)
    ("cyclin B1" . SPARSER::PROTEIN) ("cyclin A2" . SPARSER::PROTEIN)
    ("C-20" . SPARSER::PROTEIN) ("I-19" . SPARSER::PROTEIN)
    ("H-Ras" . SPARSER::PROTEIN) ("H3K27me3" . SPARSER::PROTEIN)
    ("GADD45A" . SPARSER::PROTEIN) ("ribosomal protein L26" . SPARSER::PROTEIN)
    ("LG and RAV analyzed and/or interpreted data" . SPARSER::COLLECTION)
    ("CS" . SPARSER::PROTEIN) ("LG" . SPARSER::MOLECULE)
    ("AA and RAV conceived and designed" . SPARSER::COLLECTION)
    ("PHD–KD" . SPARSER::COLLECTION)
    ("the viral Gag sequence fused" . SPARSER::PROTEIN)
    ("myristoylated-Akt" . SPARSER::COLLECTION) ("luc" . SPARSER::PROTEIN)
    ("DBE" . SPARSER::MOLECULE) ("FOXOs" . SPARSER::PROTEIN-FAMILY)
    ("AKT1-mCherry" . SPARSER::COLLECTION)
    ("the mCherry fluorescent protein" . SPARSER::PROTEIN)
    ("PIP2 and PIP3" . SPARSER::COLLECTION) ("Oncoprotein" . SPARSER::PROTEIN)
    ("orthologs" . SPARSER::PROTEIN) ("AKT1 and AKT2" . SPARSER::COLLECTION)
    ("DNA and protein" . SPARSER::COLLECTION)
    ("PIK3CA and AKT" . SPARSER::COLLECTION) ("IGFs" . SPARSER::PROTEIN)
    ("mitogens" . SPARSER::MITOGEN) ("family (FOXO)" . SPARSER::PROTEIN-FAMILY)
    ("FOXO" . SPARSER::PROTEIN-FAMILY) ("Forkhead" . SPARSER::PROTEIN)
    ("FSHR" . SPARSER::PROTEIN) ("GCTs" . SPARSER::PROTEIN)
    ("PI3K–AKT–mTOR" . SPARSER::COLLECTION) ("eEF1A2" . SPARSER::PROTEIN)
    ("PIP2" . SPARSER::PIP2) ("DNA-polymerase" . SPARSER::PROTEIN)
    ("FOXO3a" . SPARSER::PROTEIN) ("DAF-16" . SPARSER::PROTEIN)
    ("FOXL2" . SPARSER::PROTEIN) ("PI3K–AKT" . SPARSER::PROTEIN)
    ("MET, or VEGF, or MEK" . SPARSER::COLLECTION)
    ("VEGF, or MEK" . SPARSER::COLLECTION)
    ("residual VEGF protein" . SPARSER::PROTEIN)
    ("antibodies and SMIs" . SPARSER::COLLECTION)
    ("a growth factor and its cognate receptor" . SPARSER::COLLECTION)
    ("two distinct RTKs" . SPARSER::PROTEIN)
    ("IRE1α or XBP-1s" . SPARSER::COLLECTION)
    ("IRE1α and XBP-1s" . SPARSER::COLLECTION)
    ("IRE1α and its downstream transcriptional effector" . SPARSER::COLLECTION)
    ("p97 (VCP)" . SPARSER::PROTEIN)
    ("the ERAD-associated E3 ligases HRD1 and gp78" . SPARSER::COLLECTION)
    ("Cbl or Cbl-b" . SPARSER::COLLECTION)
    ("VEGF and intracrine" . SPARSER::COLLECTION)
    ("MET and VEGFR2 or MET and MEK" . SPARSER::COLLECTION)
    ("VEGFR2 or MET and MEK" . SPARSER::COLLECTION)
    ("RAS–MEK" . SPARSER::COLLECTION) ("HGF-MET" . SPARSER::COLLECTION)
    ("MET and VEGF or MET and MEK" . SPARSER::COLLECTION)
    ("VEGF or MET and MEK" . SPARSER::COLLECTION)
    ("residual VEGF" . SPARSER::PROTEIN)
    ("epithelial-derived human (h) VEGF" . SPARSER::PROTEIN)
    ("MET and MEK" . SPARSER::COLLECTION) ("MEK–ERK" . SPARSER::COLLECTION)
    ("MET and its downstream mediators Gab1" . SPARSER::COLLECTION)
    ("MEK and ERK" . SPARSER::COLLECTION) ("MET or VEGF" . SPARSER::COLLECTION)
    ("VEGF or SMI" . SPARSER::COLLECTION)
    ("either IRE1α kinase ( xref ) or RNase ( xref , xref )"
     . SPARSER::COLLECTION)
    ("RNase" . SPARSER::PROTEIN)
    ("PERK or its target C/EBP-homologous protein (CHOP) (Fig. S5G)"
     . SPARSER::COLLECTION)
    ("C/EBP-homologous protein (CHOP)" . SPARSER::PROTEIN)
    ("ATF6 and BIP" . SPARSER::COLLECTION) ("BIP" . SPARSER::PROTEIN)
    ("Inositol" . SPARSER::PROTEIN)
    ("HRD1, gp78, or VCP" . SPARSER::COLLECTION)
    ("HRD1 and gp78" . SPARSER::COLLECTION) ("p97/VCP" . SPARSER::COLLECTION)
    ("VCP" . SPARSER::PROTEIN) ("Cbl-" . SPARSER::PROTEIN)
    ("Deubiquitinase" . SPARSER::DEUBIQUITINASE)
    ("a K48-ubiquitin-specific IB" . SPARSER::DRUG)
    ("pepstatin" . SPARSER::DRUG) ("leupeptin" . SPARSER::DRUG)
    ("N-glycans, or Peptide- N" . SPARSER::COLLECTION)
    ("Endo" . SPARSER::PROTEIN) ("sugars" . SPARSER::MOLECULE)
    ("VEGF or HGF" . SPARSER::COLLECTION)
    ("Rab5 or Rab9" . SPARSER::COLLECTION) ("Rab9" . SPARSER::PROTEIN)
    ("Rab" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("VEGF:VEGFR2" . SPARSER::BIO-COMPLEX) ("P4HB/PDI" . SPARSER::COLLECTION)
    ("PDI" . SPARSER::PROTEIN) ("extracellular VEGF" . SPARSER::PROTEIN)
    ("exogenous VEGF" . SPARSER::PROTEIN)
    ("MET and VEGF" . SPARSER::COLLECTION)
    ("neutralized essentially all the detectable extracellular VEGF"
     . SPARSER::PROTEIN)
    ("HIF" . SPARSER::PROTEIN-FAMILY) ("MET or PI3K" . SPARSER::COLLECTION)
    ("MEK or JAK" . SPARSER::COLLECTION)
    ("VEGFR1, FGFR1 and EGFR" . SPARSER::COLLECTION)
    ("inhibitor (SMI)" . SPARSER::INHIBITOR) ("SMI" . SPARSER::PROTEIN)
    ("VEGF–VEGFR2" . SPARSER::COLLECTION)
    ("MET and VEGFR2" . SPARSER::COLLECTION)
    ("VEGFR2 and MET" . SPARSER::COLLECTION)
    ("the EGFR inhibitor erlotinib and the anti-MET antibody onartuzumab"
     . SPARSER::COLLECTION)
    ("onartuzumab" . SPARSER::DRUG) ("EGFR and MET" . SPARSER::COLLECTION)
    ("ERBB3–PI3-kinase" . SPARSER::COLLECTION)
    ("EGFR, ERBB2 and IGF-1R" . SPARSER::COLLECTION)
    ("Hepatocyte growth factor (HGF)" . SPARSER::PROTEIN)
    ("MET and VEGFR2—two" . SPARSER::COLLECTION)
    ("MET and either VEGF or MEK" . SPARSER::COLLECTION)
    ("VEGF or MEK" . SPARSER::COLLECTION)
    ("VEGFR2 and MEK" . SPARSER::COLLECTION)
    ("VEGF and VEGFR2" . SPARSER::COLLECTION) ("inositol" . SPARSER::PROTEIN)
    ("HGF–MET" . SPARSER::COLLECTION)
    ("their respective receptors, MET and VEGF receptor" . SPARSER::RECEPTOR)
    ("receptors, MET and VEGF" . SPARSER::COLLECTION)
    ("MET" . SPARSER::PROTEIN) ("B–E" . SPARSER::PROTEIN)
    ("C/EBP-homologous protein" . SPARSER::PROTEIN) ("S5" . SPARSER::MOLECULE)
    ("p97" . SPARSER::PROTEIN) ("VE-cadherin" . SPARSER::PROTEIN)
    ("Peptide- N" . SPARSER::PROTEIN) ("N-glycans" . SPARSER::MOLECULE)
    ("phospho-tyrosine" . SPARSER::MOLECULE) ("Rab8" . SPARSER::PROTEIN)
    ("F-actin" . SPARSER::BIO-COMPLEX) ("B20" . SPARSER::PROTEIN)
    ("IRE1α" . SPARSER::PROTEIN) ("GDC0941" . SPARSER::DRUG)
    ("IRE1 α" . SPARSER::PROTEIN) ("XBP-1" . SPARSER::PROTEIN)
    ("HRD1" . SPARSER::PROTEIN) ("gp78" . SPARSER::PROTEIN)
    ("GOLGA2" . SPARSER::PROTEIN) ("P4HB" . SPARSER::PROTEIN)
    ("anti-VEGF" . SPARSER::DRUG) ("VEGFR1" . SPARSER::PROTEIN)
    ("G10" . SPARSER::PROTEIN) ("Gab1" . SPARSER::PROTEIN)
    ("Rab5" . SPARSER::PROTEIN) ("N 2" . SPARSER::PROTEIN)
    ("1B" . SPARSER::PROTEIN) ("ERBB3" . SPARSER::PROTEIN)
    ("VEGF-A" . SPARSER::PROTEIN) ("scatter factor" . SPARSER::PROTEIN)
    ("VEGFR2" . SPARSER::PROTEIN)
    ("Hepatocyte growth factor" . SPARSER::PROTEIN)
    ("Dyrk1a and developmental malformations" . SPARSER::COLLECTION)
    ("developmental malformations" . SPARSER::PROTEIN)
    ("DS" . SPARSER::PROTEIN) ("A20" . SPARSER::PROTEIN)
    ("Dyrk1a" . SPARSER::PROTEIN) ("pathological states" . SPARSER::BIO-STATE)
    ("v" . SPARSER::PROTEIN)
    ("the GLUT4 glucose transporter and subsequent hypoglycemia [ xref ]"
     . SPARSER::COLLECTION)
    ("AKTs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the other phenotypic traits" . SPARSER::PROTEIN)
    ("gene and location" . SPARSER::COLLECTION) ("CPD" . SPARSER::PROTEIN)
    ("allelic variants" . SPARSER::VARIANT)
    ("gene and cancer" . SPARSER::COLLECTION)
    ("Akts" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mammalian target of rapamycin, Bad, Bax, Mdm2, and Foxo"
     . SPARSER::COLLECTION)
    ("Foxo" . SPARSER::PROTEIN-FAMILY) ("Akt2 and Akt3" . SPARSER::COLLECTION)
    ("the cellular homologue" . SPARSER::PROTEIN)
    ("v-Akt" . SPARSER::COLLECTION) ("serine-threonine" . SPARSER::COLLECTION)
    ("cigarettes" . SPARSER::DRUG)
    ("an elderly Japanese cohort" . SPARSER::MOLECULE)
    ("GLUT4" . SPARSER::PROTEIN) ("PKB γ" . SPARSER::PROTEIN)
    ("Akt3" . SPARSER::PROTEIN) ("Akt2" . SPARSER::PROTEIN)
    ("PKB α" . SPARSER::PROTEIN) ("Akt1" . SPARSER::PROTEIN)
    ("AKT1" . SPARSER::PROTEIN) ("enzymes and 5hmC" . SPARSER::COLLECTION)
    ("cytosines" . SPARSER::NUCLEOBASE)
    ("aspartate or lysine" . SPARSER::COLLECTION)
    ("aspartate" . SPARSER::PROTEIN) ("net" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TET1 and PARP-1/ARTD1 which seems to be strengthened by PARs"
     . SPARSER::COLLECTION)
    ("OGT" . SPARSER::PROTEIN) ("TETs" . SPARSER::PROTEIN)
    ("purifying PARylated GST-TET1" . SPARSER::COLLECTION)
    ("GST-TET1" . SPARSER::COLLECTION)
    ("TET1 and PARP-1" . SPARSER::COLLECTION)
    ("TET1 or anti" . SPARSER::COLLECTION) ("anti" . SPARSER::PROTEIN)
    ("PARP-1 and TET1" . SPARSER::COLLECTION)
    ("CD-1 and CD-2" . SPARSER::COLLECTION) ("CD-1" . SPARSER::PROTEIN)
    ("FL-1 or FL-2" . SPARSER::COLLECTION)
    ("FL-1 and FL-2" . SPARSER::COLLECTION)
    ("effector (TALE)" . SPARSER::EFFECTOR) ("dot-blot" . SPARSER::PROTEIN)
    ("CTRL" . SPARSER::PROTEIN)
    ("PARP-1, PARP-2, PARP-3 and PARG" . SPARSER::COLLECTION)
    ("two competitive inhibitors" . SPARSER::INHIBITOR)
    ("Pj-34 and ABT-888" . SPARSER::COLLECTION)
    ("active promoters" . SPARSER::PROMOTER)
    ("DNA glycosylase (TDG)" . SPARSER::PROTEIN) ("TDG" . SPARSER::PROTEIN)
    ("Thymine" . SPARSER::MOLECULE) ("methylase" . SPARSER::PROTEIN)
    ("TET1, TET2 and TET3" . SPARSER::COLLECTION) ("ISWI" . SPARSER::PROTEIN)
    ("secondary DNA" . SPARSER::DNA) ("PARG" . SPARSER::PROTEIN)
    ("PARPs" . SPARSER::MOLECULE) ("PARP-1/ARTD1" . SPARSER::COLLECTION)
    ("TET" . SPARSER::PROTEIN) ("histone 2B" . SPARSER::PROTEIN)
    ("DNAse I" . SPARSER::PROTEIN) ("Lamin B1" . SPARSER::PROTEIN)
    ("PJ-34" . SPARSER::DRUG) ("O-GlcNAc" . SPARSER::PROTEIN)
    ("N-acetylglucosamine" . SPARSER::MOLECULE)
    ("histone H2B" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CD-2" . SPARSER::PROTEIN)
    ("FL-2" . SPARSER::PROTEIN) ("FL-1" . SPARSER::PROTEIN)
    ("PARP-3" . SPARSER::PROTEIN) ("PARP-2" . SPARSER::PROTEIN)
    ("ABT-888" . SPARSER::DRUG) ("Pj-34" . SPARSER::DRUG)
    ("TET3" . SPARSER::PROTEIN) ("TET2" . SPARSER::PROTEIN)
    ("Fe(II)" . SPARSER::MOLECULE) ("KDM4D" . SPARSER::PROTEIN)
    ("KDM5B" . SPARSER::PROTEIN) ("HP1" . SPARSER::PROTEIN)
    ("SOX2" . SPARSER::PROTEIN)
    ("ADP-ribosyltransferase diphtheria toxin-like 1" . SPARSER::PROTEIN)
    ("ADP-ribosyl" . SPARSER::MOLECULE) ("ARTD1" . SPARSER::PROTEIN)
    ("TET1" . SPARSER::PROTEIN) ("proteins and peptides" . SPARSER::COLLECTION)
    ("Myc and Ras" . SPARSER::COLLECTION)
    ("arf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the weakly interacting unphosphorylated peptide" . SPARSER::PEPTIDE)
    ("the CPP-peptide" . SPARSER::MOLECULE) ("CPP-peptide" . SPARSER::MOLECULE)
    ("AuNP-protein" . SPARSER::COLLECTION)
    ("BH3 BIM (I155R/E158S) and its variants" . SPARSER::COLLECTION)
    ("BAX or PUMA" . SPARSER::COLLECTION)
    ("GST-BH3 BIM (E158S) and GST-BH3 BIM (I155R/E158A)" . SPARSER::COLLECTION)
    ("nanoparticles" . SPARSER::MOLECULE) ("-GSK3 β" . SPARSER::COLLECTION)
    ("constitutively active Akt (myristoylated Akt; Akt-Myr) or kinase-dead-Akt (Akt-KD)"
     . SPARSER::COLLECTION)
    ("ectopically expressing wild-type Akt (Akt-WT), constitutively active Akt (myristoylated Akt; Akt-Myr) or kinase-dead-Akt (Akt-KD)"
     . SPARSER::COLLECTION)
    ("Akt-KD" . SPARSER::COLLECTION) ("Myr" . SPARSER::MOLECULE)
    ("myristoylated" . SPARSER::PROTEIN) ("peptide (CPP)" . SPARSER::PEPTIDE)
    ("CPP" . SPARSER::MOLECULE)
    ("a single conformation and makes intermolecular interactions with Tyr101 and Arg100"
     . SPARSER::COLLECTION)
    ("–p-BH3" . SPARSER::MOLECULE)
    ("nearly identical conformations" . SPARSER::BIO-CONFORMATION)
    ("conformations" . SPARSER::BIO-CONFORMATION)
    ("the crystalline state" . SPARSER::BIO-STATE)
    ("–BIM" . SPARSER::COLLECTION)
    ("a dual conformation" . SPARSER::BIO-CONFORMATION)
    ("BCL-2 and GST-PUMA" . SPARSER::COLLECTION)
    ("BH3 BIM (I155R/E158S) and GST-PUMA" . SPARSER::COLLECTION)
    ("GST-PUMA" . SPARSER::COLLECTION)
    ("BAX (or BAK) and BCL-2" . SPARSER::COLLECTION)
    ("PUMA and BCL-2" . SPARSER::COLLECTION)
    ("BAX or BAK" . SPARSER::COLLECTION)
    ("BCL-2 or BCL-X" . SPARSER::COLLECTION)
    ("BAX and BAK" . SPARSER::COLLECTION) ("BAK" . SPARSER::PROTEIN)
    ("a longer 36-mer BIM BH3 peptide" . SPARSER::PEPTIDE)
    ("BCL-2 and BCL-X" . SPARSER::COLLECTION)
    ("GST and GST-tagged BH3 BIM (I155R/E158A)" . SPARSER::COLLECTION)
    ("GD" . SPARSER::PROTEIN) ("ABT-737 and ABT-263" . SPARSER::COLLECTION)
    ("BID and BIM" . SPARSER::COLLECTION) ("‘activators'" . SPARSER::ACTIVATOR)
    ("BID" . SPARSER::PROTEIN)
    ("a potent apoptogenic molecule" . SPARSER::MOLECULE)
    ("peptide or protein" . SPARSER::COLLECTION) ("CCP4" . SPARSER::PROTEIN)
    ("β -mercaptoethanol" . SPARSER::MOLECULE)
    ("receptor protein" . SPARSER::RECEPTOR-PROTEIN) ("S6K" . SPARSER::PROTEIN)
    ("Cytochrome c" . SPARSER::PROTEIN) ("GSK3 β" . SPARSER::PROTEIN)
    ("p-BH3" . SPARSER::MOLECULE) ("BCL-w" . SPARSER::PROTEIN)
    ("ABT-263" . SPARSER::DRUG) ("ABT-737" . SPARSER::DRUG)
    ("BCL-B" . SPARSER::PROTEIN) ("BCl-w" . SPARSER::PROTEIN)
    ("BH4" . SPARSER::PROTEIN-FAMILY) ("BH1" . SPARSER::PROTEIN)
    ("BCL-X" . SPARSER::PROTEIN) ("wnt/β-catenin" . SPARSER::COLLECTION)
    ("β-catenin and cyclin D" . SPARSER::COLLECTION)
    ("efficient efflux chemotherapeutic drug" . SPARSER::DRUG)
    ("cytotoxins" . SPARSER::PROTEIN)
    ("ABCG2 and stem cell surface proteins" . SPARSER::COLLECTION)
    ("ABCG2 and stem cell genes" . SPARSER::COLLECTION)
    ("the wnt target gene cyclin D1, ABCG2 and stem cell genes"
     . SPARSER::COLLECTION)
    ("wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cisplatin, paclitaxel and oxaliplatin" . SPARSER::COLLECTION)
    ("verapamil" . SPARSER::DRUG)
    ("Oct-4, Sox-2 and Nanog" . SPARSER::COLLECTION)
    ("Nanog" . SPARSER::PROTEIN) ("subsequent western blot" . SPARSER::PROTEIN)
    ("β-catenin and cyclin D1" . SPARSER::COLLECTION)
    ("OCT-4" . SPARSER::PROTEIN) ("Sox2" . SPARSER::PROTEIN)
    ("CS4" . SPARSER::PROTEIN) ("bis-benzimide" . SPARSER::MOLECULE)
    ("adenosine triphosphate" . SPARSER::MOLECULE) ("Sox-2" . SPARSER::PROTEIN)
    ("Oct-4" . SPARSER::PROTEIN) ("IL-4 and IL-13" . SPARSER::COLLECTION)
    ("Leflunomide" . SPARSER::DRUG)
    ("progesterone and its metabolite testosterone [ xref ]"
     . SPARSER::COLLECTION)
    ("IGF-1 and TGFβ1" . SPARSER::COLLECTION)
    ("amino acids, minerals and vitamins" . SPARSER::COLLECTION)
    ("disaccharide" . SPARSER::MOLECULE) ("MEK1 and p38" . SPARSER::COLLECTION)
    ("leflunomide" . SPARSER::DRUG) ("p-STAT6" . SPARSER::COLLECTION)
    ("anti-IGF-1 and MA-20" . SPARSER::COLLECTION)
    ("IGF-1 ( xref ) and the insulin receptor ( xref )" . SPARSER::COLLECTION)
    ("testosterone" . SPARSER::MOLECULE) ("MAB" . SPARSER::DRUG)
    ("PKB/Akt" . SPARSER::COLLECTION)
    ("cytoplasmic histone-associated DNA" . SPARSER::DNA)
    ("lactalbumin" . SPARSER::PROTEIN) ("polar lipids" . SPARSER::LIPID)
    ("milk-derived immunoglobulins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("immunoglobulins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("light or corticosteroids" . SPARSER::COLLECTION)
    ("strong inducer" . SPARSER::PROTEIN) ("IL-13" . SPARSER::PROTEIN)
    ("IL4" . SPARSER::PROTEIN) ("Col1A1" . SPARSER::PROTEIN)
    ("P1NP" . SPARSER::PROTEIN) ("AG1478" . SPARSER::DRUG)
    ("LY-294002" . SPARSER::PROTEIN) ("STAT6" . SPARSER::PROTEIN)
    ("1A1" . SPARSER::PROTEIN) ("Dai" . SPARSER::PROTEIN)
    ("the observed STAC induced SIRT1 dimer" . SPARSER::DIMER)
    ("apo" . SPARSER::PROTEIN) ("mer" . SPARSER::PROTEIN)
    ("esp" . SPARSER::PROTEIN)
    ("the previously reported E230K mutant" . SPARSER::MUTANT)
    ("future structure-based drug" . SPARSER::DRUG)
    ("Both mini-hSIRT1(R446E) mutant and mini-hSIRT1(E230K,R446E) mutant"
     . SPARSER::COLLECTION)
    ("the aliphatic part" . SPARSER::COMPONENT)
    ("/Ac-p53" . SPARSER::COLLECTION)
    ("STAC and substrate" . SPARSER::COLLECTION)
    ("Lys or Ala" . SPARSER::COLLECTION) ("solution" . SPARSER::MOLECULE)
    ("peptide or NAM" . SPARSER::COLLECTION) ("TFA-p53" . SPARSER::COLLECTION)
    ("FOXO-3a" . SPARSER::PROTEIN)
    ("its carboxamide nitrogen and the carbonyl oxygen" . SPARSER::COLLECTION)
    ("carboxamide" . SPARSER::MOLECULE)
    ("the most compound-dependent mutant" . SPARSER::MUTANT)
    ("ring" . SPARSER::PROTEIN)
    ("a Trifluoroacetic acid (TFA)-p53 peptide" . SPARSER::PEPTIDE)
    ("-p53" . SPARSER::COLLECTION) ("TFA" . SPARSER::PROTEIN)
    ("the polybasic linker" . SPARSER::LINKER)
    ("guanidinium" . SPARSER::MOLECULE) ("anchors" . SPARSER::ANCHOR)
    ("Inhibitor" . SPARSER::INHIBITOR)
    ("the large and small lobes" . SPARSER::PROTEIN)
    ("peptide and carbaNAD" . SPARSER::COLLECTION) ("lobes" . SPARSER::PROTEIN)
    ("a quaternary complex" . SPARSER::BIO-COMPLEX)
    ("the observed crystallographic dimer" . SPARSER::DIMER)
    ("Leu" . SPARSER::AMINO-ACID)
    ("a Rossmann-fold large lobe and a zinc-binding small lobe"
     . SPARSER::COLLECTION)
    ("SIRT1cd/CTR" . SPARSER::COLLECTION)
    ("mini-hSIRT1 and the full-length enzyme" . SPARSER::COLLECTION)
    ("more efficient deacetylase activity" . SPARSER::PROTEIN)
    ("a minimally functional hSIRT1" . SPARSER::PROTEIN)
    ("hSIRT1/Ac-p53" . SPARSER::COLLECTION) ("Ac-p53" . SPARSER::COLLECTION)
    ("SBD" . SPARSER::PROTEIN) ("CTR" . SPARSER::PROTEIN)
    ("solvent" . SPARSER::MOLECULE)
    ("a Rossmann-fold large lobe and a zinc-binding small lobe and undergoes"
     . SPARSER::COLLECTION)
    ("lobe and undergoes" . SPARSER::COLLECTION) ("Glu" . SPARSER::AMINO-ACID)
    ("NAM" . SPARSER::PROTEIN-FAMILY) ("Mus" . SPARSER::PROTEIN)
    ("HDX" . SPARSER::PROTEIN) ("deuterium" . SPARSER::MOLECULE)
    ("STAC" . SPARSER::PROTEIN) ("Sodium chloride" . SPARSER::DRUG)
    ("of 45 " . SPARSER::PROTEIN) ("min −1" . SPARSER::PROTEIN)
    ("cm −1" . SPARSER::PROTEIN) ("mM −1" . SPARSER::PROTEIN)
    ("α-ketoglutarate" . SPARSER::MOLECULE) ("PNC1" . SPARSER::PROTEIN)
    ("FOXO-3" . SPARSER::PROTEIN) ("EX-527" . SPARSER::DRUG)
    ("C - t" . SPARSER::PROTEIN) ("hSIRT1" . SPARSER::PROTEIN)
    ("relevant therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("CDR" . SPARSER::PROTEIN) ("Fab fragments" . SPARSER::FRAGMENT)
    ("src" . SPARSER::PROTEIN) ("soluble HER2" . SPARSER::PROTEIN)
    ("streptavidin (the binding functionality used to capture HER2 on beads during the panning procedure) as well as lysozyme (a highly charged globular protein known to provide an easy docking surface for binding)"
     . SPARSER::COLLECTION)
    ("lysozyme" . SPARSER::PROTEIN) ("C-cap" . SPARSER::PROTEIN)
    ("Herceptin" . SPARSER::DRUG)
    ("DNA ( xref ) and mHaeIII ( xref ) display" . SPARSER::COLLECTION)
    ("AGT" . SPARSER::PROTEIN)
    ("the HER2/neu transmembrane tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("globular proteins" . SPARSER::PROTEIN) ("cystine" . SPARSER::MOLECULE)
    ("antibodies and other binding proteins ( xref ; xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("water" . SPARSER::MOLECULE) ("SNAP" . SPARSER::PROTEIN)
    ("F3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("M −1" . SPARSER::PROTEIN)
    ("s 5a" . SPARSER::PROTEIN) ("SO 4" . SPARSER::PROTEIN)
    ("M15" . SPARSER::DRUG) ("O 6" . SPARSER::PROTEIN)
    ("tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("leucine-rich repeat" . SPARSER::PROTEIN)
    ("ankyrin repeat" . SPARSER::PROTEIN) ("run" . SPARSER::PROTEIN-FAMILY)
    ("both a tumor suppressor and an oncogene in intestinal tumors"
     . SPARSER::COLLECTION)
    ("An historical example" . SPARSER::EXAMPLE) ("Gen" . SPARSER::PROTEIN)
    ("functional miRNA" . SPARSER::PROTEIN)
    ("exosomal-delivered miRNA" . SPARSER::PROTEIN)
    ("sphingomyelinase" . SPARSER::PROTEIN)
    ("some exosomal miRNAs" . SPARSER::PROTEIN) ("-NTA" . SPARSER::MOLECULE)
    ("NTA" . SPARSER::MOLECULE)
    ("a universal zip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("zip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Zip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("anti-miRs and miRNA" . SPARSER::COLLECTION) ("Apc" . SPARSER::PROTEIN)
    ("proteins and pre-miRNAs" . SPARSER::COLLECTION)
    ("RISC" . SPARSER::PROTEIN) ("Dicer" . SPARSER::PROTEIN)
    ("more homogenous types" . TYPE)
    ("tumor-suppressive miRNAs" . SPARSER::PROTEIN)
    ("uridine" . SPARSER::PROTEIN) ("-adenylated" . SPARSER::DRUG)
    ("adenylated" . SPARSER::DRUG) ("guanosine" . SPARSER::MOLECULE)
    ("neither Drosha ( xref ) nor XPO5 ( xref )" . SPARSER::COLLECTION)
    ("Drosha" . SPARSER::PROTEIN) ("Distinct miRNA" . SPARSER::PROTEIN)
    ("Luc-mTOR" . SPARSER::COLLECTION) ("AI" . SPARSER::PROTEIN)
    ("Luc-CTL" . SPARSER::COLLECTION) ("CTL" . SPARSER::PROTEIN)
    ("Sphingomyelinase" . SPARSER::PROTEIN)
    ("exosomal miRNAs" . SPARSER::PROTEIN)
    ("distinct miRNAs" . SPARSER::PROTEIN)
    ("cellular miRNAs" . SPARSER::PROTEIN) ("DKO-1" . SPARSER::PROTEIN)
    ("KRAS DKO-1" . SPARSER::PROTEIN) ("KRAS-" . SPARSER::PROTEIN)
    ("parental DLD-1" . SPARSER::PROTEIN) ("small exosomal RNA" . SPARSER::RNA)
    ("larger RNAs" . SPARSER::RNA) ("snRNAs" . SPARSER::PROTEIN)
    ("rRNAs" . SPARSER::RNA) ("tRNAs" . SPARSER::PROTEIN)
    ("ncRNA" . SPARSER::RNA) ("The global small RNA" . SPARSER::RNA)
    ("exosomal miRNA" . SPARSER::PROTEIN) ("cellular miRNA" . SPARSER::PROTEIN)
    ("Exosomal miRNA" . SPARSER::PROTEIN)
    ("miRNAs or proteins" . SPARSER::COLLECTION)
    ("miRNAs and other RNAs" . SPARSER::COLLECTION)
    ("Mature miRNAs" . SPARSER::PROTEIN) ("ncRNAs" . SPARSER::RNA)
    ("rid" . SPARSER::DRUG) ("lipids and proteins" . SPARSER::COLLECTION)
    ("proteins and RNA" . SPARSER::COLLECTION)
    ("extracellular miRNAs" . SPARSER::PROTEIN)
    ("exosomal RNAs" . SPARSER::RNA) ("Ago2" . SPARSER::PROTEIN)
    ("cog-1" . SPARSER::PROTEIN) ("For 3" . SPARSER::PROTEIN)
    ("S18" . SPARSER::PROTEIN) ("hsa-let-7" . SPARSER::RNA)
    ("bcl2" . SPARSER::PROTEIN) ("pre-miRNAs" . SPARSER::RNA)
    ("CD43" . SPARSER::PROTEIN) ("SMARCA5" . SPARSER::PROTEIN)
    ("LGR5" . SPARSER::PROTEIN) ("XPO1" . SPARSER::PROTEIN)
    ("XPO5" . SPARSER::PROTEIN) ("miR-10" . SPARSER::PROTEIN)
    ("GW4869" . SPARSER::DRUG) ("nSMase 2" . SPARSER::PROTEIN)
    ("hnRNP A2" . SPARSER::PROTEIN)
    ("neutral sphingomyelinase" . SPARSER::PROTEIN)
    ("Argonaute 2" . SPARSER::PROTEIN)
    ("Neutral sphingomyelinase" . SPARSER::PROTEIN)
    ("miR-10b" . SPARSER::MOLECULE)
    ("those traditional nuclear receptor variants" . SPARSER::VARIANT)
    ("KDa" . SPARSER::PROTEIN)
    ("that estrogens and their receptors play critical roles in various cancers"
     . SPARSER::COLLECTION)
    ("ERs, ERα and ERβ" . SPARSER::COLLECTION) ("ERβ" . SPARSER::PROTEIN)
    ("collagenase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("extracellular proteases" . SPARSER::PROTEIN)
    ("a key transcription factor" . SPARSER::PROTEIN)
    ("Wnt or TGF-β" . SPARSER::COLLECTION)
    ("ERK and phosphatidylinositol 3-kinase" . SPARSER::COLLECTION)
    ("VPA" . SPARSER::PROTEIN) ("MMP-2 or MMP-9" . SPARSER::COLLECTION)
    ("pretreatment AKT inhibitor (LY49002, 50 μM) or ERK inhibitor (PD98059, 50 μM)"
     . SPARSER::COLLECTION)
    ("E-cadherin and tight junction protein ZO-1" . SPARSER::COLLECTION)
    ("derivative TDPN" . SPARSER::DERIVATIVE)
    ("TDPN or Vaseline" . SPARSER::COLLECTION)
    ("the mesenchymal marker fibronectin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E-cadherin and Zo-1" . SPARSER::COLLECTION)
    ("Zo-1 and E-cadherin" . SPARSER::COLLECTION) ("Zo-1" . SPARSER::PROTEIN)
    ("TGF-β1 (10 ng/ml) and TDPN" . SPARSER::COLLECTION)
    ("a PI3K inhibitor (LY49002, 50 μM) and a MEK inhibitor (PD98059, 50 μM)"
     . SPARSER::COLLECTION)
    ("TDPN or left" . SPARSER::COLLECTION)
    ("either DMSO or TDPN" . SPARSER::COLLECTION)
    ("Keratinocytes" . SPARSER::PROTEIN) ("TGF and TDPN" . SPARSER::COLLECTION)
    ("TDPN" . SPARSER::DERIVATIVE) ("derivative (TDPN)" . SPARSER::DERIVATIVE)
    ("flavones" . SPARSER::DRUG)
    ("NF-κB, JNK, and p38 MAPK" . SPARSER::COLLECTION)
    ("naphthoate" . SPARSER::MOLECULE) ("naphthol" . SPARSER::MOLECULE)
    ("Pure chalcones" . SPARSER::MOLECULE) ("chalcones" . SPARSER::MOLECULE)
    ("Snail and Slug" . SPARSER::COLLECTION) ("Snail" . SPARSER::PROTEIN)
    ("type 1-MMP" . SPARSER::COLLECTION)
    ("MMP-1, MMP-2, MMP-9, and MMP-13" . SPARSER::COLLECTION)
    ("EMT and MMPs" . SPARSER::COLLECTION)
    ("endopeptidases" . SPARSER::PROTEIN) ("Slug" . SPARSER::PROTEIN)
    ("naphthalen" . SPARSER::MOLECULE) ("protein 3" . SPARSER::PROTEIN)
    ("MAP kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3Ks" . SPARSER::PROTEIN) ("PI3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tight junction protein ZO-1" . SPARSER::PROTEIN)
    ("H-E" . SPARSER::PROTEIN) ("TGFβ1" . SPARSER::PROTEIN)
    ("R-250" . SPARSER::PROTEIN) ("Dimethyl sulfoxide" . SPARSER::MOLECULE)
    ("HSD1" . SPARSER::PROTEIN) ("MT1-MMP" . SPARSER::PROTEIN)
    ("MMP-13" . SPARSER::PROTEIN) ("MMP-1" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-1" . SPARSER::PROTEIN)
    ("CFTR" . SPARSER::PROTEIN) ("PLAU" . SPARSER::PROTEIN)
    ("YWHAZ" . SPARSER::PROTEIN) ("cyclinD1–RB" . SPARSER::COLLECTION)
    ("cyclin D1 and the proliferation marker Ki-67 ( P  <   0.0001)"
     . SPARSER::COLLECTION)
    ("pCMV-CCND1" . SPARSER::COLLECTION)
    ("pSGG-luciferase" . SPARSER::COLLECTION) ("pre-miR" . SPARSER::COLLECTION)
    ("miR-193b and CCND1" . SPARSER::COLLECTION)
    ("PC ( n  = 26) and CRPC ( n  = 9) samples using MethylMiner-qPCR"
     . SPARSER::COLLECTION)
    ("EP" . SPARSER::PROTEIN) ("LNCaP" . SPARSER::PROTEIN)
    ("the principal substrate" . SPARSER::SUBSTRATE)
    ("CCND1, ETS1 , and KIT" . SPARSER::COLLECTION) ("aka" . SPARSER::PROTEIN)
    ("hsa" . SPARSER::PROTEIN)
    ("multiple targets and one mRNA molecule" . SPARSER::COLLECTION)
    ("the second most frequently diagnosed cancer type and the sixth leading cause of cancer-related deaths"
     . SPARSER::COLLECTION)
    ("PC-3 and DU145" . SPARSER::COLLECTION)
    ("cystic fibrosis transmembrane conductance regulator" . SPARSER::PROTEIN)
    ("cyclinD1" . SPARSER::PROTEIN) ("S4" . SPARSER::PROTEIN-FAMILY)
    ("PD0332991" . SPARSER::DRUG)
    ("Methyl-CpG Binding Domain Protein 2" . SPARSER::PROTEIN)
    ("MBD2" . SPARSER::PROTEIN) ("β -Actin" . SPARSER::PROTEIN)
    ("SP4" . SPARSER::PROTEIN) ("C-15" . SPARSER::PROTEIN)
    ("androgen receptor" . SPARSER::PROTEIN) ("CDKs 4" . SPARSER::PROTEIN)
    ("prostate-specific antigen" . SPARSER::PROTEIN)
    ("DU145" . SPARSER::PROTEIN) ("miR-193b" . SPARSER::MOLECULE)
    ("Micro-RNAs" . SPARSER::MICRO-RNA)
    ("a valuable oncogene" . SPARSER::ONCOGENE)
    ("the differential miRNAs" . SPARSER::PROTEIN)
    ("si-RASA1" . SPARSER::COLLECTION)
    ("the low-miR-182 group and the high-miR-182 group (Table  xref )"
     . SPARSER::COLLECTION)
    ("normoxia and hypoxia" . SPARSER::COLLECTION)
    ("Hif" . SPARSER::PROTEIN-FAMILY) ("TMZ" . SPARSER::DRUG)
    ("Hypoxia" . SPARSER::PROTEIN) ("MSPP1" . SPARSER::PROTEIN)
    ("S1B" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor 1 alpha" . SPARSER::PROTEIN)
    ("type 3" . SPARSER::PROTEIN) ("VMP1" . SPARSER::PROTEIN)
    ("RASA1" . SPARSER::PROTEIN) ("liposomes" . SPARSER::PROTEIN)
    ("a tumour-specific gene" . SPARSER::GENE)
    ("low-grade PCa and high-grade PCa (P=0.033)" . SPARSER::COLLECTION)
    ("Para-PCa" . SPARSER::COLLECTION) ("Para" . SPARSER::PROTEIN-FAMILY)
    ("a valid molecular target" . SPARSER::TARGET-PROTEIN)
    ("Puro" . SPARSER::PROTEIN) ("antigen (PSA)" . SPARSER::PROTEIN)
    ("PSA" . SPARSER::PROTEIN) ("TEAD1 and TEAD2" . SPARSER::COLLECTION)
    ("diap1" . SPARSER::PROTEIN) ("para-PCa" . SPARSER::COLLECTION)
    ("para" . SPARSER::PROTEIN-FAMILY) ("PC-3" . SPARSER::PROTEIN)
    ("prostatic" . SPARSER::PROTEIN) ("PCa" . SPARSER::PROTEIN)
    ("androgen" . SPARSER::PROTEIN)
    ("Yes-associated protein" . SPARSER::PROTEIN)
    ("protein expressed in" . SPARSER::PROTEIN) ("YAP 1" . SPARSER::PROTEIN)
    ("YAP-1" . SPARSER::PROTEIN) ("TEAD2" . SPARSER::PROTEIN)
    ("TEAD1" . SPARSER::PROTEIN) ("family member 1" . SPARSER::PROTEIN)
    ("YAP65" . SPARSER::PROTEIN)
    ("AKT, ERK, and β -catenin" . SPARSER::COLLECTION)
    ("p-ERK1/2, and p-" . SPARSER::COLLECTION)
    ("AKT, ERK1/2, and β -catenin" . SPARSER::COLLECTION)
    ("directly target human TAZ" . SPARSER::PROTEIN) ("PLC" . SPARSER::PROTEIN)
    ("-let7" . SPARSER::RNA) ("protein (YAP)" . SPARSER::PROTEIN)
    ("Erk1/2, AKT, and β -catenin" . SPARSER::COLLECTION)
    ("HLF" . SPARSER::PROTEIN) ("HC" . SPARSER::PROTEIN)
    ("β -actin" . SPARSER::PROTEIN) ("a 15" . SPARSER::PROTEIN)
    ("let7" . SPARSER::RNA) ("β -catenin" . SPARSER::PROTEIN)
    ("SELumetinib" . SPARSER::DRUG) ("TP53 and LKB1" . SPARSER::COLLECTION)
    ("taxane" . SPARSER::DRUG) ("codons" . SPARSER::PROTEIN)
    ("RAS/RAF/MEK/ERK" . SPARSER::COLLECTION)
    ("MEK or p38" . SPARSER::COLLECTION) ("Biomarker" . SPARSER::MOLECULE)
    ("selumetinib" . SPARSER::DRUG) ("IIIB" . SPARSER::DRUG)
    ("docetaxel" . SPARSER::DRUG) ("Selumetinib" . SPARSER::DRUG)
    ("LKB1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MG2" . SPARSER::PROTEIN)
    ("−  2" . SPARSER::PROTEIN) ("ARRY-142886" . SPARSER::DRUG)
    ("AZD6244" . SPARSER::DRUG) ("mitotic centrosomes" . SPARSER::PROTEIN)
    ("Mio and SEACAT/GATOR2" . SPARSER::COLLECTION)
    ("Plk1 mitotic kinase" . SPARSER::KINASE)
    ("centrosomes and microtubules" . SPARSER::COLLECTION)
    ("Eg5 and TPX2" . SPARSER::COLLECTION)
    ("HURP, TPX2, and Eg5" . SPARSER::COLLECTION)
    ("centrosomal Plk1" . SPARSER::PROTEIN)
    ("the essential mitotic kinases" . SPARSER::KINASE)
    ("Rapamycin" . SPARSER::DRUG) ("Mio and PTEN" . SPARSER::COLLECTION)
    ("phosphatase and tensin" . SPARSER::COLLECTION)
    ("tensin" . SPARSER::PROTEIN) ("p70S6K" . SPARSER::PROTEIN)
    ("S6K1 and 4EBP1" . SPARSER::COLLECTION)
    ("the Ring8A nor ΔPHD mutants" . SPARSER::COLLECTION)
    ("RING8A , and si02" . SPARSER::COLLECTION)
    ("GFP-Mio" . SPARSER::COLLECTION)
    ("the last 91 amino acids" . SPARSER::AMINO-ACID)
    ("cysteine and histidine" . SPARSER::COLLECTION)
    ("zinc-binding" . SPARSER::PROTEIN)
    ("Cysteine and histidine" . SPARSER::COLLECTION)
    ("Cysteine" . SPARSER::AMINO-ACID) ("UBC13/MMS2" . SPARSER::COLLECTION)
    ("Bank" . SPARSER::PROTEIN) ("Homology" . SPARSER::PROTEIN)
    ("histidine and cysteine" . SPARSER::COLLECTION)
    ("RING/PHD" . SPARSER::COLLECTION) ("histidine" . SPARSER::AMINO-ACID)
    ("PHD" . SPARSER::PROTEIN) ("Ring" . SPARSER::PROTEIN)
    ("Both NuMA and the dynactin subunit p150" . SPARSER::COLLECTION)
    ("astral microtubules" . SPARSER::PROTEIN) ("NuMA" . SPARSER::PROTEIN)
    ("CDK and Plk1" . SPARSER::COLLECTION)
    ("end–directed bipolar kinesin Eg5" . SPARSER::PROTEIN)
    ("GFP-MCAK" . SPARSER::COLLECTION)
    ("kinetochore-associated MCAK" . SPARSER::PROTEIN)
    ("centrosomal MCAK" . SPARSER::PROTEIN)
    ("inner centromeres" . SPARSER::PROTEIN)
    ("TPX2 and histone" . SPARSER::COLLECTION)
    ("HURP and MCAK" . SPARSER::COLLECTION)
    ("Plk1 and active" . SPARSER::COLLECTION)
    ("Mio and PPP6C" . SPARSER::COLLECTION) ("using si02" . SPARSER::PROTEIN)
    ("si02ResGFP-Mio" . SPARSER::COLLECTION) ("BI" . SPARSER::PROTEIN)
    ("these mitotic kinases" . SPARSER::KINASE)
    ("centromeres" . SPARSER::PROTEIN)
    ("kinesin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Monastrol" . SPARSER::DRUG)
    ("γ-tubulin or pericentrin" . SPARSER::COLLECTION)
    ("These included abnormal tilt" . SPARSER::DRUG) ("tilt" . SPARSER::DRUG)
    ("α-tubulin and the centrosomal markers γ-tubulin and pericentrin"
     . SPARSER::COLLECTION)
    ("the centrosomal markers γ-tubulin and pericentrin" . SPARSER::COLLECTION)
    ("γ-tubulin and pericentrin" . SPARSER::COLLECTION)
    ("Bub1 and Sgo1" . SPARSER::COLLECTION) ("nocodazole" . SPARSER::DRUG)
    ("EGFP-H2B" . SPARSER::COLLECTION) ("EGFP–α-tubulin" . SPARSER::COLLECTION)
    ("mRFP-H2B" . SPARSER::PROTEIN-PAIR) ("nucleoporins" . SPARSER::PROTEIN)
    ("mCherry-Mio" . SPARSER::COLLECTION) ("Mio–Seh1" . SPARSER::COLLECTION)
    ("GFP-Seh1" . SPARSER::COLLECTION)
    ("Mio, WDR24, and WDR59" . SPARSER::COLLECTION)
    ("Rag-1 and mTOR" . SPARSER::COLLECTION) ("Rag" . SPARSER::PROTEIN)
    ("Almost all documented mTOR" . SPARSER::PROTEIN)
    ("kinase and 4E-binding protein 1" . SPARSER::COLLECTION)
    ("raptor" . SPARSER::PROTEIN) ("mTORC1 and mTORC2" . SPARSER::COLLECTION)
    ("Bora" . SPARSER::PROTEIN) ("dynein–dynactin" . SPARSER::COLLECTION)
    ("LGN" . SPARSER::PROTEIN) ("dynactin" . SPARSER::PROTEIN-FAMILY)
    ("pericentrin and γ-tubulin" . SPARSER::COLLECTION)
    ("pericentrin" . SPARSER::PROTEIN) ("Eg5" . SPARSER::PROTEIN)
    ("Ajuba" . SPARSER::PROTEIN) ("CDK1/Cyclin" . SPARSER::COLLECTION)
    ("Cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NPC" . SPARSER::MOLECULE)
    ("nucleoporin" . SPARSER::PROTEIN)
    ("two key regulators of mitotic spindle formation and known substrates"
     . SPARSER::COLLECTION)
    ("MCAK and HURP" . SPARSER::COLLECTION) ("HURP" . SPARSER::PROTEIN)
    ("MCAK" . SPARSER::PROTEIN)
    ("active key mitotic kinases Plk1" . SPARSER::PROTEIN)
    ("centrosomes" . SPARSER::PROTEIN)
    ("active Plk1 and Aurora kinases" . SPARSER::COLLECTION)
    ("Mio" . SPARSER::PROTEIN) ("protein C" . SPARSER::DRUG)
    ("l -arginine" . SPARSER::MOLECULE) ("H11" . SPARSER::PROTEIN)
    ("Ph1" . SPARSER::PROTEIN) ("kinesin-13" . SPARSER::PROTEIN)
    ("RNA-binding protein" . SPARSER::PROTEIN) ("FKBP12" . SPARSER::PROTEIN)
    ("S6K1" . SPARSER::PROTEIN) ("MMS2" . SPARSER::PROTEIN)
    ("UBC13" . SPARSER::PROTEIN) ("RNF8" . SPARSER::PROTEIN)
    ("p150" . SPARSER::PROTEIN) ("PPP6C" . SPARSER::PROTEIN)
    ("Protein phosphatase 6" . SPARSER::PROTEIN) ("C–E" . SPARSER::PROTEIN)
    ("ZM447439" . SPARSER::DRUG) ("MLN8237" . SPARSER::DRUG)
    ("BI2536" . SPARSER::DRUG) ("A–C" . SPARSER::PROTEIN)
    ("Sgo1" . SPARSER::PROTEIN) ("Bub1" . SPARSER::PROTEIN)
    ("H2B" . SPARSER::PROTEIN) ("WDR59" . SPARSER::PROTEIN)
    ("WDR24" . SPARSER::PROTEIN) ("Nucleoporin Seh1" . SPARSER::PROTEIN)
    ("Rag-1" . SPARSER::PROTEIN) ("4E-binding protein 1" . SPARSER::PROTEIN)
    ("Mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("TACC3" . SPARSER::PROTEIN) ("TPX2" . SPARSER::PROTEIN)
    ("Seh1" . SPARSER::PROTEIN) ("nuclear pore" . SPARSER::BIO-COMPLEX)
    ("Nup107" . SPARSER::PROTEIN) ("mTORC1" . SPARSER::PROTEIN)
    ("Plk1" . SPARSER::PROTEIN) ("protein and PI3K/AKT" . SPARSER::COLLECTION)
    ("AKT-Myc and Madcam1-Myc in HL-7702 cells" . SPARSER::COLLECTION)
    ("p-AKT/AKT" . SPARSER::COLLECTION) ("AKT/GAPDH" . SPARSER::COLLECTION)
    ("AKT or Madcam1" . SPARSER::COLLECTION)
    ("the primary antibodies, either anti-AKT or anti-Madcam1"
     . SPARSER::ANTIBODY)
    ("anti-AKT or anti-Madcam1" . SPARSER::COLLECTION)
    ("anti-Madcam1 and anti-AKT" . SPARSER::COLLECTION)
    ("bright" . SPARSER::PROTEIN) ("AKT and Madcam1" . SPARSER::COLLECTION)
    ("IPs" . SPARSER::PROTEIN) ("exogenous Madcam1-FLAG" . SPARSER::COLLECTION)
    ("AKT-Myc" . SPARSER::COLLECTION) ("Madcam1-FLAG" . SPARSER::COLLECTION)
    ("AKT-shRNA" . SPARSER::COLLECTION) ("Wortmannin" . SPARSER::MOLECULE)
    ("antibodies and antibodies" . SPARSER::COLLECTION)
    ("4EBP1 and eIF4E" . SPARSER::COLLECTION) ("p-4EBP1" . SPARSER::COLLECTION)
    ("a translational control antibody" . SPARSER::ANTIBODY)
    ("Actinomycin D (transcription inhibitor) and MG132 (proteasome inhibitor)"
     . SPARSER::COLLECTION)
    ("re-examined three pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("Fas, Bax and p73" . SPARSER::COLLECTION)
    ("Livin, Bcl-2 and Survivin" . SPARSER::COLLECTION)
    ("Livin" . SPARSER::PROTEIN)
    ("proteins, HSP27, IGF-II and sTNF" . SPARSER::COLLECTION)
    ("Doxorubicin and Madcam1" . SPARSER::COLLECTION)
    ("CCS and Madcam1" . SPARSER::COLLECTION)
    ("CCS or Madcam1" . SPARSER::COLLECTION)
    ("the 40S ribosomal subunit" . SPARSER::FRAGMENT)
    ("DMSO-" . SPARSER::MOLECULE)
    ("exogenous Madcam1-Myc" . SPARSER::COLLECTION)
    ("Madcam1-Myc" . SPARSER::COLLECTION)
    ("substrates (CCS)" . SPARSER::SUBSTRATE) ("carboxy" . SPARSER::MOLECULE)
    ("CCS" . SPARSER::PROTEIN) ("AKT and Doxo" . SPARSER::COLLECTION)
    ("Madcam1 and AKT" . SPARSER::COLLECTION)
    ("the most widely used chemotherapeutic drugs" . SPARSER::DRUG)
    ("Doxorubicin" . SPARSER::PROTEIN) ("p-S6" . SPARSER::PROTEIN)
    ("CD206" . SPARSER::PROTEIN) ("CD166" . SPARSER::PROTEIN)
    ("CD151" . SPARSER::PROTEIN) ("CD74" . SPARSER::PROTEIN)
    ("CD50" . SPARSER::PROTEIN) ("5-2" . SPARSER::PROTEIN)
    ("4EBP" . SPARSER::PROTEIN) ("α4β7" . SPARSER::PROTEIN)
    ("p-Thr" . SPARSER::PROTEIN) ("NUP98" . SPARSER::PROTEIN)
    ("EBP1" . SPARSER::PROTEIN) ("E-4" . SPARSER::PROTEIN)
    ("Eukaryotic initiation factor 4E" . SPARSER::PROTEIN-FAMILY)
    ("Actinomycin D" . SPARSER::MOLECULE)
    ("adhesion molecule" . SPARSER::PROTEIN)
    ("aspartic acid" . SPARSER::AMINO-ACID)
    ("endothelial cell adhesion molecule" . SPARSER::PROTEIN)
    ("Madcam1" . SPARSER::PROTEIN)
    ("Mucosal vascular addressin cell adhesion molecule 1" . SPARSER::PROTEIN)
    ("nimotuzumab or other anti-EGFR drugs" . SPARSER::COLLECTION)
    ("anti-HER2, anti-HER3 or anti-mTOR" . SPARSER::COLLECTION)
    ("HER2 or HER3" . SPARSER::COLLECTION)
    ("PI3K-Akt-mTOR" . SPARSER::COLLECTION)
    ("HER2 and HER3" . SPARSER::COLLECTION)
    ("EGFR/p-Erk" . SPARSER::COLLECTION) ("EGFR/p-Akt" . SPARSER::COLLECTION)
    ("erlotinib, gefitinib or lapatinib" . SPARSER::COLLECTION)
    ("erlotinib or cetuximab" . SPARSER::COLLECTION)
    ("KRAS, EGFR or BRAF" . SPARSER::COLLECTION)
    ("cetuximab or gefitinib" . SPARSER::COLLECTION)
    ("EGFR and two phosphorylated proteins" . SPARSER::COLLECTION)
    ("3D-CRT" . SPARSER::COLLECTION) ("MV" . SPARSER::PROTEIN)
    ("concurrent h-R3" . SPARSER::PROTEIN)
    ("received concurrent h-R3 and CRT" . SPARSER::COLLECTION)
    ("h-R3 and CRT" . SPARSER::COLLECTION) ("Pre" . SPARSER::PROTEIN)
    ("p-" . SPARSER::PROTEIN) ("Nimotuzumab" . SPARSER::DRUG)
    ("RAS/RAF/MEK/Erk/MAPK" . SPARSER::COLLECTION)
    ("antagonists" . SPARSER::MOLECULE) ("p-Erk" . SPARSER::COLLECTION)
    ("Erk" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CRT" . SPARSER::PROTEIN)
    ("nimotuzumab" . SPARSER::DRUG) ("PI3K-Akt" . SPARSER::COLLECTION)
    ("h-R3" . SPARSER::PROTEIN)
    ("Nrf-2 and GPx1, and iii" . SPARSER::COLLECTION)
    ("GPx1, and iii" . SPARSER::COLLECTION) ("JNKs" . SPARSER::PROTEIN)
    ("lentiviral-mediated gene" . SPARSER::GENE)
    ("cytoprotective genes" . SPARSER::GENE)
    ("cisplatin and radiotherapy [ xref ]" . SPARSER::COLLECTION)
    ("peroxiredoxin" . SPARSER::PROTEIN)
    ("Hematoxylin and eosin" . SPARSER::COLLECTION)
    ("ataxia" . SPARSER::PROTEIN)
    ("Nrf-2, GPx1 and Bmi1" . SPARSER::COLLECTION)
    ("p-Nrf-2" . SPARSER::COLLECTION) ("Bmi1 and nestin" . SPARSER::COLLECTION)
    ("p38 and ATF2" . SPARSER::COLLECTION)
    ("mitogen-activated protein kinase (MAPK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GFAP and Tuj-1" . SPARSER::COLLECTION)
    ("the differentiation markers glial fibrillary acidic protein (GFAP) (astrocytes) and Tuj-1 (neurons)"
     . SPARSER::COLLECTION)
    ("glial fibrillary acidic protein (GFAP)" . SPARSER::PROTEIN)
    ("CD133 and nestin" . SPARSER::COLLECTION) ("nestin" . SPARSER::PROTEIN)
    ("Lv" . SPARSER::MOLECULE) ("A functional GR" . SPARSER::PROTEIN)
    ("GSSG" . SPARSER::DRUG) ("GPx1 and GR" . SPARSER::COLLECTION)
    ("Nrf-2 and GPx1" . SPARSER::COLLECTION)
    ("pGL3-Luc-Nrf-2" . SPARSER::COLLECTION)
    ("miR-153 directly targets Nrf-2" . SPARSER::PROTEIN)
    ("Keap1/Nrf-2" . SPARSER::COLLECTION)
    ("γ-glutamylcysteine synthetase (γ-GCS), heme oxygenase-1 (HO-1) and GPx [ xref ]"
     . SPARSER::COLLECTION)
    ("nc-siRNA" . SPARSER::COLLECTION) ("GPx1-siRNA" . SPARSER::COLLECTION)
    ("catalase, MnSOD and GPx1" . SPARSER::COLLECTION)
    ("catalase and MnSOD" . SPARSER::COLLECTION)
    ("catalase, MnSOD, CuZnSOD and GPx1" . SPARSER::COLLECTION)
    ("superoxide and hydrogen peroxide" . SPARSER::COLLECTION)
    ("CuZnSOD" . SPARSER::PROTEIN) ("Redox" . SPARSER::PROTEIN)
    ("GSCs, U87s and SU-2" . SPARSER::COLLECTION)
    ("normoxia" . SPARSER::PROTEIN) ("GSCs and non-GSCs" . SPARSER::COLLECTION)
    ("response element (ARE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("catalase, and nicotinamide adenine dinucleotide" . SPARSER::COLLECTION)
    ("GSTs" . SPARSER::PROTEIN) ("GPx1" . SPARSER::PROTEIN)
    ("GPx" . SPARSER::PROTEIN) ("GSCs" . SPARSER::PROTEIN)
    ("oxidized glutathione" . SPARSER::DRUG)
    ("Glutathione Reductase" . SPARSER::PROTEIN)
    ("Cellular Glutathione Peroxidase" . SPARSER::PROTEIN)
    ("Mn-SOD" . SPARSER::PROTEIN) ("Glutathione reductase" . SPARSER::PROTEIN)
    ("Forkhead box O3" . SPARSER::PROTEIN)
    ("murine leukemia virus" . SPARSER::PROTEIN) ("ATF-2" . SPARSER::PROTEIN)
    ("Activating transcription factor-2" . SPARSER::PROTEIN)
    ("Manganese Superoxide Dismutase" . SPARSER::PROTEIN)
    ("basic fibroblast growth factor" . SPARSER::PROTEIN)
    ("extracellular signal regulated kinase 1/2" . SPARSER::PROTEIN)
    ("N-acetylcysteine" . SPARSER::DRUG) ("ATF2" . SPARSER::PROTEIN)
    ("FoxO3" . SPARSER::PROTEIN) ("Bmi1" . SPARSER::PROTEIN)
    ("glial fibrillary acidic protein" . SPARSER::PROTEIN)
    ("CD133" . SPARSER::PROTEIN) ("Cullin3" . SPARSER::PROTEIN)
    ("DCFH-DA" . SPARSER::DRUG) ("U87" . SPARSER::PROTEIN)
    ("NQO-1" . SPARSER::PROTEIN) ("NFE2" . SPARSER::PROTEIN)
    ("Nuclear factor-erythroid 2-related factor" . SPARSER::PROTEIN)
    ("ABCG2" . SPARSER::PROTEIN)
    ("glutathione peroxidase 1" . SPARSER::PROTEIN)
    ("Nrf-2" . SPARSER::PROTEIN)
    ("nuclear factor-erythroid 2-related factor" . SPARSER::PROTEIN)
    ("Groucho" . SPARSER::PROTEIN) ("HO-1 and VEGF" . SPARSER::COLLECTION)
    ("arsenite" . SPARSER::DRUG)
    ("a competitive inhibitor" . SPARSER::INHIBITOR)
    ("β-catenin/TCF4" . SPARSER::COLLECTION)
    ("Bach1-TCF4" . SPARSER::COLLECTION)
    ("IL-8 and VEGF" . SPARSER::COLLECTION)
    ("Bach1/TCF4" . SPARSER::COLLECTION)
    ("Bach1 and TCF4" . SPARSER::COLLECTION)
    ("that HDAC1's" . SPARSER::PROTEIN) ("Trichostatin" . SPARSER::MOLECULE)
    ("HDAC1-HA" . SPARSER::COLLECTION) ("p300-Flag" . SPARSER::COLLECTION)
    ("β-catenin/p300" . SPARSER::COLLECTION)
    ("HA-tagged β-catenin (β-catenin-HA) and Flag-tagged CBP (CBP-Flag)"
     . SPARSER::COLLECTION)
    ("β-catenin/CBP" . SPARSER::COLLECTION) ("CBP-Flag" . SPARSER::COLLECTION)
    ("β-catenin-HA" . SPARSER::COLLECTION)
    ("β-catenin and p300/CBP" . SPARSER::COLLECTION)
    ("transcriptional cofactors" . SPARSER::PROTEIN)
    ("p300 and CBP" . SPARSER::COLLECTION)
    ("exogenous TCF4 and β-catenin" . SPARSER::COLLECTION)
    ("TCF4 and β-catenin" . SPARSER::COLLECTION)
    ("bzip" . SPARSER::PROTEIN-FAMILY)
    ("expressed Flag-tagged TCF4 (TCF4-Flag) and V5-tagged"
     . SPARSER::COLLECTION)
    ("exogenous TCF4 and Bach1" . SPARSER::COLLECTION)
    ("TCF4 and Bach1" . SPARSER::COLLECTION)
    ("Bach1-GST" . SPARSER::COLLECTION) ("TCF4-Flag" . SPARSER::COLLECTION)
    ("pulldown" . SPARSER::PROTEIN) ("GST-pulldown" . SPARSER::COLLECTION)
    ("MMP3 ( xref ) and c-myc ( xref )" . SPARSER::COLLECTION)
    ("any other angiogenic cytokine" . SPARSER::PROTEIN)
    ("IL-8 or VEGF" . SPARSER::COLLECTION)
    ("Bach1 siRNA (Bach1siRNA) or a control siRNA (ConsiRNA)"
     . SPARSER::COLLECTION)
    ("hemoglobin" . SPARSER::MOLECULE)
    ("VEGF ( xref ) and a murine functional homologue" . SPARSER::COLLECTION)
    ("chemokine (KC)" . SPARSER::PROTEIN)
    ("a murine functional homologue" . SPARSER::PROTEIN)
    ("angio-genesis" . SPARSER::COLLECTION) ("genesis" . SPARSER::PROTEIN)
    ("oncoproteins" . SPARSER::PROTEIN) ("CNC" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8)"
     . SPARSER::COLLECTION)
    ("β-catenin and TCF4" . SPARSER::COLLECTION)
    ("p300/CBP" . SPARSER::COLLECTION)
    ("Interleukin-8 and vascular endothelial" . SPARSER::COLLECTION)
    ("interleukin-8 and vascular endothelial" . SPARSER::COLLECTION)
    ("proangiogenic cytokines" . SPARSER::PROTEIN)
    ("Bach1 or GFP" . SPARSER::COLLECTION)
    ("hypoxia-inducible factor-1" . SPARSER::PROTEIN)
    ("CXCR3" . SPARSER::PROTEIN) ("TC4" . SPARSER::PROTEIN)
    ("β-Catenin" . SPARSER::PROTEIN)
    ("C-terminal binding protein" . SPARSER::PROTEIN)
    ("CREB-binding protein" . SPARSER::PROTEIN) ("LEF-1" . SPARSER::PROTEIN)
    ("TCF4" . SPARSER::PROTEIN) ("Interleukin-8" . SPARSER::PROTEIN)
    ("interleukin-8" . SPARSER::PROTEIN) ("Wnt3a" . SPARSER::PROTEIN)
    ("Bach1" . SPARSER::PROTEIN) ("Arg/Arg " . SPARSER::COLLECTION)
    ("Arg " . SPARSER::AMINO-ACID) ("- 1" . SPARSER::PROTEIN)
    ("codon" . SPARSER::PROTEIN) ("The viral E6 protein" . SPARSER::PROTEIN)
    ("environment-associated damaged DNA" . SPARSER::DNA)
    ("p53 codon" . SPARSER::PROTEIN) ("Mutant" . SPARSER::MUTANT)
    ("Arg/Pro" . SPARSER::COLLECTION) ("alcohol" . SPARSER::DRUG)
    ("Pro/Pro" . SPARSER::COLLECTION) ("Arg/Pro " . SPARSER::COLLECTION)
    ("Arg/Arg" . SPARSER::COLLECTION) ("Pro " . SPARSER::AMINO-ACID)
    ("P53 Arg72Pro or codon 72 polymorphism" . SPARSER::COLLECTION)
    ("Myeloid" . SPARSER::PROTEIN)
    ("a unique somatic MEFV variant" . SPARSER::VARIANT)
    ("three other known autoinflammatory genes" . SPARSER::GENE)
    ("JAK2 and MEFV" . SPARSER::COLLECTION) ("amyloid" . SPARSER::PROTEIN)
    ("MPD" . SPARSER::PROTEIN) ("heavy proteinuria" . SPARSER::PROTEIN)
    ("proteinuria" . SPARSER::PROTEIN)
    ("the mutated MEFV variant" . SPARSER::VARIANT)
    ("Colchicine" . SPARSER::DRUG) ("neutrophil" . SPARSER::PROTEIN)
    ("a cytoplasmatic protein" . SPARSER::PROTEIN)
    ("IL-1b and IL-18" . SPARSER::COLLECTION)
    ("acute leukemia" . SPARSER::PROTEIN) ("erythroid" . SPARSER::PROTEIN)
    ("erythropoietin" . SPARSER::PROTEIN) ("myeloid" . SPARSER::PROTEIN)
    ("PV" . SPARSER::PROTEIN) ("FMF" . SPARSER::PROTEIN)
    ("Mediterranean fever (FMF)" . SPARSER::PROTEIN)
    ("gold" . SPARSER::MOLECULE) ("colchicine" . SPARSER::DRUG)
    ("CD3-depleted mononunuclear DNA" . SPARSER::DNA) ("MEFV" . SPARSER::GENE)
    ("the autoinflammatory genes NLRP3 , TNFRSF1A and MVK"
     . SPARSER::COLLECTION)
    ("NLRP3 , TNFRSF1A and MVK" . SPARSER::COLLECTION)
    ("MVK" . SPARSER::PROTEIN) ("gene ( MEFV )" . SPARSER::GENE)
    ("β5" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NLRP 3" . SPARSER::PROTEIN)
    ("a 2 " . SPARSER::HUMAN-PROTEIN-FAMILY) ("TNFRSF1A" . SPARSER::PROTEIN)
    ("Mediterranean fever" . SPARSER::PROTEIN) ("1–2 " . SPARSER::PROTEIN)
    ("Janus Kinase 2" . SPARSER::PROTEIN)
    ("HER2 and ERα" . SPARSER::COLLECTION) ("MEMO" . SPARSER::PROTEIN)
    ("antagonist, ICI-182780 or tamoxifen" . SPARSER::COLLECTION)
    ("dextran" . SPARSER::DEXTRAN) ("AP1" . SPARSER::PROTEIN)
    ("SRC/p160" . SPARSER::COLLECTION) ("SRC" . SPARSER::PROTEIN)
    ("repressors" . SPARSER::REPRESSOR)
    ("growth factors and the growth factor receptor" . SPARSER::COLLECTION)
    ("the ETS-1, MMPs, urokinase-type plasminogen activator, growth factors and the growth factor receptor"
     . SPARSER::COLLECTION)
    ("c-Met or HER2" . SPARSER::COLLECTION)
    ("exogenous E2" . SPARSER::MOLECULE)
    ("protein and regulator" . SPARSER::COLLECTION)
    ("receptor/transcription factor" . SPARSER::COLLECTION)
    ("normal FBS" . SPARSER::PROTEIN)
    ("charcoal-stripped FBS" . SPARSER::PROTEIN)
    ("MTT, trans-well, and soft agar assays" . SPARSER::COLLECTION)
    ("the downstream gene’s" . SPARSER::GENE)
    ("ETS-1 and transcription factor" . SPARSER::COLLECTION)
    ("SRC-1 or AIB-1" . SPARSER::COLLECTION)
    ("NCoR or SMRT" . SPARSER::COLLECTION)
    ("SRC-1, AIB-1, NCoR or SMRT" . SPARSER::COLLECTION)
    ("NCoR and SMRT" . SPARSER::COLLECTION)
    ("ERα, ETS-1, SRC-1 or AIB-1" . SPARSER::COLLECTION)
    ("NCoR, SMRT, ETS-1, ERα, SRC-1 and AIB-1" . SPARSER::COLLECTION)
    ("cytoplasmic/nuclear subcellular fractions" . SPARSER::COMPONENT)
    ("ERα or ETS-1" . SPARSER::COLLECTION)
    ("ICI-182780 or ARQ-197" . SPARSER::COLLECTION)
    ("ERα/ETS-1" . SPARSER::COLLECTION) ("GST-ETS1" . SPARSER::COLLECTION)
    ("GST-ERα" . SPARSER::COLLECTION) ("FLAG-ETS1" . SPARSER::COLLECTION)
    ("IB" . SPARSER::DRUG) ("FLAG-ERα" . SPARSER::COLLECTION)
    ("siRNA, or ERα" . SPARSER::COLLECTION) ("HGF/c-Met" . SPARSER::COLLECTION)
    ("HGF and the antagonist" . SPARSER::COLLECTION)
    ("MMP1 and MMP9" . SPARSER::COLLECTION)
    ("estrogen and HGF" . SPARSER::COLLECTION)
    ("ARQ-197 almost blocked HGF’s" . SPARSER::PROTEIN)
    ("ARQ-197 almost blocked HGF" . SPARSER::PROTEIN)
    ("E2 and HGF" . SPARSER::COLLECTION) ("MMP9-Luc" . SPARSER::COLLECTION)
    ("MMP1-Luc" . SPARSER::COLLECTION)
    ("mmp1 , mmp9 , c-Met and uPA" . SPARSER::COLLECTION)
    ("mmp9" . SPARSER::PROTEIN) ("mmp1" . SPARSER::PROTEIN)
    ("uPA" . SPARSER::PROTEIN)
    ("the agonist (HGF) and antagonist (ARQ-197)" . SPARSER::COLLECTION)
    ("agonist (HGF)" . SPARSER::AGONIST) ("EBS-Luc" . SPARSER::COLLECTION)
    ("ETS-1 responsible gene’s" . SPARSER::GENE) ("AHR" . SPARSER::PROTEIN)
    ("ETS-1 and ERα" . SPARSER::COLLECTION)
    ("AIB-1 (amplified in breast cancer1) and NCoR [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("SRC-1 (steroid receptor coactivator 1), AIB-1 (amplified in breast cancer1) and NCoR [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("NCoR" . SPARSER::PROTEIN)
    ("hepatocyte growth factor (HGF)" . SPARSER::PROTEIN)
    ("MMP1, MMP9, u-PA and c-Met" . SPARSER::COLLECTION)
    ("-GGAA/T-3" . SPARSER::COLLECTION) ("GGAA" . SPARSER::PROTEIN)
    ("EBS" . SPARSER::PROTEIN) ("ERα and EGFR" . SPARSER::COLLECTION)
    ("ERs" . SPARSER::PROTEIN) ("its target gene’s" . SPARSER::GENE)
    ("Trans" . SPARSER::PROTEIN-FAMILY) ("its targeted gene’s" . SPARSER::GENE)
    ("ERα and ETS-1" . SPARSER::COLLECTION)
    ("ETS-1 and its targeted genes" . SPARSER::COLLECTION)
    ("ETS-2" . SPARSER::PROTEIN) ("ER81" . SPARSER::PROTEIN)
    ("p160" . SPARSER::PROTEIN)
    ("urokinase-type plasminogen activator" . SPARSER::PROTEIN)
    ("Anti-β" . SPARSER::PROTEIN) ("E. coli )" . SPARSER::PROTEIN)
    ("Lamin A/C" . SPARSER::PROTEIN) ("ETS1" . SPARSER::PROTEIN)
    ("ICI-182780" . SPARSER::DRUG) ("β-estradiol" . SPARSER::MOLECULE)
    ("cancer1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("AIB-1" . SPARSER::PROTEIN)
    ("steroid receptor coactivator 1" . SPARSER::PROTEIN)
    ("SRC-1" . SPARSER::PROTEIN)
    ("hepatocyte growth factor" . SPARSER::PROTEIN)
    ("c-Met" . SPARSER::PROTEIN) ("u-PA" . SPARSER::PROTEIN)
    ("ETS family" . SPARSER::PROTEIN) ("IGF-IR" . SPARSER::PROTEIN)
    ("AF-2" . SPARSER::PROTEIN) ("AF-1" . SPARSER::PROTEIN)
    ("domain 1" . SPARSER::PROTEIN) ("SIRT3 and a group" . SPARSER::COLLECTION)
    ("MCT1 and MCT4" . SPARSER::COLLECTION)
    ("lactate and pyruvate" . SPARSER::COLLECTION)
    ("monocarboxylates" . SPARSER::MOLECULE)
    ("transporter (GLUT)" . SPARSER::PROTEIN) ("GLUT" . SPARSER::PROTEIN)
    ("MCT1, MCT4, HK2 and Glut1" . SPARSER::COLLECTION)
    ("dehydrogenase (LDH)" . SPARSER::PROTEIN)
    ("pyruvate and lactate" . SPARSER::COLLECTION)
    ("Foxo3 [ xref ] and IDH2 [ xref ]" . SPARSER::COLLECTION)
    ("the intestinal type" . TYPE)
    ("MCT4 (2.3-fold in AGS cells, 1.34-fold in SGC-7901 cells) and Glut1 (1.55-fold in AGS cells, 1.38-fold in SGC-7901 cells)"
     . SPARSER::COLLECTION)
    ("HK2 (1.47-fold in AGS cells, 1.3-fold in SGC-7901 cells), MCT4 (2.3-fold in AGS cells, 1.34-fold in SGC-7901 cells) and Glut1 (1.55-fold in AGS cells, 1.38-fold in SGC-7901 cells)"
     . SPARSER::COLLECTION)
    ("SIRT3-LDHA" . SPARSER::COLLECTION)
    ("using commercial human recombinant SIRT3 and bovine heart L-Lactic Dehydrogenase"
     . SPARSER::COLLECTION)
    ("bovine heart L-Lactic Dehydrogenase" . SPARSER::PROTEIN)
    ("using commercial human recombinant SIRT3" . SPARSER::PROTEIN)
    ("nicotinamide" . SPARSER::PROTEIN) ("Dehydrogenase" . SPARSER::PROTEIN)
    ("LDHA and SIRT3" . SPARSER::COLLECTION)
    ("LDHA or SIRT3" . SPARSER::COLLECTION) ("NC or Scr" . SPARSER::COLLECTION)
    ("global metabolism enzymes" . SPARSER::ENZYME) ("intestinal type" . TYPE)
    ("pyruvate and L-lactate" . SPARSER::COLLECTION)
    ("targets and substrates" . SPARSER::COLLECTION)
    ("glycolysis-associated genes" . SPARSER::GENE)
    ("lactate dehydrogenase A (LDHA)" . SPARSER::PROTEIN)
    ("LDHA" . SPARSER::PROTEIN) ("MnSOD" . SPARSER::PROTEIN)
    ("glycogen" . SPARSER::PROTEIN) ("glucose-6-phosphate" . SPARSER::MOLECULE)
    ("HK2" . SPARSER::PROTEIN) ("K14" . SPARSER::PROTEIN)
    ("K5" . SPARSER::PROTEIN) ("γ-tubulin" . SPARSER::PROTEIN)
    ("Lactic Acid" . SPARSER::MOLECULE) ("phenol red" . SPARSER::DRUG)
    ("lactate dehydrogenase A" . SPARSER::PROTEIN) ("KS" . SPARSER::PROTEIN)
    ("microbial effectors" . SPARSER::EFFECTOR)
    ("IFI16 or BRCA1" . SPARSER::COLLECTION)
    ("ASC-PYD" . SPARSER::PROTEIN-PAIR) ("viral promoters" . SPARSER::PROMOTER)
    ("different proteins and each complex" . SPARSER::COLLECTION)
    ("IFI16 and IFI16-inflammasomes" . SPARSER::COLLECTION)
    ("nucleosomes and the adenoviral genome" . SPARSER::COLLECTION)
    ("the adenoviral genome" . SPARSER::PROTEIN)
    ("exogenous DNA" . SPARSER::DNA)
    ("the viral gene promoters" . SPARSER::PROMOTER)
    ("repressive heterochromatin H3K9" . SPARSER::PROTEIN)
    ("Oct1 and TBP" . SPARSER::COLLECTION)
    ("euchromatin" . SPARSER::BIO-COMPLEX)
    ("AIM2 and cGAS" . SPARSER::COLLECTION)
    ("IL-1β and interferon" . SPARSER::COLLECTION)
    ("IL-1β and IFN-β" . SPARSER::COLLECTION) ("PMA" . SPARSER::PROTEIN)
    ("IFI16-BRCA1-STING" . SPARSER::COLLECTION)
    ("IFI16 and STING" . SPARSER::COLLECTION)
    ("herpes viral (KSHV, EBV and HSV-1) genomes" . SPARSER::PROTEIN)
    ("nuclear viral genome" . SPARSER::PROTEIN)
    ("STING-IRF3" . SPARSER::COLLECTION)
    ("Wt-HSV-1 (KOS) viral genome" . SPARSER::PROTEIN)
    ("Wt-HSV-1" . SPARSER::COLLECTION) ("cGAS and IFI16" . SPARSER::COLLECTION)
    ("drives IFI16’s" . SPARSER::PROTEIN) ("signalosome" . SPARSER::PROTEIN)
    ("GMP-AMP" . SPARSER::PROTEIN-PAIR)
    ("cGAMP-Synthase" . SPARSER::COLLECTION) ("GMP" . SPARSER::GMP)
    ("Synthase" . SPARSER::PROTEIN) ("cGAS" . SPARSER::PROTEIN)
    ("such exposed viral DNA" . SPARSER::DNA)
    ("the non-chromatinized dsDNA viral genomes" . SPARSER::PROTEIN)
    ("nucleosomes" . SPARSER::PROTEIN) ("linkers" . SPARSER::LINKER)
    ("pyrin" . SPARSER::PROTEIN) ("PYD and HIN" . SPARSER::COLLECTION)
    ("AIM2 and IFI16" . SPARSER::COLLECTION)
    ("IFI16 and AIM2" . SPARSER::COLLECTION)
    ("NAIP5 and NAIP6" . SPARSER::COLLECTION) ("Prg" . SPARSER::PROTEIN)
    ("flagellin" . SPARSER::PROTEIN) ("NAIP" . SPARSER::PROTEIN)
    ("dipeptide" . SPARSER::MOLECULE) ("muramyl" . SPARSER::MOLECULE)
    ("IFI16, STING, TBK1 and IRF3" . SPARSER::COLLECTION)
    ("herpes viral DNA" . SPARSER::DNA) ("incoming viral DNAs" . SPARSER::DNA)
    ("microbial DNAs" . SPARSER::DNA) ("microbial DNA" . SPARSER::DNA)
    ("DNA and elicitation" . SPARSER::COLLECTION)
    ("ASC-Caspase-1" . SPARSER::COLLECTION) ("HSV-1" . SPARSER::PROTEIN)
    ("BRCA1, ASC, Caspase-1 and HSV-1-ICP0" . SPARSER::COLLECTION)
    ("HSV-1-ICP0" . SPARSER::PROTEIN-PAIR)
    ("BRCA1 or Caspase-1" . SPARSER::COLLECTION)
    ("BRCA1 and Caspase-1" . SPARSER::COLLECTION)
    ("IFN-β and IL-1β" . SPARSER::COLLECTION)
    ("viral E3 ubiquitin ligase ICP0" . SPARSER::PROTEIN)
    ("p-IRF3" . SPARSER::COLLECTION)
    ("caspase-1 or IL-1β" . SPARSER::COLLECTION)
    ("both control Si-RNA and BRCA1 Si-RNA" . SPARSER::COLLECTION)
    ("EdU viral genome" . SPARSER::PROTEIN) ("VII" . SPARSER::PROTEIN)
    ("significantly less IFI16" . SPARSER::PROTEIN)
    ("the EdU viral genome" . SPARSER::PROTEIN)
    ("genome bound proteins" . SPARSER::PROTEIN)
    ("streptavidin" . SPARSER::PROTEIN) ("alkyne" . SPARSER::MOLECULE)
    ("azide" . SPARSER::MOLECULE) ("TEG" . SPARSER::MOLECULE)
    ("control Si-RNA or BRCA1 Si-RNA" . SPARSER::COLLECTION)
    ("the IFI16 and IFI16-BRCA1 PLA" . SPARSER::COLLECTION)
    ("Edu" . SPARSER::DRUG) ("the subsequent IFI16" . SPARSER::PROTEIN)
    ("late times p" . SPARSER::PROTEIN)
    ("several viral genomes" . SPARSER::PROTEIN)
    ("free viral genome" . SPARSER::PROTEIN)
    ("mature inflammasome complexes" . SPARSER::BIO-COMPLEX)
    ("a sequential PLA" . SPARSER::PROTEIN)
    ("BRCA1, IFI16 and ASC single macromolecular complexes"
     . SPARSER::BIO-COMPLEX)
    ("demonstrated possible viral genome" . SPARSER::PROTEIN)
    ("PLA-IFA" . SPARSER::COLLECTION) ("viral genomes" . SPARSER::PROTEIN)
    ("nuclear herpes viral DNA" . SPARSER::DNA)
    ("IFI16 and ASC, and undergoes" . SPARSER::COLLECTION)
    ("ASC, and undergoes" . SPARSER::COLLECTION)
    ("the endoplasmic resident protein STING" . SPARSER::PROTEIN)
    ("IFI16-ASC-Caspase-1" . SPARSER::COLLECTION)
    ("very few IFI16 and ASC PLA" . SPARSER::PROTEIN)
    ("si-BRCA1" . SPARSER::COLLECTION) ("si" . SPARSER::PROTEIN)
    ("IFI16, ASC and β-actin" . SPARSER::COLLECTION)
    ("IFI16 or Caspase-1" . SPARSER::COLLECTION)
    ("IFI16 and Caspase-1" . SPARSER::COLLECTION)
    ("anti-IFI16 or Caspase-1" . SPARSER::COLLECTION)
    ("functional BRCA1" . SPARSER::PROTEIN)
    ("lenti-BRCA1" . SPARSER::PROTEIN-PAIR)
    ("functionally active Caspase-1 and mature IL-1β" . SPARSER::COLLECTION)
    ("cleaved Caspase-1 and mature IL-1β" . SPARSER::COLLECTION)
    ("active Caspase-1 (p20) and mature IL-1β (p17)" . SPARSER::COLLECTION)
    ("late (24 h) times p" . SPARSER::PROTEIN)
    ("IFI16, ASC or β-actin" . SPARSER::COLLECTION)
    ("Caspase-1 and/or IL-1β" . SPARSER::COLLECTION)
    ("mature IL-1β" . SPARSER::PROTEIN) ("Si-BRCA1" . SPARSER::COLLECTION)
    ("functional IL-1β" . SPARSER::PROTEIN)
    ("nuclear viral genomes" . SPARSER::PROTEIN)
    ("BRCA1-IFI16-ASC" . SPARSER::COLLECTION)
    ("an individual macromolecular complex" . SPARSER::BIO-COMPLEX)
    ("IFI16, BRCA1 and ASC" . SPARSER::COLLECTION)
    ("double sequential PLAs" . SPARSER::PROTEIN) ("PLAs" . SPARSER::PROTEIN)
    ("a single macromolecular complex" . SPARSER::BIO-COMPLEX)
    ("nuclear viral DNA" . SPARSER::DNA) ("ASC and AIM2" . SPARSER::COLLECTION)
    ("Caspase" . SPARSER::PROTEIN) ("AIM2-ASC" . SPARSER::COLLECTION)
    ("nuclear herpesviral genome" . SPARSER::PROTEIN)
    ("Caspase-1 ( xref , graphs in rightmost column) as well as BRCA1"
     . SPARSER::COLLECTION)
    ("BRCA1-Caspase1" . SPARSER::COLLECTION)
    ("ASC-Caspase1" . SPARSER::COLLECTION)
    ("IFI16, ASC and Caspase-1" . SPARSER::COLLECTION)
    ("-BRCA1" . SPARSER::COLLECTION) ("ASC and BRCA1" . SPARSER::COLLECTION)
    ("BRCA1, NLRP3 and AIM2" . SPARSER::COLLECTION)
    ("NLRP3 and AIM2" . SPARSER::COLLECTION)
    ("BRCA1–ASC" . SPARSER::COLLECTION)
    ("ASC and β-actin" . SPARSER::COLLECTION) ("Si" . SPARSER::PROTEIN)
    ("Si-IFI16" . SPARSER::COLLECTION) ("ASC-BRCA1" . SPARSER::COLLECTION)
    ("BRCA1-ASC" . SPARSER::COLLECTION)
    ("Caspase-1 as well as BRCA1" . SPARSER::COLLECTION)
    ("the active inflammasome complex" . SPARSER::BIO-COMPLEX)
    ("ASC and Caspase-1" . SPARSER::COLLECTION)
    ("continuous and dynamic viral genome" . SPARSER::PROTEIN)
    ("BRCA1, IFI16 and ASC" . SPARSER::COLLECTION)
    ("BRCA1 and ASC" . SPARSER::COLLECTION)
    ("BRCA1 and procaspase-1" . SPARSER::COLLECTION)
    ("IFI16 and procaspase-1" . SPARSER::COLLECTION)
    ("anti-IFI16 and anti-BRCA1" . SPARSER::COLLECTION)
    ("both secondary antibodies" . SPARSER::ANTIBODY)
    ("only one primary antibody" . SPARSER::ANTIBODY)
    ("secondary antibodies" . SPARSER::ANTIBODY)
    ("IFI16, ASC and procaspase-1" . SPARSER::COLLECTION)
    ("anti-IFI16, anti-BRCA1, anti-ASC and anti-procaspase-1"
     . SPARSER::COLLECTION)
    ("ASC and procaspase-1" . SPARSER::COLLECTION)
    ("ASC, IFI16 and procaspase-1" . SPARSER::COLLECTION)
    ("TBP" . SPARSER::PROTEIN)
    ("anti-ASC, anti-IFI16, anti-BRCA1 and anti-procaspase-1"
     . SPARSER::COLLECTION)
    ("IFI16, BRCA1 and procaspase-1" . SPARSER::COLLECTION)
    ("the active IFI16 inflammasome complex" . SPARSER::BIO-COMPLEX)
    ("an active inflammasome complex" . SPARSER::BIO-COMPLEX)
    ("IFI16-ASC" . SPARSER::COLLECTION)
    ("BRCA1, H2AX and CHK2" . SPARSER::COLLECTION)
    ("IFI16-BRCA1" . SPARSER::COLLECTION)
    ("CHK2 and γH2AX" . SPARSER::COLLECTION)
    ("IFI16 and CHK2" . SPARSER::COLLECTION)
    ("IFI16 and γH2AX" . SPARSER::COLLECTION)
    ("IFI16 and ASC" . SPARSER::COLLECTION)
    ("BRCA1-γH2AX" . SPARSER::COLLECTION) ("BRCA1-CHK2" . SPARSER::COLLECTION)
    ("Bleomycin" . SPARSER::DRUG)
    ("two secondary antibodies" . SPARSER::ANTIBODY)
    ("antibody-antigen" . SPARSER::COLLECTION)
    ("H2AX and CHK2" . SPARSER::COLLECTION)
    ("cellular BRCA1 and IFI16" . SPARSER::COLLECTION)
    ("BRCA1-IFI16" . SPARSER::COLLECTION)
    ("BRCA1, IFI16 and CHK2" . SPARSER::COLLECTION)
    ("IFI16, BRCA1, CHK2 and H2AX" . SPARSER::COLLECTION)
    ("CHK2 and H2AX" . SPARSER::COLLECTION)
    ("BRCA1, IFI16, CHK2 and H2AX" . SPARSER::COLLECTION)
    ("the viral genomes" . SPARSER::PROTEIN)
    ("viral genome" . SPARSER::PROTEIN)
    ("capsid proteins or 5-bromo-2" . SPARSER::COLLECTION)
    ("genome, and ii" . SPARSER::COLLECTION)
    ("BrdU or EdU" . SPARSER::COLLECTION) ("ethynyl" . SPARSER::MOLECULE)
    ("bromo" . SPARSER::MOLECULE) ("IFA" . SPARSER::PROTEIN)
    ("ATM, H2AX, CHK2 and BRCA1" . SPARSER::COLLECTION)
    ("IFI16 and DDR" . SPARSER::COLLECTION)
    ("BRCA1 and IFI16" . SPARSER::COLLECTION)
    ("IFI16 and a stabilizer" . SPARSER::COLLECTION)
    ("stabilizer" . SPARSER::MOLECULE)
    ("caspase-1 and IL-1β" . SPARSER::COLLECTION)
    ("an essential component" . SPARSER::COMPONENT)
    ("superhelical plasmid DNA and cruciform DNA [ xref ]"
     . SPARSER::COLLECTION)
    ("cruciform DNA" . SPARSER::DNA)
    ("superhelical plasmid DNA" . SPARSER::DNA) ("PYD" . SPARSER::PROTEIN)
    ("APIN" . SPARSER::PROTEIN) ("HIN" . SPARSER::PROTEIN-FAMILY)
    ("the large BRCA1-associated genome surveillance (BASC) DDR complex"
     . SPARSER::BIO-COMPLEX)
    ("kinase, H2AX and BRCA1" . SPARSER::COLLECTION)
    ("exogenous genomes" . SPARSER::PROTEIN)
    ("H2AX, BRCA1, 53BP1, and Mdc1" . SPARSER::COLLECTION)
    ("CHK1 and CHK2" . SPARSER::COLLECTION)
    ("The linear epigenetically naïve virion-associated herpesviral dsDNA genome"
     . SPARSER::PROTEIN)
    ("histones and nucleosome" . SPARSER::COLLECTION)
    ("nucleosome" . SPARSER::PROTEIN) ("the viral genome" . SPARSER::PROTEIN)
    ("viral genes" . SPARSER::GENE) ("genome" . SPARSER::PROTEIN)
    ("genomes" . SPARSER::PROTEIN)
    ("adaptor protein ASC (apoptosis-associated speck-like protein containing CARD) and procaspase-1"
     . SPARSER::COLLECTION)
    ("a sensor protein, adaptor protein ASC (apoptosis-associated speck-like protein containing CARD) and procaspase-1"
     . SPARSER::COLLECTION)
    ("IL-18, and IL-33" . SPARSER::COLLECTION) ("PYRIN" . SPARSER::PROTEIN)
    ("NLRPs" . SPARSER::PROTEIN-FAMILY) ("PRRs" . SPARSER::PROTEIN)
    ("viral DNA and subsequent induction" . SPARSER::COLLECTION)
    ("IFI16-genome" . SPARSER::PROTEIN-PAIR)
    ("IFI16 and BRCA1" . SPARSER::COLLECTION)
    ("IFI16-ASC-procaspase-1" . SPARSER::COLLECTION)
    ("IL-1β and IL-18" . SPARSER::COLLECTION)
    ("TBK1 and IRF3" . SPARSER::COLLECTION)
    ("IFI16-STING" . SPARSER::COLLECTION)
    ("bleomycin and vaccinia virus" . SPARSER::COLLECTION)
    ("bleomycin" . SPARSER::DRUG) ("STING-TBK1-IRF3" . SPARSER::COLLECTION)
    ("STING" . SPARSER::PROTEIN)
    ("a sequence-independent nuclear innate sensor ALR" . SPARSER::PROTEIN)
    ("ASC and procaspase1" . SPARSER::COLLECTION)
    ("Caspase-1 and IL-1β" . SPARSER::COLLECTION)
    ("ASC" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ALR" . SPARSER::PROTEIN)
    ("NOD-like receptors (NLRs) and AIM2-like receptors (ALRs)"
     . SPARSER::COLLECTION)
    ("NLRs" . SPARSER::PROTEIN)
    ("pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("receptors (PRR)" . SPARSER::RECEPTOR)
    ("IL-1β, IL-18 or interferon" . SPARSER::COLLECTION)
    ("PRR" . SPARSER::PROTEIN) ("NaHCO3" . SPARSER::DRUG)
    ("IFN Beta" . SPARSER::PROTEIN) ("MnCl2" . SPARSER::DRUG)
    ("TMS1" . SPARSER::PROTEIN) ("butyric acid" . SPARSER::MOLECULE)
    ("core protein" . SPARSER::PROTEIN) ("Oct1" . SPARSER::PROTEIN)
    ("guanylate-binding protein 5" . SPARSER::PROTEIN)
    ("type III" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NAIP5" . SPARSER::PROTEIN)
    ("NLR family" . SPARSER::PROTEIN) ("NLRC4" . SPARSER::PROTEIN)
    ("NOD2" . SPARSER::PROTEIN) ("NLRP1" . SPARSER::PROTEIN)
    ("ICP0" . SPARSER::PROTEIN) ("p20" . SPARSER::PROTEIN)
    ("Si-RNAs" . SPARSER::RNA) ("Caspase1" . SPARSER::PROTEIN)
    ("NLRP3" . SPARSER::PROTEIN) ("Si-RNA" . SPARSER::RNA)
    ("LANA-1" . SPARSER::PROTEIN)
    ("capsid proteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CHK2" . SPARSER::PROTEIN) ("CHK1" . SPARSER::PROTEIN)
    ("Mdc1" . SPARSER::PROTEIN) ("53BP1" . SPARSER::PROTEIN)
    ("IL-33" . SPARSER::PROTEIN) ("absent in melanoma 2" . SPARSER::PROTEIN)
    ("procaspase-1" . SPARSER::PROTEIN) ("interferon-β" . SPARSER::DRUG)
    ("IRF3" . SPARSER::PROTEIN) ("TBK1" . SPARSER::PROTEIN)
    ("Caspase-1" . SPARSER::PROTEIN) ("IFI16" . SPARSER::PROTEIN)
    ("AIM2" . SPARSER::PROTEIN) ("IFN-β" . SPARSER::PROTEIN)
    ("IL-18" . SPARSER::PROTEIN) ("wtRAS/BRAF" . SPARSER::COLLECTION)
    ("mut(K)RAS and wtBRAF/(K)RAS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAS and wtBRAF/" . SPARSER::COLLECTION) ("mutated DNA" . SPARSER::DNA)
    ("upfront BRAF" . SPARSER::PROTEIN) ("MSS" . SPARSER::PROTEIN)
    ("log-rank" . SPARSER::PROTEIN) ("reliable BRAF" . SPARSER::PROTEIN)
    ("CEA" . SPARSER::PROTEIN) ("Poor PS" . SPARSER::PROTEIN)
    ("Bevacizumab" . SPARSER::DRUG) ("poor PS" . SPARSER::PROTEIN)
    ("BRAF/KRAS" . SPARSER::COLLECTION)
    ("the biologically worst mCRC" . SPARSER::PROTEIN)
    ("available TMA" . SPARSER::MOLECULE) ("good PS" . SPARSER::PROTEIN)
    ("KRAS/BRAF" . SPARSER::COLLECTION)
    ("KRAS, BRAF and MSI" . SPARSER::COLLECTION)
    ("RAS and BRAF" . SPARSER::COLLECTION) ("2–4" . SPARSER::PROTEIN)
    ("OR 2" . SPARSER::MOLECULE) ("5–2" . SPARSER::PROTEIN)
    ("MTA-1" . SPARSER::PROTEIN) ("1-2" . SPARSER::PROTEIN)
    ("PS 2" . SPARSER::PROTEIN)
    ("inhibitors and activators" . SPARSER::COLLECTION)
    ("that SIRT2’s" . SPARSER::PROTEIN)
    ("promoter, or suppressor" . SPARSER::COLLECTION)
    ("suppressor and promoter" . SPARSER::COLLECTION) ("ac" . SPARSER::PROTEIN)
    ("a nucleolar protein" . SPARSER::PROTEIN)
    ("substrates of SIRT7 and its function" . SPARSER::COLLECTION)
    ("dehydrogenase (LCAD)" . SPARSER::PROTEIN) ("LCAD" . SPARSER::PROTEIN)
    ("coenzyme" . SPARSER::MOLECULE) ("HIF1a and ROS" . SPARSER::COLLECTION)
    ("JNK2/JNK1" . SPARSER::COLLECTION) ("p53/Bcl-2" . SPARSER::COLLECTION)
    ("promoter or suppressor" . SPARSER::COLLECTION)
    ("SIRT1 and SIRT6" . SPARSER::COLLECTION)
    ("SIRT2 and SIRT6" . SPARSER::COLLECTION) ("MTR" . SPARSER::PROTEIN)
    ("predictive biomarkers" . SPARSER::MOLECULE)
    ("a novel predictive biomarker" . SPARSER::MOLECULE)
    ("SIRT3 and SIRT7" . SPARSER::COLLECTION)
    ("promoter and suppressor" . SPARSER::COLLECTION)
    ("SIRT 7" . SPARSER::PROTEIN) ("K18" . SPARSER::PROTEIN)
    ("IDH2" . SPARSER::PROTEIN) ("HIF-1α" . SPARSER::PROTEIN)
    ("fatty-acid" . SPARSER::MOLECULE) ("HIF1a" . SPARSER::PROTEIN)
    ("JNK2" . SPARSER::PROTEIN) ("SIRT 3" . SPARSER::PROTEIN)
    ("SIRT 6" . SPARSER::PROTEIN)
    ("FGFR1 and the three RAS genes" . SPARSER::COLLECTION)
    ("PI3K and mTOR" . SPARSER::COLLECTION)
    ("MEK and ALK" . SPARSER::COLLECTION)
    ("Binimetinib, SK-N-AS and NBL-S" . SPARSER::COLLECTION)
    ("ALK and RAS" . SPARSER::COLLECTION) ("RAS/MAPK" . SPARSER::COLLECTION)
    ("NF1 and ALK" . SPARSER::COLLECTION) ("RAS/RAF" . SPARSER::COLLECTION)
    ("RAS/BRAF" . SPARSER::COLLECTION)
    ("Trametinib, Cobimetinib and Binimetinib" . SPARSER::COLLECTION)
    ("Binimetinib" . SPARSER::DRUG) ("Cobimetinib" . SPARSER::DRUG)
    ("Trametinib" . SPARSER::DRUG)
    ("ALK, NRAS, HRAS, KRAS, BRAF, PTPN11 and NF1" . SPARSER::COLLECTION)
    ("p14ARF and p16" . SPARSER::COLLECTION)
    ("PPM1G-ALK" . SPARSER::COLLECTION) ("CCF" . SPARSER::COMPONENT)
    ("fraction (CCF)" . SPARSER::COMPONENT)
    ("constitutional DNA" . SPARSER::DNA) ("ATRX" . SPARSER::PROTEIN)
    ("DNAs" . SPARSER::DNA) ("RAS-MAPK" . SPARSER::COLLECTION)
    ("C − T" . SPARSER::PROTEIN) ("T − T" . SPARSER::PROTEIN)
    ("NF 1" . SPARSER::PROTEIN) ("p14ARF" . SPARSER::PROTEIN)
    ("CDKN2A" . SPARSER::PROTEIN) ("PTPN11" . SPARSER::PROTEIN)
    ("PPM1G" . SPARSER::PROTEIN) ("meta-iodobenzylguanidine" . SPARSER::DRUG)
    ("Akt-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Akt and p38 MAPK" . SPARSER::COLLECTION)
    ("Crystallin" . SPARSER::PROTEIN-FAMILY)
    ("KRAS and PIK3CA" . SPARSER::COLLECTION)
    ("cyclin D1 and β-catenin" . SPARSER::COLLECTION)
    ("Cip" . SPARSER::PROTEIN) ("cyclin D1 and cyclin E" . SPARSER::COLLECTION)
    ("functional adenomatous polyposis coli protein" . SPARSER::PROTEIN)
    ("cyclin D1-CDK4/6" . SPARSER::COLLECTION)
    ("cyclin E-CDK2" . SPARSER::COLLECTION)
    ("Cyclin D1-CDK4/6" . SPARSER::COLLECTION)
    ("Cyclin D1 and cyclin E" . SPARSER::COLLECTION)
    ("CDK4/6 and CDK2" . SPARSER::COLLECTION) ("RB" . SPARSER::PROTEIN)
    ("resibufogenin" . SPARSER::DRUG) ("bufadienolides" . SPARSER::MOLECULE)
    ("huachansu" . SPARSER::DRUG) ("Resibufogenin" . SPARSER::DRUG)
    ("Huachansu" . SPARSER::DRUG) ("FBX4" . SPARSER::PROTEIN)
    ("WAF1" . SPARSER::PROTEIN) ("p19 INK4d" . SPARSER::PROTEIN)
    ("p16 INK4a" . SPARSER::PROTEIN) ("p15 INK4b" . SPARSER::PROTEIN)
    ("CDK6" . SPARSER::PROTEIN) ("RB protein" . SPARSER::PROTEIN)
    ("CDK4/6" . SPARSER::PROTEIN) ("Cyclin D1" . SPARSER::PROTEIN)
    ("cyclin D" . SPARSER::PROTEIN)
    ("enzymes and complexes" . SPARSER::COLLECTION)
    ("Lysine" . SPARSER::AMINO-ACID) ("Mitochondria" . SPARSER::PROTEIN)
    ("GPT" . SPARSER::PROTEIN) ("TYP" . SPARSER::PROTEIN)
    ("SIRT3 and melatonin" . SPARSER::COLLECTION)
    ("a mitochondrial antioxidant" . SPARSER::PROTEIN)
    ("SOD2 and SOD2" . SPARSER::COLLECTION) ("lysines" . SPARSER::AMINO-ACID)
    ("TEMPO" . SPARSER::DRUG) ("MitoSOX" . SPARSER::DRUG)
    ("Mitochondrial ROS" . SPARSER::PROTEIN) ("GFP-LC3-" . SPARSER::PROTEIN)
    ("-ATPase" . SPARSER::COLLECTION) ("ATPase" . SPARSER::PROTEIN)
    ("Baf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("morphine" . SPARSER::MOLECULE)
    ("rotenone" . SPARSER::PROTEIN) ("methamphetamine" . SPARSER::DRUG)
    ("aminotransferase" . SPARSER::PROTEIN) ("transaminase" . SPARSER::PROTEIN)
    ("SIRT3/SOD2" . SPARSER::COLLECTION) ("SIRT3-SOD2" . SPARSER::COLLECTION)
    ("SIRT3 and SOD2" . SPARSER::COLLECTION) ("SOD1" . SPARSER::PROTEIN)
    ("S13" . SPARSER::PROTEIN) ("CdCl 2" . SPARSER::MOLECULE)
    ("mitochondrial)" . SPARSER::PROTEIN) ("a chain" . SPARSER::PROTEIN)
    ("S3B" . SPARSER::PROTEIN) ("S3A" . SPARSER::PROTEIN)
    ("Bafilomycin A 1" . SPARSER::DRUG) ("Cd–" . SPARSER::PROTEIN)
    ("sirtuin 3" . SPARSER::PROTEIN) ("sirtuin 1" . SPARSER::PROTEIN)
    ("superoxide dismutase 2, mitochondrial" . SPARSER::PROTEIN)
    ("SOD2" . SPARSER::PROTEIN) ("Cd-" . SPARSER::PROTEIN)
    ("disc and RNFL" . SPARSER::COLLECTION) ("disc" . SPARSER::BIO-COMPLEX)
    ("IL-9, IL-10, and IL-12" . SPARSER::COLLECTION)
    ("retinal MMP9" . SPARSER::PROTEIN) ("Guo" . SPARSER::MOLECULE)
    ("MMPs and IL-1β" . SPARSER::COLLECTION) ("Yan" . SPARSER::PROTEIN)
    ("pg" . SPARSER::MOLECULE) ("polymorphic variants" . SPARSER::VARIANT)
    ("MMP1, MMP9, MMP12, and TIMP1" . SPARSER::COLLECTION)
    ("TM" . SPARSER::PROTEIN) ("ACG" . SPARSER::PROTEIN)
    ("Allele" . SPARSER::ALLELE)
    ("MMP1, MMP9, MMP12, and IL-1 β" . SPARSER::COLLECTION)
    ("MMP1 , MMP9 , MMP12 , and IL-1β" . SPARSER::COLLECTION)
    ("OCT" . SPARSER::PROTEIN) ("ophthalmic" . SPARSER::DRUG)
    ("IL-1b" . SPARSER::PROTEIN) ("IL-9" . SPARSER::PROTEIN)
    ("pGL4" . SPARSER::PROTEIN) ("penicillin G" . SPARSER::MOLECULE)
    ("IL-1 β" . SPARSER::PROTEIN) ("TIMP1" . SPARSER::PROTEIN)
    ("MMP12" . SPARSER::PROTEIN)
    ("ROS and electrophiles" . SPARSER::COLLECTION)
    ("amino acids such as methionine and choline [ xref ]"
     . SPARSER::COLLECTION)
    ("methionine and choline" . SPARSER::COLLECTION)
    ("the dithiolethione oltipraz and a novel biaryl urea compound"
     . SPARSER::COLLECTION)
    ("-3-" . SPARSER::PROTEIN) ("furan" . SPARSER::MOLECULE)
    ("biaryl" . SPARSER::MOLECULE)
    ("α -smooth muscle actin and profibrogenic genes" . SPARSER::COLLECTION)
    ("profibrogenic genes" . SPARSER::GENE)
    ("-smooth muscle" . SPARSER::COLLECTION)
    ("transforming growth factor-" . SPARSER::PROTEIN)
    ("smooth muscle" . SPARSER::PROTEIN) ("isothiocyanate" . SPARSER::MOLECULE)
    ("Sulforaphane" . SPARSER::PROTEIN) ("Tecfidera" . SPARSER::DRUG)
    ("BG" . SPARSER::PROTEIN) ("Protandim" . SPARSER::DRUG)
    ("CDDO" . SPARSER::DRUG) ("dien" . SPARSER::MOLECULE)
    ("triterpenoid" . SPARSER::MOLECULE)
    ("phenolic antioxidants" . SPARSER::DRUG)
    ("triterpenoids" . SPARSER::MOLECULE) ("sulforaphane" . SPARSER::PROTEIN)
    ("isothiocyanates" . SPARSER::MOLECULE) ("dithiol" . SPARSER::MOLECULE)
    ("oltipraz" . SPARSER::DRUG)
    ("antioxidative stress response genes" . SPARSER::GENE)
    ("methionine- and choline-deficient (MCD) diet [ xref , xref , xref ]"
     . SPARSER::COLLECTION)
    ("methionine-" . SPARSER::AMINO-ACID) ("MCD" . SPARSER::PROTEIN)
    ("Ldlr" . SPARSER::PROTEIN) ("retinoid X receptor-" . SPARSER::PROTEIN)
    ("CoA" . SPARSER::MOLECULE)
    ("oxidase, and carnitine" . SPARSER::COLLECTION)
    ("receptor-" . SPARSER::RECEPTOR)
    ("palmitoyltransferase" . SPARSER::PROTEIN)
    ("Shp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("antioxidant and detoxification genes" . SPARSER::COLLECTION)
    ("lower free radical" . SPARSER::MOLECULE)
    ("protein and lipid" . SPARSER::COLLECTION)
    ("triacylglycerol and cholesteryl" . SPARSER::COLLECTION)
    ("cholesteryl" . SPARSER::PROTEIN) ("triacylglycerol" . SPARSER::MOLECULE)
    ("TCDD-" . SPARSER::PROTEIN) ("TCDD" . SPARSER::PROTEIN)
    ("dioxin" . SPARSER::MOLECULE) ("VLDL" . SPARSER::PROTEIN)
    ("proteins and dysfunctional organelles" . SPARSER::COLLECTION)
    ("mitochondria, and ER" . SPARSER::COLLECTION) ("Kras" . SPARSER::PROTEIN)
    ("xenobiotic" . SPARSER::MOLECULE) ("AhR" . SPARSER::PROTEIN)
    ("-transducin" . SPARSER::COLLECTION) ("transducin" . SPARSER::PROTEIN)
    ("Maf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("polyubiquitination" . SPARSER::PROTEIN)
    ("antioxidant enzymes, electrophile-conjugating enzymes, ubiquitin/proteasomes, and chaperone and heat-shock proteins"
     . SPARSER::COLLECTION)
    ("a basic leucine zipper transcription factor" . SPARSER::PROTEIN)
    ("enzymes, ubiquitin/proteasomes, and chaperone" . SPARSER::COLLECTION)
    ("Nfe2l2/Nrf2" . SPARSER::COLLECTION) ("electrophile" . SPARSER::MOLECULE)
    ("prooxidant" . SPARSER::MOLECULE) ("TGA" . SPARSER::PROTEIN)
    ("these cytoprotective enzymes" . SPARSER::ENZYME)
    ("AREs" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("toxic metabolites" . SPARSER::PROTEIN)
    ("largely hydrophobic organic molecules" . SPARSER::MOLECULE)
    ("oxidants and electrophiles" . SPARSER::COLLECTION)
    ("glutathione peroxidase, and catalase" . SPARSER::COLLECTION)
    ("glutathione and thioredoxin" . SPARSER::COLLECTION)
    ("thioredoxin" . SPARSER::PROTEIN) ("thiol" . SPARSER::MOLECULE)
    ("catalase" . SPARSER::PROTEIN) ("UDP" . SPARSER::UDP)
    ("glutathione" . SPARSER::DRUG) ("oxidants" . SPARSER::MOLECULE)
    ("HNE" . SPARSER::PROTEIN) ("aldehydes" . SPARSER::MOLECULE)
    ("Electrophiles" . SPARSER::MOLECULE)
    ("ROS [ xref ] and electrophiles [ xref ]" . SPARSER::COLLECTION)
    ("xenobiotics" . SPARSER::MOLECULE)
    ("the mild hepatic iron" . SPARSER::MOLECULE)
    ("proinflammatory cytokines" . SPARSER::PROTEIN)
    ("adjacent mitochondria" . SPARSER::PROTEIN)
    ("the mitochondrial quinone" . SPARSER::PROTEIN)
    ("quinone" . SPARSER::PROTEIN) ("FFA" . SPARSER::PROTEIN)
    ("FFAs" . SPARSER::PROTEIN) ("the available glucose" . SPARSER::PROTEIN)
    ("the excess dietary glucose" . SPARSER::PROTEIN)
    ("FAs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Hepatocytes" . SPARSER::PROTEIN)
    ("FA" . SPARSER::PROTEIN) ("electrophiles" . SPARSER::MOLECULE)
    ("cirrhosis" . SPARSER::PROTEIN) ("Bardoxolone methyl" . SPARSER::DRUG)
    ("bardoxolone methyl" . SPARSER::DRUG) ("CDDO-Me" . SPARSER::DRUG)
    ("oleanolic acid" . SPARSER::MOLECULE) ("H-1" . SPARSER::PROTEIN)
    ("epigallocatechin-3-gallate" . SPARSER::DRUG)
    ("retinoid X receptor" . SPARSER::PROTEIN)
    ("stearoyl-CoA" . SPARSER::MOLECULE)
    ("fatty acid synthase" . SPARSER::PROTEIN) ("protein-1" . SPARSER::PROTEIN)
    ("augmenter of liver regeneration" . SPARSER::PROTEIN)
    ("aryl hydrocarbon receptor" . SPARSER::PROTEIN)
    ("glycogen synthase" . SPARSER::PROTEIN-FAMILY)
    ("β -TrCP" . SPARSER::PROTEIN)
    ("musculoaponeurotic fibrosarcoma" . SPARSER::PROTEIN)
    ("Nfe2l2" . SPARSER::PROTEIN)
    ("nuclear factor-erythroid 2-related factor 2" . SPARSER::PROTEIN)
    ("glutathione peroxidase" . SPARSER::PROTEIN)
    ("cytochrome P450" . SPARSER::PROTEIN-FAMILY) ("E1" . SPARSER::MOLECULE)
    ("P450" . SPARSER::PROTEIN-FAMILY) ("acyl-CoA" . SPARSER::MOLECULE)
    ("low density lipoprotein" . SPARSER::PROTEIN)
    ("acetyl-CoA" . SPARSER::MOLECULE)
    ("nuclear factor erythroid 2-related factor 2" . SPARSER::PROTEIN)
    ("Transcription factor" . SPARSER::PROTEIN)
    ("IKZF1/IKZF3" . SPARSER::COLLECTION)
    ("BCR and MYD88" . SPARSER::COLLECTION) ("vFLIP" . SPARSER::PROTEIN)
    ("FLICE" . SPARSER::PROTEIN) ("BCR" . SPARSER::PROTEIN)
    ("BRD4-" . SPARSER::PROTEIN)
    ("TO/H1 promoter-driven shRNA" . SPARSER::PROTEIN)
    ("MYC and IRF4" . SPARSER::COLLECTION)
    ("TO/H1-driven shRNAs" . SPARSER::RNA)
    ("IKZF1, IRF4 and MYC" . SPARSER::COLLECTION) ("CRBN-" . SPARSER::PROTEIN)
    ("IRF4 and IKZF1" . SPARSER::COLLECTION) ("-F11" . SPARSER::COLLECTION)
    ("annexinV" . SPARSER::PROTEIN)
    ("a tetracycline-inducible-H1 (TO/H1) promoter-driven shRNA"
     . SPARSER::PROTEIN)
    ("IRF4 and MYC" . SPARSER::COLLECTION)
    ("IRF4 and its downstream target MYC" . SPARSER::COLLECTION)
    ("Luc" . SPARSER::PROTEIN)
    ("Replication and Transcription Activator (RTA)" . SPARSER::PROTEIN)
    ("regulator and marker" . SPARSER::COLLECTION) ("RTA" . SPARSER::PROTEIN)
    ("IFNs and interferon" . SPARSER::COLLECTION)
    ("lenalidomide, BC-3 and BCBL-1" . SPARSER::COLLECTION)
    ("BC-1, BCP-1 and APK-1" . SPARSER::COLLECTION) ("BC-1" . SPARSER::PROTEIN)
    ("UMPEL-3" . SPARSER::COLLECTION) ("UMPEL-1" . SPARSER::COLLECTION)
    ("BRD2, BRD3, BRD4 and BRDT" . SPARSER::COLLECTION)
    ("BRD" . SPARSER::PROTEIN) ("Bromodomain (BRD)" . SPARSER::PROTEIN)
    ("immunomodulatory drugs" . SPARSER::DRUG)
    ("IKZF1 and IKZF3" . SPARSER::COLLECTION) ("Ikaros" . SPARSER::PROTEIN)
    ("CRBN" . SPARSER::PROTEIN) ("lenalidomide and BRD4" . SPARSER::COLLECTION)
    ("NOD" . SPARSER::PROTEIN) ("PFI-1" . SPARSER::COLLECTION)
    ("JQ-1" . SPARSER::COLLECTION) ("PFI" . SPARSER::PROTEIN)
    ("Lenalidomide" . SPARSER::DRUG) ("super-enhancers" . SPARSER::PROTEIN)
    ("Bromodomain and extraterminal domain (BET) proteins"
     . SPARSER::COLLECTION)
    ("extraterminal domain (BET) proteins" . SPARSER::PROTEIN)
    ("Bromodomain" . SPARSER::PROTEIN) ("cereblon" . SPARSER::PROTEIN)
    ("Immunomodulatory drugs (IMiDs) lenalidomide and pomalidomide"
     . SPARSER::COLLECTION)
    ("lenalidomide and pomalidomide" . SPARSER::COLLECTION)
    ("pomalidomide" . SPARSER::DRUG) ("an aggressive type" . TYPE)
    ("β-cyclodextrin" . SPARSER::MOLECULE) ("K13" . SPARSER::PROTEIN)
    ("CARD11" . SPARSER::PROTEIN) ("IRF7" . SPARSER::PROTEIN)
    ("IFNβ" . SPARSER::PROTEIN) ("MYD88" . SPARSER::PROTEIN)
    ("F11" . SPARSER::PROTEIN)
    ("Replication and Transcription Activator" . SPARSER::PROTEIN)
    ("– 2" . SPARSER::PROTEIN) ("BCP-1" . SPARSER::PROTEIN)
    ("BRD2" . SPARSER::PROTEIN) ("IBET151" . SPARSER::DRUG)
    ("transcriptional coactivator" . SPARSER::PROTEIN)
    ("IKZF3" . SPARSER::PROTEIN) ("IKZF1" . SPARSER::PROTEIN)
    ("IRF4" . SPARSER::PROTEIN) ("Verteporfin" . SPARSER::DRUG)
    ("doxorubicin and etoposide" . SPARSER::COLLECTION)
    ("CTGF, cyr61, survivin, amphiregulin , and AXL" . SPARSER::COLLECTION)
    ("AXL" . SPARSER::PROTEIN) ("cisplatin and γ" . SPARSER::COLLECTION)
    ("erlotinib and surivivin inhibitors ( xref )" . SPARSER::COLLECTION)
    ("TAZ" . SPARSER::PROTEIN)
    ("Bcl-2 ( xref ) and p53 ( xref , xref )" . SPARSER::COLLECTION)
    ("validated prognostic molecular biomarkers" . SPARSER::MOLECULE)
    ("RFS" . SPARSER::PROTEIN) ("CDDP and VP" . SPARSER::COLLECTION)
    ("CDDP and p" . SPARSER::COLLECTION)
    ("cisplatin and VP" . SPARSER::COLLECTION)
    ("survivin and CTGF" . SPARSER::COLLECTION)
    ("CTGF and survivin" . SPARSER::COLLECTION) ("retina" . SPARSER::DRUG)
    ("FDA" . SPARSER::PROTEIN) ("verteporfin (VP)" . SPARSER::DRUG)
    ("VP" . SPARSER::PROTEIN) ("pATM and pH2A" . SPARSER::COLLECTION)
    ("pATM" . SPARSER::PROTEIN) ("Cyr61 and CTGF" . SPARSER::COLLECTION)
    ("the anthracycline antibiotic doxorubicin and the podophyllum peltatum toxin etoposide"
     . SPARSER::COLLECTION)
    ("etoposide" . SPARSER::PROTEIN) ("toxin" . SPARSER::MOLECULE)
    ("anthracycline" . SPARSER::MOLECULE)
    ("neither ATM nor H2A" . SPARSER::COLLECTION)
    ("ATM immediate downstream target" . SPARSER::TARGET-PROTEIN)
    ("ATM and H2A" . SPARSER::COLLECTION)
    ("the apical kinase ATM" . SPARSER::PROTEIN)
    ("caspase 3 and PARP" . SPARSER::COLLECTION) ("CTGF" . SPARSER::PROTEIN)
    ("PDXs" . SPARSER::PROTEIN) ("RP" . SPARSER::PROTEIN)
    ("DNA-damage induced apoptosis" . SPARSER::DNA) ("FAS" . SPARSER::PROTEIN)
    ("TEAD" . SPARSER::PROTEIN)
    ("methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC)"
     . SPARSER::COLLECTION)
    ("gemcitabine and cisplatin" . SPARSER::COLLECTION)
    ("methotrexate, vinblastine, doxorubicin, and cisplatin"
     . SPARSER::COLLECTION)
    ("doxorubicin" . SPARSER::PROTEIN) ("vinblastine" . SPARSER::DRUG)
    ("methotrexate" . SPARSER::DRUG) ("gemcitabine" . SPARSER::DRUG)
    ("verteporfin" . SPARSER::DRUG)
    ("Yes-associated protein (YAP)" . SPARSER::PROTEIN)
    ("doxorubicin hydrochloride" . SPARSER::DRUG) ("H 2 A" . SPARSER::PROTEIN)
    ("YAP1" . SPARSER::PROTEIN) ("sodium chloride" . SPARSER::DRUG)
    ("Y-27632" . SPARSER::MOLECULE) ("cyr61" . SPARSER::PROTEIN)
    ("p-ATM" . SPARSER::PROTEIN) ("H2A" . SPARSER::PROTEIN)
    ("connective tissue growth factor" . SPARSER::PROTEIN)
    ("Cyr61" . SPARSER::PROTEIN) ("cytokeratin 20" . SPARSER::PROTEIN)
    ("cytokeratin 5" . SPARSER::PROTEIN) ("14-3-3" . SPARSER::PROTEIN)
    ("FAK and PKM2" . SPARSER::COLLECTION)
    ("ENO1 and LDH" . SPARSER::COLLECTION)
    ("LDH and ENO1" . SPARSER::COLLECTION)
    ("the optimal PKM2 binding peptide" . SPARSER::PEPTIDE)
    ("NADH" . SPARSER::MOLECULE)
    ("ENO1, PKM2, LDH, MCT1 and MCT4" . SPARSER::COLLECTION)
    ("GFP-" . SPARSER::PROTEIN) ("normal media" . SPARSER::PROTEIN)
    ("nearly all PDAC" . SPARSER::MOLECULE)
    ("CNTF or GFP" . SPARSER::COLLECTION)
    ("Mitochondrial complex I" . SPARSER::PROTEIN)
    ("NDUFA9 and NDUFB8" . SPARSER::COLLECTION)
    ("functional mitochondria" . SPARSER::PROTEIN) ("Mito" . SPARSER::DRUG)
    ("maximal FCCP" . SPARSER::MOLECULE) ("FCCP" . SPARSER::MOLECULE)
    ("BSA" . SPARSER::PROTEIN) ("pervanadate" . SPARSER::PROTEIN)
    ("tetramers" . SPARSER::TETRAMER)
    ("phosphotyrosine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("−1" . SPARSER::PROTEIN) ("macromolecules" . SPARSER::MOLECULE)
    ("GFP or FAK" . SPARSER::COLLECTION) ("MCT" . SPARSER::PROTEIN)
    ("FAK (FAK)" . SPARSER::PROTEIN)
    ("phosphoenolpyruvate" . SPARSER::MOLECULE)
    ("phosphoglycerate" . SPARSER::MOLECULE) ("ENO" . SPARSER::PROTEIN)
    ("enolase (ENO)" . SPARSER::PROTEIN) ("GFP or CNTF" . SPARSER::COLLECTION)
    ("Seahorse" . SPARSER::PROTEIN)
    ("lactate and glucose" . SPARSER::COLLECTION)
    ("13 C lactate and 13 C glucose" . SPARSER::COLLECTION)
    ("the GFP (control) or the CNTF (the FAK F1 subdomain) gene"
     . SPARSER::COLLECTION)
    ("Pyruvate" . SPARSER::PROTEIN)
    ("processing excessive pyruvate" . SPARSER::PROTEIN)
    ("Lactate" . SPARSER::LACTATE) ("intracellular lactate" . SPARSER::LACTATE)
    ("significantly more lactate" . SPARSER::MOLECULE)
    ("GFP (control) or CNTF (the FAK F1 subdomain)" . SPARSER::COLLECTION)
    ("CR-FAK" . SPARSER::COLLECTION) ("CR" . SPARSER::PROTEIN)
    ("UK" . SPARSER::PROTEIN) ("neo" . SPARSER::PROTEIN)
    ("nuclease" . SPARSER::PROTEIN) ("FAK or GFP" . SPARSER::COLLECTION)
    ("intrinsic glucose" . SPARSER::PROTEIN)
    ("t erminal F AK (CNTF)" . SPARSER::PROTEIN)
    ("AK (CNTF)" . SPARSER::PROTEIN) ("CNTF" . SPARSER::PROTEIN)
    ("AK" . SPARSER::PROTEIN) ("receptors and matrix" . SPARSER::COLLECTION)
    ("fibronectin and integrins" . SPARSER::COLLECTION)
    ("FBS, pyruvate, and glutamine" . SPARSER::COLLECTION)
    ("analog" . SPARSER::ANALOG) ("Deoxyglucose" . SPARSER::MOLECULE)
    ("oxa" . SPARSER::MOLECULE) ("NBDG" . SPARSER::DRUG)
    ("Apsc-1" . SPARSER::COLLECTION) ("RPMI" . SPARSER::PROTEIN)
    ("Mia" . SPARSER::PROTEIN) ("glucose, and LDH" . SPARSER::COLLECTION)
    ("extracellular glucose" . SPARSER::PROTEIN)
    ("Extracellular glucose" . SPARSER::PROTEIN)
    ("FAK-Src" . SPARSER::COLLECTION)
    ("enzymes and transporters" . SPARSER::COLLECTION)
    ("particularly glycolytic PDAC" . SPARSER::MOLECULE)
    ("PDAC" . SPARSER::MOLECULE) ("mitochondrial complex I" . SPARSER::PROTEIN)
    ("dehydrogenase and monocarboxylate" . SPARSER::COLLECTION)
    ("monocarboxylate" . SPARSER::MOLECULE) ("enolase" . SPARSER::PROTEIN)
    ("lactate" . SPARSER::LACTATE) ("PDACs" . SPARSER::MOLECULE)
    ("Glut 1" . SPARSER::PROTEIN) ("SRC kinase" . SPARSER::PROTEIN)
    ("ENO1" . SPARSER::PROTEIN) ("g protein" . SPARSER::PROTEIN)
    ("NDUFB8" . SPARSER::PROTEIN) ("NDUFA9" . SPARSER::PROTEIN)
    ("ATP dependent" . SPARSER::PROTEIN) ("MCT1" . SPARSER::PROTEIN)
    ("Glut1" . SPARSER::PROTEIN) ("intrinsic factor" . SPARSER::PROTEIN)
    ("BTG2" . SPARSER::PROTEIN) ("Growth factors" . SPARSER::GROWTH-FACTOR)
    ("MCT4" . SPARSER::PROTEIN)
    ("monocarboxylate transporter 4" . SPARSER::PROTEIN)
    ("PKM2" . SPARSER::PROTEIN) ("kinase (FAK)" . SPARSER::KINASE)
    ("Nischarin" . SPARSER::PROTEIN) ("EphB2/CTF2" . SPARSER::COLLECTION)
    ("the dimerized or aggregated Eph-ephrin receptors" . SPARSER::RECEPTOR)
    ("ephrinB1 or Fc" . SPARSER::COLLECTION)
    ("the soluble form ephrinB1" . SPARSER::PROTEIN)
    ("ephrins" . SPARSER::PROTEIN)
    ("kinases and protein" . SPARSER::COLLECTION)
    ("the exogenous EphB2" . SPARSER::PROTEIN)
    ("P85 and Akt" . SPARSER::COLLECTION)
    ("PI3K/Akt/GSK-3β" . SPARSER::COLLECTION) ("wortmannin" . SPARSER::PROTEIN)
    ("PI3K and Akt" . SPARSER::COLLECTION)
    ("Tyr216-GSK-3 (the active form) and total-GSK-3 ( xref )"
     . SPARSER::COLLECTION)
    ("hippocampal CA1, CA3 and dentate gyrus (DG)" . SPARSER::PROTEIN)
    ("gyrus (DG)" . SPARSER::PROTEIN)
    ("CA1, CA3 and dentate" . SPARSER::COLLECTION) ("CA1" . SPARSER::PROTEIN)
    ("exogenous human full length tau" . SPARSER::PROTEIN)
    ("EphB2/ephrinB1" . SPARSER::COLLECTION) ("Tau" . SPARSER::PROTEIN)
    ("Eph-ephrin" . SPARSER::COLLECTION) ("gyrus" . SPARSER::PROTEIN)
    ("dentate" . SPARSER::PROTEIN) ("NMDAR" . SPARSER::PROTEIN)
    ("EphB2 and the ligand ephrinB1" . SPARSER::COLLECTION)
    ("GPI" . SPARSER::PROTEIN) ("phosphatidyl" . SPARSER::MOLECULE)
    ("EphA" . SPARSER::PROTEIN-FAMILY)
    ("The Eph receptors and their ephrin ligands" . SPARSER::COLLECTION)
    ("ephrinB" . SPARSER::PROTEIN) ("ephrin" . SPARSER::PROTEIN)
    ("Eph" . SPARSER::PROTEIN) ("the best accessible drug" . SPARSER::DRUG)
    ("the plasma membraneous receptors" . SPARSER::PROTEIN)
    ("LTP" . SPARSER::PROTEIN)
    ("paired helical filaments (PHF)" . SPARSER::PROTEIN-FAMILY)
    ("PI3K-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("tau" . SPARSER::PROTEIN)
    ("GSK-3α" . SPARSER::PROTEIN) ("edetic acid" . SPARSER::MOLECULE)
    ("S100" . SPARSER::PROTEIN) ("AP-2" . SPARSER::PROTEIN)
    ("CTF2" . SPARSER::PROTEIN) ("c-fos" . SPARSER::PROTEIN)
    ("EphrinB1" . SPARSER::PROTEIN) ("P85" . SPARSER::PROTEIN)
    ("CA3" . SPARSER::PROTEIN) ("N-methyl-D-aspartate" . SPARSER::MOLECULE)
    ("EphB receptors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("microtubule associated protein tau" . SPARSER::PROTEIN)
    ("phosphatidylinositol-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ephrinB1" . SPARSER::PROTEIN) ("EphB2" . SPARSER::PROTEIN)
    ("Jak2 and SOCS-1" . SPARSER::COLLECTION) ("Ali" . SPARSER::PROTEIN)
    ("SOCS1, SOCS3 and SOCS6" . SPARSER::COLLECTION) ("pY" . SPARSER::PROTEIN)
    ("IFN-α-" . SPARSER::PROTEIN) ("Jak-Stat1" . SPARSER::COLLECTION)
    ("the antiviral genes" . SPARSER::GENE)
    ("a poor inducer" . SPARSER::PROTEIN) ("Jak-Stat" . SPARSER::COLLECTION)
    ("functional Shp-2" . SPARSER::PROTEIN)
    ("DMSO and PHPS1" . SPARSER::COLLECTION) ("-OAS1" . SPARSER::COLLECTION)
    ("synthetase" . SPARSER::PROTEIN)
    ("RSV-F mRNA and RSV titre ( xref )" . SPARSER::COLLECTION)
    ("a widely used cell-permeable inhibitor" . SPARSER::INHIBITOR)
    ("mRNA and Shp-2" . SPARSER::COLLECTION)
    ("mRNA/protein" . SPARSER::COLLECTION)
    ("hrs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("hpi" . SPARSER::PROTEIN)
    ("Jak/Stat5" . SPARSER::COLLECTION) ("TRIF" . SPARSER::PROTEIN)
    ("cytokines [including interleukin (IL)-3, granulocyte macrophage-colony stimulating factor, eosinophil peroxidase] and IFNs"
     . SPARSER::COLLECTION)
    ("growth factors (including platelet-derived growth factor, epidermal growth factor and insulin-like growth factor 1), cytokines [including interleukin (IL)-3, granulocyte macrophage-colony stimulating factor, eosinophil peroxidase] and IFNs"
     . SPARSER::COLLECTION)
    ("platelet-derived growth factor, epidermal growth factor and insulin-like growth factor"
     . SPARSER::COLLECTION)
    ("peroxidase" . SPARSER::PROTEIN) ("Jak/Stat" . SPARSER::COLLECTION)
    ("the viral nonstructural (NS) proteins NS1 and NS2" . SPARSER::COLLECTION)
    ("NS1 and NS2" . SPARSER::COLLECTION)
    ("receptor (TLR)" . SPARSER::RECEPTOR) ("IFITM1/2/3" . SPARSER::COLLECTION)
    ("interferon induced transmembrane protein 1/2/3" . SPARSER::COLLECTION)
    ("ADAR" . SPARSER::PROTEIN)
    ("transducers and activators" . SPARSER::COLLECTION)
    ("Stats" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tyrosines" . SPARSER::AMINO-ACID)
    ("Jaks" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IFNs" . SPARSER::DRUG)
    ("Jak/Stat1" . SPARSER::COLLECTION) ("Stat1" . SPARSER::PROTEIN)
    ("Stat" . SPARSER::PROTEIN) ("IFN" . SPARSER::DRUG)
    ("interferon" . SPARSER::PROTEIN) ("SOCS-1" . SPARSER::PROTEIN)
    ("prolactin receptor" . SPARSER::PROTEIN) ("SOCS6" . SPARSER::PROTEIN)
    ("Stat3" . SPARSER::PROTEIN) ("gp130" . SPARSER::PROTEIN)
    ("IFN-γ" . SPARSER::PROTEIN) ("Interferon-α" . SPARSER::DRUG)
    ("OAS1" . SPARSER::PROTEIN)
    ("reverse-transcriptase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Stat5" . SPARSER::PROTEIN) ("IFN-beta" . SPARSER::PROTEIN)
    ("IL-1" . SPARSER::PROTEIN)
    ("macrophage-colony stimulating factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NS2" . SPARSER::PROTEIN) ("NS1" . SPARSER::PROTEIN)
    ("RIG-I" . SPARSER::PROTEIN) ("retinoic acid" . SPARSER::MOLECULE)
    ("TLR9" . SPARSER::PROTEIN) ("TLR7" . SPARSER::PROTEIN)
    ("IFITM1" . SPARSER::PROTEIN)
    ("interferon induced transmembrane protein 1" . SPARSER::PROTEIN)
    ("RNA-specific" . SPARSER::PROTEIN)
    ("adenosine deaminase" . SPARSER::PROTEIN) ("ISG15" . SPARSER::PROTEIN)
    ("ISG15 ubiquitin-like modifier" . SPARSER::PROTEIN)
    ("catalytic polypeptide-like 3G" . SPARSER::PROTEIN)
    ("apolipoprotein B mRNA editing enzyme" . SPARSER::PROTEIN)
    ("single-stranded RNA" . SPARSER::RNA) ("IFN-α" . SPARSER::PROTEIN)
    ("interferon-alpha" . SPARSER::PROTEIN) ("Shp-2" . SPARSER::PROTEIN)
    ("phosphatase 2" . SPARSER::PROTEIN)
    ("MAPK1 and HOTAIR" . SPARSER::COLLECTION)
    ("miR-1, miR-214-3p, miR-330-5p, HOTAIR, and MAPK1" . SPARSER::COLLECTION)
    ("HOTAIR or MAPK1 was" . SPARSER::COLLECTION)
    ("MiR-1, miR-214-3p, and miR-330-5p" . SPARSER::COLLECTION)
    ("miR-1, miR-214-3p, and miR-330-5p" . SPARSER::COLLECTION)
    ("HOTAIR and MAPK1 was" . SPARSER::COLLECTION) ("dicer" . SPARSER::PROTEIN)
    ("MAPK and HOTAIR" . SPARSER::COLLECTION)
    ("some key signaling components and phosphorylation events"
     . SPARSER::COLLECTION)
    ("Xist" . SPARSER::PROTEIN) ("lncRNAs" . SPARSER::RNA)
    ("HOTAIR or MAPK1" . SPARSER::COLLECTION)
    ("HOTAIR and MAPK1" . SPARSER::COLLECTION)
    ("miR-1, miR-214-3p, or miR-330-5p" . SPARSER::COLLECTION)
    ("HOTAIR (HOX antisense intergenic RNA) and MAPK1 (mitogen-activated protein kinase 1)"
     . SPARSER::COLLECTION)
    ("HOX" . SPARSER::PROTEIN) ("ES-2" . SPARSER::PROTEIN)
    ("HOTAIR" . SPARSER::PROTEIN) ("MiR-1" . SPARSER::PROTEIN)
    ("PCAT-1" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase 1" . SPARSER::PROTEIN)
    ("NOX and AMPK" . SPARSER::COLLECTION)
    ("DPI or antioxidants" . SPARSER::COLLECTION)
    ("phagocytic NADPH oxidase subunits" . SPARSER::FRAGMENT)
    ("MAPKs as well as the transcription factors NF-κB and AP-1"
     . SPARSER::COLLECTION)
    ("platelet-derived growth factor or epidermal growth factor"
     . SPARSER::COLLECTION)
    ("DPI and Apo" . SPARSER::COLLECTION) ("Apo" . SPARSER::PROTEIN)
    ("NOX2, p47phox, p67phox, and MMP-7" . SPARSER::COLLECTION)
    ("DPI and antioxidants" . SPARSER::COLLECTION)
    ("NAC and Vit" . SPARSER::COLLECTION) ("NAC" . SPARSER::PROTEIN)
    ("AICAR" . SPARSER::PROTEIN)
    ("human NF-κB (NF-κB-Luc) or AP-1 (AP-1-Luc) response element"
     . SPARSER::COLLECTION)
    ("SB203580, PD98059, and SP600125" . SPARSER::COLLECTION)
    ("AP-1-Luc" . SPARSER::PROTEIN-PAIR) ("NF-κB-Luc" . SPARSER::PROTEIN-PAIR)
    ("AP-1 and NF-κB" . SPARSER::COLLECTION) ("PDTC" . SPARSER::DRUG)
    ("NF-κB, c-Fos and c-Jun" . SPARSER::COLLECTION)
    ("PD98059, SP600125, SB203580, and DPI" . SPARSER::COLLECTION)
    ("NOX2 or its regulators" . SPARSER::COLLECTION)
    ("PD98059 and SP600125" . SPARSER::COLLECTION)
    ("ERK and JNK" . SPARSER::COLLECTION)
    ("MAPKs, ERK, p38, and JNK" . SPARSER::COLLECTION)
    ("NOX2, p67phox, and p47phox" . SPARSER::COLLECTION)
    ("exogenous ROS" . SPARSER::PROTEIN)
    ("DPI as well as antioxidants" . SPARSER::COLLECTION)
    ("antioxidants" . SPARSER::DRUG)
    ("NOX2, p47phox, and p67phox" . SPARSER::COLLECTION)
    ("NADPH oxidase, the catalytic core subunits p22phox, NOX1, and NOX2, and the regulatory subunits NOXO1, NOXA1, p47phox, p67phox, and Rac1 (Fig.  xref )"
     . SPARSER::COLLECTION)
    ("p22phox, NOX1, and NOX2" . SPARSER::COLLECTION)
    ("NOXO1, NOXA1, p47phox, p67phox, and Rac1" . SPARSER::COLLECTION)
    ("NOX1, NOX2, and MMP-7" . SPARSER::COLLECTION)
    ("NOX2 and p67phox" . SPARSER::COLLECTION) ("DCF" . SPARSER::PROTEIN)
    ("NOX2 and its activator p67phox" . SPARSER::COLLECTION)
    ("NOX1 and NOX2" . SPARSER::COLLECTION)
    ("celecoxib or antimycin" . SPARSER::COLLECTION)
    ("DPI and Vit" . SPARSER::COLLECTION)
    ("celecoxib (COX-2 inhibitor) or antimycin" . SPARSER::COLLECTION)
    ("antimycin" . SPARSER::DRUG) ("celecoxib" . SPARSER::DRUG)
    ("DPI and apocynin" . SPARSER::COLLECTION)
    ("colon cancer, and ROS" . SPARSER::COLLECTION)
    ("-tetradecanoylphorbol-1" . SPARSER::COLLECTION)
    ("AMPK and NOX" . SPARSER::COLLECTION) ("ester" . SPARSER::MOLECULE)
    ("phorbol" . SPARSER::DRUG) ("kinase (AMPK)" . SPARSER::KINASE)
    ("AMP/ATP" . SPARSER::PROTEIN-PAIR) ("AMP" . SPARSER::AMP)
    ("ERK, JNK, and p38" . SPARSER::COLLECTION)
    ("exogenous H 2 O 2" . SPARSER::DRUG) ("JNK/AP-1" . SPARSER::COLLECTION)
    ("ROS and NOX2" . SPARSER::COLLECTION)
    ("NOX2 and its regulators" . SPARSER::COLLECTION)
    ("AP-1, NF-κB, and MAPK" . SPARSER::COLLECTION)
    ("ERK, p38, and JNK" . SPARSER::COLLECTION)
    ("p47phox and p67phox" . SPARSER::COLLECTION)
    ("p38 and NF-κB" . SPARSER::COLLECTION) ("apocynin" . SPARSER::MOLECULE)
    ("DPI" . SPARSER::PROTEIN) ("Vit" . SPARSER::PROTEIN)
    ("TPA" . SPARSER::DRUG) ("exogenous hydrogen peroxide" . SPARSER::DRUG)
    ("NOX2 and MMP-7" . SPARSER::COLLECTION) ("diacetate" . SPARSER::MOLECULE)
    ("lucigenin" . SPARSER::DRUG)
    ("membrane NADPH oxidase (NOX) and AMP activated protein kinase (AMPK)"
     . SPARSER::COLLECTION)
    ("NADPH oxidase (NOX)" . SPARSER::PROTEIN) ("NOX" . SPARSER::PROTEIN)
    ("NADPH Oxidase" . SPARSER::PROTEIN) ("B-2" . SPARSER::PROTEIN)
    ("Superoxide anion" . SPARSER::MOLECULE) ("TIMP-2" . SPARSER::PROTEIN)
    ("TIMP-1" . SPARSER::PROTEIN) ("C-Jun" . SPARSER::PROTEIN)
    ("phospho-JNK" . SPARSER::PROTEIN) ("phospho-ERK" . SPARSER::PROTEIN)
    ("I-κB" . SPARSER::PROTEIN) ("cyclooxygenase-2" . SPARSER::PROTEIN)
    ("collagen-I" . SPARSER::PROTEIN) ("SB203580" . SPARSER::DRUG)
    ("SP600125" . SPARSER::PROTEIN) ("Rac1" . SPARSER::PROTEIN)
    ("NOXA1" . SPARSER::PROTEIN) ("NOXO1" . SPARSER::PROTEIN)
    ("p22phox" . SPARSER::PROTEIN) ("COX-2" . SPARSER::PROTEIN)
    ("Lysophosphatidic acid" . SPARSER::LPA)
    ("AMP-activated" . SPARSER::PROTEIN) ("K-Ras" . SPARSER::PROTEIN)
    ("activator protein 1" . SPARSER::PROTEIN) ("p67phox" . SPARSER::PROTEIN)
    ("p47phox" . SPARSER::PROTEIN) ("NOX2" . SPARSER::PROTEIN)
    ("12- O -tetradecanoylphorbol-13-acetate" . SPARSER::DRUG)
    ("NOX1" . SPARSER::PROTEIN) ("superoxide anion" . SPARSER::MOLECULE)
    ("MMP-7" . SPARSER::PROTEIN)
    ("AMP activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("miRs and their predicted targets" . SPARSER::COLLECTION)
    ("only two genes" . SPARSER::GENE)
    ("STAT1 and PIAS3" . SPARSER::COLLECTION)
    ("NF-kB/MAPK" . SPARSER::COLLECTION) ("cocaine" . SPARSER::DRUG)
    ("miR and STAT3" . SPARSER::COLLECTION)
    ("complex and distinct signaling responses" . SPARSER::COLLECTION)
    ("coreceptors" . SPARSER::PROTEIN)
    ("monocytes/macrophages" . SPARSER::COLLECTION)
    ("their own miRs" . SPARSER::PROTEIN) ("BCLxL" . SPARSER::PROTEIN)
    ("JNK" . SPARSER::PROTEIN) ("STAT1 and STAT3" . SPARSER::COLLECTION)
    ("cytokines and cytokine" . SPARSER::COLLECTION)
    ("JAK/STAT" . SPARSER::COLLECTION) ("JAK" . SPARSER::PROTEIN)
    ("the newly identified gp120 deregulated miRs" . SPARSER::PROTEIN)
    ("MiRs" . SPARSER::PROTEIN) ("gp120 and LPS" . SPARSER::COLLECTION)
    ("cytokine/chemokine" . SPARSER::COLLECTION)
    ("miR-21 and miR-181b" . SPARSER::COLLECTION) ("Stattic" . SPARSER::DRUG)
    ("miR-21 (A) and miR-181b (B)" . SPARSER::COLLECTION)
    ("STAT3/IL-6" . SPARSER::COLLECTION) ("Promoters" . SPARSER::PROMOTER)
    ("PIAS3 and STAT1" . SPARSER::COLLECTION)
    ("miRs and several components" . SPARSER::COLLECTION)
    ("the principal coreceptor" . SPARSER::PROTEIN)
    ("coreceptor" . SPARSER::PROTEIN) ("MAPK/NF-kB" . SPARSER::COLLECTION)
    ("professional antigen" . SPARSER::PROTEIN) ("DCs" . SPARSER::MOLECULE)
    ("Multiple cellular miRs" . SPARSER::PROTEIN)
    ("cellular miRs" . SPARSER::PROTEIN)
    ("Several cellular miRs" . SPARSER::PROTEIN)
    ("healthy states or diseases" . SPARSER::COLLECTION)
    ("states or diseases" . SPARSER::COLLECTION)
    ("STAT3 and potentially targeting genes" . SPARSER::COLLECTION)
    ("Bcl2" . SPARSER::PROTEIN) ("STAT-2" . SPARSER::PROTEIN)
    ("STAT −3" . SPARSER::PROTEIN) ("STAT-1" . SPARSER::PROTEIN)
    ("let-7" . SPARSER::RNA) ("IL-4" . SPARSER::PROTEIN)
    ("CD19" . SPARSER::PROTEIN) ("CD14" . SPARSER::PROTEIN)
    ("DC-SIGN" . SPARSER::PROTEIN) ("BcL2" . SPARSER::PROTEIN)
    ("IKKβ" . SPARSER::PROTEIN) ("IkBα" . SPARSER::PROTEIN)
    ("SOCS3" . SPARSER::PROTEIN) ("SOCS1" . SPARSER::PROTEIN)
    ("STAT2" . SPARSER::PROTEIN) ("IFNγ" . SPARSER::PROTEIN)
    ("IL12A" . SPARSER::PROTEIN) ("MEKK1" . SPARSER::PROTEIN)
    ("MAP3K1" . SPARSER::PROTEIN) ("MEK4" . SPARSER::PROTEIN)
    ("MAP2K4" . SPARSER::PROTEIN) ("MEK1" . SPARSER::PROTEIN)
    ("MAPK1" . SPARSER::PROTEIN) ("miR-125b" . SPARSER::MOLECULE)
    ("STAT1" . SPARSER::PROTEIN) ("PIAS3" . SPARSER::PROTEIN)
    ("chemokine receptor" . SPARSER::PROTEIN) ("NF-kB" . SPARSER::PROTEIN)
    ("envelope protein" . SPARSER::PROTEIN)
    ("HER2 or EGFR" . SPARSER::COLLECTION)
    ("NK-1R, NK-2R and NK-3R" . SPARSER::COLLECTION)
    ("inhibitors or antibodies" . SPARSER::COLLECTION)
    ("neuropeptides and pro-inflammatory" . SPARSER::COLLECTION)
    ("mediators/neuropeptides" . SPARSER::COLLECTION)
    ("Tachykinins" . SPARSER::PROTEIN-FAMILY)
    ("c-Src and NK-1R" . SPARSER::COLLECTION)
    ("c-Src, MMPs, and NK-1R" . SPARSER::COLLECTION)
    ("c-Src, MMPs and NK-1R" . SPARSER::COLLECTION)
    ("NK-1R and RTKs" . SPARSER::COLLECTION)
    ("the western blot" . SPARSER::PROTEIN) ("EGFR/EGFR" . SPARSER::COLLECTION)
    ("NK-1R and ERBB" . SPARSER::COLLECTION)
    ("c-Src and MMPs" . SPARSER::COLLECTION)
    ("NK-2R and NK-3R" . SPARSER::COLLECTION)
    ("NK-1R, NK-2R, and NK-3R" . SPARSER::COLLECTION)
    ("TACR1 or the empty vector pcDNA3.1(+)" . SPARSER::COLLECTION)
    ("Tyr" . SPARSER::AMINO-ACID) ("GPCRs and RTKs" . SPARSER::COLLECTION)
    ("GPCRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-Src and metalloproteinases" . SPARSER::COLLECTION)
    ("EGFR, HER2, HER3, and HER4" . SPARSER::COLLECTION)
    ("acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("neurokinin 2 receptor (NK-2R) and neurokinin 3 receptor (NK-3R)"
     . SPARSER::COLLECTION)
    ("the TACR2 and the TACR3 gene" . SPARSER::COLLECTION)
    ("tachykinin" . SPARSER::PROTEIN-FAMILY)
    ("G-protein coupled receptor (GPCR)" . SPARSER::PROTEIN)
    ("GPCR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the TAC1 (SP and NKA) or TAC3 (NKB) genes [ xref ]"
     . SPARSER::COLLECTION)
    ("NKB" . SPARSER::PROTEIN)
    ("a pro-inflammatory cytokine and neuropeptide" . SPARSER::COLLECTION)
    ("its preferential ligand substance P (SP)" . SPARSER::PROTEIN)
    ("substance P (SP)" . SPARSER::PROTEIN)
    ("cytokine and neuropeptide" . SPARSER::COLLECTION)
    ("tachykinins" . SPARSER::PROTEIN-FAMILY)
    ("neuropeptides" . SPARSER::PROTEIN)
    ("c-Src and MMP" . SPARSER::COLLECTION) ("HER2/EGFR" . SPARSER::COLLECTION)
    ("HER2 and EGFR" . SPARSER::COLLECTION)
    ("a pleiotropic cytokine/neuropeptide" . SPARSER::COLLECTION)
    ("cytokine/neuropeptide" . SPARSER::COLLECTION)
    ("neuropeptide" . SPARSER::PROTEIN) ("p42/44" . SPARSER::PROTEIN)
    ("NaF 1" . SPARSER::PROTEIN) ("Na3VO4" . SPARSER::MOLECULE)
    ("SP 100" . SPARSER::PROTEIN) ("NH2" . SPARSER::MOLECULE)
    ("Leu-Met" . SPARSER::MOLECULE) ("G-proteins" . SPARSER::PROTEIN)
    ("TACR3" . SPARSER::PROTEIN) ("TACR2" . SPARSER::PROTEIN)
    ("NK-3R" . SPARSER::PROTEIN) ("NK-2R" . SPARSER::PROTEIN)
    ("TAC4" . SPARSER::PROTEIN) ("TAC3" . SPARSER::PROTEIN)
    ("TAC1" . SPARSER::PROTEIN) ("substance P" . SPARSER::PROTEIN)
    ("TACR1" . SPARSER::PROTEIN) ("NK-1R" . SPARSER::PROTEIN)
    ("NK1" . SPARSER::PROTEIN) ("NK-1" . SPARSER::PROTEIN)
    ("Substance P" . SPARSER::PROTEIN)
    ("ADIPOQ , CDH13 , SIRT3 , SIRT6 , NOS1 , CXCL12 , CXCR4 , PON1 and CDKN2B"
     . SPARSER::COLLECTION)
    ("TG and HDL-C" . SPARSER::COLLECTION) ("SBP" . SPARSER::PROTEIN)
    ("allele and disease" . SPARSER::COLLECTION)
    ("AA and Aa" . SPARSER::COLLECTION) ("Aa and aa" . SPARSER::COLLECTION)
    ("Aa" . SPARSER::MOLECULE) ("AA" . SPARSER::MOLECULE)
    ("high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C)"
     . SPARSER::COLLECTION)
    ("total triglycerides (TG), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C)"
     . SPARSER::COLLECTION)
    ("triglycerides (TG)" . SPARSER::MOLECULE)
    ("glucose (FBG)" . SPARSER::MOLECULE) ("HEM" . SPARSER::MOLECULE)
    ("at least 1 cigarette" . SPARSER::DRUG) ("glass" . SPARSER::MOLECULE)
    ("PRE" . SPARSER::PROTEIN)
    ("serum albumin and C-reactive protein" . SPARSER::COLLECTION)
    ("TC and LDL-C" . SPARSER::COLLECTION) ("TC" . SPARSER::PROTEIN)
    ("Asp/Asp" . SPARSER::COLLECTION) ("SHBG" . SPARSER::PROTEIN)
    ("isoflavone" . SPARSER::MOLECULE) ("isoflavones" . SPARSER::MOLECULE)
    ("CC or CT" . SPARSER::COLLECTION) ("-Akt" . SPARSER::COLLECTION)
    ("nine different inflammatory-related genes" . SPARSER::GENE)
    ("SIRT6 or ADIPOQ" . SPARSER::COLLECTION)
    ("GT and TT genotypes (GT/TT)" . SPARSER::COLLECTION)
    ("intima-media" . SPARSER::PROTEIN-PAIR)
    ("SIRT3 and SIRT6" . SPARSER::COLLECTION)
    ("highly-conserved nicotinamide adenine dinucleotide (NAD) + -dependent enzymes"
     . SPARSER::ENZYME)
    ("Adiponectin" . SPARSER::PROTEIN)
    ("other inflammatory-related genes" . SPARSER::GENE)
    ("inflammatory-related genes" . SPARSER::GENE) ("GT" . SPARSER::PROTEIN)
    ("ADIPOQ , CDH13 , SIRT3 , SIRT6 , CXCL12 , CXCR4 , NOS1 , PON1 and CDKN2B"
     . SPARSER::COLLECTION)
    ("ADIPOQ" . SPARSER::PROTEIN)
    ("low-density lipoprotein cholesterol" . SPARSER::MOLECULE)
    ("HDL-C" . SPARSER::PROTEIN)
    ("high-density lipoprotein cholesterol" . SPARSER::MOLECULE)
    ("LDL-C" . SPARSER::PROTEIN) ("UGT1A1" . SPARSER::PROTEIN)
    ("CYP1B1" . SPARSER::PROTEIN) ("Paraoxonase 1" . SPARSER::PROTEIN)
    ("nitric oxide" . SPARSER::MOLECULE)
    ("nitric oxide synthase" . SPARSER::PROTEIN)
    ("Cadherin 13" . SPARSER::PROTEIN) ("CDKN2B" . SPARSER::PROTEIN)
    ("PON1" . SPARSER::PROTEIN) ("NOS1" . SPARSER::PROTEIN)
    ("EC" . SPARSER::PROTEIN) ("fish" . SPARSER::PROTEIN)
    ("adenosine" . SPARSER::PROTEIN) ("deoxyadenosine" . SPARSER::MOLECULE)
    ("PTEN-PI3K/Akt" . SPARSER::COLLECTION)
    ("polypeptide and phosphoinositide" . SPARSER::COLLECTION)
    ("phosphoinositide" . SPARSER::MOLECULE)
    ("MMAC1 and TEP1" . SPARSER::COLLECTION) ("MIM" . SPARSER::PROTEIN)
    ("ECG" . SPARSER::DRUG) ("two basic types" . TYPE)
    ("SAH" . SPARSER::MOLECULE) ("SH" . SPARSER::PROTEIN-FAMILY)
    ("Formalin" . SPARSER::MOLECULE) ("Mg 2+" . SPARSER::MOLECULE)
    ("phosphatidylinositol 3,4,5-triphosphate" . SPARSER::PIP3)
    ("membrane-bound" . SPARSER::PROTEIN) ("p23" . SPARSER::PROTEIN)
    ("TEP1" . SPARSER::PROTEIN) ("MMAC1" . SPARSER::PROTEIN)
    ("Phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("HIPK2-SIRT1-AROS" . SPARSER::COLLECTION) ("HAUSP" . SPARSER::PROTEIN)
    ("deubiquitinase" . SPARSER::DEUBIQUITINASE)
    ("AROS and phospho-deficient SIRT1 S682A" . SPARSER::COLLECTION)
    ("SIRT1 and AROS" . SPARSER::COLLECTION)
    ("AROS and SIRT1" . SPARSER::COLLECTION)
    ("the activator AROS and the inhibitor DBC1" . SPARSER::COLLECTION)
    ("SIRT1–DBC1" . SPARSER::COLLECTION) ("Histones" . SPARSER::PROTEIN)
    ("SIRT1–AROS" . SPARSER::COLLECTION)
    ("PUMA, NOXA and p53AIP1" . SPARSER::COLLECTION)
    ("p21, Bax, PUMA, Noxa and p53AIP1" . SPARSER::COLLECTION)
    ("Noxa" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("wild-type SIRT1 and phosphorylation-deficient SIRT1 S682A"
     . SPARSER::COLLECTION)
    ("phospho-mimetic SIRT1 S682D" . SPARSER::PROTEIN)
    ("PUMA" . SPARSER::PROTEIN) ("Luciferase" . SPARSER::PROTEIN)
    ("phosphorylation-mimetic SIRT1 S27D" . SPARSER::PROTEIN)
    ("phosphorylation-mimetic SIRT1 S682D" . SPARSER::PROTEIN)
    ("p53 and CBP" . SPARSER::COLLECTION)
    ("p53 and its acetyltransferase CBP" . SPARSER::COLLECTION)
    ("HIPK2-SIRT1" . SPARSER::COLLECTION)
    ("SIRT1, HIPK2 and PML" . SPARSER::COLLECTION)
    ("the cell cycle inhibitor p21 (which is downregulated after lethal damage  xref  ) and caspase-cleaved PARP"
     . SPARSER::COLLECTION)
    ("a commercially available phospho-specific SIRT1 pSer27 SIRT1 antibody and our SIRT1 pSer682 antibody"
     . SPARSER::COLLECTION)
    ("a commercially available phospho-specific SIRT1 pSer27 SIRT1 antibody"
     . SPARSER::ANTIBODY)
    ("truncated GST-SIRT1 proteins and GST-SIRT1 proteins"
     . SPARSER::COLLECTION)
    ("Ser/Thr" . SPARSER::COLLECTION) ("Pro" . SPARSER::AMINO-ACID)
    ("coimmunoprecipitation analyses using truncated Flag-HIPK2"
     . SPARSER::COLLECTION)
    ("GST-HIPK2" . SPARSER::COLLECTION) ("GFP-SIRT1" . SPARSER::COLLECTION)
    ("Flag-HIPK2" . SPARSER::COLLECTION) ("SIR" . SPARSER::PROTEIN)
    ("GST-SIRT1" . SPARSER::COLLECTION) ("Mapping" . SPARSER::PROTEIN)
    ("SIRT1–HIPK2" . SPARSER::COLLECTION) ("GFP-HIPK2" . SPARSER::COLLECTION)
    ("Flag-SIRT1" . SPARSER::COLLECTION)
    ("SIRT1 and wild-type p53" . SPARSER::COLLECTION)
    ("Adriamycin" . SPARSER::DRUG)
    ("a DNA damage-responsive cell fate regulator" . SPARSER::REGULATOR)
    ("Pin1 and ATM" . SPARSER::COLLECTION)
    ("activators and inhibitors" . SPARSER::COLLECTION)
    ("HIPK2 and SIRT1" . SPARSER::COLLECTION)
    ("NBs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("active regulator" . SPARSER::REGULATOR)
    ("ATM and ATR" . SPARSER::COLLECTION) ("DBC1" . SPARSER::PROTEIN)
    ("CBP and p300" . SPARSER::COLLECTION) ("CBP" . SPARSER::PROTEIN)
    ("SIRT1 and its activator AROS" . SPARSER::COLLECTION)
    ("AROS" . SPARSER::PROTEIN) ("SIRT1 and HIPK2" . SPARSER::COLLECTION)
    ("the DNA damage-responsive kinase HIPK2" . SPARSER::PROTEIN)
    ("promyelocytic" . SPARSER::PROTEIN) ("Tag1" . SPARSER::PROTEIN)
    ("1-2 " . SPARSER::PROTEIN) ("GL2" . SPARSER::DRUG)
    ("TP53AIP1" . SPARSER::PROTEIN) ("PMAIP1" . SPARSER::PROTEIN)
    ("BBC3" . SPARSER::PROTEIN) ("MG-132" . SPARSER::DRUG)
    ("NH 2" . SPARSER::MOLECULE) ("F10" . SPARSER::PROTEIN)
    ("CA5" . SPARSER::PROTEIN) ("RPS19BP1" . SPARSER::PROTEIN)
    ("H10" . SPARSER::PROTEIN) ("USP7" . SPARSER::PROTEIN)
    ("Chk2" . SPARSER::PROTEIN) ("Foxo4" . SPARSER::PROTEIN)
    ("p53AIP1" . SPARSER::PROTEIN) ("Thr-Pro" . SPARSER::MOLECULE)
    ("aa 1" . SPARSER::PROTEIN) ("Pin1" . SPARSER::PROTEIN)
    ("trans isomerase" . SPARSER::PROTEIN) ("Siah-1" . SPARSER::PROTEIN)
    ("Homeodomain interacting protein kinase 2" . SPARSER::PROTEIN)
    ("JNK1" . SPARSER::PROTEIN) ("cancer 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mdm2" . SPARSER::PROTEIN) ("Foxo3" . SPARSER::PROTEIN)
    ("HIPK2" . SPARSER::PROTEIN) ("Sirtuin 1" . SPARSER::PROTEIN)
    ("a very attractive pharmacological target" . SPARSER::TARGET-PROTEIN)
    ("MMP-2 and MMP-9" . SPARSER::COLLECTION) ("cofactors" . SPARSER::PROTEIN)
    ("streptozotocin" . SPARSER::DRUG)
    ("a potential inhibitor" . SPARSER::INHIBITOR)
    ("TRAF6-IRAK1" . SPARSER::COLLECTION) ("Macrophages" . SPARSER::PROTEIN)
    ("AP-1 ( xref ) and NF-κB ( xref )" . SPARSER::COLLECTION)
    ("growth factors and inflammatory cytokines" . SPARSER::COLLECTION)
    ("most cardiac-fibrosis-related genes" . SPARSER::GENE)
    ("fibronectin and TGF-β" . SPARSER::COLLECTION)
    ("these pro-inflammatory genes" . SPARSER::GENE)
    ("the huge miR-146a" . SPARSER::PROTEIN) ("new miRNA" . SPARSER::PROTEIN)
    ("currently unknown targets" . SPARSER::TARGET-PROTEIN)
    ("TNF-α and IL-1β" . SPARSER::COLLECTION)
    ("Fos ( xref C, middle panel, Spearman rank correlation r =−0.6208, P <0.05) and MMP-9 ( xref C, bottom panel, r =−0.5659, P <0.05)"
     . SPARSER::COLLECTION)
    ("IL-6 , MCP-1 and TNF-α" . SPARSER::COLLECTION)
    ("the pro-inflammatory stimulus TNF-α" . SPARSER::PROTEIN)
    ("interleukin-1 receptor-associated kinase (IRAK)" . SPARSER::KINASE)
    ("TRAF" . SPARSER::PROTEIN-FAMILY) ("IRAK" . SPARSER::PROTEIN)
    ("lipoprotein lipase ( LPL )" . SPARSER::PROTEIN)
    ("collagen or type IV collagen" . SPARSER::COLLECTION)
    ("protein/glucose-regulated protein" . SPARSER::COLLECTION)
    ("BiP/GRP78" . SPARSER::COLLECTION) ("LPL" . SPARSER::PROTEIN)
    ("BiP" . SPARSER::PROTEIN)
    ("metalloproteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGAC/GTCA" . SPARSER::COLLECTION) ("GTCA" . SPARSER::PROTEIN)
    ("TREs" . SPARSER::PROTEIN) ("IKK" . SPARSER::PROTEIN)
    ("p65 and Jun" . SPARSER::COLLECTION)
    ("Jun and the p65 subunit" . SPARSER::COLLECTION)
    ("miR-146a" . SPARSER::PROTEIN) ("pre-miR-146a" . SPARSER::PROTEIN-PAIR)
    ("this pro-inflammatory cytokine" . SPARSER::PROTEIN)
    ("Ctrl" . SPARSER::PROTEIN) ("antisense" . SPARSER::PROTEIN)
    ("900 mature miRNAs" . SPARSER::PROTEIN)
    ("the interstitial substance" . SPARSER::SUBSTANCE)
    ("Jun" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NF-κB and AP-1" . SPARSER::COLLECTION)
    ("activator protein-1 (AP-1) and NF-κB" . SPARSER::COLLECTION)
    ("the ubiquitous and inducible nuclear factor-κB" . SPARSER::PROTEIN)
    ("These pro-inflammatory mediators" . SPARSER::PROTEIN)
    ("monocyte chemoattractant protein-1 (MCP-1) and tumor necrosis factor-α (TNF-α)"
     . SPARSER::COLLECTION)
    ("interleukin-6 (IL-6), monocyte chemoattractant protein-1 (MCP-1) and tumor necrosis factor-α (TNF-α)"
     . SPARSER::COLLECTION)
    ("several pro-inflammatory cytokines and chemokines" . SPARSER::COLLECTION)
    ("cytokines and chemokines" . SPARSER::COLLECTION)
    ("Fos–AP-1" . SPARSER::COLLECTION) ("AP-1" . SPARSER::PROTEIN)
    ("Fos" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the pro-inflammatory cytokine TNF-α" . SPARSER::PROTEIN)
    ("pro-inflammatory molecules" . SPARSER::MOLECULE)
    ("polynucleotide kinase" . SPARSER::PROTEIN)
    ("immediate early" . SPARSER::PROTEIN)
    ("extracellular matrix protein" . SPARSER::PROTEIN)
    ("IRAK1" . SPARSER::PROTEIN) ("IRAK2" . SPARSER::PROTEIN)
    ("interleukin-1" . SPARSER::PROTEIN)
    ("type IV collagen" . SPARSER::PROTEIN) ("TGF-β1" . SPARSER::PROTEIN)
    ("lipoprotein lipase" . SPARSER::PROTEIN) ("lipin 1" . SPARSER::PROTEIN)
    ("FN1" . SPARSER::PROTEIN) ("fibronectin 1" . SPARSER::PROTEIN)
    ("ET-1" . SPARSER::PROTEIN) ("endothelin 1" . SPARSER::PROTEIN)
    ("glucose-regulated protein" . SPARSER::PROTEIN)
    ("AP-1 transcription factor" . SPARSER::PROTEIN)
    ("complex I" . SPARSER::PROTEIN) ("c-Fos" . SPARSER::PROTEIN)
    ("miR-21" . SPARSER::PROTEIN) ("activator protein-1" . SPARSER::PROTEIN)
    ("chemoattractant protein-1" . SPARSER::PROTEIN)
    ("interleukin-6" . SPARSER::PROTEIN) ("MMP-9" . SPARSER::PROTEIN)
    ("enzymes (DNMT1 and DNMT3B) enzymes" . SPARSER::ENZYME)
    ("TSGs and methyltransferases" . SPARSER::COLLECTION)
    ("smoke" . SPARSER::MOLECULE) ("tobacco" . SPARSER::DRUG)
    ("the haploinsufficient genes" . SPARSER::GENE)
    ("Stop" . SPARSER::HUMAN-PROTEIN-FAMILY) ("permease" . SPARSER::PROTEIN)
    ("FUS1 , NPRL2/G21 and RASSF1A" . SPARSER::COLLECTION)
    ("only one gene" . SPARSER::GENE) ("RQ and MI" . SPARSER::COLLECTION)
    ("RASSF1A gene (20 %) and the same gene" . SPARSER::COLLECTION)
    ("FU" . SPARSER::PROTEIN)
    ("methyltransferases and TSGs" . SPARSER::COLLECTION)
    ("methyltransferases, DNMT1 and DNMT3b" . SPARSER::COLLECTION)
    ("AC (P = 0.02, rs = 0.52) and NSCC (P = 0.002, rs = 0.60) group"
     . SPARSER::COLLECTION)
    ("AC and NSCC" . SPARSER::COLLECTION)
    ("RASSF1A and FUS1A" . SPARSER::COLLECTION) ("cigarette" . SPARSER::DRUG)
    ("NSCLC histolopathological subtypes" . SPARSER::PROTEIN)
    ("RASSF1A and NPRL2/G21" . SPARSER::COLLECTION) ("RQ " . SPARSER::MOLECULE)
    ("ESD" . SPARSER::PROTEIN) ("RQ" . SPARSER::MOLECULE)
    ("delta" . SPARSER::PROTEIN) ("DNMT1 and DNMT3B" . SPARSER::COLLECTION)
    ("pre" . SPARSER::PROTEIN) ("family and DNMT1" . SPARSER::COLLECTION)
    ("hemi-methylated DNA substrates" . SPARSER::SUBSTRATE)
    ("the potential DNA methylation biomarkers" . SPARSER::MOLECULE)
    ("APC , CDH1 , CDH13 , DAPK1 , FHIT , MGMT , p16INK4a , RARβ, RASSF1A, RUNX3 and SHOX2"
     . SPARSER::COLLECTION)
    ("FHIT" . SPARSER::PROTEIN) ("lncRNA" . SPARSER::RNA)
    ("DNMT" . SPARSER::PROTEIN) ("simultaneous RASSF1A" . SPARSER::PROTEIN)
    ("DNMTs and DNA" . SPARSER::COLLECTION)
    ("at least one RASSF1A allele" . SPARSER::ALLELE)
    ("RASSF1A and FUS1" . SPARSER::COLLECTION) ("AC" . SPARSER::PROTEIN)
    ("MSP" . SPARSER::PROTEIN)
    ("methyltransferases, DNMT1 and DNMT3B" . SPARSER::COLLECTION)
    ("FUS1, NPRL2/G21 and RASSF1A" . SPARSER::COLLECTION)
    ("TSGs" . SPARSER::PROTEIN) ("TSG" . SPARSER::PROTEIN)
    ("TUSC4" . SPARSER::PROTEIN)
    ("tumor suppressor candidate 2" . SPARSER::PROTEIN)
    ("TUSC2" . SPARSER::PROTEIN) ("RASSF1" . SPARSER::PROTEIN)
    ("Ras association domain family member 1" . SPARSER::PROTEIN)
    ("delta-" . SPARSER::PROTEIN) ("DNA Polymerase" . SPARSER::PROTEIN)
    ("DNMT3" . SPARSER::PROTEIN) ("SHOX2" . SPARSER::PROTEIN)
    ("RUNX3" . SPARSER::PROTEIN) ("RARβ" . SPARSER::PROTEIN)
    ("p16INK4a" . SPARSER::PROTEIN) ("DAPK1" . SPARSER::PROTEIN)
    ("CDH13" . SPARSER::PROTEIN) ("DNMT3B" . SPARSER::PROTEIN)
    ("NPRL2" . SPARSER::PROTEIN) ("FUS1" . SPARSER::PROTEIN)
    ("Tumor suppressor gene" . SPARSER::PROTEIN)
    ("RAS/RAF/MEK/ERK1/2" . SPARSER::COLLECTION)
    ("acetyltransferase" . SPARSER::PROTEIN) ("RAS/PI3K" . SPARSER::COLLECTION)
    ("MEK1/2 or PI3K" . SPARSER::COLLECTION)
    ("MEK1/2 (U0126) and PI3K (LY294002)" . SPARSER::COLLECTION)
    ("hnRNPA1 and hnRNPL" . SPARSER::COLLECTION)
    ("anti-hnRNPA1 or anti-hnRNPL" . SPARSER::COLLECTION)
    ("hnRNPL" . SPARSER::PROTEIN) ("hnRNPA1 and A2/B1" . SPARSER::COLLECTION)
    ("heterogeneous nuclear ribonucleoproteins" . SPARSER::PROTEIN)
    ("ribonucleoproteins" . SPARSER::PROTEIN)
    ("acetyltransferases or deacetylases" . SPARSER::COLLECTION)
    ("Lys" . SPARSER::AMINO-ACID) ("FBS" . SPARSER::PROTEIN)
    ("TNFα and several interleukins" . SPARSER::COLLECTION)
    ("HGF, IGF1,TGFβ, TNFα and several interleukins" . SPARSER::COLLECTION)
    ("cytokines and growth factors" . SPARSER::COLLECTION)
    ("interleukins" . SPARSER::PROTEIN) ("HGF" . SPARSER::PROTEIN)
    ("talin" . SPARSER::PROTEIN) ("trypsinization" . SPARSER::PROTEIN)
    ("pAKT" . SPARSER::PROTEIN-FAMILY) ("pERK" . SPARSER::PROTEIN)
    ("ERK1/2 and AKT" . SPARSER::COLLECTION)
    ("ERK and AKT" . SPARSER::COLLECTION)
    ("KRAS , BRAF or PI3KCA" . SPARSER::COLLECTION)
    ("RAS-ERK" . SPARSER::COLLECTION)
    ("histones and nonhistone" . SPARSER::COLLECTION)
    ("KATs" . SPARSER::PROTEIN) ("acetyltransferases" . SPARSER::PROTEIN)
    ("deacetylases" . SPARSER::PROTEIN) ("medicine" . SPARSER::DRUG)
    ("a mutated KRAS  G13D allele" . SPARSER::ALLELE)
    ("Epidermal Growth Factor Receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hnRNP" . SPARSER::PROTEIN) ("A2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("A 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGFβ" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CATHEPSIN L" . SPARSER::PROTEIN)
    ("CATHEPSIN C" . SPARSER::PROTEIN) ("ADAM19" . SPARSER::PROTEIN)
    ("hnRNPA2" . SPARSER::PROTEIN) ("Colon cancer" . SPARSER::PROTEIN)
    ("UO126" . SPARSER::DRUG) ("Epidermal growth factor" . SPARSER::PROTEIN)
    ("hnRNPA 2" . SPARSER::PROTEIN) ("hnRNPA3" . SPARSER::PROTEIN)
    ("Epidermal Growth Factor Receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hnRNPA1" . SPARSER::PROTEIN)
    ("some gene and its own expression in later stages" . SPARSER::COLLECTION)
    ("SMAD3 and CHD" . SPARSER::COLLECTION) ("max" . SPARSER::PROTEIN)
    ("gene and genotype" . SPARSER::COLLECTION)
    ("many familiar and sporadic CHD" . SPARSER::PROTEIN)
    ("atrial septal and ventricular septal defects etc." . SPARSER::PROTEIN)
    ("congenital anatomic malformations" . SPARSER::PROTEIN)
    ("malformations" . SPARSER::PROTEIN)
    ("Three heterozygous variants" . SPARSER::VARIANT)
    ("gene, rs2289263, rs35874463 and rs17228212" . SPARSER::COLLECTION)
    ("CHD" . SPARSER::PROTEIN) ("Nodal" . SPARSER::PROTEIN)
    ("Smad3" . SPARSER::PROTEIN) ("SMAD family member 3" . SPARSER::PROTEIN)
    ("Lefty1" . SPARSER::PROTEIN) ("Lefty2" . SPARSER::PROTEIN)
    ("ETS-1, ELF-1, ELK1, and ELK4" . SPARSER::COLLECTION)
    ("ZNF143 (Gérard et al ., xref ) and EGR1 (Fromm & Rhode, xref )"
     . SPARSER::COLLECTION)
    ("Sp1 and Sp3" . SPARSER::COLLECTION)
    ("obesity-associated gene (FTO)" . SPARSER::GENE)
    ("Ren" . SPARSER::PROTEIN) ("FTO" . SPARSER::PROTEIN)
    ("CEBP" . SPARSER::PROTEIN) ("CCAAT" . SPARSER::PROTEIN)
    ("SIRT3 and other mitochondrial genes" . SPARSER::COLLECTION)
    ("PGC-1α/NRF-2" . SPARSER::COLLECTION) ("oxidative genes" . SPARSER::GENE)
    ("NRF-2 and ERRα" . SPARSER::COLLECTION)
    ("mitochondrial transcription factor B2" . SPARSER::PROTEIN)
    ("polymerase (POLRMT)" . SPARSER::PROTEIN) ("mTERF3" . SPARSER::PROTEIN)
    ("POLRMT" . SPARSER::PROTEIN) ("mTERF" . SPARSER::PROTEIN)
    ("SIRT3 or PSMD13" . SPARSER::COLLECTION)
    ("SIRT3 and PSMD13" . SPARSER::COLLECTION)
    ("NRF-2 and SIRT3" . SPARSER::COLLECTION)
    ("many bidirectional promoters" . SPARSER::PROMOTER)
    ("the bidirectional promoter" . SPARSER::PROMOTER)
    ("a short bidirectional promoter" . SPARSER::PROMOTER)
    ("NRF-2 and its targets" . SPARSER::COLLECTION) ("ETS" . SPARSER::PROTEIN)
    ("respiratory factor 2" . SPARSER::PROTEIN) ("GABP" . SPARSER::PROTEIN)
    ("SIRT3 and co-induced" . SPARSER::COLLECTION)
    ("peroxisome" . SPARSER::PROTEIN) ("adipocytes" . SPARSER::PROTEIN)
    ("Tao" . SPARSER::DRUG) ("superoxide" . SPARSER::MOLECULE)
    ("Shi" . SPARSER::PROTEIN) ("ketone" . SPARSER::MOLECULE)
    ("nuclear respiratory factor 2" . SPARSER::PROTEIN)
    ("SIRT3 and genes" . SPARSER::COLLECTION) ("B2M" . SPARSER::PROTEIN)
    ("β2-microglobulin" . SPARSER::PROTEIN) ("Sirt3" . SPARSER::PROTEIN)
    ("ELK4" . SPARSER::PROTEIN) ("ELK1" . SPARSER::PROTEIN)
    ("ELF-1" . SPARSER::PROTEIN) ("ETS-1" . SPARSER::PROTEIN)
    ("ZNF143" . SPARSER::PROTEIN) ("RPL30" . SPARSER::PROTEIN)
    ("ribosomal protein" . SPARSER::PROTEIN) ("TFB2M" . SPARSER::PROTEIN)
    ("transcription factor B2" . SPARSER::PROTEIN)
    ("mitochondrial RNA" . SPARSER::RNA)
    ("mitochondrial transcription termination factor" . SPARSER::PROTEIN)
    ("POLG2" . SPARSER::PROTEIN) ("PSMD13" . SPARSER::PROTEIN)
    ("26S proteasome non-ATPase regulatory subunit 13" . SPARSER::PROTEIN)
    ("subunit A" . SPARSER::PROTEIN) ("ATP synthase" . SPARSER::PROTEIN)
    ("ERRα" . SPARSER::PROTEIN) ("NAD +" . SPARSER::MOLECULE)
    ("SIRT3 " . SPARSER::PROTEIN) ("NRF-2" . SPARSER::PROTEIN)
    ("multi" . SPARSER::PROTEIN) ("Gao" . SPARSER::PROTEIN)
    ("‘CC’" . SPARSER::FORM) ("CC" . SPARSER::FORM)
    ("BRCA1, BRCA2 and RAD51" . SPARSER::COLLECTION)
    ("multi-protein" . SPARSER::COLLECTION) ("guanine" . SPARSER::PROTEIN)
    ("meiotic" . SPARSER::DRUG) ("the homologous DNA" . SPARSER::DNA)
    ("filaments" . SPARSER::PROTEIN-FAMILY)
    ("nucleoprotein" . SPARSER::PROTEIN) ("chemicals" . SPARSER::MOLECULE)
    ("the homozygous form (CC)" . SPARSER::FORM) ("‘GC’" . SPARSER::PROTEIN)
    ("a homolog of bacterial RecA protein" . SPARSER::PROTEIN)
    ("dominant and recessive" . SPARSER::PROTEIN) ("RAD 51" . SPARSER::PROTEIN)
    ("RAD51" . SPARSER::PROTEIN)
    ("NPM1 [ xref , xref ] and EGFR [ xref ]" . SPARSER::COLLECTION)
    ("HSPB1, GRP78 and EGFR" . SPARSER::COLLECTION)
    ("ESR1 and STAT3" . SPARSER::COLLECTION)
    ("RKIP, NCL and NPM1" . SPARSER::COLLECTION)
    ("pre-rRNA" . SPARSER::PROTEIN-PAIR) ("rRNA" . SPARSER::PROTEIN)
    ("a nucleolar phosphoprotein" . SPARSER::PROTEIN)
    ("chromatin and pre-ribosomal" . SPARSER::COLLECTION)
    ("Nucleolin" . SPARSER::PROTEIN)
    ("a multifunctional protein" . SPARSER::PROTEIN)
    ("spliceosome" . SPARSER::BIO-COMPLEX)
    ("HSPB1 (HSP27) and nucleolin (NCL)" . SPARSER::COLLECTION)
    ("ESR1, STAT3 and SP1" . SPARSER::COLLECTION)
    ("NPM1, RKIP and GRP78" . SPARSER::COLLECTION) ("p " . SPARSER::PROTEIN)
    ("elect HSPB1" . SPARSER::PROTEIN) ("HR " . SPARSER::PROTEIN)
    ("NPM1, RKIP, HSP90B1 and NCL" . SPARSER::COLLECTION)
    ("NMP1, GRP78 and RKIP" . SPARSER::COLLECTION)
    ("inhibitor (RKIP)" . SPARSER::INHIBITOR)
    ("raf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RNA and nucleotides" . SPARSER::COLLECTION)
    ("at least one group" . SPARSER::MOLECULE) ("Peptide" . SPARSER::PEPTIDE)
    ("Scaffold" . SPARSER::SCAFFOLD) ("SS" . SPARSER::PROTEIN)
    ("temozolomide or PCV-" . SPARSER::COLLECTION) ("PCV-" . SPARSER::MOLECULE)
    ("PCV" . SPARSER::MOLECULE) ("temozolomide" . SPARSER::DRUG)
    ("the latter type" . TYPE)
    ("nucleophosmin (NPM1) and RKIP" . SPARSER::COLLECTION)
    ("NPM1, GRP78 and RKIP" . SPARSER::COLLECTION)
    ("HSP27/HSPB1" . SPARSER::COLLECTION) ("HSPB1/HSP27" . SPARSER::COLLECTION)
    ("nucleolin (NCL) and heat shock protein 90 kDa (HSP90B1)"
     . SPARSER::COLLECTION)
    ("RKIP/PEBP1" . SPARSER::COLLECTION) ("RKIP" . SPARSER::PROTEIN)
    ("Raf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NCL" . SPARSER::PROTEIN)
    ("nucleolin" . SPARSER::PROTEIN) ("nucleophosmin" . SPARSER::PROTEIN)
    ("MYT1" . SPARSER::PROTEIN) ("mTORC2" . SPARSER::PROTEIN)
    ("hnRNP A1" . SPARSER::PROTEIN) ("RBFOX2" . SPARSER::PROTEIN)
    ("PTBP1" . SPARSER::PROTEIN) ("MBNL1" . SPARSER::PROTEIN)
    ("ESRP1" . SPARSER::PROTEIN) ("splicing factor" . SPARSER::PROTEIN)
    ("heat shock protein beta-1" . SPARSER::PROTEIN)
    ("NMP1" . SPARSER::PROTEIN)
    ("phosphatidylethanolamine-binding protein 1" . SPARSER::PROTEIN)
    ("HSBP1" . SPARSER::PROTEIN) ("– 3" . SPARSER::PROTEIN)
    ("TATA-box binding protein" . SPARSER::PROTEIN)
    ("beta-glucuronidase" . SPARSER::PROTEIN)
    ("hypoxanthine phosphoribosyltransferase 1" . SPARSER::PROTEIN)
    ("NOVA-1" . SPARSER::PROTEIN) ("GRP94" . SPARSER::PROTEIN)
    ("Bis-Tris" . SPARSER::MOLECULE) ("18 h" . SPARSER::PROTEIN)
    ("heat shock protein 70" . SPARSER::PROTEIN) ("NOVA1" . SPARSER::PROTEIN)
    ("nova 1" . SPARSER::PROTEIN) ("RNA binding protein" . SPARSER::PROTEIN)
    ("HSP27" . SPARSER::PROTEIN) ("PEBP1" . SPARSER::PROTEIN)
    ("HSP90B1" . SPARSER::PROTEIN)
    ("heat shock protein 90 " . SPARSER::PROTEIN) ("GRP78" . SPARSER::PROTEIN)
    ("glucose regulated protein" . SPARSER::PROTEIN)
    ("NPM1" . SPARSER::PROTEIN) ("other potential kinases" . SPARSER::KINASE)
    ("CREB-H and SREBPs" . SPARSER::COLLECTION)
    ("additional serines and a conserved threonine" . SPARSER::COLLECTION)
    ("a single kinase or several kinases" . SPARSER::COLLECTION)
    ("Nrf2a, cdc25a, and SREBP" . SPARSER::COLLECTION)
    ("phosphospecific antibodies" . SPARSER::ANTIBODY)
    ("the erythropoietin receptor ( xref ) and the Yes-associated protein ( xref )"
     . SPARSER::COLLECTION)
    ("the Yes-associated protein" . SPARSER::PROTEIN)
    ("both the DSG-motif" . SPARSER::DRUG) ("the DSG-motif" . SPARSER::DRUG)
    ("phosphospecific antibody" . SPARSER::PROTEIN)
    ("DSG-motif" . SPARSER::DRUG) ("A IV protein" . SPARSER::PROTEIN)
    ("3S+DSG and DSG" . SPARSER::COLLECTION)
    ("Actin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("3S+DSG" . SPARSER::PROTEIN)
    ("overabundant activators" . SPARSER::ACTIVATOR)
    ("A IV promoter–Luc target" . SPARSER::TARGET-PROTEIN)
    ("activators" . SPARSER::ACTIVATOR) ("TBCA" . SPARSER::PROTEIN)
    ("the phosphospecific antibody" . SPARSER::PROTEIN)
    ("the phosphospecific antibodies" . SPARSER::ANTIBODY)
    ("NaCl" . SPARSER::PROTEIN)
    ("the relatively weak thymidine kinase (TK) promoter" . SPARSER::PROMOTER)
    ("LiCl" . SPARSER::DRUG) ("Supplemental Figure S2" . SPARSER::MOLECULE)
    ("flag" . SPARSER::PROTEIN-FAMILY)
    ("CREB-H and Fbw1a" . SPARSER::COLLECTION)
    ("SCF/Cul1" . SPARSER::COLLECTION)
    ("dominant-negative Cul1" . SPARSER::PROTEIN)
    ("wt and DSG" . SPARSER::COLLECTION) ("cdc25a" . SPARSER::PROTEIN)
    ("GSK-3 and CKII" . SPARSER::COLLECTION) ("3Sd" . SPARSER::PROTEIN)
    ("the secondary kinase" . SPARSER::KINASE) ("CKI" . SPARSER::PROTEIN)
    ("GST-wt" . SPARSER::COLLECTION) ("proteins or GST" . SPARSER::COLLECTION)
    ("wt or DSG" . SPARSER::COLLECTION) ("possible kinases" . SPARSER::KINASE)
    ("GSK-3 or CKII" . SPARSER::COLLECTION)
    ("Supplemental Figure S1b" . SPARSER::PROTEIN)
    ("wt and mutants" . SPARSER::COLLECTION)
    ("antibody (SV5) or the anti-pS73 or anti-pS81 antibodies"
     . SPARSER::COLLECTION)
    ("fluorochrome-labeled secondary antibodies" . SPARSER::ANTIBODY)
    ("fluorochrome" . SPARSER::MOLECULE) ("SV" . SPARSER::MOLECULE)
    ("pS73, pS81, and pS87" . SPARSER::COLLECTION)
    ("both wt protein ( xref , lanes 1 and 3) and the 3S mutant (lanes 2 and 4)"
     . SPARSER::COLLECTION)
    ("the mutated serines" . SPARSER::AMINO-ACID)
    ("the Western blot" . SPARSER::PROTEIN) ("3Sd+DSG" . SPARSER::PROTEIN)
    ("fluorescent secondary antibodies" . SPARSER::ANTIBODY)
    ("wt and mutant" . SPARSER::COLLECTION) ("alanines" . SPARSER::AMINO-ACID)
    ("CREB-HΔTMC" . SPARSER::PROTEIN) ("Serines" . SPARSER::AMINO-ACID)
    ("serine or threonine" . SPARSER::COLLECTION)
    ("serine and threonine" . SPARSER::COLLECTION)
    ("the full-length ER-associated form" . SPARSER::FORM)
    ("TMC" . SPARSER::PROTEIN) ("ApoA" . SPARSER::PROTEIN)
    ("GSK-3b and CKII" . SPARSER::COLLECTION)
    ("a dominant-negative mutant" . SPARSER::MUTANT)
    ("Asp-Ser-Gly-Xaa-Xaa-Ser" . SPARSER::COLLECTION)
    ("ubiquitin-" . SPARSER::PROTEIN)
    ("ligases and proteasomal" . SPARSER::COLLECTION)
    ("SREBP–SCAP" . SPARSER::COLLECTION) ("SCAP" . SPARSER::PROTEIN)
    ("SREBP" . SPARSER::PROTEIN-FAMILY) ("cues" . SPARSER::PROTEIN-FAMILY)
    ("apolipoproteins" . SPARSER::PROTEIN)
    ("OASIS and BBF2H7" . SPARSER::COLLECTION)
    ("triglyceride" . SPARSER::MOLECULE)
    ("lipids and triglycerides" . SPARSER::COLLECTION)
    ("a secretory coat protein" . SPARSER::PROTEIN)
    ("Sec23a" . SPARSER::PROTEIN) ("chondrocytes" . SPARSER::PROTEIN)
    ("OASIS" . SPARSER::SUBSTANCE) ("substance" . SPARSER::SUBSTANCE)
    ("CREB3/Luman" . SPARSER::COLLECTION) ("Luman" . SPARSER::PROTEIN)
    ("bZip" . SPARSER::PROTEIN-FAMILY)
    ("resident enzymes S1P and S2P" . SPARSER::COLLECTION)
    ("S1P and S2P" . SPARSER::COLLECTION)
    ("the sterol regulatory element-binding proteins" . SPARSER::PROTEIN)
    ("fatty acid and sterol" . SPARSER::COLLECTION)
    ("SREBPs" . SPARSER::PROTEIN-FAMILY) ("sterol" . SPARSER::PROTEIN)
    ("Examples" . SPARSER::EXAMPLE) ("RIP" . SPARSER::PROTEIN)
    ("lipid and fatty acid synthesis" . SPARSER::COLLECTION)
    ("apolipoprotein" . SPARSER::MOLECULE)
    ("a dominant-negative Cul1" . SPARSER::PROTEIN)
    ("CKII and GSK-3b" . SPARSER::COLLECTION) ("CKII" . SPARSER::PROTEIN)
    ("phosophospecific antibody" . SPARSER::PROTEIN)
    ("serines" . SPARSER::AMINO-ACID)
    ("TATA box–binding protein" . SPARSER::PROTEIN)
    ("SB216763" . SPARSER::DRUG) ("Brefeldin A" . SPARSER::MOLECULE)
    ("6B" . SPARSER::PROTEIN) ("anti–" . SPARSER::ANTIBODY)
    ("serine residue" . SPARSER::MOLECULE) ("P-3" . SPARSER::PROTEIN)
    ("Nrf2a" . SPARSER::PROTEIN) ("Keap1" . SPARSER::PROTEIN)
    ("erythropoietin receptor" . SPARSER::PROTEIN)
    ("thymidine kinase" . SPARSER::PROTEIN) ("cdc25" . SPARSER::PROTEIN)
    ("glutathione S -transferase" . SPARSER::PROTEIN)
    ("S1b" . SPARSER::PROTEIN) ("cdc25A" . SPARSER::PROTEIN)
    ("N 1" . SPARSER::PROTEIN) ("brefeldin A" . SPARSER::MOLECULE)
    ("CHIR99021" . SPARSER::MOLECULE) ("βTrCP" . SPARSER::PROTEIN)
    ("SREBP1" . SPARSER::PROTEIN) ("phospholipase A 2" . SPARSER::PROTEIN)
    ("coat protein" . SPARSER::PROTEIN) ("Sec23" . SPARSER::PROTEIN-FAMILY)
    ("CREB3L3" . SPARSER::PROTEIN) ("CREB3L2" . SPARSER::PROTEIN)
    ("CREB3L1" . SPARSER::PROTEIN)
    ("cAMP response element–binding protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("S2P" . SPARSER::PROTEIN) ("ATF6" . SPARSER::PROTEIN)
    ("activating transcription factor 6" . SPARSER::PROTEIN)
    ("GSK-3" . SPARSER::PROTEIN) ("GSK-3b" . SPARSER::PROTEIN)
    ("Fbw1a" . SPARSER::PROTEIN) ("CREB-H" . SPARSER::PROTEIN)
    ("CREB3" . SPARSER::PROTEIN) ("MYC or MMP9" . SPARSER::COLLECTION)
    ("a strong potential treatment target" . SPARSER::TARGET-PROTEIN)
    ("Same oncogenes or tumor suppressor genes" . SPARSER::COLLECTION)
    ("formalin" . SPARSER::MOLECULE)
    ("SW1990 stably knockdown SATB1" . SPARSER::PROTEIN)
    ("SATB1-MYC-MMP9" . SPARSER::COLLECTION)
    ("MYC and MMP9" . SPARSER::COLLECTION)
    ("mRNA or protein" . SPARSER::COLLECTION)
    ("the potential therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("MMP2 and MMP9" . SPARSER::COLLECTION)
    ("the special AT-rich binding protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MARs" . SPARSER::PROTEIN) ("Matrix" . SPARSER::PROTEIN-FAMILY)
    ("gene and protein" . SPARSER::COLLECTION)
    ("cytometry, and transwell" . SPARSER::COLLECTION) ("EdU" . SPARSER::DRUG)
    ("–3 " . SPARSER::PROTEIN) ("Matrix metalloproteinase" . SPARSER::PROTEIN)
    ("v-myc avian myelocytomatosis viral oncogene homolog" . SPARSER::PROTEIN)
    ("PANC-1" . SPARSER::PROTEIN) ("SATB1" . SPARSER::PROTEIN)
    ("NFκB and fibronectin" . SPARSER::COLLECTION) ("cAMP" . SPARSER::PROTEIN)
    ("surface integrins or other receptors" . SPARSER::COLLECTION)
    ("glycoproteins" . SPARSER::PROTEIN) ("Fibronectins" . SPARSER::PROTEIN)
    ("diacylglycerol" . SPARSER::PROTEIN) ("HBE" . SPARSER::PROTEIN)
    ("homo- or hetero dimeric subunits" . SPARSER::PROTEIN)
    ("p50, p52, RelB and c-Rel" . SPARSER::COLLECTION)
    ("RelB" . SPARSER::PROTEIN) ("RelA" . SPARSER::PROTEIN)
    ("Rel" . SPARSER::PROTEIN) ("calcineurin/NFAT" . SPARSER::COLLECTION)
    ("the canonical TRPC" . SPARSER::PROTEIN)
    ("oligonucleotide" . SPARSER::MOLECULE) ("IkB" . SPARSER::PROTEIN)
    ("repetitively-stretched TRPC3" . SPARSER::PROTEIN)
    ("Wedelolactone" . SPARSER::DRUG) ("biologic" . SPARSER::DRUG)
    ("TPRC" . SPARSER::PROTEIN) ("Blot" . SPARSER::PROTEIN)
    ("Collagen" . SPARSER::PROTEIN) ("TRPC and NFκB" . SPARSER::COLLECTION)
    ("Calcineurin/NFAT" . SPARSER::COLLECTION)
    ("Calcineurin" . SPARSER::PROTEIN) ("TRPC" . SPARSER::PROTEIN)
    ("Given NFκB’s" . SPARSER::PROTEIN) ("Given NFκB" . SPARSER::PROTEIN)
    ("the well-studied protein" . SPARSER::PROTEIN)
    ("glycoprotein" . SPARSER::PROTEIN)
    ("Fibronectin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ECM" . SPARSER::PROTEIN)
    ("TRPC3-NFkB" . SPARSER::COLLECTION)
    ("TRPC3 or NFκB" . SPARSER::COLLECTION) ("TRP" . SPARSER::AMINO-ACID)
    ("Receptor" . SPARSER::RECEPTOR)
    ("a complex and highly orchestrated process that ultimately results in the formation"
     . SPARSER::COLLECTION)
    ("C-3" . SPARSER::PROTEIN) ("AG-3" . SPARSER::PROTEIN)
    ("CC-3" . SPARSER::PROTEIN) ("AC-3" . SPARSER::PROTEIN)
    ("T-3" . SPARSER::PROTEIN) ("Type I" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGR-1" . SPARSER::PROTEIN) ("Ca2+" . SPARSER::CALCIUM-ION)
    ("G-protein coupled receptor" . SPARSER::PROTEIN)
    ("interleukin 1 beta" . SPARSER::PROTEIN) ("c-Rel" . SPARSER::PROTEIN)
    ("p52" . SPARSER::PROTEIN) ("p50" . SPARSER::PROTEIN)
    ("p65" . SPARSER::PROTEIN) ("Rho family" . SPARSER::PROTEIN)
    ("Fluo4" . SPARSER::DRUG) ("IκB" . SPARSER::PROTEIN)
    ("TRPC 1" . SPARSER::PROTEIN) ("ion channel" . SPARSER::PROTEIN-FAMILY)
    ("NFκB" . SPARSER::PROTEIN) ("TRPC3" . SPARSER::PROTEIN)
    ("temsirolimus and pertuzumab" . SPARSER::COLLECTION)
    ("temsirolimus or pertuzumab" . SPARSER::COLLECTION)
    ("trastuzumab- or lapatinib-resistant AU565 HER2 breast cancer cells [ xref ]"
     . SPARSER::COLLECTION)
    ("trastuzumab-" . SPARSER::DRUG)
    ("temsirolimus and G28UCM" . SPARSER::COLLECTION)
    ("FASN and HER2 or mTOR" . SPARSER::COLLECTION)
    ("HER2 or mTOR" . SPARSER::COLLECTION) ("TSC1/TSC2" . SPARSER::COLLECTION)
    ("mTOR and p-mTOR proteins" . SPARSER::COLLECTION)
    ("MAPK/ERK" . SPARSER::COLLECTION)
    ("EGFR (EGF and AR) and EGFR-HER4 (BTC, EREG and HB-EGF) ligands"
     . SPARSER::COLLECTION)
    ("EGF and AR" . SPARSER::COLLECTION)
    ("BTC, EREG and HB-EGF" . SPARSER::COLLECTION)
    ("EGFR (EGF and TGF-α) and EGFR-HER4 (EREG and HB-EGF) ligands"
     . SPARSER::COLLECTION)
    ("trastuzumab, lapatinib and trastuzumab" . SPARSER::COLLECTION)
    ("EGF and TGF-α" . SPARSER::COLLECTION)
    ("EREG and HB-EGF" . SPARSER::COLLECTION)
    ("EGFR-HER4" . SPARSER::COLLECTION) ("HER2/HER3" . SPARSER::COLLECTION)
    ("other RTKs or their ligands" . SPARSER::COLLECTION)
    ("lapatinib (SK LR ) or both (SK LTR )" . SPARSER::COLLECTION)
    ("Hematoxylin" . SPARSER::MOLECULE) ("cerulenin" . SPARSER::DRUG)
    ("EGCG, pertuzumab and temsirolimus" . SPARSER::COLLECTION)
    ("HER-PDX" . SPARSER::COLLECTION)
    ("the HER2-PDX R model EGCG (30 mg/kg for 3d/w) and pertuzumab (30 mg/kg/once weekly)"
     . SPARSER::COLLECTION)
    ("EGCG and pertuzumab" . SPARSER::COLLECTION)
    ("EGCG or pertuzumab" . SPARSER::COLLECTION)
    ("EGCG (30 mg/kg for 3d/w) and pertuzumab (30 mg/kg/once weekly)"
     . SPARSER::COLLECTION)
    ("HER2, mTOR and FASN" . SPARSER::COLLECTION)
    ("pertuzumab, temsirolimus and EGCG" . SPARSER::COLLECTION)
    ("HER2-PDX" . SPARSER::COLLECTION) ("PDX" . SPARSER::PROTEIN)
    ("pertuzumab and pertuzumab" . SPARSER::COLLECTION)
    ("FASN and mTOR" . SPARSER::COLLECTION)
    ("EGCG and temsirolimus" . SPARSER::COLLECTION)
    ("trastuzumab and/or lapatinib sensitivity in resistant cells ( xref )"
     . SPARSER::COLLECTION)
    ("Temsirolimus or EGCG" . SPARSER::COLLECTION)
    ("Temsirolimus" . SPARSER::DRUG)
    ("mTOR (temsirolimus) and FASN (EGCG)" . SPARSER::COLLECTION)
    ("trastuzumab and/or lapatinib" . SPARSER::COLLECTION)
    ("mTOR and FASN" . SPARSER::COLLECTION)
    ("EGCG and G28UCM" . SPARSER::COLLECTION)
    ("pertuzumab and p-value  Trastuzumab" . SPARSER::COLLECTION)
    ("SK and SK" . SPARSER::COLLECTION) ("Pertuzumab" . SPARSER::DRUG)
    ("pertuzumab and trastuzumab" . SPARSER::COLLECTION)
    ("cpi" . SPARSER::PROTEIN)
    ("trastuzumab and pertuzumab" . SPARSER::COLLECTION)
    ("SK, SKTR, SKLR and SKLTR" . SPARSER::COLLECTION)
    ("TR and SK" . SPARSER::COLLECTION) ("fibrinogen" . SPARSER::PROTEIN)
    ("laminin" . SPARSER::PROTEIN) ("fibronectin" . SPARSER::PROTEIN)
    ("some chemotherapeutic drugs" . SPARSER::DRUG)
    ("multidrug" . SPARSER::PROTEIN) ("BTC and EREG" . SPARSER::COLLECTION)
    ("almost all ligands" . SPARSER::LIGAND)
    ("AR and BTC" . SPARSER::COLLECTION) ("epiregulin" . SPARSER::PROTEIN)
    ("EREG" . SPARSER::PROTEIN)
    ("TGF-α (transforming growth factor-α) and BTC (beta-cellulin"
     . SPARSER::COLLECTION)
    ("BTC" . SPARSER::PROTEIN) ("amphiregulin" . SPARSER::PROTEIN)
    ("AR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("heparin" . SPARSER::PROTEIN)
    ("derivative" . SPARSER::DERIVATIVE)
    ("HER2, EGFR, HER4 and AKT" . SPARSER::COLLECTION)
    ("p-EGFR" . SPARSER::COLLECTION) ("p-ERK1/2 and AKT" . SPARSER::COLLECTION)
    ("p-HER3" . SPARSER::COLLECTION) ("p-HER2" . SPARSER::COLLECTION)
    ("HER family protein receptors and their downstream proteins"
     . SPARSER::COLLECTION)
    ("MAPK/ERK1/2" . SPARSER::COLLECTION)
    ("lapatinib (SK LR ) and lapatinib" . SPARSER::COLLECTION)
    ("lapatinib (SKLR) and lapatinib" . SPARSER::COLLECTION)
    ("trastuzumab (SKTR), lapatinib (SKLR) and lapatinib"
     . SPARSER::COLLECTION)
    ("lapatinib (SK LR ) and trastuzumab" . SPARSER::COLLECTION)
    ("our developed trastuzumab" . SPARSER::DRUG)
    ("TLR" . SPARSER::PROTEIN-FAMILY)
    ("classical FASN inhibitors" . SPARSER::INHIBITOR)
    ("new polyphenolic anti-FASN" . SPARSER::ANTIBODY)
    ("anchor" . SPARSER::ANCHOR)
    ("a homodimeric multienzymatic protein" . SPARSER::PROTEIN)
    ("other HER family receptors or its ligands [ xref ]"
     . SPARSER::COLLECTION)
    ("phosphatase and tensin homolog (PTEN)" . SPARSER::PROTEIN)
    ("PI3K/AKT/mTOR" . SPARSER::COLLECTION) ("HER2-" . SPARSER::PROTEIN)
    ("EGFR and HER2" . SPARSER::COLLECTION) ("Lapatinib" . SPARSER::DRUG)
    ("Trastuzumab" . SPARSER::DRUG)
    ("monoclonal antibodies (mAb) and small-molecule TK inhibitors (TKI)"
     . SPARSER::COLLECTION)
    ("inhibitors (TKI)" . SPARSER::INHIBITOR)
    ("monoclonal antibodies" . SPARSER::ANTIBODY) ("mAb" . SPARSER::DRUG)
    ("the phosphoinositide 3-kinase (PI3K)/protein kinase B (PKB/AKT)/mammalian target of rapamycin (mTOR) protein"
     . SPARSER::PROTEIN)
    ("MAPK or ERK1/2" . SPARSER::COLLECTION)
    ("/mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("PKB/AKT" . SPARSER::COLLECTION) ("PKB" . SPARSER::PROTEIN)
    ("HER2, HER3, and HER4" . SPARSER::COLLECTION) ("HER" . SPARSER::PROTEIN)
    ("FASN and HER2" . SPARSER::COLLECTION)
    ("pertuzumab or temsirolimus" . SPARSER::COLLECTION)
    ("lapatinib-" . SPARSER::DRUG) ("p-mTOR" . SPARSER::COLLECTION)
    ("p-AKT" . SPARSER::COLLECTION)
    ("EGFR and p-ERK1/2 and PI3KCA" . SPARSER::COLLECTION)
    ("p-ERK1/2 and PI3KCA" . SPARSER::COLLECTION)
    ("p-ERK1/2" . SPARSER::PROTEIN)
    ("pertuzumab and temsirolimus" . SPARSER::COLLECTION)
    ("temsirolimus" . SPARSER::DRUG) ("pertuzumab" . SPARSER::DRUG)
    ("EGCG" . SPARSER::DRUG)
    ("lapatinib (SK LR ) and both (SK LTR )" . SPARSER::COLLECTION)
    ("SK" . SPARSER::PROTEIN)
    ("trastuzumab and lapatinib" . SPARSER::COLLECTION)
    ("Fatty Acid Synthase (FASN)" . SPARSER::PROTEIN)
    ("FASN" . SPARSER::PROTEIN) ("TSC2" . SPARSER::PROTEIN)
    ("TSC1" . SPARSER::PROTEIN) ("(beta" . SPARSER::PROTEIN)
    ("catalytic subunit of PI3K" . SPARSER::PROTEIN) ("IL2" . SPARSER::PROTEIN)
    ("CCI-779" . SPARSER::DRUG) ("HB-EGF" . SPARSER::PROTEIN)
    ("NRG-1" . SPARSER::PROTEIN) ("TGF-α" . SPARSER::PROTEIN)
    ("Erk 1/2" . SPARSER::PROTEIN) ("Reducing Agent" . SPARSER::MOLECULE)
    ("GW572016" . SPARSER::DRUG) ("Fatty acid synthase" . SPARSER::PROTEIN)
    ("p110α" . SPARSER::PROTEIN) ("p95" . SPARSER::PROTEIN)
    ("mitogen activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("HER3" . SPARSER::PROTEIN) ("HER1" . SPARSER::PROTEIN)
    ("HER4" . SPARSER::PROTEIN) ("G28UCM" . SPARSER::DRUG)
    ("Fatty Acid Synthase" . SPARSER::PROTEIN)
    ("IGFBP2 and ADAM17" . SPARSER::COLLECTION)
    ("metalloprotease" . SPARSER::PROTEIN)
    ("IGFBP2 and ii" . SPARSER::COLLECTION)
    ("IGF/IGFR/IGFBP2" . SPARSER::COLLECTION)
    ("IGF/IGFR" . SPARSER::COLLECTION) ("IGFR" . SPARSER::PROTEIN)
    ("IGFBP2 and p16" . SPARSER::COLLECTION) ("oro" . SPARSER::MOLECULE)
    ("CIN1 and CIN3" . SPARSER::COLLECTION)
    ("proteins and ADAM17" . SPARSER::COLLECTION) ("ADAM" . SPARSER::PROTEIN)
    ("Disintegrin And Metalloprotease" . SPARSER::COLLECTION)
    ("Metalloprotease" . SPARSER::PROTEIN) ("Disintegrin" . SPARSER::PROTEIN)
    ("ETS2 and MMP1" . SPARSER::COLLECTION)
    ("KGF or FGF7" . SPARSER::COLLECTION) ("KGFR" . SPARSER::PROTEIN)
    ("IGF1R and IGF2R" . SPARSER::COLLECTION)
    ("IGF-receptors" . SPARSER::COLLECTION)
    ("IGF1 and IGF2" . SPARSER::COLLECTION)
    ("AKT and ERK" . SPARSER::COLLECTION)
    ("NcoR1 (NcoR1) and NcoR2 (SMRT) [ xref ]" . SPARSER::COLLECTION)
    ("NcoR2 (SMRT)" . SPARSER::PROTEIN)
    ("an active repressive complex" . SPARSER::BIO-COMPLEX)
    ("a repressive complex" . SPARSER::BIO-COMPLEX)
    ("NcoR2" . SPARSER::PROTEIN) ("SMRT" . SPARSER::PROTEIN)
    ("NcoR" . SPARSER::PROTEIN)
    ("a commercially available HDAC3 selective inhibitor" . SPARSER::INHIBITOR)
    ("Inhibitors" . SPARSER::INHIBITOR)
    ("proprietary inhibitors" . SPARSER::INHIBITOR)
    ("entinostat" . SPARSER::DRUG)
    ("SAHA (both pan inhibitors) and romidepsin (Romi, a class I inhibitor, which inhibits HDACs 1, 2, 3 but also HDAC4 and 6)"
     . SPARSER::COLLECTION)
    ("the HDAC inhibitors TSA, SAHA (both pan inhibitors) and romidepsin (Romi, a class I inhibitor, which inhibits HDACs 1, 2, 3 but also HDAC4 and 6)"
     . SPARSER::COLLECTION)
    ("romidepsin" . SPARSER::DRUG) ("SAHA" . SPARSER::DRUG)
    ("the invasive keratinocytes" . SPARSER::PROTEIN)
    ("HDACs" . SPARSER::PROTEIN) ("E6/E7" . SPARSER::COLLECTION)
    ("the pan-HDAC inhibitors sodium butyrate (SB) or trichostatin"
     . SPARSER::COLLECTION)
    ("invasive E6/7-expressing keratinocytes" . SPARSER::PROTEIN)
    ("butyrate (SB)" . SPARSER::PROTEIN) ("TSA" . SPARSER::PROTEIN)
    ("trichostatin" . SPARSER::MOLECULE) ("butyrate" . SPARSER::PROTEIN)
    ("p53, pRb, and IGFBP2" . SPARSER::COLLECTION)
    ("growth factors/cytokines" . SPARSER::COLLECTION)
    ("growth factors or cytokines" . SPARSER::COLLECTION)
    ("collagen" . SPARSER::PROTEIN)
    ("the stromal derived growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IGF/IGF" . SPARSER::COLLECTION) ("pro-invasive genes" . SPARSER::GENE)
    ("metalloproteases" . SPARSER::PROTEIN)
    ("the retinoblastoma protein (pRb) and p53" . SPARSER::COLLECTION)
    ("KGF" . SPARSER::PROTEIN) ("IGFI" . SPARSER::PROTEIN)
    ("E6 and E7" . SPARSER::COLLECTION) ("beta-actin" . SPARSER::PROTEIN)
    ("Ets2" . SPARSER::PROTEIN) ("INS-R" . SPARSER::PROTEIN)
    ("ERK2" . SPARSER::PROTEIN) ("pERK1/2" . SPARSER::PROTEIN)
    ("IGF-II" . SPARSER::PROTEIN) ("T3s" . SPARSER::PROTEIN)
    ("mitomycin C" . SPARSER::DRUG) ("alpha 5" . SPARSER::PROTEIN)
    ("CIN1" . SPARSER::PROTEIN) ("p16 INK4A" . SPARSER::PROTEIN)
    ("GM6001" . SPARSER::DRUG) ("ADAM17" . SPARSER::PROTEIN)
    ("IGFR1" . SPARSER::PROTEIN) ("MMP1" . SPARSER::PROTEIN)
    ("ETS2" . SPARSER::PROTEIN)
    ("Fibroblast growth factor receptor" . SPARSER::PROTEIN)
    ("FGF7" . SPARSER::PROTEIN) ("CIN3" . SPARSER::PROTEIN)
    ("insulin receptor" . SPARSER::PROTEIN) ("IGF2R" . SPARSER::PROTEIN)
    ("IGF2" . SPARSER::PROTEIN) ("NcoR1" . SPARSER::PROTEIN)
    ("H3K9" . SPARSER::PROTEIN) ("histone 3" . SPARSER::PROTEIN)
    ("HDAC4" . SPARSER::PROTEIN) ("HDAC 1" . SPARSER::PROTEIN)
    ("IGFBP3" . SPARSER::PROTEIN) ("GM-CSF" . SPARSER::PROTEIN)
    ("granulocyte-macrophage colony-stimulating factor" . SPARSER::PROTEIN)
    ("insulin-like growth factor binding protein" . SPARSER::PROTEIN)
    ("keratinocyte growth factor" . SPARSER::PROTEIN)
    ("IGF1R" . SPARSER::PROTEIN) ("receptor 1" . SPARSER::PROTEIN)
    ("insulin-like growth factor binding protein 2" . SPARSER::PROTEIN)
    ("Insulin-like growth factor" . SPARSER::PROTEIN)
    ("CIN 3" . SPARSER::PROTEIN) ("CIN 1" . SPARSER::PROTEIN)
    ("de-" . SPARSER::MOLECULE) ("E7" . SPARSER::PROTEIN-FAMILY)
    ("E6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HMGB1/RAGE/miR221/miR222" . SPARSER::COLLECTION)
    ("HMGB1 and TLR 9" . SPARSER::COLLECTION) ("CpG-ODN" . SPARSER::COLLECTION)
    ("ODN" . SPARSER::PROTEIN) ("intracytoplasmic TLR 3" . SPARSER::PROTEIN)
    ("exogenous HMGB1" . SPARSER::PROTEIN)
    ("contralateral thyroid lobe" . SPARSER::PROTEIN)
    ("lobe" . SPARSER::PROTEIN) ("HMGB1 and PTEN" . SPARSER::COLLECTION)
    ("miRs" . SPARSER::PROTEIN) ("HMGB1-RAGE" . SPARSER::COLLECTION)
    ("miRNA221 and miRNA222" . SPARSER::COLLECTION) ("CAL" . SPARSER::PROTEIN)
    ("chemotaxis" . SPARSER::PROTEIN)
    ("extracellular HMGB1" . SPARSER::PROTEIN)
    ("TLR 7 and TLR 8" . SPARSER::COLLECTION)
    ("focal adhesion kinases (FAK) and Shc" . SPARSER::COLLECTION)
    ("kinases (FAK)" . SPARSER::PROTEIN)
    ("phosphatidylinositol" . SPARSER::PROTEIN)
    ("the multiligand receptor RAGE (the receptor for advanced glycation end products) and Toll-like receptors (TLR 2, TLR 4, and TLR 9)"
     . SPARSER::COLLECTION)
    ("Extracellular HMGB1" . SPARSER::PROTEIN)
    ("TLR 2, TLR 4, and TLR 9" . SPARSER::COLLECTION)
    ("TLR 2" . SPARSER::PROTEIN) ("TLRs" . SPARSER::PROTEIN-FAMILY)
    ("HSPB1 and HSPB7" . SPARSER::COLLECTION)
    ("p53, p57, and Rb" . SPARSER::COLLECTION)
    ("miR221 and miR222" . SPARSER::COLLECTION) ("miR222" . SPARSER::PROTEIN)
    ("miR221" . SPARSER::PROTEIN)
    ("two highly homologous microRNAs" . SPARSER::RNA)
    ("either oncogenes or tumor suppressor genes" . SPARSER::COLLECTION)
    ("RAGE" . SPARSER::PROTEIN) ("microRNAs and tumor" . SPARSER::COLLECTION)
    ("Tumor cells exploit HMGB1's" . SPARSER::PROTEIN)
    ("an ubiquitous protein" . SPARSER::PROTEIN) ("EEA1" . SPARSER::PROTEIN)
    ("TLR 3" . SPARSER::PROTEIN) ("NF κ B" . SPARSER::PROTEIN)
    ("small nuclear RNA" . SPARSER::RNA) ("HMGB-1" . SPARSER::PROTEIN)
    ("TLR 8" . SPARSER::PROTEIN) ("TLR 7" . SPARSER::PROTEIN)
    ("miRNA221" . SPARSER::PROTEIN) ("TLR 4" . SPARSER::PROTEIN)
    ("TLR 9" . SPARSER::PROTEIN) ("HSPB7" . SPARSER::PROTEIN)
    ("HSPB1" . SPARSER::PROTEIN) ("p57" . SPARSER::PROTEIN)
    ("HMGB1" . SPARSER::PROTEIN)
    ("High mobility group box 1" . SPARSER::PROTEIN)
    ("Estrogen" . SPARSER::MOLECULE) ("IGFBP-2 and AH" . SPARSER::COLLECTION)
    ("adiponectin, C-reactive protein, and estradiol" . SPARSER::COLLECTION)
    ("CRP, and estradiol" . SPARSER::COLLECTION)
    ("a large prospective cohort" . SPARSER::MOLECULE)
    ("incident AH" . SPARSER::MOLECULE)
    ("estradiol, and C-reactive protein" . SPARSER::COLLECTION)
    ("adiponectin" . SPARSER::PROTEIN)
    ("insulin-like growth factors and their binding proteins"
     . SPARSER::COLLECTION)
    ("developed incident AH" . SPARSER::MOLECULE) ("AH" . SPARSER::MOLECULE)
    ("IGF-I" . SPARSER::PROTEIN) ("type II" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IGFBP-2" . SPARSER::PROTEIN)
    ("Insulin-like growth factor binding protein 2" . SPARSER::PROTEIN)
    ("the hemizygous state" . SPARSER::BIO-STATE)
    ("PTEN and p53" . SPARSER::COLLECTION) ("refs" . SPARSER::PROTEIN)
    ("INK4a/p16" . SPARSER::COLLECTION)
    ("the latter heterochromatin" . SPARSER::PROTEIN)
    ("heterochromatin" . SPARSER::PROTEIN)
    ("DDR and pRb" . SPARSER::COLLECTION)
    ("SIRT1, cyclin D1, CDKN1A and p53" . SPARSER::COLLECTION)
    ("H4K16" . SPARSER::PROTEIN) ("Ac-H3K9" . SPARSER::PROTEIN-PAIR)
    ("Ac-H4K16" . SPARSER::COLLECTION) ("Ac" . SPARSER::PROTEIN)
    ("Histone" . SPARSER::PROTEIN) ("BRCA1 or SIRT1" . SPARSER::COLLECTION)
    ("Ac-pRb" . SPARSER::COLLECTION)
    ("SIRT1 and SA-β-galactosidase" . SPARSER::COLLECTION)
    ("pRb–SIRT1" . SPARSER::COLLECTION) ("NAD" . SPARSER::MOLECULE)
    ("hairpins" . SPARSER::PROTEIN-FAMILY)
    ("E2F1-regulated genes ( t -test P <10 4 ; xref ) as well as genes"
     . SPARSER::COLLECTION)
    ("E2F target genes (cyclin A and cyclin E) in HMECs and HDEs"
     . SPARSER::COLLECTION)
    ("p19/INK4d" . SPARSER::COLLECTION) ("p18/INK4c" . SPARSER::COLLECTION)
    ("DDR and p53" . SPARSER::COLLECTION) ("p14/ARF" . SPARSER::COLLECTION)
    ("ARF" . SPARSER::PROTEIN) ("the primary inducer" . SPARSER::PROTEIN)
    ("the major inducer" . SPARSER::PROTEIN)
    ("keratinocytes" . SPARSER::PROTEIN)
    ("VHL , PTEN , NF1 or BRCA1" . SPARSER::COLLECTION)
    ("VHL" . SPARSER::PROTEIN) ("IL-6 and MMP-2" . SPARSER::COLLECTION)
    ("IL-8 or PAI-1" . SPARSER::COLLECTION)
    ("-2 and PAI-1" . SPARSER::COLLECTION) ("STD" . SPARSER::PROTEIN)
    ("p16/INK4a" . SPARSER::COLLECTION)
    ("γH2AX and p53BP1" . SPARSER::COLLECTION)
    ("ATM/ATR" . SPARSER::COLLECTION)
    ("Ataxia telangiectasia mutated/Ataxia" . SPARSER::COLLECTION)
    ("ATR" . SPARSER::PROTEIN) ("Ataxia" . SPARSER::PROTEIN)
    ("a unique cell-type-specific form" . SPARSER::FORM)
    ("p53 and pRb" . SPARSER::COLLECTION)
    ("HIS and telomere" . SPARSER::COLLECTION) ("HIS" . SPARSER::AMINO-ACID)
    ("beta-globin" . SPARSER::PROTEIN)
    ("potassium chloride" . SPARSER::MOLECULE) ("Cyclin A" . SPARSER::PROTEIN)
    ("Cyclin E" . SPARSER::PROTEIN) ("DR8" . SPARSER::PROTEIN)
    ("Epidermal Growth Factor" . SPARSER::PROTEIN) ("1–2 " . SPARSER::PROTEIN)
    ("RB1" . SPARSER::PROTEIN) ("−3" . SPARSER::PROTEIN)
    ("K56" . SPARSER::PROTEIN) ("E2F1" . SPARSER::PROTEIN)
    ("INK4d" . SPARSER::PROTEIN) ("p19" . SPARSER::PROTEIN)
    ("INK4c" . SPARSER::PROTEIN) ("p18" . SPARSER::PROTEIN)
    ("INK4b" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p14" . SPARSER::PROTEIN) ("Loss of heterozygosity" . SPARSER::PROTEIN)
    ("MMP-2" . SPARSER::PROTEIN) ("PAI-1" . SPARSER::PROTEIN)
    ("IL-8" . SPARSER::PROTEIN) ("INK4a" . SPARSER::PROTEIN)
    ("WT-1" . SPARSER::PROTEIN) ("p53BP1" . SPARSER::PROTEIN)
    ("Ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("K16" . SPARSER::PROTEIN)
    ("Rep" . SPARSER::PROTEIN)
    ("transcriptional-independent p53 and the calcium-mediated MPTP"
     . SPARSER::COLLECTION)
    ("transcriptional-independent p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("dynein" . SPARSER::PROTEIN)
    ("calcineurin and calpains" . SPARSER::COLLECTION)
    ("calpains" . SPARSER::PROTEIN)
    ("mitochondria, and trigger" . SPARSER::COLLECTION)
    ("apical protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("YL" . SPARSER::PROTEIN)
    ("caspase-9 and caspase-4/12" . SPARSER::COLLECTION)
    ("p53 and Ca 2+" . SPARSER::COLLECTION) ("-MPTP" . SPARSER::COLLECTION)
    ("the cell permeable ROS scavenger MnTBAP" . SPARSER::DRUG)
    ("XO" . SPARSER::PROTEIN) ("xanthine" . SPARSER::MOLECULE)
    ("Hypoxanthine" . SPARSER::DRUG)
    ("cell permeable fluorescent dye DHE" . SPARSER::DRUG)
    ("DHE" . SPARSER::DRUG) ("Calcium" . SPARSER::CALCIUM)
    ("chelator" . SPARSER::MOLECULE) ("BAPTA" . SPARSER::MOLECULE)
    ("calcein" . SPARSER::MOLECULE) ("Rhod" . SPARSER::PROTEIN)
    ("mitochondrial p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GFP-Bax" . SPARSER::COLLECTION) ("CHO" . SPARSER::PROTEIN)
    ("cytochrome c and Smac" . SPARSER::COLLECTION) ("Smac" . SPARSER::PROTEIN)
    ("the intense heat stress-induced early wave"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("wave" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("caspase-8 or caspase-4" . SPARSER::COLLECTION)
    ("LDH and WST-1" . SPARSER::COLLECTION) ("cysteine" . SPARSER::AMINO-ACID)
    ("calpain" . SPARSER::PROTEIN) ("caspases-9 and -3" . SPARSER::COLLECTION)
    ("inducers" . SPARSER::MOLECULE) ("MnTBAP" . SPARSER::DRUG)
    ("CsA" . SPARSER::PROTEIN) ("pifithrin" . SPARSER::DRUG)
    ("MPTP" . SPARSER::PROTEIN) ("Ca2 +" . SPARSER::CALCIUM-ION)
    ("Cytochrome C" . SPARSER::PROTEIN) ("JC-1" . SPARSER::MOLECULE)
    ("CoCl 2" . SPARSER::MOLECULE) ("green fluorescent" . SPARSER::PROTEIN)
    ("Fluo-3" . SPARSER::MOLECULE) ("caspase-4" . SPARSER::PROTEIN)
    ("caspase-8" . SPARSER::PROTEIN) ("caspase-12" . SPARSER::PROTEIN)
    ("caspases-9" . SPARSER::PROTEIN)
    ("HDAC6 and HDAC6/A3G" . SPARSER::COLLECTION)
    ("Env/CD4" . SPARSER::COLLECTION) ("wt- or A3G" . SPARSER::COLLECTION)
    ("HDAC6-deacetylase activity" . SPARSER::COLLECTION)
    ("protein-associated ubiquitin" . SPARSER::PROTEIN)
    ("Vif and/or A3G just harbouring HDAC6" . SPARSER::COLLECTION)
    ("A3G just harbouring HDAC6" . SPARSER::PROTEIN)
    ("HDAC6/A3G-Vif" . SPARSER::COLLECTION)
    ("the ternary A3G/HDAC6-Vif complexes" . SPARSER::BIO-COMPLEX)
    ("A3G and forms" . SPARSER::COLLECTION) ("MTs" . SPARSER::PROTEIN)
    ("R5-tropic HIV-1 Env" . SPARSER::PROTEIN) ("lacZ" . SPARSER::PROTEIN)
    ("vif" . SPARSER::PROTEIN) ("pNL" . SPARSER::PROTEIN)
    ("HIV-1 proviral Vif" . SPARSER::PROTEIN)
    ("Vif and p62" . SPARSER::COLLECTION) ("-HDAC6" . SPARSER::COLLECTION)
    ("p62/SQSTM1" . SPARSER::COLLECTION)
    ("p62 or sequestosome 1" . SPARSER::COLLECTION)
    ("wt- or ∆BUZ-HDAC6" . SPARSER::COLLECTION)
    ("∆BUZ-HDAC6" . SPARSER::COLLECTION) ("wt-" . SPARSER::PROTEIN)
    ("Ubiquitin" . SPARSER::PROTEIN) ("∆BUZ" . SPARSER::PROTEIN)
    ("Vif and A3G" . SPARSER::COLLECTION) ("A3G-" . SPARSER::PROTEIN)
    ("HDAC6/A3G" . SPARSER::PROTEIN) ("Vif-HDAC6/A3G" . SPARSER::PROTEIN-PAIR)
    ("Vif/HDAC6" . SPARSER::COLLECTION) ("Vif-A3G/HDAC6" . SPARSER::COLLECTION)
    ("Vif/A3G" . SPARSER::COLLECTION) ("HDAC6 and A3G" . SPARSER::COLLECTION)
    ("HDAC6-∆BUZ" . SPARSER::COLLECTION)
    ("a ternary A3G/HDAC6-Vif complex" . SPARSER::BIO-COMPLEX)
    ("HDAC6 and Vif" . SPARSER::COLLECTION)
    ("HDAC6, A3G and Vif" . SPARSER::COLLECTION)
    ("HDAC6/Vif" . SPARSER::COLLECTION)
    ("subsequent deacetylase activity" . SPARSER::PROTEIN)
    ("HDAC/A3G" . SPARSER::COLLECTION) ("A3G-Vif" . SPARSER::COLLECTION)
    ("A3G or Vif" . SPARSER::COLLECTION) ("GST-Vif" . SPARSER::COLLECTION)
    ("A3G and HDAC6" . SPARSER::COLLECTION) ("wt-A3G" . SPARSER::COLLECTION)
    ("HA-Vif" . SPARSER::COLLECTION)
    ("ternary (A3G/HDAC6-Vif) complex" . SPARSER::BIO-COMPLEX)
    ("HDAC6-Vif" . SPARSER::COLLECTION)
    ("A3G and Vif, and forms" . SPARSER::COLLECTION)
    ("Vif, and forms" . SPARSER::COLLECTION)
    ("A3G/HDAC6-Vif" . SPARSER::COLLECTION)
    ("redundant A3G" . SPARSER::PROTEIN)
    ("protein–protein" . SPARSER::COLLECTION)
    ("EGFP-HDAC6-ΔBUZ" . SPARSER::COLLECTION)
    ("HA or Flag" . SPARSER::COLLECTION) ("EGFP and HA" . SPARSER::COLLECTION)
    ("HA" . SPARSER::PROTEIN) ("A3G-HA" . SPARSER::PROTEIN-PAIR)
    ("A3G/HDAC6" . SPARSER::COLLECTION) ("A3G-Flag" . SPARSER::COLLECTION)
    ("A3G-myc" . SPARSER::COLLECTION) ("myc" . SPARSER::PROTEIN)
    ("A3G or HDAC6" . SPARSER::COLLECTION) ("EGFP-HDAC6" . SPARSER::COLLECTION)
    ("ΔBUZ" . SPARSER::PROTEIN) ("EGFP-wt-HDAC6" . SPARSER::COLLECTION)
    ("EGFP" . SPARSER::PROTEIN) ("HDAC6-ΔBUZ" . SPARSER::COLLECTION)
    ("proviral (Figure  xref c) Vif" . SPARSER::PROTEIN)
    ("Vif-Cul5" . SPARSER::COLLECTION) ("Rbx" . SPARSER::PROTEIN)
    ("wt-HDAC6" . SPARSER::COLLECTION)
    ("a ternary complex" . SPARSER::BIO-COMPLEX)
    ("A3G and Vif" . SPARSER::COLLECTION)
    ("BRCA1-associated protein BRAP2 and several ubiquitin-specific proteases"
     . SPARSER::COLLECTION)
    ("USP3-" . SPARSER::PROTEIN) ("HDAC6-" . SPARSER::PROTEIN)
    ("hydrolase" . SPARSER::PROTEIN)
    ("protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proteases" . SPARSER::PROTEIN) ("polyubiquitin" . SPARSER::PROTEIN)
    ("diglycine" . SPARSER::MOLECULE) ("microtubules (MT)" . SPARSER::PROTEIN)
    ("Env" . SPARSER::PROTEIN) ("viral DNA" . SPARSER::DNA)
    ("a heterodimeric transcription factor" . SPARSER::PROTEIN)
    ("A3G" . SPARSER::PROTEIN) ("Vif-A3G" . SPARSER::COLLECTION)
    ("EloC, and Rbx2" . SPARSER::COLLECTION) ("EloC" . SPARSER::PROTEIN)
    ("EloB" . SPARSER::PROTEIN) ("Elongin" . SPARSER::PROTEIN)
    ("its auxiliary viral genes" . SPARSER::GENE)
    ("infectious HIV-1 variants and even generating HIV-1 drug-resistant phenotypes [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("infectious HIV-1 variants" . SPARSER::VARIANT)
    ("viral RNA" . SPARSER::RNA) ("mutated viral proteins" . SPARSER::PROTEIN)
    ("-strand viral DNA" . SPARSER::DNA)
    ("A3G-hypermutated viral DNA" . SPARSER::DNA)
    ("apurinic–apyrimidinic endonuclease" . SPARSER::PROTEIN)
    ("endonuclease" . SPARSER::PROTEIN)
    ("the (+)-strand viral DNA" . SPARSER::DNA)
    ("newly synthesized (−)-strand viral DNA" . SPARSER::DNA)
    ("uracil" . SPARSER::DRUG) ("cytidine" . SPARSER::MOLECULE)
    ("APOBEC" . SPARSER::BIO-COMPLEX) ("Vif-" . SPARSER::PROTEIN)
    ("CBF" . SPARSER::PROTEIN)
    ("cellular histone deacetylase 6" . SPARSER::PROTEIN)
    ("polypeptide" . SPARSER::PEPTIDE) ("Vif" . SPARSER::PROTEIN)
    ("β-Gal" . SPARSER::PROTEIN) ("p24" . SPARSER::PROTEIN)
    ("Pr55 Gag" . SPARSER::PROTEIN)
    ("envelope glycoprotein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("G-3" . SPARSER::PROTEIN) ("1–1" . SPARSER::PROTEIN)
    ("Messenger RNA" . SPARSER::RNA) ("gp160" . SPARSER::PROTEIN)
    ("R-E" . SPARSER::PROTEIN) ("l -glutamine" . SPARSER::MOLECULE)
    ("B12)" . SPARSER::PROTEIN) ("B-1" . SPARSER::PROTEIN)
    ("B-5" . SPARSER::PROTEIN) ("p17" . SPARSER::PROTEIN)
    ("p24 " . SPARSER::PROTEIN) ("p55 " . SPARSER::PROTEIN)
    ("D-3" . SPARSER::PROTEIN) ("F-8" . SPARSER::PROTEIN)
    ("anti-viral" . SPARSER::DRUG) ("PI3 kinase" . SPARSER::PROTEIN)
    ("ASK1" . SPARSER::PROTEIN)
    ("apoptosis signal-regulating kinase 1" . SPARSER::PROTEIN)
    ("P5" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CCR5" . SPARSER::PROTEIN)
    ("GST-A" . SPARSER::PROTEIN) ("RNAse A" . SPARSER::PROTEIN)
    ("gp120" . SPARSER::DRUG) ("Hsp90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("USP3" . SPARSER::PROTEIN) ("BRAP2" . SPARSER::PROTEIN)
    ("BRCA1-associated protein" . SPARSER::PROTEIN) ("Rbx2" . SPARSER::PROTEIN)
    ("Cul5" . SPARSER::PROTEIN) ("Cullin 5" . SPARSER::PROTEIN)
    ("cytidine deaminase" . SPARSER::PROTEIN)
    ("DNA glycosylase" . SPARSER::PROTEIN) ("APOBEC3G" . SPARSER::PROTEIN)
    ("HDAC6" . SPARSER::PROTEIN) ("histone deacetylase 6" . SPARSER::PROTEIN)
    ("A3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("apolipoprotein B" . SPARSER::PROTEIN) ("type 1" . SPARSER::PROTEIN)
    ("monocytes and SMCs" . SPARSER::COLLECTION)
    ("SMC and macrophage" . SPARSER::COLLECTION)
    ("scavenger receptors and adhesion molecules" . SPARSER::COLLECTION)
    ("ABCA1 and ABCG1" . SPARSER::COLLECTION) ("ApoE-" . SPARSER::PROTEIN)
    ("HDLs" . SPARSER::PROTEIN) ("PGC" . SPARSER::PROTEIN)
    ("SMC and macrophages" . SPARSER::COLLECTION)
    ("a predominant scavenger receptor" . SPARSER::RECEPTOR)
    ("MCP-1 and adhesion molecules" . SPARSER::COLLECTION)
    ("VCAM1 and ICAM1" . SPARSER::COLLECTION)
    ("an acute proinflammatory cytokine" . SPARSER::PROTEIN)
    ("macrophages and SMCs" . SPARSER::COLLECTION)
    ("the subendothelial matrix" . SPARSER::PROTEIN-FAMILY)
    ("ApoE −/− and Pak1 −/− mice" . SPARSER::COLLECTION)
    ("esters, IL-6 and MCP-1" . SPARSER::COLLECTION)
    ("CD36 and ABCA1" . SPARSER::COLLECTION) ("esters" . SPARSER::MOLECULE)
    ("neutrophils and monocytes" . SPARSER::COLLECTION)
    ("atherosclerotic stimulant" . SPARSER::DRUG)
    ("CD36, SR-B1, ICAM1 and VCAM1" . SPARSER::COLLECTION)
    ("ApoE −/− and ApoE −/− :Pak1 −/− mice" . SPARSER::COLLECTION)
    ("Pak1 −/− and ApoE −/− mice ( xref )" . SPARSER::COLLECTION)
    ("atherogenic stimulant OxLDL" . SPARSER::MOLECULE)
    ("stimulant" . SPARSER::DRUG)
    ("scavenger receptors and reverse cholesterol transporters"
     . SPARSER::COLLECTION)
    ("chemokines" . SPARSER::PROTEIN)
    ("CD36, SR-B1 and ABCA1" . SPARSER::COLLECTION)
    ("ICAM1 and VCAM1" . SPARSER::COLLECTION)
    ("ApoE −/− and ApoE −/−" . SPARSER::COLLECTION)
    ("IL-12, TNFα and Rantes" . SPARSER::COLLECTION)
    ("cytokine and chemokine" . SPARSER::COLLECTION)
    ("IL-6, IL-12, TNFα, MCP-1 and Rantes" . SPARSER::COLLECTION)
    ("HDL, LDL and TG" . SPARSER::COLLECTION)
    ("Pak1 −/− or ApoE −/− mice ( xref )" . SPARSER::COLLECTION)
    ("CD36, SR-B1, ICAM1, VCAM1 and ABCA1" . SPARSER::COLLECTION)
    ("Pak1 −/− and ApoE −/− mice" . SPARSER::COLLECTION)
    ("the above-listed molecules" . SPARSER::MOLECULE)
    ("cytokines and chemokine" . SPARSER::COLLECTION)
    ("ICAM1, VCAM1, CD36 and SR-B1" . SPARSER::COLLECTION)
    ("Pak1 and adhesion molecules" . SPARSER::COLLECTION)
    ("Pak1 and scavenger receptors or Pak1 and reverse cholesterol transporters"
     . SPARSER::COLLECTION)
    ("receptors or Pak1" . SPARSER::COLLECTION)
    ("ICAM1, VCAM1, CD36, SR-B1 and ABCA1" . SPARSER::COLLECTION)
    ("transporters" . SPARSER::PROTEIN)
    ("IL-12 and Rantes" . SPARSER::COLLECTION) ("Rantes" . SPARSER::PROTEIN)
    ("IL-10, IL-12, IL-17A, interferon-γ, granulocyte colony-stimulating factor and granulocyte–macrophage colony-stimulating factor"
     . SPARSER::COLLECTION)
    ("granulocyte–macrophage colony-stimulating factor, and chemokine"
     . SPARSER::COLLECTION)
    ("interferon-γ" . SPARSER::PROTEIN)
    ("SMCs and macrophages" . SPARSER::COLLECTION) ("SMCs" . SPARSER::PROTEIN)
    ("FAT" . SPARSER::PROTEIN) ("LDL and triglycerides" . SPARSER::COLLECTION)
    ("TGs" . SPARSER::PROTEIN)
    ("male ApoE −/− and ApoE −/− :Pak1 −/− mice" . SPARSER::COLLECTION)
    ("SMC or macrophages" . SPARSER::COLLECTION) ("SMC" . SPARSER::PROTEIN)
    ("Electron" . SPARSER::MOLECULE)
    ("Pak2, Pak3 or Pak4" . SPARSER::COLLECTION)
    ("Pak1, Pak2, Pak3 and Pak4" . SPARSER::COLLECTION)
    ("Pak4" . SPARSER::PROTEIN) ("Pak3" . SPARSER::PROTEIN)
    ("stimulants" . SPARSER::DRUG) ("vasculature" . SPARSER::PROTEIN)
    ("interleukin (IL)" . SPARSER::PROTEIN) ("OxLDL" . SPARSER::MOLECULE)
    ("MCP" . SPARSER::PROTEIN) ("IL" . SPARSER::PROTEIN)
    ("Cdc42 and Rac" . SPARSER::COLLECTION)
    ("Rac" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Paks" . SPARSER::PROTEIN-FAMILY)
    ("platelets" . SPARSER::PROTEIN)
    ("IL-6 and chemokine" . SPARSER::COLLECTION)
    (":Pak1" . SPARSER::BIO-COMPLEX) ("LDL" . SPARSER::PROTEIN)
    ("IL-6 and MCP-1" . SPARSER::COLLECTION) ("ApoE" . SPARSER::PROTEIN)
    ("prone" . SPARSER::PROTEIN-FAMILY)
    ("p21-activated kinase 1" . SPARSER::PROTEIN) ("l −1" . SPARSER::PROTEIN)
    ("CD115" . SPARSER::PROTEIN) ("Apolipoprotein A–I" . SPARSER::PROTEIN)
    ("CL4" . SPARSER::PROTEIN) ("CD45" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NK-T" . SPARSER::PROTEIN) ("Ly6G" . SPARSER::PROTEIN)
    ("CD49b" . SPARSER::PROTEIN) ("myelin basic protein" . SPARSER::PROTEIN)
    ("ABCG1" . SPARSER::PROTEIN) ("PPARγ" . SPARSER::PROTEIN)
    ("factor-κB" . SPARSER::PROTEIN) ("Ox-LDL" . SPARSER::PROTEIN)
    ("CD31" . SPARSER::PROTEIN) ("CD11c" . SPARSER::PROTEIN)
    ("Ly6C" . SPARSER::PROTEIN) ("CD11b" . SPARSER::PROTEIN)
    ("M1" . SPARSER::MOLECULE) ("Growth factor" . SPARSER::GROWTH-FACTOR)
    ("CD-" . SPARSER::PROTEIN) ("high-density lipoprotein" . SPARSER::PROTEIN)
    ("SR-B1" . SPARSER::PROTEIN) ("VCAM1" . SPARSER::PROTEIN)
    ("ICAM1" . SPARSER::PROTEIN)
    ("granulocyte–macrophage colony-stimulating factor" . SPARSER::PROTEIN)
    ("granulocyte colony-stimulating factor" . SPARSER::PROTEIN)
    ("tumour necrosis factor" . SPARSER::PROTEIN) ("IL-17A" . SPARSER::PROTEIN)
    ("IL-12" . SPARSER::PROTEIN) ("IL-10" . SPARSER::PROTEIN)
    ("fatty acid" . SPARSER::MOLECULE) ("α-actin" . SPARSER::PROTEIN)
    ("Pak2" . SPARSER::PROTEIN) ("ABCA1" . SPARSER::PROTEIN)
    ("low-density lipoprotein" . SPARSER::PROTEIN) ("CD36" . SPARSER::PROTEIN)
    ("MCP-1" . SPARSER::PROTEIN) ("apolipoprotein E" . SPARSER::PROTEIN)
    ("Pak1" . SPARSER::PROTEIN) ("SIRT1 and mapping" . SPARSER::COLLECTION)
    ("leukocytes" . SPARSER::PROTEIN) ("versa" . SPARSER::PROTEIN)
    ("SIRT1 and SUZ12" . SPARSER::COLLECTION) ("EED" . SPARSER::PROTEIN)
    ("which targets PRC1" . SPARSER::PROTEIN)
    ("cell lineage-specific genes" . SPARSER::GENE)
    ("IRX3 , PTPRG , STK10 and KLF3" . SPARSER::COLLECTION)
    ("PTPRG" . SPARSER::PROTEIN)
    ("using anti-SIRT1 antibody and no SIRT1" . SPARSER::COLLECTION)
    ("SIRT1 and EZH2" . SPARSER::COLLECTION)
    ("methyltransferase" . SPARSER::PROTEIN)
    ("SUZ12, EZH2, BMI1 and PHC1" . SPARSER::COLLECTION)
    ("demethylase" . SPARSER::PROTEIN)
    ("SIRT1 and PCGTs" . SPARSER::COLLECTION)
    ("PRC1 and PRC2" . SPARSER::COLLECTION)
    ("at least one component" . SPARSER::COMPONENT)
    ("PRC1 or PRC2" . SPARSER::COLLECTION)
    ("polycomb repressive complex" . SPARSER::BIO-COMPLEX)
    ("Phc1 and Rnf2" . SPARSER::COLLECTION)
    ("Suz12 and Eed" . SPARSER::COLLECTION) ("Rnf2" . SPARSER::PROTEIN)
    ("Phc1" . SPARSER::PROTEIN) ("Eed" . SPARSER::PROTEIN)
    ("Promoter" . SPARSER::PROMOTER) ("spike" . SPARSER::PROTEIN)
    ("methylcytidine" . SPARSER::MOLECULE) ("GSH" . SPARSER::DRUG)
    ("the methylated component" . SPARSER::COMPONENT)
    ("se" . SPARSER::HUMAN-PROTEIN-FAMILY) ("transgene" . SPARSER::PROTEIN)
    ("Sirt1" . SPARSER::PROTEIN) ("DR" . SPARSER::MOLECULE)
    ("polycomb repressive complexes" . SPARSER::BIO-COMPLEX)
    ("clock" . SPARSER::PROTEIN) ("cytosine" . SPARSER::NUCLEOBASE)
    ("SIRT1, and SIRT1" . SPARSER::COLLECTION) ("DNMTs" . SPARSER::PROTEIN)
    ("methyltransferases" . SPARSER::PROTEIN)
    ("DNMT1 or DNMT3b" . SPARSER::COLLECTION)
    ("the methylated fraction" . SPARSER::COMPONENT)
    ("the polycomb repressive complexes" . SPARSER::BIO-COMPLEX)
    ("PRCs" . SPARSER::PROTEIN) ("polycomb" . SPARSER::PROTEIN)
    ("Polycomb" . SPARSER::PROTEIN) ("KLF3" . SPARSER::PROTEIN)
    ("STK10" . SPARSER::PROTEIN) ("IRX3" . SPARSER::PROTEIN)
    ("RNF2" . SPARSER::PROTEIN) ("PHC1" . SPARSER::PROTEIN)
    ("BMI1" . SPARSER::PROTEIN) ("SUZ12" . SPARSER::PROTEIN)
    ("KDM2B" . SPARSER::PROTEIN) ("Suz12" . SPARSER::PROTEIN)
    ("PRC1" . SPARSER::PROTEIN) ("UBE2B" . SPARSER::PROTEIN)
    ("PGC1α" . SPARSER::PROTEIN) ("Sir2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("H3K4" . SPARSER::PROTEIN) ("PRC2" . SPARSER::PROTEIN)
    ("DNMT3b" . SPARSER::PROTEIN) ("DNMT1" . SPARSER::PROTEIN)
    ("Nat" . SPARSER::PROTEIN)
    ("a potential predictive biomarker" . SPARSER::MOLECULE)
    ("monomers" . SPARSER::MONOMER)
    ("dimeric–monomeric state" . SPARSER::BIO-STATE)
    ("both monomeric and dimeric form" . SPARSER::FORM)
    ("Only monomeric Grb2" . SPARSER::PROTEIN)
    ("dimeric Grb2" . SPARSER::PROTEIN)
    ("the signalling-competent active form" . SPARSER::FORM)
    ("The monomeric form" . SPARSER::FORM)
    ("Grb2 and SOS" . SPARSER::COLLECTION)
    ("the normal cohort" . SPARSER::MOLECULE)
    ("MAP kinase and tyrosine kinase" . SPARSER::COLLECTION)
    ("receptor and non-receptor" . SPARSER::COLLECTION)
    ("a monomeric Grb2" . SPARSER::PROTEIN)
    ("RFP-tagged WT Grb2 and Y160E Grb2" . SPARSER::COLLECTION)
    ("GFP–SOS1" . SPARSER::COLLECTION)
    ("the dimeric WT Grb2" . SPARSER::PROTEIN)
    ("the monomeric Y160E Grb2 and N188/214D Grb2 form stable complexes"
     . SPARSER::BIO-COMPLEX)
    ("Ras/MAP kinase" . SPARSER::COLLECTION) ("FGF2-" . SPARSER::PROTEIN)
    ("WT Grb2 and Y160E Grb2" . SPARSER::COLLECTION)
    ("the dimerization-defective Grb2 mutants" . SPARSER::MUTANT)
    ("the dimeric Grb2" . SPARSER::PROTEIN)
    ("Monomeric Grb2" . SPARSER::PROTEIN)
    ("the oligomeric state" . SPARSER::BIO-STATE)
    ("proline" . SPARSER::AMINO-ACID) ("the monomeric form" . SPARSER::FORM)
    ("FLI" . SPARSER::PROTEIN) ("Atto550–Grb2" . SPARSER::PROTEIN-PAIR)
    ("Atto488–Grb2" . SPARSER::PROTEIN-PAIR) ("Talon" . SPARSER::DRUG)
    ("RFP–" . SPARSER::PROTEIN) ("CFP–" . SPARSER::PROTEIN)
    ("fluorescence protein (CFP)-tagged Grb2 (CFP–Grb2) and red fluorescence protein (RFP)-tagged Grb2 (RFP–Grb2)"
     . SPARSER::COLLECTION)
    ("RFP–Grb2" . SPARSER::COLLECTION) ("CFP–Grb2" . SPARSER::COLLECTION)
    ("RFP" . SPARSER::PROTEIN) ("CFP" . SPARSER::PROTEIN)
    ("FLIM" . SPARSER::PROTEIN-FAMILY) ("dynamic light" . SPARSER::PROTEIN)
    ("polyacrylamide" . SPARSER::DRUG)
    ("Grb2 and N188/214D" . SPARSER::COLLECTION) ("MST" . SPARSER::PROTEIN)
    ("a phosphorylation-independent dimerization-defective control protein"
     . SPARSER::PROTEIN)
    ("mimetic Grb2 mutant Y160E" . SPARSER::PROTEIN)
    ("the monomeric signalling active form" . SPARSER::FORM)
    ("its monomeric form" . SPARSER::FORM) ("TEL-JAK2" . SPARSER::COLLECTION)
    ("NPM-ALK" . SPARSER::COLLECTION) ("TEL" . SPARSER::PROTEIN)
    ("TPR" . SPARSER::PROTEIN) ("NPM" . SPARSER::PROTEIN)
    ("CD3 and CD4" . SPARSER::COLLECTION) ("prolactin" . SPARSER::PROTEIN)
    ("ref" . SPARSER::HUMAN-PROTEIN-FAMILY) ("monomer" . SPARSER::MONOMER)
    ("SOS" . SPARSER::PROTEIN)
    ("receptor tyrosine kinases (RTKs) and RTK-docking proteins"
     . SPARSER::COLLECTION)
    ("Shc, IRS1-4 and FRS2/3" . SPARSER::COLLECTION) ("Shc" . SPARSER::PROTEIN)
    ("RTKs" . SPARSER::PROTEIN) ("Grb2–SOS" . SPARSER::COLLECTION)
    ("guanine nucleotide exchange factor (GEF)" . SPARSER::GEF)
    ("GEF" . SPARSER::GEF) ("son" . SPARSER::PROTEIN)
    ("scaffolds" . SPARSER::SCAFFOLD)
    ("the monomeric protein" . SPARSER::PROTEIN)
    ("the dimeric state" . SPARSER::BIO-STATE)
    ("only monomeric Grb2" . SPARSER::PROTEIN)
    ("monomeric and dimeric states" . SPARSER::BIO-STATE)
    ("MAP" . SPARSER::PROTEIN) ("mitogen" . SPARSER::MITOGEN)
    ("SP5" . SPARSER::PROTEIN) ("PMA2" . SPARSER::PROTEIN)
    ("Shp2" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FGF2" . SPARSER::PROTEIN) ("SOS1" . SPARSER::PROTEIN)
    ("N-terminally" . SPARSER::PROTEIN)
    ("aspartic acids" . SPARSER::AMINO-ACID) ("pY160" . SPARSER::PROTEIN)
    ("JAK2" . SPARSER::PROTEIN) ("FGFR2" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor" . SPARSER::PROTEIN)
    ("BCR-Abl" . SPARSER::PROTEIN) ("FRS2" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factor" . SPARSER::GEF)
    ("Growth factor receptor-bound protein 2" . SPARSER::PROTEIN)
    ("receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Grb2" . SPARSER::PROTEIN)
    ("growth factor receptor-bound protein 2" . SPARSER::PROTEIN)
    ("receiving trastuzumab and chemotherapy [ xref ]" . SPARSER::COLLECTION)
    ("HER2 and dual EGFR/HER2 inhibitors [ xref ]" . SPARSER::COLLECTION)
    ("dual EGFR/HER2 inhibitors" . SPARSER::INHIBITOR)
    ("EGFR/HER2" . SPARSER::COLLECTION) ("EGFR-TKIs" . SPARSER::COLLECTION)
    ("YVMA" . SPARSER::AMINO-ACID) ("RAS/RAF/MAPK" . SPARSER::COLLECTION)
    ("TK" . SPARSER::PROTEIN) ("ERBB" . SPARSER::PROTEIN)
    ("NEU" . SPARSER::PROTEIN)
    ("relatively new biomarkers" . SPARSER::MOLECULE)
    ("HER2 or BRAF" . SPARSER::COLLECTION) ("EGFR/KRAS" . SPARSER::COLLECTION)
    ("amino acids (GSP)" . SPARSER::AMINO-ACID) ("GSP" . SPARSER::PROTEIN)
    ("amino acids (VC)" . SPARSER::AMINO-ACID) ("VC" . SPARSER::MOLECULE)
    ("amino acids (YVMA)" . SPARSER::AMINO-ACID)
    ("BRAF or HER2" . SPARSER::COLLECTION)
    ("trastuzumab and afatinib" . SPARSER::COLLECTION)
    ("trastuzumab" . SPARSER::DRUG)
    ("Vemurafenib and Dabrafenib" . SPARSER::COLLECTION)
    ("Vemurafenib" . SPARSER::DRUG) ("ALK and ROS1" . SPARSER::COLLECTION)
    ("ALK" . SPARSER::PROTEIN) ("EGFR and KRAS" . SPARSER::COLLECTION)
    ("HER2 and BRAF" . SPARSER::COLLECTION)
    ("BRAF and HER2" . SPARSER::COLLECTION)
    ("ADCs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ADC" . SPARSER::PROTEIN)
    ("Aims" . SPARSER::PROTEIN)
    ("homo/heterodimers" . SPARSER::HOMO/HETERODIMER)
    ("ROS1" . SPARSER::PROTEIN)
    ("a potential GIST predisposition gene" . SPARSER::GENE)
    ("the mitotic checkpoint genes AURKA and BUB1B" . SPARSER::COLLECTION)
    ("AURKA and BUB1B" . SPARSER::COLLECTION)
    ("SYNE2 , MAPK8IP2 and DIAPH1" . SPARSER::COLLECTION)
    ("Ile" . SPARSER::AMINO-ACID) ("the homozygous variant" . SPARSER::VARIANT)
    ("parts" . SPARSER::COMPONENT) ("Asn" . SPARSER::AMINO-ACID)
    ("Met" . SPARSER::AMINO-ACID) ("drosophila" . SPARSER::PROTEIN)
    ("the mitotic checkpoint proteins Aurora kinase A, BUB1 mitotic checkpoint kinase B, and succinate dehydrogenase subunit B"
     . SPARSER::COLLECTION)
    ("the mitotic checkpoint proteins Aurora kinase A" . SPARSER::PROTEIN)
    ("at least two tumour suppressor genes" . SPARSER::GENE)
    ("a zinc finger’s" . SPARSER::PROTEIN) ("CTCF" . SPARSER::PROTEIN)
    ("the zinc finger’s" . SPARSER::PROTEIN)
    ("the bulky amphipatic tryptophan" . SPARSER::AMINO-ACID)
    ("the hydrophilic arginine" . SPARSER::AMINO-ACID)
    ("tryptophan" . SPARSER::AMINO-ACID) ("arginine" . SPARSER::AMINO-ACID)
    ("namely two cysteines (C) and two histidines (H)" . SPARSER::COLLECTION)
    ("namely two cysteines" . SPARSER::AMINO-ACID)
    ("histidines" . SPARSER::AMINO-ACID) ("cysteines" . SPARSER::AMINO-ACID)
    ("Imatinib" . SPARSER::DRUG) ("the protein’s" . SPARSER::PROTEIN)
    ("gene and concentrate" . SPARSER::COLLECTION)
    ("RNF146 or ZNF407" . SPARSER::COLLECTION)
    ("DOPEY2 , LAMA5 , PCDHB11 and STS" . SPARSER::COLLECTION)
    ("STS" . SPARSER::PROTEIN)
    ("the 5-oxo-L-prolinase OPLAH or the zinc influx transporter SLC39A9"
     . SPARSER::COLLECTION)
    ("OPLAH" . SPARSER::PROTEIN) ("KIT and SDHB" . SPARSER::COLLECTION)
    ("NF1 or NF2" . SPARSER::COLLECTION)
    ("variants and genes" . SPARSER::COLLECTION)
    ("FUT3 (all heterozygous) as well as RET" . SPARSER::COLLECTION)
    ("AURKA , BUB1B , BRCA2 , MTHFR , IRF1 , TLR4 , ZEB1 , LIG4 , ELAC2 , FUT3 (all heterozygous) as well as RET"
     . SPARSER::COLLECTION)
    ("EVC" . SPARSER::PROTEIN) ("RET" . SPARSER::PROTEIN)
    ("MTHFR" . SPARSER::PROTEIN) ("AURKA" . SPARSER::PROTEIN)
    ("promoter and gene" . SPARSER::COLLECTION) ("CpG" . SPARSER::PROTEIN)
    ("Heterozygous variants" . SPARSER::VARIANT) ("hg" . SPARSER::MOLECULE)
    ("DOG-1 and SDHB" . SPARSER::COLLECTION) ("SDHB" . SPARSER::PROTEIN)
    ("Partial" . SPARSER::PROTEIN) ("KIT or PDGFRA" . SPARSER::COLLECTION)
    ("SDH" . SPARSER::PROTEIN) ("examples" . SPARSER::EXAMPLE)
    ("Val" . SPARSER::AMINO-ACID) ("the kinase’s" . SPARSER::KINASE)
    ("the mast cell growth factor receptor KIT or the platelet-derived growth factor receptor α ( PDGFRA ) tyrosine kinases"
     . SPARSER::COLLECTION)
    ("PDGFRA" . SPARSER::PROTEIN) ("Cajal" . SPARSER::PROTEIN)
    ("three genes and loss of the long arm" . SPARSER::COLLECTION)
    ("Aurora kinase A and BUB1" . SPARSER::COLLECTION)
    ("KIT" . SPARSER::PROTEIN) ("DIAPH1" . SPARSER::PROTEIN)
    ("MAPK8IP2" . SPARSER::PROTEIN) ("SYNE2" . SPARSER::PROTEIN)
    ("methylenetetrahydrofolate reductase" . SPARSER::PROTEIN)
    ("cancer 2" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor" . SPARSER::PROTEIN)
    ("zinc finger protein" . SPARSER::PROTEIN) ("C2H2" . SPARSER::MOLECULE)
    ("LAMA5" . SPARSER::PROTEIN) ("DOPEY2" . SPARSER::PROTEIN)
    ("SLC39A9" . SPARSER::PROTEIN) ("TESK1" . SPARSER::PROTEIN)
    ("serine/threonine protein kinase" . SPARSER::PROTEIN)
    ("NF2" . SPARSER::PROTEIN) ("IL7R" . SPARSER::PROTEIN)
    ("IL4R" . SPARSER::PROTEIN) ("FUT3" . SPARSER::PROTEIN)
    ("ELAC2" . SPARSER::PROTEIN) ("LIG4" . SPARSER::PROTEIN)
    ("TLR4" . SPARSER::PROTEIN) ("IRF1" . SPARSER::PROTEIN)
    ("BUB1B" . SPARSER::PROTEIN) ("subunit B" . SPARSER::PROTEIN)
    ("DOG-1" . SPARSER::PROTEIN) ("CD117" . SPARSER::PROTEIN)
    ("CD34" . SPARSER::PROTEIN) ("1 D" . SPARSER::PROTEIN)
    ("1 C" . SPARSER::PROTEIN) ("1 B" . SPARSER::PROTEIN)
    ("1 A" . SPARSER::PROTEIN) ("von Hippel-Lindau" . SPARSER::PROTEIN)
    ("RASSF1A" . SPARSER::PROTEIN)
    ("derived growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mast cell growth factor" . SPARSER::PROTEIN) ("BUB1" . SPARSER::PROTEIN)
    ("Aurora kinase A" . SPARSER::PROTEIN) ("ZNF407" . SPARSER::PROTEIN)
    ("zinc finger" . SPARSER::PROTEIN) ("RNF146" . SPARSER::PROTEIN)
    ("adequate nutrient" . SPARSER::MOLECULE)
    ("pro- and anti-tumorigenic" . SPARSER::COLLECTION)
    ("the ISR initiator and endoplasmic reticulum resident kinase PERK"
     . SPARSER::PROTEIN)
    ("AMPK" . SPARSER::PROTEIN) ("Glucose" . SPARSER::PROTEIN)
    ("CCAAT/enhancer-binding protein homologous protein (CHOP)"
     . SPARSER::PROTEIN)
    ("IBTK" . SPARSER::PROTEIN) ("amino acid and serum" . SPARSER::COLLECTION)
    ("trypan" . SPARSER::DRUG)
    ("complete media or media" . SPARSER::COLLECTION)
    ("media or media" . SPARSER::COLLECTION)
    ("PERK and GCN2" . SPARSER::COLLECTION)
    ("GCN2 -/- and eIF2α S51A MEFs" . SPARSER::COLLECTION)
    ("either non-targeting siRNA (siNT) or siRNA" . SPARSER::COLLECTION)
    ("either non-targeting shRNA (shNT) or shRNA" . SPARSER::COLLECTION)
    ("shp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("UTR-luciferase and p21" . SPARSER::COLLECTION)
    ("complete or leucine-free media" . SPARSER::PROTEIN)
    ("GCN2 +/+ and GCN2 -/- MEFs" . SPARSER::COLLECTION)
    ("methionine" . SPARSER::AMINO-ACID)
    ("GCN2 +/+ and eIF2α S51A MEFs" . SPARSER::COLLECTION)
    ("the predominant variant" . SPARSER::VARIANT)
    ("p21 and p27" . SPARSER::COLLECTION)
    ("GCN2 +/+ , GCN2 -/- , and eIF2α S51A MEFs cells" . SPARSER::COLLECTION)
    ("siRNA or siRNA" . SPARSER::COLLECTION)
    ("complete media" . SPARSER::PROTEIN)
    ("GCN2 and p-eIF2α" . SPARSER::COLLECTION)
    ("Leucine" . SPARSER::AMINO-ACID) ("leucine" . SPARSER::AMINO-ACID)
    ("eIF2" . SPARSER::PROTEIN) ("GTP" . SPARSER::NUCLEOTIDE)
    ("GDP" . SPARSER::NUCLEOTIDE)
    ("PKR-like endoplasmic reticulum kinase (PERK) and heme-regulated inhibitor (HRI)"
     . SPARSER::COLLECTION)
    ("the four mammalian kinases GCN2, protein kinase RNA-activated (PKR), PKR-like endoplasmic reticulum kinase (PERK) and heme-regulated inhibitor (HRI)"
     . SPARSER::COLLECTION)
    ("kinase (PERK)" . SPARSER::KINASE) ("HRI" . SPARSER::PROTEIN)
    ("PERK" . SPARSER::PROTEIN) ("ribosome" . SPARSER::BIO-COMPLEX)
    ("GCN2 and eIF2α" . SPARSER::COLLECTION)
    ("p63 and p73" . SPARSER::COLLECTION) ("Hu-antigen" . SPARSER::COLLECTION)
    ("HuR" . SPARSER::PROTEIN) ("HuD" . SPARSER::PROTEIN)
    ("a p53 target and a major effector" . SPARSER::COLLECTION)
    ("cyclin E:CDK2" . SPARSER::BIO-COMPLEX)
    ("cyclin E and cyclin dependent kinase 2" . SPARSER::COLLECTION)
    ("pRb" . SPARSER::PROTEIN) ("CIP/KIP" . SPARSER::COLLECTION)
    ("KIP" . SPARSER::PROTEIN) ("CIP" . SPARSER::PROTEIN)
    ("the eukaryotic translation initiation factor eIF2α" . SPARSER::PROTEIN)
    ("lithium chloride" . SPARSER::DRUG) ("Ku80" . SPARSER::PROTEIN)
    ("β-tubulin" . SPARSER::PROTEIN) ("pSM2" . SPARSER::PROTEIN)
    ("s 5A" . SPARSER::PROTEIN) ("Amino acid" . SPARSER::AMINO-ACID)
    ("Amino acids" . SPARSER::AMINO-ACID)
    ("inhibitor of Bruton tyrosine kinase" . SPARSER::PROTEIN)
    ("growth arrest and DNA-damage-inducible 34" . SPARSER::PROTEIN)
    ("CCAAT/enhancer-binding protein homologous protein" . SPARSER::PROTEIN)
    ("ATF5" . SPARSER::PROTEIN)
    ("activating transcription factor 5" . SPARSER::PROTEIN)
    ("sip21" . SPARSER::PROTEIN) ("eEF2" . SPARSER::PROTEIN)
    ("p27" . SPARSER::PROTEIN) ("p27 Kip1" . SPARSER::PROTEIN)
    ("heme-regulated inhibitor" . SPARSER::PROTEIN)
    ("protein kinase RNA-activated" . SPARSER::PROTEIN)
    ("activating transcription factor 4" . SPARSER::PROTEIN)
    ("Hu-antigen R" . SPARSER::PROTEIN)
    ("histone deacetylase" . SPARSER::PROTEIN)
    ("retinoblastoma protein" . SPARSER::PROTEIN)
    ("cyclin dependent kinase 2" . SPARSER::PROTEIN)
    ("cyclin E" . SPARSER::PROTEIN) ("GCN2" . SPARSER::PROTEIN)
    ("p21 Cip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AKT2 and p-AKT2in" . SPARSER::COLLECTION)
    ("Bad and GSK-3B" . SPARSER::COLLECTION)
    ("The western blot" . SPARSER::PROTEIN)
    ("Bad or GSK" . SPARSER::COLLECTION) ("p-Bad" . SPARSER::COLLECTION)
    ("Bad and GSK-B" . SPARSER::COLLECTION) ("GSK" . SPARSER::PROTEIN)
    ("MiR" . SPARSER::PROTEIN) ("Chen" . SPARSER::PROTEIN)
    ("MicroRNA" . SPARSER::RNA)
    ("novel diagnostic biomarkers" . SPARSER::MOLECULE)
    ("oncogenes or tumor suppressor genes" . SPARSER::COLLECTION)
    ("posttranscriptional regulators" . SPARSER::REGULATOR)
    ("some tumor suppressor genes and tumor-related genes"
     . SPARSER::COLLECTION)
    ("Bad and GSK-3β" . SPARSER::COLLECTION) ("Bad" . SPARSER::PROTEIN)
    ("Cdc42" . SPARSER::PROTEIN) ("site 1" . SPARSER::PROTEIN)
    ("_WT" . SPARSER::PROTEIN) ("GSK-3B" . SPARSER::PROTEIN)
    ("CCK8" . SPARSER::PROTEIN) ("CDC42" . SPARSER::PROTEIN)
    ("miR-34a" . SPARSER::MOLECULE) ("miR-1" . SPARSER::PROTEIN)
    ("down-regulated in gastric cancer" . SPARSER::PROTEIN)
    ("AKT2" . SPARSER::PROTEIN) ("GES-1" . SPARSER::PROTEIN)
    ("anion" . SPARSER::MOLECULE) ("VDAC" . SPARSER::PROTEIN)
    ("ANT" . SPARSER::PROTEIN) ("mPTP" . SPARSER::PROTEIN)
    ("Bax and Bak" . SPARSER::COLLECTION) ("primarily two types" . TYPE)
    ("BIM , E4BP4 and RCAN1-1" . SPARSER::COLLECTION)
    ("ischemia" . SPARSER::PROTEIN) ("EBPRE" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("pro- and anti-apoptotic" . SPARSER::COLLECTION)
    ("pro-" . SPARSER::AMINO-ACID) ("BIM or E4BP4" . SPARSER::COLLECTION)
    ("BIM and E4BP4" . SPARSER::COLLECTION)
    ("ethanol or 1μM" . SPARSER::COLLECTION)
    ("ethanol or Dex" . SPARSER::COLLECTION) ("ethanol" . SPARSER::PROTEIN)
    ("RCAN1 as well as E4BP4 and BIM" . SPARSER::COLLECTION)
    ("potential E4BP4 response elements (EBPRE)"
     . SPARSER::DNA-RESPONSE-ELEMENT)
    ("response elements (EBPRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("response element (GRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("huntingtin" . SPARSER::PROTEIN) ("calcium" . SPARSER::CALCIUM)
    ("oxidant-" . SPARSER::PROTEIN) ("oxidant" . SPARSER::PROTEIN)
    ("calcineurin" . SPARSER::PROTEIN)
    ("a unique first exon" . SPARSER::PROTEIN) ("elegans" . SPARSER::PROTEIN)
    ("bZIP" . SPARSER::PROTEIN-FAMILY)
    ("pro-apoptotic Bak and Bax" . SPARSER::COLLECTION)
    ("Bak and Bax" . SPARSER::COLLECTION) ("Bak" . SPARSER::PROTEIN)
    ("RCAN1 , E4BP4 and Bcl2L11" . SPARSER::COLLECTION)
    ("Bcl2L11" . SPARSER::PROTEIN)
    ("coactivators and corepressors" . SPARSER::COLLECTION)
    ("corepressors" . SPARSER::PROTEIN) ("coactivators" . SPARSER::PROTEIN)
    ("GR" . SPARSER::PROTEIN) ("RCAN1-1" . SPARSER::COLLECTION)
    ("Dexamethasone" . SPARSER::PROTEIN)
    ("RCAN1 , E4BP4 and BIM" . SPARSER::COLLECTION)
    ("lymphoid" . SPARSER::PROTEIN) ("BIM" . SPARSER::PROTEIN)
    ("BP" . SPARSER::PROTEIN) ("GC" . SPARSER::PROTEIN)
    ("GCs" . SPARSER::PROTEIN) ("Glucocorticoids" . SPARSER::PROTEIN)
    ("homolog of" . SPARSER::PROTEIN) ("voltage dependent" . SPARSER::PROTEIN)
    ("Bcl-xL" . SPARSER::PROTEIN) ("Texas Red" . SPARSER::DRUG)
    ("CO2" . SPARSER::PROTEIN) ("sodium bicarbonate" . SPARSER::DRUG)
    ("L-glutamine" . SPARSER::MOLECULE) ("CD8" . SPARSER::PROTEIN)
    ("CD7" . SPARSER::PROTEIN) ("CD5" . SPARSER::PROTEIN)
    ("CD4" . SPARSER::PROTEIN) ("CD1a" . SPARSER::PROTEIN)
    ("T- cell" . SPARSER::PROTEIN) ("amyloid beta" . SPARSER::PROTEIN)
    ("Ca 2+" . SPARSER::CALCIUM-ION) ("PP3" . SPARSER::PROTEIN)
    ("egl-1" . SPARSER::PROTEIN) ("- 2" . SPARSER::PROTEIN)
    ("NFIL3" . SPARSER::PROTEIN) ("Bcl-2" . SPARSER::PROTEIN)
    ("Bcl2L" . SPARSER::PROTEIN) ("RS4" . SPARSER::PROTEIN)
    ("B15" . SPARSER::PROTEIN) ("RCAN1" . SPARSER::PROTEIN)
    ("the positive control ESR1 and two genes" . SPARSER::COLLECTION)
    ("genome-wide gene" . SPARSER::GENE)
    ("ERBB2 and ADAM12" . SPARSER::COLLECTION)
    ("the most well-studied modulator gene" . SPARSER::GENE)
    ("ESR1 or ERBB2" . SPARSER::COLLECTION) ("cofactor" . SPARSER::MOLECULE)
    ("SERM" . SPARSER::DRUG) ("MIA" . SPARSER::PROTEIN)
    ("ESR1 and ERBB2" . SPARSER::COLLECTION)
    ("estrogen and steroid hormone" . SPARSER::COLLECTION)
    ("progesterone" . SPARSER::PROTEIN) ("VEGFA" . SPARSER::PROTEIN)
    ("sphingomyelin" . SPARSER::MOLECULE) ("NFIX" . SPARSER::PROTEIN)
    ("RECK and ERBB2" . SPARSER::COLLECTION) ("MIF" . SPARSER::PROTEIN)
    ("MK" . SPARSER::PROTEIN) ("the genome-wide gene" . SPARSER::GENE)
    ("RECK" . SPARSER::PROTEIN)
    ("v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 ( ERBB2 ; 1,772,703 pairs, 12.59%) and ADAM metallopeptidase domain 12 ( ADAM12 ; 1,764,441 pairs, 12.53%)"
     . SPARSER::COLLECTION)
    ("v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2"
     . SPARSER::PROTEIN)
    ("the well-studied modulator gene ESR1" . SPARSER::PROTEIN)
    ("forkhead box A1 ( FOXA1 ) and fructose-1,6-bisphosphatase 1 ( FBP1 )"
     . SPARSER::COLLECTION)
    ("keratin 18 ( KRT18 ) and N-acetylneuraminic acid synthase ( NANS )"
     . SPARSER::COLLECTION)
    ("synthase ( NANS )" . SPARSER::PROTEIN) ("NANS" . SPARSER::PROTEIN)
    ("synthase" . SPARSER::PROTEIN)
    ("genes, and outputs" . SPARSER::COLLECTION)
    ("individual modulator genes and the cooperative (or uncooperative) interaction"
     . SPARSER::COLLECTION)
    ("the well-studied modulator gene estrogen receptor 1" . SPARSER::PROTEIN)
    ("representing 5,308 unique genes" . SPARSER::GENE)
    ("GRN" . SPARSER::PROTEIN)
    ("Genes and Genomes (KEGG)" . SPARSER::COLLECTION)
    ("GRNs" . SPARSER::PROTEIN)
    ("complex and dynamic gene regulation" . SPARSER::COLLECTION)
    ("modulators, ESR1, ERBB2 , and ADAM12" . SPARSER::COLLECTION)
    ("modulators" . SPARSER::PROTEIN) ("log-2" . SPARSER::PROTEIN)
    ("FYCO1" . SPARSER::PROTEIN)
    ("FYVE and coiled-coil domain containing 1" . SPARSER::PROTEIN)
    ("KRT6B" . SPARSER::PROTEIN) ("keratin 6B" . SPARSER::PROTEIN)
    ("melanoma inhibitory activity" . SPARSER::PROTEIN)
    ("steroid hormone" . SPARSER::MOLECULE)
    ("vascular endothelial growth factor A" . SPARSER::PROTEIN)
    ("SMPDL3A" . SPARSER::PROTEIN) ("CCL5" . SPARSER::PROTEIN)
    ("IGF1" . SPARSER::PROTEIN) ("tumor protein p53" . SPARSER::PROTEIN)
    ("cysteine-rich protein" . SPARSER::PROTEIN)
    ("ADAM metallopeptidase domain 12" . SPARSER::PROTEIN)
    ("homolog 2" . SPARSER::PROTEIN) ("v-erb" . SPARSER::PROTEIN)
    ("DNA-binding protein" . SPARSER::PROTEIN) ("FBP1" . SPARSER::PROTEIN)
    ("fructose-1,6-bisphosphatase 1" . SPARSER::PROTEIN)
    ("FOXA1" . SPARSER::PROTEIN) ("forkhead box A1" . SPARSER::PROTEIN)
    ("N-acetylneuraminic acid" . SPARSER::MOLECULE)
    ("KRT18" . SPARSER::PROTEIN) ("keratin 18" . SPARSER::PROTEIN)
    ("estrogen receptor 1" . SPARSER::PROTEIN)
    ("Estrogen Receptor" . SPARSER::PROTEIN) ("ADAM12" . SPARSER::PROTEIN)
    ("ERBB2" . SPARSER::PROTEIN) ("ESR1" . SPARSER::PROTEIN)
    ("especially monoclonal antibody drugs" . SPARSER::DRUG)
    ("HER-2/neu" . SPARSER::COLLECTION)
    ("gefitinib and erlotinib" . SPARSER::COLLECTION)
    ("epidermal growth factor (EGF) and proliferation signaling receptors"
     . SPARSER::COLLECTION)
    ("Han, Kazakh, and Uyghur" . SPARSER::COLLECTION)
    ("VEGF, EGFR, and HER-2 and β-actin" . SPARSER::COLLECTION)
    ("HER-2 and β-actin" . SPARSER::COLLECTION) ("melting" . SPARSER::DRUG)
    ("epidermal growth factor receptor (EGFR), vascular endothelial growth factor (VEGF), and human epidermal growth factor receptor 2 (HER-2)"
     . SPARSER::COLLECTION)
    ("/mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("VEGF and HER-2" . SPARSER::COLLECTION)
    ("VEGF, HER-2, and EGFR" . SPARSER::COLLECTION)
    ("growth factor (VEGF)" . SPARSER::GROWTH-FACTOR)
    ("Han, Uyghur, and Kazakh" . SPARSER::COLLECTION)
    ("erbB-2" . SPARSER::PROTEIN) ("LRIG1" . SPARSER::PROTEIN)
    ("ddH2" . SPARSER::PROTEIN) ("mask" . SPARSER::PROTEIN)
    ("AKT and Wnt/" . SPARSER::COLLECTION)
    ("a dominant invasive CRC" . SPARSER::PROTEIN)
    ("PTEN, Ki-67, and SMAD4" . SPARSER::COLLECTION)
    ("BMP/TGF-beta" . SPARSER::COLLECTION) ("BMP" . SPARSER::PROTEIN)
    ("PI3K/Akt" . SPARSER::COLLECTION) ("TGF-beta/SMAD" . SPARSER::COLLECTION)
    ("nuc" . SPARSER::PROTEIN) ("primary CRCs" . SPARSER::PROTEIN)
    ("invasive CRC" . SPARSER::PROTEIN)
    ("PTEN and SMAD4" . SPARSER::COLLECTION)
    ("the deeper invasive ACA" . SPARSER::PROTEIN)
    ("SMAD4 and CD44" . SPARSER::COLLECTION)
    ("ALDH1 and EZH2" . SPARSER::COLLECTION)
    ("the invasive tumor component" . SPARSER::COMPONENT)
    ("a possible higher SMAD4" . SPARSER::PROTEIN) ("APC" . SPARSER::PROTEIN)
    ("the invasive ACA" . SPARSER::PROTEIN) ("OSA" . SPARSER::PROTEIN)
    ("CTNNB1 as well as KRAS , PTEN , SMAD4 , and TP53" . SPARSER::COLLECTION)
    ("KRAS , PTEN , SMAD4 , and TP53" . SPARSER::COLLECTION)
    ("SMAD4-" . SPARSER::PROTEIN) ("EZH2 and ALDH1" . SPARSER::COLLECTION)
    ("PTEN and Ki-67" . SPARSER::COLLECTION)
    ("ALDH1, EZH2, and MGMT" . SPARSER::COLLECTION) ("MGMT" . SPARSER::PROTEIN)
    ("SMAD4 and PTEN" . SPARSER::COLLECTION)
    ("PTEN-SMAD4" . SPARSER::COLLECTION)
    ("residual adenomatous component" . SPARSER::COMPONENT)
    ("the adjacent invasive ACA" . SPARSER::PROTEIN)
    ("735 primary CRC" . SPARSER::PROTEIN) ("primary CRC" . SPARSER::PROTEIN)
    ("ACA" . SPARSER::PROTEIN)
    ("the Wnt-associated beta (β)-catenin ( CTNNB1 ) complex"
     . SPARSER::BIO-COMPLEX)
    ("PTEN/PIK3CA/AKT" . SPARSER::COLLECTION)
    ("-catenin" . SPARSER::COLLECTION) ("TGF" . SPARSER::DRUG)
    ("PTEN -haploinsufficient CRC" . SPARSER::PROTEIN)
    ("TGF-β/SMAD" . SPARSER::COLLECTION) ("PTEN/AKT" . SPARSER::COLLECTION)
    ("SMAD" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ALDH1, and CD44" . SPARSER::COLLECTION)
    ("β-catenin/CTNNB1" . SPARSER::COLLECTION)
    ("the invasive component" . SPARSER::COMPONENT)
    ("PTEN-" . SPARSER::PROTEIN) ("TCL1" . SPARSER::PROTEIN)
    ("6.3" . SPARSER::PROTEIN) ("2/3" . SPARSER::PROTEIN)
    ("TGF-beta" . SPARSER::PROTEIN) ("HD 2" . SPARSER::PROTEIN)
    ("p11" . SPARSER::PROTEIN) ("GRID1" . SPARSER::PROTEIN)
    ("P53" . SPARSER::HUMAN-PROTEIN-FAMILY) ("EZH2" . SPARSER::PROTEIN)
    ("B-4" . SPARSER::PROTEIN) ("PIK3CA" . SPARSER::PROTEIN)
    ("transforming growth factor" . SPARSER::PROTEIN)
    ("CD44" . SPARSER::PROTEIN) ("ALDH1" . SPARSER::PROTEIN)
    ("CTNNB1" . SPARSER::PROTEIN)
    ("transforming growth factor-beta" . SPARSER::PROTEIN)
    ("RNP" . SPARSER::PROTEIN) ("a key global regulator" . SPARSER::REGULATOR)
    ("EIF4EBP1/4E-BP1" . SPARSER::COLLECTION)
    ("RPS6KB1/p70S6" . SPARSER::COLLECTION)
    ("protein-mRNA" . SPARSER::COLLECTION) ("TFEB" . SPARSER::PROTEIN)
    ("Dhh1, Vad1 and DDX6" . SPARSER::COLLECTION)
    ("DDX6/Vad1/Dhh1" . SPARSER::COLLECTION)
    ("the S249D phosphomimetic mutant" . SPARSER::MUTANT)
    ("LPS" . SPARSER::PROTEIN) ("IL1B and IL18" . SPARSER::COLLECTION)
    ("CASP1/caspase-1" . SPARSER::COLLECTION)
    ("a DCP2 S249A phosphodeficient mutant" . SPARSER::MUTANT)
    ("antigen" . SPARSER::PROTEIN)
    ("ribosomes and polysomes" . SPARSER::COLLECTION)
    ("ribosomes" . SPARSER::BIO-COMPLEX) ("mRNP" . SPARSER::BIO-COMPLEX)
    ("polysomes" . SPARSER::BIO-COMPLEX) ("polysome" . SPARSER::BIO-COMPLEX)
    ("ATG8 and ATG5" . SPARSER::COLLECTION)
    ("ATG5 and ATG8" . SPARSER::COLLECTION)
    ("Dhh1 and Vad1" . SPARSER::COLLECTION) ("Dcp2-Vad1" . SPARSER::COLLECTION)
    ("the phosphodeficient Dcp2" . SPARSER::PROTEIN)
    ("the phosphomimetic Dcp2" . SPARSER::PROTEIN)
    ("the double-phosphodeficient Dcp2" . SPARSER::PROTEIN)
    ("Residual phosphoserine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("the phosphodeficient mutant" . SPARSER::MUTANT)
    ("phosphodeficient (S -> A) double mutants" . SPARSER::MUTANT)
    ("TOR and Vad1" . SPARSER::COLLECTION) ("GFP-ATG8" . SPARSER::COLLECTION)
    ("other transcriptionally-regulated autophagy genes" . SPARSER::GENE)
    ("ATG 3, ATG5 , ATG8 , ATG9 and ATG22" . SPARSER::COLLECTION)
    ("ATG genes and induction of autophagy" . SPARSER::COLLECTION)
    ("northern blot" . SPARSER::PROTEIN) ("phenanthroline" . SPARSER::MOLECULE)
    ("glucose and nitrogen" . SPARSER::COLLECTION)
    ("an autophagy-incompetent atg8" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ATG8 mRNA ( xref ) and protein" . SPARSER::COLLECTION)
    ("long-lived proteins" . SPARSER::PROTEIN)
    ("glucose and amino acids" . SPARSER::COLLECTION)
    ("fungi" . SPARSER::PROTEIN) ("Vad1/Dhh1" . SPARSER::COLLECTION)
    ("autophagy-related proteins ( xref , xref ) and mRNA ( xref )"
     . SPARSER::COLLECTION)
    ("temperature-sensitive mutant" . SPARSER::MUTANT)
    ("SNX4/ATG24" . SPARSER::COLLECTION)
    ("the GFP-Atg8 fusion protein ( xref ) as well as endogenous Atg8 ( xref )"
     . SPARSER::COLLECTION)
    ("GFP-Atg8" . SPARSER::COLLECTION) ("dhh1" . SPARSER::PROTEIN)
    ("potential regulators" . SPARSER::REGULATOR) ("THP-1" . SPARSER::PROTEIN)
    ("ion" . SPARSER::MOLECULE)
    ("the RCK yeast cryptococcal member Vad1" . SPARSER::PROTEIN)
    ("RBP" . SPARSER::PROTEIN) ("nitrogen" . SPARSER::MOLECULE)
    ("RBPs" . SPARSER::PROTEIN)
    ("Additional decapping accessory proteins" . SPARSER::PROTEIN)
    ("Dhh1" . SPARSER::PROTEIN) ("Atg" . SPARSER::DRUG)
    ("PIK3CD/p110δ" . SPARSER::COLLECTION) ("ATG" . SPARSER::DRUG)
    ("TOR" . SPARSER::PROTEIN) ("nutrient" . SPARSER::MOLECULE)
    ("RCK" . SPARSER::PROTEIN) ("helicase" . SPARSER::PROTEIN)
    ("N-2" . SPARSER::PROTEIN) ("a 37" . SPARSER::PROTEIN)
    ("BS3" . SPARSER::PROTEIN) ("actinomycin D" . SPARSER::MOLECULE)
    ("bafilomycin A 1" . SPARSER::DRUG) ("D-A" . SPARSER::PROTEIN)
    ("leukemia inhibitory factor" . SPARSER::PROTEIN)
    ("βGal" . SPARSER::PROTEIN) ("CCL-2" . SPARSER::PROTEIN)
    ("1,10-phenanthroline" . SPARSER::MOLECULE) ("32 P" . SPARSER::|32P|)
    ("A-R" . SPARSER::PROTEIN) ("EF1α" . SPARSER::PROTEIN)
    ("TEF1" . SPARSER::PROTEIN) ("TAF10" . SPARSER::PROTEIN)
    ("ALG9" . SPARSER::PROTEIN) ("a 20" . SPARSER::PROTEIN)
    ("Atg9" . SPARSER::PROTEIN-FAMILY) ("4E-BP1" . SPARSER::PROTEIN)
    ("EIF4EBP1" . SPARSER::PROTEIN) ("p70S6" . SPARSER::PROTEIN)
    ("RNA binding" . SPARSER::PROTEIN) ("Rim15" . SPARSER::PROTEIN)
    ("p100" . SPARSER::PROTEIN) ("delta subunit" . SPARSER::PROTEIN)
    ("IL18" . SPARSER::PROTEIN) ("caspase-1" . SPARSER::PROTEIN)
    ("CASP1" . SPARSER::PROTEIN) ("LC3-II" . SPARSER::PROTEIN)
    ("ATG9" . SPARSER::PROTEIN-FAMILY) ("ATG 3" . SPARSER::PROTEIN)
    ("c-myc" . SPARSER::PROTEIN) ("inhibitor 1" . SPARSER::PROTEIN)
    ("atg8" . SPARSER::HUMAN-PROTEIN-FAMILY) ("dcp2" . SPARSER::PROTEIN)
    ("ATG24" . SPARSER::PROTEIN) ("SNX4" . SPARSER::PROTEIN)
    ("ATG20" . SPARSER::PROTEIN) ("ATG7" . SPARSER::PROTEIN)
    ("ATG3" . SPARSER::PROTEIN) ("DHH1" . SPARSER::PROTEIN)
    ("alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("Pho8" . SPARSER::PROTEIN) ("IL1B" . SPARSER::PROTEIN)
    ("DCP2" . SPARSER::PROTEIN) ("ATG8" . SPARSER::PROTEIN)
    ("DDX6" . SPARSER::PROTEIN) ("Vad1" . SPARSER::PROTEIN)
    ("Xrn1" . SPARSER::PROTEIN) ("S. cerevisiae" . SPARSER::PROTEIN)
    ("p110δ" . SPARSER::PROTEIN) ("PIK3CD" . SPARSER::PROTEIN)
    ("Dcp2" . SPARSER::PROTEIN) ("decapping enzyme" . SPARSER::PROTEIN)
    ("more importantly new potential regulators" . SPARSER::REGULATOR)
    ("matrigel" . SPARSER::PROTEIN) ("bad" . SPARSER::PROTEIN)
    ("IGFBP2 and GATA3" . SPARSER::COLLECTION)
    ("potential biomarkers and drivers" . SPARSER::COLLECTION)
    ("RPPA and other high throughput protein datasets" . SPARSER::COLLECTION)
    ("potential biomarkers" . SPARSER::MOLECULE)
    ("both known and novel biomarkers" . SPARSER::MOLECULE)
    ("Jurkat" . SPARSER::PROTEIN) ("protein and GATA3" . SPARSER::COLLECTION)
    ("RNA and protein" . SPARSER::COLLECTION)
    ("cytokeratin (CK) and CD3" . SPARSER::COLLECTION)
    ("Antibodies" . SPARSER::ANTIBODY) ("TMAs" . SPARSER::MOLECULE)
    ("cytokeratin" . SPARSER::PROTEIN-FAMILY)
    ("GATA3 and IGFBP2" . SPARSER::COLLECTION) ("maps" . SPARSER::PROTEIN)
    ("Beclin1, and IGFBP2" . SPARSER::COLLECTION)
    ("Bid, Bim, Rb, and Chk1" . SPARSER::COLLECTION) ("Bim" . SPARSER::PROTEIN)
    ("Bid" . SPARSER::PROTEIN) ("SMAD3, SMAD4, and MSH2" . SPARSER::COLLECTION)
    ("Proteins" . SPARSER::PROTEIN) ("traits" . SPARSER::PROTEIN)
    ("II, stages I-III," . SPARSER::PROTEIN)
    ("II, stages I-III, or stages I-IV (\"all stages\")" . SPARSER::COLLECTION)
    ("gene or protein" . SPARSER::COLLECTION)
    ("protein and phospho-protein" . SPARSER::COLLECTION)
    ("TMA" . SPARSER::MOLECULE) ("RPPA" . SPARSER::PROTEIN)
    ("Cytokeratin" . SPARSER::PROTEIN-FAMILY) ("CK" . SPARSER::PROTEIN)
    ("TH2" . SPARSER::PROTEIN) ("CD3" . SPARSER::PROTEIN)
    ("Beclin1" . SPARSER::PROTEIN) ("COX2" . SPARSER::PROTEIN)
    ("Transforming growth factor" . SPARSER::PROTEIN)
    ("MSH2" . SPARSER::PROTEIN) ("SMAD4" . SPARSER::PROTEIN)
    ("SMAD3" . SPARSER::PROTEIN) ("H 2 O 2" . SPARSER::DRUG)
    ("phospho-protein" . SPARSER::PROTEIN)
    ("Transforming Growth Factor" . SPARSER::PROTEIN)
    ("TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Insulin-like Growth Factor Binding Protein 2" . SPARSER::PROTEIN)
    ("GATA3" . SPARSER::PROTEIN) ("GATA binding protein 3" . SPARSER::PROTEIN)
    ("IGFBP2" . SPARSER::PROTEIN)
    ("the antiproliferative ITGA6B splice variant" . SPARSER::VARIANT)
    ("MYC and integrins" . SPARSER::COLLECTION)
    ("Src and p130Cas" . SPARSER::COLLECTION)
    ("ITGA6 and ITGB4" . SPARSER::COLLECTION) ("FAK" . SPARSER::PROTEIN)
    ("integrins" . SPARSER::PROTEIN) ("BRCA1 or ITGA1" . SPARSER::COLLECTION)
    ("MYC/MAX" . SPARSER::COLLECTION) ("MAD/MAX" . SPARSER::COLLECTION)
    ("DNA or RNA" . SPARSER::COLLECTION)
    ("ITGA1 and CCND1" . SPARSER::COLLECTION)
    ("N-Myc (MYCN)" . SPARSER::PROTEIN) ("MYCN" . SPARSER::PROTEIN)
    ("GATA6, Nkx3.2 and serum response factor" . SPARSER::COLLECTION)
    ("ITGA1 and MYC" . SPARSER::COLLECTION)
    ("anti-c-Myc or anti-RNA-Pol-II" . SPARSER::COLLECTION)
    ("anti-RNA-polymerase II (Pol-II) antibodies" . SPARSER::ANTIBODY)
    ("IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("its proximal promoter" . SPARSER::PROMOTER) ("CpGs" . SPARSER::PROTEIN)
    ("bisulfite" . SPARSER::MOLECULE) ("-deoxycytidine" . SPARSER::COLLECTION)
    ("deoxycytidine" . SPARSER::PROTEIN) ("aza" . SPARSER::DRUG)
    ("DLD" . SPARSER::PROTEIN) ("the proximal promoter" . SPARSER::PROMOTER)
    ("CArG" . SPARSER::PROTEIN) ("Integrin" . SPARSER::PROTEIN)
    ("Integrins" . SPARSER::PROTEIN)
    ("the ITGA1 proximal promoter" . SPARSER::PROMOTER)
    ("MAD" . SPARSER::PROTEIN) ("Chromatin" . SPARSER::PROTEIN)
    ("MYC and ITGA1" . SPARSER::COLLECTION) ("Ras/ERK" . SPARSER::COLLECTION)
    ("CD49a" . SPARSER::PROTEIN) ("ITGA6" . SPARSER::PROTEIN)
    ("ITGA6B" . SPARSER::PROTEIN) ("ITGB4" . SPARSER::PROTEIN)
    ("N-Myc" . SPARSER::PROTEIN) ("Nkx3.2" . SPARSER::PROTEIN)
    ("GATA6" . SPARSER::PROTEIN) ("CCND1" . SPARSER::PROTEIN)
    ("Pol-II" . SPARSER::PROTEIN) ("RNA-polymerase" . SPARSER::PROTEIN)
    ("ITGB1" . SPARSER::PROTEIN) ("IGFBP7" . SPARSER::PROTEIN)
    ("serum response factor" . SPARSER::PROTEIN) ("p130Cas" . SPARSER::PROTEIN)
    ("ITGA2" . SPARSER::PROTEIN) ("p38" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("extracellular signal-regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("caveolin-1" . SPARSER::PROTEIN) ("ITGA1" . SPARSER::PROTEIN)
    ("collagen receptor" . SPARSER::PROTEIN) ("α1β1" . SPARSER::PROTEIN)
    ("HRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("erlotinib or gefitinib" . SPARSER::COLLECTION)
    ("Erlotinib" . SPARSER::DRUG) ("carboplatin" . SPARSER::DRUG)
    ("erlotinib and gefitinib" . SPARSER::COLLECTION)
    ("arm" . SPARSER::PROTEIN) ("serious AEs" . SPARSER::PROTEIN)
    ("the afatinib group and 19 (67.9%)" . SPARSER::COLLECTION)
    ("Drug" . SPARSER::DRUG) ("afatinib and 89.7%" . SPARSER::COLLECTION)
    ("AEs" . SPARSER::PROTEIN) ("ErbB3, and ErbB4" . SPARSER::COLLECTION)
    ("TKIs, erlotinib and gefitinib" . SPARSER::COLLECTION)
    ("ErbB4" . SPARSER::PROTEIN) ("dimers" . SPARSER::DIMER)
    ("erlotinib" . SPARSER::DRUG) ("Afatinib" . SPARSER::DRUG)
    ("nail" . SPARSER::PROTEIN) ("pemetrexed" . SPARSER::DRUG)
    ("afatinib" . SPARSER::DRUG) ("type I" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ErbB3" . SPARSER::PROTEIN) ("ErbB1" . SPARSER::PROTEIN)
    ("Epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("βTRCP or another CRL [ xref ]" . SPARSER::COLLECTION)
    ("ATF4 [ xref ] and the Cul3-associated ligase SPOP" . SPARSER::COLLECTION)
    ("the Cul3-associated ligase SPOP" . SPARSER::PROTEIN)
    ("SPOP" . SPARSER::PROTEIN) ("ATF4 or CHOP" . SPARSER::COLLECTION)
    ("CRLs" . SPARSER::PROTEIN) ("Cln3 and Gal4" . SPARSER::COLLECTION)
    ("Gal4" . SPARSER::PROTEIN) ("Cln3" . SPARSER::PROTEIN)
    ("PIP" . SPARSER::PROTEIN) ("Gal" . SPARSER::PROTEIN)
    ("previously characterized substrates" . SPARSER::SUBSTRATE)
    ("newly-identified SCF substrates" . SPARSER::SUBSTRATE)
    ("REST" . SPARSER::PROTEIN)
    ("ligases, UBE4B and TRIM9" . SPARSER::COLLECTION)
    ("ZNF395, HIVEP1/2, ZNF704, and AEBP2" . SPARSER::COLLECTION)
    ("Nrf2 and ATF4" . SPARSER::COLLECTION) ("Sun2" . SPARSER::PROTEIN)
    ("complement" . SPARSER::PROTEIN)
    ("the well-studied ubiquitin ligase βTRCP" . SPARSER::PROTEIN)
    ("polypeptides" . SPARSER::PROTEIN) ("puromycin" . SPARSER::DRUG)
    ("GADD34 and CReP" . SPARSER::COLLECTION) ("CHOP" . SPARSER::PROTEIN)
    ("many negatively-charged amino acids" . SPARSER::AMINO-ACID)
    ("mapping" . SPARSER::PROTEIN) ("acceptors" . SPARSER::MOLECULE)
    ("acceptor" . SPARSER::MOLECULE) ("Cullin" . SPARSER::PROTEIN-FAMILY)
    ("alanine" . SPARSER::AMINO-ACID)
    ("either ultraviolet light (UV) or the topoisomerase inhibitor camptothecin (CPT)"
     . SPARSER::COLLECTION)
    ("camptothecin (CPT)" . SPARSER::DRUG)
    ("either ultraviolet light (UV)" . SPARSER::PROTEIN)
    ("CPT" . SPARSER::PROTEIN) ("topoisomerase" . SPARSER::PROTEIN)
    ("The proteostatic stress inducer thapsigargin" . SPARSER::MOLECULE)
    ("thapsigargin" . SPARSER::MOLECULE)
    ("many well-documented βTRCP substrates" . SPARSER::SUBSTRATE)
    ("CDC25A and CDC25B" . SPARSER::COLLECTION) ("DDG" . SPARSER::PROTEIN)
    ("DSG" . SPARSER::DRUG) ("pS" . SPARSER::PROTEIN)
    ("HIVEP2, UBE4B, and TRIM9" . SPARSER::COLLECTION)
    ("HIVEP2 and TRIM9" . SPARSER::COLLECTION)
    ("RASSF3 and AEBP2" . SPARSER::COLLECTION) ("RING" . SPARSER::PROTEIN)
    ("the relevant ligase" . SPARSER::LIGASE) ("paralogs" . SPARSER::PROTEIN)
    ("MED13 and MED13L" . SPARSER::COLLECTION)
    ("ß-catenin" . SPARSER::COLLECTION)
    ("catenin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Fbw7-3xFlag-RAD23" . SPARSER::COLLECTION)
    ("polyubiquitinated" . SPARSER::PROTEIN)
    ("the relevant Ligase Trap" . SPARSER::PROTEIN)
    ("proteins, FBXO24 and Fbw7" . SPARSER::COLLECTION)
    ("Fbw7" . SPARSER::PROTEIN) ("Trap" . SPARSER::PROTEIN)
    ("Ub" . SPARSER::PROTEIN)
    ("the βTRCP substrates, CReP," . SPARSER::SUBSTRATE)
    ("/CDC25" . SPARSER::COLLECTION) ("claspin" . SPARSER::PROTEIN)
    ("suppressors and oncogenes" . SPARSER::COLLECTION)
    ("suppressors" . SPARSER::SUPPRESSOR)
    ("the cullin CUL1 and the adaptor SKP1 [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("the RING finger protein RBX1, the cullin CUL1 and the adaptor SKP1 [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("ligase (CRL)" . SPARSER::LIGASE) ("cullin-RING" . SPARSER::COLLECTION)
    ("CRL" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cullin" . SPARSER::PROTEIN-FAMILY)
    ("other associated proteins" . SPARSER::PROTEIN)
    ("the E3 ligase and its ubiquitinated substrates" . SPARSER::COLLECTION)
    ("UBA" . SPARSER::PROTEIN) ("interactors" . SPARSER::PROTEIN)
    ("associated proteins" . SPARSER::PROTEIN)
    ("a particular ubiquitin ligase" . SPARSER::PROTEIN)
    ("Approximately 600 human genes" . SPARSER::GENE)
    ("ligases" . SPARSER::LIGASE) ("eIF2α" . SPARSER::PROTEIN)
    ("eIF" . SPARSER::PROTEIN)
    ("eleven new substrates and three false positives" . SPARSER::COLLECTION)
    ("twelve previously validated substrates" . SPARSER::SUBSTRATE)
    ("trap" . SPARSER::PROTEIN) ("fused" . SPARSER::PROTEIN)
    ("Ligase" . SPARSER::LIGASE) ("complex (SCF)" . SPARSER::BIO-COMPLEX)
    ("SCF" . SPARSER::PROTEIN) ("IP2" . SPARSER::PROTEIN)
    ("MgCl2" . SPARSER::MOLECULE) ("Chk1" . SPARSER::PROTEIN)
    ("PPP1" . SPARSER::PROTEIN-FAMILY) ("P4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("B12" . SPARSER::PROTEIN) ("α-HA" . SPARSER::MOLECULE)
    ("m 2" . SPARSER::MOLECULE) ("ALDH2" . SPARSER::PROTEIN)
    ("Fbxo6" . SPARSER::PROTEIN) ("FBXW11" . SPARSER::PROTEIN)
    ("RPS27A" . SPARSER::PROTEIN) ("T antigen" . SPARSER::MOLECULE)
    ("Gadd34" . SPARSER::PROTEIN) ("Cul3" . SPARSER::PROTEIN)
    ("eIF2alpha" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Gcn2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tumor suppressor protein" . SPARSER::PROTEIN)
    ("HIVEP1" . SPARSER::PROTEIN) ("transmembrane protein" . SPARSER::PROTEIN)
    ("FBW7" . SPARSER::PROTEIN) ("Ubiquitin Ligase" . SPARSER::PROTEIN)
    ("GADD34" . SPARSER::PROTEIN) ("CDC25B" . SPARSER::PROTEIN)
    ("CDC25A" . SPARSER::PROTEIN) ("1–4" . SPARSER::PROTEIN)
    ("TRIM9" . SPARSER::PROTEIN) ("HIVEP2" . SPARSER::PROTEIN)
    ("AEBP2" . SPARSER::PROTEIN) ("ZNF704" . SPARSER::PROTEIN)
    ("ZNF395" . SPARSER::PROTEIN) ("MLN4924" . SPARSER::DRUG)
    ("UBE4B" . SPARSER::PROTEIN) ("RASSF3" . SPARSER::PROTEIN)
    ("MED13L" . SPARSER::PROTEIN) ("SUN2" . SPARSER::PROTEIN)
    ("MED13" . SPARSER::PROTEIN) ("RAD23" . SPARSER::PROTEIN)
    ("ATF4" . SPARSER::PROTEIN) ("RAD23B" . SPARSER::PROTEIN)
    ("Rad23" . SPARSER::PROTEIN-FAMILY) ("Dsk2" . SPARSER::PROTEIN)
    ("factor 2" . SPARSER::PROTEIN)
    ("protein phosphatase 1" . SPARSER::PROTEIN) ("CDC25" . SPARSER::PROTEIN)
    ("WEE1" . SPARSER::PROTEIN) ("G2/M" . SPARSER::PROTEIN)
    ("SKP1" . SPARSER::PROTEIN) ("CUL1" . SPARSER::PROTEIN)
    ("RBX1" . SPARSER::PROTEIN) ("RING finger protein" . SPARSER::PROTEIN)
    ("long chain" . SPARSER::PROTEIN) ("PP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Protein Phosphatase 1" . SPARSER::PROTEIN) ("βTRCP" . SPARSER::PROTEIN)
    ("Cul1" . SPARSER::PROTEIN) ("Skp1" . SPARSER::PROTEIN)
    ("BRAF or co-existent" . SPARSER::COLLECTION) ("NCT" . SPARSER::PROTEIN)
    ("KRAS, NRAS or BRAF" . SPARSER::COLLECTION)
    ("NRAS/KRAS" . SPARSER::COLLECTION)
    ("vemurafenib-treated BRAF" . SPARSER::PROTEIN)
    ("TP53 , or IL -6" . SPARSER::COLLECTION)
    ("BRAF and RAS" . SPARSER::COLLECTION) ("GEP" . SPARSER::PROTEIN)
    ("KRAS or NRAS" . SPARSER::COLLECTION)
    ("the most common variant in melanoma and a hallmark"
     . SPARSER::COLLECTION)
    ("NRAS, KRAS and BRAF" . SPARSER::COLLECTION) ("HRAS" . SPARSER::PROTEIN)
    ("salirasib" . SPARSER::DRUG) ("CDKN1A and TP53" . SPARSER::COLLECTION)
    ("classes" . CLASS)
    ("PRKD2, SPRED2, MAPKAPK2, CD300A, ARL6IP5, DUSP6, PPM1L, GRB2, LAMTOR3, SPRED1, LYN, EDN1, RASGRP1 and ACVR1B"
     . SPARSER::COLLECTION)
    ("CD300A" . SPARSER::PROTEIN) ("LYN" . SPARSER::PROTEIN)
    ("IGH" . SPARSER::PROTEIN) ("BRAF, NRAS or KRAS" . SPARSER::COLLECTION)
    ("NRAS or KRAS" . SPARSER::COLLECTION)
    ("BRAF and NRAS" . SPARSER::COLLECTION)
    ("BRAF and KRAS" . SPARSER::COLLECTION)
    ("a smaller fraction" . SPARSER::COMPONENT)
    ("MEK/ERK" . SPARSER::COLLECTION) ("MAFB" . SPARSER::PROTEIN)
    ("Gln" . SPARSER::AMINO-ACID)
    ("NRAS (exons 2 and 3) and KRAS (exons 2, 3 and 4)" . SPARSER::COLLECTION)
    ("GTPases" . SPARSER::GTPASE) ("heterodimers" . SPARSER::HETERODIMER)
    ("MEK-ERK" . SPARSER::COLLECTION) ("glycine" . SPARSER::AMINO-ACID)
    ("Variant" . SPARSER::VARIANT) ("hot" . SPARSER::PROTEIN)
    ("NRAS and KRAS" . SPARSER::COLLECTION) ("primary PCL" . SPARSER::PROTEIN)
    ("PCL" . SPARSER::PROTEIN) ("PCs" . SPARSER::PROTEIN)
    ("BRAF, NRAS and KRAS" . SPARSER::COLLECTION) ("NRAS" . SPARSER::PROTEIN)
    ("3d" . SPARSER::PROTEIN-FAMILY) ("Gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("2-4" . SPARSER::PROTEIN) ("MM-1" . SPARSER::PROTEIN)
    ("light chain" . SPARSER::PROTEIN) ("G protein" . SPARSER::PROTEIN)
    ("proliferation-associated" . SPARSER::PROTEIN)
    ("IL -6" . SPARSER::PROTEIN) ("K-RAS" . SPARSER::PROTEIN)
    ("CDKN1A" . SPARSER::PROTEIN) ("ACVR1B" . SPARSER::PROTEIN)
    ("RASGRP1" . SPARSER::PROTEIN) ("EDN1" . SPARSER::PROTEIN)
    ("SPRED1" . SPARSER::PROTEIN) ("LAMTOR3" . SPARSER::PROTEIN)
    ("GRB2" . SPARSER::PROTEIN) ("PPM1L" . SPARSER::PROTEIN)
    ("DUSP6" . SPARSER::PROTEIN) ("ARL6IP5" . SPARSER::PROTEIN)
    ("MAPKAPK2" . SPARSER::PROTEIN) ("SPRED2" . SPARSER::PROTEIN)
    ("PRKD2" . SPARSER::PROTEIN) ("chromosome 17" . SPARSER::PROTEIN)
    ("E2F-1, FOXO1 and FOS" . SPARSER::COLLECTION) ("Active" . SPARSER::ACTIVE)
    ("c-MYC, c-FOS, and JUN" . SPARSER::COLLECTION)
    ("FOS, JUN, c-MYC and SLC30A2" . SPARSER::COLLECTION)
    ("BIRC5, CYCS, APAF1, CASP9, HSPA1A and MLKL" . SPARSER::COLLECTION)
    ("dinucleotide" . SPARSER::MOLECULE) ("adenine" . SPARSER::NUCLEOBASE)
    ("amide" . SPARSER::MOLECULE) ("nicotine" . SPARSER::DRUG)
    ("poly-ADP polymers as well as the translocation of AIF"
     . SPARSER::COLLECTION)
    ("LDH" . SPARSER::PROTEIN) ("a unique form" . SPARSER::FORM)
    ("polymers" . SPARSER::MOLECULE) ("γH2AX and PARP-1" . SPARSER::COLLECTION)
    ("interleukin enhancer-binding factor-3 (ILF3-p54/nrb complex) and SP1 [ xref , xref , xref , xref ]"
     . SPARSER::COLLECTION)
    ("ILF3-p54" . SPARSER::PROTEIN-PAIR) ("interleukin" . SPARSER::PROTEIN)
    ("SP1" . SPARSER::PROTEIN)
    ("survivin, Ki67 and PARP" . SPARSER::COLLECTION)
    ("apoptotic or necrotic genes" . SPARSER::GENE)
    ("active PARP-regulated genes" . SPARSER::GENE)
    ("FOS, JUN, and c-MYC" . SPARSER::COLLECTION)
    ("MLKL, BIRC5, CYCS, APAF1, CASP9 and HSPA1A" . SPARSER::COLLECTION)
    ("FOS, JUN, c-MYC, SLC30A2, CCNE, and NOXA" . SPARSER::COLLECTION)
    ("FOS, JUN, c-MYC, CCNE, CCND, NOXA, MLKL, BIRC5, CYCS, APAF1, CASP9, SLC30A2 and HSPA1A"
     . SPARSER::COLLECTION)
    ("CYCS" . SPARSER::PROTEIN) ("MLKL" . SPARSER::PROTEIN)
    ("NOXA" . SPARSER::PROTEIN) ("certain vital core genes" . SPARSER::GENE)
    ("FOS, JUN, c-MYC, and CCNE" . SPARSER::COLLECTION)
    ("STRING" . SPARSER::GENE) ("siRNAs" . SPARSER::PROTEIN)
    ("PARP1 and AIF" . SPARSER::COLLECTION) ("PARP1-AIF" . SPARSER::COLLECTION)
    ("PARP and AIF" . SPARSER::COLLECTION)
    ("PARP and actin" . SPARSER::COLLECTION) ("EBP" . SPARSER::PROTEIN)
    ("mTOR pathway-associated proteins" . SPARSER::PROTEIN)
    ("mTOR" . SPARSER::PROTEIN) ("Beclin" . SPARSER::PROTEIN)
    ("displayed swollen mitochondria" . SPARSER::PROTEIN)
    ("survivin and XIAP" . SPARSER::COLLECTION) ("XIAP" . SPARSER::PROTEIN)
    ("caspase-9 and caspase-3" . SPARSER::COLLECTION)
    ("caspases" . SPARSER::PROTEIN) ("PI and annexin V" . SPARSER::COLLECTION)
    ("iodide (PI)" . SPARSER::PROTEIN) ("MEF" . SPARSER::PROTEIN)
    ("SLC35F2 and survivin and KYSKE30" . SPARSER::COLLECTION)
    ("survivin and KYSKE30" . SPARSER::COLLECTION)
    ("SLC35F2 and survivin" . SPARSER::COLLECTION)
    ("transporter" . SPARSER::PROTEIN) ("PARP-1 and AIF" . SPARSER::COLLECTION)
    ("survivin and SLC35F2" . SPARSER::COLLECTION)
    ("fluorouracil" . SPARSER::DRUG) ("CDDP" . SPARSER::DRUG)
    ("Cisplatin" . SPARSER::DRUG) ("OCT1/SLC22A1" . SPARSER::COLLECTION)
    ("hepatocytes" . SPARSER::PROTEIN) ("intercalator" . SPARSER::MOLECULE)
    ("haploid" . SPARSER::PROTEIN) ("FOS, JUN and c-MYC" . SPARSER::COLLECTION)
    ("PARP-1 or AIF" . SPARSER::COLLECTION) ("poly-ADP" . SPARSER::PROTEIN)
    ("polymer" . SPARSER::MOLECULE) ("survivin" . SPARSER::PROTEIN)
    ("Reverse Transcriptase" . SPARSER::PROTEIN) ("MAS5" . SPARSER::PROTEIN)
    ("Apoptosis-inducing" . SPARSER::PROTEIN) ("4EBP1" . SPARSER::PROTEIN)
    ("Phospho-ERK" . SPARSER::PROTEIN) ("DCF-DA" . SPARSER::DRUG)
    ("FOXO1" . SPARSER::PROTEIN) ("E2F-1" . SPARSER::PROTEIN)
    ("c-FOS" . SPARSER::PROTEIN) ("NAD+" . SPARSER::MOLECULE)
    ("p54" . SPARSER::PROTEIN) ("ILF3" . SPARSER::PROTEIN)
    ("factor-3" . SPARSER::PROTEIN) ("Ki67" . SPARSER::PROTEIN)
    ("HSPA1A" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SLC30A2" . SPARSER::PROTEIN)
    ("CASP9" . SPARSER::PROTEIN) ("APAF1" . SPARSER::PROTEIN)
    ("BIRC5" . SPARSER::PROTEIN) ("SAM 3" . SPARSER::PROTEIN)
    ("CCK-8" . SPARSER::PROTEIN) ("anti-PAR" . SPARSER::DRUG)
    ("γH2AX" . SPARSER::PROTEIN) ("BNIP3" . SPARSER::PROTEIN)
    ("caspase-9" . SPARSER::PROTEIN) ("SLC39A6" . SPARSER::PROTEIN)
    ("SLC22A1" . SPARSER::PROTEIN) ("OCT1" . SPARSER::PROTEIN)
    ("organic cation transporter 1" . SPARSER::PROTEIN)
    ("SLC35F2" . SPARSER::PROTEIN) ("NF110" . SPARSER::DRUG)
    ("interleukin enhancer-binding factor 3" . SPARSER::PROTEIN)
    ("PARP-1" . SPARSER::PROTEIN) ("YM155" . SPARSER::DRUG)
    ("MDM2 and p53" . SPARSER::COLLECTION) ("neutrophils" . SPARSER::PROTEIN)
    ("p53 and anti-p53" . SPARSER::COLLECTION)
    ("recombinant anti-MDM2 protein" . SPARSER::ANTIBODY)
    ("sera (NHS)" . SPARSER::PROTEIN) ("NHS" . SPARSER::PROTEIN)
    ("MRL-Fas" . SPARSER::COLLECTION) ("Fas" . SPARSER::PROTEIN)
    ("MRL" . SPARSER::PROTEIN-FAMILY)
    ("p53 and retinoblastoma (Rb) protein" . SPARSER::COLLECTION)
    ("More new autoantibodies" . SPARSER::PROTEIN)
    ("autoantibody or its antigens" . SPARSER::COLLECTION)
    ("antigens" . SPARSER::PROTEIN) ("Autoantibodies" . SPARSER::PROTEIN)
    ("autoantibodies" . SPARSER::PROTEIN)
    ("anti-MDM2 and anti-p53" . SPARSER::COLLECTION)
    ("sera" . SPARSER::PROTEIN) ("autoantibody" . SPARSER::PROTEIN)
    ("Systemic lupus erythematosus" . SPARSER::PROTEIN)
    ("NF- κ B" . SPARSER::PROTEIN) ("Hdm2" . SPARSER::PROTEIN)
    ("MDM2 protein" . SPARSER::PROTEIN)
    ("ubiquitin-protein ligase" . SPARSER::PROTEIN)
    ("double minute 2" . SPARSER::PROTEIN) ("Family" . SPARSER::PROTEIN-FAMILY)
    ("Wiscott" . SPARSER::PROTEIN) ("visceral fat" . SPARSER::PROTEIN)
    ("subcutaneous fat" . SPARSER::PROTEIN)
    ("IRS1 and the gene" . SPARSER::COLLECTION)
    ("NYAP" . SPARSER::PROTEIN-FAMILY) ("SH-SY5Y" . SPARSER::PROTEIN)
    ("the respective fusion proteins" . SPARSER::PROTEIN)
    ("eGFP" . SPARSER::PROTEIN) ("myoblasts" . SPARSER::PROTEIN)
    ("a shorter protein" . SPARSER::PROTEIN) ("Da" . SPARSER::MOLECULE)
    ("Homologues" . SPARSER::PROTEIN) ("Alu" . SPARSER::PROTEIN)
    ("SD" . SPARSER::PROTEIN)
    ("skeletal muscles" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MyoD, Myf3, PEA3, HOXD8, and SBF1" . SPARSER::COLLECTION)
    ("MyoD" . SPARSER::PROTEIN)
    ("a long intergenic noncoding RNA" . SPARSER::RNA)
    ("lincRNA" . SPARSER::RNA) ("BF" . SPARSER::MOLECULE)
    ("IR and type 2" . SPARSER::COLLECTION) ("SAT" . SPARSER::PROTEIN)
    ("IR, and CRP" . SPARSER::COLLECTION) ("CRP" . SPARSER::PROTEIN)
    ("fat" . SPARSER::PROTEIN) ("TG" . SPARSER::PROTEIN)
    ("triglycerides" . SPARSER::MOLECULE) ("HDL" . SPARSER::PROTEIN)
    ("skeletal muscle" . SPARSER::PROTEIN) ("HOMA-IR" . SPARSER::COLLECTION)
    ("media" . SPARSER::PROTEIN) ("IR" . SPARSER::PROTEIN)
    ("a cross-sectional cohort" . SPARSER::MOLECULE)
    ("TBC1D3" . SPARSER::PROTEIN) ("member 1" . SPARSER::PROTEIN)
    ("NYAP2" . SPARSER::PROTEIN) ("PI(3)K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("KIAA1486" . SPARSER::PROTEIN)
    ("phosphoinositide-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("enhanced green fluorescent protein" . SPARSER::PROTEIN)
    ("amino acids" . SPARSER::AMINO-ACID) ("SBF1" . SPARSER::PROTEIN)
    ("HOXD8" . SPARSER::PROTEIN) ("PEA3" . SPARSER::PROTEIN)
    ("Myf3" . SPARSER::PROTEIN) ("H3K27Ac" . SPARSER::MOLECULE)
    ("MitoTracker Red" . SPARSER::MOLECULE)
    ("polyvinylidene fluoride" . SPARSER::DRUG) ("RPLP0" . SPARSER::PROTEIN)
    ("N1" . SPARSER::PROTEIN) ("pT7" . SPARSER::PROTEIN)
    ("ex1" . SPARSER::PROTEIN) ("DNase I" . SPARSER::PROTEIN)
    ("F12" . SPARSER::PROTEIN) ("CD56" . SPARSER::PROTEIN)
    ("Type 2" . SPARSER::PROTEIN) ("C-reactive protein" . SPARSER::PROTEIN)
    ("type 2" . SPARSER::PROTEIN) ("IRS1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("uvomorulin" . SPARSER::PROTEIN)
    ("the potential inhibitor" . SPARSER::INHIBITOR)
    ("PLK1 and PLK1" . SPARSER::COLLECTION) ("HAPE" . SPARSER::PROTEIN)
    ("cytometry (FCM)" . SPARSER::PROTEIN)
    ("Annexin V and Propidium" . SPARSER::COLLECTION)
    ("FCM" . SPARSER::MOLECULE) ("Propidium" . SPARSER::MOLECULE)
    ("PLK" . SPARSER::PROTEIN) ("a potential regulator" . SPARSER::REGULATOR)
    ("PLKs" . SPARSER::PROTEIN) ("homologues" . SPARSER::PROTEIN)
    ("homologue" . SPARSER::PROTEIN) ("Saccharomyces" . SPARSER::PROTEIN)
    ("serine/threonine-protein kinase PLK1, or serine/threonine-protein kinase 13"
     . SPARSER::COLLECTION)
    ("the potential regulator" . SPARSER::REGULATOR)
    ("the potential complementary microRNA" . SPARSER::RNA)
    ("Annexin V" . SPARSER::PROTEIN) ("RNase A" . SPARSER::PROTEIN)
    ("PLK 1" . SPARSER::PROTEIN) ("CDC5" . SPARSER::PROTEIN)
    ("STPK13" . SPARSER::PROTEIN)
    ("serine/threonine-protein kinase 13" . SPARSER::PROTEIN)
    ("serine/threonine-protein kinase PLK1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PLK1" . SPARSER::PROTEIN) ("Polo-like kinase" . SPARSER::PROTEIN)
    ("Wnt-4 and Wnt-5α" . SPARSER::COLLECTION)
    ("Wnt/β-catenin" . SPARSER::COLLECTION) ("TCF/LEF" . SPARSER::COLLECTION)
    ("LEF" . SPARSER::PROTEIN) ("TCF" . SPARSER::PROTEIN)
    ("Suh" . SPARSER::PROTEIN) ("cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("psychological state" . SPARSER::BIO-STATE)
    ("TNF-ɑ, IL- 1β and IL-6" . SPARSER::COLLECTION)
    ("TNF-ɑ" . SPARSER::PROTEIN-PAIR)
    ("GSK-3β, CyclinD1, Ser9-GSK-3β and β-catenin" . SPARSER::COLLECTION)
    ("Wnt4 and Wnt5" . SPARSER::COLLECTION)
    ("GSK-3βand β-catenin" . SPARSER::COLLECTION) ("nt4" . SPARSER::PROTEIN)
    ("Mut-" . SPARSER::PROTEIN) ("Wt-" . SPARSER::PROTEIN)
    ("Mut" . SPARSER::PROTEIN) ("Wt" . SPARSER::PROTEIN)
    ("Target" . SPARSER::TARGET-PROTEIN) ("group and NC" . SPARSER::COLLECTION)
    ("TAK1 and TAB3" . SPARSER::COLLECTION) ("monocytes" . SPARSER::PROTEIN)
    ("miR-301a" . SPARSER::COLLECTION) ("MiRNAs" . SPARSER::PROTEIN)
    ("nucleotides" . SPARSER::NUCLEOTIDE) ("MicroRNAs" . SPARSER::RNA)
    ("inflammatory cytokines" . SPARSER::PROTEIN) ("SF" . SPARSER::PROTEIN)
    ("human leukocyte antigen-DR4 ( HLA-DR4 ) and other non-HLA genes"
     . SPARSER::COLLECTION)
    ("protein tyrosine phosphatase, non-receptor type 22 ( PTPN22 ) and peptidyl arginine deiminase"
     . SPARSER::COLLECTION)
    ("antigen-DR4" . SPARSER::PROTEIN-PAIR) ("HLA" . SPARSER::PROTEIN)
    ("-1 " . SPARSER::PROTEIN) ("β-catenin and CyclinD1" . SPARSER::COLLECTION)
    ("TNF-α,IL-1β and IL-6" . SPARSER::COLLECTION)
    ("Wnt/GSK-3β/β-catenin" . SPARSER::COLLECTION)
    ("Wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TNF-α, IL- 1β and IL-6" . SPARSER::COLLECTION)
    ("Ser9-GSK-3β and β-catenin" . SPARSER::COLLECTION)
    ("Mock group and negative control (NC) group" . SPARSER::COLLECTION)
    ("GSK-3β and CyclinD1" . SPARSER::COLLECTION) ("NC" . SPARSER::PROTEIN)
    ("diphenyl" . SPARSER::DRUG) ("IL- 1β, and IL-6" . SPARSER::COLLECTION)
    ("Enzyme" . SPARSER::ENZYME)
    ("Wnt4, Wnt5ɑ, GSK-3β, CyclinD1, Ser9-GSK-3β and β-catenin"
     . SPARSER::COLLECTION)
    ("microRNA" . SPARSER::RNA) ("RA" . SPARSER::PROTEIN)
    ("Wnt-5" . SPARSER::PROTEIN) ("Wnt-4" . SPARSER::PROTEIN)
    ("GSK-3 β" . SPARSER::PROTEIN) ("β–catenin" . SPARSER::PROTEIN)
    ("transcriptional regulators" . SPARSER::PROTEIN-FAMILY)
    ("single-stranded RNAs" . SPARSER::RNA)
    ("dual-luciferase" . SPARSER::PROTEIN)
    ("green fluorescent protein" . SPARSER::PROTEIN)
    ("Dual-luciferase" . SPARSER::PROTEIN) ("TAB3" . SPARSER::PROTEIN)
    ("TAK1" . SPARSER::PROTEIN) ("301a" . SPARSER::PROTEIN)
    ("interleukin-1β" . SPARSER::PROTEIN) ("PADI4" . SPARSER::PROTEIN)
    ("peptidyl arginine deiminase" . SPARSER::PROTEIN)
    ("PTPN22" . SPARSER::PROTEIN)
    ("protein tyrosine phosphatase, non-receptor type 22" . SPARSER::PROTEIN)
    ("HLA-DR" . SPARSER::PROTEIN) ("DR4" . SPARSER::PROTEIN)
    ("IL-1β" . SPARSER::PROTEIN) ("TNF-α" . SPARSER::PROTEIN)
    ("IL- 1β" . SPARSER::PROTEIN) ("Tumor Necrosis Factor" . SPARSER::PROTEIN)
    ("β-catenin" . SPARSER::PROTEIN) ("CyclinD1" . SPARSER::PROTEIN)
    ("GSK-3β" . SPARSER::PROTEIN) ("Wnt4" . SPARSER::PROTEIN)
    ("thioredoxin-2, or thioredoxin reductase" . SPARSER::COLLECTION)
    ("formaldehyde" . SPARSER::MOLECULE) ("van" . SPARSER::PROTEIN)
    ("KLF" . SPARSER::PROTEIN) ("sparse astrocytes" . SPARSER::PROTEIN)
    ("PML" . SPARSER::PROTEIN) ("the respective genes" . SPARSER::GENE)
    ("Only few Nrf2-responsive genes" . SPARSER::GENE)
    ("other neuronal proteins" . SPARSER::PROTEIN)
    ("Dystrophic" . SPARSER::PROTEIN) ("glial" . SPARSER::PROTEIN)
    ("macrophages or astrocytes" . SPARSER::COLLECTION)
    ("Nrf2 and HO-1" . SPARSER::COLLECTION)
    ("HO-1 and Nrf2" . SPARSER::COLLECTION)
    ("ferrous iron and biliverdin" . SPARSER::COLLECTION)
    ("ferrous iron" . SPARSER::MOLECULE) ("bilirubin" . SPARSER::MOLECULE)
    ("heme" . SPARSER::PROTEIN)
    ("the genes, which was up-regulated" . SPARSER::GENE)
    ("oxygenase" . SPARSER::PROTEIN) ("Heme" . SPARSER::PROTEIN)
    ("Nrf2 and AIF" . SPARSER::COLLECTION) ("AIF" . SPARSER::PROTEIN)
    ("GFAP (astrocytes; Fig.  xref l) or CD68 [macrophages/microglia (Fig.  xref m)]"
     . SPARSER::COLLECTION)
    ("macrophages/microglia" . SPARSER::COLLECTION) ("GFAP" . SPARSER::PROTEIN)
    ("CAII" . SPARSER::PROTEIN) ("MRI" . SPARSER::PROTEIN)
    ("iron" . SPARSER::MOLECULE) ("redox" . SPARSER::PROTEIN)
    ("myeloperoxidase" . SPARSER::PROTEIN) ("NADPH" . SPARSER::PROTEIN)
    ("microglia" . SPARSER::PROTEIN)
    ("lipids, proteins and DNA" . SPARSER::COLLECTION)
    ("lipids" . SPARSER::PROTEIN) ("myelin" . SPARSER::PROTEIN)
    ("thioredoxin reductase" . SPARSER::PROTEIN)
    ("thioredoxin-2" . SPARSER::PROTEIN) ("PPARGC1A" . SPARSER::PROTEIN)
    ("PGC-1α" . SPARSER::PROTEIN) ("coactivator 1" . SPARSER::PROTEIN)
    ("peroxisome proliferator-activated receptor gamma" . SPARSER::PROTEIN)
    ("amyloid precursor protein" . SPARSER::PROTEIN)
    ("NADPH oxidase" . SPARSER::PROTEIN) ("HO-1" . SPARSER::PROTEIN)
    ("apoptosis-inducing" . SPARSER::PROTEIN) ("CD68" . SPARSER::PROTEIN)
    ("Kelch-like ECH-associated protein 1" . SPARSER::PROTEIN)
    ("MS13" . SPARSER::PROTEIN) ("MS3" . SPARSER::PROTEIN)
    ("MS2" . SPARSER::PROTEIN) ("per 2" . SPARSER::PROTEIN)
    ("dimethyl fumarate" . SPARSER::DRUG) ("NFE2L2" . SPARSER::PROTEIN)
    ("heme oxygenase 1" . SPARSER::PROTEIN) ("Nrf2" . SPARSER::PROTEIN)
    ("anti-oxidant" . SPARSER::DRUG) ("chemotherapeutic drugs" . SPARSER::DRUG)
    ("stathmin" . SPARSER::PROTEIN)
    ("long-noncoding RNAs, and proteins" . SPARSER::COLLECTION)
    ("RNAs, and proteins" . SPARSER::COLLECTION) ("RNAs" . SPARSER::RNA)
    ("microRNAs" . SPARSER::RNA) ("ER, PR, and HER2" . SPARSER::COLLECTION)
    ("nodal" . SPARSER::PROTEIN) ("–1" . SPARSER::PROTEIN)
    ("Adjuvant" . SPARSER::DRUG)
    ("triple-negative subtypes" . SPARSER::PROTEIN) ("Luminal" . SPARSER::DRUG)
    ("STMN1 and phospho-STMN1" . SPARSER::COLLECTION)
    ("STMN1 and its phosphorylated forms" . SPARSER::COLLECTION)
    ("Paclitaxel" . SPARSER::DRUG)
    ("mitogen-activated protein kinases (MAPKs) and cyclin-dependent kinases (CDKs)"
     . SPARSER::COLLECTION)
    ("PKC" . SPARSER::PROTEIN) ("soluble tubulin" . SPARSER::PROTEIN)
    ("tubulin" . SPARSER::PROTEIN) ("phosphoprotein" . SPARSER::PROTEIN)
    ("Stathmin" . SPARSER::PROTEIN) ("HER2/neu" . SPARSER::COLLECTION)
    ("neu" . SPARSER::PROTEIN) ("–2" . SPARSER::PROTEIN)
    ("phospho-serine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("Ca 2+ /calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Op 18" . SPARSER::PROTEIN)
    ("Oncoprotein 18" . SPARSER::PROTEIN) ("STMN1" . SPARSER::PROTEIN)
    ("Stathmin1" . SPARSER::PROTEIN) ("RANK or c-Src" . SPARSER::COLLECTION)
    ("RANK and c-Src" . SPARSER::COLLECTION)
    ("c-Src, ERK or Akt" . SPARSER::COLLECTION)
    ("PI3K/Akt-HIF-1a" . SPARSER::COLLECTION) ("hypoxia" . SPARSER::PROTEIN)
    ("macrophage" . SPARSER::PROTEIN)
    ("c-Src, ERK and Akt" . SPARSER::COLLECTION)
    ("Src-ERK/Akt" . SPARSER::COLLECTION) ("Akt and ERK" . SPARSER::COLLECTION)
    ("pro" . SPARSER::AMINO-ACID) ("Denosumab" . SPARSER::DRUG)
    ("p-Src/p-Akt" . SPARSER::COLLECTION) ("p-Src/p-ERK" . SPARSER::COLLECTION)
    ("the PI3-K inhibitor LY294002 or the MEK inhibitor PD98059"
     . SPARSER::COLLECTION)
    ("p-Akt" . SPARSER::COLLECTION) ("ERK and Akt" . SPARSER::COLLECTION)
    ("c-Src/ERK" . SPARSER::COLLECTION) ("c-Src/Akt" . SPARSER::COLLECTION)
    ("c-Src, Akt and ERK" . SPARSER::COLLECTION)
    ("western blot" . SPARSER::PROTEIN)
    ("c-Src, Akt and ERK1/2" . SPARSER::COLLECTION)
    ("lung metastatic foci" . SPARSER::PROTEIN)
    ("OPG or PBS" . SPARSER::COLLECTION) ("PBS" . SPARSER::PROTEIN)
    ("ADR" . SPARSER::PROTEIN) ("OPG" . SPARSER::PROTEIN)
    ("Cbl-b and RANK" . SPARSER::COLLECTION) ("Src/ERK" . SPARSER::COLLECTION)
    ("Src/Akt" . SPARSER::COLLECTION) ("ERK, and NF-κB" . SPARSER::COLLECTION)
    ("PI3k/Akt" . SPARSER::COLLECTION)
    ("multifunctional adaptor protein or E3 ubiquitin ligase"
     . SPARSER::PROTEIN)
    ("an essential enzyme" . SPARSER::ENZYME)
    ("adaptor protein or E3" . SPARSER::COLLECTION)
    ("TRAF6, NF-κB and NFAT" . SPARSER::COLLECTION)
    ("/Akt" . SPARSER::COLLECTION) ("NFAT" . SPARSER::PROTEIN)
    ("TNF" . SPARSER::PROTEIN) ("RANK or RANKL" . SPARSER::COLLECTION)
    ("osteoclasts" . SPARSER::PROTEIN) ("chemokine" . SPARSER::PROTEIN)
    ("Src-Akt/ERK" . SPARSER::COLLECTION)
    ("Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RANK and Cbl-b" . SPARSER::COLLECTION)
    ("an essential regulator" . SPARSER::REGULATOR)
    ("RANKL/RANK" . SPARSER::COLLECTION) ("Cbl" . SPARSER::PROTEIN)
    ("ligand (RANKL)" . SPARSER::MOLECULE) ("/RANK" . SPARSER::COLLECTION)
    ("RANK" . SPARSER::PROTEIN) ("RANKL" . SPARSER::PROTEIN)
    ("U6" . SPARSER::PROTEIN) ("- 3" . SPARSER::PROTEIN)
    ("p-ERK1" . SPARSER::PROTEIN) ("anti-ERK" . SPARSER::PROTEIN)
    ("L-15" . SPARSER::PROTEIN) ("S-P" . SPARSER::PROTEIN)
    ("HIF-1a" . SPARSER::PROTEIN) ("M-CSF" . SPARSER::PROTEIN)
    ("c-Src-" . SPARSER::PROTEIN) ("PD98059" . SPARSER::MOLECULE)
    ("LY294002" . SPARSER::MOLECULE) ("PI3-K" . SPARSER::PROTEIN)
    ("PP2" . SPARSER::DRUG) ("p-ERK" . SPARSER::PROTEIN)
    ("p-Src" . SPARSER::PROTEIN) ("PS-341" . SPARSER::DRUG)
    ("ERK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("c-Src" . SPARSER::PROTEIN)
    ("decoy receptor" . SPARSER::PROTEIN) ("CXCL12" . SPARSER::PROTEIN)
    ("SDF-1" . SPARSER::PROTEIN) ("epidermal growth factor" . SPARSER::PROTEIN)
    ("PI3" . SPARSER::PROTEIN)
    ("negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("phospho-inositide" . SPARSER::MOLECULE)
    ("mitogen activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TRAF6" . SPARSER::PROTEIN) ("Cbl-b" . SPARSER::PROTEIN)
    ("Casitas B-lineage lymphoma" . SPARSER::PROTEIN)
    ("clinically applicable MYC-inhibitor" . SPARSER::INHIBITOR)
    ("dexamethasone and lenalidomide" . SPARSER::COLLECTION)
    ("dexamethasone" . SPARSER::PROTEIN)
    ("the inhibitor specifically targets MYC" . SPARSER::PROTEIN)
    ("GAPDH" . SPARSER::PROTEIN) ("Glo" . SPARSER::PROTEIN)
    ("MYC protein and mRNA" . SPARSER::COLLECTION)
    ("The transcription factor c-MYC (hereafter termed MYC) and the related N-MYC and L-MYC oncogenes"
     . SPARSER::COLLECTION)
    ("N-MYC and L-MYC" . SPARSER::COLLECTION) ("enhancers" . SPARSER::PROTEIN)
    ("bortezomib and carfilzomib" . SPARSER::COLLECTION)
    ("lenalidomide" . SPARSER::DRUG) ("carfilzomib" . SPARSER::DRUG)
    ("bortezomib" . SPARSER::DRUG) ("PGK1" . SPARSER::PROTEIN)
    ("HPRT1" . SPARSER::PROTEIN) ("CR1" . SPARSER::PROTEIN)
    ("reverse transcriptase" . SPARSER::PROTEIN)
    ("housekeeping gene" . SPARSER::PROTEIN) ("m1" . SPARSER::MOLECULE)
    ("CD138" . SPARSER::PROTEIN) ("IL-6" . SPARSER::PROTEIN)
    ("IH-1" . SPARSER::PROTEIN) ("OH-" . SPARSER::MOLECULE)
    ("L-MYC" . SPARSER::PROTEIN) ("N-MYC" . SPARSER::PROTEIN)
    ("c-MYC" . SPARSER::PROTEIN) ("integrin" . SPARSER::PROTEIN)
    ("E-cadherin and glutamine" . SPARSER::COLLECTION)
    ("pyruvate" . SPARSER::PROTEIN) ("glucose" . SPARSER::PROTEIN)
    ("histological type" . TYPE) ("IV" . SPARSER::PROTEIN)
    ("TNM" . SPARSER::MOLECULE) ("glutaminase" . SPARSER::PROTEIN)
    ("Glutamine" . SPARSER::AMINO-ACID)
    ("SIRT4, and SIRT4" . SPARSER::COLLECTION) ("ZEB" . SPARSER::PROTEIN)
    ("VIM" . SPARSER::PROTEIN) ("vimentin" . SPARSER::PROTEIN)
    ("the colorectal cancer cell line CaR1" . SPARSER::PROTEIN)
    ("SIRT4 and E-cadherin" . SPARSER::COLLECTION)
    ("an essential metabolite" . SPARSER::MOLECULE)
    ("metabolite" . SPARSER::MOLECULE) ("GDH" . SPARSER::PROTEIN)
    ("dehydrogenase" . SPARSER::PROTEIN) ("sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("SIRT1, SIRT6, and SIRT7" . SPARSER::COLLECTION)
    ("SIRT3, SIRT4, and SIRT5" . SPARSER::COLLECTION)
    ("ADP-ribosylase" . SPARSER::COLLECTION) ("ribosylase" . SPARSER::PROTEIN)
    ("ADP" . SPARSER::PROTEIN) ("Sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("glutamine" . SPARSER::AMINO-ACID) ("CDH2" . SPARSER::PROTEIN)
    ("N-cadherin" . SPARSER::PROTEIN) ("CaR1" . SPARSER::PROTEIN)
    ("hydrogen peroxide" . SPARSER::DRUG)
    ("α -ketoglutarate" . SPARSER::MOLECULE) ("C-Myc" . SPARSER::PROTEIN)
    ("ml −1" . SPARSER::PROTEIN) ("ADP-ribosyltransferase" . SPARSER::PROTEIN)
    ("deacetylase activity" . SPARSER::PROTEIN) ("SIRT5" . SPARSER::PROTEIN)
    ("SIRT3" . SPARSER::PROTEIN) ("SIRT2" . SPARSER::PROTEIN)
    ("SIRT7" . SPARSER::PROTEIN) ("SIRT6" . SPARSER::PROTEIN)
    ("SIRT1" . SPARSER::PROTEIN)
    ("nicotinamide adenine dinucleotide" . SPARSER::MOLECULE)
    ("SIRT4" . SPARSER::PROTEIN) ("monomeric BRAF" . SPARSER::PROTEIN)
    ("RAF1 and BRAF" . SPARSER::COLLECTION) ("BRAF-" . SPARSER::PROTEIN)
    ("RAF1-" . SPARSER::PROTEIN) ("glycolipid" . SPARSER::MOLECULE)
    ("galectins" . SPARSER::PROTEIN)
    ("the typical apoptosis-inducer TNFSF10/TRAIL" . SPARSER::COLLECTION)
    ("apoptosis-inducer" . SPARSER::PROTEIN) ("cisplatin" . SPARSER::DRUG)
    ("ATG5 and BECN1" . SPARSER::COLLECTION)
    ("mCherry/GFP" . SPARSER::COLLECTION)
    ("mCherry-GFP-LC3" . SPARSER::COLLECTION) ("mCherry" . SPARSER::PROTEIN)
    ("LAMP2-LC3B" . SPARSER::COLLECTION)
    ("LAMP2 and LC3B" . SPARSER::COLLECTION) ("rapamycin" . SPARSER::DRUG)
    ("SQSTM1/p62" . SPARSER::COLLECTION) ("chloroquine" . SPARSER::PROTEIN)
    ("BECN1/Beclin 1" . SPARSER::COLLECTION)
    ("mut and BRAF" . SPARSER::COLLECTION) ("MTOR" . SPARSER::PROTEIN)
    ("cyto-ID" . SPARSER::COLLECTION) ("Cyto-ID" . SPARSER::COLLECTION)
    ("monodansylcadaverine" . SPARSER::DRUG)
    ("rLGALS9-treated cells such LC3B puncta" . SPARSER::PROTEIN)
    ("puncta" . SPARSER::PROTEIN) ("punctate" . SPARSER::PROTEIN)
    ("MAP1LC3 B/LC3B" . SPARSER::COLLECTION) ("LysoTracker" . SPARSER::DRUG)
    ("a mutated KRAS allele" . SPARSER::ALLELE)
    ("TNFSF10/TRAIL" . SPARSER::COLLECTION) ("TRAIL" . SPARSER::PROTEIN)
    ("inducer" . SPARSER::MOLECULE) ("BAX" . SPARSER::PROTEIN)
    ("KRAS and BRAF" . SPARSER::COLLECTION)
    ("MAP2K1 and RAF1" . SPARSER::COLLECTION)
    ("prominent cytotoxic" . SPARSER::PROTEIN)
    ("RAF1 and MAP2K1" . SPARSER::COLLECTION) ("PS" . SPARSER::PROTEIN)
    ("the predominant MEK isoform" . SPARSER::ISOFORM)
    ("isoform" . SPARSER::ISOFORM) ("MEK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAP2K1 and MAP2K2" . SPARSER::COLLECTION)
    ("RAF1/CRAF" . SPARSER::COLLECTION) ("Dabrafenib" . SPARSER::DRUG)
    ("CRAF" . SPARSER::PROTEIN) ("PRKCI" . SPARSER::PROTEIN)
    ("PRKCZ" . SPARSER::PROTEIN) ("isoforms" . SPARSER::ISOFORM)
    ("DNM/dynamin" . SPARSER::COLLECTION) ("dynasore" . SPARSER::MOLECULE)
    ("GTPase" . SPARSER::GTPASE) ("dynamin" . SPARSER::PROTEIN)
    ("DNM" . SPARSER::PROTEIN) ("Rr" . SPARSER::MOLECULE)
    ("t" . SPARSER::PROTEIN) ("EPCAM" . SPARSER::PROTEIN)
    ("the irrelevant sugar sucrose" . SPARSER::MOLECULE)
    ("sucrose" . SPARSER::MOLECULE) ("sugar" . SPARSER::MOLECULE)
    ("established epithelial monolayers" . SPARSER::PROTEIN)
    ("linker" . SPARSER::LINKER) ("clathrin- and PRKC" . SPARSER::COLLECTION)
    ("clathrin-" . SPARSER::PROTEIN) ("PRKC" . SPARSER::PROTEIN-FAMILY)
    ("clathrin" . SPARSER::PROTEIN)
    ("exogenous recombinant LGALS9" . SPARSER::PROTEIN)
    ("monolayers" . SPARSER::PROTEIN) ("70kDa" . SPARSER::PROTEIN)
    ("class" . CLASS) ("phosphatidylserine" . SPARSER::PROTEIN)
    ("galactose" . SPARSER::MOLECULE)
    ("lectin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Kirsten rat sarcoma viral oncogene" . SPARSER::ONCOGENE)
    ("BCL2-associated X protein" . SPARSER::PROTEIN)
    ("excessive lysosomal" . SPARSER::PROTEIN) ("lysosomal" . SPARSER::PROTEIN)
    ("LGALS9/Galectin-9" . SPARSER::COLLECTION)
    ("Kirsten rat sarcoma viral oncogene homolog)" . SPARSER::PROTEIN)
    ("Foxn1" . SPARSER::PROTEIN) ("α-tubulin" . SPARSER::PROTEIN)
    ("p70S6K1" . SPARSER::PROTEIN) ("Caspase-3" . SPARSER::PROTEIN)
    ("Na 3 VO 4" . SPARSER::MOLECULE) ("Red DND-99" . SPARSER::DRUG)
    ("SP8" . SPARSER::PROTEIN) ("annexin-V" . SPARSER::PROTEIN)
    ("ANXA5" . SPARSER::PROTEIN) ("–3" . SPARSER::PROTEIN)
    ("MEK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("necrostatin-1" . SPARSER::MOLECULE) ("Gal-9" . SPARSER::PROTEIN)
    ("SW480" . SPARSER::PROTEIN) ("T-cell" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase kinases"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LC3" . SPARSER::PROTEIN) ("GFP-LC3" . SPARSER::PROTEIN)
    ("p62" . SPARSER::PROTEIN) ("SQSTM1" . SPARSER::PROTEIN)
    ("BECN1" . SPARSER::PROTEIN) ("autophagy related 5" . SPARSER::PROTEIN)
    ("ATG5" . SPARSER::PROTEIN) ("RPS6KB1" . SPARSER::PROTEIN)
    ("mechanistic target of rapamycin" . SPARSER::PROTEIN)
    ("LC3B" . SPARSER::PROTEIN) ("MAP1LC3 B" . SPARSER::PROTEIN)
    ("acridine orange" . SPARSER::MOLECULE)
    ("tumor necrosis factor" . SPARSER::PROTEIN) ("TNFSF10" . SPARSER::PROTEIN)
    ("PtdIns3K" . SPARSER::PROTEIN) ("Z-VAD-fmk" . SPARSER::DRUG)
    ("caspase-3" . SPARSER::PROTEIN) ("CASP3" . SPARSER::PROTEIN)
    ("MAP2K" . SPARSER::HUMAN-PROTEIN-FAMILY) ("U0126" . SPARSER::DRUG)
    ("MAP2K2" . SPARSER::PROTEIN) ("GW5074" . SPARSER::DRUG)
    ("UCN-01" . SPARSER::DRUG) ("1A" . SPARSER::PROTEIN)
    ("LAMP2" . SPARSER::PROTEIN) ("RAB7A" . SPARSER::PROTEIN)
    ("RAB5A" . SPARSER::PROTEIN) ("cell membrane" . SPARSER::PROTEIN)
    ("DLD-1" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase kinase 1" . SPARSER::PROTEIN)
    ("MAP2K1" . SPARSER::PROTEIN) ("galectin-8" . SPARSER::PROTEIN)
    ("LGALS8" . SPARSER::PROTEIN) ("Galectin-3" . SPARSER::PROTEIN)
    ("LGALS3" . SPARSER::PROTEIN) ("member 10" . SPARSER::PROTEIN)
    ("tumor necrosis factor (ligand) superfamily" . SPARSER::PROTEIN)
    ("sequestosome 1" . SPARSER::PROTEIN) ("polypeptide 1" . SPARSER::PROTEIN)
    ("ribosomal protein S6 kinase" . SPARSER::PROTEIN)
    ("Raf-1" . SPARSER::PROTEIN) ("light chain 3" . SPARSER::PROTEIN)
    ("microtubule-associated protein" . SPARSER::PROTEIN)
    ("membrane protein" . SPARSER::PROTEIN)
    ("epithelial cell adhesion molecule" . SPARSER::PROTEIN)
    ("apoptosis-related cysteine peptidase" . SPARSER::PROTEIN)
    ("caspase 3" . SPARSER::PROTEIN) ("Beclin 1" . SPARSER::PROTEIN)
    ("B-Raf proto-oncogene, serine/threonine kinase" . SPARSER::PROTEIN)
    ("Galectin-9" . SPARSER::PROTEIN) ("LGALS9" . SPARSER::PROTEIN)
    ("homolog)" . SPARSER::PROTEIN) ("protein and RNA" . SPARSER::COLLECTION)
    ("MMPs and VEGF" . SPARSER::COLLECTION)
    ("MMPs, MMP2 and MMP9" . SPARSER::COLLECTION)
    ("STAT5b-IGF-1Rβ" . SPARSER::PROTEIN-PAIR)
    ("VEGF and its receptor" . SPARSER::COLLECTION)
    ("STAT5b and phospho-STAT5" . SPARSER::COLLECTION)
    ("opted" . SPARSER::HUMAN-PROTEIN-FAMILY) ("food" . SPARSER::MOLECULE)
    ("individual drug" . SPARSER::DRUG)
    ("IGF-1, IGF-1Rβ, and STAT5b" . SPARSER::COLLECTION)
    ("STAT5b/IGF-1R" . SPARSER::COLLECTION) ("aims" . SPARSER::PROTEIN)
    ("Jak2, STAT5b, STAT3, and IGF-1Rβ" . SPARSER::COLLECTION)
    ("Jak2 and STAT3" . SPARSER::COLLECTION)
    ("STAT5b and IGF-1Rβ" . SPARSER::COLLECTION)
    ("VEGF and VEGF-R2" . SPARSER::COLLECTION)
    ("the individual drugs and their combination" . SPARSER::COLLECTION)
    ("MMP2, MMP3, and MMP9" . SPARSER::COLLECTION) ("MMP" . SPARSER::PROTEIN)
    ("MMPs" . SPARSER::PROTEIN)
    ("cyclin D1, VEGF, IGF-1, and IGF-1Rβ" . SPARSER::COLLECTION)
    ("VEGF" . SPARSER::PROTEIN) ("MSM-tamoxifen" . SPARSER::DRUG)
    ("STAT5, STAT3, and IGF-1Rβ" . SPARSER::COLLECTION)
    ("Tam or MSM" . SPARSER::COLLECTION)
    ("Jak2, STAT3, STAT5b, and IGF-1Rβ" . SPARSER::COLLECTION)
    ("Jak2/STAT" . SPARSER::COLLECTION) ("Bax" . SPARSER::PROTEIN)
    ("Tam (30 %) and MSM (38 %)" . SPARSER::COLLECTION)
    ("camptothecin" . SPARSER::DRUG) ("FITC" . SPARSER::MOLECULE)
    ("Fa " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tam and MSM" . SPARSER::COLLECTION)
    ("tamoxifen and MSM" . SPARSER::COLLECTION)
    ("Jak2/STAT5b" . SPARSER::COLLECTION) ("the anti-BCa" . SPARSER::ANTIBODY)
    ("MSM and Tam" . SPARSER::COLLECTION)
    ("STAT5b and STAT3" . SPARSER::COLLECTION)
    ("STAT3 and STAT5b" . SPARSER::COLLECTION)
    ("antioxidant and anti-inflammatory" . SPARSER::COLLECTION)
    ("Methylsulfonylmethane (MSM)" . SPARSER::DRUG)
    ("estrogen" . SPARSER::MOLECULE) ("ER and forms" . SPARSER::COLLECTION)
    ("tam-ER" . SPARSER::COLLECTION) ("tam" . SPARSER::PROTEIN)
    ("estradiol" . SPARSER::PROTEIN)
    ("other hormonally-responsive BCa" . SPARSER::PROTEIN)
    ("antagonist" . SPARSER::MOLECULE) ("agonist" . SPARSER::AGONIST)
    ("Tam" . SPARSER::PROTEIN) ("endocrine" . SPARSER::PROTEIN)
    ("a transmembrane tyrosine kinase" . SPARSER::PROTEIN)
    ("IGF-1, IGF-1Rβ, and cyclin D1" . SPARSER::COLLECTION)
    ("receptors" . SPARSER::RECEPTOR) ("IGF" . SPARSER::PROTEIN)
    ("STAT" . SPARSER::PROTEIN) ("Jak" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Janus" . SPARSER::PROTEIN-FAMILY) ("BCa" . SPARSER::PROTEIN)
    ("MSM and tamoxifen" . SPARSER::COLLECTION)
    ("Tamoxifen" . SPARSER::MOLECULE) ("MSM" . SPARSER::DRUG)
    ("Methylsulfonylmethane" . SPARSER::DRUG)
    ("its receptor" . SPARSER::PROTEIN) ("growth hormone" . SPARSER::PROTEIN)
    ("annexin V" . SPARSER::PROTEIN) ("dimethyl sulfoxide" . SPARSER::MOLECULE)
    ("17β-estradiol" . SPARSER::PROTEIN) ("MMP2" . SPARSER::PROTEIN)
    ("Reverse transcriptase" . SPARSER::PROTEIN) ("STAT5" . SPARSER::PROTEIN)
    ("MMP9" . SPARSER::PROTEIN) ("MMP3" . SPARSER::PROTEIN)
    ("matrix metalloproteinase" . SPARSER::PROTEIN)
    ("VEGF-R2" . SPARSER::PROTEIN) ("vascular endothelial" . SPARSER::PROTEIN)
    ("STAT3" . SPARSER::PROTEIN) ("dimethyl sulfone" . SPARSER::DRUG)
    ("cyclin D1" . SPARSER::PROTEIN) ("IGF-1R" . SPARSER::PROTEIN)
    ("IGF-1" . SPARSER::PROTEIN)
    ("insulin-like growth factor" . SPARSER::PROTEIN)
    ("insulin-like growth factor-1" . SPARSER::PROTEIN)
    ("STAT5b" . SPARSER::PROTEIN) ("Jak2" . SPARSER::PROTEIN)
    ("Janus kinase 2" . SPARSER::PROTEIN)
    ("a potential biomarker" . SPARSER::MOLECULE)
    ("subtypes" . SPARSER::PROTEIN) ("bevacizumab" . SPARSER::DRUG)
    ("a potential molecular target" . SPARSER::TARGET-PROTEIN)
    ("TRAP1/BRAF" . SPARSER::COLLECTION)
    ("a client protein" . SPARSER::PROTEIN)
    ("TNFα/cycloheximide" . SPARSER::COLLECTION)
    ("staurosporine" . SPARSER::DRUG)
    ("mitochondrial ERK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclophilin" . SPARSER::PROTEIN) ("RAF and ERK" . SPARSER::COLLECTION)
    ("EGFR or RAS and RAF" . SPARSER::COLLECTION)
    ("RAS and RAF" . SPARSER::COLLECTION) ("RAS/RAF/ERK" . SPARSER::COLLECTION)
    ("HSP90/TRAP1" . SPARSER::COLLECTION) ("IRI" . SPARSER::DRUG)
    ("TRAP1 and the BRAF-V600E mutant" . SPARSER::COLLECTION)
    ("anti-TRAP1 or anti-phosphoserine" . SPARSER::COLLECTION)
    ("phosphoserine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("TRAP1 and a mutant" . SPARSER::COLLECTION)
    ("transfectants" . SPARSER::PROTEIN)
    ("serine/threonine" . SPARSER::COLLECTION)
    ("threonine" . SPARSER::AMINO-ACID)
    ("TRAP1 and BRAF" . SPARSER::COLLECTION) ("75kDa" . SPARSER::PROTEIN)
    ("paclitaxel" . SPARSER::DRUG) ("MCF7" . SPARSER::PROTEIN)
    ("mitochondrial TRAP1" . SPARSER::PROTEIN)
    ("fractions" . SPARSER::COMPONENT) ("wt" . SPARSER::PROTEIN)
    ("oxaliplatin (l-OHP) and irinotecan (IRI)" . SPARSER::COLLECTION)
    ("either BRAF-wt or the BRAF-V600E mutant" . SPARSER::COLLECTION)
    ("BRAF-wt" . SPARSER::COLLECTION) ("l-OHP" . SPARSER::COLLECTION)
    ("OHP" . SPARSER::PROTEIN) ("MTP and BRAF" . SPARSER::COLLECTION)
    ("RAS-RAF-ERK" . SPARSER::COLLECTION)
    ("RAF" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ER-associated TRAP1" . SPARSER::PROTEIN)
    ("specific client proteins" . SPARSER::PROTEIN)
    ("other client proteins" . SPARSER::PROTEIN) ("MTP" . SPARSER::PROTEIN)
    ("thyroid" . SPARSER::PROTEIN)
    ("mitochondria and TRAP1" . SPARSER::COLLECTION)
    ("chaperones" . SPARSER::PROTEIN) ("mitochondria" . SPARSER::PROTEIN)
    ("a BRAF dominant-negative mutant" . SPARSER::MUTANT)
    ("BRAFV" . SPARSER::PROTEIN) ("BRAF and TRAP1" . SPARSER::COLLECTION)
    ("serine" . SPARSER::AMINO-ACID)
    ("human BRAF-driven CRCs" . SPARSER::PROTEIN) ("CRCs" . SPARSER::PROTEIN)
    ("translational regulator" . SPARSER::REGULATOR)
    ("ERK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("chaperone" . SPARSER::PROTEIN)
    ("Erk1/2" . SPARSER::PROTEIN) ("MAPK 1" . SPARSER::PROTEIN)
    ("pErk1/2" . SPARSER::PROTEIN) ("3D" . SPARSER::PROTEIN-FAMILY)
    ("ATP5B" . SPARSER::PROTEIN) ("HSP75" . SPARSER::PROTEIN)
    ("18 h" . SPARSER::PROTEIN) ("actinomycin-D" . SPARSER::MOLECULE)
    ("Annexin-V" . SPARSER::PROTEIN) ("Full-length" . SPARSER::PROTEIN)
    ("TNFα" . SPARSER::PROTEIN) ("BCL-2" . SPARSER::PROTEIN)
    ("glycogen synthase kinase-3" . SPARSER::PROTEIN)
    ("TBP7" . SPARSER::PROTEIN) ("cytochrome c" . SPARSER::PROTEIN)
    ("TRAP1" . SPARSER::PROTEIN) ("HSP90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("both total Pol II and the Ser2-phosphorylated Pol II"
     . SPARSER::COLLECTION)
    ("the active SEC complex" . SPARSER::BIO-COMPLEX)
    ("the signature 7SK snRNP component HEXIM1 and the signature Super Elongation Complex (SEC) components AFF4 and ELL2"
     . SPARSER::COLLECTION)
    ("Complex" . SPARSER::BIO-COMPLEX) ("Elongation" . SPARSER::PROTEIN)
    ("CDK9 and BRD4" . SPARSER::COLLECTION)
    ("the dominant-negative CDK9 mutant D167N" . SPARSER::PROTEIN)
    ("HMBA" . SPARSER::DRUG) ("Dr" . SPARSER::MOLECULE)
    ("Flag-tagged CDK12 (CDK12-F) and CDK9 (CDK9-F)" . SPARSER::COLLECTION)
    ("CDK12 and CDK9" . SPARSER::COLLECTION)
    ("MYC and other genes" . SPARSER::COLLECTION)
    ("Flavopiridol" . SPARSER::DRUG) ("i-Cdk9" . SPARSER::COLLECTION)
    ("Ctk1" . SPARSER::PROTEIN) ("Cdk12" . SPARSER::PROTEIN)
    ("Cdk" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pol" . SPARSER::PROTEIN)
    ("JUN and other Brd4-sensitive genes" . SPARSER::COLLECTION)
    ("MYC, FOS, JUN and other Brd4-sensitive genes" . SPARSER::COLLECTION)
    ("JUN" . SPARSER::HUMAN-PROTEIN-FAMILY) ("chemical" . SPARSER::MOLECULE)
    ("BRD4, CDK9 and Pol" . SPARSER::COLLECTION)
    ("CDK9/cyclin T1" . SPARSER::COLLECTION)
    ("MYC and CDK9" . SPARSER::COLLECTION)
    ("MYC and some other genes" . SPARSER::COLLECTION)
    ("gene (MYC)" . SPARSER::GENE)
    ("the editorial decision letter and author response" . SPARSER::COLLECTION)
    ("the editorial decision letter" . SPARSER::MOLECULE)
    ("letter" . SPARSER::MOLECULE)
    ("Pol II transcriptional elongation" . SPARSER::PROTEIN)
    ("dimer" . SPARSER::DIMER) ("a modest fraction" . SPARSER::COMPONENT)
    ("CycT1 and CDK9" . SPARSER::COLLECTION)
    ("employed both the synthetic CTD peptides as well as the full-length human CTD containing"
     . SPARSER::COLLECTION)
    ("employed both the synthetic CTD peptides" . SPARSER::PEPTIDE)
    ("peptides" . SPARSER::PEPTIDE)
    ("FOS, JUNB, EGR1, and GADD45B" . SPARSER::COLLECTION)
    ("both CDK9 and cell cycle CDKs" . SPARSER::COLLECTION)
    ("duplex DNA" . SPARSER::DNA) ("iodide" . SPARSER::PROTEIN)
    ("propidium" . SPARSER::MOLECULE) ("cytometry" . SPARSER::PROTEIN)
    ("matrices" . SPARSER::PROTEIN-FAMILY) ("essential genes" . SPARSER::GENE)
    ("CDK9, CycT1, and BRD4" . SPARSER::COLLECTION)
    ("MYC-MAX" . SPARSER::COLLECTION) ("heterodimer" . SPARSER::HETERODIMER)
    ("MAX" . SPARSER::PROTEIN)
    ("MYC and other BDPR genes" . SPARSER::COLLECTION)
    ("three well-studied PRGs, MYC, FOS, and JUNB" . SPARSER::COLLECTION)
    ("PRGs, MYC, FOS, and JUNB" . SPARSER::COLLECTION)
    ("FOS" . SPARSER::PROTEIN) ("virtually all the genes" . SPARSER::GENE)
    ("essentially all the 27 genes" . SPARSER::GENE) ("NES" . SPARSER::PROTEIN)
    ("GSEA" . SPARSER::PROTEIN) ("macrophages" . SPARSER::PROTEIN)
    ("a classic example" . SPARSER::EXAMPLE) ("example" . SPARSER::EXAMPLE)
    ("finally productive transcriptional elongation" . SPARSER::PROTEIN)
    ("favorable chromatin" . SPARSER::PROTEIN) ("histones" . SPARSER::PROTEIN)
    ("II and Pol" . SPARSER::COLLECTION)
    ("CDK9 and total Pol II" . SPARSER::COLLECTION)
    ("BRD4, CDK9, total Pol II, and the Ser2-phosphoryalted Pol II"
     . SPARSER::COLLECTION)
    ("weaker" . SPARSER::PROTEIN) ("an atypical kinase" . SPARSER::KINASE)
    ("P-TEFb increases CDK9's" . SPARSER::PROTEIN)
    ("CDK9 and CycT1" . SPARSER::COLLECTION) ("aa" . SPARSER::MOLECULE)
    ("PID" . SPARSER::PROTEIN) ("BRD4 and P-TEFb" . SPARSER::COLLECTION)
    ("BRD4 and CDK9" . SPARSER::COLLECTION) ("acetyl" . SPARSER::MOLECULE)
    ("recombinase" . SPARSER::PROTEIN) ("Cre" . SPARSER::PROTEIN)
    ("KD" . SPARSER::PROTEIN)
    ("this heterologous promoter" . SPARSER::PROMOTER)
    ("doxycycline" . SPARSER::DRUG) ("cycloheximide (CHX)" . SPARSER::PROTEIN)
    ("just 0.1 µM i-CDK9" . SPARSER::COLLECTION)
    ("states" . SPARSER::BIO-STATE)
    ("SMUG1, TMEM115, SEC13 and CSNK1D" . SPARSER::COLLECTION)
    ("DMSO" . SPARSER::MOLECULE) ("polymerase (PARP)" . SPARSER::PROTEIN)
    ("caspase" . SPARSER::PROTEIN) ("labile" . SPARSER::PROTEIN)
    ("pThr" . SPARSER::PHOSPHORYLATED-AMINO-ACID) ("ICK" . SPARSER::PROTEIN)
    ("Kinase" . SPARSER::KINASE)
    ("CDK9 and the next two best targets DYRK1A and DYRK1B (IC50 < 0.0004 µM for CDK9 vs IC50 = 0.055 and 0.047 for DYRK1A and B, respectively; column D in xref )"
     . SPARSER::COLLECTION)
    ("the next two best targets DYRK1A and DYRK1B" . SPARSER::COLLECTION)
    ("DYRK1A and DYRK1B" . SPARSER::COLLECTION)
    ("CDK9 and CDK12" . SPARSER::COLLECTION)
    ("CDK12-CycK" . SPARSER::COLLECTION) ("CycK" . SPARSER::PROTEIN)
    ("kinases" . SPARSER::PROTEIN) ("pSer" . SPARSER::PROTEIN)
    ("GST" . SPARSER::PROTEIN) ("ligands" . SPARSER::LIGAND)
    ("CDK3, CDK5, CDK11 and CDK13" . SPARSER::COLLECTION)
    ("CDKs" . SPARSER::PROTEIN) ("CDK-cyclin" . SPARSER::COLLECTION)
    ("CDK8-CycC" . SPARSER::COLLECTION)
    ("CDK7-CycH-MAT1" . SPARSER::COLLECTION)
    ("CDK4-CycD1" . SPARSER::COLLECTION) ("CDK2-CycA" . SPARSER::COLLECTION)
    ("CDK1-CycB" . SPARSER::COLLECTION) ("CycC" . SPARSER::PROTEIN)
    ("CycH" . SPARSER::PROTEIN) ("CycA" . SPARSER::PROTEIN)
    ("CycB" . SPARSER::PROTEIN) ("CDK9-CycT1" . SPARSER::COLLECTION)
    ("flavopiridol and all the other known non-selective CDK inhibitors ( xref )"
     . SPARSER::COLLECTION)
    ("-bipyridine-2" . SPARSER::COLLECTION) ("scaffold" . SPARSER::SCAFFOLD)
    ("diamine" . SPARSER::MOLECULE) ("trans" . SPARSER::PROTEIN-FAMILY)
    ("both CDK9's" . SPARSER::PROTEIN)
    ("the proto-oncogene MYC and several other key PRGs" . SPARSER::COLLECTION)
    ("several other key PRGs" . SPARSER::PROTEIN)
    ("the DSIF subunit SPT5 and causes widespread Pol II"
     . SPARSER::COLLECTION)
    ("a potential therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("flavopiridol and SNS-032" . SPARSER::COLLECTION)
    ("flavopiridol" . SPARSER::DRUG) ("CDK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MYC and other PRGs" . SPARSER::COLLECTION)
    ("many membrane-associated ligand–receptor complexes"
     . SPARSER::BIO-COMPLEX)
    ("active P-TEFb complexes" . SPARSER::BIO-COMPLEX)
    ("the viral promoter" . SPARSER::PROMOTER) ("reagents" . SPARSER::MOLECULE)
    ("leukemia" . SPARSER::PROTEIN) ("MLL" . SPARSER::PROTEIN)
    ("acetylated chromatin or the transcriptional mediator complex ( xref ; xref , xref )"
     . SPARSER::COLLECTION)
    ("PRGs" . SPARSER::PROTEIN) ("BET" . SPARSER::PROTEIN)
    ("a BRD4-containing complex and the super elongation complex (SEC) ( xref )"
     . SPARSER::COLLECTION)
    ("complex (SEC)" . SPARSER::BIO-COMPLEX)
    ("the inactive 7SK snRNP" . SPARSER::BIO-COMPLEX) ("snRNA" . SPARSER::RNA)
    ("transcriptional elongation" . SPARSER::PROTEIN)
    ("DSIF and the NelfE subunit" . SPARSER::COLLECTION)
    ("NELF" . SPARSER::PROTEIN) ("NelfE" . SPARSER::PROTEIN)
    ("DSIF" . SPARSER::PROTEIN) ("elongation and RNA" . SPARSER::COLLECTION)
    ("cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Serine" . SPARSER::AMINO-ACID)
    ("Drosophila" . SPARSER::PROTEIN)
    ("active pre-initiation complexes" . SPARSER::BIO-COMPLEX)
    ("promoters" . SPARSER::PROMOTER) ("CDK9 and MYC" . SPARSER::COLLECTION)
    ("enzymes" . SPARSER::ENZYME) ("subunits" . SPARSER::FRAGMENT)
    ("‘elongation’" . SPARSER::PROTEIN)
    ("too much MYC protein" . SPARSER::PROTEIN)
    ("MYC/BRD4" . SPARSER::COLLECTION) ("snRNP" . SPARSER::BIO-COMPLEX)
    ("bromodomain" . SPARSER::PROTEIN) ("MYC" . SPARSER::PROTEIN)
    ("causes genome-wide Pol II" . SPARSER::PROTEIN)
    ("i-CDK9" . SPARSER::COLLECTION)
    ("productive elongation" . SPARSER::PROTEIN)
    ("elongation" . SPARSER::PROTEIN) ("Pol" . SPARSER::PROTEIN)
    ("subunit" . SPARSER::FRAGMENT) ("ELL2" . SPARSER::PROTEIN)
    ("2-P" . SPARSER::PROTEIN) ("Brd4" . SPARSER::PROTEIN)
    ("Cdk9" . SPARSER::PROTEIN) ("Spt5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin T1" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 9" . SPARSER::PROTEIN)
    ("DYRK1a" . SPARSER::PROTEIN) ("Glo 3" . SPARSER::PROTEIN)
    ("cycT1" . SPARSER::PROTEIN) ("Tween 20" . SPARSER::MOLECULE)
    ("Protein A" . SPARSER::PROTEIN) ("an 1" . SPARSER::DRUG)
    ("S2" . SPARSER::MOLECULE) ("β-Actin" . SPARSER::PROTEIN)
    ("Mcl-1" . SPARSER::PROTEIN) ("F-12" . SPARSER::PROTEIN)
    ("GADD45B" . SPARSER::PROTEIN) ("EGR1" . SPARSER::PROTEIN)
    ("ERG1" . SPARSER::PROTEIN)
    ("cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Caspase 3" . SPARSER::PROTEIN)
    ("proto-oncogenes" . SPARSER::PROTO-ONCOGENE) ("−2" . SPARSER::PROTEIN)
    ("1C" . SPARSER::PROTEIN) ("1–2" . SPARSER::PROTEIN)
    ("CSNK1D" . SPARSER::PROTEIN) ("SEC13" . SPARSER::PROTEIN)
    ("TMEM115" . SPARSER::PROTEIN) ("SMUG1" . SPARSER::PROTEIN)
    ("MCL-1" . SPARSER::PROTEIN) ("DYRK1B" . SPARSER::PROTEIN)
    ("DYRK1A" . SPARSER::PROTEIN) ("CLK4" . SPARSER::PROTEIN)
    ("CDK12" . SPARSER::PROTEIN) ("CDK11" . SPARSER::PROTEIN)
    ("CDK5" . SPARSER::PROTEIN) ("CDK3" . SPARSER::PROTEIN)
    ("CDK8" . SPARSER::PROTEIN) ("MAT1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CDK7" . SPARSER::PROTEIN) ("CycD1" . SPARSER::PROTEIN)
    ("CDK2" . SPARSER::PROTEIN) ("CDK1" . SPARSER::PROTEIN)
    ("non-selective" . SPARSER::PROTEIN) ("N2" . SPARSER::PROTEIN)
    ("SNS-032" . SPARSER::DRUG) ("immediate early response" . SPARSER::PROTEIN)
    ("proto-oncogene" . SPARSER::PROTEIN) ("HEXIM1" . SPARSER::PROTEIN)
    ("kinase activity" . SPARSER::PROTEIN) ("SPT5" . SPARSER::PROTEIN)
    ("CycT1" . SPARSER::PROTEIN) ("messenger RNA" . SPARSER::RNA)
    ("messenger RNAs" . SPARSER::RNA) ("RNA polymerase II" . SPARSER::PROTEIN)
    ("MYC protein" . SPARSER::PROTEIN) ("7SK" . SPARSER::RNA)
    ("BRD4" . SPARSER::PROTEIN) ("elongation factor" . SPARSER::PROTEIN)
    ("CDK9" . SPARSER::PROTEIN)
    ("inoperable or recurrent PAs" . SPARSER::PROTEIN)
    ("a prognostic biomarker" . SPARSER::MOLECULE)
    ("inoperable PAs" . SPARSER::PROTEIN) ("ponatinib" . SPARSER::DRUG)
    ("an attractive therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("an earlier extracerebellar (diencephalic) PA" . SPARSER::PROTEIN)
    ("The mutated form" . SPARSER::FORM) ("PLX-PB3" . SPARSER::COLLECTION)
    ("PLX" . SPARSER::PROTEIN) ("vemurafenib" . SPARSER::DRUG)
    ("1 unusual BRAF point mutation" . SPARSER::PROTEIN)
    ("The usual p" . SPARSER::PROTEIN) ("BRAF or FGFR1" . SPARSER::COLLECTION)
    ("BRAF and/or FGFR1" . SPARSER::COLLECTION)
    ("PAs, diffuse astrocytomas (WHO grade II), and other neoplasms"
     . SPARSER::COLLECTION)
    ("EFS" . SPARSER::PROTEIN) ("FGFR" . SPARSER::PROTEIN)
    ("the nonneoplastic astrocytes" . SPARSER::PROTEIN)
    ("astrocytes" . SPARSER::PROTEIN) ("a cerebellar PA" . SPARSER::PROTEIN)
    ("FISH" . SPARSER::PROTEIN) ("extracerebellar PAs" . SPARSER::PROTEIN)
    ("lysine" . SPARSER::AMINO-ACID) ("asparagine" . SPARSER::AMINO-ACID)
    ("valine" . SPARSER::AMINO-ACID) ("FAM131B-BRAF" . SPARSER::COLLECTION)
    ("SRGAP3-RAF1" . SPARSER::COLLECTION) ("FAM" . SPARSER::PROTEIN)
    ("KIAA1549 and BRAF" . SPARSER::COLLECTION)
    ("neurofibromin" . SPARSER::PROTEIN) ("PAs and NF1" . SPARSER::COLLECTION)
    ("sporadic PAs" . SPARSER::PROTEIN) ("PAs" . SPARSER::PROTEIN)
    ("NF1-PAs" . SPARSER::COLLECTION) ("radical" . SPARSER::MOLECULE)
    ("BRAF and FGFR1" . SPARSER::COLLECTION)
    ("KIAA1549:BRAF" . SPARSER::BIO-COMPLEX) ("exon" . SPARSER::PROTEIN)
    ("PA" . SPARSER::PROTEIN) ("PB3" . SPARSER::PROTEIN)
    ("PLX4032" . SPARSER::DRUG) ("as 2" . SPARSER::PROTEIN)
    ("P44" . SPARSER::PROTEIN) ("a 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P21" . SPARSER::PROTEIN) ("P32" . SPARSER::PROTEIN)
    ("of 45" . SPARSER::PROTEIN) ("P31" . SPARSER::PROTEIN)
    ("P37" . SPARSER::PROTEIN) ("or 2" . SPARSER::MOLECULE)
    ("Texas red" . SPARSER::DRUG)
    ("fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("IDH1" . SPARSER::PROTEIN) ("tyrosine-kinase receptor" . SPARSER::PROTEIN)
    ("glutamic acid" . SPARSER::AMINO-ACID) ("RAF1" . SPARSER::PROTEIN)
    ("SRGAP3" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("loss of heterozygosity" . SPARSER::PROTEIN)
    ("tumor suppressor gene" . SPARSER::PROTEIN)
    ("autosomal dominant" . SPARSER::PROTEIN) ("NF1" . SPARSER::PROTEIN)
    ("KIAA1549" . SPARSER::PROTEIN) ("FGFR1" . SPARSER::PROTEIN)
    ("Fibroblast growth factor receptor 1" . SPARSER::PROTEIN)
    ("possibly predictive biomarkers" . SPARSER::MOLECULE)
    ("high ERCC1 and high TS" . SPARSER::COLLECTION)
    ("high ERCC1 and low TS" . SPARSER::COLLECTION)
    ("ERCC1 or TS" . SPARSER::COLLECTION) ("TS or ERCC1" . SPARSER::COLLECTION)
    ("cytotoxic chemotherapeutic drugs" . SPARSER::DRUG)
    ("fit" . SPARSER::PROTEIN-FAMILY) ("exact p" . SPARSER::PROTEIN)
    ("biomarker" . SPARSER::MOLECULE)
    ("low ERCC1 and high TS" . SPARSER::COLLECTION)
    ("the shortest TTF" . SPARSER::PROTEIN) ("Cohort" . SPARSER::MOLECULE)
    ("adjuvant" . SPARSER::DRUG) ("male" . SPARSER::MOLECULE)
    ("met" . SPARSER::AMINO-ACID)
    ("de novo mCRC as well as a cohort" . SPARSER::COLLECTION)
    ("high TS and/or high ERCC1" . SPARSER::COLLECTION)
    ("actin" . SPARSER::PROTEIN) ("-1" . SPARSER::PROTEIN)
    ("antimetabolite" . SPARSER::DRUG)
    ("the nucleic acid thymine" . SPARSER::MOLECULE)
    ("thymine" . SPARSER::MOLECULE) ("dTMP" . SPARSER::MOLECULE)
    ("deoxythymidine" . SPARSER::MOLECULE)
    ("cetuximab and panitumumab" . SPARSER::COLLECTION)
    ("panitumumab" . SPARSER::DRUG) ("cetuximab" . SPARSER::DRUG)
    ("Thymidylate Synthase (TS) [ xref , xref ] and Excision Repair Cross-Complementation Group"
     . SPARSER::COLLECTION)
    ("Thymidylate Synthase (TS)" . SPARSER::PROTEIN)
    ("Group" . SPARSER::MOLECULE) ("MSI" . SPARSER::PROTEIN)
    ("BRAF [ xref , xref ] and TP53[ xref – xref ]" . SPARSER::COLLECTION)
    ("KRAS[ xref , xref ], BRAF [ xref , xref ] and TP53[ xref – xref ]"
     . SPARSER::COLLECTION)
    ("KRAS" . SPARSER::PROTEIN)
    ("Many potential predictive biomarkers" . SPARSER::MOLECULE)
    ("biomarkers" . SPARSER::MOLECULE) ("FOLFIRI" . SPARSER::DRUG)
    ("RR" . SPARSER::MOLECULE)
    ("either oxaliplatin (FOLFOX) or irinotecan (FOLFIRI)"
     . SPARSER::COLLECTION)
    ("oxaliplatin (FOLFOX)" . SPARSER::DRUG)
    ("EGFR or VEGFR" . SPARSER::COLLECTION) ("VEGFR" . SPARSER::PROTEIN)
    ("irinotecan" . SPARSER::DRUG) ("oxaliplatin" . SPARSER::DRUG)
    ("Fluorouracil" . SPARSER::DRUG) ("metastatic CRC" . SPARSER::PROTEIN)
    ("mCRC" . SPARSER::PROTEIN) ("States" . SPARSER::BIO-STATE)
    ("ERCC1/TS" . SPARSER::COLLECTION) ("TTF" . SPARSER::PROTEIN)
    ("rank" . SPARSER::PROTEIN) ("HR" . SPARSER::PROTEIN)
    ("de novo metastatic colon cancer" . SPARSER::PROTEIN)
    ("ERCC1 and TS" . SPARSER::COLLECTION) ("San" . SPARSER::PROTEIN)
    ("Los" . SPARSER::MOLECULE) ("TS" . SPARSER::PROTEIN)
    ("metastatic colon cancer" . SPARSER::PROTEIN) ("5-FU" . SPARSER::PROTEIN)
    ("Thymidylate Synthase" . SPARSER::PROTEIN) ("RR 1" . SPARSER::PROTEIN)
    ("RR 2" . SPARSER::PROTEIN) ("ERCC1" . SPARSER::PROTEIN)
    ("derivatives" . SPARSER::DERIVATIVE)
    ("BRCA1 and several other genes" . SPARSER::COLLECTION)
    ("nibrin and BRCA1" . SPARSER::COLLECTION)
    ("PARP inhibitors and platinum therapy" . SPARSER::COLLECTION)
    ("inhibitors or inhibitors" . SPARSER::COLLECTION)
    ("TP53 , ATM and CHEK2" . SPARSER::COLLECTION)
    ("fraction" . SPARSER::COMPONENT) ("ATM and CHEK2" . SPARSER::COLLECTION)
    ("Homologous recombination pathway proteins" . SPARSER::PROTEIN)
    ("BRCA1 , BRCA2 and PALB2" . SPARSER::COLLECTION)
    ("anthracyclines" . SPARSER::MOLECULE) ("taxanes" . SPARSER::DRUG)
    ("microtubules" . SPARSER::PROTEIN) ("variant" . SPARSER::VARIANT)
    ("monoallelic PALB2" . SPARSER::PROTEIN)
    ("BRCA2/PALB2" . SPARSER::COLLECTION)
    ("stop" . SPARSER::HUMAN-PROTEIN-FAMILY) ("delC" . SPARSER::PROTEIN)
    ("CHEK2 , NBN , and PALB2" . SPARSER::COLLECTION)
    ("NBN , CHEK2 and ATM" . SPARSER::COLLECTION)
    ("CHEK2 , NBN , ATM and PALB2" . SPARSER::COLLECTION)
    ("luminal" . SPARSER::DRUG) ("pathogenic variants" . SPARSER::VARIANT)
    ("families" . SPARSER::PROTEIN-FAMILY) ("cohort" . SPARSER::MOLECULE)
    ("CHEK2 and NBN" . SPARSER::COLLECTION) ("BRCA1/NBN" . SPARSER::COLLECTION)
    ("BRCA1/CHEK2" . SPARSER::COLLECTION)
    ("BRCA2 , BARD1 , or RAD51D" . SPARSER::COLLECTION)
    ("cohorts" . SPARSER::MOLECULE) ("BRCA1–BARD1" . SPARSER::COLLECTION)
    ("ATM and MRN" . SPARSER::COLLECTION)
    ("MRE11/RAD50/NBN" . SPARSER::COLLECTION) ("nibrin" . SPARSER::PROTEIN)
    ("mediators, transducers and effector" . SPARSER::COLLECTION)
    ("transducers" . SPARSER::PROTEIN)
    ("Functionally competent BRCA1 and BRCA2 genes" . SPARSER::GENE)
    ("BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("commonly used chemotherapeutic drugs" . SPARSER::DRUG)
    ("cytotoxic" . SPARSER::PROTEIN)
    ("anti-estrogen and anti-HER2" . SPARSER::COLLECTION)
    ("the estrogen receptor (ER) or progesterone receptor (PR)"
     . SPARSER::COLLECTION)
    ("estrogen receptor (ER)" . SPARSER::PROTEIN)
    ("PR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CHEK2 , NBN , and ATM" . SPARSER::COLLECTION)
    ("BRCA1 , NBN , and PALB2" . SPARSER::COLLECTION)
    ("the hereditary non-triple-negative group" . SPARSER::MOLECULE)
    ("BRCA1 , BRCA2 , CHEK2 , NBN , ATM , PALB2 , BARD1 , and RAD51D"
     . SPARSER::COLLECTION)
    ("ATM" . SPARSER::PROTEIN) ("NBN" . SPARSER::PROTEIN)
    ("PARP" . SPARSER::PROTEIN) ("platinum" . SPARSER::MOLECULE)
    ("PARP1" . SPARSER::PROTEIN) ("ligase activity" . SPARSER::PROTEIN)
    ("BRCA 1" . SPARSER::PROTEIN) ("RAD50" . SPARSER::PROTEIN)
    ("MRE11" . SPARSER::PROTEIN) ("HER2" . SPARSER::PROTEIN)
    ("HER-2" . SPARSER::PROTEIN) ("progesterone receptor" . SPARSER::PROTEIN)
    ("RAD51D" . SPARSER::PROTEIN) ("BARD1" . SPARSER::PROTEIN)
    ("PALB2" . SPARSER::PROTEIN) ("CHEK2" . SPARSER::PROTEIN)
    ("BRCA2" . SPARSER::PROTEIN) ("BRCA1" . SPARSER::PROTEIN)
    ("ADP-ribose" . SPARSER::MOLECULE)
    ("protein-protein" . SPARSER::COLLECTION)
    ("MKRN1 and hTERT" . SPARSER::COLLECTION)
    ("phospholipid" . SPARSER::PHOSPHOLIPID)
    ("systemic SK2" . SPARSER::PROTEIN) ("cellular S1P" . SPARSER::PROTEIN)
    ("TRF" . SPARSER::PROTEIN) ("fragment" . SPARSER::FRAGMENT)
    ("phosphorylated histone H2AX (γ-H2AX) and telomeric repeat-binding factor 2 (TRF2)"
     . SPARSER::COLLECTION)
    ("TIF" . SPARSER::PROTEIN) ("foci" . SPARSER::PROTEIN)
    ("histone" . SPARSER::PROTEIN)
    ("the phosphomimetic mutant" . SPARSER::MUTANT)
    ("S1P binding-defective hTERT D684A-S921D -FLAG" . SPARSER::COLLECTION)
    ("phosphorylatable" . SPARSER::PROTEIN) ("NHLF" . SPARSER::PROTEIN)
    ("geldanamycin" . SPARSER::DRUG) ("hTERT-MKRN1" . SPARSER::COLLECTION)
    ("MKRN1-hTERT" . SPARSER::COLLECTION)
    ("S1P nor C3-O-CH3-S1P" . SPARSER::COLLECTION)
    ("hTERT and MKRN1" . SPARSER::COLLECTION)
    ("V5-tagged MKRN1" . SPARSER::PROTEIN) ("Ser" . SPARSER::AMINO-ACID)
    ("His" . SPARSER::AMINO-ACID) ("Phe" . SPARSER::AMINO-ACID)
    ("Gly" . SPARSER::AMINO-ACID)
    ("cycloheximide and MG132" . SPARSER::COLLECTION)
    ("exogenous hTERT WT -FLAG" . SPARSER::COLLECTION)
    ("HA-ubiquitin" . SPARSER::COLLECTION) ("exogenous S1P" . SPARSER::PROTEIN)
    ("lactacystin" . SPARSER::DRUG)
    ("SK2 and its product S1P" . SPARSER::COLLECTION)
    ("hTERT-S1P" . SPARSER::COLLECTION) ("S1P or hTERT" . SPARSER::COLLECTION)
    ("S1P and other nuclear proteins" . SPARSER::COLLECTION)
    ("histone deacetylase 3 (HDAC3) or SET [Su(var), Enhancer-of-zeste, Trithorax domain containing oncoprotein]"
     . SPARSER::COLLECTION)
    ("SET" . SPARSER::PROTEIN) ("S1P-hTERT" . SPARSER::COLLECTION)
    ("DAPI" . SPARSER::DRUG) ("S1P ( xref ) and hTERT" . SPARSER::COLLECTION)
    ("antibodies" . SPARSER::ANTIBODY) ("PLA" . SPARSER::PROTEIN)
    ("S1P-TERT" . SPARSER::COLLECTION)
    ("D684A -FLAG in A549 cells" . SPARSER::PROTEIN-FAMILY)
    ("S1P and hTERT" . SPARSER::COLLECTION)
    ("S1P and tcTERT" . SPARSER::COLLECTION)
    ("S1P or LPA" . SPARSER::COLLECTION) ("POPC" . SPARSER::PROTEIN)
    ("phosphatidylethanolamine" . SPARSER::MOLECULE)
    ("phosphatidylcholine" . SPARSER::MOLECULE) ("PC" . SPARSER::PROTEIN)
    ("phospholipids" . SPARSER::PHOSPHOLIPID)
    ("S1P- or lysophosphatidic acid (LPA)" . SPARSER::COLLECTION)
    ("S1P and TERT" . SPARSER::COLLECTION)
    ("S1P- or lysophosphatidic acid" . SPARSER::COLLECTION)
    ("S1P-" . SPARSER::PROTEIN) ("LPA" . SPARSER::LPA)
    ("SPR" . SPARSER::PROTEIN)
    ("D684A -FLAG in GM00847 fibroblasts" . SPARSER::PROTEIN-FAMILY)
    ("TRAP" . SPARSER::PROTEIN) ("polymerase" . SPARSER::PROTEIN)
    ("biotinylated-S1P and hTERT" . SPARSER::COLLECTION)
    ("hTERT and biotinylated-S1P" . SPARSER::COLLECTION)
    ("Biotinylated-S1P-bound proteins" . SPARSER::PROTEIN)
    ("SDS" . SPARSER::PROTEIN) ("agarose" . SPARSER::MOLECULE)
    ("avidin" . SPARSER::PROTEIN) ("-S1P" . SPARSER::COLLECTION)
    ("hTERT and S1P" . SPARSER::COLLECTION) ("-TERT" . SPARSER::COLLECTION)
    ("TERT" . SPARSER::PROTEIN) ("ray" . SPARSER::PROTEIN)
    ("-FLAG" . SPARSER::COLLECTION) ("Lipid" . SPARSER::LIPID)
    ("Calnexin and lamin B" . SPARSER::COLLECTION)
    ("Calnexin" . SPARSER::PROTEIN)
    ("V5-tagged wild-type SK2" . SPARSER::PROTEIN)
    ("hTERT-FLAG" . SPARSER::COLLECTION) ("MEFs" . SPARSER::PROTEIN)
    ("Flag" . SPARSER::PROTEIN-FAMILY) ("CHX" . SPARSER::PROTEIN)
    ("SK1 or SK2" . SPARSER::COLLECTION) ("oxidase" . SPARSER::PROTEIN)
    ("HDAC1 and HDAC2" . SPARSER::COLLECTION) ("NFkB" . SPARSER::PROTEIN)
    ("cytoplasmic sphingosine kinase 1 (SK1) or nuclear SK2 ( xref , xref )"
     . SPARSER::COLLECTION)
    ("Ceramide" . SPARSER::MOLECULE)
    ("ceramide and sphingosine 1 phosphate (S1P)" . SPARSER::COLLECTION)
    ("The bioactive sphingolipids" . SPARSER::MOLECULE)
    ("ceramide" . SPARSER::MOLECULE) ("sphingolipids" . SPARSER::MOLECULE)
    ("SUMO" . SPARSER::PROTEIN) ("filament" . SPARSER::PROTEIN-FAMILY)
    ("Lamins" . SPARSER::PROTEIN) ("TR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Asp" . SPARSER::AMINO-ACID) ("group" . SPARSER::MOLECULE)
    ("lysophospholipid" . SPARSER::MOLECULE) ("hTERT" . SPARSER::PROTEIN)
    ("beta galactosidase" . SPARSER::PROTEIN)
    ("triton X-100" . SPARSER::MOLECULE) ("NP-40" . SPARSER::DRUG)
    ("O14746" . SPARSER::PROTEIN) ("full-length" . SPARSER::PROTEIN)
    ("β-mercaptoethanol" . SPARSER::MOLECULE) ("MgCl 2" . SPARSER::MOLECULE)
    ("protein A" . SPARSER::PROTEIN) ("M2" . SPARSER::MOLECULE)
    ("pMD2" . SPARSER::MOLECULE)
    ("PHD and RING finger domains 1" . SPARSER::PROTEIN)
    ("UHRF1" . SPARSER::PROTEIN) ("PI5" . SPARSER::PROTEIN)
    ("Atg8" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TRF2" . SPARSER::PROTEIN)
    ("telomeric repeat-binding factor 2" . SPARSER::PROTEIN)
    ("γ-H2AX" . SPARSER::PROTEIN) ("H2AX" . SPARSER::PROTEIN)
    ("β-galactosidase" . SPARSER::PROTEIN)
    ("siRNA-mediated" . SPARSER::PROTEIN) ("MG132" . SPARSER::PROTEIN)
    ("HDAC3" . SPARSER::PROTEIN) ("histone deacetylase 3" . SPARSER::PROTEIN)
    ("lysophosphatidic acid" . SPARSER::LPA) ("CH3" . SPARSER::MOLECULE)
    ("isoform 2" . SPARSER::PROTEIN) ("lamin B" . SPARSER::PROTEIN-FAMILY)
    ("sphingosine-1-phosphate" . SPARSER::DRUG)
    ("prohibitin-2" . SPARSER::PROTEIN) ("HDAC2" . SPARSER::PROTEIN)
    ("TNF receptor-associated factor 2" . SPARSER::PROTEIN)
    ("TRAF2" . SPARSER::PROTEIN) ("SK1" . SPARSER::PROTEIN)
    ("sphingosine kinase 1" . SPARSER::PROTEIN) ("Sp1" . SPARSER::PROTEIN)
    ("Sp3" . SPARSER::PROTEIN) ("HDAC1" . SPARSER::PROTEIN)
    ("histone deacetylase 1" . SPARSER::PROTEIN) ("PP2A" . SPARSER::PROTEIN)
    ("protein phosphatase 2" . SPARSER::PROTEIN)
    ("lamin B1" . SPARSER::PROTEIN) ("DNA polymerase" . SPARSER::PROTEIN)
    ("MKRN1" . SPARSER::PROTEIN) ("SK2" . SPARSER::PROTEIN)
    ("sphingosine kinase 2" . SPARSER::PROTEIN) ("S1P" . SPARSER::PROTEIN)
    ("sphingosine 1-phosphate" . SPARSER::DRUG)
    ("telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("catalytic subunit" . SPARSER::PROTEIN)
    ("telomerase activity" . SPARSER::PROTEIN)
    ("a common pathogenic gene" . SPARSER::GENE)
    ("variants" . SPARSER::VARIANT) ("gonadotropin" . SPARSER::PROTEIN)
    ("POI and any risk alleles, genotypes or haplotypes" . SPARSER::COLLECTION)
    ("alleles, genotypes or haplotypes" . SPARSER::COLLECTION)
    ("alleles" . SPARSER::ALLELE) ("p  " . SPARSER::PROTEIN)
    ("human ovarian cortical fragments" . SPARSER::FRAGMENT)
    ("fragments" . SPARSER::FRAGMENT) ("FSH and LH" . SPARSER::COLLECTION)
    ("FSH" . SPARSER::DRUG) ("Pten" . SPARSER::PROTEIN)
    ("molecules" . SPARSER::MOLECULE) ("state and wait" . SPARSER::COLLECTION)
    ("partial" . SPARSER::PROTEIN) ("gonadotropins" . SPARSER::PROTEIN)
    ("PTEN and POI" . SPARSER::COLLECTION) ("allele" . SPARSER::ALLELE)
    ("seven" . SPARSER::PROTEIN) ("matrix" . SPARSER::PROTEIN-FAMILY)
    ("Han" . SPARSER::PROTEIN) ("nucleotide" . SPARSER::NUCLEOTIDE)
    ("PTEN (the phosphatase and tensin homolog located on chromosome ten in humans) and POI (primary ovarian insufficiency)"
     . SPARSER::COLLECTION)
    ("POI" . SPARSER::PROTEIN) ("Ribosomal protein S6" . SPARSER::PROTEIN)
    ("T-T" . SPARSER::PROTEIN) ("etc." . SPARSER::PROTEIN)
    ("phosphoinositide-3 kinase" . SPARSER::PROTEIN)
    ("Wnt5a" . SPARSER::PROTEIN) ("E2F2 and CREB" . SPARSER::COLLECTION)
    ("CREB" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p53-MDM2" . SPARSER::COLLECTION)
    ("potential therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("genes and 192" . SPARSER::COLLECTION)
    ("E2F transcription factor 2 (E2F2) and homeobox A1 (HOXA1)"
     . SPARSER::COLLECTION)
    ("GO" . SPARSER::PROTEIN) ("map" . SPARSER::PROTEIN)
    ("Differentially" . SPARSER::PROTEIN)
    ("p53 and its target genes" . SPARSER::COLLECTION)
    ("FC" . SPARSER::PROTEIN) ("activator" . SPARSER::ACTIVATOR)
    ("the most common histological form" . SPARSER::FORM)
    ("cis" . SPARSER::PROTEIN) ("E2F2 and HOXA1" . SPARSER::COLLECTION)
    ("cytokine-cytokine" . SPARSER::COLLECTION) ("cytokine" . SPARSER::PROTEIN)
    ("373 upregulated genes and 192 downregulated genes" . SPARSER::COLLECTION)
    ("Genes and Genomes" . SPARSER::COLLECTION)
    ("differentially" . SPARSER::PROTEIN) ("Wnt5" . SPARSER::PROTEIN)
    ("member 5" . SPARSER::PROTEIN)
    ("wingless-type MMTV integration site family" . SPARSER::PROTEIN)
    ("MAP kinase" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p44" . SPARSER::PROTEIN)
    ("CDKN1B" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinase inhibitor 1B" . SPARSER::PROTEIN)
    ("E2F" . SPARSER::PROTEIN-FAMILY) ("FGF1" . SPARSER::PROTEIN)
    ("Fibroblast growth factor 1" . SPARSER::PROTEIN)
    ("STX6" . SPARSER::PROTEIN) ("Syntaxin 6" . SPARSER::PROTEIN)
    ("MDM2 proto-oncogene" . SPARSER::PROTEIN)
    ("homeobox A1" . SPARSER::PROTEIN)
    ("E2F transcription factor 2" . SPARSER::PROTEIN)
    ("Tumor protein p53" . SPARSER::PROTEIN) ("HOXA1" . SPARSER::PROTEIN)
    ("E2F2" . SPARSER::PROTEIN) ("tumor suppressor p53" . SPARSER::PROTEIN)
    ("PTPH1 and EGFR" . SPARSER::COLLECTION) ("EGFR/Y1173" . SPARSER::PROTEIN)
    ("p-EGFR/Y1173" . SPARSER::COLLECTION) ("p" . SPARSER::PROTEIN)
    ("Arg" . SPARSER::AMINO-ACID) ("p-ERKs" . SPARSER::PROTEIN-PAIR)
    ("ERKs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PTPs" . SPARSER::PROTEIN)
    ("-2 dual inhibitor Lap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TKIs and/or anti-estrogens" . SPARSER::COLLECTION)
    ("TKIs and anti-estrogens" . SPARSER::COLLECTION)
    ("the nuclear-localization-defective ER/T311A mutant" . SPARSER::MUTANT)
    ("forms" . SPARSER::FORM)
    ("the membranous EGFR and the nuclear ER" . SPARSER::COLLECTION)
    ("both the membranous EGFR" . SPARSER::PROTEIN)
    ("Lap or Gef" . SPARSER::COLLECTION)
    ("the membranous EGFR" . SPARSER::PROTEIN)
    ("PTPH1 and its phosphatase-inactive PTPH1/S459A mutant"
     . SPARSER::COLLECTION)
    ("cycloheximide" . SPARSER::PROTEIN) ("inactive" . SPARSER::INACTIVE)
    ("EGFR and EGFR/Y1173F" . SPARSER::COLLECTION)
    ("EGFR and its Y1173F mutant" . SPARSER::COLLECTION)
    ("PTPH1 and/or ER" . SPARSER::COLLECTION)
    ("their respective wild-type (WT) proteins" . SPARSER::PROTEIN)
    ("GFP" . SPARSER::PROTEIN) ("ER and ER/T311A" . SPARSER::COLLECTION)
    ("Myc-EGFR" . SPARSER::COLLECTION) ("Myc" . SPARSER::PROTEIN)
    ("Ala" . SPARSER::AMINO-ACID) ("Thr" . SPARSER::AMINO-ACID)
    ("ER and its mutant ER/T311A" . SPARSER::COLLECTION)
    ("ER/T311A" . SPARSER::PROTEIN)
    ("extra-nuclear ER proteins" . SPARSER::PROTEIN)
    ("A nuclear-localization defective ER" . SPARSER::PROTEIN)
    ("phosphatases" . SPARSER::PHOSPHATASE)
    ("complexes" . SPARSER::BIO-COMPLEX) ("ant-ER" . SPARSER::COLLECTION)
    ("ant" . SPARSER::HUMAN-PROTEIN-FAMILY) ("EGFR/ER" . SPARSER::COLLECTION)
    ("Gef" . SPARSER::PROTEIN) ("gefitinib" . SPARSER::DRUG)
    ("AAG" . SPARSER::PROTEIN) ("-2 dual inhibitor" . SPARSER::INHIBITOR)
    ("Lap" . SPARSER::HUMAN-PROTEIN-FAMILY) ("lapatinib" . SPARSER::DRUG)
    ("antibiotic" . SPARSER::DRUG) ("Tet" . SPARSER::PROTEIN)
    ("tetracycline" . SPARSER::DRUG) ("mutants" . SPARSER::MUTANT)
    ("DA" . SPARSER::MOLECULE) ("Tyrosine" . SPARSER::AMINO-ACID)
    ("VDR" . SPARSER::PROTEIN) ("MAPK" . SPARSER::PROTEIN)
    ("PTP" . SPARSER::PROTEIN) ("ER-EGFR" . SPARSER::COLLECTION)
    ("hormone" . SPARSER::MOLECULE) ("tamoxifen (TAM)" . SPARSER::DRUG)
    ("TAM" . SPARSER::PROTEIN) ("tamoxifen" . SPARSER::DRUG)
    ("estrogens" . SPARSER::MOLECULE) ("ERα or ER" . SPARSER::COLLECTION)
    ("inhibitor (TKI)" . SPARSER::INHIBITOR) ("ATP" . SPARSER::ATP)
    ("antibody" . SPARSER::ANTIBODY) ("Ras/MAPKs" . SPARSER::COLLECTION)
    ("MAPKs" . SPARSER::PROTEIN) ("EGF" . SPARSER::PROTEIN)
    ("ligand" . SPARSER::LIGAND)
    ("epidermal growth factor receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("therapeutics" . SPARSER::THERAPEUTICS)
    ("EGFR and ER" . SPARSER::COLLECTION) ("EGFR-ER" . SPARSER::COLLECTION)
    ("enzyme" . SPARSER::ENZYME) ("substrates" . SPARSER::SUBSTRATE)
    ("a nuclear-localization defective ER" . SPARSER::PROTEIN)
    ("TKI" . SPARSER::PROTEIN) ("TKIs" . SPARSER::PROTEIN)
    ("receptor" . SPARSER::RECEPTOR) ("ER" . SPARSER::PROTEIN)
    ("EGFR" . SPARSER::PROTEIN) ("tyrosine" . SPARSER::AMINO-ACID)
    ("Protein-protein" . SPARSER::COLLECTION) ("Protein" . SPARSER::PROTEIN)
    ("NP40" . SPARSER::MOLECULE) ("Triton X-100" . SPARSER::MOLECULE)
    ("Nonidet P-40" . SPARSER::DRUG) ("G418" . SPARSER::MOLECULE)
    ("E2" . SPARSER::MOLECULE) ("α-Tubulin" . SPARSER::PROTEIN)
    ("c-Jun" . SPARSER::PROTEIN) ("Lamin B" . SPARSER::PROTEIN-FAMILY)
    ("anti-β" . SPARSER::PROTEIN) ("α-Actinin" . SPARSER::PROTEIN)
    ("Anti-" . SPARSER::ANTIBODY) ("PTPN2" . SPARSER::PROTEIN)
    ("PTPN6" . SPARSER::PROTEIN) ("SHP-1" . SPARSER::PROTEIN)
    ("heat shock protein 90" . SPARSER::PROTEIN) ("-2" . SPARSER::PROTEIN)
    ("vitamin D" . SPARSER::MOLECULE) ("p38γ" . SPARSER::PROTEIN)
    ("colon cancer" . SPARSER::PROTEIN) ("PTPN3" . SPARSER::PROTEIN)
    ("Protein-tyrosine phosphatase H1" . SPARSER::PROTEIN)
    ("anti-estrogens" . SPARSER::DRUG) ("ERα" . SPARSER::PROTEIN)
    ("Estrogen receptor" . SPARSER::PROTEIN)
    ("protein tyrosine phosphatase" . SPARSER::PROTEIN)
    ("anti-EGFR" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("anti-estrogen" . SPARSER::DRUG) ("tyrosine kinase" . SPARSER::PROTEIN)
    ("PTPH1" . SPARSER::PROTEIN)
    ("Protein tyrosine phosphatase" . SPARSER::PROTEIN)
    ("estrogen receptor" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("effector" . SPARSER::EFFECTOR) ("Dasatinib" . SPARSER::DRUG)
    ("dasatinib" . SPARSER::DRUG) ("BRAF" . SPARSER::PROTEIN)
    ("RTK" . SPARSER::PROTEIN) ("RAS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Wang" . SPARSER::PROTEIN)
    ("growth factors and cytokines" . SPARSER::COLLECTION)
    ("variety" . SPARSER::VARIETY) ("substrate" . SPARSER::SUBSTRATE)
    ("cytokines" . SPARSER::PROTEIN) ("CRK" . SPARSER::PROTEIN)
    ("forkhead" . SPARSER::PROTEIN) ("mediators" . SPARSER::PROTEIN)
    ("around two miR-200 family" . SPARSER::PROTEIN-FAMILY)
    ("mRNAs" . SPARSER::PROTEIN) ("HDAC" . SPARSER::PROTEIN)
    ("Survivin and hepatoma-derived growth factor (HDGF)"
     . SPARSER::COLLECTION)
    ("Survivin and hepatoma-derived growth factor" . SPARSER::COLLECTION)
    ("HDGF" . SPARSER::PROTEIN) ("Survivin" . SPARSER::PROTEIN)
    ("Gene" . SPARSER::GENE) ("Matrigel" . SPARSER::PROTEIN)
    ("CRKL and ZEB1" . SPARSER::COLLECTION) ("EMT" . SPARSER::PROTEIN)
    ("MTT" . SPARSER::MOLECULE)
    ("adriamycin or Nutlin-3" . SPARSER::COLLECTION) ("HOS" . SPARSER::PROTEIN)
    ("adriamycin" . SPARSER::DRUG)
    ("p53, TAp73 and TAp63" . SPARSER::COLLECTION)
    ("p53 or TAp63γ" . SPARSER::COLLECTION)
    ("p53, TAp73β and TAp63γ" . SPARSER::COLLECTION)
    ("TAp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protein and mRNA" . SPARSER::COLLECTION)
    ("miR-200c or miR-429" . SPARSER::COLLECTION)
    ("CRKL-mut" . SPARSER::COLLECTION) ("pMIR-CRKL-3" . SPARSER::COLLECTION)
    ("miRNA–mRNA" . SPARSER::COLLECTION)
    ("miR-200a or miR-141 mimics" . SPARSER::COLLECTION)
    ("mismatch" . SPARSER::PROTEIN)
    ("miR-200c or miR-429 mimics downregulated CRKL protein levels (Fig. xref )"
     . SPARSER::COLLECTION)
    ("oligonucleotides" . SPARSER::MOLECULE) ("mut" . SPARSER::PROTEIN)
    ("FLAG" . SPARSER::PROTEIN-FAMILY)
    ("an oncogene and tumor suppressive miRNAs" . SPARSER::PROTEIN)
    ("oncogene and tumor" . SPARSER::COLLECTION)
    ("the actionable CRKL oncogene" . SPARSER::ONCOGENE)
    ("CDK4, cyclin E2 and BCL2" . SPARSER::COLLECTION)
    ("CDC7, LMNB2, MAD2L1 and CUL5" . SPARSER::COLLECTION)
    ("components" . SPARSER::COMPONENT) ("oncoprotein" . SPARSER::PROTEIN)
    ("DHFR" . SPARSER::PROTEIN)
    ("a sequence-specific transcription factor" . SPARSER::PROTEIN)
    ("Several tumor suppressive miRNAs" . SPARSER::PROTEIN)
    ("siRNA" . SPARSER::PROTEIN) ("mRNA and protein" . SPARSER::COLLECTION)
    ("CRKL" . SPARSER::PROTEIN) ("miRNA" . SPARSER::PROTEIN)
    ("miR" . SPARSER::PROTEIN)
    ("tumor suppressive miRNAs and their target oncogenes"
     . SPARSER::COLLECTION)
    ("tumor suppressive miRNAs" . SPARSER::PROTEIN)
    ("Tumor suppressive miRNAs" . SPARSER::PROTEIN)
    ("miRNAs" . SPARSER::PROTEIN) ("RAS family" . SPARSER::PROTEIN)
    ("receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("miR-126" . SPARSER::PROTEIN) ("BCR-ABL" . SPARSER::PROTEIN)
    ("growth factors" . SPARSER::GROWTH-FACTOR)
    ("p53 " . SPARSER::HUMAN-PROTEIN-FAMILY) ("CDH1" . SPARSER::PROTEIN)
    ("FOXF1" . SPARSER::PROTEIN)
    ("hepatoma-derived growth factor" . SPARSER::PROTEIN)
    ("Nutlin-3" . SPARSER::DRUG) ("TAp63" . SPARSER::PROTEIN)
    ("U87MG" . SPARSER::PROTEIN) ("A 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("transcriptional regulator" . SPARSER::PROTEIN-FAMILY)
    ("p13" . SPARSER::PROTEIN) ("miR-200a" . SPARSER::MOLECULE)
    ("p36" . SPARSER::PROTEIN) ("Dual-Luciferase" . SPARSER::PROTEIN)
    ("-3" . SPARSER::PROTEIN) ("X-gal" . SPARSER::MOLECULE)
    ("p63" . SPARSER::PROTEIN) ("p73" . SPARSER::PROTEIN)
    ("Ad-p53" . SPARSER::DRUG) ("adaptor protein" . SPARSER::PROTEIN)
    ("E-cadherin" . SPARSER::PROTEIN) ("ZEB1" . SPARSER::PROTEIN)
    ("c-Myc" . SPARSER::PROTEIN) ("CUL5" . SPARSER::PROTEIN)
    ("MAD2L1" . SPARSER::PROTEIN) ("LMNB2" . SPARSER::PROTEIN)
    ("CDC7" . SPARSER::PROTEIN) ("BCL2" . SPARSER::PROTEIN)
    ("cyclin E2" . SPARSER::PROTEIN) ("CDK4" . SPARSER::PROTEIN)
    ("negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("TP53" . SPARSER::PROTEIN) ("p53 family" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("miR-200c" . SPARSER::MOLECULE) ("drug" . SPARSER::DRUG)
    ("AFP-PTEN" . SPARSER::COLLECTION) ("form" . SPARSER::FORM)
    ("salt" . SPARSER::MOLECULE) ("active" . SPARSER::ACTIVE)
    ("AFP/PTEN" . SPARSER::COLLECTION) ("phosphatase" . SPARSER::PHOSPHATASE)
    ("HSA/FcRn" . SPARSER::COLLECTION) ("complex" . SPARSER::BIO-COMPLEX)
    ("FcRn" . SPARSER::PROTEIN) ("conformation" . SPARSER::BIO-CONFORMATION)
    ("Cys" . SPARSER::AMINO-ACID) ("disulfide" . SPARSER::MOLECULE)
    ("fits" . SPARSER::PROTEIN-FAMILY) ("ID" . SPARSER::PROTEIN)
    ("II" . SPARSER::PROTEIN)
    ("alpha-fetoprotein (AFP) and human serum albumin (HSA)"
     . SPARSER::COLLECTION)
    ("bank (PDB)" . SPARSER::PROTEIN) ("PDB" . SPARSER::MOLECULE)
    ("bank" . SPARSER::PROTEIN) ("CXCR4 and Src" . SPARSER::COLLECTION)
    ("PI3K/AKT" . SPARSER::COLLECTION) ("Src" . SPARSER::PROTEIN)
    ("HSA and PTEN" . SPARSER::COLLECTION) ("/AKT" . SPARSER::COLLECTION)
    ("PIP3 and the activation of AKT" . SPARSER::COLLECTION)
    ("molecule" . SPARSER::MOLECULE) ("kinase" . SPARSER::KINASE)
    ("effectors" . SPARSER::EFFECTOR) ("lipid" . SPARSER::LIPID)
    ("PI" . SPARSER::PROTEIN) ("suppressor" . SPARSER::SUPPRESSOR)
    ("albumin and other proteins" . SPARSER::COLLECTION)
    ("PI3K/AFT" . SPARSER::COLLECTION) ("AFT" . SPARSER::PROTEIN)
    ("type" . TYPE) ("metabolites, and drugs" . SPARSER::COLLECTION)
    ("metabolites" . SPARSER::PROTEIN) ("albumin" . SPARSER::PROTEIN)
    ("carbohydrate" . SPARSER::MOLECULE) ("peptide" . SPARSER::PEPTIDE)
    ("kDa" . SPARSER::PROTEIN) ("an oncofetal protein" . SPARSER::PROTEIN)
    ("HCC" . SPARSER::PROTEIN) ("drugs and vaccines" . SPARSER::COLLECTION)
    ("drugs" . SPARSER::DRUG) ("targets" . SPARSER::TARGET-PROTEIN)
    ("AFP and PTEN" . SPARSER::COLLECTION) ("PTEN" . SPARSER::PROTEIN)
    ("AFP and HSA" . SPARSER::COLLECTION)
    ("/protein kinase B" . SPARSER::COLLECTION)
    ("AKT" . SPARSER::HUMAN-PROTEIN-FAMILY) ("regulator" . SPARSER::REGULATOR)
    ("serum albumin (HSA)" . SPARSER::PROTEIN) ("HSA" . SPARSER::PROTEIN)
    ("homology" . SPARSER::PROTEIN)
    ("alpha-fetoprotein (AFP)" . SPARSER::PROTEIN)
    ("family" . SPARSER::PROTEIN-FAMILY) ("AFP" . SPARSER::PROTEIN)
    ("1D" . SPARSER::PROTEIN) ("SP2" . SPARSER::PROTEIN)
    ("monoclonal antibody" . SPARSER::DRUG) ("CO 2" . SPARSER::PROTEIN)
    ("P13" . SPARSER::PROTEIN) ("Y14" . SPARSER::PROTEIN)
    ("two domains" . SPARSER::PROTEIN) ("a 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("three domains" . SPARSER::PROTEIN) ("protein can" . SPARSER::PROTEIN)
    ("CXCR4" . SPARSER::PROTEIN) ("Akt/PKB" . SPARSER::PROTEIN)
    ("phosphoinositide 3-kinase" . SPARSER::PROTEIN)
    ("P3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PIP3" . SPARSER::PIP3)
    ("phosphatidylinositol-3" . SPARSER::PROTEIN)
    ("phosphatidylinositol-4,5-bisphosphate 3-kinase"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("alpha-" . SPARSER::PROTEIN) ("amino acid" . SPARSER::AMINO-ACID)
    ("growth factor" . SPARSER::GROWTH-FACTOR)
    ("phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("protein kinase B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    (NIL . SPARSER::PROTEIN) ("PI3K" . SPARSER::PROTEIN-FAMILY)
    ("phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("serum albumin" . SPARSER::PROTEIN)
    ("alpha-fetoprotein" . SPARSER::PROTEIN) ("CRC" . SPARSER::PROTEIN)
    ("ROS-NQO1-p53" . SPARSER::COLLECTION) ("oncogenes" . SPARSER::ONCOGENE)
    ("the transcription factor NRF2 and its repressor protein KEAP1"
     . SPARSER::COLLECTION)
    ("ROS" . SPARSER::PROTEIN) ("oxygen" . SPARSER::MOLECULE)
    ("proteasomes" . SPARSER::PROTEIN) ("ligase" . SPARSER::LIGASE)
    ("component" . SPARSER::COMPONENT)
    ("Ras G12V and shNQO1#1 or Cont" . SPARSER::COLLECTION)
    ("directly target NRF2" . SPARSER::PROTEIN)
    ("sh-NRF2" . SPARSER::COLLECTION) ("NRF2 and NQO1" . SPARSER::COLLECTION)
    ("chromatin" . SPARSER::BIO-COMPLEX) ("repressor" . SPARSER::REPRESSOR)
    ("luciferase" . SPARSER::PROTEIN) ("the gene's" . SPARSER::GENE)
    ("promoter" . SPARSER::PROMOTER)
    ("ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("antioxidant" . SPARSER::PROTEIN) ("gene" . SPARSER::GENE)
    ("sh-p53/Ras" . SPARSER::COLLECTION) ("sh-p53" . SPARSER::COLLECTION)
    ("sh" . SPARSER::PROTEIN-FAMILY)
    ("curcumin and dicoumarol" . SPARSER::COLLECTION)
    ("inhibitors" . SPARSER::INHIBITOR) ("dicoumarol" . SPARSER::DRUG)
    ("curcumin" . SPARSER::DRUG) ("NQO1-p53" . SPARSER::COLLECTION)
    ("target" . SPARSER::TARGET-PROTEIN) ("inhibitor" . SPARSER::INHIBITOR)
    ("genes" . SPARSER::GENE) ("Cont" . SPARSER::PROTEIN)
    ("shRNAs" . SPARSER::RNA) ("mRNA" . SPARSER::PROTEIN)
    ("stably knock-down NQO1" . SPARSER::PROTEIN) ("shRNA" . SPARSER::PROTEIN)
    ("RNA" . SPARSER::RNA) ("types" . TYPE) ("Western blot" . SPARSER::PROTEIN)
    ("protein" . SPARSER::PROTEIN) ("p53, p21 and p16" . SPARSER::COLLECTION)
    ("blot" . SPARSER::PROTEIN) ("BS" . SPARSER::PROTEIN)
    ("first performed senescence-associated beta-galactosidase"
     . SPARSER::PROTEIN)
    ("BrdU" . SPARSER::DRUG) ("Ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mutant" . SPARSER::MUTANT) ("light" . SPARSER::PROTEIN)
    ("kappa" . SPARSER::PROTEIN-FAMILY) ("proteins" . SPARSER::PROTEIN)
    ("proteasomal" . SPARSER::PROTEIN) ("regulators" . SPARSER::REGULATOR)
    ("DNA-damage" . SPARSER::DNA) ("p16/pRB" . SPARSER::COLLECTION)
    ("Arf/p53/p21" . SPARSER::COLLECTION) ("DDR" . SPARSER::PROTEIN)
    ("pRB" . SPARSER::PROTEIN) ("Arf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("trigger" . SPARSER::PROTEIN) ("Genes" . SPARSER::GENE)
    ("DNA" . SPARSER::DNA) ("part" . SPARSER::COMPONENT)
    ("NRF2/KEAP1" . SPARSER::COLLECTION)
    ("MDM2 and ubiquitin" . SPARSER::COLLECTION)
    ("ubiquitin" . SPARSER::PROTEIN) ("oncogene" . SPARSER::ONCOGENE)
    ("electron" . SPARSER::MOLECULE) ("barrier" . SPARSER::PROTEIN)
    ("state" . SPARSER::BIO-STATE) ("Ha-Ras" . SPARSER::PROTEIN)
    ("ubiquitin ligase" . SPARSER::PROTEIN) ("E3" . SPARSER::MOLECULE)
    ("protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("response element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("nuclear factor (erythroid-derived 2)" . SPARSER::PROTEIN)
    ("transcription factor" . SPARSER::PROTEIN) ("B-E" . SPARSER::PROTEIN)
    ("p16 protein" . SPARSER::PROTEIN) ("p21 protein" . SPARSER::PROTEIN)
    ("beta-galactosidase" . SPARSER::PROTEIN) ("c-MAF" . SPARSER::PROTEIN)
    ("β-actin" . SPARSER::PROTEIN) ("pGL3" . SPARSER::PROTEIN)
    ("β-gal" . SPARSER::PROTEIN) ("p300" . SPARSER::PROTEIN)
    ("NF-κB" . SPARSER::PROTEIN) ("p16" . SPARSER::PROTEIN)
    ("p21" . SPARSER::PROTEIN) ("anti-" . SPARSER::ANTIBODY)
    ("KEAP1" . SPARSER::PROTEIN) ("NRF2" . SPARSER::PROTEIN)
    ("MDM2" . SPARSER::PROTEIN) ("p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cytoplasmic 2" . SPARSER::PROTEIN) ("NQO1" . SPARSER::PROTEIN)
    ("quinone oxidoreductase" . SPARSER::PROTEIN)
    ("NAD(P)H" . SPARSER::MOLECULE)))